data_2lu7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lu7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.556 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.675 0.274 . . . . 74.019999999999996 110.795 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.8 m -73.41 95.16 2.17 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 124.297 1.039 . . . . 73.519999999999996 110.093 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.451 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -83.87 136.27 34.18 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.889 0.876 . . . . 72.239999999999995 111.668 -166.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.6 143.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.923 0.889 . . . . 75.540000000000006 110.344 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -121.71 138.54 54.31 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.298 1.039 . . . . 74.319999999999993 110.377 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t -137.34 178.08 7.37 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.464 0.706 . . . . 71.019999999999996 110.45 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 81' ' ' GLU . 4.2 p -124.99 147.71 57.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 124.016 0.926 . . . . 62.549999999999997 111.655 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -69.85 87.61 0.56 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.486 2.791 . . . . 74.040000000000006 113.402 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.22 -27.11 2.0 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.337 -0.847 . . . . 64.340000000000003 112.431 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.71 17.01 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.102 0.401 . . . . 74.540000000000006 114.102 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.47 158.25 16.35 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.382 0.673 . . . . 72.519999999999996 110.874 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 54.7 tp -119.24 108.25 14.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.337 0.655 . . . . 74.420000000000002 110.064 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.34 114.85 23.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.161 0.584 . . . . 74.329999999999998 110.242 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 15.2 mt -103.62 103.29 13.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.815 -0.809 . . . . 75.030000000000001 108.815 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.455 HG23 HG22 ' A' ' 50' ' ' VAL . 67.3 t -105.56 122.1 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.14 -0.689 . . . . 74.319999999999993 109.14 175.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -100.78 148.27 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.742 0.417 . . . . 51.210000000000001 110.717 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 67.4 m80 -128.25 51.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.187 0.994 . . . . 73.25 109.827 166.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.22 170.26 14.43 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.228 -1.351 . . . . 72.409999999999997 112.961 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.7 m -90.7 23.89 2.91 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.565 1.146 . . . . 75.530000000000001 112.705 -175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.82 157.28 18.08 Favored Glycine 0 CA--C 1.546 2.025 0 CA-C-O 119.959 -0.356 . . . . 74.049999999999997 113.933 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.23 -168.14 0.57 Allowed 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.615 2.876 . . . . 74.140000000000001 113.428 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.18 -51.24 55.44 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 123.264 0.459 . . . . 41.43 114.066 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.29 -97.2 1.22 Allowed Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.474 0.95 . . . . 73.510000000000005 115.474 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.85 126.44 9.63 Favored 'Cis proline' 0 C--N 1.383 2.353 0 CA-C-N 120.891 2.345 . . . . 73.140000000000001 114.384 5.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.503 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 89.7 t -66.58 131.62 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.439 0.696 . . . . 71.319999999999993 110.274 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.06 150.81 20.07 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.46 0.647 . . . . 74.319999999999993 110.637 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -110.34 125.24 52.97 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.893 0.877 . . . . 74.319999999999993 109.296 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.76 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 81.0 m-85 -111.71 161.7 16.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.149 0.58 . . . . 71.0 110.438 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB3' HD21 ' A' ' 34' ' ' LEU . 27.2 tptp -146.68 122.9 10.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.741 0.816 . . . . 74.219999999999999 109.51 171.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 54.54 25.74 6.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.929 0.891 . . . . 72.129999999999995 113.068 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.76 -30.52 7.73 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-N 116.121 -0.491 . . . . 64.129999999999995 114.165 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.9 131.79 55.14 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.788 0.794 . . . . 75.329999999999998 111.379 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.76 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -62.18 151.89 34.7 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.107 0.963 . . . . 75.530000000000001 113.536 -177.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 29' ' ' LYS . 27.3 mt -100.99 142.32 32.64 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.165 0.986 . . . . 74.129999999999995 110.345 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.63 157.46 17.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.997 0.919 . . . . 74.140000000000001 109.996 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.9 p -61.62 97.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.841 0.829 . . . . 71.530000000000001 111.035 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' NE2' ' H ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -109.55 163.28 13.59 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.887 1.275 . . . . 73.439999999999998 108.135 -175.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' H ' ' NE2' ' A' ' 37' ' ' GLN . . . -53.92 -35.84 54.4 Favored Glycine 0 CA--C 1.543 1.798 0 N-CA-C 114.145 0.418 . . . . 74.400000000000006 114.145 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -89.5 -33.06 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.021 0.528 . . . . 74.530000000000001 110.821 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.04 86.01 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.93 0.892 . . . . 75.200000000000003 111.152 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.582 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 68.1 mt-30 -82.82 101.25 10.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.623 0.769 . . . . 75.430000000000007 110.751 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD22 HD23 ' A' ' 51' ' ' LEU . 61.2 mt -89.91 152.86 21.03 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.33 0.586 . . . . 74.420000000000002 112.201 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.524 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.5 tm-20 -146.48 131.83 18.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.743 -1.206 . . . . 74.519999999999996 107.743 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -124.8 103.14 7.92 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.012 0.525 . . . . 75.150000000000006 111.034 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 48' ' ' ARG . . . -120.86 11.17 11.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.937 0.895 . . . . 74.230000000000004 111.969 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.67 -86.36 1.47 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.179 0.419 . . . . 61.409999999999997 113.408 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' HIS . . . -72.56 -5.39 36.79 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.347 0.659 . . . . 63.149999999999999 111.865 175.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 54.0 ttp180 -133.71 101.21 5.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.003 0.921 . . . . 75.209999999999994 109.745 172.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.503 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.0 mm100 -106.09 126.58 52.37 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 109.549 -0.537 . . . . 73.439999999999998 109.549 173.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 40.6 t -115.83 122.15 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-O 120.869 0.366 . . . . 62.509999999999998 111.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.42 HD23 HD22 ' A' ' 42' ' ' LEU . 1.9 tm? -111.34 114.47 27.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.334 1.054 . . . . 74.549999999999997 108.402 169.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 83.6 mtm180 -114.43 108.31 16.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.992 0.517 . . . . 71.420000000000002 111.202 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.7 t -96.55 120.89 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.634 -0.506 . . . . 72.230000000000004 109.634 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -79.2 116.08 19.25 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.257 0.623 . . . . 74.230000000000004 109.731 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.61 72.45 1.26 Allowed Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.336 -0.393 . . . . 72.519999999999996 113.429 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 12' ' ' LEU . . . -80.48 102.54 9.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.683 0.793 . . . . 74.25 111.447 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.34 -73.63 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.599 0.759 . . . . 74.5 111.614 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.8 m -127.71 -67.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.855 0.462 . . . . 75.510000000000005 111.867 -171.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.1 -12.53 60.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 113.974 0.349 . . . . 72.219999999999999 113.974 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.87 -17.48 43.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.292 1.037 . . . . 74.439999999999998 110.694 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.64 134.17 34.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.023 0.929 . . . . 63.200000000000003 109.554 172.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.04 -178.64 36.92 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.867 -0.606 . . . . 70.140000000000001 113.066 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.1 117.67 25.99 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.357 0.599 . . . . 75.340000000000003 110.467 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.555 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 38.4 m-85 -94.57 157.02 16.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.283 1.033 . . . . 75.340000000000003 109.934 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.4 tp -127.94 105.56 8.5 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.828 -0.545 . . . . 74.019999999999996 110.525 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' A' ' 16' ' ' VAL . 48.6 t -82.93 88.22 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.637 -0.875 . . . . 75.310000000000002 108.637 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -79.36 86.72 5.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.121 0.968 . . . . 72.129999999999995 111.684 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' A' ' 25' ' ' VAL . . . -81.01 140.57 49.96 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.816 -0.629 . . . . 74.319999999999993 110.054 171.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.32 -35.86 16.44 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 124.498 3.466 . . . . 72.319999999999993 115.896 -173.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -124.18 0.38 8.41 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.802 0.841 . . . . 74.219999999999999 112.406 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -156.49 49.45 0.48 Allowed 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.785 0.802 . . . . 73.099999999999994 111.046 -165.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -66.8 121.6 15.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.148 0.979 . . . . 72.400000000000006 112.025 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -127.47 142.66 51.34 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.933 0.716 . . . . 70.510000000000005 112.933 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.556 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mp -91.05 139.95 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.962 0.905 . . . . 74.319999999999993 109.947 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 9.3 m-85 -102.06 114.89 29.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.563 1.145 . . . . 74.530000000000001 111.121 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 93.9 mt -77.36 93.87 4.12 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.591 -0.892 . . . . 75.420000000000002 108.591 166.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 75' ' ' PHE . 73.5 t -105.45 113.14 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.345 0.658 . . . . 74.019999999999996 110.691 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 t -118.1 117.65 29.76 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.564 -0.744 . . . . 64.439999999999998 110.747 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.3 t -84.82 106.26 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 107.947 -1.131 . . . . 73.549999999999997 107.947 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.41 -173.95 4.17 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.184 0.994 . . . . 74.239999999999995 109.922 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' O ' HG23 ' A' ' 7' ' ' THR . 44.6 tt0 59.78 81.15 0.25 Allowed Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.763 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo . . . . . 0 CA--C 1.575 2.566 0 C-N-CA 124.278 3.318 . . . . 74.439999999999998 115.875 -177.112 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.579 0.228 . . . . 73.239999999999995 111.528 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -79.67 95.19 5.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.674 -0.861 . . . . 75.549999999999997 108.674 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.565 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 41.2 mtp180 -93.9 148.34 22.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.567 0.747 . . . . 74.530000000000001 112.824 -166.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 79.4 t -130.57 138.57 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.031 0.932 . . . . 73.25 109.473 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.17 119.13 32.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.023 0.929 . . . . 72.010000000000005 109.076 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 79' ' ' VAL . 35.0 t -132.45 163.16 29.38 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.796 0.808 . . . . 73.129999999999995 112.568 -170.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.1 p -99.74 155.82 36.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.047 -0.978 . . . . 73.409999999999997 111.189 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -82.02 46.71 2.28 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.444 2.762 . . . . 70.299999999999997 113.292 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.1 45.67 0.56 Allowed Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.316 -0.402 . . . . 70.299999999999997 113.115 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.73 172.98 36.12 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-O 119.635 -0.536 . . . . 72.519999999999996 112.193 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.78 135.37 41.71 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.553 0.677 . . . . 73.530000000000001 111.131 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.454 HD23 HG12 ' A' ' 77' ' ' VAL . 49.5 tp -78.84 107.44 11.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.782 0.433 . . . . 70.129999999999995 110.883 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 36.2 tt0 -111.24 104.59 13.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.922 0.489 . . . . 74.409999999999997 110.171 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.462 ' HG ' HD13 ' A' ' 51' ' ' LEU . 29.3 mt -94.45 106.12 18.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.96 0.904 . . . . 75.109999999999999 110.402 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -93.95 113.27 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.588 0.755 . . . . 64.420000000000002 110.003 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 18' ' ' LEU . 2.1 t -100.05 149.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.688 0.795 . . . . 72.0 110.631 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -112.02 15.15 20.77 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.308 0.643 . . . . 70.040000000000006 111.14 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 16' ' ' VAL . 14.4 mt -54.24 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.514 0.725 . . . . 73.510000000000005 112.003 174.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.8 t -68.24 81.36 0.24 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.637 0.775 . . . . 75.409999999999997 110.349 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.29 164.18 30.63 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.292 -0.867 . . . . 74.530000000000001 113.268 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.09 23.7 0.51 Allowed 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.231 2.621 . . . . 74.219999999999999 113.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.74 59.76 4.26 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 122.838 0.256 . . . . 25.149999999999999 112.501 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.31 -69.49 1.37 Allowed Glycine 0 CA--C 1.551 2.299 0 CA-C-O 119.616 -0.547 . . . . 73.099999999999994 114.44 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.7 -167.35 5.99 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 120.19 1.995 . . . . 75.530000000000001 113.534 0.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HB ' ' HG3' ' A' ' 49' ' ' GLN . 92.6 t -87.77 146.11 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 123.705 0.802 . . . . 73.329999999999998 110.459 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.701 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 97.4 mtt180 -96.2 169.72 9.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 75.209999999999994 110.66 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.433 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 94.8 m95 -131.22 136.92 48.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.824 0.85 . . . . 74.140000000000001 110.168 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 59.9 m-85 -134.46 123.67 24.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 123.036 0.535 . . . . 75.019999999999996 110.569 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.1 tptp -117.93 133.74 55.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.002 -0.74 . . . . 73.409999999999997 109.002 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 61.29 22.31 12.69 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.808 0.843 . . . . 74.209999999999994 111.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.09 5.6 82.96 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 114.268 0.467 . . . . 63.310000000000002 114.268 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -130.66 133.95 46.54 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.901 0.851 . . . . 73.140000000000001 112.358 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -62.85 150.87 40.61 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.022 1.489 . . . . 75.420000000000002 115.022 -171.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 40' ' ' VAL . 3.8 mm? -92.61 163.79 13.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.237 1.415 . . . . 72.25 111.024 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.65 140.04 42.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.555 0.742 . . . . 70.409999999999997 110.407 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.1 p -81.74 31.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.509 0.724 . . . . 61.100000000000001 112.813 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -121.87 124.97 45.36 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.03 0.932 . . . . 74.420000000000002 110.655 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.71 -100.03 0.46 Allowed Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.731 0.652 . . . . 71.140000000000001 114.731 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -52.37 -46.04 66.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 125.024 1.33 . . . . 74.519999999999996 113.03 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.536 HG22 HD12 ' A' ' 34' ' ' LEU . 98.9 t -116.96 143.12 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.366 -0.834 . . . . 73.439999999999998 110.616 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -126.0 131.02 52.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.349 1.06 . . . . 72.420000000000002 110.156 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 82.6 mt -119.66 145.15 46.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.887 0.475 . . . . 62.130000000000003 112.068 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.46 130.69 54.81 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.32 0.648 . . . . 74.430000000000007 109.329 166.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -106.32 103.71 13.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.826 0.851 . . . . 75.310000000000002 110.018 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.55 178.12 6.31 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.37 0.668 . . . . 74.349999999999994 111.316 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.92 -24.79 75.33 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.332 -0.395 . . . . 64.099999999999994 113.501 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.65 -55.14 0.73 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.179 0.592 . . . . 73.109999999999999 111.868 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 46.7 ttp180 -81.8 97.83 8.18 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.959 0.409 . . . . 74.340000000000003 112.053 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 39.6 mm-40 -91.65 133.72 35.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.57 -0.9 . . . . 75.310000000000002 108.57 173.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 87.8 t -121.44 115.68 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 122.014 -0.429 . . . . 73.140000000000001 110.894 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.6 tm? -95.51 129.61 42.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.153 0.981 . . . . 73.329999999999998 108.644 171.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 63.1 mtp180 -131.66 105.34 7.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.853 0.752 . . . . 73.319999999999993 111.334 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.23 105.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.836 -0.801 . . . . 70.420000000000002 108.836 171.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -72.39 109.96 6.47 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.53 0.732 . . . . 72.310000000000002 112.612 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.01 48.8 1.42 Allowed Glycine 0 C--N 1.35 1.348 0 CA-C-N 116.253 -0.431 . . . . 43.219999999999999 113.472 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.11 115.13 12.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.466 0.706 . . . . 74.310000000000002 111.551 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -157.5 -65.48 0.09 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.586 0.754 . . . . 73.409999999999997 111.989 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.5 m -80.22 -70.48 0.52 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.2 0.815 . . . . 75.349999999999994 113.2 -163.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -116.31 30.14 6.65 Favored Glycine 0 N--CA 1.487 2.034 0 CA-C-O 121.075 0.264 . . . . 74.319999999999993 112.859 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.95 -6.14 43.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 62.25 112.314 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.536 ' HB3' ' H ' ' A' ' 79' ' ' VAL . . . -83.63 129.09 34.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.366 -0.605 . . . . 75.540000000000006 109.366 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 163.39 -174.2 39.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.121 -0.561 . . . . 72.209999999999994 114.212 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -91.53 110.65 21.97 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.107 0.563 . . . . 75.219999999999999 110.395 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.8 m-85 -95.6 113.63 25.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.854 0.461 . . . . 73.219999999999999 110.031 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 54.2 tp -92.85 101.77 14.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.547 0.739 . . . . 74.129999999999995 110.277 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.401 ' SG ' ' CH2' ' A' ' 27' ' ' TRP . 72.6 m -71.41 88.48 0.89 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.335 -0.848 . . . . 54.350000000000001 109.614 169.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.0 t70 -80.04 89.85 5.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.39 0.614 . . . . 72.430000000000007 110.599 -176.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.44 151.39 50.74 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.226 -0.897 . . . . 73.400000000000006 111.31 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.62 -21.86 73.05 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.409 2.073 . . . . 71.439999999999998 112.633 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.92 93.19 3.92 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.529 -0.915 . . . . 74.140000000000001 108.529 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.53 109.61 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 125.3 1.44 . . . . 72.519999999999996 113.216 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -75.93 134.34 40.26 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.873 0.869 . . . . 73.140000000000001 112.035 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -107.39 141.37 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.329 0.652 . . . . 74.430000000000007 110.962 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.478 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.5 mp -104.84 137.78 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.092 0.557 . . . . 72.140000000000001 110.289 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 7.0 m-85 -108.46 105.44 15.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.312 1.045 . . . . 73.209999999999994 110.861 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.565 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 95.6 mt -77.17 97.78 4.88 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.324 -0.621 . . . . 63.340000000000003 109.324 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.454 HG12 HD23 ' A' ' 12' ' ' LEU . 45.3 t -107.65 131.58 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.834 0.454 . . . . 74.420000000000002 111.171 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.6 m -119.6 111.62 18.3 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.116 0.567 . . . . 70.319999999999993 109.788 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.536 ' H ' ' HB3' ' A' ' 61' ' ' ALA . 40.5 t -109.31 105.25 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.138 -1.06 . . . . 73.400000000000006 108.138 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.59 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.523 0.935 . . . . 72.439999999999998 113.523 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 51.3 mt-10 -68.57 108.31 2.78 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.132 0.573 . . . . 74.349999999999994 110.995 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 26.4 Cg_exo . . . . . 0 C--N 1.383 2.355 0 C-N-CA 123.243 2.628 . . . . 74.209999999999994 113.879 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.965 0.412 . . . . 75.010000000000005 111.414 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -76.48 156.03 33.34 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.932 0.893 . . . . 63.32 112.29 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -150.75 129.92 12.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.28 1.032 . . . . 74.239999999999995 109.587 172.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 99.0 t -129.67 134.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.724 0.81 . . . . 74.530000000000001 109.612 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.3 144.17 26.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.026 0.53 . . . . 75.310000000000002 110.865 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.487 ' HB2' HD13 ' A' ' 12' ' ' LEU . 40.4 t -125.66 153.7 43.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.021 0.928 . . . . 65.329999999999998 109.851 172.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -102.0 150.42 37.43 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.354 0.662 . . . . 73.040000000000006 111.024 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.35 96.48 0.19 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.284 2.656 . . . . 75.530000000000001 113.769 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.24 38.49 4.53 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.673 -0.694 . . . . 65.129999999999995 113.975 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.57 168.85 22.58 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-O 120.085 -0.286 . . . . 74.310000000000002 112.547 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 37.0 t70 -70.42 140.95 52.16 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.222 0.534 . . . . 73.409999999999997 111.34 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 6' ' ' SER . 64.3 tp -109.41 152.39 25.41 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.421 1.088 . . . . 71.540000000000006 109.538 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.73 130.66 19.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.393 0.677 . . . . 71.019999999999996 109.653 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.31 105.39 14.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.501 0.721 . . . . 74.109999999999999 109.214 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.35 120.72 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.477 0.711 . . . . 73.140000000000001 109.239 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 49' ' ' GLN . 94.5 t -107.64 131.3 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.893 0.877 . . . . 75.530000000000001 111.964 -172.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -143.28 31.33 1.37 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.222 1.009 . . . . 75.439999999999998 110.897 172.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -57.61 168.14 0.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.857 0.688 . . . . 74.230000000000004 112.857 169.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.3 t -89.58 31.97 0.9 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.074 0.55 . . . . 71.409999999999997 111.168 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.62 80.42 0.29 Allowed Glycine 0 CA--C 1.541 1.661 0 CA-C-O 119.367 -0.685 . . . . 75.25 112.683 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.18 175.28 11.02 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.296 2.664 . . . . 70.430000000000007 113.466 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.2 -84.78 0.6 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.156 -0.474 . . . . 72.5 113.028 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.28 -161.85 17.4 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.401 -0.666 . . . . 52.229999999999997 113.75 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.45 116.1 4.18 Favored 'Cis proline' 0 C--N 1.378 2.129 0 CA-C-N 119.844 1.822 . . . . 63.409999999999997 113.422 -1.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.34 123.33 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.787 -0.642 . . . . 71.549999999999997 109.636 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -103.85 159.77 15.36 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.276 0.63 . . . . 74.519999999999996 111.819 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -115.49 137.61 51.88 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.956 0.902 . . . . 74.140000000000001 110.249 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -135.29 123.33 22.77 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.381 0.672 . . . . 72.120000000000005 110.823 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 24.9 tptp -103.53 112.74 25.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.158 0.583 . . . . 74.219999999999999 110.379 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 55.59 3.07 0.07 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 126.12 1.768 . . . . 74.030000000000001 115.38 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.3 -27.43 1.54 Allowed Glycine 0 N--CA 1.481 1.675 0 O-C-N 121.152 -0.967 . . . . 65.219999999999999 114.738 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -113.28 147.15 38.14 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.366 1.083 . . . . 72.530000000000001 111.549 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.494 ' HD3' ' H ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -69.18 153.08 44.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.741 0.645 . . . . 75.329999999999998 112.741 175.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.37 154.74 19.45 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.408 -0.815 . . . . 73.400000000000006 109.888 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.6 125.62 12.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.211 1.004 . . . . 43.32 108.671 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 p -55.4 99.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.746 0.818 . . . . 73.230000000000004 112.592 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -159.7 116.28 2.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.474 0.71 . . . . 72.430000000000007 111.62 -171.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.42 -89.88 0.06 OUTLIER Glycine 0 C--N 1.353 1.522 0 O-C-N 123.547 0.53 . . . . 74.530000000000001 113.655 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -75.27 -42.76 54.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.832 0.853 . . . . 74.150000000000006 111.601 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.27 106.71 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 116.116 -0.493 . . . . 74.439999999999998 110.151 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.663 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.5 mm100 -110.09 104.6 13.49 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.109 0.564 . . . . 70.400000000000006 109.625 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.441 HD22 HD22 ' A' ' 51' ' ' LEU . 84.9 mt -98.59 143.85 28.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 74.420000000000002 112.098 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 40.1 tt0 -140.47 136.75 33.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.224 1.01 . . . . 74.319999999999993 109.01 173.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.02 106.56 9.16 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.873 0.844 . . . . 72.439999999999998 110.869 -176.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -111.76 21.5 15.98 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.428 1.091 . . . . 72.299999999999997 110.967 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.17 -87.09 0.95 Allowed Glycine 0 N--CA 1.477 1.393 0 CA-C-N 116.34 -0.391 . . . . 74.239999999999995 112.787 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.87 -40.75 18.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.306 0.642 . . . . 70.450000000000003 110.647 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 46.3 ttt180 -78.5 106.38 10.41 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.416 -0.811 . . . . 73.439999999999998 110.699 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.597 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 79.9 mm-40 -106.91 155.45 19.75 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.616 0.766 . . . . 72.420000000000002 109.587 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 65.1 t -135.76 117.39 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.867 0.467 . . . . 64.540000000000006 109.953 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.441 HD22 HD22 ' A' ' 42' ' ' LEU . 2.8 tm? -110.51 118.7 36.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.834 -0.802 . . . . 74.450000000000003 108.834 168.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 84.2 mtt180 -113.81 141.42 47.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.06 0.544 . . . . 75.209999999999994 110.854 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.7 t -128.83 101.73 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.742 0.817 . . . . 65.120000000000005 108.992 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -74.23 121.73 21.72 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.051 -0.351 . . . . 73.230000000000004 110.051 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.34 36.47 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.79 -0.186 . . . . 62.409999999999997 113.291 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 90.31 0.06 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.573 0.749 . . . . 71.319999999999993 111.362 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -88.35 -56.68 3.21 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.055 1.132 . . . . 74.109999999999999 114.055 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -161.67 -58.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.326 0.25 . . . . 73.230000000000004 111.563 -174.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -9.96 55.03 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.485 -0.325 . . . . 70.030000000000001 113.442 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.78 -3.42 44.32 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.687 1.195 . . . . 73.409999999999997 111.973 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.67 127.5 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.509 0.724 . . . . 55.130000000000003 109.955 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 164.59 -172.72 40.41 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 121.225 0.347 . . . . 75.299999999999997 113.695 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -87.26 111.85 21.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.676 0.79 . . . . 72.530000000000001 111.45 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -99.35 111.35 23.73 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.819 -0.808 . . . . 73.439999999999998 108.819 170.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 tp -94.09 106.63 18.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.249 1.02 . . . . 74.140000000000001 110.379 -171.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.468 ' HG ' HD21 ' A' ' 18' ' ' LEU . 42.2 t -79.89 88.06 5.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.629 0.728 . . . . 70.340000000000003 109.165 171.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -78.18 89.93 4.28 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.994 -1.003 . . . . 62.109999999999999 110.845 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.51 148.31 34.73 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.491 0.717 . . . . 73.239999999999995 111.264 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -55.04 -32.1 77.73 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 123.538 2.825 . . . . 62.049999999999997 114.774 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -86.81 -51.73 5.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.969 0.508 . . . . 70.019999999999996 111.592 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.39 126.02 11.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.287 0.635 . . . . 62.240000000000002 112.164 -175.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -87.08 118.93 26.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.83 0.852 . . . . 72.219999999999999 110.41 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -105.79 131.21 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.227 0.611 . . . . 74.140000000000001 111.325 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.5 mt -88.87 117.96 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.791 0.837 . . . . 60.240000000000002 109.939 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CZ ' HG23 ' A' ' 16' ' ' VAL . 17.8 m-85 -98.58 103.63 15.6 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.831 -0.803 . . . . 75.209999999999994 108.831 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.18 93.56 3.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.178 -0.675 . . . . 72.420000000000002 109.178 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.1 t -85.2 99.95 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.734 0.778 . . . . 64.530000000000001 109.748 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.4 p -95.51 108.79 21.05 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.744 -1.116 . . . . 73.129999999999995 109.937 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 6' ' ' SER . 85.6 t -82.37 106.09 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 107.682 -1.229 . . . . 75.030000000000001 107.682 173.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -156.24 -178.11 7.08 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.513 1.125 . . . . 71.349999999999994 109.888 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 58.25 75.06 0.56 Allowed Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.591 0.757 . . . . 74.319999999999993 110.563 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 CA--C 1.572 2.383 0 C-N-CA 123.154 2.57 . . . . 73.349999999999994 113.459 -176.69 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.457 0.17 . . . . 75.540000000000006 111.311 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -62.06 133.67 55.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.374 0.67 . . . . 54.119999999999997 110.124 167.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -126.63 111.74 14.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.345 0.658 . . . . 73.420000000000002 109.818 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.2 t -115.16 139.39 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.31 0.644 . . . . 74.420000000000002 111.092 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -90.05 136.05 33.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.64 0.776 . . . . 70.200000000000003 110.209 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 t -125.37 152.03 45.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.677 0.791 . . . . 74.5 110.145 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' GLU . 1.6 p -104.67 152.28 39.43 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.564 0.745 . . . . 75.25 111.752 177.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 57.1 Cg_endo -80.54 42.71 1.38 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.368 2.712 . . . . 64.310000000000002 113.747 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.73 66.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.926 0 N-CA-C 112.293 -0.323 . . . . 64.230000000000004 112.293 -173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.32 -136.3 4.12 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-O 120.164 -0.242 . . . . 75.129999999999995 112.782 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.47 152.57 51.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.648 0.779 . . . . 54.409999999999997 110.761 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.2 tp -89.71 146.73 24.3 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.29 0.636 . . . . 73.439999999999998 109.903 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -145.57 114.06 6.73 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.913 -0.402 . . . . 74.140000000000001 109.913 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 63.4 mt -106.82 102.02 11.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.582 0.753 . . . . 73.420000000000002 110.061 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -94.52 113.19 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.283 -1.006 . . . . 75.329999999999998 108.283 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 18' ' ' LEU . 2.9 t -100.01 146.7 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.035 0.534 . . . . 65.530000000000001 111.429 -169.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -131.86 43.71 3.0 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.461 0.705 . . . . 75.040000000000006 110.426 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.504 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -59.19 164.59 3.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.018 0.747 . . . . 74.329999999999998 113.018 172.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.2 p -84.78 38.31 0.69 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.807 0.843 . . . . 64.209999999999994 112.319 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 70' ' ' GLN . . . -127.05 84.84 0.34 Allowed Glycine 0 N--CA 1.478 1.482 0 CA-C-O 119.537 -0.59 . . . . 43.32 112.502 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.41 156.77 60.95 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.079 2.519 . . . . 70.209999999999994 113.269 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.8 -119.85 11.65 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.908 -0.587 . . . . 65.430000000000007 113.473 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -173.74 -164.42 28.86 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-O 119.493 -0.615 . . . . 72.420000000000002 113.305 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.0 101.79 0.38 Allowed 'Cis proline' 0 CA--C 1.565 2.032 0 CA-C-N 120.096 1.948 . . . . 72.040000000000006 113.029 -3.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.435 HG23 ' HA2' ' A' ' 23' ' ' GLY . 30.7 t -79.89 123.0 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 109.817 -0.438 . . . . 73.140000000000001 109.817 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -100.68 158.41 15.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.558 0.743 . . . . 74.319999999999993 111.449 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.459 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 62.8 m95 -114.33 142.37 46.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 73.439999999999998 111.157 175.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 54.6 m-85 -135.76 160.2 39.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.316 1.047 . . . . 74.230000000000004 110.597 177.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.62 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.6 tptp -140.75 130.71 24.58 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 73.319999999999993 109.591 165.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 57.68 27.71 14.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.268 1.027 . . . . 65.329999999999998 112.63 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 -1.13 76.17 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 115.829 -0.623 . . . . 70.200000000000003 114.507 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -124.78 131.04 53.49 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.325 1.063 . . . . 71.420000000000002 111.496 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.08 143.35 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.524 1.13 . . . . 74.129999999999995 113.94 -172.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.62 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.6 mt -95.62 147.54 23.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 72.400000000000006 111.011 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.49 150.52 23.3 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.936 0.894 . . . . 62.310000000000002 110.402 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.9 p -76.36 77.34 3.11 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.281 0.562 . . . . 75.340000000000003 110.177 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -76.09 -64.69 1.04 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.7 0.8 . . . . 71.25 112.488 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.36 -49.58 0.24 Allowed Glycine 0 N--CA 1.475 1.266 0 N-CA-C 112.257 -0.337 . . . . 65.109999999999999 112.257 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.07 -46.22 15.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.798 -0.816 . . . . 72.219999999999999 108.798 164.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.38 93.26 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 108.919 -0.771 . . . . 75.420000000000002 108.919 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.227 1.011 . . . . 73.319999999999993 110.788 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.22 137.95 51.7 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.084 0.554 . . . . 74.439999999999998 110.69 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -122.88 114.4 20.41 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.483 -0.932 . . . . 71.049999999999997 108.483 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -103.54 104.03 14.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.76 0.79 . . . . 74.019999999999996 110.519 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.13 178.28 6.12 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.499 1.12 . . . . 73.049999999999997 110.56 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 95.07 0.22 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.619 -0.545 . . . . 74.510000000000005 113.212 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.55 -34.6 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.573 1.549 . . . . 73.409999999999997 113.597 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 69.9 ttp85 -85.76 94.08 9.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.5 0.667 . . . . 74.409999999999997 110.893 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HG3' ' SG ' ' A' ' 66' ' ' CYS . 15.7 mm100 -94.64 142.79 27.04 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.485 -0.78 . . . . 72.450000000000003 110.102 172.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 47.4 t -131.26 109.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.037 0.446 . . . . 70.129999999999995 111.069 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.7 130.9 43.84 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.381 -0.97 . . . . 74.5 108.381 169.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -128.57 108.67 10.71 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 74.140000000000001 109.339 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.4 t -98.2 96.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.625 0.648 . . . . 74.319999999999993 109.868 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.06 96.83 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.204 0.602 . . . . 74.129999999999995 110.314 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.38 46.47 0.2 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.839 -0.619 . . . . 74.230000000000004 112.019 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.4 113.86 17.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.755 0.822 . . . . 64.25 110.317 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 44.1 ttt85 -161.29 -41.77 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.168 0.803 . . . . 75.299999999999997 113.168 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.2 m -129.43 -77.55 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 122.75 0.42 . . . . 65.230000000000004 111.759 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.33 -3.37 70.42 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 114.479 0.552 . . . . 74.329999999999998 114.479 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -67.51 -26.28 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.15 0.98 . . . . 74.5 112.501 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.28 117.56 16.23 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.638 0.375 . . . . 73.310000000000002 110.083 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.31 -171.51 41.34 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 114.196 0.438 . . . . 54.140000000000001 114.196 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -87.45 117.17 26.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 75.340000000000003 111.277 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 77.7 m-85 -105.36 108.12 19.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.4 0.68 . . . . 71.420000000000002 110.096 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.1 tp -92.59 110.41 21.84 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.284 0.564 . . . . 74.019999999999996 109.924 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 49' ' ' GLN . 37.9 t -89.1 88.06 7.42 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.846 0.858 . . . . 61.310000000000002 108.98 170.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.6 95.45 6.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.238 1.015 . . . . 73.340000000000003 112.473 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.41 137.46 30.69 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.884 0.473 . . . . 75.120000000000005 111.004 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.42 -23.51 47.48 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.319 2.679 . . . . 72.430000000000007 113.873 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.511 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 24.8 mp0 -85.58 -57.49 3.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.62 0.768 . . . . 75.349999999999994 111.096 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -157.0 117.11 3.51 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 112.135 0.42 . . . . 74.519999999999996 112.135 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.5 m -76.06 140.26 41.81 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 74.010000000000005 112.204 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 126.86 54.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.672 0.789 . . . . 75.319999999999993 110.645 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.1 mp -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.417 -0.586 . . . . 73.0 109.417 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 37.8 m-85 -100.45 125.52 46.76 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.235 1.014 . . . . 74.200000000000003 110.386 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.2 mt -102.6 93.88 5.35 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.424 -0.954 . . . . 73.120000000000005 108.424 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.04 126.77 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.638 0.775 . . . . 72.030000000000001 110.469 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -119.0 117.52 29.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.689 0.796 . . . . 74.140000000000001 110.667 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.0 t -84.82 108.14 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.048 0.452 . . . . 71.510000000000005 109.894 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -164.61 -170.04 1.91 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.511 1.125 . . . . 75.420000000000002 109.617 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 7' ' ' THR . 32.3 tt0 59.84 72.81 0.72 Allowed Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.571 0.748 . . . . 72.450000000000003 110.322 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.571 2.329 0 C-N-CA 122.578 2.186 . . . . 74.299999999999997 113.357 -172.542 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.72 0.295 . . . . 73.439999999999998 111.139 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.8 m -83.59 88.71 7.03 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.806 0.842 . . . . 75.420000000000002 108.93 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -98.8 135.5 40.17 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.787 0.835 . . . . 72.450000000000003 112.14 -166.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.57 143.49 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.967 0.907 . . . . 75.140000000000001 110.233 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -92.21 145.23 24.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.727 0.411 . . . . 73.409999999999997 110.712 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.673 ' HB2' HD12 ' A' ' 12' ' ' LEU . 37.8 t -120.95 166.66 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.68 0.792 . . . . 61.310000000000002 110.081 166.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.07 138.57 21.78 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 123.069 0.548 . . . . 73.120000000000005 111.303 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 96.0 Cg_exo -47.32 117.11 2.09 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 124.13 3.22 . . . . 52.130000000000003 114.434 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.69 13.32 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 116.254 -0.43 . . . . 55.109999999999999 113.934 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.82 52.92 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 121.151 0.306 . . . . 74.549999999999997 113.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 5.5 p-10 -91.5 129.51 37.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.146 0.498 . . . . 73.420000000000002 111.463 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 6' ' ' SER . 51.5 tp -74.65 150.15 39.7 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.706 0.802 . . . . 71.200000000000003 109.292 169.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.7 115.56 8.27 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.036 0.534 . . . . 75.030000000000001 109.943 170.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 76.2 mt -99.18 101.6 12.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.519 0.728 . . . . 75.409999999999997 109.729 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.3 t -90.36 113.02 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.386 -0.968 . . . . 70.200000000000003 108.386 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.462 HG23 ' CZ ' ' A' ' 75' ' ' PHE . 47.4 t -96.72 122.11 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.242 0.544 . . . . 53.25 112.144 -165.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -120.0 70.53 0.87 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 122.06 0.933 . . . . 74.510000000000005 108.823 170.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HG ' ' CG1' ' A' ' 16' ' ' VAL . 19.7 mt -55.68 156.22 5.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.299 1.44 . . . . 74.140000000000001 113.278 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.8 m -77.72 -33.53 52.98 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.4 -0.818 . . . . 72.310000000000002 110.665 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA3' ' NE2' ' A' ' 70' ' ' GLN . . . -141.37 79.86 0.27 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-N 115.853 -0.612 . . . . 73.430000000000007 112.123 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.8 -167.93 0.54 Allowed 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 122.983 2.456 . . . . 70.109999999999999 114.007 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.97 -169.72 42.67 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.635 -0.711 . . . . 42.119999999999997 112.595 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.99 136.61 5.65 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.355 -0.692 . . . . 64.420000000000002 112.911 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.86 162.97 84.0 Favored 'Cis proline' 0 C--N 1.381 2.257 0 CA-C-N 120.032 1.916 . . . . 74.129999999999995 113.489 -6.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.564 HG13 ' SG ' ' A' ' 66' ' ' CYS . 53.9 t -115.09 134.57 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.926 0.89 . . . . 72.239999999999995 110.321 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -97.6 131.77 43.87 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.827 0.851 . . . . 72.200000000000003 110.643 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.2 137.29 41.55 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.796 0.839 . . . . 74.200000000000003 111.605 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.7 m-85 -130.51 124.04 31.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.695 0.798 . . . . 73.120000000000005 110.316 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HB3' HD21 ' A' ' 34' ' ' LEU . 18.7 tptm -104.4 120.26 40.81 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 73.409999999999997 109.231 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.44 22.45 13.25 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.113 0.965 . . . . 75.120000000000005 111.216 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.17 -26.5 22.8 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.841 -0.618 . . . . 53.509999999999998 113.724 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.15 129.96 44.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.431 0.692 . . . . 71.120000000000005 110.805 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 152.55 16.14 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.888 0.875 . . . . 75.230000000000004 112.953 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 29' ' ' LYS . 28.6 mt -107.71 138.74 43.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.886 0.474 . . . . 72.329999999999998 111.293 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 144.8 29.07 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.773 0.829 . . . . 42.310000000000002 111.089 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -71.76 92.68 1.22 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.658 0.783 . . . . 64.299999999999997 111.678 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.455 0.702 . . . . 74.230000000000004 112.309 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.03 -57.21 21.06 Favored Glycine 0 C--N 1.36 1.87 0 N-CA-C 115.078 0.791 . . . . 71.239999999999995 115.078 -172.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -77.4 -40.71 42.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.812 0.445 . . . . 71.219999999999999 111.544 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 54.7 t -95.41 85.6 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.425 0.69 . . . . 70.340000000000003 110.541 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 67.1 mt-30 -92.79 125.11 37.24 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.995 0.518 . . . . 74.430000000000007 112.145 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.34 93.38 4.5 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.522 0.729 . . . . 71.099999999999994 111.049 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.743 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 37.0 tt0 -87.57 105.48 17.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.778 0.831 . . . . 70.400000000000006 110.566 173.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.22 110.04 21.8 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.226 0.61 . . . . 74.420000000000002 110.506 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.16 -45.65 5.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.428 0.691 . . . . 72.129999999999995 111.254 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.09 -91.1 0.12 Allowed Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.534 -0.626 . . . . 73.099999999999994 111.534 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -38.55 64.48 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.615 0.721 . . . . 72.400000000000006 109.913 169.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -81.19 125.89 30.83 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.417 -1.265 . . . . 74.400000000000006 110.431 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -117.49 152.42 35.09 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.898 -1.149 . . . . 75.510000000000005 107.898 164.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.743 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t -138.71 116.24 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.671 0.388 . . . . 72.439999999999998 110.617 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.47 128.48 54.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.554 0.742 . . . . 63.310000000000002 109.28 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 57.4 mtt180 -116.3 136.73 52.74 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.91 0.884 . . . . 75.230000000000004 110.393 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.26 97.57 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.298 0.639 . . . . 74.5 109.532 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -75.2 130.01 38.45 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.942 -0.392 . . . . 73.239999999999995 109.942 178.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.56 23.43 39.69 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.485 -0.325 . . . . 74.099999999999994 112.868 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.6 99.23 0.42 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.496 0.718 . . . . 74.150000000000006 110.221 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 63.9 mtp85 -104.9 -177.28 3.32 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.588 0.755 . . . . 74.239999999999995 112.113 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.0 m -62.57 108.68 1.19 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.299 0.64 . . . . 64.409999999999997 110.896 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.62 -15.36 8.02 Favored Glycine 0 N--CA 1.481 1.634 0 CA-C-N 116.233 -0.439 . . . . 63.5 112.88 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.43 -12.08 59.99 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.991 0.917 . . . . 74.319999999999993 111.809 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 79' ' ' VAL . . . -63.61 92.36 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.557 1.143 . . . . 73.409999999999997 111.545 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.13 -179.93 20.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.488 -0.778 . . . . 60.109999999999999 113.511 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.33 124.89 31.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.109 0.564 . . . . 72.519999999999996 111.24 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 71.0 m-85 -112.9 108.65 17.68 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.177 0.991 . . . . 75.109999999999999 109.51 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 65.4 tp -91.14 103.41 16.1 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.952 -0.467 . . . . 72.409999999999997 110.364 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.564 ' SG ' HG13 ' A' ' 25' ' ' VAL . 40.5 t -77.67 86.91 3.96 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.682 0.753 . . . . 71.25 109.316 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.01 97.02 9.05 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.019 -0.991 . . . . 44.409999999999997 110.747 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.57 159.37 46.9 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 122.96 0.504 . . . . 70.400000000000006 111.039 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.94 36.21 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.635 2.223 . . . . 72.019999999999996 113.596 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.477 ' NE2' ' HA3' ' A' ' 20' ' ' GLY . 0.4 OUTLIER -165.47 -54.33 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.14 0.576 . . . . 75.310000000000002 109.641 -176.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -138.58 108.73 6.41 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.848 0.859 . . . . 74.200000000000003 110.862 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 p -93.38 124.05 37.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 71.140000000000001 110.985 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.83 139.22 48.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.794 0.437 . . . . 72.329999999999998 112.107 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.5 mt -89.04 130.82 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 109.478 -0.564 . . . . 72.319999999999993 109.478 170.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 3.0 m-85 -103.75 103.39 13.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.452 0.701 . . . . 74.420000000000002 109.333 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.42 93.05 5.93 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.725 -0.843 . . . . 75.209999999999994 108.725 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -91.13 127.86 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.084 0.554 . . . . 73.510000000000005 111.014 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.8 p -107.08 108.77 20.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.147 0.579 . . . . 71.329999999999998 109.918 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.646 HG23 ' HB3' ' A' ' 6' ' ' SER . 22.2 t -98.45 106.36 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.073 -0.714 . . . . 72.129999999999995 109.073 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -168.56 172.89 7.8 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.692 0.397 . . . . 72.230000000000004 111.992 -171.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 58.56 86.85 0.15 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 124.577 1.151 . . . . 73.549999999999997 110.85 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.574 2.491 0 C-N-CA 122.817 2.345 . . . . 71.430000000000007 114.034 -173.206 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.603 -0.517 . . . . 65.420000000000002 109.603 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -62.37 127.24 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.22 0.608 . . . . 73.099999999999994 110.946 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 81.5 mtm180 -137.77 126.85 24.32 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.776 0.831 . . . . 74.049999999999997 109.982 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.1 131.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 121.423 0.63 . . . . 73.140000000000001 111.808 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.435 ' NH2' ' HB2' ' A' ' 81' ' ' GLU . 60.3 ttt85 -90.38 139.73 30.39 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.789 1.236 . . . . 74.519999999999996 110.054 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 79' ' ' VAL . 34.1 t -137.69 172.0 13.6 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.121 0.568 . . . . 74.25 110.613 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 p -130.81 148.16 69.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.873 0.869 . . . . 74.129999999999995 111.214 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.33 145.88 39.18 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.637 2.225 . . . . 75.010000000000005 112.659 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.77 37.29 8.68 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 116.049 -0.523 . . . . 64.200000000000003 113.931 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.23 -134.67 1.7 Allowed Glycine 0 N--CA 1.475 1.275 0 CA-C-O 119.972 -0.349 . . . . 61.409999999999997 112.675 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.24 155.43 49.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 117.275 0.538 . . . . 73.400000000000006 111.18 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.11 143.18 32.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.505 1.122 . . . . 73.200000000000003 109.185 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.81 99.0 3.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.107 0.48 . . . . 64.400000000000006 111.267 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.0 mt -92.23 105.53 17.72 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.106 0.962 . . . . 70.349999999999994 110.732 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.2 t -103.58 127.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.902 -0.407 . . . . 73.430000000000007 109.902 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.513 ' HB ' ' HG ' ' A' ' 18' ' ' LEU . 3.4 m -108.3 149.93 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.412 0.685 . . . . 75.219999999999999 111.693 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -128.36 31.41 5.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.104 0.962 . . . . 75.109999999999999 109.444 163.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' HG ' ' HB ' ' A' ' 16' ' ' VAL . 1.2 pp -51.69 166.02 0.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.89 1.07 . . . . 74.109999999999999 113.89 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -86.64 32.86 0.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.338 0.655 . . . . 74.129999999999995 112.756 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.572 ' HA3' ' HB1' ' A' ' 68' ' ' ALA . . . -112.39 90.11 0.55 Allowed Glycine 0 CA--C 1.544 1.888 0 CA-C-O 119.506 -0.608 . . . . 64.109999999999999 112.654 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.19 165.4 23.73 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.116 2.544 . . . . 75.340000000000003 113.237 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.87 -86.23 0.17 Allowed Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.879 -0.601 . . . . 51.520000000000003 113.62 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.07 8.56 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-O 118.782 -1.01 . . . . 74.400000000000006 114.028 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.28 117.44 2.67 Favored 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.828 2.314 . . . . 73.099999999999994 113.635 1.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 91.3 t -65.24 124.05 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.706 -0.679 . . . . 72.409999999999997 110.084 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -94.89 164.43 12.92 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.511 0.725 . . . . 71.299999999999997 111.003 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -120.81 134.96 55.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.96 0.904 . . . . 74.439999999999998 109.716 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.9 m-85 -122.1 162.53 21.08 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.244 1.018 . . . . 74.420000000000002 110.791 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.6 tptp -154.32 128.33 8.9 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.425 1.09 . . . . 75.340000000000003 108.929 169.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 64.72 17.3 10.88 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.011 0.924 . . . . 74.030000000000001 111.988 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.47 -7.14 81.9 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.534 -0.303 . . . . 71.420000000000002 113.726 -173.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -109.31 121.58 45.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.713 0.805 . . . . 73.239999999999995 110.444 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.9 143.58 57.34 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.732 0.642 . . . . 75.319999999999993 112.732 -175.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.2 mt -87.49 152.62 22.07 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.291 1.037 . . . . 74.450000000000003 110.988 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.42 158.85 20.12 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.835 0.854 . . . . 65.219999999999999 110.343 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -70.62 82.8 0.6 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.789 0.804 . . . . 70.0 110.954 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -96.78 170.47 9.16 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.104 1.362 . . . . 75.310000000000002 110.509 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.15 -43.25 93.47 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.544 0.116 . . . . 73.430000000000007 113.348 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.26 -53.6 13.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.935 0.494 . . . . 75.310000000000002 110.708 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 34' ' ' LEU . 59.7 t -88.17 90.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 124.138 0.975 . . . . 73.430000000000007 112.03 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.633 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.2 mt-30 -82.32 114.89 21.1 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.45 0.7 . . . . 71.239999999999995 110.379 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.42 ' HB3' HE22 ' A' ' 44' ' ' GLN . 29.1 mt -110.06 104.36 13.22 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.203 0.601 . . . . 75.030000000000001 111.76 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.81 98.55 11.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.925 0.89 . . . . 70.540000000000006 110.559 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.42 HE22 ' HB3' ' A' ' 42' ' ' LEU . 23.4 mp0 -99.92 132.02 45.53 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.364 0.666 . . . . 75.310000000000002 110.994 172.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.26 -49.0 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.97 0.908 . . . . 72.219999999999999 110.415 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.98 122.15 1.52 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-O 119.045 -0.864 . . . . 63.109999999999999 111.155 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 69.21 -65.58 0.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.944 1.297 . . . . 74.430000000000007 112.288 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 ttp180 -79.07 95.91 5.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.866 0.466 . . . . 72.430000000000007 110.806 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 8.6 mm100 -116.49 136.95 52.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.753 0.821 . . . . 75.530000000000001 109.458 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 36.0 t -121.52 124.24 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.152 0.501 . . . . 74.129999999999995 111.18 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.67 120.36 40.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 74.140000000000001 108.562 168.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 73.6 mtp180 -119.61 107.91 13.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.944 0.498 . . . . 72.310000000000002 110.094 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -96.42 100.96 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.943 0.497 . . . . 64.329999999999998 110.005 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -71.79 103.09 3.01 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.936 0.494 . . . . 73.219999999999999 109.975 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.39 42.51 0.25 Allowed Glycine 0 N--CA 1.474 1.198 0 CA-C-N 116.293 -0.412 . . . . 74.219999999999999 112.695 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.44 131.5 49.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.007 0.523 . . . . 74.340000000000003 110.642 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -163.56 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.232 0.827 . . . . 74.409999999999997 113.232 -167.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 m -159.07 -56.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 123.273 0.629 . . . . 73.200000000000003 111.305 -171.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -20.59 70.92 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.069 0.388 . . . . 61.130000000000003 114.069 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -81.46 -16.0 53.32 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.146 0.978 . . . . 62.450000000000003 111.193 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB3' HG21 ' A' ' 79' ' ' VAL . . . -74.13 111.57 9.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.88 0.472 . . . . 72.129999999999995 109.737 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.2 -171.9 44.78 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 114.081 0.393 . . . . 72.540000000000006 114.081 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -81.25 113.46 19.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.391 0.676 . . . . 73.420000000000002 110.941 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.708 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 32.8 m-85 -95.36 155.95 16.53 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.994 0.918 . . . . 74.430000000000007 109.334 167.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.63 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.9 tp -133.57 104.89 6.58 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.135 -0.353 . . . . 74.219999999999999 110.075 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.51 ' SG ' HG23 ' A' ' 16' ' ' VAL . 34.4 t -74.99 89.35 2.4 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.883 . . . . 74.25 108.617 169.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.86 92.09 2.5 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.659 1.184 . . . . 75.25 111.582 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB1' ' HA3' ' A' ' 20' ' ' GLY . . . -96.05 148.4 34.46 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.256 0.623 . . . . 70.349999999999994 111.355 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.42 -21.75 66.2 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.985 2.457 . . . . 73.409999999999997 113.625 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.522 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 86.1 mm-40 -112.57 -51.44 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.25 0.62 . . . . 74.340000000000003 112.147 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.45 97.41 3.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.728 0.411 . . . . 74.019999999999996 111.467 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -85.09 141.9 29.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.298 0.639 . . . . 75.219999999999999 110.706 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -130.26 131.97 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.055 0.542 . . . . 71.319999999999993 112.191 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.73 131.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.506 1.122 . . . . 74.340000000000003 109.93 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.708 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 39.8 m-85 -100.79 111.26 23.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.388 0.675 . . . . 73.109999999999999 110.772 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 38.9 mt -82.33 93.56 7.18 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.786 -1.19 . . . . 73.329999999999998 107.786 167.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.0 119.94 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.126 0.57 . . . . 72.439999999999998 110.684 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.1 p -118.4 112.22 19.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.526 0.731 . . . . 60.229999999999997 110.411 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 6' ' ' SER . 44.7 t -86.08 107.21 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 121.287 0.565 . . . . 73.230000000000004 109.492 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.4 -171.21 2.54 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.637 1.175 . . . . 70.409999999999997 110.103 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . 31.2 tt0 60.09 63.41 3.08 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 124.056 0.942 . . . . 74.109999999999999 111.944 166.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.574 2.519 0 C-N-CA 122.69 2.26 . . . . 71.400000000000006 114.491 -166.157 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.869 0.366 . . . . 74.329999999999998 111.206 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -83.72 85.89 7.22 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.935 0.894 . . . . 73.319999999999993 110.37 -170.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.59 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 40.6 mtm180 -84.53 144.74 28.48 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.772 0.829 . . . . 72.140000000000001 112.098 -170.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 74.9 t -139.58 133.83 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.175 0.99 . . . . 74.420000000000002 110.604 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -101.14 145.86 28.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.504 0.722 . . . . 73.239999999999995 110.85 171.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 163.25 32.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.064 0.546 . . . . 73.150000000000006 111.65 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 81' ' ' GLU . 23.7 p -98.24 146.04 30.86 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 123.676 0.79 . . . . 72.040000000000006 111.608 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.16 92.07 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.051 2.5 . . . . 62.140000000000001 112.022 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.16 -14.92 5.38 Favored Glycine 0 N--CA 1.477 1.399 0 CA-C-N 115.617 -0.719 . . . . 43.109999999999999 113.24 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.71 149.34 18.52 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-O 119.504 -0.609 . . . . 74.030000000000001 112.066 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.02 131.09 44.83 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.845 0.823 . . . . 75.549999999999997 111.74 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 55.6 tp -78.83 98.28 6.27 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.778 -0.646 . . . . 75.329999999999998 109.747 172.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -101.51 109.67 21.53 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 110.077 -0.342 . . . . 74.150000000000006 110.077 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.0 103.5 15.8 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.311 -0.626 . . . . 73.450000000000003 109.311 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 t -92.43 101.45 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.769 -0.826 . . . . 73.319999999999993 108.769 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.523 HG12 ' SG ' ' A' ' 66' ' ' CYS . 12.1 t -101.63 130.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.166 0.586 . . . . 73.209999999999994 111.565 -168.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.0 45.58 1.77 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.752 0.821 . . . . 71.120000000000005 110.753 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.521 ' HG ' HG11 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.4 178.04 0.11 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 113.479 0.918 . . . . 70.109999999999999 113.479 169.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 m -87.41 24.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.615 0.766 . . . . 73.049999999999997 112.534 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.24 90.85 0.55 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 119.395 -0.669 . . . . 51.350000000000001 112.197 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.38 127.95 14.79 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.031 2.487 . . . . 73.209999999999994 113.547 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 -111.59 4.3 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.353 -0.385 . . . . 72.430000000000007 113.319 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 -82.99 0.31 Allowed Glycine 0 CA--C 1.547 2.061 0 CA-C-O 119.121 -0.822 . . . . 71.400000000000006 113.744 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HG2' HH22 ' A' ' 26' ' ' ARG . 90.7 Cg_endo -73.99 148.16 91.28 Favored 'Cis proline' 0 C--N 1.382 2.308 0 CA-C-N 120.778 2.289 . . . . 63.439999999999998 113.041 1.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.63 HG13 ' SG ' ' A' ' 66' ' ' CYS . 86.9 t -62.63 136.92 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.57 0.748 . . . . 75.0 111.681 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.51 HH22 ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -97.73 128.98 44.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.421 0.688 . . . . 74.099999999999994 109.762 -177.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -97.57 136.41 38.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.107 0.563 . . . . 71.430000000000007 111.102 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.67 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 88.0 m-85 -133.14 147.97 52.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.028 0.931 . . . . 74.200000000000003 110.516 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 28.3 tptp -136.36 133.38 36.74 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.422 1.089 . . . . 72.5 108.945 165.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.85 17.62 11.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.217 1.007 . . . . 63.329999999999998 112.259 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.01 86.69 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 113.753 0.261 . . . . 71.299999999999997 113.753 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -117.05 135.11 53.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.436 0.694 . . . . 71.409999999999997 109.777 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.85 151.86 17.11 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 113.257 0.836 . . . . 65.129999999999995 113.257 -176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.5 mt -98.18 163.59 12.67 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.347 0.594 . . . . 71.420000000000002 111.204 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.53 151.9 49.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.128 0.971 . . . . 72.340000000000003 109.729 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 77.6 p -79.29 98.39 6.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.843 0.457 . . . . 73.040000000000006 110.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -102.75 -78.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.95 -0.469 . . . . 73.329999999999998 110.925 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.42 -59.66 0.01 OUTLIER Glycine 0 N--CA 1.472 1.071 0 N-CA-C 111.563 -0.615 . . . . 72.400000000000006 111.563 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -70.04 -44.28 69.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.247 0.619 . . . . 74.230000000000004 110.412 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.7 t -82.53 99.03 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.237 0.615 . . . . 70.310000000000002 109.428 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.3 mt-30 -95.2 110.6 22.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.538 0.735 . . . . 74.310000000000002 110.148 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 54.9 mt -106.31 111.99 24.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.914 0.486 . . . . 71.099999999999994 111.206 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.4 tp10 -94.98 106.29 18.27 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.659 1.184 . . . . 70.439999999999998 110.098 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.35 103.76 16.37 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.939 0.496 . . . . 72.150000000000006 109.926 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.02 -164.03 1.24 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.385 0.674 . . . . 73.510000000000005 110.595 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.67 -89.29 0.14 Allowed Glycine 0 C--N 1.353 1.503 0 N-CA-C 112.586 -0.206 . . . . 42.43 112.586 172.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.36 -27.35 24.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.367 0.667 . . . . 70.450000000000003 112.102 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -90.04 87.99 7.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.332 0.653 . . . . 74.530000000000001 111.669 -175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -91.75 129.2 37.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.462 -0.57 . . . . 74.510000000000005 109.462 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 33.5 t -130.31 110.92 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-O 120.811 0.339 . . . . 73.340000000000003 111.582 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -100.25 113.86 26.86 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.775 0.83 . . . . 72.219999999999999 108.807 168.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 72.5 mtp180 -111.34 107.77 17.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.029 0.532 . . . . 75.340000000000003 110.404 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.0 95.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.22 -0.659 . . . . 74.5 109.22 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.24 121.29 9.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.763 0.825 . . . . 74.25 112.241 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 60.35 8.14 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 123.205 0.316 . . . . 73.109999999999999 113.636 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.98 110.55 14.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.523 0.729 . . . . 74.209999999999994 112.623 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -171.75 3.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.368 0.667 . . . . 74.439999999999998 111.26 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m -61.66 -26.28 67.92 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.991 0.737 . . . . 71.430000000000007 112.991 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.92 73.28 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.565 -0.289 . . . . 54.119999999999997 113.761 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.15 0.1 57.34 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.038 0.935 . . . . 74.239999999999995 112.35 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.33 101.32 6.26 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.178 0.591 . . . . 74.140000000000001 109.912 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -167.62 -175.25 37.34 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 114.228 0.451 . . . . 74.450000000000003 114.228 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -89.21 108.86 19.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.122 0.569 . . . . 74.540000000000006 110.575 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -98.62 112.32 24.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.397 0.679 . . . . 73.129999999999995 109.758 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 38.1 tp -91.43 104.34 16.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.457 0.646 . . . . 73.109999999999999 110.336 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.63 ' SG ' HG13 ' A' ' 25' ' ' VAL . 51.3 t -85.7 86.33 7.37 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.738 -0.838 . . . . 70.25 108.738 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.09 105.88 13.54 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.299 -0.864 . . . . 63.350000000000001 110.204 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -113.9 160.33 32.58 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.285 0.634 . . . . 74.310000000000002 111.959 -174.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.78 120.45 8.36 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.587 2.192 . . . . 74.329999999999998 112.351 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 75.53 -60.92 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.526 1.53 . . . . 74.209999999999994 112.387 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 38.4 t70 -105.68 98.91 8.54 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.282 0.633 . . . . 73.430000000000007 111.872 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 t -95.01 129.52 42.05 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.921 0.889 . . . . 73.430000000000007 111.196 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -119.03 131.05 55.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.412 0.685 . . . . 73.510000000000005 112.344 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.46 135.55 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.857 -0.794 . . . . 64.349999999999994 108.857 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -106.2 103.39 12.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.512 0.725 . . . . 72.109999999999999 109.747 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 78.9 mt -78.08 92.87 4.42 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.944 -0.761 . . . . 72.230000000000004 108.944 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 12' ' ' LEU . 55.6 t -87.77 132.88 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.554 -0.748 . . . . 71.349999999999994 110.774 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.0 m -134.56 109.23 8.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.618 -0.719 . . . . 75.230000000000004 110.798 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.6 t -89.08 106.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 107.985 -1.117 . . . . 64.349999999999994 107.985 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.57 12.06 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 113.565 0.95 . . . . 64.549999999999997 113.565 -167.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 7' ' ' THR . 34.7 tt0 -125.71 100.4 31.32 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.781 -0.628 . . . . 74.510000000000005 109.55 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 CA--C 1.568 2.18 0 C-N-CA 123.43 2.753 . . . . 75.040000000000006 114.255 -178.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.559 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 49.7 tpp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.135 -0.321 . . . . 73.340000000000003 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 p -65.22 93.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.37 0.668 . . . . 63.439999999999998 112.045 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -90.93 129.57 36.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 71.030000000000001 110.344 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 78.0 t -131.27 138.34 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 124.062 0.945 . . . . 74.409999999999997 110.007 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -106.45 130.28 54.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.206 0.602 . . . . 72.310000000000002 110.82 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.417 ' HB3' HG21 ' A' ' 79' ' ' VAL . 37.0 t -112.99 171.76 7.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.636 0.774 . . . . 75.409999999999997 111.626 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 81' ' ' GLU . 22.5 p -120.81 138.2 27.37 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 113.453 0.909 . . . . 71.129999999999995 113.453 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.8 Cg_endo -77.49 91.09 1.2 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.605 2.87 . . . . 74.510000000000005 112.734 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.74 -13.58 8.65 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.221 -0.9 . . . . 71.209999999999994 112.23 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.81 -137.39 8.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.495 -0.058 . . . . 63.119999999999997 113.015 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -149.88 150.71 32.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.243 0.617 . . . . 71.400000000000006 111.135 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.88 148.24 23.96 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.527 0.731 . . . . 74.340000000000003 110.795 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.01 109.73 5.01 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.453 0.701 . . . . 74.519999999999996 110.043 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 79.7 mt -106.48 101.58 11.03 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.384 -0.599 . . . . 74.5 109.384 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.6 114.81 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.724 -0.843 . . . . 71.239999999999995 108.724 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.456 HG13 ' HG ' ' A' ' 18' ' ' LEU . 6.9 t -103.24 138.97 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 111.576 -166.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -132.23 30.07 4.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.549 0.74 . . . . 63.130000000000003 110.917 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.456 ' HG ' HG13 ' A' ' 16' ' ' VAL . 1.7 pp -54.77 158.89 2.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.193 0.812 . . . . 72.439999999999998 113.193 171.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -90.83 48.31 1.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.175 0.59 . . . . 73.239999999999995 111.093 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.91 128.25 8.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.983 -0.898 . . . . 73.030000000000001 112.69 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.34 89.92 0.26 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.991 2.461 . . . . 74.150000000000006 113.753 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.49 -84.15 0.1 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.905 -0.589 . . . . 75.510000000000005 114.346 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.41 -173.68 44.79 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.631 -0.538 . . . . 72.340000000000003 113.269 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.33 114.33 3.29 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 119.586 1.693 . . . . 72.150000000000006 112.814 -4.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.67 120.93 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 109.369 -0.604 . . . . 71.209999999999994 109.369 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 50.0 mtt180 -95.38 164.99 12.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.386 1.074 . . . . 73.319999999999993 110.904 -173.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -128.46 130.67 47.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.052 0.941 . . . . 73.219999999999999 109.985 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.761 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 97.9 m-85 -123.35 164.64 18.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.754 0.822 . . . . 75.400000000000006 110.81 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 19.3 tptm -154.3 125.64 7.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.566 0.746 . . . . 75.5 110.05 174.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.09 17.15 9.92 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.187 0.995 . . . . 71.200000000000003 111.333 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.06 -31.07 5.44 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.752 -0.471 . . . . 75.140000000000001 114.237 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.32 147.06 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.091 0.946 . . . . 74.209999999999994 112.614 -170.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.93 153.03 30.39 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 74.319999999999993 115.249 -167.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.5 154.94 18.13 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.753 0.821 . . . . 74.239999999999995 111.17 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.82 148.54 51.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.421 1.088 . . . . 73.209999999999994 109.021 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 t -58.78 97.48 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.383 0.673 . . . . 61.219999999999999 110.747 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -136.05 84.23 2.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.753 0.821 . . . . 72.549999999999997 110.732 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.77 -88.65 0.02 OUTLIER Glycine 0 N--CA 1.478 1.467 0 CA-C-N 115.336 -0.847 . . . . 75.120000000000005 114.424 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.253 1.021 . . . . 72.510000000000005 111.003 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.03 104.83 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.382 0.673 . . . . 64.319999999999993 109.672 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 74.1 mt-30 -109.86 119.3 38.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.13 0.972 . . . . 75.329999999999998 110.354 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.65 137.38 46.69 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.469 0.707 . . . . 73.120000000000005 112.013 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.645 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 15.2 tp10 -133.36 102.3 5.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.534 1.134 . . . . 74.430000000000007 109.369 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -101.9 104.05 14.75 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.421 0.629 . . . . 73.409999999999997 111.361 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.15 75.74 1.64 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.61 0.764 . . . . 75.239999999999995 110.331 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.58 -117.15 6.93 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 115.877 -0.601 . . . . 64.310000000000002 112.783 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.85 -21.99 27.78 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.45 0.7 . . . . 75.109999999999999 111.125 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.92 91.0 1.5 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.743 0.817 . . . . 73.510000000000005 110.155 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -102.93 139.14 38.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.616 0.767 . . . . 75.5 110.068 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 99.7 t -129.16 124.91 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 110.664 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -117.09 122.91 45.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.09 0.956 . . . . 75.109999999999999 108.66 170.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -119.57 134.84 55.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.493 0.717 . . . . 74.310000000000002 109.972 176.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.46 98.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.097 -0.705 . . . . 72.019999999999996 109.097 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.74 115.39 16.46 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.61 -0.723 . . . . 63.32 110.846 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.18 52.95 1.3 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-O 120.881 0.156 . . . . 75.209999999999994 113.089 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.32 160.89 30.47 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.666 0.786 . . . . 72.099999999999994 111.794 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 29.9 ttm180 -166.97 -55.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.991 0.516 . . . . 74.340000000000003 111.495 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -147.64 -47.43 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 122.855 0.462 . . . . 75.239999999999995 111.382 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.48 -17.13 59.43 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.778 0.671 . . . . 42.229999999999997 114.778 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 79' ' ' VAL . 30.7 t70 -72.22 -27.48 62.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.024 0.93 . . . . 72.019999999999996 112.186 174.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.95 103.74 3.85 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 72.299999999999997 111.514 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.422 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . -177.0 -173.5 42.61 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.85 -0.614 . . . . 74.25 113.659 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -90.58 117.13 29.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.78 0.432 . . . . 72.209999999999994 110.039 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -102.27 106.33 17.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.879 0.872 . . . . 73.319999999999993 110.55 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 63.4 tp -91.94 102.08 14.64 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.028 -0.42 . . . . 74.129999999999995 110.242 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -79.34 87.18 5.02 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.771 -0.826 . . . . 73.230000000000004 108.771 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 17.5 t70 -76.04 130.54 38.53 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.764 0.826 . . . . 75.25 111.275 -173.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.555 ' HB1' ' H ' ' A' ' 72' ' ' SER . . . -127.77 143.83 49.04 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 118.664 -0.684 . . . . 74.129999999999995 110.393 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.56 -29.49 7.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 124.248 3.299 . . . . 75.439999999999998 115.099 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -152.32 66.74 0.83 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.632 0.773 . . . . 74.239999999999995 109.494 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.449 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 28.9 t70 -172.42 -80.2 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 123.917 0.887 . . . . 71.129999999999995 110.709 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.555 ' H ' ' HB1' ' A' ' 68' ' ' ALA . 40.0 m 65.46 106.24 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.052 1.341 . . . . 71.109999999999999 112.548 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.15 135.15 49.17 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.818 0.847 . . . . 73.319999999999993 110.938 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.559 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 64.6 mt -100.96 119.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.961 0.504 . . . . 71.200000000000003 110.804 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 2' ' ' THR . 29.3 m-85 -100.34 101.81 12.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.286 0.634 . . . . 74.019999999999996 110.631 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.0 mt -81.88 93.84 6.97 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.317 -0.623 . . . . 74.040000000000006 109.317 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 75.5 t -98.12 121.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.69 0.796 . . . . 60.399999999999999 111.269 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.2 p -121.46 116.64 25.1 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 73.409999999999997 111.371 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 6' ' ' SER . 21.9 t -83.81 110.6 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.316 -0.624 . . . . 73.400000000000006 109.316 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -151.57 -41.63 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.589 0.588 . . . . 71.209999999999994 112.589 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' HG21 ' A' ' 7' ' ' THR . 10.8 tp10 -66.8 106.03 1.03 Allowed Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.93 0.892 . . . . 73.219999999999999 110.607 -175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo . . . . . 0 CA--C 1.57 2.295 0 C-N-CA 123.078 2.519 . . . . 74.409999999999997 113.747 -172.759 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.442 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 110.158 -0.312 . . . . 71.219999999999999 110.158 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.1 m -80.38 83.92 6.12 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.536 0.735 . . . . 75.400000000000006 110.061 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 55.4 mtm180 -83.67 140.41 32.17 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.548 0.739 . . . . 74.040000000000006 112.342 -172.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.01 144.0 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.06 0.944 . . . . 73.150000000000006 109.97 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.94 145.28 51.98 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.455 0.702 . . . . 73.409999999999997 110.848 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.7 t -146.85 171.66 14.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.907 0.883 . . . . 73.099999999999994 110.31 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -76.03 148.87 82.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 112.982 0.734 . . . . 72.239999999999995 112.982 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HA ' HG11 ' A' ' 79' ' ' VAL . 68.0 Cg_endo -75.16 110.87 3.19 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.391 2.727 . . . . 73.400000000000006 112.907 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.47 -7.73 43.29 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.318 -0.855 . . . . 73.140000000000001 112.981 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.67 -156.67 31.53 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 122.767 0.222 . . . . 64.200000000000003 113.174 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 164.41 23.48 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.874 0.47 . . . . 72.540000000000006 110.502 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 47.5 tp -135.58 110.95 9.07 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.623 -0.51 . . . . 74.150000000000006 109.623 167.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.11 110.75 15.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.068 -0.345 . . . . 73.310000000000002 110.068 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.7 mt -89.41 104.72 17.25 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.679 -0.86 . . . . 75.200000000000003 108.679 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.76 107.65 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.445 -0.946 . . . . 74.209999999999994 108.445 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.424 HG11 ' HG ' ' A' ' 18' ' ' LEU . 16.0 t -115.35 129.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.384 0.674 . . . . 71.010000000000005 111.116 -170.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -140.82 43.71 1.83 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.711 0.804 . . . . 71.209999999999994 110.489 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' HG ' HG11 ' A' ' 16' ' ' VAL . 1.7 pp -58.71 167.52 1.49 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.464 0.706 . . . . 74.530000000000001 112.55 170.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -59.77 -49.1 79.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.862 0.465 . . . . 75.450000000000003 111.145 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.0 66.0 1.82 Allowed Glycine 0 C--N 1.356 1.668 0 N-CA-C 115.544 0.978 . . . . 64.200000000000003 115.544 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.24 97.02 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.669 2.246 . . . . 74.329999999999998 112.682 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.0 -154.33 22.4 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.797 -0.638 . . . . 74.409999999999997 113.079 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.24 -179.82 41.42 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.584 -0.564 . . . . 74.409999999999997 113.039 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.9 156.72 97.63 Favored 'Cis proline' 0 C--N 1.376 1.99 0 CA-C-N 119.791 1.796 . . . . 75.230000000000004 113.99 -4.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.87 130.23 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 123.504 0.722 . . . . 73.340000000000003 109.534 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -104.31 147.39 27.56 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.073 0.949 . . . . 72.409999999999997 111.232 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -104.96 132.41 51.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.993 0.517 . . . . 74.150000000000006 111.106 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.726 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.5 m-85 -126.84 165.36 19.49 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.493 1.117 . . . . 72.209999999999994 110.387 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -152.35 114.83 4.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.805 0.842 . . . . 73.230000000000004 110.05 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 t70 72.64 -27.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.653 1.581 . . . . 52.219999999999999 113.965 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.03 -11.17 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.138 0.399 . . . . 71.400000000000006 112.784 -172.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -129.45 138.47 51.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.256 0.623 . . . . 75.230000000000004 110.739 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.726 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.67 150.95 26.12 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.938 0.895 . . . . 71.409999999999997 112.692 177.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.08 134.28 34.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.879 0.472 . . . . 75.310000000000002 110.563 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.07 163.32 12.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.817 0.847 . . . . 71.340000000000003 110.383 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 p -68.74 89.38 0.39 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.601 0.715 . . . . 73.040000000000006 110.854 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 46.9 tt0 -99.1 164.79 12.02 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.42 1.088 . . . . 72.349999999999994 109.935 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.12 -40.09 90.92 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 113.52 0.168 . . . . 74.439999999999998 113.52 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -77.98 -54.34 6.4 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.157 0.583 . . . . 74.430000000000007 110.485 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 66.9 t -82.46 86.77 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 124.086 0.954 . . . . 70.150000000000006 111.63 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 37.8 mt-30 -80.25 133.34 35.98 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.926 0.89 . . . . 74.319999999999993 110.822 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.7 mt -118.95 154.67 32.64 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.102 0.561 . . . . 73.510000000000005 112.131 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.622 ' HG3' HH12 ' A' ' 52' ' ' ARG . 39.8 mt-10 -126.46 113.83 17.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.235 1.014 . . . . 73.400000000000006 110.58 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -94.01 114.9 27.18 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.684 0.794 . . . . 65.340000000000003 110.691 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.88 -68.23 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.765 0.426 . . . . 73.439999999999998 111.596 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.59 139.08 6.02 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 119.19 -0.783 . . . . 65.400000000000006 111.38 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 64.15 -69.87 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.235 1.014 . . . . 55.509999999999998 110.488 -165.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -71.41 116.59 11.92 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.25 0.547 . . . . 74.019999999999996 110.286 166.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -134.13 133.79 41.47 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.075 1.35 . . . . 74.040000000000006 108.269 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -136.53 117.14 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 121.775 -0.578 . . . . 74.109999999999999 110.374 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -101.77 123.92 46.54 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.248 1.019 . . . . 74.0 109.136 172.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.622 HH12 ' HG3' ' A' ' 43' ' ' GLU . 1.5 mpp_? -116.19 108.02 15.61 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.184 0.594 . . . . 75.420000000000002 110.799 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.2 t -96.67 96.71 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.271 -0.64 . . . . 75.510000000000005 109.271 169.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.24 129.18 38.22 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.469 0.708 . . . . 73.150000000000006 110.987 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.47 40.34 33.09 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.151 0.306 . . . . 74.409999999999997 112.891 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 131.87 36.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.137 0.975 . . . . 71.549999999999997 112.265 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -156.75 -84.47 0.05 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.239 0.616 . . . . 73.239999999999995 110.768 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.1 t -92.45 121.9 34.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.623 0.769 . . . . 64.549999999999997 110.547 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.3 -31.7 5.3 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.531 -0.304 . . . . 75.409999999999997 112.732 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.2 -29.21 60.26 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.088 0.955 . . . . 74.200000000000003 111.435 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.15 113.67 10.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.23 -0.655 . . . . 62.340000000000003 109.23 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.12 -170.22 43.32 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 123.123 0.264 . . . . 73.420000000000002 113.242 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -89.16 114.26 25.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.0 0.52 . . . . 74.400000000000006 111.126 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -96.77 154.34 17.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.742 0.817 . . . . 73.230000000000004 109.797 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.4 tp -132.88 105.13 6.94 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.687 0.395 . . . . 75.040000000000006 110.759 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.73 87.93 6.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.226 -1.027 . . . . 65.129999999999995 108.226 169.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.74 95.24 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.796 -1.093 . . . . 74.219999999999999 110.907 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 71' ' ' ASP . . . -100.99 145.67 30.81 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.466 0.706 . . . . 54.420000000000002 110.644 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.206 2.604 . . . . 75.329999999999998 113.19 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 61.09 35.02 18.88 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.51 1.124 . . . . 72.010000000000005 112.335 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 12.6 t70 -140.79 -83.06 0.23 Allowed 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 123.628 0.771 . . . . 70.140000000000001 109.726 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.9 m 56.73 103.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.701 1.371 . . . . 74.430000000000007 114.701 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -107.1 135.54 48.47 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.201 0.6 . . . . 75.140000000000001 111.815 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.39 138.95 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.114 0.965 . . . . 73.200000000000003 109.225 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -115.91 104.1 11.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.586 1.155 . . . . 74.349999999999994 109.546 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.601 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 73.9 mt -78.35 91.28 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.944 -1.132 . . . . 75.540000000000006 107.944 171.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.45 HG12 HD23 ' A' ' 12' ' ' LEU . 82.0 t -99.16 119.64 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 115.344 -0.844 . . . . 72.299999999999997 110.884 -175.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.4 p -112.94 108.07 16.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.828 0.851 . . . . 74.409999999999997 110.037 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 8' ' ' PRO . 46.0 t -95.56 104.28 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.309 -0.997 . . . . 75.420000000000002 108.309 171.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -173.82 -165.43 0.25 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.516 1.126 . . . . 73.450000000000003 108.893 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 64.55 82.34 0.21 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.674 0.79 . . . . 64.230000000000004 109.45 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 C--N 1.384 2.403 0 C-N-CA 123.359 2.706 . . . . 71.109999999999999 114.029 -171.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.645 -0.502 . . . . 75.349999999999994 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 33.3 m -83.23 106.86 15.35 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.911 0.484 . . . . 64.430000000000007 110.595 -172.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -112.44 145.24 40.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.781 0.832 . . . . 75.400000000000006 110.908 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.1 t -138.22 137.55 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 123.636 0.775 . . . . 74.129999999999995 110.68 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -113.55 138.84 49.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.387 0.675 . . . . 74.219999999999999 110.4 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.1 t -129.95 166.02 20.92 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.502 0.721 . . . . 73.120000000000005 110.575 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.2 p -83.28 148.83 56.92 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.237 0.615 . . . . 62.119999999999997 112.208 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -78.78 75.14 5.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.308 2.672 . . . . 73.420000000000002 113.206 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.77 -32.4 0.21 Allowed Glycine 0 C--N 1.342 0.861 0 CA-C-N 115.455 -0.793 . . . . 75.439999999999998 113.159 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.51 -138.1 3.9 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.885 0.314 . . . . 72.0 113.885 -174.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.51 140.08 49.48 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.028 0.531 . . . . 75.329999999999998 109.926 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD21 HG12 ' A' ' 77' ' ' VAL . 55.3 tp -85.74 99.87 11.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.201 0.6 . . . . 72.120000000000005 110.021 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.66 103.15 13.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.116 0.567 . . . . 71.430000000000007 110.279 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 45.0 mt -96.1 102.72 14.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.303 0.641 . . . . 73.420000000000002 110.383 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.77 115.58 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.367 0.667 . . . . 71.140000000000001 109.711 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.523 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -99.35 138.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-O 121.022 0.439 . . . . 75.219999999999999 110.068 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -104.63 38.06 1.98 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.894 0.878 . . . . 75.140000000000001 109.973 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 73' ' ' ARG . 17.2 mt -53.73 -40.12 65.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.96 1.304 . . . . 73.019999999999996 112.334 173.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 t 62.75 19.99 11.8 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.358 1.063 . . . . 54.399999999999999 111.811 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.75 135.36 14.61 Favored Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.911 -0.939 . . . . 75.519999999999996 112.167 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.19 89.37 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.125 2.55 . . . . 73.120000000000005 114.017 -173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.9 -95.11 0.26 Allowed Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.639 -0.71 . . . . 72.129999999999995 113.853 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA2' ' HB3' ' A' ' 69' ' ' PRO . . . 121.67 -89.48 0.43 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-O 119.155 -0.803 . . . . 74.049999999999997 113.082 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.66 145.13 82.23 Favored 'Cis proline' 0 C--N 1.379 2.183 0 CA-C-N 120.266 2.033 . . . . 73.120000000000005 113.859 4.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 68' ' ' ALA . 75.8 t -65.93 129.69 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.4 -0.818 . . . . 72.450000000000003 110.882 173.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 99.2 mtt180 -96.41 127.66 42.61 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.342 -0.614 . . . . 75.150000000000006 109.342 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -98.31 131.59 44.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.02 0.528 . . . . 72.439999999999998 110.014 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.717 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 84.2 m-85 -126.0 136.66 53.24 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.854 0.862 . . . . 65.409999999999997 109.809 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HD3' ' CZ ' ' A' ' 64' ' ' TYR . 17.3 tptm -104.81 116.86 32.73 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.821 0.848 . . . . 74.340000000000003 108.994 171.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.71 -59.51 0.53 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.773 1.629 . . . . 71.120000000000005 111.13 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.79 -9.93 0.03 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 123.867 0.746 . . . . 61.219999999999999 112.355 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -106.2 135.26 47.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.716 0.807 . . . . 75.430000000000007 110.667 -175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 152.82 20.88 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.072 1.138 . . . . 75.209999999999994 114.072 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB3' HG13 ' A' ' 40' ' ' VAL . 4.0 mm? -86.3 161.42 18.75 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.62 -0.718 . . . . 73.120000000000005 110.309 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.51 106.33 5.92 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.916 0.886 . . . . 71.409999999999997 109.637 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 p -63.91 99.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.655 0.782 . . . . 74.340000000000003 111.307 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -124.7 -65.04 1.06 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.468 0.707 . . . . 75.299999999999997 111.565 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.09 -64.9 0.01 OUTLIER Glycine 0 N--CA 1.478 1.438 0 N-CA-C 112.748 -0.141 . . . . 74.319999999999993 112.748 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -67.3 -58.97 3.83 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.979 -0.749 . . . . 73.140000000000001 108.979 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 34' ' ' LEU . 86.9 t -72.91 124.04 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.713 -1.131 . . . . 74.329999999999998 110.47 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.34 113.83 11.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.223 1.009 . . . . 72.519999999999996 109.525 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.413 HD23 HD22 ' A' ' 51' ' ' LEU . 79.5 mt -97.53 108.25 20.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.6 0.76 . . . . 72.129999999999995 110.52 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.553 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.7 tm-20 -98.33 108.29 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.59 1.156 . . . . 74.120000000000005 109.474 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.524 ' HG3' HE22 ' A' ' 49' ' ' GLN . 2.7 mp0 -99.5 102.22 13.7 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.532 0.733 . . . . 65.109999999999999 109.354 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.78 -29.63 17.5 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.232 0.613 . . . . 71.049999999999997 112.207 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 -42.41 1.6 Allowed Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.789 0.233 . . . . 62.219999999999999 112.528 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.17 -28.26 7.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.756 0.822 . . . . 74.340000000000003 110.192 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -105.92 141.3 37.56 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.279 1.032 . . . . 73.150000000000006 111.166 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.524 HE22 ' HG3' ' A' ' 44' ' ' GLN . 16.7 mm100 -125.2 128.34 48.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.778 0.831 . . . . 71.409999999999997 109.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 39.3 t -129.58 110.59 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 112.252 0.464 . . . . 61.119999999999997 112.252 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -93.98 112.81 24.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.084 -0.71 . . . . 73.530000000000001 109.084 168.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 67.4 mtp180 -106.52 119.59 39.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.216 0.606 . . . . 74.030000000000001 110.223 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.25 102.24 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.274 0.629 . . . . 74.439999999999998 109.492 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -74.9 131.93 41.08 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.231 0.613 . . . . 74.340000000000003 111.27 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.5 5.35 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 116.015 -0.538 . . . . 71.230000000000004 112.29 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.38 114.81 25.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.992 0.917 . . . . 73.519999999999996 112.242 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.23 -80.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.13 0.972 . . . . 73.310000000000002 112.262 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.2 p -101.22 -76.65 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.415 0.686 . . . . 74.530000000000001 112.439 -163.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 -6.29 58.29 Favored Glycine 0 C--N 1.356 1.689 0 N-CA-C 114.142 0.417 . . . . 64.140000000000001 114.142 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.38 -24.05 63.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.295 1.038 . . . . 73.340000000000003 111.322 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.533 ' HB3' ' H ' ' A' ' 79' ' ' VAL . . . -73.49 128.4 35.39 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.667 0.787 . . . . 74.430000000000007 109.608 172.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.0 178.78 39.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.67 -0.3 . . . . 72.540000000000006 113.344 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -84.73 115.88 22.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.599 0.36 . . . . 62.240000000000002 110.478 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.46 ' CZ ' ' HD3' ' A' ' 29' ' ' LYS . 50.1 m-85 -102.08 123.19 45.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.132 0.492 . . . . 65.150000000000006 110.966 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 58.8 tp -94.12 100.71 12.76 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.748 0.819 . . . . 73.230000000000004 109.471 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.523 ' SG ' HG21 ' A' ' 16' ' ' VAL . 46.2 t -90.34 88.08 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.622 0.725 . . . . 52.43 109.658 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.4 t70 -72.09 94.87 1.56 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.48 1.112 . . . . 75.450000000000003 111.485 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HA ' HG21 ' A' ' 25' ' ' VAL . . . -76.46 163.11 68.13 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.543 1.137 . . . . 63.310000000000002 113.058 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.493 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 77.7 Cg_endo -75.22 -4.22 15.03 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.569 2.18 . . . . 74.409999999999997 113.892 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -117.63 -56.17 2.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.457 0.703 . . . . 74.049999999999997 110.972 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.21 119.56 5.53 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.346 0.659 . . . . 73.439999999999998 110.011 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.7 t -62.35 128.08 34.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.551 0.741 . . . . 75.129999999999995 111.924 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.478 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -107.37 147.15 30.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.48 0.712 . . . . 75.409999999999997 111.136 -177.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.82 146.96 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.225 0.61 . . . . 74.299999999999997 110.337 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.625 ' HB3' HG22 ' A' ' 77' ' ' VAL . 10.7 m-85 -107.47 139.03 42.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.841 1.256 . . . . 74.230000000000004 110.893 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.11 93.77 4.87 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.599 -1.259 . . . . 65.109999999999999 107.599 162.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG22 ' HB3' ' A' ' 75' ' ' PHE . 78.8 t -101.02 132.2 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.688 -0.687 . . . . 73.040000000000006 111.356 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 76.7 p -127.17 124.54 39.27 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.154 0.982 . . . . 75.319999999999993 108.987 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 61' ' ' ALA . 39.5 t -104.43 105.2 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.012 -1.107 . . . . 72.319999999999993 108.012 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.93 -168.39 0.66 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.923 1.289 . . . . 72.120000000000005 109.618 -170.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 62.53 85.8 0.16 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 123.849 0.86 . . . . 72.230000000000004 109.786 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.572 2.422 0 C-N-CA 123.131 2.554 . . . . 73.430000000000007 113.235 -174.769 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 76' ' ' LEU . 62.9 mtt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.517 0.199 . . . . 75.239999999999995 110.591 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 m -102.58 88.46 3.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.908 0.883 . . . . 74.120000000000005 110.097 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 76' ' ' LEU . 3.8 mpt_? -78.35 138.58 38.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.503 0.721 . . . . 73.310000000000002 111.966 -172.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 91.6 t -140.91 134.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.161 0.984 . . . . 64.239999999999995 109.663 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -90.68 145.28 24.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.098 0.559 . . . . 73.510000000000005 110.401 176.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.42 ' HB2' HD12 ' A' ' 12' ' ' LEU . 41.0 t -127.91 159.73 34.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.212 0.605 . . . . 74.439999999999998 111.848 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' GLU . 18.2 p -112.95 150.67 43.22 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 124.603 1.161 . . . . 63.539999999999999 111.529 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.43 98.49 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.272 2.648 . . . . 72.140000000000001 113.682 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.81 -14.33 22.02 Favored Glycine 0 N--CA 1.479 1.514 0 CA-C-N 116.006 -0.543 . . . . 63.32 114.245 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.53 -143.17 3.89 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 117.54 0.67 . . . . 74.120000000000005 113.764 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.08 127.0 37.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.153 0.581 . . . . 74.340000000000003 111.024 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.9 tp -77.64 123.6 26.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.45 0.7 . . . . 54.509999999999998 110.022 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -115.87 112.65 22.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.199 0.454 . . . . 73.120000000000005 109.891 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 79.0 mt -91.75 101.64 14.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.409 -0.589 . . . . 74.239999999999995 109.409 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.59 108.03 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 108.842 -0.799 . . . . 74.140000000000001 108.842 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.425 HG12 ' HZ ' ' A' ' 75' ' ' PHE . 6.1 t -98.63 113.53 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.572 0.349 . . . . 71.019999999999996 110.863 -169.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -90.2 33.85 0.88 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 122.944 0.498 . . . . 71.109999999999999 111.672 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 mt -51.07 155.93 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.327 1.051 . . . . 74.430000000000007 111.866 164.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 t -75.28 74.14 2.39 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 167.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.52 119.48 16.52 Favored Glycine 0 CA--C 1.541 1.696 0 CA-C-N 115.48 -0.782 . . . . 72.129999999999995 114.415 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.6 29.97 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.818 2.346 . . . . 73.340000000000003 112.895 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -59.42 4.9 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.876 0.274 . . . . 73.209999999999994 112.441 -174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.01 174.69 24.44 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.759 -0.467 . . . . 55.420000000000002 112.719 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.27 148.04 28.46 Favored 'Cis proline' 0 CA--C 1.559 1.736 0 CA-C-N 119.147 1.474 . . . . 72.349999999999994 113.571 -4.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.416 HG13 ' SG ' ' A' ' 66' ' ' CYS . 85.4 t -114.57 136.42 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.223 0.609 . . . . 72.140000000000001 109.695 174.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -98.25 128.17 44.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 74.219999999999999 110.586 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 77.4 m95 -99.39 143.3 29.8 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.399 0.68 . . . . 74.230000000000004 110.76 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 93.3 m-85 -135.45 124.25 23.95 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.426 0.691 . . . . 75.340000000000003 110.725 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.9 tptp -118.51 132.45 56.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.281 0.632 . . . . 73.200000000000003 109.431 172.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.3 26.09 15.97 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.816 0.846 . . . . 71.510000000000005 111.51 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -2.06 86.36 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 114.941 0.737 . . . . 72.510000000000005 114.941 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -125.01 144.29 50.47 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.531 1.166 . . . . 72.400000000000006 111.367 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' TRP . 0.3 OUTLIER -65.68 152.66 43.7 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.053 1.131 . . . . 74.439999999999998 114.053 -172.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.429 ' HB3' HG12 ' A' ' 40' ' ' VAL . 3.9 mm? -88.85 162.02 16.39 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.837 0.855 . . . . 71.349999999999994 111.397 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.16 107.5 4.38 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.05 0.94 . . . . 54.439999999999998 110.164 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 p -66.42 91.94 0.19 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.692 0.797 . . . . 75.109999999999999 112.251 -176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -139.94 -73.3 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.267 0.627 . . . . 73.510000000000005 111.131 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -94.4 1.75 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 122.684 0.183 . . . . 52.049999999999997 113.141 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -70.18 -32.36 70.25 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.474 0.31 . . . . 72.450000000000003 111.495 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 34' ' ' LEU . 87.2 t -81.86 120.27 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.44 0.696 . . . . 74.25 110.493 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 72.6 mt-30 -126.16 97.1 4.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.044 0.938 . . . . 74.25 109.392 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.1 152.38 23.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.28 0.562 . . . . 73.5 112.024 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.75 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.0 tm-20 -138.54 106.45 5.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 107.774 -1.195 . . . . 71.409999999999997 107.774 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -100.34 102.75 14.07 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.533 0.333 . . . . 74.230000000000004 110.152 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.37 3.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.791 0.836 . . . . 72.140000000000001 111.115 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.61 -72.82 0.65 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 116.356 -0.384 . . . . 75.109999999999999 113.318 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.6 19.97 12.62 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.728 0.811 . . . . 74.400000000000006 112.23 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -148.23 151.41 35.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.259 0.552 . . . . 75.219999999999999 112.182 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.1 155.45 38.36 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.143 0.977 . . . . 75.510000000000005 108.61 164.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 84.7 t -141.91 136.62 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.175 0.512 . . . . 73.510000000000005 110.432 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.409 HD13 HD13 ' A' ' 14' ' ' LEU . 1.7 tm? -120.5 116.14 24.82 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.445 -0.946 . . . . 64.420000000000002 108.445 171.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 99.6 mtt180 -108.14 109.43 20.84 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.328 0.651 . . . . 73.329999999999998 111.349 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.3 t -88.42 98.08 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.985 0.514 . . . . 74.530000000000001 110.264 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.95 127.35 32.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.943 0.497 . . . . 62.340000000000003 109.974 168.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.77 33.69 15.21 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 112.675 -0.17 . . . . 62.109999999999999 112.675 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.71 110.87 2.95 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.763 0.825 . . . . 64.200000000000003 111.288 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -163.28 124.49 2.4 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.132 0.573 . . . . 74.030000000000001 109.95 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.516 ' H ' HG11 ' A' ' 79' ' ' VAL . 50.2 m 55.93 -82.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.305 1.442 . . . . 54.240000000000002 113.851 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.9 -7.24 55.41 Favored Glycine 0 C--N 1.363 2.043 0 N-CA-C 114.702 0.641 . . . . 74.019999999999996 114.702 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.69 -32.81 74.41 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.767 0.827 . . . . 73.299999999999997 111.618 170.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.582 ' HB3' ' H ' ' A' ' 79' ' ' VAL . . . -67.82 100.68 0.96 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 75.349999999999994 111.286 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.485 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -166.65 -174.07 35.59 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.679 -0.691 . . . . 62.109999999999999 113.059 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -93.49 113.02 25.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.506 0.722 . . . . 64.310000000000002 110.536 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.663 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 49.2 m-85 -101.17 111.89 24.22 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.393 0.677 . . . . 73.329999999999998 109.947 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 72' ' ' SER . 61.0 tp -92.1 100.6 13.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 122.869 0.468 . . . . 75.129999999999995 110.122 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 25' ' ' VAL . 37.8 t -79.0 86.09 4.89 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.926 0.87 . . . . 73.409999999999997 108.74 170.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -94.13 115.69 28.01 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.423 -1.262 . . . . 73.540000000000006 112.229 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.04 154.48 55.66 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.776 0.83 . . . . 65.010000000000005 109.36 171.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.48 -19.32 17.31 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.616 2.211 . . . . 71.409999999999997 113.003 171.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -76.35 -72.83 0.31 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.879 0.872 . . . . 75.400000000000006 110.92 170.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -139.25 144.12 38.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.834 0.854 . . . . 64.120000000000005 111.4 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.552 ' HB2' HD11 ' A' ' 65' ' ' LEU . 51.5 p -112.4 109.32 18.86 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.916 0.886 . . . . 71.510000000000005 110.382 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.98 127.77 53.37 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.07 0.948 . . . . 74.409999999999997 110.987 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.32 128.43 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.574 0.75 . . . . 73.219999999999999 110.179 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 4.1 m-85 -102.2 111.18 23.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 64.519999999999996 110.15 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.597 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 78.9 mt -85.02 94.12 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 75.519999999999996 109.734 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.6 t -94.71 137.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.711 0.804 . . . . 74.019999999999996 110.639 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -137.17 111.26 8.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.141 0.576 . . . . 75.329999999999998 110.865 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.582 ' H ' ' HB3' ' A' ' 61' ' ' ALA . 46.4 t -83.94 103.43 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.089 -1.078 . . . . 74.409999999999997 108.089 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.94 33.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.848 0.832 . . . . 71.310000000000002 110.978 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 7' ' ' THR . 10.1 tp10 -130.91 92.87 32.66 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 115.17 -0.923 . . . . 75.420000000000002 109.131 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo . . . . . 0 CA--C 1.571 2.342 0 C-N-CA 122.526 2.151 . . . . 53.119999999999997 113.197 -179.472 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.631 0.253 . . . . 75.310000000000002 111.004 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m -75.44 79.17 2.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.31 1.052 . . . . 61.240000000000002 109.746 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -92.55 131.63 37.51 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.512 -1.222 . . . . 74.310000000000002 111.971 -163.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.0 t -121.78 127.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.837 0.855 . . . . 75.310000000000002 110.694 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -93.2 142.89 26.8 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.729 0.812 . . . . 74.420000000000002 109.918 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -137.25 160.23 39.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.647 0.779 . . . . 65.019999999999996 110.968 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -96.16 148.46 34.55 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 123.686 0.795 . . . . 74.150000000000006 111.135 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 95.4 Cg_endo -72.9 128.36 13.14 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.131 2.554 . . . . 65.340000000000003 112.938 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.81 66.12 1.23 Allowed Glycine 0 C--N 1.357 1.748 0 CA-C-N 116.656 -0.247 . . . . 63.140000000000001 113.162 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.74 -115.73 0.38 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 113.439 0.136 . . . . 55.439999999999998 113.439 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -144.67 131.47 20.17 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.054 0.941 . . . . 73.340000000000003 109.731 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 65.3 tp -96.65 101.63 13.27 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.031 0.532 . . . . 74.430000000000007 110.092 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.18 112.08 24.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.905 0.482 . . . . 74.25 110.302 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.6 mt -108.17 103.93 13.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.887 0.875 . . . . 64.120000000000005 109.584 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.577 HG11 ' HG3' ' A' ' 48' ' ' ARG . 74.4 t -91.31 134.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.5 0.72 . . . . 74.109999999999999 109.34 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 49' ' ' GLN . 39.6 t -99.09 141.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 121.292 0.568 . . . . 73.25 111.678 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.57 -34.85 5.71 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.851 0.86 . . . . 75.340000000000003 110.876 166.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' ' 73' ' ' ARG . 6.8 mt 63.52 178.07 0.16 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 123.857 0.863 . . . . 71.400000000000006 113.117 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 t -102.77 -24.72 13.7 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.992 -0.549 . . . . 74.439999999999998 110.144 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.54 103.38 0.83 Allowed Glycine 0 CA--C 1.543 1.819 0 CA-C-O 119.635 -0.536 . . . . 75.150000000000006 112.985 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.51 102.3 1.54 Allowed 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 122.798 2.332 . . . . 70.329999999999998 113.379 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.5 131.57 1.58 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 121.455 -0.402 . . . . 74.219999999999999 113.891 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.94 169.94 49.06 Favored Glycine 0 CA--C 1.547 2.087 0 CA-C-O 119.477 -0.624 . . . . 53.030000000000001 113.587 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.26 115.49 3.92 Favored 'Cis proline' 0 C--N 1.379 2.163 0 CA-C-N 120.079 1.939 . . . . 63.200000000000003 112.962 1.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.87 118.9 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 122.986 0.514 . . . . 74.239999999999995 109.967 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -99.96 146.54 26.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.522 0.729 . . . . 70.450000000000003 111.783 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.406 ' CD1' HD23 ' A' ' 42' ' ' LEU . 79.6 m95 -100.17 134.18 43.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.164 0.986 . . . . 74.010000000000005 110.844 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.59 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 41.6 m-85 -130.03 139.28 51.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.323 1.049 . . . . 74.430000000000007 109.007 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.1 tptp -116.55 127.05 54.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.566 0.621 . . . . 74.329999999999998 110.098 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 56.39 20.49 4.75 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.088 1.355 . . . . 70.239999999999995 113.57 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.53 4.42 32.4 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.095 0.798 . . . . 74.209999999999994 115.095 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -141.3 141.11 33.93 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 1.168 . . . . 74.349999999999994 111.594 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.71 151.77 16.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.456 1.28 . . . . 75.109999999999999 114.456 -171.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 29' ' ' LYS . 19.5 mt -103.34 157.33 17.1 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.753 0.821 . . . . 74.439999999999998 111.002 172.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.86 143.68 44.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.161 0.985 . . . . 75.140000000000001 110.197 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.8 p -80.09 73.21 6.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.178 0.591 . . . . 61.420000000000002 110.511 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -134.68 -92.65 0.31 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.759 0.652 . . . . 75.310000000000002 112.759 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.81 87.28 1.51 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-O 120.012 -0.326 . . . . 64.319999999999993 113.29 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 69.88 -11.52 0.54 Allowed 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.947 1.299 . . . . 74.230000000000004 113.269 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.16 114.17 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.518 1.127 . . . . 71.340000000000003 108.933 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 45.6 mt-30 -113.18 132.25 55.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.476 1.11 . . . . 74.510000000000005 110.145 -173.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.406 HD23 ' CD1' ' A' ' 27' ' ' TRP . 79.6 mt -119.03 92.14 3.73 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.721 0.408 . . . . 74.140000000000001 110.651 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 2.6 mp0 -82.06 98.7 8.77 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.434 0.694 . . . . 73.340000000000003 110.369 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.28 126.88 34.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.178 0.514 . . . . 75.109999999999999 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.81 13.34 2.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.559 0.744 . . . . 63.450000000000003 112.095 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.15 -77.68 0.87 Allowed Glycine 0 C--N 1.35 1.349 0 N-CA-C 112.49 -0.244 . . . . 73.420000000000002 112.49 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.07 -54.02 5.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.035 0.534 . . . . 70.5 110.145 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' HG11 ' A' ' 15' ' ' VAL . 48.3 ttp180 -82.84 90.45 6.93 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.603 0.716 . . . . 74.340000000000003 111.675 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' HG23 ' A' ' 16' ' ' VAL . 9.8 mm100 -95.97 126.67 41.37 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.447 -0.946 . . . . 71.230000000000004 108.447 170.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 46.6 t -114.9 108.94 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 O-C-N 121.911 -0.493 . . . . 74.310000000000002 110.836 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -91.23 112.51 24.45 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.668 -0.864 . . . . 72.140000000000001 108.668 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 74.2 mtp180 -113.49 104.73 12.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.809 0.444 . . . . 74.420000000000002 110.988 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -93.33 97.01 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.185 -1.043 . . . . 71.150000000000006 108.185 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.05 96.09 0.42 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.469 -0.787 . . . . 73.239999999999995 110.705 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.36 -60.1 0.19 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.833 -1.076 . . . . 64.540000000000006 110.886 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . 45.5 69.69 0.43 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.404 1.481 . . . . 73.549999999999997 112.734 174.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.68 -56.24 0.08 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.158 0.429 . . . . 73.150000000000006 112.158 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -141.86 117.81 10.56 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.137 0.575 . . . . 74.340000000000003 110.986 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.25 80.7 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.484 -0.326 . . . . 74.420000000000002 113.462 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.05 -31.87 39.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.341 1.056 . . . . 75.420000000000002 111.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.02 120.19 21.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.583 0.753 . . . . 72.450000000000003 109.784 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.08 -175.58 45.97 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.657 -0.306 . . . . 50.420000000000002 113.706 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.79 112.45 24.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.836 0.454 . . . . 72.409999999999997 110.159 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.456 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 59.4 m-85 -98.84 124.1 43.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.294 0.637 . . . . 75.120000000000005 111.717 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 46.5 tp -94.75 118.32 31.55 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.969 0.508 . . . . 72.230000000000004 110.683 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.3 t -92.63 88.95 6.49 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.157 0.983 . . . . 73.349999999999994 109.93 170.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.59 ' HB3' ' HE1' ' A' ' 28' ' ' TYR . 14.0 t70 -91.11 107.23 19.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.787 0.835 . . . . 63.43 111.44 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.66 157.86 43.34 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.762 0.825 . . . . 60.219999999999999 111.038 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.02 -32.06 96.84 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.334 2.023 . . . . 75.340000000000003 111.979 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.0 101.85 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.259 1.024 . . . . 74.400000000000006 109.138 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 71.42 143.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.709 1.203 . . . . 73.219999999999999 113.811 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.3 p -118.58 120.58 37.91 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.951 0.9 . . . . 72.25 108.97 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HB2' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -109.62 149.32 29.86 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.183 0.593 . . . . 73.349999999999994 111.313 -174.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.05 134.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.183 0.593 . . . . 74.319999999999993 110.581 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 6.5 m-85 -114.7 104.05 11.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.707 1.203 . . . . 74.340000000000003 109.903 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.09 112.39 20.18 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.799 -0.445 . . . . 74.230000000000004 109.799 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.5 t -106.65 131.09 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.059 0.543 . . . . 73.349999999999994 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -126.76 108.8 11.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.527 0.731 . . . . 73.439999999999998 110.322 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.16 107.4 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.336 0.655 . . . . 62.020000000000003 109.328 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.34 178.45 8.67 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.542 0.737 . . . . 55.130000000000003 111.479 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 61.39 79.78 0.27 Allowed Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 124.696 1.198 . . . . 75.120000000000005 111.213 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.573 2.452 0 C-N-CA 123.393 2.729 . . . . 74.099999999999994 114.291 -176.568 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.87 0.366 . . . . 65.230000000000004 111.44 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.0 m -75.55 86.41 2.64 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.333 1.053 . . . . 73.230000000000004 110.562 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 44.7 mtm180 -89.08 152.1 21.85 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.778 0.659 . . . . 74.450000000000003 112.778 -172.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.7 t -139.64 135.5 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 124.328 1.051 . . . . 72.439999999999998 110.34 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -94.36 145.95 24.4 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 122.992 0.517 . . . . 74.109999999999999 110.927 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.459 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.2 t -134.29 156.52 48.3 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.601 0.76 . . . . 72.219999999999999 110.762 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -84.62 147.01 48.09 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 123.144 0.577 . . . . 70.5 111.419 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.9 82.12 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.29 2.66 . . . . 72.239999999999995 113.298 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.3 7.38 4.45 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 114.521 -1.218 . . . . 71.450000000000003 112.543 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.94 26.38 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 114.724 0.649 . . . . 72.319999999999993 114.724 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.71 110.53 21.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.865 0.866 . . . . 74.209999999999994 110.456 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.9 tp -74.09 138.92 44.26 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.433 -0.58 . . . . 74.150000000000006 109.433 169.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -145.02 111.39 5.65 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.27 0.628 . . . . 74.530000000000001 109.957 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 46.0 mt -98.99 101.65 13.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.098 -0.705 . . . . 74.340000000000003 109.098 175.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -97.4 106.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 108.46 -0.941 . . . . 70.019999999999996 108.46 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 18.2 t -98.93 141.37 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.974 0.91 . . . . 74.420000000000002 111.324 -166.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -137.75 48.86 1.99 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.371 0.668 . . . . 74.239999999999995 109.89 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -57.04 174.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.075 1.139 . . . . 74.510000000000005 114.075 172.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -91.49 20.52 5.27 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.556 0.742 . . . . 64.109999999999999 112.408 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 121.36 19.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.905 -0.941 . . . . 72.030000000000001 112.888 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.89 21.99 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.472 2.781 . . . . 73.349999999999994 115.006 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.51 -105.27 0.22 Allowed Glycine 0 C--N 1.35 1.353 0 O-C-N 122.416 -0.177 . . . . 51.549999999999997 113.157 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.96 -176.91 40.65 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.421 -0.655 . . . . 63.439999999999998 113.103 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.18 161.76 84.53 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 119.783 1.791 . . . . 65.400000000000006 112.771 -4.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.452 HG12 ' SG ' ' A' ' 66' ' ' CYS . 62.4 t -107.23 147.35 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.93 0.892 . . . . 74.219999999999999 110.293 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.622 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 94.6 mtt180 -97.83 164.79 12.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.726 0.81 . . . . 73.209999999999994 111.105 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -133.14 122.98 24.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.755 0.822 . . . . 75.349999999999994 111.101 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.2 m-85 -120.2 163.97 16.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.868 0.867 . . . . 74.519999999999996 110.908 175.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -152.3 119.98 6.09 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.953 0.901 . . . . 75.049999999999997 109.898 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 62.65 21.07 12.48 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 124.557 1.143 . . . . 72.450000000000003 111.965 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.54 55.64 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 114.696 0.638 . . . . 75.329999999999998 114.696 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -128.78 128.79 44.67 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.865 0.832 . . . . 75.340000000000003 110.988 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.47 151.04 25.03 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.037 0.754 . . . . 74.329999999999998 113.037 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.3 mt -95.24 154.46 17.18 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.278 0.631 . . . . 72.310000000000002 110.536 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.04 146.82 28.56 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.491 0.716 . . . . 62.399999999999999 110.43 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 45.3 p -74.46 85.03 2.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.252 0.621 . . . . 75.150000000000006 110.899 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -121.35 -175.94 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.968 0.907 . . . . 72.439999999999998 112.073 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.76 147.38 43.31 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 110.905 -0.878 . . . . 64.420000000000002 110.905 164.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 74.7 -55.22 0.66 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.232 1.413 . . . . 74.040000000000006 111.843 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.06 89.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.141 0.976 . . . . 73.450000000000003 110.117 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -91.86 134.36 34.83 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.028 0.931 . . . . 62.450000000000003 111.657 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.522 HD23 HD23 ' A' ' 51' ' ' LEU . 66.8 mt -114.25 130.98 56.65 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.936 0.494 . . . . 75.519999999999996 110.374 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.19 121.58 39.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.573 0.749 . . . . 74.140000000000001 110.146 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -108.06 102.05 11.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.532 0.682 . . . . 70.150000000000006 110.095 171.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.98 -56.09 2.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.226 0.61 . . . . 74.140000000000001 109.612 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.3 -90.47 0.1 Allowed Glycine 0 N--CA 1.475 1.242 0 N-CA-C 111.192 -0.763 . . . . 71.209999999999994 111.192 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.64 -42.0 82.97 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.37 0.668 . . . . 74.129999999999995 110.367 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.6 ttp180 -91.99 118.34 30.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.332 -0.849 . . . . 72.319999999999993 110.968 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -116.42 135.22 54.03 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.569 -0.9 . . . . 73.140000000000001 108.569 169.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 61.6 t -125.78 109.74 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.246 0.546 . . . . 74.420000000000002 111.932 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.522 HD23 HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -101.11 121.96 42.74 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.246 1.018 . . . . 73.299999999999997 108.725 169.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -120.08 107.51 13.14 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.717 -0.475 . . . . 74.329999999999998 109.717 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -104.1 109.33 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 118.576 0.625 . . . . 60.140000000000001 110.017 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -83.62 145.78 28.64 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.526 0.73 . . . . 72.239999999999995 110.799 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.6 54.26 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 112.325 -0.31 . . . . 71.409999999999997 112.325 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 112.1 7.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.616 1.166 . . . . 62.340000000000003 111.763 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.26 -95.39 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 118.46 0.573 . . . . 71.019999999999996 112.534 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -83.43 -61.81 1.75 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.749 -0.595 . . . . 45.32 111.631 -168.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.68 -5.27 73.4 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 116.217 -0.447 . . . . 64.400000000000006 114.184 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.01 -35.26 43.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.387 0.675 . . . . 74.439999999999998 111.673 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 106.56 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.035 0.534 . . . . 63.020000000000003 111.149 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.71 -169.81 40.88 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.854 -0.612 . . . . 65.140000000000001 114.369 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.6 121.67 27.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.924 0.89 . . . . 75.150000000000006 111.062 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.2 m-85 -111.7 112.61 24.42 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.94 0.896 . . . . 75.409999999999997 110.174 173.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -93.21 101.25 13.52 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.752 -0.592 . . . . 74.349999999999994 111.027 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.452 ' SG ' HG12 ' A' ' 25' ' ' VAL . 37.8 t -82.2 89.82 6.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.908 0.883 . . . . 75.120000000000005 109.028 171.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 31.3 t70 -89.0 92.59 9.29 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.627 0.771 . . . . 70.519999999999996 112.261 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 71' ' ' ASP . . . -85.64 159.29 55.64 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 122.957 0.503 . . . . 53.32 111.752 177.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -45.61 101.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 123.615 2.877 . . . . 73.140000000000001 114.159 171.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 63.68 13.98 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.2 1.4 . . . . 71.150000000000006 114.025 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.442 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 24.3 t70 -147.19 81.1 1.53 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.48 0.657 . . . . 74.340000000000003 111.045 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 65' ' ' LEU . 88.1 p -78.99 148.52 32.53 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.331 -0.395 . . . . 72.010000000000005 110.803 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 126.83 29.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.948 0.499 . . . . 73.239999999999995 110.303 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.0 130.16 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.852 -0.425 . . . . 73.219999999999999 109.852 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 14.0 m-85 -109.26 102.94 11.83 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.336 1.054 . . . . 73.140000000000001 109.611 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 71.0 mt -81.48 92.15 6.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.212 -1.033 . . . . 72.450000000000003 108.212 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.8 t -83.12 114.98 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.767 -0.651 . . . . 74.25 110.012 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -103.07 107.58 18.43 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.227 -0.657 . . . . 72.25 109.227 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 6' ' ' SER . 20.6 t -94.17 107.98 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 109.765 -0.457 . . . . 74.219999999999999 109.765 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.64 -172.2 3.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.107 0.963 . . . . 73.430000000000007 109.828 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 63.86 84.27 0.19 Allowed Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 123.965 0.906 . . . . 72.239999999999995 110.677 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--N 1.384 2.43 0 C-N-CA 123.247 2.631 . . . . 71.340000000000003 114.089 -175.033 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.529 ' SD ' HD13 ' A' ' 76' ' ' LEU . 65.7 mtt . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.545 0.212 . . . . 73.109999999999999 110.62 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 m -80.6 91.35 5.81 Favored 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 124.875 1.27 . . . . 74.209999999999994 110.933 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.624 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 32.6 mtt180 -82.05 139.43 34.47 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.37 1.248 . . . . 74.430000000000007 114.37 -170.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 76.9 t -141.8 135.83 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 124.926 1.29 . . . . 63.32 109.956 172.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -106.48 144.43 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.175 0.59 . . . . 73.219999999999999 110.36 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.45 ' HB3' HG23 ' A' ' 79' ' ' VAL . 37.3 t -135.14 161.92 33.97 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.419 0.688 . . . . 74.129999999999995 110.718 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -102.96 147.16 33.69 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 123.555 0.742 . . . . 73.040000000000006 111.696 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.44 107.95 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.584 2.856 . . . . 73.209999999999994 114.086 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.89 47.23 1.28 Allowed Glycine 0 C--N 1.355 1.622 0 C-N-CA 123.001 0.334 . . . . 74.109999999999999 113.593 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.45 -114.17 0.93 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 112.167 -0.373 . . . . 72.200000000000003 112.167 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.1 164.14 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.48 0.712 . . . . 64.109999999999999 110.478 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 62.4 tp -128.98 102.49 6.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.441 0.697 . . . . 73.120000000000005 109.613 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -110.11 104.63 13.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.101 0.56 . . . . 72.530000000000001 109.794 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.471 HD13 HD11 ' A' ' 51' ' ' LEU . 65.7 mt -90.43 101.94 14.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.529 -0.545 . . . . 74.540000000000006 109.529 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.73 119.7 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.129 -1.063 . . . . 72.040000000000006 108.129 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 20.1 t -113.36 133.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.621 0.768 . . . . 74.349999999999994 111.075 -168.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -134.58 54.72 1.93 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.839 0.856 . . . . 75.030000000000001 109.351 166.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.447 ' H ' HG11 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -59.07 160.71 5.83 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.071 0.767 . . . . 71.109999999999999 113.071 170.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -77.87 -1.59 32.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.773 0.829 . . . . 74.209999999999994 112.281 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.92 -178.41 41.27 Favored Glycine 0 CA--C 1.545 1.942 0 CA-C-O 119.918 -0.379 . . . . 71.030000000000001 113.543 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 -37.98 3.68 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.842 2.361 . . . . 74.230000000000004 113.54 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.89 -130.19 8.15 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.75 -0.54 . . . . 71.109999999999999 111.75 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.434 ' HA2' ' N ' ' A' ' 25' ' ' VAL . . . -91.23 156.93 24.55 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.445 -0.642 . . . . 65.049999999999997 114.297 -174.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.76 106.2 0.82 Allowed 'Cis proline' 0 C--N 1.383 2.388 0 CA-C-N 119.548 1.674 . . . . 72.329999999999998 112.552 1.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.434 ' N ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -86.1 162.16 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 C-N-CA 123.029 0.532 . . . . 75.530000000000001 110.991 -174.407 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 36.6 mmt180 -98.87 150.63 21.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.041 0.936 . . . . 74.25 110.105 171.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.39 145.33 51.14 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.376 1.07 . . . . 73.409999999999997 109.066 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.5 m-85 -135.72 124.3 23.64 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.098 0.559 . . . . 73.200000000000003 110.668 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 21.1 tptm -122.19 131.79 54.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.313 0.645 . . . . 74.510000000000005 109.951 172.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 68.15 16.25 9.41 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.624 1.169 . . . . 75.25 111.627 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.95 61.23 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 113.609 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.31 135.93 39.33 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.569 0.747 . . . . 64.109999999999999 110.584 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 145.29 40.92 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.861 0.864 . . . . 71.230000000000004 113.111 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.481 ' HB3' HG12 ' A' ' 40' ' ' VAL . 53.6 mt -89.31 135.4 33.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.484 0.714 . . . . 74.140000000000001 110.428 174.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.44 158.97 15.98 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.783 0.833 . . . . 74.25 110.256 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 p -69.85 89.98 0.59 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.723 0.773 . . . . 75.239999999999995 110.212 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -112.76 166.02 11.76 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.424 1.09 . . . . 73.450000000000003 111.088 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.18 97.01 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 113.791 0.276 . . . . 72.420000000000002 113.791 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HG3' ' HB3' ' A' ' 54' ' ' GLN . 5.0 mpt_? -77.29 -37.73 52.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.675 0.39 . . . . 75.409999999999997 111.422 172.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 34' ' ' LEU . 53.9 t -102.69 82.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.637 0.732 . . . . 63.219999999999999 110.712 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.55 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 73.5 mt-30 -82.23 104.59 12.65 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.547 0.739 . . . . 74.019999999999996 111.378 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -98.65 113.52 25.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.566 0.747 . . . . 74.349999999999994 112.4 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -91.81 132.46 36.41 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.567 0.747 . . . . 74.450000000000003 109.861 170.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.614 ' HA ' HE22 ' A' ' 49' ' ' GLN . 9.8 pt20 -125.28 109.35 12.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.764 0.826 . . . . 75.439999999999998 110.315 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.69 177.4 9.54 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.552 0.741 . . . . 73.239999999999995 111.925 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.02 113.25 5.08 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.416 -0.658 . . . . 71.549999999999997 112.769 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.26 -56.83 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 125.657 1.583 . . . . 63.530000000000001 113.593 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 44.7 ttp180 -83.18 111.92 19.37 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.182 0.438 . . . . 71.099999999999994 112.182 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.614 HE22 ' HA ' ' A' ' 44' ' ' GLN . 11.2 mm100 -101.97 147.21 26.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.674 0.79 . . . . 73.510000000000005 109.111 166.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 61.3 t -137.94 110.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.782 -0.573 . . . . 73.239999999999995 111.001 175.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -95.7 123.59 39.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.663 -0.866 . . . . 74.239999999999995 108.663 169.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.0 mtm180 -121.68 108.52 13.64 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.889 0.476 . . . . 75.400000000000006 111.403 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -91.47 120.87 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.328 0.651 . . . . 75.420000000000002 110.242 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.448 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . 33.4 tt0 -75.35 122.58 23.97 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.46 0.704 . . . . 63.130000000000003 109.853 173.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.28 -78.5 0.38 Allowed Glycine 0 C--N 1.346 1.138 0 N-CA-C 112.357 -0.297 . . . . 52.119999999999997 112.357 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 56.13 80.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.521 1.129 . . . . 72.120000000000005 112.178 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -159.96 -68.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.9 0.48 . . . . 74.540000000000006 111.62 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.5 m -137.51 119.19 15.03 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.384 0.673 . . . . 73.549999999999997 110.227 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.79 -15.77 53.64 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 116.433 -0.349 . . . . 74.439999999999998 112.931 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.14 -20.6 51.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.525 1.13 . . . . 75.430000000000007 111.845 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.59 122.1 27.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.449 0.7 . . . . 74.340000000000003 109.948 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . 168.45 -170.5 42.21 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.319 -0.4 . . . . 73.430000000000007 113.352 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -89.63 119.15 29.8 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.845 0.858 . . . . 75.219999999999999 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 62.0 m-85 -104.96 106.07 16.39 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.797 0.839 . . . . 63.210000000000001 109.667 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.673 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.1 tp -94.71 99.69 11.75 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.425 0.69 . . . . 74.230000000000004 110.489 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.1 t -81.77 93.19 6.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.335 0.654 . . . . 72.530000000000001 110.167 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 28.2 t70 -97.04 132.54 42.75 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.592 0.757 . . . . 74.400000000000006 112.238 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.22 152.98 80.49 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.835 0.854 . . . . 73.239999999999995 109.317 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.99 -21.2 33.04 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.286 2.657 . . . . 74.219999999999999 113.883 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -59.36 2.22 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.6 0.76 . . . . 65.120000000000005 110.132 174.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.72 149.94 37.9 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.05 0.54 . . . . 73.129999999999995 111.784 -171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -131.45 135.2 46.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.769 0.828 . . . . 74.120000000000005 111.041 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -113.5 134.75 54.5 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.88 . . . . 74.219999999999999 111.267 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.435 HG12 HD11 ' A' ' 65' ' ' LEU . 57.5 mt -89.17 123.11 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.1 -0.704 . . . . 70.120000000000005 109.1 170.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.499 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.0 m-85 -100.11 103.84 15.36 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.933 -0.395 . . . . 73.349999999999994 109.933 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.624 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 82.1 mt -78.1 92.53 4.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.949 -0.76 . . . . 73.25 108.949 175.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.5 t -101.49 113.11 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.112 -0.949 . . . . 71.430000000000007 110.1 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -110.4 107.78 17.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.25 0.547 . . . . 75.140000000000001 109.588 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 6' ' ' SER . 61.5 t -84.74 120.56 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.405 -0.961 . . . . 71.230000000000004 108.405 171.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.4 -177.71 4.16 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.63 0.772 . . . . 65.010000000000005 110.459 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 60.77 81.77 0.24 Allowed Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.937 0.895 . . . . 74.209999999999994 111.431 166.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo . . . . . 0 C--N 1.382 2.313 0 C-N-CA 123.133 2.555 . . . . 72.450000000000003 113.429 -177.189 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.886 -0.413 . . . . 74.129999999999995 109.886 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 m -94.12 95.88 9.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.75 -0.833 . . . . 74.239999999999995 108.75 -174.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -122.79 148.97 44.75 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.51 0.724 . . . . 75.420000000000002 112.42 -169.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.9 t -138.93 138.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.874 0.87 . . . . 72.209999999999994 110.427 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.94 117.95 35.33 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.357 0.663 . . . . 74.409999999999997 110.029 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t -94.49 161.6 14.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.634 0.774 . . . . 73.099999999999994 110.546 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.2 153.7 37.88 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 123.283 0.633 . . . . 73.450000000000003 111.387 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -56.24 99.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.533 2.822 . . . . 65.299999999999997 112.95 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.34 18.62 68.51 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 116.118 -0.492 . . . . 51.32 113.733 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.81 -10.45 69.67 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 114.485 0.554 . . . . 63.43 114.485 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 67.64 118.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.676 1.59 . . . . 71.299999999999997 112.263 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.7 tp -81.44 140.49 34.61 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.671 0.789 . . . . 74.310000000000002 111.678 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HG2' HG22 ' A' ' 15' ' ' VAL . 45.2 tt0 -142.22 100.8 3.79 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.69 0.796 . . . . 75.340000000000003 110.273 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.0 mt -89.86 103.63 16.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.641 0.776 . . . . 75.319999999999993 109.916 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.439 HG22 ' HG2' ' A' ' 13' ' ' GLU . 61.4 t -104.79 110.21 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.646 0.778 . . . . 75.450000000000003 109.339 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.428 HG21 ' SG ' ' A' ' 66' ' ' CYS . 11.6 m -99.17 146.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.626 0.726 . . . . 60.43 111.05 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -122.38 29.42 6.97 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.864 -1.062 . . . . 73.5 109.234 165.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.506 HD23 ' SG ' ' A' ' 66' ' ' CYS . 0.9 OUTLIER -41.75 139.25 1.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.052 1.13 . . . . 72.349999999999994 114.052 176.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -94.66 31.46 1.79 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.462 0.705 . . . . 63.409999999999997 111.285 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.99 -176.3 45.82 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-N 116.258 -0.428 . . . . 61.32 113.064 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 175.75 10.89 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 75.430000000000007 113.53 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.83 132.92 46.76 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.877 -0.601 . . . . 63.340000000000003 112.936 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.02 -131.78 0.96 Allowed Glycine 0 CA--C 1.548 2.134 0 CA-C-O 119.146 -0.808 . . . . 61.420000000000002 114.872 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.1 124.29 5.19 Favored 'Cis proline' 0 C--N 1.386 2.514 0 CA-C-N 120.695 2.247 . . . . 73.230000000000004 113.641 -0.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.44 HG13 ' SG ' ' A' ' 66' ' ' CYS . 98.6 t -73.7 142.84 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 C-N-CA 123.394 0.677 . . . . 74.5 110.855 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -96.54 169.89 9.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.26 1.024 . . . . 73.019999999999996 111.199 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.471 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 81.6 m95 -131.52 125.96 33.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.958 0.903 . . . . 73.319999999999993 110.467 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.3 m-85 -116.93 163.16 16.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.353 1.061 . . . . 74.530000000000001 109.973 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -159.48 128.21 5.15 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.303 0.641 . . . . 75.129999999999995 110.547 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.52 23.29 13.59 Favored 'General case' 0 CA--C 1.566 1.585 0 C-N-CA 124.306 1.042 . . . . 75.540000000000006 111.631 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.6 -8.36 63.95 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 115.754 -0.657 . . . . 52.140000000000001 114.505 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -129.64 138.13 51.04 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.199 0.999 . . . . 73.430000000000007 111.46 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.748 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -58.35 146.61 33.97 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.754 0.822 . . . . 64.420000000000002 112.759 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.556 ' HB3' HG13 ' A' ' 40' ' ' VAL . 38.6 mt -87.2 134.8 33.49 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.309 -0.405 . . . . 75.219999999999999 110.066 171.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.14 160.46 15.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.552 0.741 . . . . 74.030000000000001 110.775 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 p -72.47 83.7 1.1 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.705 0.764 . . . . 65.109999999999999 110.687 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.71 165.08 11.57 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.987 0.915 . . . . 72.299999999999997 110.378 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.28 -44.66 93.31 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 114.088 0.395 . . . . 73.019999999999996 114.088 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.592 ' HG3' HG23 ' A' ' 40' ' ' VAL . 15.5 ptm180 -77.95 -37.74 46.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.002 0.521 . . . . 74.5 111.075 174.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.592 HG23 ' HG3' ' A' ' 39' ' ' ARG . 59.7 t -94.34 83.08 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.704 0.802 . . . . 74.510000000000005 110.387 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 34.0 mm-40 -81.46 106.09 13.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.608 0.763 . . . . 72.329999999999998 111.237 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.44 101.59 13.52 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.184 0.594 . . . . 72.5 110.86 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 32.0 tt0 -92.42 98.76 11.68 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.442 0.697 . . . . 73.340000000000003 109.842 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.619 ' HG2' HE22 ' A' ' 49' ' ' GLN . 0.2 OUTLIER -87.27 102.06 14.13 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 74.129999999999995 108.215 173.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.07 -179.27 3.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.843 0.857 . . . . 74.409999999999997 110.922 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.26 89.31 0.07 OUTLIER Glycine 0 C--N 1.352 1.452 0 O-C-N 123.387 0.429 . . . . 74.310000000000002 112.819 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.39 -27.93 0.19 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 125.965 1.706 . . . . 75.310000000000002 113.36 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -85.3 104.54 15.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.441 0.696 . . . . 74.099999999999994 111.002 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.619 HE22 ' HG2' ' A' ' 44' ' ' GLN . 14.2 mm100 -98.5 112.16 24.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.097 0.559 . . . . 73.319999999999993 109.549 173.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 61.6 t -109.5 108.98 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.054 0.454 . . . . 72.129999999999995 110.836 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.21 117.53 30.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.641 -0.874 . . . . 74.129999999999995 108.641 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.7 mtm-85 -113.04 117.33 31.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.525 0.73 . . . . 74.329999999999998 109.891 174.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.06 100.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.31 0.576 . . . . 75.430000000000007 109.681 171.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.46 139.75 42.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.727 -0.67 . . . . 74.129999999999995 109.666 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.86 24.79 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 112.311 -0.316 . . . . 75.099999999999994 112.311 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.3 87.19 2.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.143 0.577 . . . . 73.200000000000003 111.189 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.406 ' O ' HG12 ' A' ' 79' ' ' VAL . 78.7 ttt180 -127.51 -82.86 0.6 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.229 0.612 . . . . 74.310000000000002 111.592 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 m -93.09 -70.66 0.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.172 0.589 . . . . 74.310000000000002 111.539 -173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.93 28.33 4.11 Favored Glycine 0 CA--C 1.543 1.784 0 N-CA-C 114.754 0.662 . . . . 55.43 114.754 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -93.44 -31.86 14.44 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.398 0.679 . . . . 73.299999999999997 110.812 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.13 107.43 2.31 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.804 0.842 . . . . 64.129999999999995 111.285 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.25 178.02 43.21 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 114.14 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.03 108.8 17.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.08 0.552 . . . . 73.310000000000002 110.14 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 19.5 m-85 -93.95 155.52 17.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.495 0.718 . . . . 74.430000000000007 109.898 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.698 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 44.2 tp -144.1 102.87 3.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.031 0.382 . . . . 74.140000000000001 112.031 -173.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 18' ' ' LEU . 34.3 t -79.57 88.85 5.09 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 109.147 -0.686 . . . . 73.049999999999997 109.147 170.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.56 102.12 14.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.288 1.035 . . . . 64.109999999999999 112.786 -167.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.14 162.99 59.75 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.397 0.679 . . . . 75.230000000000004 110.51 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.73 31.9 0.19 Allowed 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.067 2.511 . . . . 74.430000000000007 115.104 174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -172.39 -62.96 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.544 1.138 . . . . 75.430000000000007 109.065 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.67 176.35 6.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.705 0.802 . . . . 64.140000000000001 111.019 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.501 ' HB2' HD11 ' A' ' 65' ' ' LEU . 85.5 p -165.64 134.89 3.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.406 0.682 . . . . 71.319999999999993 110.322 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -106.78 124.4 49.56 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.38 0.672 . . . . 73.319999999999993 110.351 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.56 HG13 HD12 ' A' ' 65' ' ' LEU . 3.2 mp -102.32 124.49 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.238 0.615 . . . . 74.510000000000005 110.073 -175.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 64.1 m-85 -101.17 126.38 47.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.344 1.058 . . . . 75.019999999999996 111.207 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.52 93.36 8.05 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.747 -1.205 . . . . 74.349999999999994 107.747 161.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 63.2 t -85.34 106.32 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.273 -0.639 . . . . 73.0 109.273 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.1 p -103.51 117.25 34.0 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.801 . . . . 63.420000000000002 110.027 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 57' ' ' ARG . 63.3 t -84.17 106.64 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.022 -0.732 . . . . 63.520000000000003 109.022 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 11.3 pt-20 -150.39 -166.94 2.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.336 1.054 . . . . 74.409999999999997 110.216 -174.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.41 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 40.1 mt-10 57.88 54.37 6.29 Favored Pre-proline 0 CA--C 1.571 1.765 0 C-N-CA 124.209 1.004 . . . . 73.540000000000006 112.121 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 81' ' ' GLU . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.455 0 C-N-CA 123.11 2.54 . . . . 73.25 112.466 -174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 tpp . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 109.616 -0.513 . . . . 73.129999999999995 109.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.4 p -62.94 108.01 1.11 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.359 0.664 . . . . 75.140000000000001 111.363 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.79 120.28 38.76 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.485 -0.931 . . . . 73.409999999999997 108.485 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.496 ' HB ' HG23 ' A' ' 77' ' ' VAL . 98.8 t -122.24 140.94 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.706 0.802 . . . . 73.230000000000004 109.948 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.87 127.93 44.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.058 0.543 . . . . 75.409999999999997 109.54 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -122.34 162.33 21.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.245 0.618 . . . . 60.549999999999997 111.179 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.75 140.5 26.42 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.35 0.66 . . . . 75.230000000000004 111.939 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.84 119.33 6.01 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.103 2.535 . . . . 75.120000000000005 112.97 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.56 30.79 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.073 -0.512 . . . . 62.119999999999997 113.078 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.93 -131.22 3.98 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 117.094 0.447 . . . . 74.430000000000007 112.957 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -146.97 150.05 34.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.472 0.709 . . . . 73.450000000000003 110.837 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 14' ' ' LEU . 64.3 tp -97.61 143.62 28.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.017 0.927 . . . . 73.019999999999996 110.283 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.56 113.38 6.76 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.284 0.633 . . . . 64.409999999999997 109.771 171.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 12' ' ' LEU . 75.6 mt -107.21 103.18 12.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.988 0.915 . . . . 64.530000000000001 109.6 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG23 HG21 ' A' ' 50' ' ' VAL . 44.7 t -104.09 117.2 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 109.105 -0.702 . . . . 74.310000000000002 109.105 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.617 HG21 ' SG ' ' A' ' 66' ' ' CYS . 1.6 t -97.85 147.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.095 0.474 . . . . 74.109999999999999 110.493 -174.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.41 29.81 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.853 0.861 . . . . 71.439999999999998 110.09 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' H ' HG13 ' A' ' 16' ' ' VAL . 1.1 pp -53.2 158.59 1.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.791 1.034 . . . . 71.230000000000004 113.791 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 m -95.05 23.53 5.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.414 -0.812 . . . . 71.329999999999998 111.214 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.73 119.14 8.83 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.14 -0.811 . . . . 51.399999999999999 112.79 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.93 104.99 0.89 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.29 2.66 . . . . 75.099999999999994 114.221 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.38 52.01 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.358 0.903 . . . . 70.530000000000001 115.358 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.14 176.29 18.39 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-O 119.318 -0.712 . . . . 35.329999999999998 112.99 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.36 119.97 5.52 Favored 'Cis proline' 0 C--N 1.377 2.038 0 CA-C-N 120.052 1.926 . . . . 64.109999999999999 113.962 1.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -82.54 115.72 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 109.088 -0.708 . . . . 55.130000000000003 109.088 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -98.33 137.09 37.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.646 0.778 . . . . 75.140000000000001 111.659 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -96.3 124.34 40.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.459 0.704 . . . . 74.420000000000002 110.629 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 86.9 m-85 -119.03 134.71 55.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.778 0.831 . . . . 74.140000000000001 110.486 176.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.4 tptp -119.46 128.12 53.7 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.053 0.541 . . . . 75.439999999999998 109.842 173.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 63.37 5.7 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.644 1.178 . . . . 55.210000000000001 113.858 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.97 -25.01 4.2 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.555 -0.58 . . . . 75.129999999999995 114.046 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -131.03 150.2 52.26 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.516 1.158 . . . . 72.439999999999998 112.33 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -67.41 154.86 40.37 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.743 1.386 . . . . 72.519999999999996 114.743 -169.092 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.561 ' HB3' HG13 ' A' ' 40' ' ' VAL . 26.6 mt -102.55 162.29 13.04 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.805 1.242 . . . . 74.530000000000001 110.446 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.77 153.2 46.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.725 0.81 . . . . 74.450000000000003 110.533 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -71.26 83.14 0.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.956 0.884 . . . . 63.109999999999999 110.955 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.36 -178.63 3.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.114 0.965 . . . . 75.340000000000003 110.765 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.61 97.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 114.089 0.395 . . . . 73.409999999999997 114.089 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -90.5 -14.87 31.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.44 0.696 . . . . 74.510000000000005 112.05 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 34' ' ' LEU . 54.3 t -124.74 81.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.42 0.688 . . . . 73.519999999999996 109.831 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.629 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.4 mt-30 -85.11 125.66 32.97 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.263 0.625 . . . . 75.400000000000006 111.062 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD21 HD23 ' A' ' 51' ' ' LEU . 89.8 mt -118.48 96.86 5.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.538 0.735 . . . . 73.109999999999999 112.185 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 1.7 mp0 -85.86 96.63 9.84 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.88 -0.785 . . . . 75.329999999999998 108.88 165.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -111.21 113.85 26.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.725 0.81 . . . . 73.329999999999998 111.227 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.19 -157.95 0.85 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.413 1.085 . . . . 74.239999999999995 111.083 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.29 111.47 3.31 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 119.385 -0.675 . . . . 74.150000000000006 111.997 172.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.39 -52.6 0.7 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 125.925 1.69 . . . . 65.200000000000003 112.716 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 30.0 ttt85 -66.75 101.21 0.78 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.708 0.803 . . . . 74.519999999999996 111.515 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -112.04 125.8 54.47 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.749 -0.834 . . . . 74.439999999999998 108.749 172.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 51.5 t -117.96 110.53 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 122.705 0.402 . . . . 75.010000000000005 110.904 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.443 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -102.56 121.2 41.9 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.736 0.814 . . . . 72.120000000000005 109.452 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.629 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 68.3 mtp180 -120.68 109.15 14.87 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.08 0.552 . . . . 74.099999999999994 111.153 -176.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.405 HG13 ' HB3' ' A' ' 60' ' ' ASP . 61.6 t -92.61 114.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.244 0.545 . . . . 75.400000000000006 110.678 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -79.1 123.24 27.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.501 1.121 . . . . 72.439999999999998 110.351 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 42.88 23.97 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.736 -0.211 . . . . 74.099999999999994 113.394 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.78 112.83 4.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.275 0.63 . . . . 72.019999999999996 111.409 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -68.25 0.2 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.012 0.525 . . . . 73.129999999999995 111.256 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -95.49 -87.19 0.29 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.935 0.717 . . . . 74.239999999999995 112.935 -167.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.83 6.1 63.29 Favored Glycine 0 C--N 1.36 1.907 0 O-C-N 122.109 -0.37 . . . . 73.439999999999998 113.785 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.405 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.9 m-20 -84.2 -5.01 59.19 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.544 1.138 . . . . 72.010000000000005 110.995 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.15 128.17 36.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.035 0.934 . . . . 73.519999999999996 109.487 171.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.6 -173.34 41.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.238 -0.437 . . . . 75.140000000000001 112.915 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.27 126.74 33.94 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.058 0.543 . . . . 73.209999999999994 110.508 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.603 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 76.5 m-85 -112.85 110.2 20.14 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.93 0.892 . . . . 64.230000000000004 110.096 175.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -91.97 102.26 14.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.221 0.608 . . . . 73.140000000000001 110.331 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.617 ' SG ' HG21 ' A' ' 16' ' ' VAL . 44.9 t -82.12 89.11 6.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.545 0.738 . . . . 73.200000000000003 109.378 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -96.39 94.12 7.24 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.019 1.328 . . . . 71.129999999999995 112.192 -168.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.64 158.66 82.82 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.437 1.095 . . . . 63.210000000000001 111.784 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -47.76 -32.77 17.6 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.873 3.048 . . . . 74.420000000000002 115.239 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.29 49.02 1.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.262 0.553 . . . . 71.129999999999995 109.638 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -178.61 162.63 1.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.056 1.342 . . . . 71.319999999999993 109.564 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.7 p -160.36 121.01 2.95 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.169 0.44 . . . . 73.540000000000006 110.772 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -106.43 127.94 53.67 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.518 0.727 . . . . 75.530000000000001 110.36 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.62 121.51 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.044 -0.725 . . . . 73.340000000000003 109.044 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.603 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 32.0 m-85 -98.21 100.73 12.05 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.1 -0.704 . . . . 74.25 109.1 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.7 91.78 4.08 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.176 -1.046 . . . . 60.130000000000003 108.176 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 4' ' ' VAL . 67.4 t -104.27 112.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 115.194 -0.912 . . . . 75.0 110.482 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 p -111.12 110.52 21.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.137 0.575 . . . . 63.149999999999999 109.455 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.42 104.05 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.907 -1.145 . . . . 75.129999999999995 107.907 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.97 179.12 9.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.716 0.807 . . . . 74.540000000000006 110.7 -170.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 61.71 90.63 0.09 OUTLIER Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.132 0.973 . . . . 74.120000000000005 110.974 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 C--N 1.383 2.343 0 C-N-CA 123.154 2.569 . . . . 75.319999999999993 113.891 -171.265 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.405 ' SD ' ' HG ' ' A' ' 76' ' ' LEU . 52.9 ttm . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.38 -0.23 . . . . 75.400000000000006 110.38 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 p -65.17 105.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.864 0.466 . . . . 74.150000000000006 111.26 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -107.58 109.74 21.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.366 1.067 . . . . 65.120000000000005 110.671 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 86.8 t -122.95 118.08 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.589 . . . . 74.239999999999995 110.863 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.5 134.86 33.91 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.856 -0.424 . . . . 73.409999999999997 109.856 173.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.782 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.7 t -112.23 157.11 21.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.928 0.491 . . . . 74.319999999999993 110.237 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -83.46 146.03 49.48 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.289 0.635 . . . . 74.109999999999999 111.559 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.02 105.86 0.72 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.145 2.563 . . . . 73.010000000000005 113.502 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.65 15.8 56.06 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 115.404 -0.816 . . . . 41.030000000000001 113.346 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.96 -167.75 30.59 Favored Glycine 0 N--CA 1.477 1.403 0 N-CA-C 112.558 -0.217 . . . . 64.430000000000007 112.558 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -107.01 119.75 40.22 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.099 -0.648 . . . . 63.200000000000003 111.198 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 6' ' ' SER . 58.9 tp -75.82 147.78 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.999 0.92 . . . . 72.310000000000002 110.453 174.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -145.0 116.42 8.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.027 0.531 . . . . 73.230000000000004 109.583 169.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 77.4 mt -102.08 101.23 11.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.354 0.662 . . . . 63.329999999999998 109.374 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.18 113.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.476 -0.935 . . . . 72.5 108.476 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 3.5 t -108.34 137.71 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.906 0.882 . . . . 74.219999999999999 110.536 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -134.48 51.27 2.12 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.437 0.637 . . . . 74.239999999999995 109.35 169.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.46 ' H ' HG11 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -54.57 159.88 1.98 Allowed 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.53 -0.759 . . . . 71.099999999999994 112.598 166.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.1 m -82.39 41.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.782 0.833 . . . . 54.030000000000001 111.496 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.17 85.72 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.528 -0.595 . . . . 75.439999999999998 112.564 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.38 151.59 26.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.8 2.334 . . . . 54.0 113.021 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -90.02 0.7 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 116.211 -0.45 . . . . 45.340000000000003 112.384 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.01 -114.36 4.01 Favored Glycine 0 CA--C 1.546 1.997 0 CA-C-O 118.729 -1.039 . . . . 74.230000000000004 113.792 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -72.57 158.03 97.87 Favored 'Cis proline' 0 C--N 1.383 2.386 0 CA-C-N 120.999 2.399 . . . . 72.420000000000002 113.532 -0.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.499 HG11 ' SG ' ' A' ' 66' ' ' CYS . 32.2 t -90.29 129.11 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.033 0.533 . . . . 72.120000000000005 110.7 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -98.12 132.2 43.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.583 0.753 . . . . 75.209999999999994 110.778 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.47 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 70.3 m95 -97.74 118.24 33.82 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.649 0.379 . . . . 74.319999999999993 111.869 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.8 m-85 -112.29 147.98 35.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.315 1.046 . . . . 65.120000000000005 109.468 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' NZ ' ' HA ' ' A' ' 60' ' ' ASP . 15.6 tptm -128.31 113.11 15.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.156 0.503 . . . . 65.530000000000001 110.288 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.07 13.26 2.81 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 125.912 1.685 . . . . 71.109999999999999 113.281 168.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.1 -39.34 0.67 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.499 -0.611 . . . . 71.209999999999994 113.234 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -154.07 156.5 37.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.071 0.936 . . . . 74.230000000000004 112.773 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -60.62 152.68 25.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.953 1.834 . . . . 75.329999999999998 115.953 -166.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.3 mt -95.56 161.59 13.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.307 -0.861 . . . . 73.200000000000003 111.197 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.86 134.59 49.41 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.942 0.897 . . . . 64.109999999999999 109.782 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.7 p -68.16 89.07 0.31 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.37 0.668 . . . . 72.219999999999999 111.72 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -134.84 98.55 4.06 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.835 0.854 . . . . 73.200000000000003 111.163 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 -89.31 0.07 OUTLIER Glycine 0 C--N 1.357 1.726 0 O-C-N 123.841 0.713 . . . . 73.519999999999996 114.517 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -70.04 -38.51 75.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.676 0.79 . . . . 75.450000000000003 111.299 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 59.7 t -89.65 121.88 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.663 . . . . 65.030000000000001 109.365 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -129.54 121.35 27.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.401 0.68 . . . . 74.319999999999993 110.51 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.44 100.07 8.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 73.219999999999999 111.092 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.598 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.0 tm-20 -93.36 125.83 38.17 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.218 -1.03 . . . . 62.43 108.218 168.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.35 103.15 7.49 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.414 0.626 . . . . 70.239999999999995 111.159 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 48' ' ' ARG . . . -100.81 -2.32 32.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.224 1.01 . . . . 75.030000000000001 112.101 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.52 -99.24 0.98 Allowed Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.192 -0.763 . . . . 74.150000000000006 111.192 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.66 -33.02 73.28 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.935 0.494 . . . . 74.329999999999998 111.616 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 58.3 ttp180 -89.19 115.65 26.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.992 0.517 . . . . 74.420000000000002 110.091 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' HB3' ' HE1' ' A' ' 27' ' ' TRP . 37.9 mm-40 -114.29 141.45 47.57 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.706 0.803 . . . . 75.439999999999998 109.532 171.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 94.2 t -131.38 110.94 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.129 0.571 . . . . 75.340000000000003 110.264 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.84 112.16 24.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.677 0.791 . . . . 75.510000000000005 109.464 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 42.3 mtt-85 -100.14 137.36 38.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.04 0.536 . . . . 74.25 111.218 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.98 100.01 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.552 0.741 . . . . 70.239999999999995 109.337 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -75.18 126.26 30.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.793 -0.447 . . . . 73.120000000000005 109.793 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.43 30.18 19.82 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.411 0.444 . . . . 53.539999999999999 113.062 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.6 101.36 0.24 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.784 0.834 . . . . 65.120000000000005 111.519 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.11 -62.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.921 0.889 . . . . 71.430000000000007 109.795 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 m -54.66 -55.29 31.25 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.324 1.05 . . . . 55.530000000000001 113.721 -168.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.45 17.52 4.48 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 122.597 0.141 . . . . 70.340000000000003 112.912 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.465 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 13.8 m-20 -126.02 90.97 3.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 61.229999999999997 110.947 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.61 65.09 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.476 1.11 . . . . 74.230000000000004 109.369 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.84 -153.5 6.43 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-N 115.535 -0.757 . . . . 72.329999999999998 113.29 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 128.31 34.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.92 0.488 . . . . 74.540000000000006 111.329 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.478 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 57.2 m-85 -115.27 107.66 15.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.073 0.949 . . . . 75.310000000000002 109.095 173.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.6 tp -92.0 100.15 12.85 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.364 0.602 . . . . 74.420000000000002 110.608 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.499 ' SG ' HG11 ' A' ' 25' ' ' VAL . 29.8 t -80.55 87.31 5.74 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.539 -0.911 . . . . 71.549999999999997 108.539 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.01 96.05 10.42 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.349 1.06 . . . . 74.310000000000002 112.527 -168.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' H ' ' HA ' ' A' ' 72' ' ' SER . . . -90.42 138.73 26.81 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 122.932 0.493 . . . . 65.109999999999999 111.408 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.84 -29.62 64.0 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 123.677 2.918 . . . . 71.400000000000006 113.943 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -75.35 -63.8 1.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.013 0.525 . . . . 74.150000000000006 110.003 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -153.71 127.67 8.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.748 0.419 . . . . 64.519999999999996 110.927 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 31.2 t -72.65 177.6 4.64 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.222 1.009 . . . . 72.430000000000007 112.392 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.568 ' HE ' ' HA ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -154.99 127.18 7.74 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.536 0.735 . . . . 62.539999999999999 111.172 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.99 123.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.043 0.537 . . . . 75.439999999999998 109.685 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 36.8 m-85 -102.12 104.96 15.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.343 0.657 . . . . 74.439999999999998 111.419 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.405 ' HG ' ' SD ' ' A' ' 1' ' ' MET . 94.3 mt -76.25 93.63 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.598 -0.889 . . . . 75.340000000000003 108.598 169.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.1 t -99.36 114.51 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.898 0.479 . . . . 72.120000000000005 110.545 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.1 p -112.46 108.76 18.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.214 0.606 . . . . 64.319999999999993 110.135 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.782 HG22 ' HB3' ' A' ' 6' ' ' SER . 47.2 t -91.16 106.01 17.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.657 -0.868 . . . . 75.129999999999995 108.657 175.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -178.56 -27.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.314 0.646 . . . . 72.439999999999998 111.454 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.5 101.64 0.29 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.714 0.805 . . . . 74.340000000000003 109.992 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 CA--C 1.567 2.152 0 C-N-CA 122.883 2.389 . . . . 74.340000000000003 114.072 -165.223 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.618 0.247 . . . . 75.329999999999998 110.571 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m -75.57 90.8 2.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.747 0.819 . . . . 75.530000000000001 111.465 -171.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.34 135.25 33.8 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.542 0.737 . . . . 75.239999999999995 111.97 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.81 124.12 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.492 0.717 . . . . 74.340000000000003 110.948 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -90.25 142.06 28.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.173 0.589 . . . . 75.239999999999995 109.556 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.49 ' HB3' HG22 ' A' ' 79' ' ' VAL . 46.7 t -145.91 148.63 33.02 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.429 0.633 . . . . 74.219999999999999 112.021 -173.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 p -82.15 147.54 57.63 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 74.319999999999993 112.314 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -84.04 147.51 11.77 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.37 2.713 . . . . 71.420000000000002 112.716 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.12 -22.28 23.58 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 113.988 0.355 . . . . 54.219999999999999 113.988 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.05 -151.29 23.86 Favored Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.956 0.378 . . . . 71.200000000000003 113.32 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -112.93 127.0 56.09 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.26 0.53 . . . . 74.519999999999996 110.657 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.1 tp -75.8 128.65 35.61 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 109.155 -0.683 . . . . 72.439999999999998 109.155 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -129.13 105.34 8.11 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.923 -0.399 . . . . 65.230000000000004 109.923 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 50.1 mt -91.68 101.78 14.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.185 -0.672 . . . . 72.230000000000004 109.185 175.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.9 t -99.51 109.98 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 107.924 -1.139 . . . . 73.329999999999998 107.924 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.464 HG23 ' HZ ' ' A' ' 75' ' ' PHE . 2.8 t -98.37 135.86 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.781 0.324 . . . . 72.109999999999999 110.755 -168.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -116.66 32.75 5.96 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.849 0.859 . . . . 74.129999999999995 109.83 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.89 156.1 9.54 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.878 1.066 . . . . 75.329999999999998 113.878 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -82.71 5.68 20.5 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.184 0.994 . . . . 73.310000000000002 112.327 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.71 -175.35 23.38 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 114.422 0.529 . . . . 71.319999999999993 114.422 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 41.1 Cg_endo -83.66 179.6 4.77 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.486 2.791 . . . . 74.310000000000002 114.019 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA2' ' HA3' ' A' ' 46' ' ' GLY . . . -83.13 61.31 4.79 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.61 -0.723 . . . . 75.340000000000003 113.299 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 81.03 174.72 49.21 Favored Glycine 0 CA--C 1.543 1.814 0 N-CA-C 115.228 0.851 . . . . 75.140000000000001 115.228 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.52 99.77 0.28 Allowed 'Cis proline' 0 C--N 1.38 2.197 0 CA-C-N 118.893 1.346 . . . . 74.25 112.066 -6.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 22.8 t -79.27 132.88 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.167 0.587 . . . . 64.549999999999997 110.819 -176.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -98.28 153.19 18.69 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.968 0.907 . . . . 75.510000000000005 111.608 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -109.88 134.03 52.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.637 0.775 . . . . 72.540000000000006 111.291 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.765 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 46.5 m-85 -128.12 161.31 29.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.167 0.987 . . . . 72.120000000000005 110.646 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -153.77 129.03 9.74 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.434 1.094 . . . . 71.129999999999995 109.604 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 63.81 22.95 13.25 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.945 0.898 . . . . 72.0 111.189 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.04 -4.62 81.49 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.395 -0.82 . . . . 63.420000000000002 114.342 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.1 128.8 49.82 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.983 0.913 . . . . 74.040000000000006 111.054 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.49 146.2 49.35 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.999 1.111 . . . . 73.409999999999997 113.999 -175.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.408 ' HB3' HG12 ' A' ' 40' ' ' VAL . 52.2 mt -91.98 154.74 18.6 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.97 -1.014 . . . . 74.400000000000006 110.817 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.0 159.2 26.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.209 1.003 . . . . 73.420000000000002 110.278 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.7 p -66.22 91.96 0.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.436 0.694 . . . . 72.310000000000002 110.789 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 36.4 tt0 -114.83 164.41 14.14 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.29 1.036 . . . . 53.5 110.204 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.8 -18.83 47.63 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.265 0.866 . . . . 43.140000000000001 115.265 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -121.6 4.81 10.09 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.404 0.602 . . . . 74.409999999999997 111.973 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 70.5 t -127.59 86.27 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.244 1.017 . . . . 72.439999999999998 109.121 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 82.4 mt-30 -87.97 108.26 19.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.843 0.857 . . . . 72.239999999999995 111.158 -174.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 mt -98.21 141.57 30.96 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.079 0.551 . . . . 72.0 112.323 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -123.27 138.5 54.61 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.037 0.935 . . . . 73.219999999999999 110.234 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -118.03 108.79 15.67 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.433 0.693 . . . . 74.530000000000001 110.809 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.72 -48.98 1.25 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.872 0.869 . . . . 73.099999999999994 109.577 168.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' HA3' ' HA2' ' A' ' 22' ' ' GLY . . . 129.42 -75.01 0.43 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.577 -0.738 . . . . 74.319999999999993 112.149 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.23 -36.53 84.44 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.632 . . . . 65.420000000000002 111.015 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -111.64 109.63 19.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.336 0.654 . . . . 73.010000000000005 110.361 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.519 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.8 mm100 -107.28 135.38 48.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.47 0.708 . . . . 73.409999999999997 109.489 169.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 60.1 t -129.94 114.13 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 121.074 0.464 . . . . 72.340000000000003 111.647 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 120.48 42.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.802 1.241 . . . . 75.549999999999997 108.519 170.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 43.7 mtp180 -118.11 106.37 12.8 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.667 0.387 . . . . 72.430000000000007 110.783 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.522 HG11 ' HB3' ' A' ' 60' ' ' ASP . 70.7 t -84.59 95.52 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.848 0.459 . . . . 74.420000000000002 110.089 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -75.13 107.33 7.15 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.488 0.715 . . . . 74.420000000000002 110.402 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.38 36.8 3.98 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.4 -0.363 . . . . 73.329999999999998 112.526 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.82 112.01 8.47 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.039 0.936 . . . . 75.120000000000005 112.011 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -167.96 -56.0 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.593 0.757 . . . . 74.430000000000007 112.101 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 m -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.119 0.967 . . . . 63.539999999999999 113.16 -167.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.88 26.38 1.46 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.235 -0.746 . . . . 75.040000000000006 111.235 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.522 ' HB3' HG11 ' A' ' 53' ' ' VAL . 6.0 m-20 -87.03 3.91 44.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.761 1.224 . . . . 74.5 111.903 -172.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 161.14 18.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 124.061 0.944 . . . . 74.230000000000004 109.603 166.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.56 -160.92 23.26 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 114.083 0.393 . . . . 71.439999999999998 114.083 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.2 mt-10 -93.9 118.16 31.09 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.224 0.61 . . . . 74.439999999999998 111.977 -172.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.18 152.86 22.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.226 1.01 . . . . 72.150000000000006 110.215 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.765 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.5 tp -128.98 101.93 6.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.788 0.435 . . . . 75.209999999999994 110.233 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -81.94 87.03 6.43 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 108.545 -0.909 . . . . 71.239999999999995 108.545 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.2 t70 -95.45 104.31 16.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.467 1.107 . . . . 75.109999999999999 111.918 -169.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.85 152.83 37.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.815 0.846 . . . . 72.430000000000007 110.878 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.43 -36.49 58.81 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.197 2.598 . . . . 72.540000000000006 114.925 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.62 ' HB2' ' HD3' ' A' ' 21' ' ' PRO . 82.0 mm-40 -90.3 -28.89 18.47 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.898 0.703 . . . . 71.430000000000007 112.898 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -157.35 128.76 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 112.176 0.436 . . . . 73.239999999999995 112.176 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 65' ' ' LEU . 77.6 p -97.6 139.75 33.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.689 0.796 . . . . 73.450000000000003 110.529 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -123.83 123.43 40.45 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.739 0.416 . . . . 71.340000000000003 110.839 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -97.04 144.14 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 122.882 0.473 . . . . 74.319999999999993 110.118 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' HZ ' HG23 ' A' ' 16' ' ' VAL . 5.8 m-85 -117.71 139.03 51.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.036 1.334 . . . . 74.25 110.155 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.7 94.89 5.26 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.381 -0.97 . . . . 73.420000000000002 108.381 164.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.07 139.04 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.181 0.592 . . . . 75.519999999999996 111.711 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.2 p -126.49 108.89 11.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.782 0.833 . . . . 64.310000000000002 110.468 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.6 t -109.04 104.11 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.187 -1.042 . . . . 74.409999999999997 108.187 172.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 8.5 pt-20 179.03 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.501 0.72 . . . . 74.129999999999995 111.246 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 37.7 mt-10 -75.17 106.37 2.78 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.943 0.897 . . . . 75.430000000000007 110.622 -174.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 6.1 Cg_exo . . . . . 0 CA--C 1.569 2.239 0 C-N-CA 123.242 2.628 . . . . 74.430000000000007 113.58 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.684 0.278 . . . . 74.439999999999998 110.818 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.23 84.62 1.88 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.406 1.082 . . . . 74.120000000000005 111.099 -172.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 64.8 mtt85 -76.37 141.14 41.59 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.545 0.738 . . . . 74.540000000000006 112.254 -174.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.425 HG23 HD22 ' A' ' 14' ' ' LEU . 78.9 t -130.03 131.24 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.647 0.779 . . . . 54.32 110.977 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -90.25 129.62 36.47 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.291 1.037 . . . . 74.120000000000005 109.855 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -139.16 158.88 43.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.818 0.847 . . . . 74.540000000000006 111.136 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -101.33 152.77 38.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 123.881 0.873 . . . . 73.209999999999994 111.63 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.2 Cg_endo -83.06 73.11 5.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.499 2.8 . . . . 65.219999999999999 113.622 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.99 60.23 0.01 OUTLIER Glycine 0 N--CA 1.474 1.169 0 CA-C-N 115.794 -0.639 . . . . 60.310000000000002 112.36 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.51 -176.26 39.81 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 122.853 -0.204 . . . . 73.310000000000002 113.428 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.05 119.66 31.95 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.337 0.589 . . . . 75.450000000000003 110.681 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 61.4 tp -74.8 136.58 41.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.745 0.818 . . . . 75.400000000000006 109.568 174.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -134.5 107.95 7.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.953 0.501 . . . . 74.040000000000006 110.053 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.425 HD22 HG23 ' A' ' 4' ' ' VAL . 44.4 mt -92.78 104.18 16.46 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.45 0.7 . . . . 74.25 109.524 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.09 112.08 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.974 -0.75 . . . . 71.230000000000004 108.974 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.456 HG23 ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t -100.64 126.66 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.738 0.415 . . . . 75.150000000000006 110.131 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -99.17 21.37 11.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.298 0.639 . . . . 75.430000000000007 111.483 174.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.7 mt -49.25 138.16 13.0 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.616 0.766 . . . . 70.349999999999994 111.792 163.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.8 t -79.17 76.89 5.69 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.498 0.666 . . . . 62.240000000000002 110.11 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.82 85.2 0.39 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.985 -0.846 . . . . 53.509999999999998 110.985 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.37 -51.39 5.38 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.097 2.531 . . . . 72.019999999999996 113.71 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.69 96.52 0.28 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.347 -0.701 . . . . 73.439999999999998 111.347 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.68 -110.45 3.5 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 118.96 -0.911 . . . . 44.32 113.525 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.31 179.47 28.01 Favored 'Cis proline' 0 C--N 1.38 2.187 0 CA-C-N 120.382 2.091 . . . . 73.209999999999994 113.971 2.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 68' ' ' ALA . 42.0 t -80.31 145.54 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.461 -0.79 . . . . 75.409999999999997 110.441 171.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.5 128.05 43.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 74.109999999999999 109.09 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.403 ' CH2' ' SG ' ' A' ' 66' ' ' CYS . 92.4 m95 -100.37 137.08 39.28 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.554 0.742 . . . . 74.140000000000001 111.41 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 90.8 m-85 -131.61 119.99 22.22 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.014 0.525 . . . . 75.129999999999995 110.91 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -107.52 124.82 50.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.413 0.685 . . . . 75.099999999999994 109.686 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t70 65.73 12.48 8.33 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 124.657 1.183 . . . . 73.140000000000001 110.896 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.09 -23.42 23.34 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 123.604 0.621 . . . . 73.030000000000001 113.673 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -101.46 141.89 33.65 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.897 0.849 . . . . 72.239999999999995 111.277 -173.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 152.83 14.89 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.895 0.878 . . . . 74.239999999999995 113.238 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -93.19 158.65 15.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.09 0.556 . . . . 73.319999999999993 110.326 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 128.96 43.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.663 0.785 . . . . 65.099999999999994 110.447 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.8 p -65.09 88.91 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.663 0.785 . . . . 74.439999999999998 111.283 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -126.25 -171.1 2.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.736 1.214 . . . . 70.420000000000002 110.503 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.4 -34.03 78.76 Favored Glycine 0 N--CA 1.48 1.627 0 O-C-N 123.017 0.198 . . . . 75.230000000000004 113.345 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -71.99 -60.89 2.0 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 75.230000000000004 110.507 173.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.8 t -101.46 92.07 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.983 0.913 . . . . 73.530000000000001 110.977 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -97.85 115.89 28.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.84 0.856 . . . . 72.049999999999997 111.402 -174.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 51' ' ' LEU . 96.2 mt -94.64 133.61 38.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.173 0.589 . . . . 75.439999999999998 110.984 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -123.94 103.07 8.11 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.618 -0.882 . . . . 71.549999999999997 108.618 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -85.07 121.98 28.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.407 0.683 . . . . 74.319999999999993 111.637 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.73 169.02 16.24 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.587 0.755 . . . . 64.239999999999995 110.604 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.52 111.9 4.49 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.359 -0.689 . . . . 71.439999999999998 112.003 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.59 -54.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.503 1.521 . . . . 64.150000000000006 112.195 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.5 ttt-85 -67.94 112.57 5.03 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.673 0.789 . . . . 74.150000000000006 112.136 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -107.97 137.06 46.63 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.582 0.753 . . . . 74.540000000000006 109.068 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 73.0 t -125.8 124.18 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 122.09 -0.381 . . . . 71.400000000000006 111.81 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.409 HD23 HD21 ' A' ' 42' ' ' LEU . 2.3 tm? -113.25 115.43 28.18 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.729 1.212 . . . . 75.409999999999997 108.454 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 75.0 mtt180 -112.54 106.96 15.52 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 122.056 -0.402 . . . . 74.219999999999999 111.779 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.1 t -98.25 95.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 109.651 -0.499 . . . . 75.420000000000002 109.651 172.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -71.68 101.6 2.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.103 -0.702 . . . . 73.409999999999997 109.103 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.48 11.99 0.53 Allowed Glycine 0 N--CA 1.471 0.998 0 CA-C-O 119.258 -0.745 . . . . 63.520000000000003 113.1 -173.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 12' ' ' LEU . . . -62.02 100.27 0.16 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.738 0.815 . . . . 73.549999999999997 110.918 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.4 tmm_? -158.74 -48.31 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 O-C-N 123.382 0.426 . . . . 75.450000000000003 112.027 -170.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.3 m -113.16 -97.5 0.43 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 118.183 0.447 . . . . 71.140000000000001 111.894 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.95 21.9 13.9 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 117.917 0.326 . . . . 73.319999999999993 113.672 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.21 -14.7 55.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.373 1.069 . . . . 74.010000000000005 110.8 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.77 104.4 8.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.386 0.675 . . . . 74.25 109.502 170.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.67 -173.93 40.97 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 113.404 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -85.22 115.51 23.04 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.428 0.691 . . . . 74.040000000000006 111.082 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 45.4 m-85 -106.05 111.71 24.45 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.767 0.827 . . . . 73.5 109.706 172.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.5 tp -91.5 107.81 19.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.267 0.627 . . . . 75.310000000000002 110.371 -171.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.403 ' SG ' ' CH2' ' A' ' 27' ' ' TRP . 80.3 m -73.58 90.98 1.8 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.839 -0.801 . . . . 73.319999999999993 108.839 164.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -52.32 -47.06 66.2 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.354 1.062 . . . . 72.450000000000003 111.399 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.661 ' HA ' HG21 ' A' ' 25' ' ' VAL . . . 67.37 132.8 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 114.602 1.334 . . . . 60.420000000000002 114.602 167.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD3' HG21 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -77.68 37.76 0.63 Allowed 'Trans proline' 0 CA--C 1.57 2.276 0 C-N-CA 123.277 2.652 . . . . 74.010000000000005 113.477 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -161.92 -60.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.548 0.739 . . . . 75.140000000000001 110.996 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.59 127.17 7.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.295 0.638 . . . . 75.219999999999999 110.547 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.3 p -73.94 138.09 44.02 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 113.551 0.945 . . . . 63.119999999999997 113.551 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -127.56 126.99 43.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.399 1.08 . . . . 73.120000000000005 111.005 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.27 142.01 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.755 0.422 . . . . 75.430000000000007 110.445 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 11.6 m-85 -101.74 109.76 21.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.204 1.002 . . . . 74.439999999999998 109.943 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.651 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 63.1 mt -86.19 91.7 8.53 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.648 -0.871 . . . . 74.219999999999999 108.648 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -89.5 124.03 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.66 -0.7 . . . . 75.030000000000001 110.658 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -108.37 107.07 17.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.834 0.853 . . . . 71.010000000000005 110.037 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -94.1 106.68 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 108.363 -0.977 . . . . 74.450000000000003 108.363 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -164.01 176.03 9.74 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.22 1.008 . . . . 73.319999999999993 110.658 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.6 84.72 0.2 Allowed Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.112 0.965 . . . . 74.150000000000006 111.514 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo . . . . . 0 CA--C 1.567 2.138 0 C-N-CA 123.222 2.614 . . . . 74.409999999999997 114.121 178.052 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 24.6 mmt . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.123 0.487 . . . . 64.219999999999999 111.069 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 p -92.9 140.96 28.95 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.392 1.077 . . . . 74.519999999999996 109.842 171.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -132.44 116.84 17.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.472 0.709 . . . . 74.319999999999993 110.342 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.2 t -129.98 147.49 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.765 0.826 . . . . 73.120000000000005 110.825 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -124.25 146.93 48.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.251 1.021 . . . . 74.239999999999995 112.226 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -141.09 163.54 32.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.314 1.046 . . . . 74.25 110.315 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 81' ' ' GLU . 1.1 p -93.66 145.39 29.83 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 123.31 0.644 . . . . 72.230000000000004 111.706 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.11 130.88 22.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.269 2.646 . . . . 74.120000000000005 113.231 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.81 -18.41 34.53 Favored Glycine 0 N--CA 1.474 1.219 0 CA-C-N 116.156 -0.474 . . . . 62.32 113.557 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.2 -127.56 5.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 117.202 0.501 . . . . 73.420000000000002 112.289 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.34 155.45 46.79 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.417 0.627 . . . . 75.329999999999998 111.389 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.25 152.81 25.0 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.639 0.776 . . . . 71.299999999999997 109.86 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.23 108.09 4.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.975 0.51 . . . . 75.340000000000003 110.357 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.511 HD11 HD13 ' A' ' 51' ' ' LEU . 65.3 mt -106.34 102.04 11.47 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.385 0.674 . . . . 64.530000000000001 110.054 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -96.53 125.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.044 -0.725 . . . . 72.549999999999997 109.044 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.518 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 2.8 t -112.75 142.66 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.48 0.712 . . . . 73.049999999999997 111.361 -170.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -138.1 45.63 2.1 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.092 0.957 . . . . 75.510000000000005 110.191 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' H ' HG13 ' A' ' 16' ' ' VAL . 1.7 pp -57.46 151.01 17.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.144 0.794 . . . . 73.120000000000005 113.144 170.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.6 m -91.68 3.62 54.65 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.694 0.798 . . . . 72.239999999999995 111.996 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.36 116.9 6.01 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 119.053 -0.86 . . . . 74.010000000000005 113.484 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.41 111.51 1.16 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.95 2.434 . . . . 75.230000000000004 112.363 173.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' HA3' ' HD2' ' A' ' 69' ' ' PRO . . . 177.25 138.26 2.93 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.304 -0.407 . . . . 64.109999999999999 112.691 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.78 112.61 0.55 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.956 -0.913 . . . . 74.239999999999995 112.057 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.67 162.07 79.17 Favored 'Cis proline' 0 C--N 1.375 1.944 0 CA-C-N 120.192 1.996 . . . . 73.319999999999993 113.612 -3.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.464 HG23 ' HA2' ' A' ' 46' ' ' GLY . 89.5 t -86.9 151.25 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-N 115.146 -0.934 . . . . 71.010000000000005 109.624 172.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -93.24 164.41 13.24 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.125 0.57 . . . . 74.25 110.56 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 78.9 m95 -133.03 127.88 35.06 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.85 0.86 . . . . 73.150000000000006 110.773 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 87.8 m-85 -131.28 126.15 34.65 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.222 1.009 . . . . 75.239999999999995 110.865 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB3' HD21 ' A' ' 34' ' ' LEU . 20.8 tptm -113.67 132.96 55.59 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.673 0.789 . . . . 73.5 108.994 169.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.24 22.27 13.26 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.294 1.045 . . . . 72.030000000000001 110.224 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.71 -6.16 71.19 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.543 -0.753 . . . . 63.420000000000002 114.108 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -107.26 136.45 47.07 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.988 0.894 . . . . 73.209999999999994 111.15 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -59.89 147.97 36.62 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.344 0.868 . . . . 75.099999999999994 113.344 -173.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 29' ' ' LYS . 41.6 mt -100.45 125.53 46.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.301 0.641 . . . . 72.230000000000004 110.238 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.46 139.12 32.41 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.752 0.821 . . . . 73.430000000000007 109.932 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 p -64.04 92.95 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.515 0.674 . . . . 71.129999999999995 111.11 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -111.88 -171.27 1.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.936 0.894 . . . . 75.420000000000002 111.834 -175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.29 -44.73 95.07 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.285 -0.416 . . . . 71.0 112.764 174.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.524 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 84.3 mtt180 -73.61 -52.87 11.94 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.352 0.661 . . . . 72.299999999999997 111.133 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 34' ' ' LEU . 67.5 t -79.48 95.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 123.322 0.649 . . . . 75.329999999999998 111.421 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.5 mt-30 -90.79 100.05 12.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.018 0.927 . . . . 75.230000000000004 109.996 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.63 133.05 41.62 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.139 0.575 . . . . 75.120000000000005 111.752 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 52.4 mm-40 -107.71 130.42 54.94 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.223 1.009 . . . . 72.540000000000006 110.301 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -103.02 141.77 35.25 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.933 0.493 . . . . 75.299999999999997 110.883 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.52 -49.05 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.84 1.256 . . . . 74.129999999999995 109.457 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 121.2 -72.17 0.37 Allowed Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.106 -0.952 . . . . 72.030000000000001 111.226 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -17.97 61.91 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.701 0.8 . . . . 72.25 112.19 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -135.06 107.96 7.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 110.34 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.434 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 13.8 mm100 -115.12 143.03 45.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.319 0.648 . . . . 74.450000000000003 109.402 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 58.6 t -133.42 114.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 117.984 0.356 . . . . 74.409999999999997 110.417 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD13 HD11 ' A' ' 14' ' ' LEU . 1.1 tm? -104.98 117.14 33.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.753 0.821 . . . . 73.230000000000004 108.889 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 81.5 mtp180 -115.69 112.95 22.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.92 -0.582 . . . . 74.510000000000005 110.568 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.16 102.24 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.719 -0.474 . . . . 75.25 109.719 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 39' ' ' ARG . 0.6 OUTLIER -66.87 116.59 7.91 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.168 -0.679 . . . . 65.129999999999995 109.168 174.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.14 43.9 2.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.203 -0.453 . . . . 65.140000000000001 112.511 -173.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.92 118.2 17.62 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.877 0.471 . . . . 73.099999999999994 110.107 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -158.34 112.44 2.5 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.863 0.465 . . . . 74.439999999999998 111.579 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m 53.38 -78.87 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.323 1.449 . . . . 74.230000000000004 114.413 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -11.87 59.99 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 114.815 0.686 . . . . 74.400000000000006 114.815 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.444 ' HB3' HG21 ' A' ' 79' ' ' VAL . 17.7 t70 -66.26 -25.87 67.09 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.507 0.723 . . . . 70.299999999999997 111.132 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.647 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -66.97 100.04 0.7 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.082 0.953 . . . . 75.200000000000003 110.689 176.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -164.23 -172.71 32.04 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.979 -0.555 . . . . 60.119999999999997 113.346 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -86.28 111.03 20.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.387 0.675 . . . . 65.340000000000003 110.824 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.749 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 44.1 m-85 -96.44 156.88 16.15 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.087 0.955 . . . . 73.310000000000002 109.442 169.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.7 tp -140.44 101.34 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.873 0.368 . . . . 73.239999999999995 110.824 -173.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.415 ' SG ' HG13 ' A' ' 25' ' ' VAL . 16.6 t -85.71 89.97 7.89 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.77 -0.826 . . . . 61.210000000000001 108.77 172.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -100.76 99.9 10.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.706 0.802 . . . . 74.150000000000006 112.664 -168.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.8 155.91 67.86 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.614 0.766 . . . . 73.540000000000006 110.068 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' ' HA3' ' A' ' 22' ' ' GLY . 50.3 Cg_exo -59.77 -2.43 1.56 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.273 2.649 . . . . 73.319999999999993 115.746 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -126.01 -43.63 1.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.696 0.798 . . . . 71.540000000000006 111.088 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.46 149.04 51.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.033 0.533 . . . . 74.540000000000006 111.246 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD11 ' A' ' 65' ' ' LEU . 79.7 p -129.92 133.18 46.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.637 0.775 . . . . 73.239999999999995 110.871 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -106.77 125.22 50.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.273 0.629 . . . . 65.310000000000002 110.035 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.436 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 2.2 mp -92.7 125.67 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.853 -0.795 . . . . 74.010000000000005 108.853 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 33.6 m-85 -98.15 101.95 13.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.437 0.695 . . . . 75.340000000000003 109.302 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.6 mt -77.55 92.94 4.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.03 -1.1 . . . . 75.120000000000005 108.03 172.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.8 t -94.03 139.17 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.153 -0.93 . . . . 73.420000000000002 110.718 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.9 p -131.2 107.4 8.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.86 -0.609 . . . . 72.109999999999999 109.763 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.647 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 57.4 t -90.11 107.34 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.594 -0.891 . . . . 74.439999999999998 108.594 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.79 179.71 7.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.995 0.918 . . . . 73.340000000000003 111.06 -167.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.421 ' O ' HG23 ' A' ' 7' ' ' THR . 12.5 tp10 64.21 87.97 0.12 Allowed Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 124.462 1.105 . . . . 73.409999999999997 110.584 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo . . . . . 0 C--N 1.383 2.344 0 C-N-CA 124.493 3.462 . . . . 72.109999999999999 115.742 -174.86 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.675 0.274 . . . . 74.019999999999996 110.795 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.8 m -73.41 95.16 2.17 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 124.297 1.039 . . . . 73.519999999999996 110.093 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.451 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -83.87 136.27 34.18 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.889 0.876 . . . . 72.239999999999995 111.668 -166.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.6 143.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.923 0.889 . . . . 75.540000000000006 110.344 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -121.71 138.54 54.31 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.298 1.039 . . . . 74.319999999999993 110.377 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t -137.34 178.08 7.37 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.464 0.706 . . . . 71.019999999999996 110.45 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 81' ' ' GLU . 4.2 p -124.99 147.71 57.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 124.016 0.926 . . . . 62.549999999999997 111.655 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -69.85 87.61 0.56 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.486 2.791 . . . . 74.040000000000006 113.402 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.22 -27.11 2.0 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.337 -0.847 . . . . 64.340000000000003 112.431 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.71 17.01 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.102 0.401 . . . . 74.540000000000006 114.102 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.47 158.25 16.35 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.382 0.673 . . . . 72.519999999999996 110.874 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 54.7 tp -119.24 108.25 14.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.337 0.655 . . . . 74.420000000000002 110.064 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.34 114.85 23.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.161 0.584 . . . . 74.329999999999998 110.242 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 15.2 mt -103.62 103.29 13.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.815 -0.809 . . . . 75.030000000000001 108.815 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.455 HG23 HG22 ' A' ' 50' ' ' VAL . 67.3 t -105.56 122.1 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.14 -0.689 . . . . 74.319999999999993 109.14 175.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG23 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -100.78 148.27 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.742 0.417 . . . . 51.210000000000001 110.717 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 67.4 m80 -128.25 51.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.187 0.994 . . . . 73.25 109.827 166.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.22 170.26 14.43 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.228 -1.351 . . . . 72.409999999999997 112.961 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.7 m -90.7 23.89 2.91 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.565 1.146 . . . . 75.530000000000001 112.705 -175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.82 157.28 18.08 Favored Glycine 0 CA--C 1.546 2.025 0 CA-C-O 119.959 -0.356 . . . . 74.049999999999997 113.933 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.23 -168.14 0.57 Allowed 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.615 2.876 . . . . 74.140000000000001 113.428 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.18 -51.24 55.44 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 123.264 0.459 . . . . 41.43 114.066 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.29 -97.2 1.22 Allowed Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.474 0.95 . . . . 73.510000000000005 115.474 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.85 126.44 9.63 Favored 'Cis proline' 0 C--N 1.383 2.353 0 CA-C-N 120.891 2.345 . . . . 73.140000000000001 114.384 5.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.503 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 89.7 t -66.58 131.62 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.439 0.696 . . . . 71.319999999999993 110.274 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.06 150.81 20.07 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.46 0.647 . . . . 74.319999999999993 110.637 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -110.34 125.24 52.97 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.893 0.877 . . . . 74.319999999999993 109.296 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.76 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 81.0 m-85 -111.71 161.7 16.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.149 0.58 . . . . 71.0 110.438 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB3' HD21 ' A' ' 34' ' ' LEU . 27.2 tptp -146.68 122.9 10.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.741 0.816 . . . . 74.219999999999999 109.51 171.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 54.54 25.74 6.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.929 0.891 . . . . 72.129999999999995 113.068 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.76 -30.52 7.73 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-N 116.121 -0.491 . . . . 64.129999999999995 114.165 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.9 131.79 55.14 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.788 0.794 . . . . 75.329999999999998 111.379 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.76 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -62.18 151.89 34.7 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.107 0.963 . . . . 75.530000000000001 113.536 -177.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 29' ' ' LYS . 27.3 mt -100.99 142.32 32.64 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.165 0.986 . . . . 74.129999999999995 110.345 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.63 157.46 17.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.997 0.919 . . . . 74.140000000000001 109.996 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.9 p -61.62 97.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.841 0.829 . . . . 71.530000000000001 111.035 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' NE2' ' H ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -109.55 163.28 13.59 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.887 1.275 . . . . 73.439999999999998 108.135 -175.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' H ' ' NE2' ' A' ' 37' ' ' GLN . . . -53.92 -35.84 54.4 Favored Glycine 0 CA--C 1.543 1.798 0 N-CA-C 114.145 0.418 . . . . 74.400000000000006 114.145 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -89.5 -33.06 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.021 0.528 . . . . 74.530000000000001 110.821 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.04 86.01 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.93 0.892 . . . . 75.200000000000003 111.152 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.582 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 68.1 mt-30 -82.82 101.25 10.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.623 0.769 . . . . 75.430000000000007 110.751 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD22 HD23 ' A' ' 51' ' ' LEU . 61.2 mt -89.91 152.86 21.03 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.33 0.586 . . . . 74.420000000000002 112.201 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.524 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.5 tm-20 -146.48 131.83 18.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.743 -1.206 . . . . 74.519999999999996 107.743 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -124.8 103.14 7.92 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.012 0.525 . . . . 75.150000000000006 111.034 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 48' ' ' ARG . . . -120.86 11.17 11.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.937 0.895 . . . . 74.230000000000004 111.969 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.67 -86.36 1.47 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.179 0.419 . . . . 61.409999999999997 113.408 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' HIS . . . -72.56 -5.39 36.79 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.347 0.659 . . . . 63.149999999999999 111.865 175.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 54.0 ttp180 -133.71 101.21 5.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.003 0.921 . . . . 75.209999999999994 109.745 172.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.503 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.0 mm100 -106.09 126.58 52.37 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 109.549 -0.537 . . . . 73.439999999999998 109.549 173.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 40.6 t -115.83 122.15 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-O 120.869 0.366 . . . . 62.509999999999998 111.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 HD23 HD22 ' A' ' 42' ' ' LEU . 1.9 tm? -111.34 114.47 27.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.334 1.054 . . . . 74.549999999999997 108.402 169.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 83.6 mtm180 -114.43 108.31 16.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.992 0.517 . . . . 71.420000000000002 111.202 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.7 t -96.55 120.89 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.634 -0.506 . . . . 72.230000000000004 109.634 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -79.2 116.08 19.25 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.257 0.623 . . . . 74.230000000000004 109.731 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.61 72.45 1.26 Allowed Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.336 -0.393 . . . . 72.519999999999996 113.429 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 12' ' ' LEU . . . -80.48 102.54 9.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.683 0.793 . . . . 74.25 111.447 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.34 -73.63 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.599 0.759 . . . . 74.5 111.614 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.8 m -127.71 -67.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.855 0.462 . . . . 75.510000000000005 111.867 -171.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.1 -12.53 60.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 113.974 0.349 . . . . 72.219999999999999 113.974 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.87 -17.48 43.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.292 1.037 . . . . 74.439999999999998 110.694 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.64 134.17 34.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.023 0.929 . . . . 63.200000000000003 109.554 172.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.04 -178.64 36.92 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.867 -0.606 . . . . 70.140000000000001 113.066 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.1 117.67 25.99 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.357 0.599 . . . . 75.340000000000003 110.467 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.555 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 38.4 m-85 -94.57 157.02 16.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.283 1.033 . . . . 75.340000000000003 109.934 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.4 tp -127.94 105.56 8.5 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.828 -0.545 . . . . 74.019999999999996 110.525 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' A' ' 16' ' ' VAL . 48.6 t -82.93 88.22 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.637 -0.875 . . . . 75.310000000000002 108.637 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -79.36 86.72 5.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.121 0.968 . . . . 72.129999999999995 111.684 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.426 ' HA ' HG21 ' A' ' 25' ' ' VAL . . . -81.01 140.57 49.96 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.816 -0.629 . . . . 74.319999999999993 110.054 171.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.32 -35.86 16.44 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 124.498 3.466 . . . . 72.319999999999993 115.896 -173.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -124.18 0.38 8.41 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.802 0.841 . . . . 74.219999999999999 112.406 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -156.49 49.45 0.48 Allowed 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.785 0.802 . . . . 73.099999999999994 111.046 -165.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -66.8 121.6 15.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.148 0.979 . . . . 72.400000000000006 112.025 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -127.47 142.66 51.34 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.933 0.716 . . . . 70.510000000000005 112.933 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.556 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mp -91.05 139.95 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.962 0.905 . . . . 74.319999999999993 109.947 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 9.3 m-85 -102.06 114.89 29.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.563 1.145 . . . . 74.530000000000001 111.121 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 93.9 mt -77.36 93.87 4.12 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.591 -0.892 . . . . 75.420000000000002 108.591 166.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 75' ' ' PHE . 73.5 t -105.45 113.14 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.345 0.658 . . . . 74.019999999999996 110.691 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 t -118.1 117.65 29.76 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.564 -0.744 . . . . 64.439999999999998 110.747 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.3 t -84.82 106.26 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 107.947 -1.131 . . . . 73.549999999999997 107.947 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.41 -173.95 4.17 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.184 0.994 . . . . 74.239999999999995 109.922 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' O ' HG23 ' A' ' 7' ' ' THR . 44.6 tt0 59.78 81.15 0.25 Allowed Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.763 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo . . . . . 0 CA--C 1.575 2.566 0 C-N-CA 124.278 3.318 . . . . 74.439999999999998 115.875 -177.112 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.579 0.228 . . . . 73.239999999999995 111.528 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -79.67 95.19 5.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.674 -0.861 . . . . 75.549999999999997 108.674 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.565 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 41.2 mtp180 -93.9 148.34 22.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.567 0.747 . . . . 74.530000000000001 112.824 -166.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 79.4 t -130.57 138.57 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.031 0.932 . . . . 73.25 109.473 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.17 119.13 32.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.023 0.929 . . . . 72.010000000000005 109.076 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.414 ' HB3' HG23 ' A' ' 79' ' ' VAL . 35.0 t -132.45 163.16 29.38 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.796 0.808 . . . . 73.129999999999995 112.568 -170.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.1 p -99.74 155.82 36.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.047 -0.978 . . . . 73.409999999999997 111.189 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -82.02 46.71 2.28 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.444 2.762 . . . . 70.299999999999997 113.292 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.1 45.67 0.56 Allowed Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.316 -0.402 . . . . 70.299999999999997 113.115 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.73 172.98 36.12 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-O 119.635 -0.536 . . . . 72.519999999999996 112.193 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.78 135.37 41.71 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.553 0.677 . . . . 73.530000000000001 111.131 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.454 HD23 HG12 ' A' ' 77' ' ' VAL . 49.5 tp -78.84 107.44 11.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.782 0.433 . . . . 70.129999999999995 110.883 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 36.2 tt0 -111.24 104.59 13.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.922 0.489 . . . . 74.409999999999997 110.171 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.462 ' HG ' HD13 ' A' ' 51' ' ' LEU . 29.3 mt -94.45 106.12 18.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.96 0.904 . . . . 75.109999999999999 110.402 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -93.95 113.27 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.588 0.755 . . . . 64.420000000000002 110.003 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG13 ' H ' ' A' ' 18' ' ' LEU . 2.1 t -100.05 149.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.688 0.795 . . . . 72.0 110.631 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -112.02 15.15 20.77 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.308 0.643 . . . . 70.040000000000006 111.14 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 16' ' ' VAL . 14.4 mt -54.24 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.514 0.725 . . . . 73.510000000000005 112.003 174.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.8 t -68.24 81.36 0.24 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.637 0.775 . . . . 75.409999999999997 110.349 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.29 164.18 30.63 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.292 -0.867 . . . . 74.530000000000001 113.268 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.09 23.7 0.51 Allowed 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.231 2.621 . . . . 74.219999999999999 113.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.74 59.76 4.26 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 122.838 0.256 . . . . 25.149999999999999 112.501 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.31 -69.49 1.37 Allowed Glycine 0 CA--C 1.551 2.299 0 CA-C-O 119.616 -0.547 . . . . 73.099999999999994 114.44 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.7 -167.35 5.99 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 120.19 1.995 . . . . 75.530000000000001 113.534 0.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HB ' ' HG3' ' A' ' 49' ' ' GLN . 92.6 t -87.77 146.11 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 123.705 0.802 . . . . 73.329999999999998 110.459 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.701 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 97.4 mtt180 -96.2 169.72 9.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 75.209999999999994 110.66 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.433 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 94.8 m95 -131.22 136.92 48.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.824 0.85 . . . . 74.140000000000001 110.168 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 59.9 m-85 -134.46 123.67 24.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 123.036 0.535 . . . . 75.019999999999996 110.569 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.1 tptp -117.93 133.74 55.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.002 -0.74 . . . . 73.409999999999997 109.002 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 61.29 22.31 12.69 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.808 0.843 . . . . 74.209999999999994 111.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.09 5.6 82.96 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 114.268 0.467 . . . . 63.310000000000002 114.268 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -130.66 133.95 46.54 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.901 0.851 . . . . 73.140000000000001 112.358 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -62.85 150.87 40.61 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.022 1.489 . . . . 75.420000000000002 115.022 -171.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 40' ' ' VAL . 3.8 mm? -92.61 163.79 13.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.237 1.415 . . . . 72.25 111.024 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.65 140.04 42.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.555 0.742 . . . . 70.409999999999997 110.407 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.1 p -81.74 31.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.509 0.724 . . . . 61.100000000000001 112.813 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -121.87 124.97 45.36 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.03 0.932 . . . . 74.420000000000002 110.655 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.71 -100.03 0.46 Allowed Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.731 0.652 . . . . 71.140000000000001 114.731 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -52.37 -46.04 66.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 125.024 1.33 . . . . 74.519999999999996 113.03 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.536 HG22 HD12 ' A' ' 34' ' ' LEU . 98.9 t -116.96 143.12 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.366 -0.834 . . . . 73.439999999999998 110.616 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -126.0 131.02 52.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.349 1.06 . . . . 72.420000000000002 110.156 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 82.6 mt -119.66 145.15 46.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.887 0.475 . . . . 62.130000000000003 112.068 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.46 130.69 54.81 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.32 0.648 . . . . 74.430000000000007 109.329 166.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -106.32 103.71 13.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.826 0.851 . . . . 75.310000000000002 110.018 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.55 178.12 6.31 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.37 0.668 . . . . 74.349999999999994 111.316 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.92 -24.79 75.33 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.332 -0.395 . . . . 64.099999999999994 113.501 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.65 -55.14 0.73 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.179 0.592 . . . . 73.109999999999999 111.868 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 46.7 ttp180 -81.8 97.83 8.18 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.959 0.409 . . . . 74.340000000000003 112.053 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 39.6 mm-40 -91.65 133.72 35.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.57 -0.9 . . . . 75.310000000000002 108.57 173.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 87.8 t -121.44 115.68 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 122.014 -0.429 . . . . 73.140000000000001 110.894 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.6 tm? -95.51 129.61 42.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.153 0.981 . . . . 73.329999999999998 108.644 171.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 63.1 mtp180 -131.66 105.34 7.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.853 0.752 . . . . 73.319999999999993 111.334 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.5 t -96.23 105.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.836 -0.801 . . . . 70.420000000000002 108.836 171.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -72.39 109.96 6.47 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.53 0.732 . . . . 72.310000000000002 112.612 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.01 48.8 1.42 Allowed Glycine 0 C--N 1.35 1.348 0 CA-C-N 116.253 -0.431 . . . . 43.219999999999999 113.472 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.11 115.13 12.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.466 0.706 . . . . 74.310000000000002 111.551 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -157.5 -65.48 0.09 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.586 0.754 . . . . 73.409999999999997 111.989 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.5 m -80.22 -70.48 0.52 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.2 0.815 . . . . 75.349999999999994 113.2 -163.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -116.31 30.14 6.65 Favored Glycine 0 N--CA 1.487 2.034 0 CA-C-O 121.075 0.264 . . . . 74.319999999999993 112.859 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.95 -6.14 43.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 62.25 112.314 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.536 ' HB3' ' H ' ' A' ' 79' ' ' VAL . . . -83.63 129.09 34.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.366 -0.605 . . . . 75.540000000000006 109.366 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 163.39 -174.2 39.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.121 -0.561 . . . . 72.209999999999994 114.212 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -91.53 110.65 21.97 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.107 0.563 . . . . 75.219999999999999 110.395 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.8 m-85 -95.6 113.63 25.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.854 0.461 . . . . 73.219999999999999 110.031 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 54.2 tp -92.85 101.77 14.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.547 0.739 . . . . 74.129999999999995 110.277 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.401 ' SG ' ' CH2' ' A' ' 27' ' ' TRP . 72.6 m -71.41 88.48 0.89 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.335 -0.848 . . . . 54.350000000000001 109.614 169.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.0 t70 -80.04 89.85 5.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.39 0.614 . . . . 72.430000000000007 110.599 -176.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.44 151.39 50.74 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.226 -0.897 . . . . 73.400000000000006 111.31 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.62 -21.86 73.05 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.409 2.073 . . . . 71.439999999999998 112.633 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.92 93.19 3.92 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.529 -0.915 . . . . 74.140000000000001 108.529 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.53 109.61 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 125.3 1.44 . . . . 72.519999999999996 113.216 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -75.93 134.34 40.26 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.873 0.869 . . . . 73.140000000000001 112.035 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -107.39 141.37 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.329 0.652 . . . . 74.430000000000007 110.962 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.478 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.5 mp -104.84 137.78 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.092 0.557 . . . . 72.140000000000001 110.289 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 7.0 m-85 -108.46 105.44 15.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.312 1.045 . . . . 73.209999999999994 110.861 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.565 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 95.6 mt -77.17 97.78 4.88 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.324 -0.621 . . . . 63.340000000000003 109.324 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.454 HG12 HD23 ' A' ' 12' ' ' LEU . 45.3 t -107.65 131.58 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.834 0.454 . . . . 74.420000000000002 111.171 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.6 m -119.6 111.62 18.3 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.116 0.567 . . . . 70.319999999999993 109.788 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.536 ' H ' ' HB3' ' A' ' 61' ' ' ALA . 40.5 t -109.31 105.25 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.138 -1.06 . . . . 73.400000000000006 108.138 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.59 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.523 0.935 . . . . 72.439999999999998 113.523 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 51.3 mt-10 -68.57 108.31 2.78 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.132 0.573 . . . . 74.349999999999994 110.995 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 26.4 Cg_exo . . . . . 0 C--N 1.383 2.355 0 C-N-CA 123.243 2.628 . . . . 74.209999999999994 113.879 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.965 0.412 . . . . 75.010000000000005 111.414 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -76.48 156.03 33.34 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.932 0.893 . . . . 63.32 112.29 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -150.75 129.92 12.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.28 1.032 . . . . 74.239999999999995 109.587 172.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 99.0 t -129.67 134.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.724 0.81 . . . . 74.530000000000001 109.612 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.3 144.17 26.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.026 0.53 . . . . 75.310000000000002 110.865 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.487 ' HB2' HD13 ' A' ' 12' ' ' LEU . 40.4 t -125.66 153.7 43.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.021 0.928 . . . . 65.329999999999998 109.851 172.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -102.0 150.42 37.43 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.354 0.662 . . . . 73.040000000000006 111.024 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.35 96.48 0.19 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.284 2.656 . . . . 75.530000000000001 113.769 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.24 38.49 4.53 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.673 -0.694 . . . . 65.129999999999995 113.975 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.57 168.85 22.58 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-O 120.085 -0.286 . . . . 74.310000000000002 112.547 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 37.0 t70 -70.42 140.95 52.16 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.222 0.534 . . . . 73.409999999999997 111.34 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 6' ' ' SER . 64.3 tp -109.41 152.39 25.41 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.421 1.088 . . . . 71.540000000000006 109.538 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.73 130.66 19.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.393 0.677 . . . . 71.019999999999996 109.653 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.31 105.39 14.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.501 0.721 . . . . 74.109999999999999 109.214 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.35 120.72 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.477 0.711 . . . . 73.140000000000001 109.239 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 49' ' ' GLN . 94.5 t -107.64 131.3 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.893 0.877 . . . . 75.530000000000001 111.964 -172.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -143.28 31.33 1.37 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.222 1.009 . . . . 75.439999999999998 110.897 172.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -57.61 168.14 0.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.857 0.688 . . . . 74.230000000000004 112.857 169.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.3 t -89.58 31.97 0.9 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.074 0.55 . . . . 71.409999999999997 111.168 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.62 80.42 0.29 Allowed Glycine 0 CA--C 1.541 1.661 0 CA-C-O 119.367 -0.685 . . . . 75.25 112.683 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.18 175.28 11.02 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.296 2.664 . . . . 70.430000000000007 113.466 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.2 -84.78 0.6 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.156 -0.474 . . . . 72.5 113.028 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.28 -161.85 17.4 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.401 -0.666 . . . . 52.229999999999997 113.75 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.45 116.1 4.18 Favored 'Cis proline' 0 C--N 1.378 2.129 0 CA-C-N 119.844 1.822 . . . . 63.409999999999997 113.422 -1.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.34 123.33 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.787 -0.642 . . . . 71.549999999999997 109.636 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -103.85 159.77 15.36 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.276 0.63 . . . . 74.519999999999996 111.819 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -115.49 137.61 51.88 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.956 0.902 . . . . 74.140000000000001 110.249 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -135.29 123.33 22.77 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.381 0.672 . . . . 72.120000000000005 110.823 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 24.9 tptp -103.53 112.74 25.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.158 0.583 . . . . 74.219999999999999 110.379 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 55.59 3.07 0.07 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 126.12 1.768 . . . . 74.030000000000001 115.38 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.3 -27.43 1.54 Allowed Glycine 0 N--CA 1.481 1.675 0 O-C-N 121.152 -0.967 . . . . 65.219999999999999 114.738 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -113.28 147.15 38.14 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.366 1.083 . . . . 72.530000000000001 111.549 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.494 ' HD3' ' H ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -69.18 153.08 44.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.741 0.645 . . . . 75.329999999999998 112.741 175.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.37 154.74 19.45 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.408 -0.815 . . . . 73.400000000000006 109.888 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.6 125.62 12.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.211 1.004 . . . . 43.32 108.671 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 p -55.4 99.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.746 0.818 . . . . 73.230000000000004 112.592 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -159.7 116.28 2.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.474 0.71 . . . . 72.430000000000007 111.62 -171.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.42 -89.88 0.06 OUTLIER Glycine 0 C--N 1.353 1.522 0 O-C-N 123.547 0.53 . . . . 74.530000000000001 113.655 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -75.27 -42.76 54.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.832 0.853 . . . . 74.150000000000006 111.601 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.27 106.71 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 116.116 -0.493 . . . . 74.439999999999998 110.151 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.663 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.5 mm100 -110.09 104.6 13.49 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.109 0.564 . . . . 70.400000000000006 109.625 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.441 HD22 HD22 ' A' ' 51' ' ' LEU . 84.9 mt -98.59 143.85 28.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 74.420000000000002 112.098 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 40.1 tt0 -140.47 136.75 33.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.224 1.01 . . . . 74.319999999999993 109.01 173.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.02 106.56 9.16 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.873 0.844 . . . . 72.439999999999998 110.869 -176.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -111.76 21.5 15.98 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.428 1.091 . . . . 72.299999999999997 110.967 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.17 -87.09 0.95 Allowed Glycine 0 N--CA 1.477 1.393 0 CA-C-N 116.34 -0.391 . . . . 74.239999999999995 112.787 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.87 -40.75 18.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.306 0.642 . . . . 70.450000000000003 110.647 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 46.3 ttt180 -78.5 106.38 10.41 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.416 -0.811 . . . . 73.439999999999998 110.699 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.597 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 79.9 mm-40 -106.91 155.45 19.75 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.616 0.766 . . . . 72.420000000000002 109.587 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 65.1 t -135.76 117.39 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.867 0.467 . . . . 64.540000000000006 109.953 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.441 HD22 HD22 ' A' ' 42' ' ' LEU . 2.8 tm? -110.51 118.7 36.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.834 -0.802 . . . . 74.450000000000003 108.834 168.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.663 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 84.2 mtt180 -113.81 141.42 47.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.06 0.544 . . . . 75.209999999999994 110.854 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.7 t -128.83 101.73 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.742 0.817 . . . . 65.120000000000005 108.992 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -74.23 121.73 21.72 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.051 -0.351 . . . . 73.230000000000004 110.051 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.34 36.47 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.79 -0.186 . . . . 62.409999999999997 113.291 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 90.31 0.06 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.573 0.749 . . . . 71.319999999999993 111.362 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -88.35 -56.68 3.21 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.055 1.132 . . . . 74.109999999999999 114.055 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -161.67 -58.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.326 0.25 . . . . 73.230000000000004 111.563 -174.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -9.96 55.03 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.485 -0.325 . . . . 70.030000000000001 113.442 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.78 -3.42 44.32 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.687 1.195 . . . . 73.409999999999997 111.973 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.67 127.5 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.509 0.724 . . . . 55.130000000000003 109.955 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 164.59 -172.72 40.41 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 121.225 0.347 . . . . 75.299999999999997 113.695 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -87.26 111.85 21.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.676 0.79 . . . . 72.530000000000001 111.45 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -99.35 111.35 23.73 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.819 -0.808 . . . . 73.439999999999998 108.819 170.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 tp -94.09 106.63 18.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.249 1.02 . . . . 74.140000000000001 110.379 -171.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.468 ' HG ' HD21 ' A' ' 18' ' ' LEU . 42.2 t -79.89 88.06 5.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.629 0.728 . . . . 70.340000000000003 109.165 171.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -78.18 89.93 4.28 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.994 -1.003 . . . . 62.109999999999999 110.845 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.51 148.31 34.73 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.491 0.717 . . . . 73.239999999999995 111.264 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -55.04 -32.1 77.73 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 123.538 2.825 . . . . 62.049999999999997 114.774 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -86.81 -51.73 5.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.969 0.508 . . . . 70.019999999999996 111.592 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.39 126.02 11.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.287 0.635 . . . . 62.240000000000002 112.164 -175.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -87.08 118.93 26.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.83 0.852 . . . . 72.219999999999999 110.41 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -105.79 131.21 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.227 0.611 . . . . 74.140000000000001 111.325 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.5 mt -88.87 117.96 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.791 0.837 . . . . 60.240000000000002 109.939 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CZ ' HG23 ' A' ' 16' ' ' VAL . 17.8 m-85 -98.58 103.63 15.6 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.831 -0.803 . . . . 75.209999999999994 108.831 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.18 93.56 3.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.178 -0.675 . . . . 72.420000000000002 109.178 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.1 t -85.2 99.95 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.734 0.778 . . . . 64.530000000000001 109.748 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.4 p -95.51 108.79 21.05 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.744 -1.116 . . . . 73.129999999999995 109.937 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 6' ' ' SER . 85.6 t -82.37 106.09 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 107.682 -1.229 . . . . 75.030000000000001 107.682 173.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -156.24 -178.11 7.08 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.513 1.125 . . . . 71.349999999999994 109.888 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 58.25 75.06 0.56 Allowed Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.591 0.757 . . . . 74.319999999999993 110.563 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 CA--C 1.572 2.383 0 C-N-CA 123.154 2.57 . . . . 73.349999999999994 113.459 -176.69 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.457 0.17 . . . . 75.540000000000006 111.311 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -62.06 133.67 55.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.374 0.67 . . . . 54.119999999999997 110.124 167.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -126.63 111.74 14.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.345 0.658 . . . . 73.420000000000002 109.818 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.2 t -115.16 139.39 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.31 0.644 . . . . 74.420000000000002 111.092 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -90.05 136.05 33.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.64 0.776 . . . . 70.200000000000003 110.209 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 t -125.37 152.03 45.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.677 0.791 . . . . 74.5 110.145 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 81' ' ' GLU . 1.6 p -104.67 152.28 39.43 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.564 0.745 . . . . 75.25 111.752 177.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 57.1 Cg_endo -80.54 42.71 1.38 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.368 2.712 . . . . 64.310000000000002 113.747 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.73 66.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.926 0 N-CA-C 112.293 -0.323 . . . . 64.230000000000004 112.293 -173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.32 -136.3 4.12 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-O 120.164 -0.242 . . . . 75.129999999999995 112.782 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.47 152.57 51.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.648 0.779 . . . . 54.409999999999997 110.761 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.2 tp -89.71 146.73 24.3 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.29 0.636 . . . . 73.439999999999998 109.903 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -145.57 114.06 6.73 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.913 -0.402 . . . . 74.140000000000001 109.913 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 63.4 mt -106.82 102.02 11.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.582 0.753 . . . . 73.420000000000002 110.061 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -94.52 113.19 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.283 -1.006 . . . . 75.329999999999998 108.283 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 18' ' ' LEU . 2.9 t -100.01 146.7 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.035 0.534 . . . . 65.530000000000001 111.429 -169.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -131.86 43.71 3.0 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.461 0.705 . . . . 75.040000000000006 110.426 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.504 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -59.19 164.59 3.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.018 0.747 . . . . 74.329999999999998 113.018 172.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.2 p -84.78 38.31 0.69 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.807 0.843 . . . . 64.209999999999994 112.319 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 70' ' ' GLN . . . -127.05 84.84 0.34 Allowed Glycine 0 N--CA 1.478 1.482 0 CA-C-O 119.537 -0.59 . . . . 43.32 112.502 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.41 156.77 60.95 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.079 2.519 . . . . 70.209999999999994 113.269 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.8 -119.85 11.65 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.908 -0.587 . . . . 65.430000000000007 113.473 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -173.74 -164.42 28.86 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-O 119.493 -0.615 . . . . 72.420000000000002 113.305 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.0 101.79 0.38 Allowed 'Cis proline' 0 CA--C 1.565 2.032 0 CA-C-N 120.096 1.948 . . . . 72.040000000000006 113.029 -3.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.435 HG23 ' HA2' ' A' ' 23' ' ' GLY . 30.7 t -79.89 123.0 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 109.817 -0.438 . . . . 73.140000000000001 109.817 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -100.68 158.41 15.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.558 0.743 . . . . 74.319999999999993 111.449 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.459 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 62.8 m95 -114.33 142.37 46.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 73.439999999999998 111.157 175.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 54.6 m-85 -135.76 160.2 39.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.316 1.047 . . . . 74.230000000000004 110.597 177.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.62 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.6 tptp -140.75 130.71 24.58 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 73.319999999999993 109.591 165.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 57.68 27.71 14.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.268 1.027 . . . . 65.329999999999998 112.63 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 -1.13 76.17 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 115.829 -0.623 . . . . 70.200000000000003 114.507 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -124.78 131.04 53.49 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.325 1.063 . . . . 71.420000000000002 111.496 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.08 143.35 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.524 1.13 . . . . 74.129999999999995 113.94 -172.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.62 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.6 mt -95.62 147.54 23.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 72.400000000000006 111.011 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.49 150.52 23.3 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.936 0.894 . . . . 62.310000000000002 110.402 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.9 p -76.36 77.34 3.11 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.281 0.562 . . . . 75.340000000000003 110.177 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -76.09 -64.69 1.04 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.7 0.8 . . . . 71.25 112.488 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.36 -49.58 0.24 Allowed Glycine 0 N--CA 1.475 1.266 0 N-CA-C 112.257 -0.337 . . . . 65.109999999999999 112.257 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.07 -46.22 15.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.798 -0.816 . . . . 72.219999999999999 108.798 164.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.38 93.26 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 108.919 -0.771 . . . . 75.420000000000002 108.919 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.227 1.011 . . . . 73.319999999999993 110.788 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.22 137.95 51.7 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.084 0.554 . . . . 74.439999999999998 110.69 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -122.88 114.4 20.41 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.483 -0.932 . . . . 71.049999999999997 108.483 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -103.54 104.03 14.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.76 0.79 . . . . 74.019999999999996 110.519 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.13 178.28 6.12 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.499 1.12 . . . . 73.049999999999997 110.56 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 95.07 0.22 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.619 -0.545 . . . . 74.510000000000005 113.212 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.55 -34.6 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.573 1.549 . . . . 73.409999999999997 113.597 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 69.9 ttp85 -85.76 94.08 9.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.5 0.667 . . . . 74.409999999999997 110.893 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HG3' ' SG ' ' A' ' 66' ' ' CYS . 15.7 mm100 -94.64 142.79 27.04 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.485 -0.78 . . . . 72.450000000000003 110.102 172.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 47.4 t -131.26 109.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.037 0.446 . . . . 70.129999999999995 111.069 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.7 130.9 43.84 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.381 -0.97 . . . . 74.5 108.381 169.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -128.57 108.67 10.71 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 74.140000000000001 109.339 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.4 t -98.2 96.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.625 0.648 . . . . 74.319999999999993 109.868 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.06 96.83 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.204 0.602 . . . . 74.129999999999995 110.314 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.38 46.47 0.2 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.839 -0.619 . . . . 74.230000000000004 112.019 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.4 113.86 17.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.755 0.822 . . . . 64.25 110.317 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 44.1 ttt85 -161.29 -41.77 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.168 0.803 . . . . 75.299999999999997 113.168 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.2 m -129.43 -77.55 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 122.75 0.42 . . . . 65.230000000000004 111.759 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.33 -3.37 70.42 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 114.479 0.552 . . . . 74.329999999999998 114.479 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -67.51 -26.28 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.15 0.98 . . . . 74.5 112.501 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.28 117.56 16.23 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.638 0.375 . . . . 73.310000000000002 110.083 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.31 -171.51 41.34 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 114.196 0.438 . . . . 54.140000000000001 114.196 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -87.45 117.17 26.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 75.340000000000003 111.277 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 77.7 m-85 -105.36 108.12 19.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.4 0.68 . . . . 71.420000000000002 110.096 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.1 tp -92.59 110.41 21.84 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.284 0.564 . . . . 74.019999999999996 109.924 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 49' ' ' GLN . 37.9 t -89.1 88.06 7.42 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.846 0.858 . . . . 61.310000000000002 108.98 170.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.6 95.45 6.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.238 1.015 . . . . 73.340000000000003 112.473 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.41 137.46 30.69 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.884 0.473 . . . . 75.120000000000005 111.004 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.42 -23.51 47.48 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.319 2.679 . . . . 72.430000000000007 113.873 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.511 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 24.8 mp0 -85.58 -57.49 3.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.62 0.768 . . . . 75.349999999999994 111.096 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -157.0 117.11 3.51 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 112.135 0.42 . . . . 74.519999999999996 112.135 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.5 m -76.06 140.26 41.81 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 74.010000000000005 112.204 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 126.86 54.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.672 0.789 . . . . 75.319999999999993 110.645 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.1 mp -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.417 -0.586 . . . . 73.0 109.417 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.539 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 37.8 m-85 -100.45 125.52 46.76 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.235 1.014 . . . . 74.200000000000003 110.386 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.2 mt -102.6 93.88 5.35 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.424 -0.954 . . . . 73.120000000000005 108.424 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.04 126.77 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.638 0.775 . . . . 72.030000000000001 110.469 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -119.0 117.52 29.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.689 0.796 . . . . 74.140000000000001 110.667 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.0 t -84.82 108.14 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.048 0.452 . . . . 71.510000000000005 109.894 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -164.61 -170.04 1.91 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.511 1.125 . . . . 75.420000000000002 109.617 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 7' ' ' THR . 32.3 tt0 59.84 72.81 0.72 Allowed Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.571 0.748 . . . . 72.450000000000003 110.322 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.571 2.329 0 C-N-CA 122.578 2.186 . . . . 74.299999999999997 113.357 -172.542 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.72 0.295 . . . . 73.439999999999998 111.139 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.8 m -83.59 88.71 7.03 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.806 0.842 . . . . 75.420000000000002 108.93 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -98.8 135.5 40.17 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.787 0.835 . . . . 72.450000000000003 112.14 -166.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.57 143.49 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.967 0.907 . . . . 75.140000000000001 110.233 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -92.21 145.23 24.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.727 0.411 . . . . 73.409999999999997 110.712 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.673 ' HB2' HD12 ' A' ' 12' ' ' LEU . 37.8 t -120.95 166.66 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.68 0.792 . . . . 61.310000000000002 110.081 166.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.07 138.57 21.78 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 123.069 0.548 . . . . 73.120000000000005 111.303 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 96.0 Cg_exo -47.32 117.11 2.09 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 124.13 3.22 . . . . 52.130000000000003 114.434 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.69 13.32 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 116.254 -0.43 . . . . 55.109999999999999 113.934 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.82 52.92 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 121.151 0.306 . . . . 74.549999999999997 113.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 5.5 p-10 -91.5 129.51 37.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.146 0.498 . . . . 73.420000000000002 111.463 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 6' ' ' SER . 51.5 tp -74.65 150.15 39.7 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.706 0.802 . . . . 71.200000000000003 109.292 169.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.7 115.56 8.27 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.036 0.534 . . . . 75.030000000000001 109.943 170.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 76.2 mt -99.18 101.6 12.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.519 0.728 . . . . 75.409999999999997 109.729 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.3 t -90.36 113.02 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.386 -0.968 . . . . 70.200000000000003 108.386 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.462 HG23 ' CZ ' ' A' ' 75' ' ' PHE . 47.4 t -96.72 122.11 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.242 0.544 . . . . 53.25 112.144 -165.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -120.0 70.53 0.87 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 122.06 0.933 . . . . 74.510000000000005 108.823 170.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HG ' ' CG1' ' A' ' 16' ' ' VAL . 19.7 mt -55.68 156.22 5.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.299 1.44 . . . . 74.140000000000001 113.278 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.8 m -77.72 -33.53 52.98 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.4 -0.818 . . . . 72.310000000000002 110.665 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' HA3' ' NE2' ' A' ' 70' ' ' GLN . . . -141.37 79.86 0.27 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-N 115.853 -0.612 . . . . 73.430000000000007 112.123 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.8 -167.93 0.54 Allowed 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 122.983 2.456 . . . . 70.109999999999999 114.007 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.97 -169.72 42.67 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.635 -0.711 . . . . 42.119999999999997 112.595 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.99 136.61 5.65 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.355 -0.692 . . . . 64.420000000000002 112.911 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.86 162.97 84.0 Favored 'Cis proline' 0 C--N 1.381 2.257 0 CA-C-N 120.032 1.916 . . . . 74.129999999999995 113.489 -6.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.564 HG13 ' SG ' ' A' ' 66' ' ' CYS . 53.9 t -115.09 134.57 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.926 0.89 . . . . 72.239999999999995 110.321 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -97.6 131.77 43.87 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.827 0.851 . . . . 72.200000000000003 110.643 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.2 137.29 41.55 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.796 0.839 . . . . 74.200000000000003 111.605 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.7 m-85 -130.51 124.04 31.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.695 0.798 . . . . 73.120000000000005 110.316 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HB3' HD21 ' A' ' 34' ' ' LEU . 18.7 tptm -104.4 120.26 40.81 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 73.409999999999997 109.231 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.44 22.45 13.25 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.113 0.965 . . . . 75.120000000000005 111.216 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.17 -26.5 22.8 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.841 -0.618 . . . . 53.509999999999998 113.724 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.15 129.96 44.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.431 0.692 . . . . 71.120000000000005 110.805 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 152.55 16.14 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.888 0.875 . . . . 75.230000000000004 112.953 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 29' ' ' LYS . 28.6 mt -107.71 138.74 43.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.886 0.474 . . . . 72.329999999999998 111.293 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 144.8 29.07 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.773 0.829 . . . . 42.310000000000002 111.089 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -71.76 92.68 1.22 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.658 0.783 . . . . 64.299999999999997 111.678 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.455 0.702 . . . . 74.230000000000004 112.309 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.03 -57.21 21.06 Favored Glycine 0 C--N 1.36 1.87 0 N-CA-C 115.078 0.791 . . . . 71.239999999999995 115.078 -172.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -77.4 -40.71 42.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.812 0.445 . . . . 71.219999999999999 111.544 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 54.7 t -95.41 85.6 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.425 0.69 . . . . 70.340000000000003 110.541 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 67.1 mt-30 -92.79 125.11 37.24 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.995 0.518 . . . . 74.430000000000007 112.145 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.34 93.38 4.5 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.522 0.729 . . . . 71.099999999999994 111.049 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.743 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 37.0 tt0 -87.57 105.48 17.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.778 0.831 . . . . 70.400000000000006 110.566 173.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.22 110.04 21.8 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.226 0.61 . . . . 74.420000000000002 110.506 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.16 -45.65 5.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.428 0.691 . . . . 72.129999999999995 111.254 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.09 -91.1 0.12 Allowed Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.534 -0.626 . . . . 73.099999999999994 111.534 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -38.55 64.48 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.615 0.721 . . . . 72.400000000000006 109.913 169.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -81.19 125.89 30.83 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.417 -1.265 . . . . 74.400000000000006 110.431 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -117.49 152.42 35.09 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.898 -1.149 . . . . 75.510000000000005 107.898 164.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.743 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t -138.71 116.24 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.671 0.388 . . . . 72.439999999999998 110.617 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.47 128.48 54.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.554 0.742 . . . . 63.310000000000002 109.28 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 57.4 mtt180 -116.3 136.73 52.74 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.91 0.884 . . . . 75.230000000000004 110.393 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.26 97.57 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.298 0.639 . . . . 74.5 109.532 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -75.2 130.01 38.45 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.942 -0.392 . . . . 73.239999999999995 109.942 178.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.56 23.43 39.69 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.485 -0.325 . . . . 74.099999999999994 112.868 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.6 99.23 0.42 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.496 0.718 . . . . 74.150000000000006 110.221 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 63.9 mtp85 -104.9 -177.28 3.32 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.588 0.755 . . . . 74.239999999999995 112.113 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.0 m -62.57 108.68 1.19 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.299 0.64 . . . . 64.409999999999997 110.896 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.62 -15.36 8.02 Favored Glycine 0 N--CA 1.481 1.634 0 CA-C-N 116.233 -0.439 . . . . 63.5 112.88 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.43 -12.08 59.99 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.991 0.917 . . . . 74.319999999999993 111.809 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 79' ' ' VAL . . . -63.61 92.36 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.557 1.143 . . . . 73.409999999999997 111.545 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.13 -179.93 20.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.488 -0.778 . . . . 60.109999999999999 113.511 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.33 124.89 31.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.109 0.564 . . . . 72.519999999999996 111.24 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 71.0 m-85 -112.9 108.65 17.68 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.177 0.991 . . . . 75.109999999999999 109.51 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 65.4 tp -91.14 103.41 16.1 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.952 -0.467 . . . . 72.409999999999997 110.364 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.564 ' SG ' HG13 ' A' ' 25' ' ' VAL . 40.5 t -77.67 86.91 3.96 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.682 0.753 . . . . 71.25 109.316 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.01 97.02 9.05 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.019 -0.991 . . . . 44.409999999999997 110.747 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.57 159.37 46.9 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 122.96 0.504 . . . . 70.400000000000006 111.039 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.94 36.21 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.635 2.223 . . . . 72.019999999999996 113.596 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.477 ' NE2' ' HA3' ' A' ' 20' ' ' GLY . 0.4 OUTLIER -165.47 -54.33 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.14 0.576 . . . . 75.310000000000002 109.641 -176.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -138.58 108.73 6.41 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.848 0.859 . . . . 74.200000000000003 110.862 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 p -93.38 124.05 37.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 71.140000000000001 110.985 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.83 139.22 48.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.794 0.437 . . . . 72.329999999999998 112.107 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.5 mt -89.04 130.82 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 109.478 -0.564 . . . . 72.319999999999993 109.478 170.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 3.0 m-85 -103.75 103.39 13.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.452 0.701 . . . . 74.420000000000002 109.333 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.42 93.05 5.93 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.725 -0.843 . . . . 75.209999999999994 108.725 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -91.13 127.86 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.084 0.554 . . . . 73.510000000000005 111.014 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.8 p -107.08 108.77 20.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.147 0.579 . . . . 71.329999999999998 109.918 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.646 HG23 ' HB3' ' A' ' 6' ' ' SER . 22.2 t -98.45 106.36 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.073 -0.714 . . . . 72.129999999999995 109.073 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -168.56 172.89 7.8 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.692 0.397 . . . . 72.230000000000004 111.992 -171.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 58.56 86.85 0.15 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 124.577 1.151 . . . . 73.549999999999997 110.85 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.574 2.491 0 C-N-CA 122.817 2.345 . . . . 71.430000000000007 114.034 -173.206 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.603 -0.517 . . . . 65.420000000000002 109.603 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -62.37 127.24 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.22 0.608 . . . . 73.099999999999994 110.946 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 81.5 mtm180 -137.77 126.85 24.32 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.776 0.831 . . . . 74.049999999999997 109.982 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.1 131.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 121.423 0.63 . . . . 73.140000000000001 111.808 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.435 ' NH2' ' HB2' ' A' ' 81' ' ' GLU . 60.3 ttt85 -90.38 139.73 30.39 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.789 1.236 . . . . 74.519999999999996 110.054 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 79' ' ' VAL . 34.1 t -137.69 172.0 13.6 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.121 0.568 . . . . 74.25 110.613 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 p -130.81 148.16 69.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.873 0.869 . . . . 74.129999999999995 111.214 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.33 145.88 39.18 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.637 2.225 . . . . 75.010000000000005 112.659 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.77 37.29 8.68 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 116.049 -0.523 . . . . 64.200000000000003 113.931 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.23 -134.67 1.7 Allowed Glycine 0 N--CA 1.475 1.275 0 CA-C-O 119.972 -0.349 . . . . 61.409999999999997 112.675 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.24 155.43 49.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 117.275 0.538 . . . . 73.400000000000006 111.18 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.11 143.18 32.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.505 1.122 . . . . 73.200000000000003 109.185 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.81 99.0 3.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.107 0.48 . . . . 64.400000000000006 111.267 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.0 mt -92.23 105.53 17.72 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.106 0.962 . . . . 70.349999999999994 110.732 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.2 t -103.58 127.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.902 -0.407 . . . . 73.430000000000007 109.902 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.513 ' HB ' ' HG ' ' A' ' 18' ' ' LEU . 3.4 m -108.3 149.93 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.412 0.685 . . . . 75.219999999999999 111.693 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -128.36 31.41 5.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.104 0.962 . . . . 75.109999999999999 109.444 163.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' HG ' ' HB ' ' A' ' 16' ' ' VAL . 1.2 pp -51.69 166.02 0.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.89 1.07 . . . . 74.109999999999999 113.89 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -86.64 32.86 0.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.338 0.655 . . . . 74.129999999999995 112.756 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.572 ' HA3' ' HB1' ' A' ' 68' ' ' ALA . . . -112.39 90.11 0.55 Allowed Glycine 0 CA--C 1.544 1.888 0 CA-C-O 119.506 -0.608 . . . . 64.109999999999999 112.654 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.19 165.4 23.73 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.116 2.544 . . . . 75.340000000000003 113.237 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.87 -86.23 0.17 Allowed Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.879 -0.601 . . . . 51.520000000000003 113.62 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.07 8.56 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-O 118.782 -1.01 . . . . 74.400000000000006 114.028 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.28 117.44 2.67 Favored 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.828 2.314 . . . . 73.099999999999994 113.635 1.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 91.3 t -65.24 124.05 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.706 -0.679 . . . . 72.409999999999997 110.084 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -94.89 164.43 12.92 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.511 0.725 . . . . 71.299999999999997 111.003 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -120.81 134.96 55.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.96 0.904 . . . . 74.439999999999998 109.716 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.694 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.9 m-85 -122.1 162.53 21.08 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.244 1.018 . . . . 74.420000000000002 110.791 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.6 tptp -154.32 128.33 8.9 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.425 1.09 . . . . 75.340000000000003 108.929 169.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 64.72 17.3 10.88 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.011 0.924 . . . . 74.030000000000001 111.988 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.47 -7.14 81.9 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.534 -0.303 . . . . 71.420000000000002 113.726 -173.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -109.31 121.58 45.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.713 0.805 . . . . 73.239999999999995 110.444 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.9 143.58 57.34 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.732 0.642 . . . . 75.319999999999993 112.732 -175.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.2 mt -87.49 152.62 22.07 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.291 1.037 . . . . 74.450000000000003 110.988 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.42 158.85 20.12 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.835 0.854 . . . . 65.219999999999999 110.343 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -70.62 82.8 0.6 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.789 0.804 . . . . 70.0 110.954 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -96.78 170.47 9.16 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.104 1.362 . . . . 75.310000000000002 110.509 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.15 -43.25 93.47 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.544 0.116 . . . . 73.430000000000007 113.348 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.26 -53.6 13.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.935 0.494 . . . . 75.310000000000002 110.708 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 34' ' ' LEU . 59.7 t -88.17 90.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 124.138 0.975 . . . . 73.430000000000007 112.03 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.633 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.2 mt-30 -82.32 114.89 21.1 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.45 0.7 . . . . 71.239999999999995 110.379 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.42 ' HB3' HE22 ' A' ' 44' ' ' GLN . 29.1 mt -110.06 104.36 13.22 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.203 0.601 . . . . 75.030000000000001 111.76 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.81 98.55 11.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.925 0.89 . . . . 70.540000000000006 110.559 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.42 HE22 ' HB3' ' A' ' 42' ' ' LEU . 23.4 mp0 -99.92 132.02 45.53 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.364 0.666 . . . . 75.310000000000002 110.994 172.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.26 -49.0 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.97 0.908 . . . . 72.219999999999999 110.415 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.98 122.15 1.52 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-O 119.045 -0.864 . . . . 63.109999999999999 111.155 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 69.21 -65.58 0.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.944 1.297 . . . . 74.430000000000007 112.288 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 ttp180 -79.07 95.91 5.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.866 0.466 . . . . 72.430000000000007 110.806 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 8.6 mm100 -116.49 136.95 52.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.753 0.821 . . . . 75.530000000000001 109.458 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 36.0 t -121.52 124.24 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.152 0.501 . . . . 74.129999999999995 111.18 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.67 120.36 40.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 74.140000000000001 108.562 168.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 73.6 mtp180 -119.61 107.91 13.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.944 0.498 . . . . 72.310000000000002 110.094 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -96.42 100.96 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.943 0.497 . . . . 64.329999999999998 110.005 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -71.79 103.09 3.01 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.936 0.494 . . . . 73.219999999999999 109.975 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.39 42.51 0.25 Allowed Glycine 0 N--CA 1.474 1.198 0 CA-C-N 116.293 -0.412 . . . . 74.219999999999999 112.695 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.44 131.5 49.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.007 0.523 . . . . 74.340000000000003 110.642 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -163.56 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.232 0.827 . . . . 74.409999999999997 113.232 -167.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 m -159.07 -56.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 123.273 0.629 . . . . 73.200000000000003 111.305 -171.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -20.59 70.92 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.069 0.388 . . . . 61.130000000000003 114.069 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -81.46 -16.0 53.32 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.146 0.978 . . . . 62.450000000000003 111.193 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB3' HG21 ' A' ' 79' ' ' VAL . . . -74.13 111.57 9.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.88 0.472 . . . . 72.129999999999995 109.737 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.2 -171.9 44.78 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 114.081 0.393 . . . . 72.540000000000006 114.081 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -81.25 113.46 19.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.391 0.676 . . . . 73.420000000000002 110.941 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.708 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 32.8 m-85 -95.36 155.95 16.53 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.994 0.918 . . . . 74.430000000000007 109.334 167.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.63 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.9 tp -133.57 104.89 6.58 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.135 -0.353 . . . . 74.219999999999999 110.075 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.51 ' SG ' HG23 ' A' ' 16' ' ' VAL . 34.4 t -74.99 89.35 2.4 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.883 . . . . 74.25 108.617 169.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.86 92.09 2.5 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.659 1.184 . . . . 75.25 111.582 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB1' ' HA3' ' A' ' 20' ' ' GLY . . . -96.05 148.4 34.46 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.256 0.623 . . . . 70.349999999999994 111.355 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.42 -21.75 66.2 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.985 2.457 . . . . 73.409999999999997 113.625 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.522 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 86.1 mm-40 -112.57 -51.44 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.25 0.62 . . . . 74.340000000000003 112.147 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.45 97.41 3.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.728 0.411 . . . . 74.019999999999996 111.467 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -85.09 141.9 29.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.298 0.639 . . . . 75.219999999999999 110.706 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -130.26 131.97 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.055 0.542 . . . . 71.319999999999993 112.191 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.73 131.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.506 1.122 . . . . 74.340000000000003 109.93 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.708 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 39.8 m-85 -100.79 111.26 23.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.388 0.675 . . . . 73.109999999999999 110.772 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 38.9 mt -82.33 93.56 7.18 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.786 -1.19 . . . . 73.329999999999998 107.786 167.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.0 119.94 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.126 0.57 . . . . 72.439999999999998 110.684 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.1 p -118.4 112.22 19.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.526 0.731 . . . . 60.229999999999997 110.411 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 6' ' ' SER . 44.7 t -86.08 107.21 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 121.287 0.565 . . . . 73.230000000000004 109.492 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.4 -171.21 2.54 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.637 1.175 . . . . 70.409999999999997 110.103 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . 31.2 tt0 60.09 63.41 3.08 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 124.056 0.942 . . . . 74.109999999999999 111.944 166.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.574 2.519 0 C-N-CA 122.69 2.26 . . . . 71.400000000000006 114.491 -166.157 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.869 0.366 . . . . 74.329999999999998 111.206 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -83.72 85.89 7.22 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.935 0.894 . . . . 73.319999999999993 110.37 -170.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.59 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 40.6 mtm180 -84.53 144.74 28.48 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.772 0.829 . . . . 72.140000000000001 112.098 -170.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 74.9 t -139.58 133.83 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.175 0.99 . . . . 74.420000000000002 110.604 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -101.14 145.86 28.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.504 0.722 . . . . 73.239999999999995 110.85 171.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 163.25 32.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.064 0.546 . . . . 73.150000000000006 111.65 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 81' ' ' GLU . 23.7 p -98.24 146.04 30.86 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 123.676 0.79 . . . . 72.040000000000006 111.608 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.16 92.07 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.051 2.5 . . . . 62.140000000000001 112.022 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.16 -14.92 5.38 Favored Glycine 0 N--CA 1.477 1.399 0 CA-C-N 115.617 -0.719 . . . . 43.109999999999999 113.24 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.71 149.34 18.52 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-O 119.504 -0.609 . . . . 74.030000000000001 112.066 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.02 131.09 44.83 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.845 0.823 . . . . 75.549999999999997 111.74 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 55.6 tp -78.83 98.28 6.27 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.778 -0.646 . . . . 75.329999999999998 109.747 172.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -101.51 109.67 21.53 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 110.077 -0.342 . . . . 74.150000000000006 110.077 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.0 103.5 15.8 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.311 -0.626 . . . . 73.450000000000003 109.311 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 t -92.43 101.45 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.769 -0.826 . . . . 73.319999999999993 108.769 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.523 HG12 ' SG ' ' A' ' 66' ' ' CYS . 12.1 t -101.63 130.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.166 0.586 . . . . 73.209999999999994 111.565 -168.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.0 45.58 1.77 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.752 0.821 . . . . 71.120000000000005 110.753 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.521 ' HG ' HG11 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.4 178.04 0.11 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 113.479 0.918 . . . . 70.109999999999999 113.479 169.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 m -87.41 24.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.615 0.766 . . . . 73.049999999999997 112.534 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.24 90.85 0.55 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 119.395 -0.669 . . . . 51.350000000000001 112.197 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.38 127.95 14.79 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.031 2.487 . . . . 73.209999999999994 113.547 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 -111.59 4.3 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.353 -0.385 . . . . 72.430000000000007 113.319 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 -82.99 0.31 Allowed Glycine 0 CA--C 1.547 2.061 0 CA-C-O 119.121 -0.822 . . . . 71.400000000000006 113.744 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HG2' HH22 ' A' ' 26' ' ' ARG . 90.7 Cg_endo -73.99 148.16 91.28 Favored 'Cis proline' 0 C--N 1.382 2.308 0 CA-C-N 120.778 2.289 . . . . 63.439999999999998 113.041 1.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.63 HG13 ' SG ' ' A' ' 66' ' ' CYS . 86.9 t -62.63 136.92 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.57 0.748 . . . . 75.0 111.681 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.51 HH22 ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -97.73 128.98 44.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.421 0.688 . . . . 74.099999999999994 109.762 -177.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -97.57 136.41 38.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.107 0.563 . . . . 71.430000000000007 111.102 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.67 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 88.0 m-85 -133.14 147.97 52.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.028 0.931 . . . . 74.200000000000003 110.516 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 28.3 tptp -136.36 133.38 36.74 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.422 1.089 . . . . 72.5 108.945 165.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.85 17.62 11.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.217 1.007 . . . . 63.329999999999998 112.259 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.01 86.69 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 113.753 0.261 . . . . 71.299999999999997 113.753 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -117.05 135.11 53.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.436 0.694 . . . . 71.409999999999997 109.777 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.85 151.86 17.11 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 113.257 0.836 . . . . 65.129999999999995 113.257 -176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.5 mt -98.18 163.59 12.67 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.347 0.594 . . . . 71.420000000000002 111.204 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.53 151.9 49.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.128 0.971 . . . . 72.340000000000003 109.729 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 77.6 p -79.29 98.39 6.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.843 0.457 . . . . 73.040000000000006 110.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -102.75 -78.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.95 -0.469 . . . . 73.329999999999998 110.925 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.42 -59.66 0.01 OUTLIER Glycine 0 N--CA 1.472 1.071 0 N-CA-C 111.563 -0.615 . . . . 72.400000000000006 111.563 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -70.04 -44.28 69.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.247 0.619 . . . . 74.230000000000004 110.412 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.7 t -82.53 99.03 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.237 0.615 . . . . 70.310000000000002 109.428 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.3 mt-30 -95.2 110.6 22.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.538 0.735 . . . . 74.310000000000002 110.148 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 54.9 mt -106.31 111.99 24.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.914 0.486 . . . . 71.099999999999994 111.206 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.4 tp10 -94.98 106.29 18.27 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.659 1.184 . . . . 70.439999999999998 110.098 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.35 103.76 16.37 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.939 0.496 . . . . 72.150000000000006 109.926 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.02 -164.03 1.24 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.385 0.674 . . . . 73.510000000000005 110.595 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.67 -89.29 0.14 Allowed Glycine 0 C--N 1.353 1.503 0 N-CA-C 112.586 -0.206 . . . . 42.43 112.586 172.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.36 -27.35 24.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.367 0.667 . . . . 70.450000000000003 112.102 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -90.04 87.99 7.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.332 0.653 . . . . 74.530000000000001 111.669 -175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -91.75 129.2 37.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.462 -0.57 . . . . 74.510000000000005 109.462 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 33.5 t -130.31 110.92 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-O 120.811 0.339 . . . . 73.340000000000003 111.582 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -100.25 113.86 26.86 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.775 0.83 . . . . 72.219999999999999 108.807 168.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 72.5 mtp180 -111.34 107.77 17.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.029 0.532 . . . . 75.340000000000003 110.404 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.0 95.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.22 -0.659 . . . . 74.5 109.22 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.24 121.29 9.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.763 0.825 . . . . 74.25 112.241 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 60.35 8.14 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 123.205 0.316 . . . . 73.109999999999999 113.636 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.98 110.55 14.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.523 0.729 . . . . 74.209999999999994 112.623 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -171.75 3.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.368 0.667 . . . . 74.439999999999998 111.26 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m -61.66 -26.28 67.92 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.991 0.737 . . . . 71.430000000000007 112.991 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.92 73.28 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.565 -0.289 . . . . 54.119999999999997 113.761 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.15 0.1 57.34 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.038 0.935 . . . . 74.239999999999995 112.35 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.33 101.32 6.26 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.178 0.591 . . . . 74.140000000000001 109.912 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -167.62 -175.25 37.34 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 114.228 0.451 . . . . 74.450000000000003 114.228 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -89.21 108.86 19.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.122 0.569 . . . . 74.540000000000006 110.575 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -98.62 112.32 24.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.397 0.679 . . . . 73.129999999999995 109.758 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 38.1 tp -91.43 104.34 16.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.457 0.646 . . . . 73.109999999999999 110.336 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.63 ' SG ' HG13 ' A' ' 25' ' ' VAL . 51.3 t -85.7 86.33 7.37 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.738 -0.838 . . . . 70.25 108.738 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.09 105.88 13.54 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.299 -0.864 . . . . 63.350000000000001 110.204 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -113.9 160.33 32.58 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.285 0.634 . . . . 74.310000000000002 111.959 -174.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.78 120.45 8.36 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.587 2.192 . . . . 74.329999999999998 112.351 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 75.53 -60.92 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.526 1.53 . . . . 74.209999999999994 112.387 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 38.4 t70 -105.68 98.91 8.54 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.282 0.633 . . . . 73.430000000000007 111.872 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 t -95.01 129.52 42.05 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.921 0.889 . . . . 73.430000000000007 111.196 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -119.03 131.05 55.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.412 0.685 . . . . 73.510000000000005 112.344 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.46 135.55 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.857 -0.794 . . . . 64.349999999999994 108.857 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -106.2 103.39 12.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.512 0.725 . . . . 72.109999999999999 109.747 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 78.9 mt -78.08 92.87 4.42 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.944 -0.761 . . . . 72.230000000000004 108.944 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.453 HG21 HD23 ' A' ' 12' ' ' LEU . 55.6 t -87.77 132.88 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.554 -0.748 . . . . 71.349999999999994 110.774 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.0 m -134.56 109.23 8.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.618 -0.719 . . . . 75.230000000000004 110.798 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.6 t -89.08 106.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 107.985 -1.117 . . . . 64.349999999999994 107.985 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.57 12.06 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 113.565 0.95 . . . . 64.549999999999997 113.565 -167.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 7' ' ' THR . 34.7 tt0 -125.71 100.4 31.32 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.781 -0.628 . . . . 74.510000000000005 109.55 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 CA--C 1.568 2.18 0 C-N-CA 123.43 2.753 . . . . 75.040000000000006 114.255 -178.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.559 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 49.7 tpp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.135 -0.321 . . . . 73.340000000000003 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 p -65.22 93.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.37 0.668 . . . . 63.439999999999998 112.045 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -90.93 129.57 36.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 71.030000000000001 110.344 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 78.0 t -131.27 138.34 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 124.062 0.945 . . . . 74.409999999999997 110.007 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -106.45 130.28 54.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.206 0.602 . . . . 72.310000000000002 110.82 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.417 ' HB3' HG21 ' A' ' 79' ' ' VAL . 37.0 t -112.99 171.76 7.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.636 0.774 . . . . 75.409999999999997 111.626 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.507 HG21 ' O ' ' A' ' 81' ' ' GLU . 22.5 p -120.81 138.2 27.37 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 113.453 0.909 . . . . 71.129999999999995 113.453 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.8 Cg_endo -77.49 91.09 1.2 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.605 2.87 . . . . 74.510000000000005 112.734 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.74 -13.58 8.65 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.221 -0.9 . . . . 71.209999999999994 112.23 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.81 -137.39 8.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.495 -0.058 . . . . 63.119999999999997 113.015 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -149.88 150.71 32.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.243 0.617 . . . . 71.400000000000006 111.135 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.88 148.24 23.96 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.527 0.731 . . . . 74.340000000000003 110.795 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.01 109.73 5.01 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.453 0.701 . . . . 74.519999999999996 110.043 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 79.7 mt -106.48 101.58 11.03 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.384 -0.599 . . . . 74.5 109.384 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.6 114.81 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.724 -0.843 . . . . 71.239999999999995 108.724 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.456 HG13 ' HG ' ' A' ' 18' ' ' LEU . 6.9 t -103.24 138.97 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 111.576 -166.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -132.23 30.07 4.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.549 0.74 . . . . 63.130000000000003 110.917 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.456 ' HG ' HG13 ' A' ' 16' ' ' VAL . 1.7 pp -54.77 158.89 2.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.193 0.812 . . . . 72.439999999999998 113.193 171.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -90.83 48.31 1.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.175 0.59 . . . . 73.239999999999995 111.093 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.91 128.25 8.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.983 -0.898 . . . . 73.030000000000001 112.69 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.34 89.92 0.26 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.991 2.461 . . . . 74.150000000000006 113.753 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.49 -84.15 0.1 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.905 -0.589 . . . . 75.510000000000005 114.346 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.41 -173.68 44.79 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.631 -0.538 . . . . 72.340000000000003 113.269 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.33 114.33 3.29 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 119.586 1.693 . . . . 72.150000000000006 112.814 -4.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.67 120.93 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 109.369 -0.604 . . . . 71.209999999999994 109.369 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 50.0 mtt180 -95.38 164.99 12.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.386 1.074 . . . . 73.319999999999993 110.904 -173.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -128.46 130.67 47.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.052 0.941 . . . . 73.219999999999999 109.985 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.761 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 97.9 m-85 -123.35 164.64 18.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.754 0.822 . . . . 75.400000000000006 110.81 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 19.3 tptm -154.3 125.64 7.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.566 0.746 . . . . 75.5 110.05 174.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.09 17.15 9.92 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.187 0.995 . . . . 71.200000000000003 111.333 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.06 -31.07 5.44 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.752 -0.471 . . . . 75.140000000000001 114.237 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.32 147.06 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.091 0.946 . . . . 74.209999999999994 112.614 -170.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.761 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.93 153.03 30.39 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 74.319999999999993 115.249 -167.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.5 154.94 18.13 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.753 0.821 . . . . 74.239999999999995 111.17 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.82 148.54 51.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.421 1.088 . . . . 73.209999999999994 109.021 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 t -58.78 97.48 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.383 0.673 . . . . 61.219999999999999 110.747 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -136.05 84.23 2.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.753 0.821 . . . . 72.549999999999997 110.732 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.77 -88.65 0.02 OUTLIER Glycine 0 N--CA 1.478 1.467 0 CA-C-N 115.336 -0.847 . . . . 75.120000000000005 114.424 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.253 1.021 . . . . 72.510000000000005 111.003 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.03 104.83 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.382 0.673 . . . . 64.319999999999993 109.672 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 74.1 mt-30 -109.86 119.3 38.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.13 0.972 . . . . 75.329999999999998 110.354 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.65 137.38 46.69 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.469 0.707 . . . . 73.120000000000005 112.013 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.645 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 15.2 tp10 -133.36 102.3 5.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.534 1.134 . . . . 74.430000000000007 109.369 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -101.9 104.05 14.75 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.421 0.629 . . . . 73.409999999999997 111.361 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.15 75.74 1.64 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.61 0.764 . . . . 75.239999999999995 110.331 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.58 -117.15 6.93 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 115.877 -0.601 . . . . 64.310000000000002 112.783 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.85 -21.99 27.78 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.45 0.7 . . . . 75.109999999999999 111.125 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.92 91.0 1.5 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.743 0.817 . . . . 73.510000000000005 110.155 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -102.93 139.14 38.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.616 0.767 . . . . 75.5 110.068 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 99.7 t -129.16 124.91 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 110.664 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -117.09 122.91 45.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.09 0.956 . . . . 75.109999999999999 108.66 170.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -119.57 134.84 55.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.493 0.717 . . . . 74.310000000000002 109.972 176.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.46 98.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.097 -0.705 . . . . 72.019999999999996 109.097 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.74 115.39 16.46 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.61 -0.723 . . . . 63.32 110.846 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.18 52.95 1.3 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-O 120.881 0.156 . . . . 75.209999999999994 113.089 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.32 160.89 30.47 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.666 0.786 . . . . 72.099999999999994 111.794 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 29.9 ttm180 -166.97 -55.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.991 0.516 . . . . 74.340000000000003 111.495 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -147.64 -47.43 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 122.855 0.462 . . . . 75.239999999999995 111.382 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.48 -17.13 59.43 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.778 0.671 . . . . 42.229999999999997 114.778 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' HB3' HG22 ' A' ' 79' ' ' VAL . 30.7 t70 -72.22 -27.48 62.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.024 0.93 . . . . 72.019999999999996 112.186 174.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.95 103.74 3.85 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 72.299999999999997 111.514 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.422 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . -177.0 -173.5 42.61 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.85 -0.614 . . . . 74.25 113.659 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -90.58 117.13 29.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.78 0.432 . . . . 72.209999999999994 110.039 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -102.27 106.33 17.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.879 0.872 . . . . 73.319999999999993 110.55 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 63.4 tp -91.94 102.08 14.64 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.028 -0.42 . . . . 74.129999999999995 110.242 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -79.34 87.18 5.02 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.771 -0.826 . . . . 73.230000000000004 108.771 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 17.5 t70 -76.04 130.54 38.53 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.764 0.826 . . . . 75.25 111.275 -173.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.555 ' HB1' ' H ' ' A' ' 72' ' ' SER . . . -127.77 143.83 49.04 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 118.664 -0.684 . . . . 74.129999999999995 110.393 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.56 -29.49 7.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 124.248 3.299 . . . . 75.439999999999998 115.099 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -152.32 66.74 0.83 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.632 0.773 . . . . 74.239999999999995 109.494 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.449 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 28.9 t70 -172.42 -80.2 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 123.917 0.887 . . . . 71.129999999999995 110.709 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.555 ' H ' ' HB1' ' A' ' 68' ' ' ALA . 40.0 m 65.46 106.24 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.052 1.341 . . . . 71.109999999999999 112.548 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.15 135.15 49.17 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.818 0.847 . . . . 73.319999999999993 110.938 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.559 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 64.6 mt -100.96 119.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.961 0.504 . . . . 71.200000000000003 110.804 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 2' ' ' THR . 29.3 m-85 -100.34 101.81 12.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.286 0.634 . . . . 74.019999999999996 110.631 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.0 mt -81.88 93.84 6.97 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.317 -0.623 . . . . 74.040000000000006 109.317 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 75.5 t -98.12 121.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.69 0.796 . . . . 60.399999999999999 111.269 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.2 p -121.46 116.64 25.1 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 73.409999999999997 111.371 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 6' ' ' SER . 21.9 t -83.81 110.6 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.316 -0.624 . . . . 73.400000000000006 109.316 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -151.57 -41.63 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.589 0.588 . . . . 71.209999999999994 112.589 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' HG21 ' A' ' 7' ' ' THR . 10.8 tp10 -66.8 106.03 1.03 Allowed Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.93 0.892 . . . . 73.219999999999999 110.607 -175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo . . . . . 0 CA--C 1.57 2.295 0 C-N-CA 123.078 2.519 . . . . 74.409999999999997 113.747 -172.759 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.442 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 110.158 -0.312 . . . . 71.219999999999999 110.158 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.1 m -80.38 83.92 6.12 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.536 0.735 . . . . 75.400000000000006 110.061 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 55.4 mtm180 -83.67 140.41 32.17 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.548 0.739 . . . . 74.040000000000006 112.342 -172.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.01 144.0 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.06 0.944 . . . . 73.150000000000006 109.97 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.94 145.28 51.98 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.455 0.702 . . . . 73.409999999999997 110.848 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.7 t -146.85 171.66 14.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.907 0.883 . . . . 73.099999999999994 110.31 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -76.03 148.87 82.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 112.982 0.734 . . . . 72.239999999999995 112.982 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HA ' HG11 ' A' ' 79' ' ' VAL . 68.0 Cg_endo -75.16 110.87 3.19 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.391 2.727 . . . . 73.400000000000006 112.907 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.47 -7.73 43.29 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.318 -0.855 . . . . 73.140000000000001 112.981 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.67 -156.67 31.53 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 122.767 0.222 . . . . 64.200000000000003 113.174 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 164.41 23.48 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.874 0.47 . . . . 72.540000000000006 110.502 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 47.5 tp -135.58 110.95 9.07 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.623 -0.51 . . . . 74.150000000000006 109.623 167.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.11 110.75 15.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.068 -0.345 . . . . 73.310000000000002 110.068 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.7 mt -89.41 104.72 17.25 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.679 -0.86 . . . . 75.200000000000003 108.679 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.76 107.65 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.445 -0.946 . . . . 74.209999999999994 108.445 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.424 HG11 ' HG ' ' A' ' 18' ' ' LEU . 16.0 t -115.35 129.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.384 0.674 . . . . 71.010000000000005 111.116 -170.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -140.82 43.71 1.83 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.711 0.804 . . . . 71.209999999999994 110.489 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' HG ' HG11 ' A' ' 16' ' ' VAL . 1.7 pp -58.71 167.52 1.49 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.464 0.706 . . . . 74.530000000000001 112.55 170.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -59.77 -49.1 79.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.862 0.465 . . . . 75.450000000000003 111.145 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.0 66.0 1.82 Allowed Glycine 0 C--N 1.356 1.668 0 N-CA-C 115.544 0.978 . . . . 64.200000000000003 115.544 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.24 97.02 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.669 2.246 . . . . 74.329999999999998 112.682 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.0 -154.33 22.4 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.797 -0.638 . . . . 74.409999999999997 113.079 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.24 -179.82 41.42 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.584 -0.564 . . . . 74.409999999999997 113.039 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.9 156.72 97.63 Favored 'Cis proline' 0 C--N 1.376 1.99 0 CA-C-N 119.791 1.796 . . . . 75.230000000000004 113.99 -4.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.87 130.23 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 123.504 0.722 . . . . 73.340000000000003 109.534 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -104.31 147.39 27.56 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.073 0.949 . . . . 72.409999999999997 111.232 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -104.96 132.41 51.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.993 0.517 . . . . 74.150000000000006 111.106 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.726 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.5 m-85 -126.84 165.36 19.49 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.493 1.117 . . . . 72.209999999999994 110.387 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -152.35 114.83 4.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.805 0.842 . . . . 73.230000000000004 110.05 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 t70 72.64 -27.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.653 1.581 . . . . 52.219999999999999 113.965 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.03 -11.17 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.138 0.399 . . . . 71.400000000000006 112.784 -172.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -129.45 138.47 51.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.256 0.623 . . . . 75.230000000000004 110.739 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.726 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.67 150.95 26.12 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.938 0.895 . . . . 71.409999999999997 112.692 177.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.08 134.28 34.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.879 0.472 . . . . 75.310000000000002 110.563 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.07 163.32 12.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.817 0.847 . . . . 71.340000000000003 110.383 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 p -68.74 89.38 0.39 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.601 0.715 . . . . 73.040000000000006 110.854 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 46.9 tt0 -99.1 164.79 12.02 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.42 1.088 . . . . 72.349999999999994 109.935 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.12 -40.09 90.92 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 113.52 0.168 . . . . 74.439999999999998 113.52 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -77.98 -54.34 6.4 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.157 0.583 . . . . 74.430000000000007 110.485 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 66.9 t -82.46 86.77 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 124.086 0.954 . . . . 70.150000000000006 111.63 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 37.8 mt-30 -80.25 133.34 35.98 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.926 0.89 . . . . 74.319999999999993 110.822 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.7 mt -118.95 154.67 32.64 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.102 0.561 . . . . 73.510000000000005 112.131 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.622 ' HG3' HH12 ' A' ' 52' ' ' ARG . 39.8 mt-10 -126.46 113.83 17.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.235 1.014 . . . . 73.400000000000006 110.58 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -94.01 114.9 27.18 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.684 0.794 . . . . 65.340000000000003 110.691 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.88 -68.23 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.765 0.426 . . . . 73.439999999999998 111.596 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.59 139.08 6.02 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 119.19 -0.783 . . . . 65.400000000000006 111.38 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 64.15 -69.87 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.235 1.014 . . . . 55.509999999999998 110.488 -165.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -71.41 116.59 11.92 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.25 0.547 . . . . 74.019999999999996 110.286 166.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -134.13 133.79 41.47 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.075 1.35 . . . . 74.040000000000006 108.269 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -136.53 117.14 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 121.775 -0.578 . . . . 74.109999999999999 110.374 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -101.77 123.92 46.54 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.248 1.019 . . . . 74.0 109.136 172.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.622 HH12 ' HG3' ' A' ' 43' ' ' GLU . 1.5 mpp_? -116.19 108.02 15.61 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.184 0.594 . . . . 75.420000000000002 110.799 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.2 t -96.67 96.71 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.271 -0.64 . . . . 75.510000000000005 109.271 169.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.24 129.18 38.22 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.469 0.708 . . . . 73.150000000000006 110.987 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.47 40.34 33.09 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.151 0.306 . . . . 74.409999999999997 112.891 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 131.87 36.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.137 0.975 . . . . 71.549999999999997 112.265 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -156.75 -84.47 0.05 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.239 0.616 . . . . 73.239999999999995 110.768 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.1 t -92.45 121.9 34.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.623 0.769 . . . . 64.549999999999997 110.547 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.3 -31.7 5.3 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.531 -0.304 . . . . 75.409999999999997 112.732 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.2 -29.21 60.26 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.088 0.955 . . . . 74.200000000000003 111.435 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.15 113.67 10.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.23 -0.655 . . . . 62.340000000000003 109.23 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.12 -170.22 43.32 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 123.123 0.264 . . . . 73.420000000000002 113.242 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -89.16 114.26 25.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.0 0.52 . . . . 74.400000000000006 111.126 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -96.77 154.34 17.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.742 0.817 . . . . 73.230000000000004 109.797 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.4 tp -132.88 105.13 6.94 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.687 0.395 . . . . 75.040000000000006 110.759 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.73 87.93 6.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.226 -1.027 . . . . 65.129999999999995 108.226 169.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.74 95.24 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.796 -1.093 . . . . 74.219999999999999 110.907 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 71' ' ' ASP . . . -100.99 145.67 30.81 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.466 0.706 . . . . 54.420000000000002 110.644 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.206 2.604 . . . . 75.329999999999998 113.19 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 61.09 35.02 18.88 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.51 1.124 . . . . 72.010000000000005 112.335 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 12.6 t70 -140.79 -83.06 0.23 Allowed 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 123.628 0.771 . . . . 70.140000000000001 109.726 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.9 m 56.73 103.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.701 1.371 . . . . 74.430000000000007 114.701 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -107.1 135.54 48.47 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.201 0.6 . . . . 75.140000000000001 111.815 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.39 138.95 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.114 0.965 . . . . 73.200000000000003 109.225 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -115.91 104.1 11.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.586 1.155 . . . . 74.349999999999994 109.546 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.601 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 73.9 mt -78.35 91.28 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.944 -1.132 . . . . 75.540000000000006 107.944 171.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.45 HG12 HD23 ' A' ' 12' ' ' LEU . 82.0 t -99.16 119.64 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 115.344 -0.844 . . . . 72.299999999999997 110.884 -175.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.4 p -112.94 108.07 16.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.828 0.851 . . . . 74.409999999999997 110.037 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 8' ' ' PRO . 46.0 t -95.56 104.28 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.309 -0.997 . . . . 75.420000000000002 108.309 171.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -173.82 -165.43 0.25 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.516 1.126 . . . . 73.450000000000003 108.893 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 64.55 82.34 0.21 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.674 0.79 . . . . 64.230000000000004 109.45 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 C--N 1.384 2.403 0 C-N-CA 123.359 2.706 . . . . 71.109999999999999 114.029 -171.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.645 -0.502 . . . . 75.349999999999994 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 33.3 m -83.23 106.86 15.35 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.911 0.484 . . . . 64.430000000000007 110.595 -172.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -112.44 145.24 40.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.781 0.832 . . . . 75.400000000000006 110.908 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.1 t -138.22 137.55 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 123.636 0.775 . . . . 74.129999999999995 110.68 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -113.55 138.84 49.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.387 0.675 . . . . 74.219999999999999 110.4 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.1 t -129.95 166.02 20.92 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.502 0.721 . . . . 73.120000000000005 110.575 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.2 p -83.28 148.83 56.92 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.237 0.615 . . . . 62.119999999999997 112.208 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -78.78 75.14 5.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.308 2.672 . . . . 73.420000000000002 113.206 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.77 -32.4 0.21 Allowed Glycine 0 C--N 1.342 0.861 0 CA-C-N 115.455 -0.793 . . . . 75.439999999999998 113.159 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.51 -138.1 3.9 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.885 0.314 . . . . 72.0 113.885 -174.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.51 140.08 49.48 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.028 0.531 . . . . 75.329999999999998 109.926 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD21 HG12 ' A' ' 77' ' ' VAL . 55.3 tp -85.74 99.87 11.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.201 0.6 . . . . 72.120000000000005 110.021 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.66 103.15 13.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.116 0.567 . . . . 71.430000000000007 110.279 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 45.0 mt -96.1 102.72 14.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.303 0.641 . . . . 73.420000000000002 110.383 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.77 115.58 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.367 0.667 . . . . 71.140000000000001 109.711 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.523 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -99.35 138.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-O 121.022 0.439 . . . . 75.219999999999999 110.068 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -104.63 38.06 1.98 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.894 0.878 . . . . 75.140000000000001 109.973 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 73' ' ' ARG . 17.2 mt -53.73 -40.12 65.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.96 1.304 . . . . 73.019999999999996 112.334 173.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 t 62.75 19.99 11.8 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.358 1.063 . . . . 54.399999999999999 111.811 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.75 135.36 14.61 Favored Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.911 -0.939 . . . . 75.519999999999996 112.167 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.19 89.37 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.125 2.55 . . . . 73.120000000000005 114.017 -173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.9 -95.11 0.26 Allowed Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.639 -0.71 . . . . 72.129999999999995 113.853 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA2' ' HB3' ' A' ' 69' ' ' PRO . . . 121.67 -89.48 0.43 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-O 119.155 -0.803 . . . . 74.049999999999997 113.082 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.66 145.13 82.23 Favored 'Cis proline' 0 C--N 1.379 2.183 0 CA-C-N 120.266 2.033 . . . . 73.120000000000005 113.859 4.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 68' ' ' ALA . 75.8 t -65.93 129.69 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.4 -0.818 . . . . 72.450000000000003 110.882 173.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 99.2 mtt180 -96.41 127.66 42.61 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.342 -0.614 . . . . 75.150000000000006 109.342 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -98.31 131.59 44.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.02 0.528 . . . . 72.439999999999998 110.014 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.717 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 84.2 m-85 -126.0 136.66 53.24 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.854 0.862 . . . . 65.409999999999997 109.809 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HD3' ' CZ ' ' A' ' 64' ' ' TYR . 17.3 tptm -104.81 116.86 32.73 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.821 0.848 . . . . 74.340000000000003 108.994 171.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.71 -59.51 0.53 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.773 1.629 . . . . 71.120000000000005 111.13 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.79 -9.93 0.03 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 123.867 0.746 . . . . 61.219999999999999 112.355 172.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -106.2 135.26 47.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.716 0.807 . . . . 75.430000000000007 110.667 -175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 152.82 20.88 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.072 1.138 . . . . 75.209999999999994 114.072 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB3' HG13 ' A' ' 40' ' ' VAL . 4.0 mm? -86.3 161.42 18.75 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.62 -0.718 . . . . 73.120000000000005 110.309 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.51 106.33 5.92 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.916 0.886 . . . . 71.409999999999997 109.637 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 p -63.91 99.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.655 0.782 . . . . 74.340000000000003 111.307 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -124.7 -65.04 1.06 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.468 0.707 . . . . 75.299999999999997 111.565 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.09 -64.9 0.01 OUTLIER Glycine 0 N--CA 1.478 1.438 0 N-CA-C 112.748 -0.141 . . . . 74.319999999999993 112.748 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -67.3 -58.97 3.83 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.979 -0.749 . . . . 73.140000000000001 108.979 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 34' ' ' LEU . 86.9 t -72.91 124.04 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.713 -1.131 . . . . 74.329999999999998 110.47 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.34 113.83 11.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.223 1.009 . . . . 72.519999999999996 109.525 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.413 HD23 HD22 ' A' ' 51' ' ' LEU . 79.5 mt -97.53 108.25 20.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.6 0.76 . . . . 72.129999999999995 110.52 -178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.553 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.7 tm-20 -98.33 108.29 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.59 1.156 . . . . 74.120000000000005 109.474 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.524 ' HG3' HE22 ' A' ' 49' ' ' GLN . 2.7 mp0 -99.5 102.22 13.7 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.532 0.733 . . . . 65.109999999999999 109.354 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.78 -29.63 17.5 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.232 0.613 . . . . 71.049999999999997 112.207 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 -42.41 1.6 Allowed Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.789 0.233 . . . . 62.219999999999999 112.528 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.17 -28.26 7.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.756 0.822 . . . . 74.340000000000003 110.192 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -105.92 141.3 37.56 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.279 1.032 . . . . 73.150000000000006 111.166 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.524 HE22 ' HG3' ' A' ' 44' ' ' GLN . 16.7 mm100 -125.2 128.34 48.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.778 0.831 . . . . 71.409999999999997 109.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 39.3 t -129.58 110.59 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 112.252 0.464 . . . . 61.119999999999997 112.252 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -93.98 112.81 24.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.084 -0.71 . . . . 73.530000000000001 109.084 168.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 67.4 mtp180 -106.52 119.59 39.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.216 0.606 . . . . 74.030000000000001 110.223 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.25 102.24 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.274 0.629 . . . . 74.439999999999998 109.492 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -74.9 131.93 41.08 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.231 0.613 . . . . 74.340000000000003 111.27 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.5 5.35 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 116.015 -0.538 . . . . 71.230000000000004 112.29 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.38 114.81 25.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.992 0.917 . . . . 73.519999999999996 112.242 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.23 -80.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.13 0.972 . . . . 73.310000000000002 112.262 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.2 p -101.22 -76.65 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.415 0.686 . . . . 74.530000000000001 112.439 -163.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 -6.29 58.29 Favored Glycine 0 C--N 1.356 1.689 0 N-CA-C 114.142 0.417 . . . . 64.140000000000001 114.142 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.38 -24.05 63.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.295 1.038 . . . . 73.340000000000003 111.322 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.533 ' HB3' ' H ' ' A' ' 79' ' ' VAL . . . -73.49 128.4 35.39 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.667 0.787 . . . . 74.430000000000007 109.608 172.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.0 178.78 39.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.67 -0.3 . . . . 72.540000000000006 113.344 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -84.73 115.88 22.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.599 0.36 . . . . 62.240000000000002 110.478 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.46 ' CZ ' ' HD3' ' A' ' 29' ' ' LYS . 50.1 m-85 -102.08 123.19 45.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.132 0.492 . . . . 65.150000000000006 110.966 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 58.8 tp -94.12 100.71 12.76 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.748 0.819 . . . . 73.230000000000004 109.471 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.523 ' SG ' HG21 ' A' ' 16' ' ' VAL . 46.2 t -90.34 88.08 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.622 0.725 . . . . 52.43 109.658 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.4 t70 -72.09 94.87 1.56 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.48 1.112 . . . . 75.450000000000003 111.485 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' HA ' HG21 ' A' ' 25' ' ' VAL . . . -76.46 163.11 68.13 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.543 1.137 . . . . 63.310000000000002 113.058 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.493 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 77.7 Cg_endo -75.22 -4.22 15.03 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.569 2.18 . . . . 74.409999999999997 113.892 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -117.63 -56.17 2.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.457 0.703 . . . . 74.049999999999997 110.972 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.21 119.56 5.53 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.346 0.659 . . . . 73.439999999999998 110.011 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.7 t -62.35 128.08 34.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.551 0.741 . . . . 75.129999999999995 111.924 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.478 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -107.37 147.15 30.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.48 0.712 . . . . 75.409999999999997 111.136 -177.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.82 146.96 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.225 0.61 . . . . 74.299999999999997 110.337 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.625 ' HB3' HG22 ' A' ' 77' ' ' VAL . 10.7 m-85 -107.47 139.03 42.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.841 1.256 . . . . 74.230000000000004 110.893 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.11 93.77 4.87 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.599 -1.259 . . . . 65.109999999999999 107.599 162.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG22 ' HB3' ' A' ' 75' ' ' PHE . 78.8 t -101.02 132.2 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.688 -0.687 . . . . 73.040000000000006 111.356 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 76.7 p -127.17 124.54 39.27 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.154 0.982 . . . . 75.319999999999993 108.987 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.533 ' H ' ' HB3' ' A' ' 61' ' ' ALA . 39.5 t -104.43 105.2 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.012 -1.107 . . . . 72.319999999999993 108.012 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.93 -168.39 0.66 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.923 1.289 . . . . 72.120000000000005 109.618 -170.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 62.53 85.8 0.16 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 123.849 0.86 . . . . 72.230000000000004 109.786 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.572 2.422 0 C-N-CA 123.131 2.554 . . . . 73.430000000000007 113.235 -174.769 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' HD11 ' A' ' 76' ' ' LEU . 62.9 mtt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.517 0.199 . . . . 75.239999999999995 110.591 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 m -102.58 88.46 3.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.908 0.883 . . . . 74.120000000000005 110.097 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 76' ' ' LEU . 3.8 mpt_? -78.35 138.58 38.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.503 0.721 . . . . 73.310000000000002 111.966 -172.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 91.6 t -140.91 134.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.161 0.984 . . . . 64.239999999999995 109.663 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -90.68 145.28 24.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.098 0.559 . . . . 73.510000000000005 110.401 176.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.42 ' HB2' HD12 ' A' ' 12' ' ' LEU . 41.0 t -127.91 159.73 34.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.212 0.605 . . . . 74.439999999999998 111.848 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 81' ' ' GLU . 18.2 p -112.95 150.67 43.22 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 124.603 1.161 . . . . 63.539999999999999 111.529 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.43 98.49 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.272 2.648 . . . . 72.140000000000001 113.682 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.81 -14.33 22.02 Favored Glycine 0 N--CA 1.479 1.514 0 CA-C-N 116.006 -0.543 . . . . 63.32 114.245 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.53 -143.17 3.89 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 117.54 0.67 . . . . 74.120000000000005 113.764 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.08 127.0 37.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.153 0.581 . . . . 74.340000000000003 111.024 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.9 tp -77.64 123.6 26.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.45 0.7 . . . . 54.509999999999998 110.022 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -115.87 112.65 22.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.199 0.454 . . . . 73.120000000000005 109.891 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 79.0 mt -91.75 101.64 14.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.409 -0.589 . . . . 74.239999999999995 109.409 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.59 108.03 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 108.842 -0.799 . . . . 74.140000000000001 108.842 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.425 HG12 ' HZ ' ' A' ' 75' ' ' PHE . 6.1 t -98.63 113.53 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.572 0.349 . . . . 71.019999999999996 110.863 -169.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -90.2 33.85 0.88 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 122.944 0.498 . . . . 71.109999999999999 111.672 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 mt -51.07 155.93 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.327 1.051 . . . . 74.430000000000007 111.866 164.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 t -75.28 74.14 2.39 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 167.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.52 119.48 16.52 Favored Glycine 0 CA--C 1.541 1.696 0 CA-C-N 115.48 -0.782 . . . . 72.129999999999995 114.415 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.6 29.97 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.818 2.346 . . . . 73.340000000000003 112.895 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -59.42 4.9 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.876 0.274 . . . . 73.209999999999994 112.441 -174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.01 174.69 24.44 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.759 -0.467 . . . . 55.420000000000002 112.719 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.27 148.04 28.46 Favored 'Cis proline' 0 CA--C 1.559 1.736 0 CA-C-N 119.147 1.474 . . . . 72.349999999999994 113.571 -4.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG13 ' SG ' ' A' ' 66' ' ' CYS . 85.4 t -114.57 136.42 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.223 0.609 . . . . 72.140000000000001 109.695 174.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -98.25 128.17 44.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 74.219999999999999 110.586 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 77.4 m95 -99.39 143.3 29.8 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.399 0.68 . . . . 74.230000000000004 110.76 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.505 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 93.3 m-85 -135.45 124.25 23.95 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.426 0.691 . . . . 75.340000000000003 110.725 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.9 tptp -118.51 132.45 56.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.281 0.632 . . . . 73.200000000000003 109.431 172.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.3 26.09 15.97 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.816 0.846 . . . . 71.510000000000005 111.51 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -2.06 86.36 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 114.941 0.737 . . . . 72.510000000000005 114.941 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -125.01 144.29 50.47 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.531 1.166 . . . . 72.400000000000006 111.367 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 27' ' ' TRP . 0.3 OUTLIER -65.68 152.66 43.7 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.053 1.131 . . . . 74.439999999999998 114.053 -172.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.429 ' HB3' HG12 ' A' ' 40' ' ' VAL . 3.9 mm? -88.85 162.02 16.39 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.837 0.855 . . . . 71.349999999999994 111.397 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.16 107.5 4.38 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.05 0.94 . . . . 54.439999999999998 110.164 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 p -66.42 91.94 0.19 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.692 0.797 . . . . 75.109999999999999 112.251 -176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -139.94 -73.3 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.267 0.627 . . . . 73.510000000000005 111.131 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -94.4 1.75 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 122.684 0.183 . . . . 52.049999999999997 113.141 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -70.18 -32.36 70.25 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.474 0.31 . . . . 72.450000000000003 111.495 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 34' ' ' LEU . 87.2 t -81.86 120.27 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.44 0.696 . . . . 74.25 110.493 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 72.6 mt-30 -126.16 97.1 4.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.044 0.938 . . . . 74.25 109.392 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.1 152.38 23.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.28 0.562 . . . . 73.5 112.024 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.75 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.0 tm-20 -138.54 106.45 5.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 107.774 -1.195 . . . . 71.409999999999997 107.774 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -100.34 102.75 14.07 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.533 0.333 . . . . 74.230000000000004 110.152 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.37 3.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.791 0.836 . . . . 72.140000000000001 111.115 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.61 -72.82 0.65 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 116.356 -0.384 . . . . 75.109999999999999 113.318 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.6 19.97 12.62 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.728 0.811 . . . . 74.400000000000006 112.23 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -148.23 151.41 35.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.259 0.552 . . . . 75.219999999999999 112.182 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.1 155.45 38.36 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.143 0.977 . . . . 75.510000000000005 108.61 164.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.75 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 84.7 t -141.91 136.62 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.175 0.512 . . . . 73.510000000000005 110.432 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.409 HD13 HD13 ' A' ' 14' ' ' LEU . 1.7 tm? -120.5 116.14 24.82 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.445 -0.946 . . . . 64.420000000000002 108.445 171.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 99.6 mtt180 -108.14 109.43 20.84 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.328 0.651 . . . . 73.329999999999998 111.349 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.3 t -88.42 98.08 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.985 0.514 . . . . 74.530000000000001 110.264 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.95 127.35 32.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.943 0.497 . . . . 62.340000000000003 109.974 168.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.77 33.69 15.21 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 112.675 -0.17 . . . . 62.109999999999999 112.675 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.71 110.87 2.95 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.763 0.825 . . . . 64.200000000000003 111.288 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -163.28 124.49 2.4 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.132 0.573 . . . . 74.030000000000001 109.95 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.516 ' H ' HG11 ' A' ' 79' ' ' VAL . 50.2 m 55.93 -82.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.305 1.442 . . . . 54.240000000000002 113.851 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.9 -7.24 55.41 Favored Glycine 0 C--N 1.363 2.043 0 N-CA-C 114.702 0.641 . . . . 74.019999999999996 114.702 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.69 -32.81 74.41 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.767 0.827 . . . . 73.299999999999997 111.618 170.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.582 ' HB3' ' H ' ' A' ' 79' ' ' VAL . . . -67.82 100.68 0.96 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 75.349999999999994 111.286 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.485 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -166.65 -174.07 35.59 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.679 -0.691 . . . . 62.109999999999999 113.059 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -93.49 113.02 25.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.506 0.722 . . . . 64.310000000000002 110.536 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.663 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 49.2 m-85 -101.17 111.89 24.22 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.393 0.677 . . . . 73.329999999999998 109.947 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 72' ' ' SER . 61.0 tp -92.1 100.6 13.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 122.869 0.468 . . . . 75.129999999999995 110.122 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 25' ' ' VAL . 37.8 t -79.0 86.09 4.89 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.926 0.87 . . . . 73.409999999999997 108.74 170.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -94.13 115.69 28.01 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.423 -1.262 . . . . 73.540000000000006 112.229 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.04 154.48 55.66 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.776 0.83 . . . . 65.010000000000005 109.36 171.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.48 -19.32 17.31 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.616 2.211 . . . . 71.409999999999997 113.003 171.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -76.35 -72.83 0.31 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.879 0.872 . . . . 75.400000000000006 110.92 170.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -139.25 144.12 38.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.834 0.854 . . . . 64.120000000000005 111.4 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.552 ' HB2' HD11 ' A' ' 65' ' ' LEU . 51.5 p -112.4 109.32 18.86 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.916 0.886 . . . . 71.510000000000005 110.382 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.98 127.77 53.37 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.07 0.948 . . . . 74.409999999999997 110.987 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.32 128.43 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.574 0.75 . . . . 73.219999999999999 110.179 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.663 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 4.1 m-85 -102.2 111.18 23.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 64.519999999999996 110.15 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.597 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 78.9 mt -85.02 94.12 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 75.519999999999996 109.734 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.6 t -94.71 137.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.711 0.804 . . . . 74.019999999999996 110.639 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -137.17 111.26 8.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.141 0.576 . . . . 75.329999999999998 110.865 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.582 ' H ' ' HB3' ' A' ' 61' ' ' ALA . 46.4 t -83.94 103.43 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.089 -1.078 . . . . 74.409999999999997 108.089 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.94 33.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.848 0.832 . . . . 71.310000000000002 110.978 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 7' ' ' THR . 10.1 tp10 -130.91 92.87 32.66 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 115.17 -0.923 . . . . 75.420000000000002 109.131 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo . . . . . 0 CA--C 1.571 2.342 0 C-N-CA 122.526 2.151 . . . . 53.119999999999997 113.197 -179.472 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.631 0.253 . . . . 75.310000000000002 111.004 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m -75.44 79.17 2.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.31 1.052 . . . . 61.240000000000002 109.746 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -92.55 131.63 37.51 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.512 -1.222 . . . . 74.310000000000002 111.971 -163.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.0 t -121.78 127.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.837 0.855 . . . . 75.310000000000002 110.694 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -93.2 142.89 26.8 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.729 0.812 . . . . 74.420000000000002 109.918 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -137.25 160.23 39.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.647 0.779 . . . . 65.019999999999996 110.968 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -96.16 148.46 34.55 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 123.686 0.795 . . . . 74.150000000000006 111.135 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 95.4 Cg_endo -72.9 128.36 13.14 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.131 2.554 . . . . 65.340000000000003 112.938 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.81 66.12 1.23 Allowed Glycine 0 C--N 1.357 1.748 0 CA-C-N 116.656 -0.247 . . . . 63.140000000000001 113.162 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.74 -115.73 0.38 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 113.439 0.136 . . . . 55.439999999999998 113.439 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -144.67 131.47 20.17 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.054 0.941 . . . . 73.340000000000003 109.731 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 65.3 tp -96.65 101.63 13.27 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.031 0.532 . . . . 74.430000000000007 110.092 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.18 112.08 24.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.905 0.482 . . . . 74.25 110.302 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.6 mt -108.17 103.93 13.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.887 0.875 . . . . 64.120000000000005 109.584 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.577 HG11 ' HG3' ' A' ' 48' ' ' ARG . 74.4 t -91.31 134.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.5 0.72 . . . . 74.109999999999999 109.34 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 49' ' ' GLN . 39.6 t -99.09 141.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 121.292 0.568 . . . . 73.25 111.678 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.57 -34.85 5.71 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.851 0.86 . . . . 75.340000000000003 110.876 166.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' ' 73' ' ' ARG . 6.8 mt 63.52 178.07 0.16 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 123.857 0.863 . . . . 71.400000000000006 113.117 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 t -102.77 -24.72 13.7 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.992 -0.549 . . . . 74.439999999999998 110.144 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.54 103.38 0.83 Allowed Glycine 0 CA--C 1.543 1.819 0 CA-C-O 119.635 -0.536 . . . . 75.150000000000006 112.985 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.51 102.3 1.54 Allowed 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 122.798 2.332 . . . . 70.329999999999998 113.379 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.5 131.57 1.58 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 121.455 -0.402 . . . . 74.219999999999999 113.891 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.94 169.94 49.06 Favored Glycine 0 CA--C 1.547 2.087 0 CA-C-O 119.477 -0.624 . . . . 53.030000000000001 113.587 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.26 115.49 3.92 Favored 'Cis proline' 0 C--N 1.379 2.163 0 CA-C-N 120.079 1.939 . . . . 63.200000000000003 112.962 1.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.87 118.9 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 122.986 0.514 . . . . 74.239999999999995 109.967 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -99.96 146.54 26.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.522 0.729 . . . . 70.450000000000003 111.783 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.406 ' CD1' HD23 ' A' ' 42' ' ' LEU . 79.6 m95 -100.17 134.18 43.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.164 0.986 . . . . 74.010000000000005 110.844 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.59 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 41.6 m-85 -130.03 139.28 51.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.323 1.049 . . . . 74.430000000000007 109.007 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.1 tptp -116.55 127.05 54.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.566 0.621 . . . . 74.329999999999998 110.098 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 56.39 20.49 4.75 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.088 1.355 . . . . 70.239999999999995 113.57 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.53 4.42 32.4 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.095 0.798 . . . . 74.209999999999994 115.095 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -141.3 141.11 33.93 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 1.168 . . . . 74.349999999999994 111.594 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.71 151.77 16.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.456 1.28 . . . . 75.109999999999999 114.456 -171.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 29' ' ' LYS . 19.5 mt -103.34 157.33 17.1 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.753 0.821 . . . . 74.439999999999998 111.002 172.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.86 143.68 44.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.161 0.985 . . . . 75.140000000000001 110.197 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.8 p -80.09 73.21 6.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.178 0.591 . . . . 61.420000000000002 110.511 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -134.68 -92.65 0.31 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.759 0.652 . . . . 75.310000000000002 112.759 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.81 87.28 1.51 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-O 120.012 -0.326 . . . . 64.319999999999993 113.29 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 69.88 -11.52 0.54 Allowed 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.947 1.299 . . . . 74.230000000000004 113.269 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.16 114.17 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.518 1.127 . . . . 71.340000000000003 108.933 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 45.6 mt-30 -113.18 132.25 55.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.476 1.11 . . . . 74.510000000000005 110.145 -173.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.406 HD23 ' CD1' ' A' ' 27' ' ' TRP . 79.6 mt -119.03 92.14 3.73 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.721 0.408 . . . . 74.140000000000001 110.651 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 2.6 mp0 -82.06 98.7 8.77 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.434 0.694 . . . . 73.340000000000003 110.369 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.28 126.88 34.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.178 0.514 . . . . 75.109999999999999 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.81 13.34 2.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.559 0.744 . . . . 63.450000000000003 112.095 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.15 -77.68 0.87 Allowed Glycine 0 C--N 1.35 1.349 0 N-CA-C 112.49 -0.244 . . . . 73.420000000000002 112.49 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.07 -54.02 5.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.035 0.534 . . . . 70.5 110.145 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' HG11 ' A' ' 15' ' ' VAL . 48.3 ttp180 -82.84 90.45 6.93 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.603 0.716 . . . . 74.340000000000003 111.675 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' HG23 ' A' ' 16' ' ' VAL . 9.8 mm100 -95.97 126.67 41.37 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.447 -0.946 . . . . 71.230000000000004 108.447 170.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 46.6 t -114.9 108.94 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 O-C-N 121.911 -0.493 . . . . 74.310000000000002 110.836 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -91.23 112.51 24.45 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.668 -0.864 . . . . 72.140000000000001 108.668 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 74.2 mtp180 -113.49 104.73 12.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.809 0.444 . . . . 74.420000000000002 110.988 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -93.33 97.01 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.185 -1.043 . . . . 71.150000000000006 108.185 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.05 96.09 0.42 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.469 -0.787 . . . . 73.239999999999995 110.705 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.36 -60.1 0.19 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.833 -1.076 . . . . 64.540000000000006 110.886 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . 45.5 69.69 0.43 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.404 1.481 . . . . 73.549999999999997 112.734 174.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.68 -56.24 0.08 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.158 0.429 . . . . 73.150000000000006 112.158 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -141.86 117.81 10.56 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.137 0.575 . . . . 74.340000000000003 110.986 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.25 80.7 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.484 -0.326 . . . . 74.420000000000002 113.462 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.05 -31.87 39.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.341 1.056 . . . . 75.420000000000002 111.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.02 120.19 21.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.583 0.753 . . . . 72.450000000000003 109.784 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.08 -175.58 45.97 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.657 -0.306 . . . . 50.420000000000002 113.706 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.79 112.45 24.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.836 0.454 . . . . 72.409999999999997 110.159 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 59.4 m-85 -98.84 124.1 43.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.294 0.637 . . . . 75.120000000000005 111.717 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 46.5 tp -94.75 118.32 31.55 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.969 0.508 . . . . 72.230000000000004 110.683 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.3 t -92.63 88.95 6.49 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.157 0.983 . . . . 73.349999999999994 109.93 170.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.59 ' HB3' ' HE1' ' A' ' 28' ' ' TYR . 14.0 t70 -91.11 107.23 19.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.787 0.835 . . . . 63.43 111.44 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.66 157.86 43.34 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.762 0.825 . . . . 60.219999999999999 111.038 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.02 -32.06 96.84 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.334 2.023 . . . . 75.340000000000003 111.979 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.0 101.85 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.259 1.024 . . . . 74.400000000000006 109.138 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 71.42 143.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.709 1.203 . . . . 73.219999999999999 113.811 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.3 p -118.58 120.58 37.91 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.951 0.9 . . . . 72.25 108.97 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HB2' HD22 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -109.62 149.32 29.86 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.183 0.593 . . . . 73.349999999999994 111.313 -174.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.05 134.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.183 0.593 . . . . 74.319999999999993 110.581 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 6.5 m-85 -114.7 104.05 11.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.707 1.203 . . . . 74.340000000000003 109.903 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.09 112.39 20.18 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.799 -0.445 . . . . 74.230000000000004 109.799 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.5 t -106.65 131.09 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.059 0.543 . . . . 73.349999999999994 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -126.76 108.8 11.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.527 0.731 . . . . 73.439999999999998 110.322 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.16 107.4 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.336 0.655 . . . . 62.020000000000003 109.328 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.34 178.45 8.67 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.542 0.737 . . . . 55.130000000000003 111.479 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 61.39 79.78 0.27 Allowed Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 124.696 1.198 . . . . 75.120000000000005 111.213 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.573 2.452 0 C-N-CA 123.393 2.729 . . . . 74.099999999999994 114.291 -176.568 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.87 0.366 . . . . 65.230000000000004 111.44 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.0 m -75.55 86.41 2.64 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.333 1.053 . . . . 73.230000000000004 110.562 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 44.7 mtm180 -89.08 152.1 21.85 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.778 0.659 . . . . 74.450000000000003 112.778 -172.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.7 t -139.64 135.5 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 124.328 1.051 . . . . 72.439999999999998 110.34 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -94.36 145.95 24.4 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 122.992 0.517 . . . . 74.109999999999999 110.927 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.459 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.2 t -134.29 156.52 48.3 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.601 0.76 . . . . 72.219999999999999 110.762 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -84.62 147.01 48.09 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 123.144 0.577 . . . . 70.5 111.419 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.9 82.12 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.29 2.66 . . . . 72.239999999999995 113.298 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.3 7.38 4.45 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 114.521 -1.218 . . . . 71.450000000000003 112.543 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.94 26.38 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 114.724 0.649 . . . . 72.319999999999993 114.724 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.71 110.53 21.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.865 0.866 . . . . 74.209999999999994 110.456 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.9 tp -74.09 138.92 44.26 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.433 -0.58 . . . . 74.150000000000006 109.433 169.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -145.02 111.39 5.65 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.27 0.628 . . . . 74.530000000000001 109.957 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 46.0 mt -98.99 101.65 13.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.098 -0.705 . . . . 74.340000000000003 109.098 175.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -97.4 106.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 108.46 -0.941 . . . . 70.019999999999996 108.46 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 18.2 t -98.93 141.37 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.974 0.91 . . . . 74.420000000000002 111.324 -166.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -137.75 48.86 1.99 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.371 0.668 . . . . 74.239999999999995 109.89 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -57.04 174.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.075 1.139 . . . . 74.510000000000005 114.075 172.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -91.49 20.52 5.27 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.556 0.742 . . . . 64.109999999999999 112.408 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 121.36 19.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.905 -0.941 . . . . 72.030000000000001 112.888 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.89 21.99 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.472 2.781 . . . . 73.349999999999994 115.006 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.51 -105.27 0.22 Allowed Glycine 0 C--N 1.35 1.353 0 O-C-N 122.416 -0.177 . . . . 51.549999999999997 113.157 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.96 -176.91 40.65 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.421 -0.655 . . . . 63.439999999999998 113.103 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.18 161.76 84.53 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 119.783 1.791 . . . . 65.400000000000006 112.771 -4.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.452 HG12 ' SG ' ' A' ' 66' ' ' CYS . 62.4 t -107.23 147.35 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.93 0.892 . . . . 74.219999999999999 110.293 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.622 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 94.6 mtt180 -97.83 164.79 12.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.726 0.81 . . . . 73.209999999999994 111.105 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -133.14 122.98 24.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.755 0.822 . . . . 75.349999999999994 111.101 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.2 m-85 -120.2 163.97 16.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.868 0.867 . . . . 74.519999999999996 110.908 175.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -152.3 119.98 6.09 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.953 0.901 . . . . 75.049999999999997 109.898 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 62.65 21.07 12.48 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 124.557 1.143 . . . . 72.450000000000003 111.965 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.54 55.64 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 114.696 0.638 . . . . 75.329999999999998 114.696 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -128.78 128.79 44.67 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.865 0.832 . . . . 75.340000000000003 110.988 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.47 151.04 25.03 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.037 0.754 . . . . 74.329999999999998 113.037 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.3 mt -95.24 154.46 17.18 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.278 0.631 . . . . 72.310000000000002 110.536 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.04 146.82 28.56 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.491 0.716 . . . . 62.399999999999999 110.43 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 45.3 p -74.46 85.03 2.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.252 0.621 . . . . 75.150000000000006 110.899 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -121.35 -175.94 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.968 0.907 . . . . 72.439999999999998 112.073 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.76 147.38 43.31 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 110.905 -0.878 . . . . 64.420000000000002 110.905 164.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 74.7 -55.22 0.66 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.232 1.413 . . . . 74.040000000000006 111.843 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.06 89.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.141 0.976 . . . . 73.450000000000003 110.117 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -91.86 134.36 34.83 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.028 0.931 . . . . 62.450000000000003 111.657 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.522 HD23 HD23 ' A' ' 51' ' ' LEU . 66.8 mt -114.25 130.98 56.65 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.936 0.494 . . . . 75.519999999999996 110.374 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.19 121.58 39.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.573 0.749 . . . . 74.140000000000001 110.146 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -108.06 102.05 11.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.532 0.682 . . . . 70.150000000000006 110.095 171.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.98 -56.09 2.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.226 0.61 . . . . 74.140000000000001 109.612 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.3 -90.47 0.1 Allowed Glycine 0 N--CA 1.475 1.242 0 N-CA-C 111.192 -0.763 . . . . 71.209999999999994 111.192 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.64 -42.0 82.97 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.37 0.668 . . . . 74.129999999999995 110.367 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.6 ttp180 -91.99 118.34 30.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.332 -0.849 . . . . 72.319999999999993 110.968 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -116.42 135.22 54.03 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.569 -0.9 . . . . 73.140000000000001 108.569 169.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 61.6 t -125.78 109.74 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.246 0.546 . . . . 74.420000000000002 111.932 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.522 HD23 HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -101.11 121.96 42.74 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.246 1.018 . . . . 73.299999999999997 108.725 169.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -120.08 107.51 13.14 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.717 -0.475 . . . . 74.329999999999998 109.717 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -104.1 109.33 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 118.576 0.625 . . . . 60.140000000000001 110.017 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -83.62 145.78 28.64 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.526 0.73 . . . . 72.239999999999995 110.799 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.6 54.26 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 112.325 -0.31 . . . . 71.409999999999997 112.325 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 112.1 7.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.616 1.166 . . . . 62.340000000000003 111.763 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.26 -95.39 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 118.46 0.573 . . . . 71.019999999999996 112.534 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -83.43 -61.81 1.75 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.749 -0.595 . . . . 45.32 111.631 -168.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.68 -5.27 73.4 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 116.217 -0.447 . . . . 64.400000000000006 114.184 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.01 -35.26 43.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.387 0.675 . . . . 74.439999999999998 111.673 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 106.56 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.035 0.534 . . . . 63.020000000000003 111.149 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.71 -169.81 40.88 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.854 -0.612 . . . . 65.140000000000001 114.369 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.6 121.67 27.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.924 0.89 . . . . 75.150000000000006 111.062 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.2 m-85 -111.7 112.61 24.42 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.94 0.896 . . . . 75.409999999999997 110.174 173.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -93.21 101.25 13.52 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.752 -0.592 . . . . 74.349999999999994 111.027 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.452 ' SG ' HG12 ' A' ' 25' ' ' VAL . 37.8 t -82.2 89.82 6.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.908 0.883 . . . . 75.120000000000005 109.028 171.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 31.3 t70 -89.0 92.59 9.29 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.627 0.771 . . . . 70.519999999999996 112.261 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 71' ' ' ASP . . . -85.64 159.29 55.64 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 122.957 0.503 . . . . 53.32 111.752 177.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -45.61 101.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 123.615 2.877 . . . . 73.140000000000001 114.159 171.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 63.68 13.98 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.2 1.4 . . . . 71.150000000000006 114.025 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.442 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 24.3 t70 -147.19 81.1 1.53 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.48 0.657 . . . . 74.340000000000003 111.045 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 65' ' ' LEU . 88.1 p -78.99 148.52 32.53 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.331 -0.395 . . . . 72.010000000000005 110.803 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 126.83 29.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.948 0.499 . . . . 73.239999999999995 110.303 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.0 130.16 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.852 -0.425 . . . . 73.219999999999999 109.852 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 14.0 m-85 -109.26 102.94 11.83 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.336 1.054 . . . . 73.140000000000001 109.611 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 71.0 mt -81.48 92.15 6.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.212 -1.033 . . . . 72.450000000000003 108.212 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.8 t -83.12 114.98 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.767 -0.651 . . . . 74.25 110.012 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -103.07 107.58 18.43 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.227 -0.657 . . . . 72.25 109.227 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' A' ' 6' ' ' SER . 20.6 t -94.17 107.98 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 109.765 -0.457 . . . . 74.219999999999999 109.765 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.64 -172.2 3.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.107 0.963 . . . . 73.430000000000007 109.828 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 63.86 84.27 0.19 Allowed Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 123.965 0.906 . . . . 72.239999999999995 110.677 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--N 1.384 2.43 0 C-N-CA 123.247 2.631 . . . . 71.340000000000003 114.089 -175.033 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' SD ' HD13 ' A' ' 76' ' ' LEU . 65.7 mtt . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.545 0.212 . . . . 73.109999999999999 110.62 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 m -80.6 91.35 5.81 Favored 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 124.875 1.27 . . . . 74.209999999999994 110.933 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.624 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 32.6 mtt180 -82.05 139.43 34.47 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.37 1.248 . . . . 74.430000000000007 114.37 -170.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 76.9 t -141.8 135.83 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 124.926 1.29 . . . . 63.32 109.956 172.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -106.48 144.43 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.175 0.59 . . . . 73.219999999999999 110.36 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.45 ' HB3' HG23 ' A' ' 79' ' ' VAL . 37.3 t -135.14 161.92 33.97 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.419 0.688 . . . . 74.129999999999995 110.718 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -102.96 147.16 33.69 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 123.555 0.742 . . . . 73.040000000000006 111.696 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.44 107.95 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.584 2.856 . . . . 73.209999999999994 114.086 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.89 47.23 1.28 Allowed Glycine 0 C--N 1.355 1.622 0 C-N-CA 123.001 0.334 . . . . 74.109999999999999 113.593 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.45 -114.17 0.93 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 112.167 -0.373 . . . . 72.200000000000003 112.167 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.1 164.14 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.48 0.712 . . . . 64.109999999999999 110.478 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 62.4 tp -128.98 102.49 6.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.441 0.697 . . . . 73.120000000000005 109.613 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -110.11 104.63 13.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.101 0.56 . . . . 72.530000000000001 109.794 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.471 HD13 HD11 ' A' ' 51' ' ' LEU . 65.7 mt -90.43 101.94 14.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.529 -0.545 . . . . 74.540000000000006 109.529 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.73 119.7 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.129 -1.063 . . . . 72.040000000000006 108.129 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 20.1 t -113.36 133.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.621 0.768 . . . . 74.349999999999994 111.075 -168.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -134.58 54.72 1.93 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.839 0.856 . . . . 75.030000000000001 109.351 166.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.447 ' H ' HG11 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -59.07 160.71 5.83 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.071 0.767 . . . . 71.109999999999999 113.071 170.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -77.87 -1.59 32.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.773 0.829 . . . . 74.209999999999994 112.281 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.92 -178.41 41.27 Favored Glycine 0 CA--C 1.545 1.942 0 CA-C-O 119.918 -0.379 . . . . 71.030000000000001 113.543 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 -37.98 3.68 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.842 2.361 . . . . 74.230000000000004 113.54 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.89 -130.19 8.15 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.75 -0.54 . . . . 71.109999999999999 111.75 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.434 ' HA2' ' N ' ' A' ' 25' ' ' VAL . . . -91.23 156.93 24.55 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.445 -0.642 . . . . 65.049999999999997 114.297 -174.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.76 106.2 0.82 Allowed 'Cis proline' 0 C--N 1.383 2.388 0 CA-C-N 119.548 1.674 . . . . 72.329999999999998 112.552 1.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.434 ' N ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -86.1 162.16 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 C-N-CA 123.029 0.532 . . . . 75.530000000000001 110.991 -174.407 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 36.6 mmt180 -98.87 150.63 21.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.041 0.936 . . . . 74.25 110.105 171.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.39 145.33 51.14 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.376 1.07 . . . . 73.409999999999997 109.066 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.5 m-85 -135.72 124.3 23.64 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.098 0.559 . . . . 73.200000000000003 110.668 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 21.1 tptm -122.19 131.79 54.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.313 0.645 . . . . 74.510000000000005 109.951 172.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 68.15 16.25 9.41 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.624 1.169 . . . . 75.25 111.627 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.95 61.23 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 113.609 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.31 135.93 39.33 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.569 0.747 . . . . 64.109999999999999 110.584 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 145.29 40.92 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.861 0.864 . . . . 71.230000000000004 113.111 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.481 ' HB3' HG12 ' A' ' 40' ' ' VAL . 53.6 mt -89.31 135.4 33.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.484 0.714 . . . . 74.140000000000001 110.428 174.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.44 158.97 15.98 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.783 0.833 . . . . 74.25 110.256 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 p -69.85 89.98 0.59 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.723 0.773 . . . . 75.239999999999995 110.212 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -112.76 166.02 11.76 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.424 1.09 . . . . 73.450000000000003 111.088 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.18 97.01 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 113.791 0.276 . . . . 72.420000000000002 113.791 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HG3' ' HB3' ' A' ' 54' ' ' GLN . 5.0 mpt_? -77.29 -37.73 52.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.675 0.39 . . . . 75.409999999999997 111.422 172.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 34' ' ' LEU . 53.9 t -102.69 82.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.637 0.732 . . . . 63.219999999999999 110.712 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.55 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 73.5 mt-30 -82.23 104.59 12.65 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.547 0.739 . . . . 74.019999999999996 111.378 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -98.65 113.52 25.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.566 0.747 . . . . 74.349999999999994 112.4 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -91.81 132.46 36.41 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.567 0.747 . . . . 74.450000000000003 109.861 170.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.614 ' HA ' HE22 ' A' ' 49' ' ' GLN . 9.8 pt20 -125.28 109.35 12.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.764 0.826 . . . . 75.439999999999998 110.315 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.69 177.4 9.54 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.552 0.741 . . . . 73.239999999999995 111.925 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.02 113.25 5.08 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.416 -0.658 . . . . 71.549999999999997 112.769 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.26 -56.83 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 125.657 1.583 . . . . 63.530000000000001 113.593 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 44.7 ttp180 -83.18 111.92 19.37 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.182 0.438 . . . . 71.099999999999994 112.182 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.614 HE22 ' HA ' ' A' ' 44' ' ' GLN . 11.2 mm100 -101.97 147.21 26.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.674 0.79 . . . . 73.510000000000005 109.111 166.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 61.3 t -137.94 110.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.782 -0.573 . . . . 73.239999999999995 111.001 175.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -95.7 123.59 39.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.663 -0.866 . . . . 74.239999999999995 108.663 169.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.0 mtm180 -121.68 108.52 13.64 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.889 0.476 . . . . 75.400000000000006 111.403 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -91.47 120.87 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.328 0.651 . . . . 75.420000000000002 110.242 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.448 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . 33.4 tt0 -75.35 122.58 23.97 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.46 0.704 . . . . 63.130000000000003 109.853 173.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.28 -78.5 0.38 Allowed Glycine 0 C--N 1.346 1.138 0 N-CA-C 112.357 -0.297 . . . . 52.119999999999997 112.357 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 56.13 80.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.521 1.129 . . . . 72.120000000000005 112.178 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -159.96 -68.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.9 0.48 . . . . 74.540000000000006 111.62 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.5 m -137.51 119.19 15.03 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.384 0.673 . . . . 73.549999999999997 110.227 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.79 -15.77 53.64 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 116.433 -0.349 . . . . 74.439999999999998 112.931 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.14 -20.6 51.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.525 1.13 . . . . 75.430000000000007 111.845 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.59 122.1 27.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.449 0.7 . . . . 74.340000000000003 109.948 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . 168.45 -170.5 42.21 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.319 -0.4 . . . . 73.430000000000007 113.352 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -89.63 119.15 29.8 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.845 0.858 . . . . 75.219999999999999 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 62.0 m-85 -104.96 106.07 16.39 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.797 0.839 . . . . 63.210000000000001 109.667 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.673 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.1 tp -94.71 99.69 11.75 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.425 0.69 . . . . 74.230000000000004 110.489 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.1 t -81.77 93.19 6.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.335 0.654 . . . . 72.530000000000001 110.167 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 28.2 t70 -97.04 132.54 42.75 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.592 0.757 . . . . 74.400000000000006 112.238 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.22 152.98 80.49 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.835 0.854 . . . . 73.239999999999995 109.317 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.99 -21.2 33.04 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.286 2.657 . . . . 74.219999999999999 113.883 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -59.36 2.22 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.6 0.76 . . . . 65.120000000000005 110.132 174.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.72 149.94 37.9 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.05 0.54 . . . . 73.129999999999995 111.784 -171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -131.45 135.2 46.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.769 0.828 . . . . 74.120000000000005 111.041 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -113.5 134.75 54.5 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.88 . . . . 74.219999999999999 111.267 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.435 HG12 HD11 ' A' ' 65' ' ' LEU . 57.5 mt -89.17 123.11 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.1 -0.704 . . . . 70.120000000000005 109.1 170.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.499 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.0 m-85 -100.11 103.84 15.36 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.933 -0.395 . . . . 73.349999999999994 109.933 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.624 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 82.1 mt -78.1 92.53 4.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.949 -0.76 . . . . 73.25 108.949 175.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.5 t -101.49 113.11 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.112 -0.949 . . . . 71.430000000000007 110.1 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -110.4 107.78 17.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.25 0.547 . . . . 75.140000000000001 109.588 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.45 HG23 ' HB3' ' A' ' 6' ' ' SER . 61.5 t -84.74 120.56 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.405 -0.961 . . . . 71.230000000000004 108.405 171.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.4 -177.71 4.16 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.63 0.772 . . . . 65.010000000000005 110.459 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 60.77 81.77 0.24 Allowed Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.937 0.895 . . . . 74.209999999999994 111.431 166.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo . . . . . 0 C--N 1.382 2.313 0 C-N-CA 123.133 2.555 . . . . 72.450000000000003 113.429 -177.189 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.886 -0.413 . . . . 74.129999999999995 109.886 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 m -94.12 95.88 9.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.75 -0.833 . . . . 74.239999999999995 108.75 -174.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -122.79 148.97 44.75 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.51 0.724 . . . . 75.420000000000002 112.42 -169.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.9 t -138.93 138.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.874 0.87 . . . . 72.209999999999994 110.427 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.94 117.95 35.33 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.357 0.663 . . . . 74.409999999999997 110.029 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t -94.49 161.6 14.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.634 0.774 . . . . 73.099999999999994 110.546 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.2 153.7 37.88 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 123.283 0.633 . . . . 73.450000000000003 111.387 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -56.24 99.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.533 2.822 . . . . 65.299999999999997 112.95 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.34 18.62 68.51 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 116.118 -0.492 . . . . 51.32 113.733 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.81 -10.45 69.67 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 114.485 0.554 . . . . 63.43 114.485 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 67.64 118.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.676 1.59 . . . . 71.299999999999997 112.263 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.7 tp -81.44 140.49 34.61 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.671 0.789 . . . . 74.310000000000002 111.678 -174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HG2' HG22 ' A' ' 15' ' ' VAL . 45.2 tt0 -142.22 100.8 3.79 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.69 0.796 . . . . 75.340000000000003 110.273 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.0 mt -89.86 103.63 16.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.641 0.776 . . . . 75.319999999999993 109.916 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.439 HG22 ' HG2' ' A' ' 13' ' ' GLU . 61.4 t -104.79 110.21 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.646 0.778 . . . . 75.450000000000003 109.339 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.428 HG21 ' SG ' ' A' ' 66' ' ' CYS . 11.6 m -99.17 146.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.626 0.726 . . . . 60.43 111.05 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -122.38 29.42 6.97 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.864 -1.062 . . . . 73.5 109.234 165.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.506 HD23 ' SG ' ' A' ' 66' ' ' CYS . 0.9 OUTLIER -41.75 139.25 1.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.052 1.13 . . . . 72.349999999999994 114.052 176.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -94.66 31.46 1.79 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.462 0.705 . . . . 63.409999999999997 111.285 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.99 -176.3 45.82 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-N 116.258 -0.428 . . . . 61.32 113.064 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 175.75 10.89 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 75.430000000000007 113.53 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.83 132.92 46.76 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.877 -0.601 . . . . 63.340000000000003 112.936 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.02 -131.78 0.96 Allowed Glycine 0 CA--C 1.548 2.134 0 CA-C-O 119.146 -0.808 . . . . 61.420000000000002 114.872 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.1 124.29 5.19 Favored 'Cis proline' 0 C--N 1.386 2.514 0 CA-C-N 120.695 2.247 . . . . 73.230000000000004 113.641 -0.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.44 HG13 ' SG ' ' A' ' 66' ' ' CYS . 98.6 t -73.7 142.84 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 C-N-CA 123.394 0.677 . . . . 74.5 110.855 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -96.54 169.89 9.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.26 1.024 . . . . 73.019999999999996 111.199 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.471 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 81.6 m95 -131.52 125.96 33.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.958 0.903 . . . . 73.319999999999993 110.467 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.3 m-85 -116.93 163.16 16.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.353 1.061 . . . . 74.530000000000001 109.973 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -159.48 128.21 5.15 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.303 0.641 . . . . 75.129999999999995 110.547 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.52 23.29 13.59 Favored 'General case' 0 CA--C 1.566 1.585 0 C-N-CA 124.306 1.042 . . . . 75.540000000000006 111.631 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.6 -8.36 63.95 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 115.754 -0.657 . . . . 52.140000000000001 114.505 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -129.64 138.13 51.04 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.199 0.999 . . . . 73.430000000000007 111.46 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.748 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -58.35 146.61 33.97 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.754 0.822 . . . . 64.420000000000002 112.759 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.556 ' HB3' HG13 ' A' ' 40' ' ' VAL . 38.6 mt -87.2 134.8 33.49 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.309 -0.405 . . . . 75.219999999999999 110.066 171.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.14 160.46 15.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.552 0.741 . . . . 74.030000000000001 110.775 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 p -72.47 83.7 1.1 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.705 0.764 . . . . 65.109999999999999 110.687 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.71 165.08 11.57 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.987 0.915 . . . . 72.299999999999997 110.378 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.28 -44.66 93.31 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 114.088 0.395 . . . . 73.019999999999996 114.088 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.592 ' HG3' HG23 ' A' ' 40' ' ' VAL . 15.5 ptm180 -77.95 -37.74 46.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.002 0.521 . . . . 74.5 111.075 174.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.592 HG23 ' HG3' ' A' ' 39' ' ' ARG . 59.7 t -94.34 83.08 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.704 0.802 . . . . 74.510000000000005 110.387 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 34.0 mm-40 -81.46 106.09 13.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.608 0.763 . . . . 72.329999999999998 111.237 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.44 101.59 13.52 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.184 0.594 . . . . 72.5 110.86 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 32.0 tt0 -92.42 98.76 11.68 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.442 0.697 . . . . 73.340000000000003 109.842 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.619 ' HG2' HE22 ' A' ' 49' ' ' GLN . 0.2 OUTLIER -87.27 102.06 14.13 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 74.129999999999995 108.215 173.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.07 -179.27 3.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.843 0.857 . . . . 74.409999999999997 110.922 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.26 89.31 0.07 OUTLIER Glycine 0 C--N 1.352 1.452 0 O-C-N 123.387 0.429 . . . . 74.310000000000002 112.819 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.39 -27.93 0.19 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 125.965 1.706 . . . . 75.310000000000002 113.36 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -85.3 104.54 15.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.441 0.696 . . . . 74.099999999999994 111.002 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.619 HE22 ' HG2' ' A' ' 44' ' ' GLN . 14.2 mm100 -98.5 112.16 24.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.097 0.559 . . . . 73.319999999999993 109.549 173.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 61.6 t -109.5 108.98 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.054 0.454 . . . . 72.129999999999995 110.836 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.21 117.53 30.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.641 -0.874 . . . . 74.129999999999995 108.641 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.7 mtm-85 -113.04 117.33 31.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.525 0.73 . . . . 74.329999999999998 109.891 174.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.06 100.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.31 0.576 . . . . 75.430000000000007 109.681 171.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.46 139.75 42.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.727 -0.67 . . . . 74.129999999999995 109.666 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.86 24.79 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 112.311 -0.316 . . . . 75.099999999999994 112.311 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.3 87.19 2.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.143 0.577 . . . . 73.200000000000003 111.189 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' O ' HG12 ' A' ' 79' ' ' VAL . 78.7 ttt180 -127.51 -82.86 0.6 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.229 0.612 . . . . 74.310000000000002 111.592 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 m -93.09 -70.66 0.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.172 0.589 . . . . 74.310000000000002 111.539 -173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.93 28.33 4.11 Favored Glycine 0 CA--C 1.543 1.784 0 N-CA-C 114.754 0.662 . . . . 55.43 114.754 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -93.44 -31.86 14.44 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.398 0.679 . . . . 73.299999999999997 110.812 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.13 107.43 2.31 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.804 0.842 . . . . 64.129999999999995 111.285 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.25 178.02 43.21 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 114.14 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.03 108.8 17.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.08 0.552 . . . . 73.310000000000002 110.14 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 19.5 m-85 -93.95 155.52 17.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.495 0.718 . . . . 74.430000000000007 109.898 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.698 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 44.2 tp -144.1 102.87 3.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.031 0.382 . . . . 74.140000000000001 112.031 -173.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 18' ' ' LEU . 34.3 t -79.57 88.85 5.09 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 109.147 -0.686 . . . . 73.049999999999997 109.147 170.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.56 102.12 14.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.288 1.035 . . . . 64.109999999999999 112.786 -167.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.14 162.99 59.75 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.397 0.679 . . . . 75.230000000000004 110.51 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.73 31.9 0.19 Allowed 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.067 2.511 . . . . 74.430000000000007 115.104 174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -172.39 -62.96 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.544 1.138 . . . . 75.430000000000007 109.065 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.67 176.35 6.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.705 0.802 . . . . 64.140000000000001 111.019 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.501 ' HB2' HD11 ' A' ' 65' ' ' LEU . 85.5 p -165.64 134.89 3.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.406 0.682 . . . . 71.319999999999993 110.322 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -106.78 124.4 49.56 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.38 0.672 . . . . 73.319999999999993 110.351 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.56 HG13 HD12 ' A' ' 65' ' ' LEU . 3.2 mp -102.32 124.49 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.238 0.615 . . . . 74.510000000000005 110.073 -175.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 64.1 m-85 -101.17 126.38 47.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.344 1.058 . . . . 75.019999999999996 111.207 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.52 93.36 8.05 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.747 -1.205 . . . . 74.349999999999994 107.747 161.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 63.2 t -85.34 106.32 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.273 -0.639 . . . . 73.0 109.273 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.1 p -103.51 117.25 34.0 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.801 . . . . 63.420000000000002 110.027 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 57' ' ' ARG . 63.3 t -84.17 106.64 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.022 -0.732 . . . . 63.520000000000003 109.022 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 11.3 pt-20 -150.39 -166.94 2.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.336 1.054 . . . . 74.409999999999997 110.216 -174.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.41 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 40.1 mt-10 57.88 54.37 6.29 Favored Pre-proline 0 CA--C 1.571 1.765 0 C-N-CA 124.209 1.004 . . . . 73.540000000000006 112.121 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 81' ' ' GLU . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.455 0 C-N-CA 123.11 2.54 . . . . 73.25 112.466 -174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 tpp . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 109.616 -0.513 . . . . 73.129999999999995 109.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.4 p -62.94 108.01 1.11 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.359 0.664 . . . . 75.140000000000001 111.363 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.79 120.28 38.76 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.485 -0.931 . . . . 73.409999999999997 108.485 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.496 ' HB ' HG23 ' A' ' 77' ' ' VAL . 98.8 t -122.24 140.94 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.706 0.802 . . . . 73.230000000000004 109.948 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.87 127.93 44.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.058 0.543 . . . . 75.409999999999997 109.54 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -122.34 162.33 21.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.245 0.618 . . . . 60.549999999999997 111.179 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.75 140.5 26.42 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.35 0.66 . . . . 75.230000000000004 111.939 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.84 119.33 6.01 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.103 2.535 . . . . 75.120000000000005 112.97 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.56 30.79 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.073 -0.512 . . . . 62.119999999999997 113.078 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.93 -131.22 3.98 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 117.094 0.447 . . . . 74.430000000000007 112.957 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -146.97 150.05 34.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.472 0.709 . . . . 73.450000000000003 110.837 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 14' ' ' LEU . 64.3 tp -97.61 143.62 28.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.017 0.927 . . . . 73.019999999999996 110.283 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.56 113.38 6.76 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.284 0.633 . . . . 64.409999999999997 109.771 171.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 12' ' ' LEU . 75.6 mt -107.21 103.18 12.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.988 0.915 . . . . 64.530000000000001 109.6 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG23 HG21 ' A' ' 50' ' ' VAL . 44.7 t -104.09 117.2 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 109.105 -0.702 . . . . 74.310000000000002 109.105 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.617 HG21 ' SG ' ' A' ' 66' ' ' CYS . 1.6 t -97.85 147.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.095 0.474 . . . . 74.109999999999999 110.493 -174.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.41 29.81 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.853 0.861 . . . . 71.439999999999998 110.09 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' H ' HG13 ' A' ' 16' ' ' VAL . 1.1 pp -53.2 158.59 1.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.791 1.034 . . . . 71.230000000000004 113.791 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 m -95.05 23.53 5.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.414 -0.812 . . . . 71.329999999999998 111.214 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.73 119.14 8.83 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.14 -0.811 . . . . 51.399999999999999 112.79 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.93 104.99 0.89 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.29 2.66 . . . . 75.099999999999994 114.221 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.38 52.01 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.358 0.903 . . . . 70.530000000000001 115.358 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.14 176.29 18.39 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-O 119.318 -0.712 . . . . 35.329999999999998 112.99 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.36 119.97 5.52 Favored 'Cis proline' 0 C--N 1.377 2.038 0 CA-C-N 120.052 1.926 . . . . 64.109999999999999 113.962 1.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -82.54 115.72 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 109.088 -0.708 . . . . 55.130000000000003 109.088 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -98.33 137.09 37.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.646 0.778 . . . . 75.140000000000001 111.659 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -96.3 124.34 40.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.459 0.704 . . . . 74.420000000000002 110.629 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 86.9 m-85 -119.03 134.71 55.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.778 0.831 . . . . 74.140000000000001 110.486 176.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.4 tptp -119.46 128.12 53.7 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.053 0.541 . . . . 75.439999999999998 109.842 173.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 63.37 5.7 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.644 1.178 . . . . 55.210000000000001 113.858 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.97 -25.01 4.2 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.555 -0.58 . . . . 75.129999999999995 114.046 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -131.03 150.2 52.26 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.516 1.158 . . . . 72.439999999999998 112.33 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -67.41 154.86 40.37 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.743 1.386 . . . . 72.519999999999996 114.743 -169.092 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.561 ' HB3' HG13 ' A' ' 40' ' ' VAL . 26.6 mt -102.55 162.29 13.04 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.805 1.242 . . . . 74.530000000000001 110.446 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.77 153.2 46.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.725 0.81 . . . . 74.450000000000003 110.533 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -71.26 83.14 0.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.956 0.884 . . . . 63.109999999999999 110.955 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.36 -178.63 3.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.114 0.965 . . . . 75.340000000000003 110.765 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.61 97.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 114.089 0.395 . . . . 73.409999999999997 114.089 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -90.5 -14.87 31.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.44 0.696 . . . . 74.510000000000005 112.05 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 34' ' ' LEU . 54.3 t -124.74 81.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.42 0.688 . . . . 73.519999999999996 109.831 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.629 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.4 mt-30 -85.11 125.66 32.97 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.263 0.625 . . . . 75.400000000000006 111.062 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD21 HD23 ' A' ' 51' ' ' LEU . 89.8 mt -118.48 96.86 5.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.538 0.735 . . . . 73.109999999999999 112.185 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 1.7 mp0 -85.86 96.63 9.84 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.88 -0.785 . . . . 75.329999999999998 108.88 165.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -111.21 113.85 26.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.725 0.81 . . . . 73.329999999999998 111.227 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.19 -157.95 0.85 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.413 1.085 . . . . 74.239999999999995 111.083 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.29 111.47 3.31 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 119.385 -0.675 . . . . 74.150000000000006 111.997 172.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.39 -52.6 0.7 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 125.925 1.69 . . . . 65.200000000000003 112.716 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 30.0 ttt85 -66.75 101.21 0.78 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.708 0.803 . . . . 74.519999999999996 111.515 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -112.04 125.8 54.47 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.749 -0.834 . . . . 74.439999999999998 108.749 172.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 51.5 t -117.96 110.53 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 122.705 0.402 . . . . 75.010000000000005 110.904 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.443 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -102.56 121.2 41.9 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.736 0.814 . . . . 72.120000000000005 109.452 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.629 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 68.3 mtp180 -120.68 109.15 14.87 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.08 0.552 . . . . 74.099999999999994 111.153 -176.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.405 HG13 ' HB3' ' A' ' 60' ' ' ASP . 61.6 t -92.61 114.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.244 0.545 . . . . 75.400000000000006 110.678 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -79.1 123.24 27.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.501 1.121 . . . . 72.439999999999998 110.351 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 42.88 23.97 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.736 -0.211 . . . . 74.099999999999994 113.394 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.78 112.83 4.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.275 0.63 . . . . 72.019999999999996 111.409 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -68.25 0.2 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.012 0.525 . . . . 73.129999999999995 111.256 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -95.49 -87.19 0.29 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.935 0.717 . . . . 74.239999999999995 112.935 -167.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.83 6.1 63.29 Favored Glycine 0 C--N 1.36 1.907 0 O-C-N 122.109 -0.37 . . . . 73.439999999999998 113.785 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.405 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.9 m-20 -84.2 -5.01 59.19 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.544 1.138 . . . . 72.010000000000005 110.995 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.15 128.17 36.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.035 0.934 . . . . 73.519999999999996 109.487 171.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.6 -173.34 41.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.238 -0.437 . . . . 75.140000000000001 112.915 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.27 126.74 33.94 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.058 0.543 . . . . 73.209999999999994 110.508 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.603 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 76.5 m-85 -112.85 110.2 20.14 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.93 0.892 . . . . 64.230000000000004 110.096 175.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -91.97 102.26 14.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.221 0.608 . . . . 73.140000000000001 110.331 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.617 ' SG ' HG21 ' A' ' 16' ' ' VAL . 44.9 t -82.12 89.11 6.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.545 0.738 . . . . 73.200000000000003 109.378 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -96.39 94.12 7.24 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.019 1.328 . . . . 71.129999999999995 112.192 -168.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.64 158.66 82.82 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.437 1.095 . . . . 63.210000000000001 111.784 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -47.76 -32.77 17.6 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.873 3.048 . . . . 74.420000000000002 115.239 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.29 49.02 1.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.262 0.553 . . . . 71.129999999999995 109.638 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -178.61 162.63 1.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.056 1.342 . . . . 71.319999999999993 109.564 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.7 p -160.36 121.01 2.95 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.169 0.44 . . . . 73.540000000000006 110.772 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -106.43 127.94 53.67 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.518 0.727 . . . . 75.530000000000001 110.36 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.62 121.51 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.044 -0.725 . . . . 73.340000000000003 109.044 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.603 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 32.0 m-85 -98.21 100.73 12.05 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.1 -0.704 . . . . 74.25 109.1 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.7 91.78 4.08 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.176 -1.046 . . . . 60.130000000000003 108.176 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 4' ' ' VAL . 67.4 t -104.27 112.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 115.194 -0.912 . . . . 75.0 110.482 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 p -111.12 110.52 21.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.137 0.575 . . . . 63.149999999999999 109.455 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.42 104.05 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.907 -1.145 . . . . 75.129999999999995 107.907 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.97 179.12 9.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.716 0.807 . . . . 74.540000000000006 110.7 -170.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 61.71 90.63 0.09 OUTLIER Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.132 0.973 . . . . 74.120000000000005 110.974 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 C--N 1.383 2.343 0 C-N-CA 123.154 2.569 . . . . 75.319999999999993 113.891 -171.265 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' SD ' ' HG ' ' A' ' 76' ' ' LEU . 52.9 ttm . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.38 -0.23 . . . . 75.400000000000006 110.38 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 p -65.17 105.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.864 0.466 . . . . 74.150000000000006 111.26 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -107.58 109.74 21.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.366 1.067 . . . . 65.120000000000005 110.671 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 86.8 t -122.95 118.08 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.589 . . . . 74.239999999999995 110.863 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.5 134.86 33.91 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.856 -0.424 . . . . 73.409999999999997 109.856 173.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.782 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.7 t -112.23 157.11 21.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.928 0.491 . . . . 74.319999999999993 110.237 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -83.46 146.03 49.48 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.289 0.635 . . . . 74.109999999999999 111.559 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.02 105.86 0.72 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.145 2.563 . . . . 73.010000000000005 113.502 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.65 15.8 56.06 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 115.404 -0.816 . . . . 41.030000000000001 113.346 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.96 -167.75 30.59 Favored Glycine 0 N--CA 1.477 1.403 0 N-CA-C 112.558 -0.217 . . . . 64.430000000000007 112.558 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -107.01 119.75 40.22 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.099 -0.648 . . . . 63.200000000000003 111.198 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 6' ' ' SER . 58.9 tp -75.82 147.78 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.999 0.92 . . . . 72.310000000000002 110.453 174.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -145.0 116.42 8.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.027 0.531 . . . . 73.230000000000004 109.583 169.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 77.4 mt -102.08 101.23 11.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.354 0.662 . . . . 63.329999999999998 109.374 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.18 113.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.476 -0.935 . . . . 72.5 108.476 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 3.5 t -108.34 137.71 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.906 0.882 . . . . 74.219999999999999 110.536 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -134.48 51.27 2.12 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.437 0.637 . . . . 74.239999999999995 109.35 169.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.46 ' H ' HG11 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -54.57 159.88 1.98 Allowed 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.53 -0.759 . . . . 71.099999999999994 112.598 166.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.1 m -82.39 41.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.782 0.833 . . . . 54.030000000000001 111.496 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.17 85.72 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.528 -0.595 . . . . 75.439999999999998 112.564 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.38 151.59 26.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.8 2.334 . . . . 54.0 113.021 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -90.02 0.7 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 116.211 -0.45 . . . . 45.340000000000003 112.384 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.01 -114.36 4.01 Favored Glycine 0 CA--C 1.546 1.997 0 CA-C-O 118.729 -1.039 . . . . 74.230000000000004 113.792 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -72.57 158.03 97.87 Favored 'Cis proline' 0 C--N 1.383 2.386 0 CA-C-N 120.999 2.399 . . . . 72.420000000000002 113.532 -0.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.499 HG11 ' SG ' ' A' ' 66' ' ' CYS . 32.2 t -90.29 129.11 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.033 0.533 . . . . 72.120000000000005 110.7 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -98.12 132.2 43.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.583 0.753 . . . . 75.209999999999994 110.778 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.47 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 70.3 m95 -97.74 118.24 33.82 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.649 0.379 . . . . 74.319999999999993 111.869 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.8 m-85 -112.29 147.98 35.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.315 1.046 . . . . 65.120000000000005 109.468 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' NZ ' ' HA ' ' A' ' 60' ' ' ASP . 15.6 tptm -128.31 113.11 15.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.156 0.503 . . . . 65.530000000000001 110.288 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.07 13.26 2.81 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 125.912 1.685 . . . . 71.109999999999999 113.281 168.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.1 -39.34 0.67 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.499 -0.611 . . . . 71.209999999999994 113.234 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -154.07 156.5 37.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.071 0.936 . . . . 74.230000000000004 112.773 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -60.62 152.68 25.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.953 1.834 . . . . 75.329999999999998 115.953 -166.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.3 mt -95.56 161.59 13.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.307 -0.861 . . . . 73.200000000000003 111.197 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.86 134.59 49.41 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.942 0.897 . . . . 64.109999999999999 109.782 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.7 p -68.16 89.07 0.31 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.37 0.668 . . . . 72.219999999999999 111.72 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -134.84 98.55 4.06 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.835 0.854 . . . . 73.200000000000003 111.163 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 -89.31 0.07 OUTLIER Glycine 0 C--N 1.357 1.726 0 O-C-N 123.841 0.713 . . . . 73.519999999999996 114.517 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -70.04 -38.51 75.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.676 0.79 . . . . 75.450000000000003 111.299 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 59.7 t -89.65 121.88 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.663 . . . . 65.030000000000001 109.365 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -129.54 121.35 27.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.401 0.68 . . . . 74.319999999999993 110.51 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.44 100.07 8.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 73.219999999999999 111.092 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.598 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.0 tm-20 -93.36 125.83 38.17 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.218 -1.03 . . . . 62.43 108.218 168.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.35 103.15 7.49 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.414 0.626 . . . . 70.239999999999995 111.159 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 48' ' ' ARG . . . -100.81 -2.32 32.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.224 1.01 . . . . 75.030000000000001 112.101 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.52 -99.24 0.98 Allowed Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.192 -0.763 . . . . 74.150000000000006 111.192 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.66 -33.02 73.28 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.935 0.494 . . . . 74.329999999999998 111.616 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 58.3 ttp180 -89.19 115.65 26.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.992 0.517 . . . . 74.420000000000002 110.091 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' HB3' ' HE1' ' A' ' 27' ' ' TRP . 37.9 mm-40 -114.29 141.45 47.57 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.706 0.803 . . . . 75.439999999999998 109.532 171.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 94.2 t -131.38 110.94 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.129 0.571 . . . . 75.340000000000003 110.264 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.84 112.16 24.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.677 0.791 . . . . 75.510000000000005 109.464 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 42.3 mtt-85 -100.14 137.36 38.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.04 0.536 . . . . 74.25 111.218 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.98 100.01 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.552 0.741 . . . . 70.239999999999995 109.337 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -75.18 126.26 30.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.793 -0.447 . . . . 73.120000000000005 109.793 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.43 30.18 19.82 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.411 0.444 . . . . 53.539999999999999 113.062 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.6 101.36 0.24 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.784 0.834 . . . . 65.120000000000005 111.519 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.11 -62.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.921 0.889 . . . . 71.430000000000007 109.795 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 m -54.66 -55.29 31.25 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.324 1.05 . . . . 55.530000000000001 113.721 -168.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.45 17.52 4.48 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 122.597 0.141 . . . . 70.340000000000003 112.912 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.465 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 13.8 m-20 -126.02 90.97 3.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 61.229999999999997 110.947 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.61 65.09 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.476 1.11 . . . . 74.230000000000004 109.369 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.84 -153.5 6.43 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-N 115.535 -0.757 . . . . 72.329999999999998 113.29 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 128.31 34.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.92 0.488 . . . . 74.540000000000006 111.329 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.478 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 57.2 m-85 -115.27 107.66 15.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.073 0.949 . . . . 75.310000000000002 109.095 173.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.6 tp -92.0 100.15 12.85 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.364 0.602 . . . . 74.420000000000002 110.608 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.499 ' SG ' HG11 ' A' ' 25' ' ' VAL . 29.8 t -80.55 87.31 5.74 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.539 -0.911 . . . . 71.549999999999997 108.539 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.01 96.05 10.42 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.349 1.06 . . . . 74.310000000000002 112.527 -168.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' H ' ' HA ' ' A' ' 72' ' ' SER . . . -90.42 138.73 26.81 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 122.932 0.493 . . . . 65.109999999999999 111.408 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.84 -29.62 64.0 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 123.677 2.918 . . . . 71.400000000000006 113.943 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -75.35 -63.8 1.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.013 0.525 . . . . 74.150000000000006 110.003 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -153.71 127.67 8.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.748 0.419 . . . . 64.519999999999996 110.927 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 31.2 t -72.65 177.6 4.64 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.222 1.009 . . . . 72.430000000000007 112.392 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.568 ' HE ' ' HA ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -154.99 127.18 7.74 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.536 0.735 . . . . 62.539999999999999 111.172 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.99 123.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.043 0.537 . . . . 75.439999999999998 109.685 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 36.8 m-85 -102.12 104.96 15.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.343 0.657 . . . . 74.439999999999998 111.419 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' HG ' ' SD ' ' A' ' 1' ' ' MET . 94.3 mt -76.25 93.63 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.598 -0.889 . . . . 75.340000000000003 108.598 169.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.1 t -99.36 114.51 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.898 0.479 . . . . 72.120000000000005 110.545 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.1 p -112.46 108.76 18.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.214 0.606 . . . . 64.319999999999993 110.135 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.782 HG22 ' HB3' ' A' ' 6' ' ' SER . 47.2 t -91.16 106.01 17.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.657 -0.868 . . . . 75.129999999999995 108.657 175.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -178.56 -27.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.314 0.646 . . . . 72.439999999999998 111.454 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.5 101.64 0.29 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.714 0.805 . . . . 74.340000000000003 109.992 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 CA--C 1.567 2.152 0 C-N-CA 122.883 2.389 . . . . 74.340000000000003 114.072 -165.223 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.618 0.247 . . . . 75.329999999999998 110.571 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m -75.57 90.8 2.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.747 0.819 . . . . 75.530000000000001 111.465 -171.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.34 135.25 33.8 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.542 0.737 . . . . 75.239999999999995 111.97 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.81 124.12 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.492 0.717 . . . . 74.340000000000003 110.948 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -90.25 142.06 28.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.173 0.589 . . . . 75.239999999999995 109.556 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.49 ' HB3' HG22 ' A' ' 79' ' ' VAL . 46.7 t -145.91 148.63 33.02 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.429 0.633 . . . . 74.219999999999999 112.021 -173.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 p -82.15 147.54 57.63 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 74.319999999999993 112.314 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -84.04 147.51 11.77 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.37 2.713 . . . . 71.420000000000002 112.716 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.12 -22.28 23.58 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 113.988 0.355 . . . . 54.219999999999999 113.988 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.05 -151.29 23.86 Favored Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.956 0.378 . . . . 71.200000000000003 113.32 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -112.93 127.0 56.09 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.26 0.53 . . . . 74.519999999999996 110.657 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.1 tp -75.8 128.65 35.61 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 109.155 -0.683 . . . . 72.439999999999998 109.155 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -129.13 105.34 8.11 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.923 -0.399 . . . . 65.230000000000004 109.923 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 50.1 mt -91.68 101.78 14.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.185 -0.672 . . . . 72.230000000000004 109.185 175.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.9 t -99.51 109.98 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 107.924 -1.139 . . . . 73.329999999999998 107.924 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.464 HG23 ' HZ ' ' A' ' 75' ' ' PHE . 2.8 t -98.37 135.86 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.781 0.324 . . . . 72.109999999999999 110.755 -168.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -116.66 32.75 5.96 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.849 0.859 . . . . 74.129999999999995 109.83 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.89 156.1 9.54 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.878 1.066 . . . . 75.329999999999998 113.878 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -82.71 5.68 20.5 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.184 0.994 . . . . 73.310000000000002 112.327 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.71 -175.35 23.38 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 114.422 0.529 . . . . 71.319999999999993 114.422 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 41.1 Cg_endo -83.66 179.6 4.77 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.486 2.791 . . . . 74.310000000000002 114.019 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA2' ' HA3' ' A' ' 46' ' ' GLY . . . -83.13 61.31 4.79 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.61 -0.723 . . . . 75.340000000000003 113.299 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 81.03 174.72 49.21 Favored Glycine 0 CA--C 1.543 1.814 0 N-CA-C 115.228 0.851 . . . . 75.140000000000001 115.228 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.52 99.77 0.28 Allowed 'Cis proline' 0 C--N 1.38 2.197 0 CA-C-N 118.893 1.346 . . . . 74.25 112.066 -6.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.519 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 22.8 t -79.27 132.88 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.167 0.587 . . . . 64.549999999999997 110.819 -176.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -98.28 153.19 18.69 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.968 0.907 . . . . 75.510000000000005 111.608 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -109.88 134.03 52.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.637 0.775 . . . . 72.540000000000006 111.291 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.765 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 46.5 m-85 -128.12 161.31 29.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.167 0.987 . . . . 72.120000000000005 110.646 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -153.77 129.03 9.74 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.434 1.094 . . . . 71.129999999999995 109.604 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 63.81 22.95 13.25 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.945 0.898 . . . . 72.0 111.189 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.04 -4.62 81.49 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.395 -0.82 . . . . 63.420000000000002 114.342 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.1 128.8 49.82 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.983 0.913 . . . . 74.040000000000006 111.054 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.49 146.2 49.35 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.999 1.111 . . . . 73.409999999999997 113.999 -175.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.408 ' HB3' HG12 ' A' ' 40' ' ' VAL . 52.2 mt -91.98 154.74 18.6 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.97 -1.014 . . . . 74.400000000000006 110.817 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.0 159.2 26.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.209 1.003 . . . . 73.420000000000002 110.278 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.7 p -66.22 91.96 0.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.436 0.694 . . . . 72.310000000000002 110.789 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 36.4 tt0 -114.83 164.41 14.14 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.29 1.036 . . . . 53.5 110.204 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.8 -18.83 47.63 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.265 0.866 . . . . 43.140000000000001 115.265 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -121.6 4.81 10.09 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.404 0.602 . . . . 74.409999999999997 111.973 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 70.5 t -127.59 86.27 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.244 1.017 . . . . 72.439999999999998 109.121 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 82.4 mt-30 -87.97 108.26 19.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.843 0.857 . . . . 72.239999999999995 111.158 -174.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 mt -98.21 141.57 30.96 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.079 0.551 . . . . 72.0 112.323 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -123.27 138.5 54.61 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.037 0.935 . . . . 73.219999999999999 110.234 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -118.03 108.79 15.67 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.433 0.693 . . . . 74.530000000000001 110.809 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.72 -48.98 1.25 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.872 0.869 . . . . 73.099999999999994 109.577 168.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' HA3' ' HA2' ' A' ' 22' ' ' GLY . . . 129.42 -75.01 0.43 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.577 -0.738 . . . . 74.319999999999993 112.149 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.23 -36.53 84.44 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.632 . . . . 65.420000000000002 111.015 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -111.64 109.63 19.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.336 0.654 . . . . 73.010000000000005 110.361 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.519 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.8 mm100 -107.28 135.38 48.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.47 0.708 . . . . 73.409999999999997 109.489 169.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 60.1 t -129.94 114.13 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 121.074 0.464 . . . . 72.340000000000003 111.647 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 120.48 42.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.802 1.241 . . . . 75.549999999999997 108.519 170.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 43.7 mtp180 -118.11 106.37 12.8 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.667 0.387 . . . . 72.430000000000007 110.783 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.522 HG11 ' HB3' ' A' ' 60' ' ' ASP . 70.7 t -84.59 95.52 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.848 0.459 . . . . 74.420000000000002 110.089 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -75.13 107.33 7.15 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.488 0.715 . . . . 74.420000000000002 110.402 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.38 36.8 3.98 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.4 -0.363 . . . . 73.329999999999998 112.526 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.82 112.01 8.47 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.039 0.936 . . . . 75.120000000000005 112.011 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -167.96 -56.0 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.593 0.757 . . . . 74.430000000000007 112.101 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 m -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.119 0.967 . . . . 63.539999999999999 113.16 -167.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.88 26.38 1.46 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.235 -0.746 . . . . 75.040000000000006 111.235 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.522 ' HB3' HG11 ' A' ' 53' ' ' VAL . 6.0 m-20 -87.03 3.91 44.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.761 1.224 . . . . 74.5 111.903 -172.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 161.14 18.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 124.061 0.944 . . . . 74.230000000000004 109.603 166.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.56 -160.92 23.26 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 114.083 0.393 . . . . 71.439999999999998 114.083 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.2 mt-10 -93.9 118.16 31.09 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.224 0.61 . . . . 74.439999999999998 111.977 -172.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.18 152.86 22.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.226 1.01 . . . . 72.150000000000006 110.215 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.765 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.5 tp -128.98 101.93 6.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.788 0.435 . . . . 75.209999999999994 110.233 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -81.94 87.03 6.43 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 108.545 -0.909 . . . . 71.239999999999995 108.545 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.2 t70 -95.45 104.31 16.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.467 1.107 . . . . 75.109999999999999 111.918 -169.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.85 152.83 37.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.815 0.846 . . . . 72.430000000000007 110.878 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.43 -36.49 58.81 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.197 2.598 . . . . 72.540000000000006 114.925 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.62 ' HB2' ' HD3' ' A' ' 21' ' ' PRO . 82.0 mm-40 -90.3 -28.89 18.47 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.898 0.703 . . . . 71.430000000000007 112.898 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -157.35 128.76 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 112.176 0.436 . . . . 73.239999999999995 112.176 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.537 ' HB2' HD12 ' A' ' 65' ' ' LEU . 77.6 p -97.6 139.75 33.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.689 0.796 . . . . 73.450000000000003 110.529 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -123.83 123.43 40.45 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.739 0.416 . . . . 71.340000000000003 110.839 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -97.04 144.14 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 122.882 0.473 . . . . 74.319999999999993 110.118 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' HZ ' HG23 ' A' ' 16' ' ' VAL . 5.8 m-85 -117.71 139.03 51.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.036 1.334 . . . . 74.25 110.155 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.7 94.89 5.26 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.381 -0.97 . . . . 73.420000000000002 108.381 164.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.07 139.04 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.181 0.592 . . . . 75.519999999999996 111.711 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.2 p -126.49 108.89 11.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.782 0.833 . . . . 64.310000000000002 110.468 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.6 t -109.04 104.11 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.187 -1.042 . . . . 74.409999999999997 108.187 172.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 8.5 pt-20 179.03 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.501 0.72 . . . . 74.129999999999995 111.246 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 37.7 mt-10 -75.17 106.37 2.78 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.943 0.897 . . . . 75.430000000000007 110.622 -174.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 6.1 Cg_exo . . . . . 0 CA--C 1.569 2.239 0 C-N-CA 123.242 2.628 . . . . 74.430000000000007 113.58 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.684 0.278 . . . . 74.439999999999998 110.818 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.23 84.62 1.88 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.406 1.082 . . . . 74.120000000000005 111.099 -172.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 64.8 mtt85 -76.37 141.14 41.59 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.545 0.738 . . . . 74.540000000000006 112.254 -174.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.425 HG23 HD22 ' A' ' 14' ' ' LEU . 78.9 t -130.03 131.24 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.647 0.779 . . . . 54.32 110.977 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -90.25 129.62 36.47 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.291 1.037 . . . . 74.120000000000005 109.855 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -139.16 158.88 43.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.818 0.847 . . . . 74.540000000000006 111.136 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -101.33 152.77 38.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 123.881 0.873 . . . . 73.209999999999994 111.63 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.2 Cg_endo -83.06 73.11 5.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.499 2.8 . . . . 65.219999999999999 113.622 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.99 60.23 0.01 OUTLIER Glycine 0 N--CA 1.474 1.169 0 CA-C-N 115.794 -0.639 . . . . 60.310000000000002 112.36 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.51 -176.26 39.81 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 122.853 -0.204 . . . . 73.310000000000002 113.428 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.05 119.66 31.95 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.337 0.589 . . . . 75.450000000000003 110.681 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 61.4 tp -74.8 136.58 41.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.745 0.818 . . . . 75.400000000000006 109.568 174.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -134.5 107.95 7.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.953 0.501 . . . . 74.040000000000006 110.053 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.425 HD22 HG23 ' A' ' 4' ' ' VAL . 44.4 mt -92.78 104.18 16.46 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.45 0.7 . . . . 74.25 109.524 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.09 112.08 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.974 -0.75 . . . . 71.230000000000004 108.974 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.456 HG23 ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t -100.64 126.66 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.738 0.415 . . . . 75.150000000000006 110.131 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -99.17 21.37 11.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.298 0.639 . . . . 75.430000000000007 111.483 174.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.7 mt -49.25 138.16 13.0 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.616 0.766 . . . . 70.349999999999994 111.792 163.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.8 t -79.17 76.89 5.69 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.498 0.666 . . . . 62.240000000000002 110.11 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.82 85.2 0.39 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.985 -0.846 . . . . 53.509999999999998 110.985 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.37 -51.39 5.38 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.097 2.531 . . . . 72.019999999999996 113.71 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.69 96.52 0.28 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.347 -0.701 . . . . 73.439999999999998 111.347 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.68 -110.45 3.5 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 118.96 -0.911 . . . . 44.32 113.525 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.31 179.47 28.01 Favored 'Cis proline' 0 C--N 1.38 2.187 0 CA-C-N 120.382 2.091 . . . . 73.209999999999994 113.971 2.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 68' ' ' ALA . 42.0 t -80.31 145.54 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.461 -0.79 . . . . 75.409999999999997 110.441 171.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.5 128.05 43.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 74.109999999999999 109.09 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.403 ' CH2' ' SG ' ' A' ' 66' ' ' CYS . 92.4 m95 -100.37 137.08 39.28 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.554 0.742 . . . . 74.140000000000001 111.41 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 90.8 m-85 -131.61 119.99 22.22 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.014 0.525 . . . . 75.129999999999995 110.91 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -107.52 124.82 50.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.413 0.685 . . . . 75.099999999999994 109.686 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t70 65.73 12.48 8.33 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 124.657 1.183 . . . . 73.140000000000001 110.896 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.09 -23.42 23.34 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 123.604 0.621 . . . . 73.030000000000001 113.673 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -101.46 141.89 33.65 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.897 0.849 . . . . 72.239999999999995 111.277 -173.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 152.83 14.89 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.895 0.878 . . . . 74.239999999999995 113.238 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -93.19 158.65 15.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.09 0.556 . . . . 73.319999999999993 110.326 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 128.96 43.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.663 0.785 . . . . 65.099999999999994 110.447 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.8 p -65.09 88.91 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.663 0.785 . . . . 74.439999999999998 111.283 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -126.25 -171.1 2.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.736 1.214 . . . . 70.420000000000002 110.503 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.4 -34.03 78.76 Favored Glycine 0 N--CA 1.48 1.627 0 O-C-N 123.017 0.198 . . . . 75.230000000000004 113.345 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -71.99 -60.89 2.0 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 75.230000000000004 110.507 173.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.8 t -101.46 92.07 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.983 0.913 . . . . 73.530000000000001 110.977 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -97.85 115.89 28.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.84 0.856 . . . . 72.049999999999997 111.402 -174.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 51' ' ' LEU . 96.2 mt -94.64 133.61 38.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.173 0.589 . . . . 75.439999999999998 110.984 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -123.94 103.07 8.11 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.618 -0.882 . . . . 71.549999999999997 108.618 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -85.07 121.98 28.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.407 0.683 . . . . 74.319999999999993 111.637 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.73 169.02 16.24 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.587 0.755 . . . . 64.239999999999995 110.604 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.52 111.9 4.49 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.359 -0.689 . . . . 71.439999999999998 112.003 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.59 -54.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.503 1.521 . . . . 64.150000000000006 112.195 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.5 ttt-85 -67.94 112.57 5.03 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.673 0.789 . . . . 74.150000000000006 112.136 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -107.97 137.06 46.63 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.582 0.753 . . . . 74.540000000000006 109.068 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 73.0 t -125.8 124.18 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 122.09 -0.381 . . . . 71.400000000000006 111.81 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.409 HD23 HD21 ' A' ' 42' ' ' LEU . 2.3 tm? -113.25 115.43 28.18 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.729 1.212 . . . . 75.409999999999997 108.454 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 75.0 mtt180 -112.54 106.96 15.52 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 122.056 -0.402 . . . . 74.219999999999999 111.779 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.1 t -98.25 95.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 109.651 -0.499 . . . . 75.420000000000002 109.651 172.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -71.68 101.6 2.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.103 -0.702 . . . . 73.409999999999997 109.103 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.48 11.99 0.53 Allowed Glycine 0 N--CA 1.471 0.998 0 CA-C-O 119.258 -0.745 . . . . 63.520000000000003 113.1 -173.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 12' ' ' LEU . . . -62.02 100.27 0.16 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.738 0.815 . . . . 73.549999999999997 110.918 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.4 tmm_? -158.74 -48.31 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 O-C-N 123.382 0.426 . . . . 75.450000000000003 112.027 -170.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.3 m -113.16 -97.5 0.43 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 118.183 0.447 . . . . 71.140000000000001 111.894 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.95 21.9 13.9 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 117.917 0.326 . . . . 73.319999999999993 113.672 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.21 -14.7 55.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.373 1.069 . . . . 74.010000000000005 110.8 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.77 104.4 8.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.386 0.675 . . . . 74.25 109.502 170.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.67 -173.93 40.97 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 113.404 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -85.22 115.51 23.04 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.428 0.691 . . . . 74.040000000000006 111.082 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 45.4 m-85 -106.05 111.71 24.45 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.767 0.827 . . . . 73.5 109.706 172.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.5 tp -91.5 107.81 19.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.267 0.627 . . . . 75.310000000000002 110.371 -171.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.403 ' SG ' ' CH2' ' A' ' 27' ' ' TRP . 80.3 m -73.58 90.98 1.8 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.839 -0.801 . . . . 73.319999999999993 108.839 164.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -52.32 -47.06 66.2 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.354 1.062 . . . . 72.450000000000003 111.399 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.661 ' HA ' HG21 ' A' ' 25' ' ' VAL . . . 67.37 132.8 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 114.602 1.334 . . . . 60.420000000000002 114.602 167.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD3' HG21 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -77.68 37.76 0.63 Allowed 'Trans proline' 0 CA--C 1.57 2.276 0 C-N-CA 123.277 2.652 . . . . 74.010000000000005 113.477 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -161.92 -60.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.548 0.739 . . . . 75.140000000000001 110.996 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.59 127.17 7.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.295 0.638 . . . . 75.219999999999999 110.547 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.3 p -73.94 138.09 44.02 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 113.551 0.945 . . . . 63.119999999999997 113.551 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -127.56 126.99 43.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.399 1.08 . . . . 73.120000000000005 111.005 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.27 142.01 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.755 0.422 . . . . 75.430000000000007 110.445 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 11.6 m-85 -101.74 109.76 21.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.204 1.002 . . . . 74.439999999999998 109.943 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.651 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 63.1 mt -86.19 91.7 8.53 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.648 -0.871 . . . . 74.219999999999999 108.648 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -89.5 124.03 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.66 -0.7 . . . . 75.030000000000001 110.658 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -108.37 107.07 17.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.834 0.853 . . . . 71.010000000000005 110.037 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -94.1 106.68 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 108.363 -0.977 . . . . 74.450000000000003 108.363 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -164.01 176.03 9.74 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.22 1.008 . . . . 73.319999999999993 110.658 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.6 84.72 0.2 Allowed Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.112 0.965 . . . . 74.150000000000006 111.514 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo . . . . . 0 CA--C 1.567 2.138 0 C-N-CA 123.222 2.614 . . . . 74.409999999999997 114.121 178.052 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 24.6 mmt . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.123 0.487 . . . . 64.219999999999999 111.069 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 p -92.9 140.96 28.95 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.392 1.077 . . . . 74.519999999999996 109.842 171.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -132.44 116.84 17.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.472 0.709 . . . . 74.319999999999993 110.342 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.2 t -129.98 147.49 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.765 0.826 . . . . 73.120000000000005 110.825 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -124.25 146.93 48.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.251 1.021 . . . . 74.239999999999995 112.226 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -141.09 163.54 32.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.314 1.046 . . . . 74.25 110.315 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 81' ' ' GLU . 1.1 p -93.66 145.39 29.83 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 123.31 0.644 . . . . 72.230000000000004 111.706 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.11 130.88 22.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.269 2.646 . . . . 74.120000000000005 113.231 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.81 -18.41 34.53 Favored Glycine 0 N--CA 1.474 1.219 0 CA-C-N 116.156 -0.474 . . . . 62.32 113.557 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.2 -127.56 5.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 117.202 0.501 . . . . 73.420000000000002 112.289 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.34 155.45 46.79 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.417 0.627 . . . . 75.329999999999998 111.389 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.25 152.81 25.0 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.639 0.776 . . . . 71.299999999999997 109.86 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.23 108.09 4.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.975 0.51 . . . . 75.340000000000003 110.357 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.511 HD11 HD13 ' A' ' 51' ' ' LEU . 65.3 mt -106.34 102.04 11.47 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.385 0.674 . . . . 64.530000000000001 110.054 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -96.53 125.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.044 -0.725 . . . . 72.549999999999997 109.044 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.518 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 2.8 t -112.75 142.66 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.48 0.712 . . . . 73.049999999999997 111.361 -170.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -138.1 45.63 2.1 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.092 0.957 . . . . 75.510000000000005 110.191 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' H ' HG13 ' A' ' 16' ' ' VAL . 1.7 pp -57.46 151.01 17.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.144 0.794 . . . . 73.120000000000005 113.144 170.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.6 m -91.68 3.62 54.65 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.694 0.798 . . . . 72.239999999999995 111.996 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.36 116.9 6.01 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 119.053 -0.86 . . . . 74.010000000000005 113.484 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.41 111.51 1.16 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.95 2.434 . . . . 75.230000000000004 112.363 173.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' HA3' ' HD2' ' A' ' 69' ' ' PRO . . . 177.25 138.26 2.93 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.304 -0.407 . . . . 64.109999999999999 112.691 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.78 112.61 0.55 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.956 -0.913 . . . . 74.239999999999995 112.057 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.67 162.07 79.17 Favored 'Cis proline' 0 C--N 1.375 1.944 0 CA-C-N 120.192 1.996 . . . . 73.319999999999993 113.612 -3.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.464 HG23 ' HA2' ' A' ' 46' ' ' GLY . 89.5 t -86.9 151.25 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-N 115.146 -0.934 . . . . 71.010000000000005 109.624 172.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -93.24 164.41 13.24 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.125 0.57 . . . . 74.25 110.56 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.403 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 78.9 m95 -133.03 127.88 35.06 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.85 0.86 . . . . 73.150000000000006 110.773 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 87.8 m-85 -131.28 126.15 34.65 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.222 1.009 . . . . 75.239999999999995 110.865 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB3' HD21 ' A' ' 34' ' ' LEU . 20.8 tptm -113.67 132.96 55.59 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.673 0.789 . . . . 73.5 108.994 169.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.24 22.27 13.26 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.294 1.045 . . . . 72.030000000000001 110.224 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.71 -6.16 71.19 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.543 -0.753 . . . . 63.420000000000002 114.108 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -107.26 136.45 47.07 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.988 0.894 . . . . 73.209999999999994 111.15 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -59.89 147.97 36.62 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.344 0.868 . . . . 75.099999999999994 113.344 -173.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 29' ' ' LYS . 41.6 mt -100.45 125.53 46.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.301 0.641 . . . . 72.230000000000004 110.238 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.46 139.12 32.41 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.752 0.821 . . . . 73.430000000000007 109.932 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 p -64.04 92.95 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.515 0.674 . . . . 71.129999999999995 111.11 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -111.88 -171.27 1.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.936 0.894 . . . . 75.420000000000002 111.834 -175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.29 -44.73 95.07 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.285 -0.416 . . . . 71.0 112.764 174.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.524 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 84.3 mtt180 -73.61 -52.87 11.94 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.352 0.661 . . . . 72.299999999999997 111.133 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 34' ' ' LEU . 67.5 t -79.48 95.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 123.322 0.649 . . . . 75.329999999999998 111.421 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.5 mt-30 -90.79 100.05 12.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.018 0.927 . . . . 75.230000000000004 109.996 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.63 133.05 41.62 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.139 0.575 . . . . 75.120000000000005 111.752 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 52.4 mm-40 -107.71 130.42 54.94 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.223 1.009 . . . . 72.540000000000006 110.301 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -103.02 141.77 35.25 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.933 0.493 . . . . 75.299999999999997 110.883 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.52 -49.05 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.84 1.256 . . . . 74.129999999999995 109.457 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 121.2 -72.17 0.37 Allowed Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.106 -0.952 . . . . 72.030000000000001 111.226 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -17.97 61.91 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.701 0.8 . . . . 72.25 112.19 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -135.06 107.96 7.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 110.34 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.434 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 13.8 mm100 -115.12 143.03 45.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.319 0.648 . . . . 74.450000000000003 109.402 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 58.6 t -133.42 114.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 117.984 0.356 . . . . 74.409999999999997 110.417 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD13 HD11 ' A' ' 14' ' ' LEU . 1.1 tm? -104.98 117.14 33.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.753 0.821 . . . . 73.230000000000004 108.889 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 81.5 mtp180 -115.69 112.95 22.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.92 -0.582 . . . . 74.510000000000005 110.568 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.16 102.24 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.719 -0.474 . . . . 75.25 109.719 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 39' ' ' ARG . 0.6 OUTLIER -66.87 116.59 7.91 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.168 -0.679 . . . . 65.129999999999995 109.168 174.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.14 43.9 2.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.203 -0.453 . . . . 65.140000000000001 112.511 -173.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.92 118.2 17.62 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.877 0.471 . . . . 73.099999999999994 110.107 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -158.34 112.44 2.5 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.863 0.465 . . . . 74.439999999999998 111.579 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m 53.38 -78.87 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.323 1.449 . . . . 74.230000000000004 114.413 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -11.87 59.99 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 114.815 0.686 . . . . 74.400000000000006 114.815 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.444 ' HB3' HG21 ' A' ' 79' ' ' VAL . 17.7 t70 -66.26 -25.87 67.09 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.507 0.723 . . . . 70.299999999999997 111.132 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.647 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -66.97 100.04 0.7 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.082 0.953 . . . . 75.200000000000003 110.689 176.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -164.23 -172.71 32.04 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.979 -0.555 . . . . 60.119999999999997 113.346 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -86.28 111.03 20.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.387 0.675 . . . . 65.340000000000003 110.824 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.749 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 44.1 m-85 -96.44 156.88 16.15 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.087 0.955 . . . . 73.310000000000002 109.442 169.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.7 tp -140.44 101.34 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.873 0.368 . . . . 73.239999999999995 110.824 -173.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.415 ' SG ' HG13 ' A' ' 25' ' ' VAL . 16.6 t -85.71 89.97 7.89 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.77 -0.826 . . . . 61.210000000000001 108.77 172.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -100.76 99.9 10.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.706 0.802 . . . . 74.150000000000006 112.664 -168.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.8 155.91 67.86 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.614 0.766 . . . . 73.540000000000006 110.068 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' ' HA3' ' A' ' 22' ' ' GLY . 50.3 Cg_exo -59.77 -2.43 1.56 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.273 2.649 . . . . 73.319999999999993 115.746 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -126.01 -43.63 1.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.696 0.798 . . . . 71.540000000000006 111.088 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.46 149.04 51.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.033 0.533 . . . . 74.540000000000006 111.246 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD11 ' A' ' 65' ' ' LEU . 79.7 p -129.92 133.18 46.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.637 0.775 . . . . 73.239999999999995 110.871 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -106.77 125.22 50.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.273 0.629 . . . . 65.310000000000002 110.035 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.436 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 2.2 mp -92.7 125.67 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.853 -0.795 . . . . 74.010000000000005 108.853 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 33.6 m-85 -98.15 101.95 13.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.437 0.695 . . . . 75.340000000000003 109.302 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.6 mt -77.55 92.94 4.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.03 -1.1 . . . . 75.120000000000005 108.03 172.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.8 t -94.03 139.17 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.153 -0.93 . . . . 73.420000000000002 110.718 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.9 p -131.2 107.4 8.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.86 -0.609 . . . . 72.109999999999999 109.763 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.647 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 57.4 t -90.11 107.34 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.594 -0.891 . . . . 74.439999999999998 108.594 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.79 179.71 7.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.995 0.918 . . . . 73.340000000000003 111.06 -167.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.421 ' O ' HG23 ' A' ' 7' ' ' THR . 12.5 tp10 64.21 87.97 0.12 Allowed Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 124.462 1.105 . . . . 73.409999999999997 110.584 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo . . . . . 0 C--N 1.383 2.344 0 C-N-CA 124.493 3.462 . . . . 72.109999999999999 115.742 -174.86 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.564 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.675 0.274 . . . . 74.02 110.795 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.8 m -73.41 95.16 2.17 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 124.297 1.039 . . . . 73.34 110.093 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -83.87 136.27 34.18 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.889 0.876 . . . . 60.14 111.668 -166.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.6 143.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.923 0.889 . . . . 54.32 110.344 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -121.71 138.54 54.31 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.298 1.039 . . . . 74.32 110.377 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t -137.34 178.08 7.37 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.464 0.706 . . . . 71.02 110.45 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 81' ' ' GLU . 4.2 p -124.99 147.71 57.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 124.016 0.926 . . . . 62.55 111.655 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -69.85 87.61 0.56 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.486 2.791 . . . . 74.04 113.402 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.22 -27.11 2.0 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.337 -0.847 . . . . 64.34 112.431 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.71 17.01 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.102 0.401 . . . . 43.3 114.102 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.47 158.25 16.35 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.382 0.673 . . . . 72.52 110.874 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 54.7 tp -119.24 108.25 14.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.337 0.655 . . . . 74.42 110.064 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.34 114.85 23.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.161 0.584 . . . . 72.43 110.242 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 15.2 mt -103.62 103.29 13.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.815 -0.809 . . . . 73.33 108.815 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.467 HG22 HG22 ' A' ' 50' ' ' VAL . 67.3 t -105.56 122.1 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.14 -0.689 . . . . 73.42 109.14 175.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.549 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -100.78 148.27 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.742 0.417 . . . . 42.31 110.717 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 67.4 m80 -128.25 51.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.187 0.994 . . . . 73.25 109.827 166.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.22 170.26 14.43 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.228 -1.351 . . . . 72.41 112.961 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.7 m -90.7 23.89 2.91 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.565 1.146 . . . . 72.51 112.705 -175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.82 157.28 18.08 Favored Glycine 0 CA--C 1.546 2.025 0 CA-C-O 119.959 -0.356 . . . . 64.14 113.933 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.23 -168.14 0.57 Allowed 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.615 2.876 . . . . 61.51 113.428 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.18 -51.24 55.44 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 123.264 0.459 . . . . 41.43 114.066 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.29 -97.2 1.22 Allowed Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.474 0.95 . . . . 73.51 115.474 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.85 126.44 9.63 Favored 'Cis proline' 0 C--N 1.383 2.353 0 CA-C-N 120.891 2.345 . . . . 60.11 114.384 5.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 89.7 t -66.58 131.62 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.439 0.696 . . . . 63.25 110.274 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.06 150.81 20.07 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.46 0.647 . . . . 72.22 110.637 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -110.34 125.24 52.97 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.893 0.877 . . . . 74.32 109.296 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.772 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 81.0 m-85 -111.71 161.7 16.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.149 0.58 . . . . 71.0 110.438 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HB3' HD21 ' A' ' 34' ' ' LEU . 27.2 tptp -146.68 122.9 10.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.741 0.816 . . . . 74.01 109.51 171.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 54.54 25.74 6.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.929 0.891 . . . . 72.13 113.068 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.76 -30.52 7.73 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-N 116.121 -0.491 . . . . 60.24 114.165 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.9 131.79 55.14 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.788 0.794 . . . . 75.33 111.379 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -62.18 151.89 34.7 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.107 0.963 . . . . 75.53 113.536 -177.195 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 29' ' ' LYS . 27.3 mt -100.99 142.32 32.64 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.165 0.986 . . . . 52.21 110.345 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.63 157.46 17.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.997 0.919 . . . . 72.1 109.996 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.9 p -61.62 97.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.841 0.829 . . . . 71.53 111.035 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.506 ' NE2' ' H ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -109.55 163.28 13.59 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.887 1.275 . . . . 73.44 108.135 -175.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' H ' ' NE2' ' A' ' 37' ' ' GLN . . . -53.92 -35.84 54.4 Favored Glycine 0 CA--C 1.543 1.798 0 N-CA-C 114.145 0.418 . . . . 74.4 114.145 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -89.5 -33.06 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.021 0.528 . . . . 74.53 110.821 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.04 86.01 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.93 0.892 . . . . 75.2 111.152 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 68.1 mt-30 -82.82 101.25 10.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.623 0.769 . . . . 75.43 110.751 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.441 HD21 HD23 ' A' ' 51' ' ' LEU . 61.2 mt -89.91 152.86 21.03 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.33 0.586 . . . . 72.41 112.201 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.5 tm-20 -146.48 131.83 18.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.743 -1.206 . . . . 74.32 107.743 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -124.8 103.14 7.92 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.012 0.525 . . . . 75.15 111.034 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.86 11.17 11.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.937 0.895 . . . . 74.23 111.969 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.67 -86.36 1.47 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.179 0.419 . . . . 61.41 113.408 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' HIS . . . -72.56 -5.39 36.79 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.347 0.659 . . . . 32.14 111.865 175.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 54.0 ttp180 -133.71 101.21 5.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.003 0.921 . . . . 60.32 109.745 172.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.0 mm100 -106.09 126.58 52.37 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 109.549 -0.537 . . . . 70.15 109.549 173.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 40.6 t -115.83 122.15 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-O 120.869 0.366 . . . . 62.41 111.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -111.34 114.47 27.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.334 1.054 . . . . 72.22 108.402 169.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.601 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 83.6 mtm180 -114.43 108.31 16.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.992 0.517 . . . . 62.15 111.202 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.7 t -96.55 120.89 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.634 -0.506 . . . . 63.31 109.634 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -79.2 116.08 19.25 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.257 0.623 . . . . 74.23 109.731 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.61 72.45 1.26 Allowed Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.336 -0.393 . . . . 72.52 113.429 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . . . -80.48 102.54 9.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.683 0.793 . . . . 51.23 111.447 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.34 -73.63 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.599 0.759 . . . . 74.5 111.614 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.8 m -127.71 -67.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.855 0.462 . . . . 75.51 111.867 -171.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.1 -12.53 60.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 113.974 0.349 . . . . 72.22 113.974 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.87 -17.48 43.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.292 1.037 . . . . 64.44 110.694 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.64 134.17 34.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.023 0.929 . . . . 55.35 109.554 172.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.04 -178.64 36.92 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.867 -0.606 . . . . 70.14 113.066 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.1 117.67 25.99 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.357 0.599 . . . . 75.34 110.467 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 38.4 m-85 -94.57 157.02 16.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.283 1.033 . . . . 75.34 109.934 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.4 tp -127.94 105.56 8.5 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.828 -0.545 . . . . 74.02 110.525 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' HG21 ' A' ' 16' ' ' VAL . 48.6 t -82.93 88.22 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.637 -0.875 . . . . 41.44 108.637 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -79.36 86.72 5.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.121 0.968 . . . . 63.31 111.684 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -81.01 140.57 49.96 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.816 -0.629 . . . . 74.32 110.054 171.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.32 -35.86 16.44 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 124.498 3.466 . . . . 71.22 115.896 -173.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -124.18 0.38 8.41 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.802 0.841 . . . . 71.24 112.406 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -156.49 49.45 0.48 Allowed 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.785 0.802 . . . . 73.1 111.046 -165.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -66.8 121.6 15.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.148 0.979 . . . . 35.32 112.025 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -127.47 142.66 51.34 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.933 0.716 . . . . 64.31 112.933 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mp -91.05 139.95 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.962 0.905 . . . . 74.32 109.947 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.586 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 9.3 m-85 -102.06 114.89 29.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.563 1.145 . . . . 73.52 111.121 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 93.9 mt -77.36 93.87 4.12 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.591 -0.892 . . . . 75.41 108.591 166.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.486 HG11 HD21 ' A' ' 12' ' ' LEU . 73.5 t -105.45 113.14 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.345 0.658 . . . . 63.01 110.691 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 t -118.1 117.65 29.76 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.564 -0.744 . . . . 64.44 110.747 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.3 t -84.82 106.26 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 107.947 -1.131 . . . . 72.02 107.947 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.41 -173.95 4.17 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.184 0.994 . . . . 74.24 109.922 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 7' ' ' THR . 44.6 tt0 59.78 81.15 0.25 Allowed Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.978 0.911 . . . . 74.14 110.763 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo . . . . . 0 CA--C 1.575 2.566 0 C-N-CA 124.278 3.318 . . . . 74.44 115.875 -177.112 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.579 0.228 . . . . 71.41 111.528 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -79.67 95.19 5.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.674 -0.861 . . . . 75.55 108.674 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.566 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 41.2 mtp180 -93.9 148.34 22.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.567 0.747 . . . . 74.41 112.824 -166.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 79.4 t -130.57 138.57 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.031 0.932 . . . . 64.44 109.473 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.17 119.13 32.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.023 0.929 . . . . 55.15 109.076 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.419 ' HB3' HG22 ' A' ' 79' ' ' VAL . 35.0 t -132.45 163.16 29.38 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.796 0.808 . . . . 53.13 112.568 -170.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.1 p -99.74 155.82 36.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.047 -0.978 . . . . 72.15 111.189 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -82.02 46.71 2.28 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.444 2.762 . . . . 70.3 113.292 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.1 45.67 0.56 Allowed Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.316 -0.402 . . . . 63.5 113.115 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.73 172.98 36.12 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-O 119.635 -0.536 . . . . 72.52 112.193 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.78 135.37 41.71 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.553 0.677 . . . . 73.53 111.131 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.489 HD21 HG11 ' A' ' 77' ' ' VAL . 49.5 tp -78.84 107.44 11.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.782 0.433 . . . . 44.33 110.883 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 36.2 tt0 -111.24 104.59 13.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.922 0.489 . . . . 74.41 110.171 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HG ' HD12 ' A' ' 51' ' ' LEU . 29.3 mt -94.45 106.12 18.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.96 0.904 . . . . 75.11 110.402 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -93.95 113.27 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.588 0.755 . . . . 64.42 110.003 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 18' ' ' LEU . 2.1 t -100.05 149.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.688 0.795 . . . . 71.21 110.631 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -112.02 15.15 20.77 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.308 0.643 . . . . 51.35 111.14 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.609 ' H ' HG12 ' A' ' 16' ' ' VAL . 14.4 mt -54.24 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.514 0.725 . . . . 72.11 112.003 174.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.8 t -68.24 81.36 0.24 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.637 0.775 . . . . 62.21 110.349 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.29 164.18 30.63 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.292 -0.867 . . . . 73.24 113.268 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.09 23.7 0.51 Allowed 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.231 2.621 . . . . 74.22 113.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.74 59.76 4.26 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 122.838 0.256 . . . . 25.15 112.501 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.31 -69.49 1.37 Allowed Glycine 0 CA--C 1.551 2.299 0 CA-C-O 119.616 -0.547 . . . . 73.1 114.44 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.7 -167.35 5.99 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 120.19 1.995 . . . . 65.42 113.534 0.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' HB ' ' HG3' ' A' ' 49' ' ' GLN . 92.6 t -87.77 146.11 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 123.705 0.802 . . . . 54.21 110.459 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.709 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 97.4 mtt180 -96.2 169.72 9.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 75.21 110.66 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 94.8 m95 -131.22 136.92 48.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.824 0.85 . . . . 74.14 110.168 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 59.9 m-85 -134.46 123.67 24.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 123.036 0.535 . . . . 74.34 110.569 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.1 tptp -117.93 133.74 55.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.002 -0.74 . . . . 73.13 109.002 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 61.29 22.31 12.69 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.808 0.843 . . . . 74.21 111.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.09 5.6 82.96 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 114.268 0.467 . . . . 53.24 114.268 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -130.66 133.95 46.54 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.901 0.851 . . . . 72.4 112.358 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.511 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -62.85 150.87 40.61 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.022 1.489 . . . . 75.42 115.022 -171.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.567 HD12 HG21 ' A' ' 40' ' ' VAL . 3.8 mm? -92.61 163.79 13.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.237 1.415 . . . . 72.25 111.024 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.65 140.04 42.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.555 0.742 . . . . 54.31 110.407 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.1 p -81.74 31.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.509 0.724 . . . . 54.12 112.813 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -121.87 124.97 45.36 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.03 0.932 . . . . 74.42 110.655 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.71 -100.03 0.46 Allowed Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.731 0.652 . . . . 71.14 114.731 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -52.37 -46.04 66.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 125.024 1.33 . . . . 74.52 113.03 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.567 HG21 HD12 ' A' ' 34' ' ' LEU . 98.9 t -116.96 143.12 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.366 -0.834 . . . . 72.42 110.616 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -126.0 131.02 52.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.349 1.06 . . . . 62.04 110.156 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 82.6 mt -119.66 145.15 46.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.887 0.475 . . . . 62.13 112.068 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.46 130.69 54.81 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.32 0.648 . . . . 74.43 109.329 166.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -106.32 103.71 13.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.826 0.851 . . . . 64.33 110.018 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.55 178.12 6.31 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.37 0.668 . . . . 74.35 111.316 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.92 -24.79 75.33 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.332 -0.395 . . . . 62.13 113.501 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.65 -55.14 0.73 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.179 0.592 . . . . 73.11 111.868 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 46.7 ttp180 -81.8 97.83 8.18 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.959 0.409 . . . . 64.04 112.053 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.439 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 39.6 mm-40 -91.65 133.72 35.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.57 -0.9 . . . . 70.25 108.57 173.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 87.8 t -121.44 115.68 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 122.014 -0.429 . . . . 65.52 110.894 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.6 tm? -95.51 129.61 42.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.153 0.981 . . . . 73.33 108.644 171.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 63.1 mtp180 -131.66 105.34 7.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.853 0.752 . . . . 73.32 111.334 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 51' ' ' LEU . 46.5 t -96.23 105.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.836 -0.801 . . . . 63.21 108.836 171.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -72.39 109.96 6.47 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.53 0.732 . . . . 63.12 112.612 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.01 48.8 1.42 Allowed Glycine 0 C--N 1.35 1.348 0 CA-C-N 116.253 -0.431 . . . . 43.22 113.472 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.11 115.13 12.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.466 0.706 . . . . 74.31 111.551 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -157.5 -65.48 0.09 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.586 0.754 . . . . 53.34 111.989 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.5 m -80.22 -70.48 0.52 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.2 0.815 . . . . 61.12 113.2 -163.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -116.31 30.14 6.65 Favored Glycine 0 N--CA 1.487 2.034 0 CA-C-O 121.075 0.264 . . . . 74.32 112.859 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.95 -6.14 43.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 52.44 112.314 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -83.63 129.09 34.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.366 -0.605 . . . . 75.54 109.366 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 163.39 -174.2 39.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.121 -0.561 . . . . 45.32 114.212 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -91.53 110.65 21.97 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.107 0.563 . . . . 75.22 110.395 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.8 m-85 -95.6 113.63 25.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.854 0.461 . . . . 73.22 110.031 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 54.2 tp -92.85 101.77 14.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.547 0.739 . . . . 74.13 110.277 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 26' ' ' ARG . 72.6 m -71.41 88.48 0.89 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.335 -0.848 . . . . 54.35 109.614 169.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.0 t70 -80.04 89.85 5.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.39 0.614 . . . . 72.43 110.599 -176.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.44 151.39 50.74 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.226 -0.897 . . . . 73.4 111.31 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.62 -21.86 73.05 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.409 2.073 . . . . 71.3 112.633 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.92 93.19 3.92 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.529 -0.915 . . . . 74.14 108.529 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.53 109.61 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 125.3 1.44 . . . . 72.52 113.216 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -75.93 134.34 40.26 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.873 0.869 . . . . 73.14 112.035 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -107.39 141.37 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.329 0.652 . . . . 74.43 110.962 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.5 mp -104.84 137.78 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.092 0.557 . . . . 72.14 110.289 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 7.0 m-85 -108.46 105.44 15.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.312 1.045 . . . . 73.21 110.861 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 95.6 mt -77.17 97.78 4.88 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.324 -0.621 . . . . 63.34 109.324 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG11 HD21 ' A' ' 12' ' ' LEU . 45.3 t -107.65 131.58 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.834 0.454 . . . . 72.24 111.171 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.6 m -119.6 111.62 18.3 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.116 0.567 . . . . 70.32 109.788 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.62 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 40.5 t -109.31 105.25 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.138 -1.06 . . . . 71.11 108.138 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.59 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.523 0.935 . . . . 65.13 113.523 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 51.3 mt-10 -68.57 108.31 2.78 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.132 0.573 . . . . 74.13 110.995 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 26.4 Cg_exo . . . . . 0 C--N 1.383 2.355 0 C-N-CA 123.243 2.628 . . . . 62.23 113.879 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.965 0.412 . . . . 75.01 111.414 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -76.48 156.03 33.34 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.932 0.893 . . . . 62.34 112.29 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -150.75 129.92 12.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.28 1.032 . . . . 72.0 109.587 172.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 99.0 t -129.67 134.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.724 0.81 . . . . 72.1 109.612 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.3 144.17 26.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.026 0.53 . . . . 74.54 110.865 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.483 ' HB2' HD13 ' A' ' 12' ' ' LEU . 40.4 t -125.66 153.7 43.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.021 0.928 . . . . 65.33 109.851 172.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -102.0 150.42 37.43 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.354 0.662 . . . . 73.04 111.024 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.35 96.48 0.19 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.284 2.656 . . . . 75.53 113.769 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.24 38.49 4.53 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.673 -0.694 . . . . 65.13 113.975 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.57 168.85 22.58 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-O 120.085 -0.286 . . . . 74.31 112.547 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 37.0 t70 -70.42 140.95 52.16 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.222 0.534 . . . . 71.12 111.34 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 6' ' ' SER . 64.3 tp -109.41 152.39 25.41 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.421 1.088 . . . . 52.03 109.538 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.73 130.66 19.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.393 0.677 . . . . 71.02 109.653 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.31 105.39 14.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.501 0.721 . . . . 50.42 109.214 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.35 120.72 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.477 0.711 . . . . 65.31 109.239 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.668 ' HB ' ' H ' ' A' ' 49' ' ' GLN . 94.5 t -107.64 131.3 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.893 0.877 . . . . 73.4 111.964 -172.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -143.28 31.33 1.37 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.222 1.009 . . . . 64.0 110.897 172.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -57.61 168.14 0.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.857 0.688 . . . . 72.12 112.857 169.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.3 t -89.58 31.97 0.9 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.074 0.55 . . . . 71.41 111.168 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.62 80.42 0.29 Allowed Glycine 0 CA--C 1.541 1.661 0 CA-C-O 119.367 -0.685 . . . . 75.25 112.683 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.18 175.28 11.02 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.296 2.664 . . . . 53.54 113.466 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.2 -84.78 0.6 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.156 -0.474 . . . . 72.5 113.028 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.28 -161.85 17.4 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.401 -0.666 . . . . 52.23 113.75 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.45 116.1 4.18 Favored 'Cis proline' 0 C--N 1.378 2.129 0 CA-C-N 119.844 1.822 . . . . 63.41 113.422 -1.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.34 123.33 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.787 -0.642 . . . . 71.25 109.636 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -103.85 159.77 15.36 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.276 0.63 . . . . 52.5 111.819 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.43 ' HB3' HD23 ' A' ' 34' ' ' LEU . 86.0 m95 -115.49 137.61 51.88 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.956 0.902 . . . . 72.15 110.249 173.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 98.2 m-85 -135.29 123.33 22.77 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.381 0.672 . . . . 64.02 110.823 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 24.9 tptp -103.53 112.74 25.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.158 0.583 . . . . 72.32 110.379 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 55.59 3.07 0.07 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 126.12 1.768 . . . . 74.03 115.38 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.3 -27.43 1.54 Allowed Glycine 0 N--CA 1.481 1.675 0 O-C-N 121.152 -0.967 . . . . 64.45 114.738 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -113.28 147.15 38.14 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.366 1.083 . . . . 65.12 111.549 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.577 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -69.18 153.08 44.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.741 0.645 . . . . 75.33 112.741 175.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 27' ' ' TRP . 3.2 mm? -90.37 154.74 19.45 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.408 -0.815 . . . . 43.23 109.888 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.6 125.62 12.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.211 1.004 . . . . 33.31 108.671 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 p -55.4 99.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.746 0.818 . . . . 73.23 112.592 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -159.7 116.28 2.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.474 0.71 . . . . 72.43 111.62 -171.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.42 -89.88 0.06 OUTLIER Glycine 0 C--N 1.353 1.522 0 O-C-N 123.547 0.53 . . . . 51.12 113.655 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -75.27 -42.76 54.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.832 0.853 . . . . 73.12 111.601 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.27 106.71 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 116.116 -0.493 . . . . 74.44 110.151 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.658 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.5 mm100 -110.09 104.6 13.49 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.109 0.564 . . . . 70.4 109.625 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD21 HD23 ' A' ' 51' ' ' LEU . 84.9 mt -98.59 143.85 28.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 74.33 112.098 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 40.1 tt0 -140.47 136.75 33.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.224 1.01 . . . . 74.32 109.01 173.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.02 106.56 9.16 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.873 0.844 . . . . 72.44 110.869 -176.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -111.76 21.5 15.98 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.428 1.091 . . . . 72.3 110.967 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.17 -87.09 0.95 Allowed Glycine 0 N--CA 1.477 1.393 0 CA-C-N 116.34 -0.391 . . . . 74.24 112.787 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.87 -40.75 18.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.306 0.642 . . . . 70.45 110.647 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 46.3 ttt180 -78.5 106.38 10.41 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.416 -0.811 . . . . 73.23 110.699 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.668 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 79.9 mm-40 -106.91 155.45 19.75 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.616 0.766 . . . . 72.42 109.587 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 65.1 t -135.76 117.39 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.867 0.467 . . . . 63.0 109.953 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.434 HD23 HD21 ' A' ' 42' ' ' LEU . 2.8 tm? -110.51 118.7 36.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.834 -0.802 . . . . 74.42 108.834 168.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 84.2 mtt180 -113.81 141.42 47.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.06 0.544 . . . . 75.21 110.854 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.7 t -128.83 101.73 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.742 0.817 . . . . 65.12 108.992 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -74.23 121.73 21.72 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.051 -0.351 . . . . 73.23 110.051 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.34 36.47 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.79 -0.186 . . . . 62.41 113.291 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 90.31 0.06 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.573 0.749 . . . . 71.32 111.362 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -88.35 -56.68 3.21 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.055 1.132 . . . . 74.11 114.055 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -161.67 -58.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.326 0.25 . . . . 73.23 111.563 -174.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -9.96 55.03 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.485 -0.325 . . . . 63.33 113.442 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.78 -3.42 44.32 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.687 1.195 . . . . 73.41 111.973 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.67 127.5 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.509 0.724 . . . . 31.32 109.955 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 164.59 -172.72 40.41 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 121.225 0.347 . . . . 75.3 113.695 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -87.26 111.85 21.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.676 0.79 . . . . 51.04 111.45 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -99.35 111.35 23.73 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.819 -0.808 . . . . 73.44 108.819 170.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 tp -94.09 106.63 18.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.249 1.02 . . . . 74.14 110.379 -171.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.433 ' SG ' HD21 ' A' ' 18' ' ' LEU . 42.2 t -79.89 88.06 5.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.629 0.728 . . . . 70.34 109.165 171.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -78.18 89.93 4.28 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.994 -1.003 . . . . 61.34 110.845 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -94.51 148.31 34.73 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.491 0.717 . . . . 64.14 111.264 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -55.04 -32.1 77.73 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 123.538 2.825 . . . . 55.11 114.774 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -86.81 -51.73 5.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.969 0.508 . . . . 44.32 111.592 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -149.39 126.02 11.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.287 0.635 . . . . 62.24 112.164 -175.197 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -87.08 118.93 26.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.83 0.852 . . . . 72.13 110.41 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.524 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -105.79 131.21 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.227 0.611 . . . . 74.14 111.325 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.5 mt -88.87 117.96 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.791 0.837 . . . . 60.24 109.939 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.487 ' CZ ' HG22 ' A' ' 16' ' ' VAL . 17.8 m-85 -98.58 103.63 15.6 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.831 -0.803 . . . . 65.35 108.831 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.18 93.56 3.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.178 -0.675 . . . . 71.12 109.178 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.1 t -85.2 99.95 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.734 0.778 . . . . 64.53 109.748 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.4 p -95.51 108.79 21.05 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.744 -1.116 . . . . 73.13 109.937 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 6' ' ' SER . 85.6 t -82.37 106.09 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 107.682 -1.229 . . . . 54.01 107.682 173.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -156.24 -178.11 7.08 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.513 1.125 . . . . 65.41 109.888 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 58.25 75.06 0.56 Allowed Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.591 0.757 . . . . 61.02 110.563 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 CA--C 1.572 2.383 0 C-N-CA 123.154 2.57 . . . . 72.23 113.459 -176.69 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.457 0.17 . . . . 75.54 111.311 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -62.06 133.67 55.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.374 0.67 . . . . 54.12 110.124 167.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -126.63 111.74 14.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.345 0.658 . . . . 73.42 109.818 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.2 t -115.16 139.39 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.31 0.644 . . . . 65.32 111.092 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -90.05 136.05 33.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.64 0.776 . . . . 70.2 110.209 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 t -125.37 152.03 45.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.677 0.791 . . . . 74.5 110.145 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 81' ' ' GLU . 1.6 p -104.67 152.28 39.43 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.564 0.745 . . . . 73.23 111.752 177.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 57.1 Cg_endo -80.54 42.71 1.38 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.368 2.712 . . . . 64.31 113.747 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.73 66.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.926 0 N-CA-C 112.293 -0.323 . . . . 35.25 112.293 -173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.32 -136.3 4.12 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-O 120.164 -0.242 . . . . 73.03 112.782 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.47 152.57 51.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.648 0.779 . . . . 50.01 110.761 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.2 tp -89.71 146.73 24.3 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.29 0.636 . . . . 73.44 109.903 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -145.57 114.06 6.73 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.913 -0.402 . . . . 74.14 109.913 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 63.4 mt -106.82 102.02 11.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.582 0.753 . . . . 73.42 110.061 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -94.52 113.19 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.283 -1.006 . . . . 75.33 108.283 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 18' ' ' LEU . 2.9 t -100.01 146.7 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.035 0.534 . . . . 63.11 111.429 -169.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -131.86 43.71 3.0 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.461 0.705 . . . . 75.04 110.426 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.527 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -59.19 164.59 3.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.018 0.747 . . . . 74.33 113.018 172.033 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.2 p -84.78 38.31 0.69 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.807 0.843 . . . . 53.15 112.319 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 70' ' ' GLN . . . -127.05 84.84 0.34 Allowed Glycine 0 N--CA 1.478 1.482 0 CA-C-O 119.537 -0.59 . . . . 43.32 112.502 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.41 156.77 60.95 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.079 2.519 . . . . 41.55 113.269 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.8 -119.85 11.65 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.908 -0.587 . . . . 65.43 113.473 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -173.74 -164.42 28.86 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-O 119.493 -0.615 . . . . 72.42 113.305 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.0 101.79 0.38 Allowed 'Cis proline' 0 CA--C 1.565 2.032 0 CA-C-N 120.096 1.948 . . . . 62.42 113.029 -3.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HA2' ' A' ' 23' ' ' GLY . 30.7 t -79.89 123.0 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 109.817 -0.438 . . . . 62.31 109.817 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -100.68 158.41 15.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.558 0.743 . . . . 74.22 111.449 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.474 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 62.8 m95 -114.33 142.37 46.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 73.44 111.157 175.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 54.6 m-85 -135.76 160.2 39.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.316 1.047 . . . . 73.51 110.597 177.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.6 tptp -140.75 130.71 24.58 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.54 109.591 165.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 57.68 27.71 14.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.268 1.027 . . . . 65.33 112.63 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 -1.13 76.17 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 115.829 -0.623 . . . . 70.2 114.507 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HG3' HH11 ' A' ' 33' ' ' ARG . 35.3 tt0 -124.78 131.04 53.49 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.325 1.063 . . . . 71.42 111.496 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.611 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.08 143.35 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.524 1.13 . . . . 74.13 113.94 -172.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.6 mt -95.62 147.54 23.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 72.22 111.011 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.49 150.52 23.3 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.936 0.894 . . . . 62.31 110.402 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.9 p -76.36 77.34 3.11 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.281 0.562 . . . . 75.34 110.177 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -76.09 -64.69 1.04 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.7 0.8 . . . . 64.44 112.488 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.36 -49.58 0.24 Allowed Glycine 0 N--CA 1.475 1.266 0 N-CA-C 112.257 -0.337 . . . . 65.11 112.257 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.07 -46.22 15.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.798 -0.816 . . . . 63.13 108.798 164.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.38 93.26 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 108.919 -0.771 . . . . 75.42 108.919 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.227 1.011 . . . . 73.32 110.788 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.22 137.95 51.7 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.084 0.554 . . . . 74.44 110.69 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -122.88 114.4 20.41 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.483 -0.932 . . . . 71.05 108.483 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -103.54 104.03 14.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.76 0.79 . . . . 72.24 110.519 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.13 178.28 6.12 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.499 1.12 . . . . 71.0 110.56 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 95.07 0.22 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.619 -0.545 . . . . 74.51 113.212 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.55 -34.6 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.573 1.549 . . . . 73.41 113.597 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 69.9 ttp85 -85.76 94.08 9.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.5 0.667 . . . . 74.41 110.893 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' HG3' ' SG ' ' A' ' 66' ' ' CYS . 15.7 mm100 -94.64 142.79 27.04 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.485 -0.78 . . . . 72.45 110.102 172.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 47.4 t -131.26 109.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.037 0.446 . . . . 64.13 111.069 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 HG23 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -96.7 130.9 43.84 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.381 -0.97 . . . . 74.5 108.381 169.027 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -128.57 108.67 10.71 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 61.44 109.339 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 HD11 ' A' ' 51' ' ' LEU . 89.4 t -98.2 96.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.625 0.648 . . . . 74.32 109.868 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.06 96.83 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.204 0.602 . . . . 62.0 110.314 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.38 46.47 0.2 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.839 -0.619 . . . . 74.23 112.019 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.4 113.86 17.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.755 0.822 . . . . 52.2 110.317 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 44.1 ttt85 -161.29 -41.77 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.168 0.803 . . . . 73.52 113.168 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.2 m -129.43 -77.55 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 122.75 0.42 . . . . 64.32 111.759 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.33 -3.37 70.42 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 114.479 0.552 . . . . 44.11 114.479 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -67.51 -26.28 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.15 0.98 . . . . 61.54 112.501 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.28 117.56 16.23 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.638 0.375 . . . . 63.33 110.083 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.31 -171.51 41.34 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 114.196 0.438 . . . . 44.3 114.196 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -87.45 117.17 26.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 74.13 111.277 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.572 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 77.7 m-85 -105.36 108.12 19.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.4 0.68 . . . . 71.41 110.096 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.1 tp -92.59 110.41 21.84 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.284 0.564 . . . . 74.02 109.924 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.506 ' SG ' ' HG3' ' A' ' 49' ' ' GLN . 37.9 t -89.1 88.06 7.42 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.846 0.858 . . . . 53.32 108.98 170.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.6 95.45 6.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.238 1.015 . . . . 62.41 112.473 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.41 137.46 30.69 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.884 0.473 . . . . 75.12 111.004 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.42 -23.51 47.48 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.319 2.679 . . . . 64.0 113.873 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.515 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 24.8 mp0 -85.58 -57.49 3.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.62 0.768 . . . . 62.13 111.096 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -157.0 117.11 3.51 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 112.135 0.42 . . . . 74.52 112.135 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 65' ' ' LEU . 10.5 m -76.06 140.26 41.81 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 64.53 112.204 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 126.86 54.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.672 0.789 . . . . 75.32 110.645 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.1 mp -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.417 -0.586 . . . . 55.2 109.417 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.572 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 37.8 m-85 -100.45 125.52 46.76 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.235 1.014 . . . . 74.2 110.386 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.2 mt -102.6 93.88 5.35 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.424 -0.954 . . . . 63.34 108.424 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.04 126.77 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.638 0.775 . . . . 64.44 110.469 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -119.0 117.52 29.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.689 0.796 . . . . 74.14 110.667 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.0 t -84.82 108.14 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.048 0.452 . . . . 60.03 109.894 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -164.61 -170.04 1.91 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.511 1.125 . . . . 73.2 109.617 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 7' ' ' THR . 32.3 tt0 59.84 72.81 0.72 Allowed Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.571 0.748 . . . . 72.45 110.322 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.571 2.329 0 C-N-CA 122.578 2.186 . . . . 74.24 113.357 -172.542 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.72 0.295 . . . . 71.23 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.8 m -83.59 88.71 7.03 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.806 0.842 . . . . 74.54 108.93 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -98.8 135.5 40.17 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.787 0.835 . . . . 72.45 112.14 -166.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.57 143.49 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.967 0.907 . . . . 71.33 110.233 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -92.21 145.23 24.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.727 0.411 . . . . 73.41 110.712 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.716 ' HB2' HD13 ' A' ' 12' ' ' LEU . 37.8 t -120.95 166.66 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.68 0.792 . . . . 61.31 110.081 166.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.07 138.57 21.78 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 123.069 0.548 . . . . 31.21 111.303 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 96.0 Cg_exo -47.32 117.11 2.09 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 124.13 3.22 . . . . 52.13 114.434 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.69 13.32 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 116.254 -0.43 . . . . 55.11 113.934 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.82 52.92 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 121.151 0.306 . . . . 74.55 113.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 5.5 p-10 -91.5 129.51 37.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.146 0.498 . . . . 73.42 111.463 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.716 HD13 ' HB2' ' A' ' 6' ' ' SER . 51.5 tp -74.65 150.15 39.7 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.706 0.802 . . . . 71.2 109.292 169.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.7 115.56 8.27 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.036 0.534 . . . . 65.21 109.943 170.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 76.2 mt -99.18 101.6 12.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.519 0.728 . . . . 71.14 109.729 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.3 t -90.36 113.02 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.386 -0.968 . . . . 64.51 108.386 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 47.4 t -96.72 122.11 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.242 0.544 . . . . 53.25 112.144 -165.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -120.0 70.53 0.87 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 122.06 0.933 . . . . 74.21 108.823 170.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HG ' ' CG1' ' A' ' 16' ' ' VAL . 19.7 mt -55.68 156.22 5.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.299 1.44 . . . . 73.12 113.278 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.8 m -77.72 -33.53 52.98 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.4 -0.818 . . . . 62.45 110.665 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.37 79.86 0.27 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-N 115.853 -0.612 . . . . 73.43 112.123 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.8 -167.93 0.54 Allowed 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 122.983 2.456 . . . . 44.24 114.007 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.97 -169.72 42.67 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.635 -0.711 . . . . 42.12 112.595 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.99 136.61 5.65 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.355 -0.692 . . . . 45.2 112.911 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.86 162.97 84.0 Favored 'Cis proline' 0 C--N 1.381 2.257 0 CA-C-N 120.032 1.916 . . . . 50.12 113.489 -6.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.566 HG11 ' SG ' ' A' ' 66' ' ' CYS . 53.9 t -115.09 134.57 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.926 0.89 . . . . 72.24 110.321 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -97.6 131.77 43.87 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.827 0.851 . . . . 72.2 110.643 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.2 137.29 41.55 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.796 0.839 . . . . 74.2 111.605 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.7 m-85 -130.51 124.04 31.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.695 0.798 . . . . 73.12 110.316 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB3' HD21 ' A' ' 34' ' ' LEU . 18.7 tptm -104.4 120.26 40.81 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 73.24 109.231 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.44 22.45 13.25 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.113 0.965 . . . . 75.12 111.216 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.17 -26.5 22.8 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.841 -0.618 . . . . 53.51 113.724 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.15 129.96 44.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.431 0.692 . . . . 63.32 110.805 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 152.55 16.14 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.888 0.875 . . . . 70.43 112.953 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 29' ' ' LYS . 28.6 mt -107.71 138.74 43.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.886 0.474 . . . . 72.31 111.293 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 144.8 29.07 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.773 0.829 . . . . 42.31 111.089 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -71.76 92.68 1.22 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.658 0.783 . . . . 51.42 111.678 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.455 0.702 . . . . 74.23 112.309 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.03 -57.21 21.06 Favored Glycine 0 C--N 1.36 1.87 0 N-CA-C 115.078 0.791 . . . . 71.24 115.078 -172.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -77.4 -40.71 42.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.812 0.445 . . . . 62.12 111.544 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 54.7 t -95.41 85.6 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.425 0.69 . . . . 70.34 110.541 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -92.79 125.11 37.24 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.995 0.518 . . . . 74.43 112.145 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.34 93.38 4.5 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.522 0.729 . . . . 63.04 111.049 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.756 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 37.0 tt0 -87.57 105.48 17.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.778 0.831 . . . . 70.4 110.566 173.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -94.22 110.04 21.8 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.226 0.61 . . . . 74.42 110.506 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.16 -45.65 5.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.428 0.691 . . . . 63.44 111.254 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.09 -91.1 0.12 Allowed Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.534 -0.626 . . . . 73.1 111.534 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -38.55 64.48 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.615 0.721 . . . . 70.51 109.913 169.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -81.19 125.89 30.83 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.417 -1.265 . . . . 74.14 110.431 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 83.4 mm-40 -117.49 152.42 35.09 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.898 -1.149 . . . . 54.44 107.898 164.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t -138.71 116.24 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.671 0.388 . . . . 72.44 110.617 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.47 128.48 54.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.554 0.742 . . . . 60.25 109.28 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 57.4 mtt180 -116.3 136.73 52.74 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.91 0.884 . . . . 72.41 110.393 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.26 97.57 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.298 0.639 . . . . 74.5 109.532 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -75.2 130.01 38.45 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.942 -0.392 . . . . 73.24 109.942 178.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.56 23.43 39.69 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.485 -0.325 . . . . 71.34 112.868 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.6 99.23 0.42 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.496 0.718 . . . . 74.15 110.221 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.632 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 63.9 mtp85 -104.9 -177.28 3.32 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.588 0.755 . . . . 73.31 112.113 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.0 m -62.57 108.68 1.19 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.299 0.64 . . . . 64.41 110.896 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.62 -15.36 8.02 Favored Glycine 0 N--CA 1.481 1.634 0 CA-C-N 116.233 -0.439 . . . . 53.33 112.88 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.43 -12.08 59.99 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.991 0.917 . . . . 73.21 111.809 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.621 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -63.61 92.36 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.557 1.143 . . . . 73.41 111.545 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.13 -179.93 20.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.488 -0.778 . . . . 60.11 113.511 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.33 124.89 31.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.109 0.564 . . . . 72.52 111.24 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 71.0 m-85 -112.9 108.65 17.68 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.177 0.991 . . . . 75.11 109.51 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 65.4 tp -91.14 103.41 16.1 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.952 -0.467 . . . . 72.41 110.364 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.566 ' SG ' HG11 ' A' ' 25' ' ' VAL . 40.5 t -77.67 86.91 3.96 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.682 0.753 . . . . 71.25 109.316 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.01 97.02 9.05 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.019 -0.991 . . . . 43.21 110.747 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.57 159.37 46.9 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 122.96 0.504 . . . . 70.4 111.039 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.94 36.21 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.635 2.223 . . . . 72.02 113.596 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -165.47 -54.33 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.14 0.576 . . . . 74.53 109.641 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -138.58 108.73 6.41 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.848 0.859 . . . . 64.52 110.862 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 p -93.38 124.05 37.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 70.03 110.985 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.83 139.22 48.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.794 0.437 . . . . 71.21 112.107 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.5 mt -89.04 130.82 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 109.478 -0.564 . . . . 62.11 109.478 170.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 3.0 m-85 -103.75 103.39 13.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.452 0.701 . . . . 74.42 109.333 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.42 93.05 5.93 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.725 -0.843 . . . . 75.21 108.725 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -91.13 127.86 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.084 0.554 . . . . 63.43 111.014 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.8 p -107.08 108.77 20.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.147 0.579 . . . . 70.04 109.918 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 6' ' ' SER . 22.2 t -98.45 106.36 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.073 -0.714 . . . . 72.13 109.073 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -168.56 172.89 7.8 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.692 0.397 . . . . 72.23 111.992 -171.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 58.56 86.85 0.15 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 124.577 1.151 . . . . 73.55 110.85 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.574 2.491 0 C-N-CA 122.817 2.345 . . . . 36.5 114.034 -173.206 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.603 -0.517 . . . . 54.44 109.603 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -62.37 127.24 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.22 0.608 . . . . 54.31 110.946 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -137.77 126.85 24.32 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.776 0.831 . . . . 74.05 109.982 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.1 131.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 121.423 0.63 . . . . 65.41 111.808 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.439 ' NH2' ' HB2' ' A' ' 81' ' ' GLU . 60.3 ttt85 -90.38 139.73 30.39 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.789 1.236 . . . . 74.52 110.054 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.549 ' HB3' HG22 ' A' ' 79' ' ' VAL . 34.1 t -137.69 172.0 13.6 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.121 0.568 . . . . 74.25 110.613 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 p -130.81 148.16 69.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.873 0.869 . . . . 74.13 111.214 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.33 145.88 39.18 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.637 2.225 . . . . 75.01 112.659 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.77 37.29 8.68 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 116.049 -0.523 . . . . 33.42 113.931 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.23 -134.67 1.7 Allowed Glycine 0 N--CA 1.475 1.275 0 CA-C-O 119.972 -0.349 . . . . 61.41 112.675 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.24 155.43 49.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 117.275 0.538 . . . . 72.4 111.18 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.11 143.18 32.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.505 1.122 . . . . 73.2 109.185 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.81 99.0 3.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.107 0.48 . . . . 64.4 111.267 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 51' ' ' LEU . 49.0 mt -92.23 105.53 17.72 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.106 0.962 . . . . 64.41 110.732 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.2 t -103.58 127.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.902 -0.407 . . . . 73.43 109.902 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 66' ' ' CYS . 3.4 m -108.3 149.93 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.412 0.685 . . . . 75.22 111.693 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -128.36 31.41 5.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.104 0.962 . . . . 75.11 109.444 163.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' HG ' ' HB ' ' A' ' 16' ' ' VAL . 1.2 pp -51.69 166.02 0.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.89 1.07 . . . . 42.03 113.89 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -86.64 32.86 0.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.338 0.655 . . . . 74.13 112.756 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.586 ' HA3' ' HB1' ' A' ' 68' ' ' ALA . . . -112.39 90.11 0.55 Allowed Glycine 0 CA--C 1.544 1.888 0 CA-C-O 119.506 -0.608 . . . . 64.11 112.654 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.19 165.4 23.73 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.116 2.544 . . . . 73.32 113.237 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.87 -86.23 0.17 Allowed Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.879 -0.601 . . . . 42.45 113.62 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.07 8.56 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-O 118.782 -1.01 . . . . 52.41 114.028 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.28 117.44 2.67 Favored 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.828 2.314 . . . . 71.13 113.635 1.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.501 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 91.3 t -65.24 124.05 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.706 -0.679 . . . . 72.41 110.084 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 89.0 mtm180 -94.89 164.43 12.92 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.511 0.725 . . . . 71.3 111.003 -171.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -120.81 134.96 55.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.96 0.904 . . . . 74.44 109.716 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.9 m-85 -122.1 162.53 21.08 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.244 1.018 . . . . 74.42 110.791 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.6 tptp -154.32 128.33 8.9 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.425 1.09 . . . . 72.41 108.929 169.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 64.72 17.3 10.88 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.011 0.924 . . . . 74.03 111.988 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.47 -7.14 81.9 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.534 -0.303 . . . . 71.42 113.726 -173.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -109.31 121.58 45.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.713 0.805 . . . . 70.41 110.444 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.7 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.9 143.58 57.34 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.732 0.642 . . . . 75.32 112.732 -175.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.2 mt -87.49 152.62 22.07 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.291 1.037 . . . . 74.45 110.988 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.42 158.85 20.12 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.835 0.854 . . . . 65.22 110.343 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -70.62 82.8 0.6 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.789 0.804 . . . . 62.05 110.954 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -96.78 170.47 9.16 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.104 1.362 . . . . 75.31 110.509 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.15 -43.25 93.47 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.544 0.116 . . . . 73.43 113.348 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.26 -53.6 13.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.935 0.494 . . . . 75.31 110.708 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 34' ' ' LEU . 59.7 t -88.17 90.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 124.138 0.975 . . . . 73.43 112.03 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.628 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.2 mt-30 -82.32 114.89 21.1 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.45 0.7 . . . . 71.24 110.379 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.411 ' HB3' HE22 ' A' ' 44' ' ' GLN . 29.1 mt -110.06 104.36 13.22 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.203 0.601 . . . . 53.53 111.76 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.81 98.55 11.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.925 0.89 . . . . 70.54 110.559 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.411 HE22 ' HB3' ' A' ' 42' ' ' LEU . 23.4 mp0 -99.92 132.02 45.53 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.364 0.666 . . . . 75.31 110.994 172.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.26 -49.0 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.97 0.908 . . . . 52.25 110.415 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.98 122.15 1.52 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-O 119.045 -0.864 . . . . 63.11 111.155 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 69.21 -65.58 0.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.944 1.297 . . . . 63.24 112.288 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 ttp180 -79.07 95.91 5.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.866 0.466 . . . . 72.43 110.806 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.501 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 8.6 mm100 -116.49 136.95 52.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.753 0.821 . . . . 75.53 109.458 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG12 ' HG3' ' A' ' 52' ' ' ARG . 36.0 t -121.52 124.24 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.152 0.501 . . . . 65.42 111.18 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.67 120.36 40.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 52.54 108.562 168.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 73.6 mtp180 -119.61 107.91 13.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.944 0.498 . . . . 72.24 110.094 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -96.42 100.96 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.943 0.497 . . . . 62.21 110.005 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -71.79 103.09 3.01 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.936 0.494 . . . . 73.22 109.975 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.39 42.51 0.25 Allowed Glycine 0 N--CA 1.474 1.198 0 CA-C-N 116.293 -0.412 . . . . 74.22 112.695 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.44 131.5 49.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.007 0.523 . . . . 71.41 110.642 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -163.56 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.232 0.827 . . . . 74.41 113.232 -167.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 m -159.07 -56.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 123.273 0.629 . . . . 33.14 111.305 -171.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -20.59 70.92 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.069 0.388 . . . . 61.13 114.069 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -81.46 -16.0 53.32 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.146 0.978 . . . . 62.45 111.193 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 79' ' ' VAL . . . -74.13 111.57 9.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.88 0.472 . . . . 72.13 109.737 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.2 -171.9 44.78 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 114.081 0.393 . . . . 72.54 114.081 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -81.25 113.46 19.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.391 0.676 . . . . 70.21 110.941 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 32.8 m-85 -95.36 155.95 16.53 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.994 0.918 . . . . 74.43 109.334 167.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.9 tp -133.57 104.89 6.58 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.135 -0.353 . . . . 72.2 110.075 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 16' ' ' VAL . 34.4 t -74.99 89.35 2.4 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.883 . . . . 74.25 108.617 169.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 22.5 t70 -74.86 92.09 2.5 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.659 1.184 . . . . 62.01 111.582 -173.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB1' ' HA3' ' A' ' 20' ' ' GLY . . . -96.05 148.4 34.46 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.256 0.623 . . . . 70.35 111.355 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.42 -21.75 66.2 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.985 2.457 . . . . 73.41 113.625 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.525 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 86.1 mm-40 -112.57 -51.44 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.25 0.62 . . . . 74.13 112.147 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.45 97.41 3.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.728 0.411 . . . . 74.02 111.467 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -85.09 141.9 29.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.298 0.639 . . . . 75.22 110.706 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -130.26 131.97 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.055 0.542 . . . . 71.21 112.191 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.73 131.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.506 1.122 . . . . 71.23 109.93 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 39.8 m-85 -100.79 111.26 23.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.388 0.675 . . . . 73.11 110.772 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.33 93.56 7.18 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.786 -1.19 . . . . 71.24 107.786 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.0 119.94 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.126 0.57 . . . . 72.44 110.684 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.1 p -118.4 112.22 19.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.526 0.731 . . . . 55.22 110.411 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 6' ' ' SER . 44.7 t -86.08 107.21 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 121.287 0.565 . . . . 72.4 109.492 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.4 -171.21 2.54 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.637 1.175 . . . . 64.13 110.103 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . 31.2 tt0 60.09 63.41 3.08 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 124.056 0.942 . . . . 65.24 111.944 166.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.574 2.519 0 C-N-CA 122.69 2.26 . . . . 71.4 114.491 -166.157 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.869 0.366 . . . . 71.32 111.206 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -83.72 85.89 7.22 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.935 0.894 . . . . 43.45 110.37 -170.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.587 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 40.6 mtm180 -84.53 144.74 28.48 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.772 0.829 . . . . 70.3 112.098 -170.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 74.9 t -139.58 133.83 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.175 0.99 . . . . 74.42 110.604 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -101.14 145.86 28.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.504 0.722 . . . . 70.21 110.85 171.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 163.25 32.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.064 0.546 . . . . 73.15 111.65 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 81' ' ' GLU . 23.7 p -98.24 146.04 30.86 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 123.676 0.79 . . . . 72.04 111.608 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.16 92.07 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.051 2.5 . . . . 62.14 112.022 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.16 -14.92 5.38 Favored Glycine 0 N--CA 1.477 1.399 0 CA-C-N 115.617 -0.719 . . . . 35.34 113.24 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.71 149.34 18.52 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-O 119.504 -0.609 . . . . 74.03 112.066 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.02 131.09 44.83 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.845 0.823 . . . . 75.42 111.74 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 77' ' ' VAL . 55.6 tp -78.83 98.28 6.27 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.778 -0.646 . . . . 61.53 109.747 172.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -101.51 109.67 21.53 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 110.077 -0.342 . . . . 74.15 110.077 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.0 103.5 15.8 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.311 -0.626 . . . . 63.25 109.311 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 t -92.43 101.45 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.769 -0.826 . . . . 73.32 108.769 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.54 HG12 ' HG ' ' A' ' 18' ' ' LEU . 12.1 t -101.63 130.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.166 0.586 . . . . 54.22 111.565 -168.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.0 45.58 1.77 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.752 0.821 . . . . 43.23 110.753 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.54 ' HG ' HG12 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.4 178.04 0.11 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 113.479 0.918 . . . . 52.41 113.479 169.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 m -87.41 24.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.615 0.766 . . . . 73.05 112.534 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.24 90.85 0.55 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 119.395 -0.669 . . . . 43.42 112.197 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.38 127.95 14.79 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.031 2.487 . . . . 73.21 113.547 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 -111.59 4.3 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.353 -0.385 . . . . 72.43 113.319 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 -82.99 0.31 Allowed Glycine 0 CA--C 1.547 2.061 0 CA-C-O 119.121 -0.822 . . . . 71.4 113.744 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HG2' HH22 ' A' ' 26' ' ' ARG . 90.7 Cg_endo -73.99 148.16 91.28 Favored 'Cis proline' 0 C--N 1.382 2.308 0 CA-C-N 120.778 2.289 . . . . 54.32 113.041 1.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.633 HG11 ' SG ' ' A' ' 66' ' ' CYS . 86.9 t -62.63 136.92 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.57 0.748 . . . . 73.42 111.681 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.536 HH22 ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -97.73 128.98 44.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.421 0.688 . . . . 74.1 109.762 -177.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -97.57 136.41 38.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.107 0.563 . . . . 65.41 111.102 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 88.0 m-85 -133.14 147.97 52.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.028 0.931 . . . . 74.2 110.516 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 28.3 tptp -136.36 133.38 36.74 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.422 1.089 . . . . 72.5 108.945 165.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.85 17.62 11.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.217 1.007 . . . . 63.33 112.259 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.01 86.69 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 113.753 0.261 . . . . 71.3 113.753 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -117.05 135.11 53.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.436 0.694 . . . . 71.41 109.777 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.85 151.86 17.11 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 113.257 0.836 . . . . 63.55 113.257 -176.066 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 29' ' ' LYS . 21.5 mt -98.18 163.59 12.67 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.347 0.594 . . . . 64.34 111.204 171.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.53 151.9 49.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.128 0.971 . . . . 64.32 109.729 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 77.6 p -79.29 98.39 6.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.843 0.457 . . . . 73.04 110.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -102.75 -78.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.95 -0.469 . . . . 54.12 110.925 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.42 -59.66 0.01 OUTLIER Glycine 0 N--CA 1.472 1.071 0 N-CA-C 111.563 -0.615 . . . . 72.4 111.563 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -70.04 -44.28 69.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.247 0.619 . . . . 71.54 110.412 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.7 t -82.53 99.03 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.237 0.615 . . . . 70.25 109.428 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.3 mt-30 -95.2 110.6 22.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.538 0.735 . . . . 74.31 110.148 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 54.9 mt -106.31 111.99 24.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.914 0.486 . . . . 63.23 111.206 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.4 tp10 -94.98 106.29 18.27 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.659 1.184 . . . . 64.34 110.098 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.35 103.76 16.37 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.939 0.496 . . . . 54.54 109.926 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 48' ' ' ARG . . . -125.02 -164.03 1.24 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.385 0.674 . . . . 73.51 110.595 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.67 -89.29 0.14 Allowed Glycine 0 C--N 1.353 1.503 0 N-CA-C 112.586 -0.206 . . . . 34.52 112.586 172.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.36 -27.35 24.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.367 0.667 . . . . 70.45 112.102 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 62.6 ttp180 -90.04 87.99 7.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.332 0.653 . . . . 60.41 111.669 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -91.75 129.2 37.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.462 -0.57 . . . . 74.51 109.462 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 33.5 t -130.31 110.92 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-O 120.811 0.339 . . . . 54.44 111.582 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -100.25 113.86 26.86 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.775 0.83 . . . . 71.44 108.807 168.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 72.5 mtp180 -111.34 107.77 17.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.029 0.532 . . . . 75.34 110.404 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 57.6 t -88.0 95.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.22 -0.659 . . . . 64.25 109.22 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.24 121.29 9.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.763 0.825 . . . . 60.12 112.241 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 60.35 8.14 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 123.205 0.316 . . . . 73.11 113.636 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.98 110.55 14.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.523 0.729 . . . . 74.21 112.623 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -171.75 3.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.368 0.667 . . . . 74.44 111.26 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m -61.66 -26.28 67.92 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.991 0.737 . . . . 62.1 112.991 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.92 73.28 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.565 -0.289 . . . . 54.12 113.761 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.15 0.1 57.34 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.038 0.935 . . . . 74.24 112.35 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -77.33 101.32 6.26 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.178 0.591 . . . . 52.22 109.912 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.43 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -167.62 -175.25 37.34 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 114.228 0.451 . . . . 60.44 114.228 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -89.21 108.86 19.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.122 0.569 . . . . 72.44 110.575 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -98.62 112.32 24.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.397 0.679 . . . . 73.13 109.758 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 38.1 tp -91.43 104.34 16.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.457 0.646 . . . . 63.31 110.336 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.633 ' SG ' HG11 ' A' ' 25' ' ' VAL . 51.3 t -85.7 86.33 7.37 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.738 -0.838 . . . . 54.05 108.738 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.09 105.88 13.54 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.299 -0.864 . . . . 55.23 110.204 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -113.9 160.33 32.58 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.285 0.634 . . . . 32.12 111.959 -174.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.78 120.45 8.36 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.587 2.192 . . . . 74.33 112.351 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 75.53 -60.92 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.526 1.53 . . . . 74.21 112.387 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 38.4 t70 -105.68 98.91 8.54 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.282 0.633 . . . . 73.43 111.872 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 t -95.01 129.52 42.05 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.921 0.889 . . . . 73.43 111.196 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -119.03 131.05 55.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.412 0.685 . . . . 50.33 112.344 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.46 135.55 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.857 -0.794 . . . . 61.35 108.857 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.414 ' CZ ' HG22 ' A' ' 16' ' ' VAL . 4.8 m-85 -106.2 103.39 12.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.512 0.725 . . . . 71.03 109.747 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.587 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 78.9 mt -78.08 92.87 4.42 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.944 -0.761 . . . . 62.31 108.944 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.507 HG21 HD21 ' A' ' 12' ' ' LEU . 55.6 t -87.77 132.88 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.554 -0.748 . . . . 71.35 110.774 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.0 m -134.56 109.23 8.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.618 -0.719 . . . . 75.23 110.798 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.409 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 76.6 t -89.08 106.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 107.985 -1.117 . . . . 64.35 107.985 173.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.57 12.06 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 113.565 0.95 . . . . 64.55 113.565 -167.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 7' ' ' THR . 34.7 tt0 -125.71 100.4 31.32 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.781 -0.628 . . . . 74.51 109.55 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 CA--C 1.568 2.18 0 C-N-CA 123.43 2.753 . . . . 71.31 114.255 -178.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.561 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 49.7 tpp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.135 -0.321 . . . . 42.43 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 p -65.22 93.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.37 0.668 . . . . 45.41 112.045 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -90.93 129.57 36.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 71.03 110.344 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 78.0 t -131.27 138.34 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 124.062 0.945 . . . . 63.32 110.007 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -106.45 130.28 54.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.206 0.602 . . . . 71.42 110.82 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.438 ' HB3' HG22 ' A' ' 79' ' ' VAL . 37.0 t -112.99 171.76 7.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.636 0.774 . . . . 51.33 111.626 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 81' ' ' GLU . 22.5 p -120.81 138.2 27.37 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 113.453 0.909 . . . . 62.13 113.453 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.8 Cg_endo -77.49 91.09 1.2 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.605 2.87 . . . . 74.51 112.734 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.74 -13.58 8.65 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.221 -0.9 . . . . 71.21 112.23 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.81 -137.39 8.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.495 -0.058 . . . . 63.12 113.015 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -149.88 150.71 32.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.243 0.617 . . . . 71.4 111.135 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.88 148.24 23.96 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.527 0.731 . . . . 74.34 110.795 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.01 109.73 5.01 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.453 0.701 . . . . 74.52 110.043 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 79.7 mt -106.48 101.58 11.03 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.384 -0.599 . . . . 73.24 109.384 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.6 114.81 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.724 -0.843 . . . . 70.31 108.724 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.48 HG12 ' HG ' ' A' ' 18' ' ' LEU . 6.9 t -103.24 138.97 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.364 0.666 . . . . 75.01 111.576 -166.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -132.23 30.07 4.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.549 0.74 . . . . 63.13 110.917 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.48 ' HG ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -54.77 158.89 2.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.193 0.812 . . . . 72.44 113.193 171.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -90.83 48.31 1.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.175 0.59 . . . . 73.24 111.093 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.91 128.25 8.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.983 -0.898 . . . . 73.03 112.69 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.34 89.92 0.26 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.991 2.461 . . . . 74.15 113.753 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.49 -84.15 0.1 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.905 -0.589 . . . . 75.51 114.346 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.41 -173.68 44.79 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.631 -0.538 . . . . 72.34 113.269 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.33 114.33 3.29 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 119.586 1.693 . . . . 65.42 112.814 -4.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.67 120.93 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 109.369 -0.604 . . . . 71.14 109.369 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 50.0 mtt180 -95.38 164.99 12.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.386 1.074 . . . . 73.32 110.904 -173.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -128.46 130.67 47.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.052 0.941 . . . . 72.4 109.985 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.784 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 97.9 m-85 -123.35 164.64 18.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.754 0.822 . . . . 75.4 110.81 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 19.3 tptm -154.3 125.64 7.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.566 0.746 . . . . 70.02 110.05 174.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.09 17.15 9.92 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.187 0.995 . . . . 71.2 111.333 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.06 -31.07 5.44 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.752 -0.471 . . . . 72.24 114.237 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.32 147.06 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.091 0.946 . . . . 74.21 112.614 -170.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.93 153.03 30.39 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 74.32 115.249 -167.013 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.5 154.94 18.13 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.753 0.821 . . . . 73.32 111.17 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.82 148.54 51.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.421 1.088 . . . . 64.35 109.021 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 t -58.78 97.48 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.383 0.673 . . . . 61.22 110.747 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -136.05 84.23 2.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.753 0.821 . . . . 63.21 110.732 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.77 -88.65 0.02 OUTLIER Glycine 0 N--CA 1.478 1.467 0 CA-C-N 115.336 -0.847 . . . . 61.12 114.424 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.253 1.021 . . . . 72.33 111.003 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.03 104.83 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.382 0.673 . . . . 64.32 109.672 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 74.1 mt-30 -109.86 119.3 38.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.13 0.972 . . . . 75.33 110.354 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.65 137.38 46.69 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.469 0.707 . . . . 63.32 112.013 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 15.2 tp10 -133.36 102.3 5.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.534 1.134 . . . . 74.2 109.369 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -101.9 104.05 14.75 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.421 0.629 . . . . 65.22 111.361 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.15 75.74 1.64 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.61 0.764 . . . . 75.24 110.331 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.58 -117.15 6.93 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 115.877 -0.601 . . . . 64.31 112.783 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.85 -21.99 27.78 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.45 0.7 . . . . 63.14 111.125 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.92 91.0 1.5 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.743 0.817 . . . . 73.51 110.155 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -102.93 139.14 38.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.616 0.767 . . . . 54.51 110.068 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 99.7 t -129.16 124.91 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.841 0.353 . . . . 54.35 110.664 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -117.09 122.91 45.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.09 0.956 . . . . 75.11 108.66 170.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.548 HH11 ' HB3' ' A' ' 52' ' ' ARG . 0.8 OUTLIER -119.57 134.84 55.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.493 0.717 . . . . 74.31 109.972 176.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.46 98.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.097 -0.705 . . . . 63.43 109.097 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.74 115.39 16.46 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.61 -0.723 . . . . 63.32 110.846 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.18 52.95 1.3 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-O 120.881 0.156 . . . . 75.21 113.089 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.32 160.89 30.47 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.666 0.786 . . . . 72.1 111.794 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 29.9 ttm180 -166.97 -55.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.991 0.516 . . . . 73.33 111.495 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -147.64 -47.43 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 122.855 0.462 . . . . 74.22 111.382 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.48 -17.13 59.43 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.778 0.671 . . . . 42.23 114.778 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.407 ' HB3' HG21 ' A' ' 79' ' ' VAL . 30.7 t70 -72.22 -27.48 62.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.024 0.93 . . . . 72.02 112.186 174.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -72.95 103.74 3.85 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 72.3 111.514 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . -177.0 -173.5 42.61 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.85 -0.614 . . . . 74.25 113.659 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -90.58 117.13 29.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.78 0.432 . . . . 72.21 110.039 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 66.8 m-85 -102.27 106.33 17.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.879 0.872 . . . . 73.32 110.55 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 63.4 tp -91.94 102.08 14.64 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.028 -0.42 . . . . 72.03 110.242 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -79.34 87.18 5.02 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.771 -0.826 . . . . 73.23 108.771 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 17.5 t70 -76.04 130.54 38.53 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.764 0.826 . . . . 65.53 111.275 -173.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.599 ' HB3' ' H ' ' A' ' 72' ' ' SER . . . -127.77 143.83 49.04 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 118.664 -0.684 . . . . 61.33 110.393 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.56 -29.49 7.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 124.248 3.299 . . . . 73.44 115.099 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -152.32 66.74 0.83 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.632 0.773 . . . . 74.11 109.494 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 28.9 t70 -172.42 -80.2 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 123.917 0.887 . . . . 71.13 110.709 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.599 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 40.0 m 65.46 106.24 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.052 1.341 . . . . 71.11 112.548 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.15 135.15 49.17 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.818 0.847 . . . . 72.41 110.938 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.561 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 64.6 mt -100.96 119.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.961 0.504 . . . . 71.2 110.804 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 2' ' ' THR . 29.3 m-85 -100.34 101.81 12.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.286 0.634 . . . . 72.34 110.631 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.0 mt -81.88 93.84 6.97 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.317 -0.623 . . . . 73.43 109.317 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 75.5 t -98.12 121.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.69 0.796 . . . . 50.33 111.269 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.2 p -121.46 116.64 25.1 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 73.41 111.371 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.9 t -83.81 110.6 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.316 -0.624 . . . . 73.4 109.316 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -151.57 -41.63 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.589 0.588 . . . . 65.01 112.589 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 7' ' ' THR . 10.8 tp10 -66.8 106.03 1.03 Allowed Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.93 0.892 . . . . 73.22 110.607 -175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo . . . . . 0 CA--C 1.57 2.295 0 C-N-CA 123.078 2.519 . . . . 74.41 113.747 -172.759 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 110.158 -0.312 . . . . 65.51 110.158 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.1 m -80.38 83.92 6.12 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.536 0.735 . . . . 75.4 110.061 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.594 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 55.4 mtm180 -83.67 140.41 32.17 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.548 0.739 . . . . 74.04 112.342 -172.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.01 144.0 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.06 0.944 . . . . 71.14 109.97 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.94 145.28 51.98 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.455 0.702 . . . . 65.22 110.848 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.7 t -146.85 171.66 14.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.907 0.883 . . . . 73.1 110.31 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -76.03 148.87 82.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 112.982 0.734 . . . . 71.42 112.982 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.16 110.87 3.19 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.391 2.727 . . . . 73.4 112.907 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.47 -7.73 43.29 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.318 -0.855 . . . . 73.14 112.981 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.67 -156.67 31.53 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 122.767 0.222 . . . . 64.2 113.174 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 164.41 23.48 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.874 0.47 . . . . 61.44 110.502 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.494 HD21 HG11 ' A' ' 77' ' ' VAL . 47.5 tp -135.58 110.95 9.07 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.623 -0.51 . . . . 62.23 109.623 167.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.11 110.75 15.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.068 -0.345 . . . . 71.1 110.068 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.7 mt -89.41 104.72 17.25 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.679 -0.86 . . . . 74.22 108.679 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.76 107.65 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.445 -0.946 . . . . 42.3 108.445 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.431 HG12 ' HG ' ' A' ' 18' ' ' LEU . 16.0 t -115.35 129.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.384 0.674 . . . . 41.44 111.116 -170.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -140.82 43.71 1.83 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.711 0.804 . . . . 71.21 110.489 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.431 ' HG ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -58.71 167.52 1.49 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.464 0.706 . . . . 73.43 112.55 170.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -59.77 -49.1 79.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.862 0.465 . . . . 75.45 111.145 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.0 66.0 1.82 Allowed Glycine 0 C--N 1.356 1.668 0 N-CA-C 115.544 0.978 . . . . 64.2 115.544 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.24 97.02 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.669 2.246 . . . . 74.33 112.682 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.0 -154.33 22.4 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.797 -0.638 . . . . 74.11 113.079 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.24 -179.82 41.42 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.584 -0.564 . . . . 62.23 113.039 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.9 156.72 97.63 Favored 'Cis proline' 0 C--N 1.376 1.99 0 CA-C-N 119.791 1.796 . . . . 74.21 113.99 -4.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.87 130.23 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 123.504 0.722 . . . . 73.34 109.534 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -104.31 147.39 27.56 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.073 0.949 . . . . 72.41 111.232 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -104.96 132.41 51.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.993 0.517 . . . . 74.15 111.106 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.5 m-85 -126.84 165.36 19.49 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.493 1.117 . . . . 72.14 110.387 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -152.35 114.83 4.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.805 0.842 . . . . 73.23 110.05 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 t70 72.64 -27.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.653 1.581 . . . . 52.0 113.965 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.03 -11.17 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.138 0.399 . . . . 71.4 112.784 -172.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -129.45 138.47 51.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.256 0.623 . . . . 75.23 110.739 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.747 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.67 150.95 26.12 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.938 0.895 . . . . 71.41 112.692 177.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.08 134.28 34.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.879 0.472 . . . . 75.23 110.563 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.07 163.32 12.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.817 0.847 . . . . 70.34 110.383 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 p -68.74 89.38 0.39 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.601 0.715 . . . . 71.2 110.854 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 46.9 tt0 -99.1 164.79 12.02 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.42 1.088 . . . . 72.35 109.935 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.12 -40.09 90.92 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 113.52 0.168 . . . . 74.44 113.52 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -77.98 -54.34 6.4 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.157 0.583 . . . . 73.11 110.485 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 66.9 t -82.46 86.77 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 124.086 0.954 . . . . 65.31 111.63 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 37.8 mt-30 -80.25 133.34 35.98 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.926 0.89 . . . . 74.32 110.822 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.7 mt -118.95 154.67 32.64 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.102 0.561 . . . . 70.54 112.131 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.624 ' HG3' HH12 ' A' ' 52' ' ' ARG . 39.8 mt-10 -126.46 113.83 17.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.235 1.014 . . . . 64.43 110.58 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -94.01 114.9 27.18 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.684 0.794 . . . . 65.34 110.691 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.88 -68.23 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.765 0.426 . . . . 71.31 111.596 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.59 139.08 6.02 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 119.19 -0.783 . . . . 44.13 111.38 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 64.15 -69.87 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.235 1.014 . . . . 55.03 110.488 -165.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -71.41 116.59 11.92 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.25 0.547 . . . . 64.43 110.286 166.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -134.13 133.79 41.47 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.075 1.35 . . . . 71.04 108.269 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -136.53 117.14 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 121.775 -0.578 . . . . 74.11 110.374 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -101.77 123.92 46.54 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.248 1.019 . . . . 73.22 109.136 172.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.624 HH12 ' HG3' ' A' ' 43' ' ' GLU . 1.5 mpp_? -116.19 108.02 15.61 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.184 0.594 . . . . 75.42 110.799 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.432 HG23 HD11 ' A' ' 51' ' ' LEU . 76.2 t -96.67 96.71 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.271 -0.64 . . . . 75.51 109.271 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.24 129.18 38.22 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.469 0.708 . . . . 71.31 110.987 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.47 40.34 33.09 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.151 0.306 . . . . 72.34 112.891 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 131.87 36.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.137 0.975 . . . . 42.45 112.265 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -156.75 -84.47 0.05 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.239 0.616 . . . . 73.24 110.768 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.1 t -92.45 121.9 34.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.623 0.769 . . . . 61.44 110.547 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.3 -31.7 5.3 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.531 -0.304 . . . . 62.14 112.732 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.2 -29.21 60.26 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.088 0.955 . . . . 74.2 111.435 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.15 113.67 10.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.23 -0.655 . . . . 62.34 109.23 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.12 -170.22 43.32 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 123.123 0.264 . . . . 73.42 113.242 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -89.16 114.26 25.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.0 0.52 . . . . 74.4 111.126 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 46.5 m-85 -96.77 154.34 17.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.742 0.817 . . . . 73.13 109.797 171.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.4 tp -132.88 105.13 6.94 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.687 0.395 . . . . 64.31 110.759 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.73 87.93 6.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.226 -1.027 . . . . 51.35 108.226 169.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.74 95.24 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.796 -1.093 . . . . 64.12 110.907 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -100.99 145.67 30.81 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.466 0.706 . . . . 54.42 110.644 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.206 2.604 . . . . 75.33 113.19 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 61.09 35.02 18.88 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.51 1.124 . . . . 52.14 112.335 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 12.6 t70 -140.79 -83.06 0.23 Allowed 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 123.628 0.771 . . . . 70.14 109.726 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.9 m 56.73 103.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.701 1.371 . . . . 74.43 114.701 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -107.1 135.54 48.47 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.201 0.6 . . . . 75.14 111.815 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.39 138.95 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.114 0.965 . . . . 54.21 109.225 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.8 m-85 -115.91 104.1 11.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.586 1.155 . . . . 74.35 109.546 -174.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.594 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 73.9 mt -78.35 91.28 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.944 -1.132 . . . . 72.3 107.944 171.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.494 HG11 HD21 ' A' ' 12' ' ' LEU . 82.0 t -99.16 119.64 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 115.344 -0.844 . . . . 72.3 110.884 -175.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.4 p -112.94 108.07 16.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.828 0.851 . . . . 74.01 110.037 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.0 t -95.56 104.28 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.309 -0.997 . . . . 54.23 108.309 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -173.82 -165.43 0.25 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.516 1.126 . . . . 73.24 108.893 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 64.55 82.34 0.21 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.674 0.79 . . . . 50.41 109.45 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 C--N 1.384 2.403 0 C-N-CA 123.359 2.706 . . . . 71.11 114.029 -171.965 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.645 -0.502 . . . . 55.04 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 33.3 m -83.23 106.86 15.35 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.911 0.484 . . . . 61.04 110.595 -172.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -112.44 145.24 40.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.781 0.832 . . . . 73.2 110.908 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.1 t -138.22 137.55 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 123.636 0.775 . . . . 72.24 110.68 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -113.55 138.84 49.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.387 0.675 . . . . 74.22 110.4 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.1 t -129.95 166.02 20.92 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.502 0.721 . . . . 73.12 110.575 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.2 p -83.28 148.83 56.92 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.237 0.615 . . . . 62.12 112.208 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -78.78 75.14 5.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.308 2.672 . . . . 73.42 113.206 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.77 -32.4 0.21 Allowed Glycine 0 C--N 1.342 0.861 0 CA-C-N 115.455 -0.793 . . . . 75.44 113.159 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.51 -138.1 3.9 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.885 0.314 . . . . 72.0 113.885 -174.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.51 140.08 49.48 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.028 0.531 . . . . 75.33 109.926 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 HG11 ' A' ' 77' ' ' VAL . 55.3 tp -85.74 99.87 11.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.201 0.6 . . . . 62.13 110.021 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.66 103.15 13.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.116 0.567 . . . . 71.43 110.279 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 51' ' ' LEU . 45.0 mt -96.1 102.72 14.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.303 0.641 . . . . 73.42 110.383 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.77 115.58 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.367 0.667 . . . . 71.14 109.711 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -99.35 138.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-O 121.022 0.439 . . . . 74.23 110.068 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -104.63 38.06 1.98 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.894 0.878 . . . . 74.5 109.973 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 73' ' ' ARG . 17.2 mt -53.73 -40.12 65.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.96 1.304 . . . . 60.24 112.334 173.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 t 62.75 19.99 11.8 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.358 1.063 . . . . 54.4 111.811 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.75 135.36 14.61 Favored Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.911 -0.939 . . . . 53.3 112.167 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.19 89.37 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.125 2.55 . . . . 72.15 114.017 -173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.9 -95.11 0.26 Allowed Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.639 -0.71 . . . . 50.23 113.853 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 69' ' ' PRO . . . 121.67 -89.48 0.43 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-O 119.155 -0.803 . . . . 74.05 113.082 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.66 145.13 82.23 Favored 'Cis proline' 0 C--N 1.379 2.183 0 CA-C-N 120.266 2.033 . . . . 73.12 113.859 4.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 68' ' ' ALA . 75.8 t -65.93 129.69 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.4 -0.818 . . . . 63.2 110.882 173.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.466 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 99.2 mtt180 -96.41 127.66 42.61 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.342 -0.614 . . . . 51.55 109.342 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -98.31 131.59 44.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.02 0.528 . . . . 72.44 110.014 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.722 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 84.2 m-85 -126.0 136.66 53.24 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.854 0.862 . . . . 65.41 109.809 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' A' ' 64' ' ' TYR . 17.3 tptm -104.81 116.86 32.73 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.821 0.848 . . . . 74.34 108.994 171.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.71 -59.51 0.53 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.773 1.629 . . . . 71.12 111.13 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 32' ' ' GLU . . . -164.79 -9.93 0.03 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 123.867 0.746 . . . . 61.22 112.355 172.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 31' ' ' GLY . 44.6 tt0 -106.2 135.26 47.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.716 0.807 . . . . 70.51 110.667 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.49 152.82 20.88 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.072 1.138 . . . . 75.21 114.072 -171.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -86.3 161.42 18.75 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.62 -0.718 . . . . 72.32 110.309 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.51 106.33 5.92 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.916 0.886 . . . . 54.42 109.637 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 p -63.91 99.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.655 0.782 . . . . 72.34 111.307 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -124.7 -65.04 1.06 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.468 0.707 . . . . 75.3 111.565 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.09 -64.9 0.01 OUTLIER Glycine 0 N--CA 1.478 1.438 0 N-CA-C 112.748 -0.141 . . . . 32.23 112.748 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -67.3 -58.97 3.83 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.979 -0.749 . . . . 72.22 108.979 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.9 t -72.91 124.04 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.713 -1.131 . . . . 74.33 110.47 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -135.34 113.83 11.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.223 1.009 . . . . 72.52 109.525 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -97.53 108.25 20.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.6 0.76 . . . . 72.13 110.52 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.7 tm-20 -98.33 108.29 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.59 1.156 . . . . 54.34 109.474 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -99.5 102.22 13.7 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.532 0.733 . . . . 65.11 109.354 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.78 -29.63 17.5 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.232 0.613 . . . . 71.05 112.207 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 -42.41 1.6 Allowed Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.789 0.233 . . . . 25.03 112.528 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.17 -28.26 7.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.756 0.822 . . . . 74.34 110.192 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -105.92 141.3 37.56 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.279 1.032 . . . . 71.24 111.166 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HG3' HG21 ' A' ' 25' ' ' VAL . 84.3 mm-40 -125.2 128.34 48.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.778 0.831 . . . . 63.45 109.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 39.3 t -129.58 110.59 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 112.252 0.464 . . . . 52.51 112.252 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -93.98 112.81 24.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.084 -0.71 . . . . 73.53 109.084 168.564 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 67.4 mtp180 -106.52 119.59 39.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.216 0.606 . . . . 71.24 110.223 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.25 102.24 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.274 0.629 . . . . 72.45 109.492 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -74.9 131.93 41.08 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.231 0.613 . . . . 73.22 111.27 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.5 5.35 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 116.015 -0.538 . . . . 70.04 112.29 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.38 114.81 25.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.992 0.917 . . . . 65.01 112.242 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.23 -80.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.13 0.972 . . . . 73.31 112.262 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.2 p -101.22 -76.65 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.415 0.686 . . . . 53.2 112.439 -163.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 -6.29 58.29 Favored Glycine 0 C--N 1.356 1.689 0 N-CA-C 114.142 0.417 . . . . 64.14 114.142 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.38 -24.05 63.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.295 1.038 . . . . 73.34 111.322 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.617 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -73.49 128.4 35.39 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.667 0.787 . . . . 74.43 109.608 172.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.0 178.78 39.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.67 -0.3 . . . . 65.41 113.344 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -84.73 115.88 22.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.599 0.36 . . . . 61.23 110.478 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' CZ ' ' HD3' ' A' ' 29' ' ' LYS . 50.1 m-85 -102.08 123.19 45.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.132 0.492 . . . . 65.15 110.966 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 58.8 tp -94.12 100.71 12.76 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.748 0.819 . . . . 60.12 109.471 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 16' ' ' VAL . 46.2 t -90.34 88.08 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.622 0.725 . . . . 52.24 109.658 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.4 t70 -72.09 94.87 1.56 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.48 1.112 . . . . 75.45 111.485 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -76.46 163.11 68.13 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.543 1.137 . . . . 63.31 113.058 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.528 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 77.7 Cg_endo -75.22 -4.22 15.03 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.569 2.18 . . . . 74.14 113.892 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -117.63 -56.17 2.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.457 0.703 . . . . 74.05 110.972 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.21 119.56 5.53 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.346 0.659 . . . . 71.31 110.011 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.407 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 35.7 t -62.35 128.08 34.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.551 0.741 . . . . 74.21 111.924 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -107.37 147.15 30.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.48 0.712 . . . . 75.41 111.136 -177.36 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.82 146.96 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.225 0.61 . . . . 74.3 110.337 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.622 ' HB3' HG23 ' A' ' 77' ' ' VAL . 10.7 m-85 -107.47 139.03 42.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.841 1.256 . . . . 74.23 110.893 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.11 93.77 4.87 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.599 -1.259 . . . . 61.23 107.599 162.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 75' ' ' PHE . 78.8 t -101.02 132.2 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.688 -0.687 . . . . 54.24 111.356 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 76.7 p -127.17 124.54 39.27 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.154 0.982 . . . . 71.34 108.987 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.617 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 39.5 t -104.43 105.2 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.012 -1.107 . . . . 62.1 108.012 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.93 -168.39 0.66 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.923 1.289 . . . . 72.12 109.618 -170.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 62.53 85.8 0.16 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 123.849 0.86 . . . . 54.11 109.786 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.572 2.422 0 C-N-CA 123.131 2.554 . . . . 73.43 113.235 -174.769 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.463 ' SD ' HD11 ' A' ' 76' ' ' LEU . 62.9 mtt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.517 0.199 . . . . 75.24 110.591 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 m -102.58 88.46 3.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.908 0.883 . . . . 35.12 110.097 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.604 ' HG3' ' HB2' ' A' ' 76' ' ' LEU . 3.8 mpt_? -78.35 138.58 38.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.503 0.721 . . . . 54.33 111.966 -172.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 91.6 t -140.91 134.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.161 0.984 . . . . 64.24 109.663 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -90.68 145.28 24.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.098 0.559 . . . . 65.52 110.401 176.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB2' HD13 ' A' ' 12' ' ' LEU . 41.0 t -127.91 159.73 34.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.212 0.605 . . . . 74.44 111.848 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 81' ' ' GLU . 18.2 p -112.95 150.67 43.22 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 124.603 1.161 . . . . 54.53 111.529 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.43 98.49 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.272 2.648 . . . . 72.14 113.682 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.81 -14.33 22.02 Favored Glycine 0 N--CA 1.479 1.514 0 CA-C-N 116.006 -0.543 . . . . 42.01 114.245 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.53 -143.17 3.89 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 117.54 0.67 . . . . 74.12 113.764 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.08 127.0 37.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.153 0.581 . . . . 64.13 111.024 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.9 tp -77.64 123.6 26.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.45 0.7 . . . . 54.51 110.022 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -115.87 112.65 22.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.199 0.454 . . . . 73.0 109.891 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 51' ' ' LEU . 79.0 mt -91.75 101.64 14.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.409 -0.589 . . . . 65.12 109.409 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.59 108.03 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 108.842 -0.799 . . . . 74.14 108.842 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 18' ' ' LEU . 6.1 t -98.63 113.53 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.572 0.349 . . . . 61.41 110.863 -169.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -90.2 33.85 0.88 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 122.944 0.498 . . . . 71.11 111.672 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' H ' HG12 ' A' ' 16' ' ' VAL . 9.9 mt -51.07 155.93 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.327 1.051 . . . . 74.43 111.866 164.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 t -75.28 74.14 2.39 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.691 -0.855 . . . . 72.42 108.691 167.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.52 119.48 16.52 Favored Glycine 0 CA--C 1.541 1.696 0 CA-C-N 115.48 -0.782 . . . . 72.03 114.415 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.6 29.97 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.818 2.346 . . . . 73.34 112.895 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -59.42 4.9 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.876 0.274 . . . . 64.52 112.441 -174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.01 174.69 24.44 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.759 -0.467 . . . . 55.42 112.719 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.27 148.04 28.46 Favored 'Cis proline' 0 CA--C 1.559 1.736 0 CA-C-N 119.147 1.474 . . . . 72.35 113.571 -4.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' SG ' ' A' ' 66' ' ' CYS . 85.4 t -114.57 136.42 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.223 0.609 . . . . 62.3 109.695 174.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -98.25 128.17 44.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 74.22 110.586 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.414 ' HB3' HD23 ' A' ' 34' ' ' LEU . 77.4 m95 -99.39 143.3 29.8 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.399 0.68 . . . . 74.23 110.76 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 93.3 m-85 -135.45 124.25 23.95 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.426 0.691 . . . . 72.02 110.725 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.9 tptp -118.51 132.45 56.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.281 0.632 . . . . 73.2 109.431 172.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.3 26.09 15.97 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.816 0.846 . . . . 71.51 111.51 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -2.06 86.36 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 114.941 0.737 . . . . 72.51 114.941 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -125.01 144.29 50.47 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.531 1.166 . . . . 72.4 111.367 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.68 152.66 43.7 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.053 1.131 . . . . 73.41 114.053 -172.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.444 ' HB3' HG11 ' A' ' 40' ' ' VAL . 3.9 mm? -88.85 162.02 16.39 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.837 0.855 . . . . 55.3 111.397 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.16 107.5 4.38 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.05 0.94 . . . . 13.34 110.164 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 p -66.42 91.94 0.19 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.692 0.797 . . . . 75.11 112.251 -176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -139.94 -73.3 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.267 0.627 . . . . 73.51 111.131 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -94.4 1.75 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 122.684 0.183 . . . . 41.52 113.141 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -70.18 -32.36 70.25 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.474 0.31 . . . . 63.34 111.495 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 34' ' ' LEU . 87.2 t -81.86 120.27 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.44 0.696 . . . . 65.42 110.493 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 72.6 mt-30 -126.16 97.1 4.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.044 0.938 . . . . 74.25 109.392 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.1 152.38 23.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.28 0.562 . . . . 55.04 112.024 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.77 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.0 tm-20 -138.54 106.45 5.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 107.774 -1.195 . . . . 71.14 107.774 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -100.34 102.75 14.07 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.533 0.333 . . . . 72.2 110.152 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.37 3.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.791 0.836 . . . . 72.14 111.115 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.61 -72.82 0.65 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 116.356 -0.384 . . . . 33.2 113.318 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.6 19.97 12.62 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.728 0.811 . . . . 74.4 112.23 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -148.23 151.41 35.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.259 0.552 . . . . 73.04 112.182 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.1 155.45 38.36 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.143 0.977 . . . . 63.04 108.61 164.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 84.7 t -141.91 136.62 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.175 0.512 . . . . 73.51 110.432 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 14' ' ' LEU . 1.7 tm? -120.5 116.14 24.82 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.445 -0.946 . . . . 64.42 108.445 171.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 99.6 mtt180 -108.14 109.43 20.84 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.328 0.651 . . . . 62.24 111.349 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.3 t -88.42 98.08 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.985 0.514 . . . . 73.41 110.264 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.95 127.35 32.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.943 0.497 . . . . 62.34 109.974 168.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.77 33.69 15.21 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 112.675 -0.17 . . . . 23.53 112.675 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.71 110.87 2.95 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.763 0.825 . . . . 64.2 111.288 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -163.28 124.49 2.4 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.132 0.573 . . . . 65.15 109.95 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.539 ' H ' HG11 ' A' ' 79' ' ' VAL . 50.2 m 55.93 -82.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.305 1.442 . . . . 54.24 113.851 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.9 -7.24 55.41 Favored Glycine 0 C--N 1.363 2.043 0 N-CA-C 114.702 0.641 . . . . 74.02 114.702 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.69 -32.81 74.41 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.767 0.827 . . . . 71.43 111.618 170.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.679 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -67.82 100.68 0.96 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 72.03 111.286 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -166.65 -174.07 35.59 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.679 -0.691 . . . . 62.11 113.059 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -93.49 113.02 25.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.506 0.722 . . . . 64.31 110.536 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.684 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 49.2 m-85 -101.17 111.89 24.22 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.393 0.677 . . . . 70.34 109.947 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 72' ' ' SER . 61.0 tp -92.1 100.6 13.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 122.869 0.468 . . . . 75.13 110.122 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.418 ' SG ' HG11 ' A' ' 25' ' ' VAL . 37.8 t -79.0 86.09 4.89 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.926 0.87 . . . . 73.41 108.74 170.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -94.13 115.69 28.01 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.423 -1.262 . . . . 73.54 112.229 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.04 154.48 55.66 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.776 0.83 . . . . 61.42 109.36 171.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.48 -19.32 17.31 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.616 2.211 . . . . 71.41 113.003 171.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -76.35 -72.83 0.31 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.879 0.872 . . . . 64.53 110.92 170.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -139.25 144.12 38.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.834 0.854 . . . . 63.34 111.4 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 65' ' ' LEU . 51.5 p -112.4 109.32 18.86 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.916 0.886 . . . . 44.4 110.382 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.98 127.77 53.37 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.07 0.948 . . . . 74.41 110.987 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.32 128.43 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.574 0.75 . . . . 55.41 110.179 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 4.1 m-85 -102.2 111.18 23.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 61.44 110.15 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.604 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 78.9 mt -85.02 94.12 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 75.52 109.734 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.6 t -94.71 137.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.711 0.804 . . . . 74.02 110.639 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -137.17 111.26 8.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.141 0.576 . . . . 74.0 110.865 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.679 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 46.4 t -83.94 103.43 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.089 -1.078 . . . . 65.15 108.089 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.94 33.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.848 0.832 . . . . 70.22 110.978 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' O ' HG22 ' A' ' 7' ' ' THR . 10.1 tp10 -130.91 92.87 32.66 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 115.17 -0.923 . . . . 52.45 109.131 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo . . . . . 0 CA--C 1.571 2.342 0 C-N-CA 122.526 2.151 . . . . 53.12 113.197 -179.472 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.631 0.253 . . . . 73.44 111.004 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m -75.44 79.17 2.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.31 1.052 . . . . 61.24 109.746 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -92.55 131.63 37.51 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.512 -1.222 . . . . 73.33 111.971 -163.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.0 t -121.78 127.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.837 0.855 . . . . 72.42 110.694 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -93.2 142.89 26.8 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.729 0.812 . . . . 74.42 109.918 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -137.25 160.23 39.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.647 0.779 . . . . 60.31 110.968 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -96.16 148.46 34.55 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 123.686 0.795 . . . . 74.15 111.135 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 95.4 Cg_endo -72.9 128.36 13.14 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.131 2.554 . . . . 65.34 112.938 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.81 66.12 1.23 Allowed Glycine 0 C--N 1.357 1.748 0 CA-C-N 116.656 -0.247 . . . . 63.14 113.162 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.74 -115.73 0.38 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 113.439 0.136 . . . . 55.44 113.439 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -144.67 131.47 20.17 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.054 0.941 . . . . 73.34 109.731 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 65.3 tp -96.65 101.63 13.27 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.031 0.532 . . . . 74.43 110.092 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.18 112.08 24.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.905 0.482 . . . . 74.25 110.302 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.42 HD12 HD12 ' A' ' 51' ' ' LEU . 41.6 mt -108.17 103.93 13.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.887 0.875 . . . . 64.12 109.584 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' A' ' 48' ' ' ARG . 74.4 t -91.31 134.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.5 0.72 . . . . 63.12 109.34 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 49' ' ' GLN . 39.6 t -99.09 141.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 121.292 0.568 . . . . 72.2 111.678 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.57 -34.85 5.71 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.851 0.86 . . . . 75.34 110.876 166.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 73' ' ' ARG . 6.8 mt 63.52 178.07 0.16 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 123.857 0.863 . . . . 61.15 113.117 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 t -102.77 -24.72 13.7 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.992 -0.549 . . . . 74.44 110.144 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.54 103.38 0.83 Allowed Glycine 0 CA--C 1.543 1.819 0 CA-C-O 119.635 -0.536 . . . . 75.15 112.985 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.51 102.3 1.54 Allowed 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 122.798 2.332 . . . . 61.33 113.379 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.5 131.57 1.58 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 121.455 -0.402 . . . . 62.03 113.891 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.94 169.94 49.06 Favored Glycine 0 CA--C 1.547 2.087 0 CA-C-O 119.477 -0.624 . . . . 53.03 113.587 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.26 115.49 3.92 Favored 'Cis proline' 0 C--N 1.379 2.163 0 CA-C-N 120.079 1.939 . . . . 63.2 112.962 1.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.87 118.9 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 122.986 0.514 . . . . 74.24 109.967 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -99.96 146.54 26.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.522 0.729 . . . . 64.23 111.783 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.415 ' CD1' HD22 ' A' ' 42' ' ' LEU . 79.6 m95 -100.17 134.18 43.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.164 0.986 . . . . 74.01 110.844 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.593 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 41.6 m-85 -130.03 139.28 51.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.323 1.049 . . . . 74.43 109.007 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.1 tptp -116.55 127.05 54.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.566 0.621 . . . . 73.33 110.098 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 56.39 20.49 4.75 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.088 1.355 . . . . 70.24 113.57 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.53 4.42 32.4 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.095 0.798 . . . . 74.21 115.095 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -141.3 141.11 33.93 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 1.168 . . . . 74.35 111.594 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.71 151.77 16.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.456 1.28 . . . . 61.53 114.456 -171.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 29' ' ' LYS . 19.5 mt -103.34 157.33 17.1 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.753 0.821 . . . . 51.24 111.002 172.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.86 143.68 44.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.161 0.985 . . . . 72.42 110.197 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.8 p -80.09 73.21 6.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.178 0.591 . . . . 61.42 110.511 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -134.68 -92.65 0.31 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.759 0.652 . . . . 75.31 112.759 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.81 87.28 1.51 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-O 120.012 -0.326 . . . . 42.14 113.29 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 69.88 -11.52 0.54 Allowed 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.947 1.299 . . . . 71.43 113.269 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.16 114.17 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.518 1.127 . . . . 64.05 108.933 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 45.6 mt-30 -113.18 132.25 55.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.476 1.11 . . . . 72.41 110.145 -173.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 27' ' ' TRP . 79.6 mt -119.03 92.14 3.73 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.721 0.408 . . . . 74.14 110.651 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 2.6 mp0 -82.06 98.7 8.77 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.434 0.694 . . . . 71.53 110.369 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.28 126.88 34.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.178 0.514 . . . . 72.22 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.81 13.34 2.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.559 0.744 . . . . 63.45 112.095 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.15 -77.68 0.87 Allowed Glycine 0 C--N 1.35 1.349 0 N-CA-C 112.49 -0.244 . . . . 73.42 112.49 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.07 -54.02 5.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.035 0.534 . . . . 70.5 110.145 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.589 ' HG3' HG13 ' A' ' 15' ' ' VAL . 48.3 ttp180 -82.84 90.45 6.93 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.603 0.716 . . . . 72.51 111.675 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 16' ' ' VAL . 9.8 mm100 -95.97 126.67 41.37 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.447 -0.946 . . . . 71.23 108.447 170.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 46.6 t -114.9 108.94 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 O-C-N 121.911 -0.493 . . . . 34.21 110.836 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.42 HD12 HD12 ' A' ' 14' ' ' LEU . 1.5 tm? -91.23 112.51 24.45 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.668 -0.864 . . . . 72.14 108.668 170.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 74.2 mtp180 -113.49 104.73 12.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.809 0.444 . . . . 74.42 110.988 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 51' ' ' LEU . 61.2 t -93.33 97.01 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.185 -1.043 . . . . 64.33 108.185 168.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.05 96.09 0.42 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.469 -0.787 . . . . 73.24 110.705 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.36 -60.1 0.19 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.833 -1.076 . . . . 64.54 110.886 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . 45.5 69.69 0.43 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.404 1.481 . . . . 73.55 112.734 174.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.68 -56.24 0.08 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.158 0.429 . . . . 65.31 112.158 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -141.86 117.81 10.56 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.137 0.575 . . . . 74.34 110.986 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.25 80.7 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.484 -0.326 . . . . 74.42 113.462 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.05 -31.87 39.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.341 1.056 . . . . 74.12 111.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.02 120.19 21.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.583 0.753 . . . . 53.33 109.784 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.08 -175.58 45.97 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.657 -0.306 . . . . 50.42 113.706 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.79 112.45 24.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.836 0.454 . . . . 63.5 110.159 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 59.4 m-85 -98.84 124.1 43.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.294 0.637 . . . . 75.12 111.717 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 46.5 tp -94.75 118.32 31.55 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.969 0.508 . . . . 65.5 110.683 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.3 t -92.63 88.95 6.49 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.157 0.983 . . . . 71.04 109.93 170.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.593 ' HB3' ' HE1' ' A' ' 28' ' ' TYR . 14.0 t70 -91.11 107.23 19.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.787 0.835 . . . . 63.43 111.44 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.66 157.86 43.34 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.762 0.825 . . . . 42.31 111.038 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.02 -32.06 96.84 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.334 2.023 . . . . 75.34 111.979 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.0 101.85 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.259 1.024 . . . . 74.1 109.138 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 71.42 143.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.709 1.203 . . . . 55.35 113.811 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.3 p -118.58 120.58 37.91 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.951 0.9 . . . . 72.25 108.97 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -109.62 149.32 29.86 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.183 0.593 . . . . 63.1 111.313 -174.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.05 134.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.183 0.593 . . . . 74.13 110.581 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 6.5 m-85 -114.7 104.05 11.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.707 1.203 . . . . 61.21 109.903 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.09 112.39 20.18 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.799 -0.445 . . . . 74.23 109.799 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.5 t -106.65 131.09 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.059 0.543 . . . . 73.35 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -126.76 108.8 11.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.527 0.731 . . . . 73.44 110.322 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.16 107.4 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.336 0.655 . . . . 62.02 109.328 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.34 178.45 8.67 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.542 0.737 . . . . 55.13 111.479 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 61.39 79.78 0.27 Allowed Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 124.696 1.198 . . . . 75.12 111.213 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.573 2.452 0 C-N-CA 123.393 2.729 . . . . 74.1 114.291 -176.568 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.87 0.366 . . . . 65.23 111.44 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.0 m -75.55 86.41 2.64 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.333 1.053 . . . . 72.31 110.562 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 44.7 mtm180 -89.08 152.1 21.85 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.778 0.659 . . . . 74.0 112.778 -172.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.7 t -139.64 135.5 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 124.328 1.051 . . . . 72.44 110.34 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -94.36 145.95 24.4 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 122.992 0.517 . . . . 71.52 110.927 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.2 t -134.29 156.52 48.3 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.601 0.76 . . . . 72.22 110.762 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -84.62 147.01 48.09 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 123.144 0.577 . . . . 70.5 111.419 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.9 82.12 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.29 2.66 . . . . 72.24 113.298 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.3 7.38 4.45 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 114.521 -1.218 . . . . 63.24 112.543 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.94 26.38 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 114.724 0.649 . . . . 72.32 114.724 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.71 110.53 21.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.865 0.866 . . . . 74.21 110.456 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.9 tp -74.09 138.92 44.26 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.433 -0.58 . . . . 74.15 109.433 169.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -145.02 111.39 5.65 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.27 0.628 . . . . 74.53 109.957 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 46.0 mt -98.99 101.65 13.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.098 -0.705 . . . . 73.33 109.098 175.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -97.4 106.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 108.46 -0.941 . . . . 61.14 108.46 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 18.2 t -98.93 141.37 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.974 0.91 . . . . 64.32 111.324 -166.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -137.75 48.86 1.99 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.371 0.668 . . . . 73.3 109.89 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -57.04 174.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.075 1.139 . . . . 74.51 114.075 172.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -91.49 20.52 5.27 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.556 0.742 . . . . 64.11 112.408 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 121.36 19.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.905 -0.941 . . . . 72.03 112.888 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.89 21.99 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.472 2.781 . . . . 73.35 115.006 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.51 -105.27 0.22 Allowed Glycine 0 C--N 1.35 1.353 0 O-C-N 122.416 -0.177 . . . . 44.04 113.157 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.96 -176.91 40.65 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.421 -0.655 . . . . 63.44 113.103 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.18 161.76 84.53 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 119.783 1.791 . . . . 62.35 112.771 -4.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.446 HG11 ' SG ' ' A' ' 66' ' ' CYS . 62.4 t -107.23 147.35 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.93 0.892 . . . . 73.43 110.293 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 94.6 mtt180 -97.83 164.79 12.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.726 0.81 . . . . 73.21 111.105 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -133.14 122.98 24.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.755 0.822 . . . . 75.35 111.101 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.2 m-85 -120.2 163.97 16.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.868 0.867 . . . . 74.52 110.908 175.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -152.3 119.98 6.09 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.953 0.901 . . . . 55.14 109.898 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 62.65 21.07 12.48 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 124.557 1.143 . . . . 72.45 111.965 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.54 55.64 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 114.696 0.638 . . . . 75.33 114.696 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -128.78 128.79 44.67 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.865 0.832 . . . . 75.34 110.988 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.47 151.04 25.03 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.037 0.754 . . . . 74.33 113.037 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.3 mt -95.24 154.46 17.18 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.278 0.631 . . . . 55.24 110.536 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.04 146.82 28.56 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.491 0.716 . . . . 62.4 110.43 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 45.3 p -74.46 85.03 2.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.252 0.621 . . . . 75.15 110.899 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -121.35 -175.94 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.968 0.907 . . . . 71.13 112.073 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.76 147.38 43.31 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 110.905 -0.878 . . . . 34.44 110.905 164.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 74.7 -55.22 0.66 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.232 1.413 . . . . 74.04 111.843 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.06 89.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.141 0.976 . . . . 51.23 110.117 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -91.86 134.36 34.83 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.028 0.931 . . . . 62.45 111.657 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 51' ' ' LEU . 66.8 mt -114.25 130.98 56.65 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.936 0.494 . . . . 54.33 110.374 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.19 121.58 39.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.573 0.749 . . . . 72.02 110.146 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -108.06 102.05 11.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.532 0.682 . . . . 70.15 110.095 171.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.98 -56.09 2.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.226 0.61 . . . . 72.21 109.612 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.3 -90.47 0.1 Allowed Glycine 0 N--CA 1.475 1.242 0 N-CA-C 111.192 -0.763 . . . . 54.34 111.192 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.64 -42.0 82.97 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.37 0.668 . . . . 45.32 110.367 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.6 ttp180 -91.99 118.34 30.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.332 -0.849 . . . . 70.11 110.968 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -116.42 135.22 54.03 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.569 -0.9 . . . . 73.14 108.569 169.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 61.6 t -125.78 109.74 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.246 0.546 . . . . 63.3 111.932 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -101.11 121.96 42.74 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.246 1.018 . . . . 73.3 108.725 169.172 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -120.08 107.51 13.14 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.717 -0.475 . . . . 72.31 109.717 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -104.1 109.33 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 118.576 0.625 . . . . 54.3 110.017 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -83.62 145.78 28.64 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.526 0.73 . . . . 72.24 110.799 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.6 54.26 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 112.325 -0.31 . . . . 71.41 112.325 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 112.1 7.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.616 1.166 . . . . 35.24 111.763 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.26 -95.39 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 118.46 0.573 . . . . 64.44 112.534 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -83.43 -61.81 1.75 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.749 -0.595 . . . . 45.32 111.631 -168.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.68 -5.27 73.4 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 116.217 -0.447 . . . . 64.01 114.184 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.01 -35.26 43.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.387 0.675 . . . . 74.02 111.673 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 106.56 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.035 0.534 . . . . 62.31 111.149 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.71 -169.81 40.88 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.854 -0.612 . . . . 65.14 114.369 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.6 121.67 27.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.924 0.89 . . . . 75.15 111.062 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.2 m-85 -111.7 112.61 24.42 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.94 0.896 . . . . 71.43 110.174 173.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -93.21 101.25 13.52 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.752 -0.592 . . . . 73.4 111.027 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.446 ' SG ' HG11 ' A' ' 25' ' ' VAL . 37.8 t -82.2 89.82 6.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.908 0.883 . . . . 50.13 109.028 171.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 31.3 t70 -89.0 92.59 9.29 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.627 0.771 . . . . 61.41 112.261 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -85.64 159.29 55.64 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 122.957 0.503 . . . . 53.32 111.752 177.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -45.61 101.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 123.615 2.877 . . . . 54.24 114.159 171.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 63.68 13.98 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.2 1.4 . . . . 65.21 114.025 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 24.3 t70 -147.19 81.1 1.53 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.48 0.657 . . . . 71.13 111.045 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.538 ' HB2' HD11 ' A' ' 65' ' ' LEU . 88.1 p -78.99 148.52 32.53 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.331 -0.395 . . . . 72.01 110.803 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 126.83 29.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.948 0.499 . . . . 73.24 110.303 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.0 130.16 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.852 -0.425 . . . . 71.41 109.852 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 14.0 m-85 -109.26 102.94 11.83 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.336 1.054 . . . . 73.14 109.611 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 71.0 mt -81.48 92.15 6.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.212 -1.033 . . . . 60.22 108.212 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.8 t -83.12 114.98 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.767 -0.651 . . . . 63.12 110.012 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -103.07 107.58 18.43 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.227 -0.657 . . . . 72.25 109.227 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 6' ' ' SER . 20.6 t -94.17 107.98 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 109.765 -0.457 . . . . 54.13 109.765 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.64 -172.2 3.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.107 0.963 . . . . 73.43 109.828 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 63.86 84.27 0.19 Allowed Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 123.965 0.906 . . . . 72.24 110.677 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--N 1.384 2.43 0 C-N-CA 123.247 2.631 . . . . 71.34 114.089 -175.033 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.528 ' SD ' HD11 ' A' ' 76' ' ' LEU . 65.7 mtt . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.545 0.212 . . . . 73.11 110.62 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 m -80.6 91.35 5.81 Favored 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 124.875 1.27 . . . . 74.21 110.933 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 32.6 mtt180 -82.05 139.43 34.47 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.37 1.248 . . . . 71.15 114.37 -170.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 76.9 t -141.8 135.83 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 124.926 1.29 . . . . 63.32 109.956 172.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -106.48 144.43 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.175 0.59 . . . . 73.22 110.36 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 79' ' ' VAL . 37.3 t -135.14 161.92 33.97 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.419 0.688 . . . . 74.13 110.718 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -102.96 147.16 33.69 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 123.555 0.742 . . . . 72.52 111.696 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.44 107.95 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.584 2.856 . . . . 72.33 114.086 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.89 47.23 1.28 Allowed Glycine 0 C--N 1.355 1.622 0 C-N-CA 123.001 0.334 . . . . 73.01 113.593 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.45 -114.17 0.93 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 112.167 -0.373 . . . . 63.21 112.167 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.1 164.14 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.48 0.712 . . . . 63.41 110.478 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 62.4 tp -128.98 102.49 6.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.441 0.697 . . . . 65.22 109.613 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -110.11 104.63 13.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.101 0.56 . . . . 72.53 109.794 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.492 HD12 HD12 ' A' ' 51' ' ' LEU . 65.7 mt -90.43 101.94 14.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.529 -0.545 . . . . 74.54 109.529 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.73 119.7 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.129 -1.063 . . . . 72.04 108.129 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 18' ' ' LEU . 20.1 t -113.36 133.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.621 0.768 . . . . 65.43 111.075 -168.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -134.58 54.72 1.93 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.839 0.856 . . . . 75.03 109.351 166.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.463 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -59.07 160.71 5.83 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.071 0.767 . . . . 71.11 113.071 170.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -77.87 -1.59 32.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.773 0.829 . . . . 54.21 112.281 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.92 -178.41 41.27 Favored Glycine 0 CA--C 1.545 1.942 0 CA-C-O 119.918 -0.379 . . . . 71.03 113.543 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 -37.98 3.68 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.842 2.361 . . . . 71.21 113.54 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.89 -130.19 8.15 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.75 -0.54 . . . . 42.11 111.75 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' ' N ' ' A' ' 25' ' ' VAL . . . -91.23 156.93 24.55 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.445 -0.642 . . . . 51.2 114.297 -174.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.76 106.2 0.82 Allowed 'Cis proline' 0 C--N 1.383 2.388 0 CA-C-N 119.548 1.674 . . . . 72.33 112.552 1.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' N ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -86.1 162.16 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 C-N-CA 123.029 0.532 . . . . 75.53 110.991 -174.407 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 36.6 mmt180 -98.87 150.63 21.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.041 0.936 . . . . 74.25 110.105 171.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.39 145.33 51.14 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.376 1.07 . . . . 73.33 109.066 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.682 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.5 m-85 -135.72 124.3 23.64 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.098 0.559 . . . . 61.13 110.668 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 21.1 tptm -122.19 131.79 54.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.313 0.645 . . . . 71.35 109.951 172.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 68.15 16.25 9.41 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.624 1.169 . . . . 75.25 111.627 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.95 61.23 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.247 -0.433 . . . . 74.12 113.609 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.31 135.93 39.33 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.569 0.747 . . . . 61.13 110.584 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 145.29 40.92 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.861 0.864 . . . . 54.42 113.111 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB3' HG11 ' A' ' 40' ' ' VAL . 53.6 mt -89.31 135.4 33.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.484 0.714 . . . . 73.22 110.428 174.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.44 158.97 15.98 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.783 0.833 . . . . 74.25 110.256 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 p -69.85 89.98 0.59 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.723 0.773 . . . . 63.02 110.212 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -112.76 166.02 11.76 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.424 1.09 . . . . 73.45 111.088 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.18 97.01 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 113.791 0.276 . . . . 72.42 113.791 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 54' ' ' GLN . 5.0 mpt_? -77.29 -37.73 52.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.675 0.39 . . . . 75.41 111.422 172.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 34' ' ' LEU . 53.9 t -102.69 82.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.637 0.732 . . . . 44.13 110.712 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 73.5 mt-30 -82.23 104.59 12.65 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.547 0.739 . . . . 64.22 111.378 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -98.65 113.52 25.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.566 0.747 . . . . 65.11 112.4 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -91.81 132.46 36.41 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.567 0.747 . . . . 74.45 109.861 170.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.718 ' HA ' HE22 ' A' ' 49' ' ' GLN . 9.8 pt20 -125.28 109.35 12.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.764 0.826 . . . . 75.44 110.315 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.69 177.4 9.54 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.552 0.741 . . . . 73.24 111.925 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.02 113.25 5.08 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.416 -0.658 . . . . 71.55 112.769 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.26 -56.83 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 125.657 1.583 . . . . 63.52 113.593 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 44.7 ttp180 -83.18 111.92 19.37 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.182 0.438 . . . . 71.1 112.182 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.718 HE22 ' HA ' ' A' ' 44' ' ' GLN . 11.2 mm100 -101.97 147.21 26.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.674 0.79 . . . . 43.22 109.111 166.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.94 110.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.782 -0.573 . . . . 73.24 111.001 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 HD12 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -95.7 123.59 39.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.663 -0.866 . . . . 74.24 108.663 169.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.0 mtm180 -121.68 108.52 13.64 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.889 0.476 . . . . 75.4 111.403 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -91.47 120.87 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.328 0.651 . . . . 74.25 110.242 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.45 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . 33.4 tt0 -75.35 122.58 23.97 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.46 0.704 . . . . 45.02 109.853 173.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.28 -78.5 0.38 Allowed Glycine 0 C--N 1.346 1.138 0 N-CA-C 112.357 -0.297 . . . . 43.42 112.357 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 56.13 80.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.521 1.129 . . . . 72.12 112.178 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -159.96 -68.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.9 0.48 . . . . 74.02 111.62 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.5 m -137.51 119.19 15.03 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.384 0.673 . . . . 73.55 110.227 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.79 -15.77 53.64 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 116.433 -0.349 . . . . 74.44 112.931 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.14 -20.6 51.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.525 1.13 . . . . 75.43 111.845 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.59 122.1 27.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.449 0.7 . . . . 60.23 109.948 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . 168.45 -170.5 42.21 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.319 -0.4 . . . . 73.43 113.352 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -89.63 119.15 29.8 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.845 0.858 . . . . 75.22 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 62.0 m-85 -104.96 106.07 16.39 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.797 0.839 . . . . 63.21 109.667 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.1 tp -94.71 99.69 11.75 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.425 0.69 . . . . 62.1 110.489 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.1 t -81.77 93.19 6.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.335 0.654 . . . . 72.53 110.167 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 28.2 t70 -97.04 132.54 42.75 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.592 0.757 . . . . 74.4 112.238 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.22 152.98 80.49 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.835 0.854 . . . . 71.25 109.317 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.99 -21.2 33.04 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.286 2.657 . . . . 64.02 113.883 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -59.36 2.22 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.6 0.76 . . . . 65.12 110.132 174.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.72 149.94 37.9 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.05 0.54 . . . . 54.24 111.784 -171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -131.45 135.2 46.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.769 0.828 . . . . 74.12 111.041 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -113.5 134.75 54.5 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.88 . . . . 73.41 111.267 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.45 HG12 HD13 ' A' ' 65' ' ' LEU . 57.5 mt -89.17 123.11 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.1 -0.704 . . . . 70.12 109.1 170.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.0 m-85 -100.11 103.84 15.36 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.933 -0.395 . . . . 73.32 109.933 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.651 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 82.1 mt -78.1 92.53 4.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.949 -0.76 . . . . 73.25 108.949 175.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.5 t -101.49 113.11 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.112 -0.949 . . . . 71.43 110.1 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -110.4 107.78 17.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.25 0.547 . . . . 75.14 109.588 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 6' ' ' SER . 61.5 t -84.74 120.56 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.405 -0.961 . . . . 64.42 108.405 171.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.4 -177.71 4.16 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.63 0.772 . . . . 53.51 110.459 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 60.77 81.77 0.24 Allowed Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.937 0.895 . . . . 65.43 111.431 166.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo . . . . . 0 C--N 1.382 2.313 0 C-N-CA 123.133 2.555 . . . . 44.44 113.429 -177.189 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.886 -0.413 . . . . 72.3 109.886 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 m -94.12 95.88 9.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.75 -0.833 . . . . 54.34 108.75 -174.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -122.79 148.97 44.75 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.51 0.724 . . . . 72.41 112.42 -169.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.9 t -138.93 138.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.874 0.87 . . . . 71.54 110.427 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.94 117.95 35.33 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.357 0.663 . . . . 73.55 110.029 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t -94.49 161.6 14.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.634 0.774 . . . . 73.1 110.546 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.2 153.7 37.88 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 123.283 0.633 . . . . 73.45 111.387 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -56.24 99.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.533 2.822 . . . . 64.13 112.95 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.34 18.62 68.51 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 116.118 -0.492 . . . . 43.13 113.733 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.81 -10.45 69.67 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 114.485 0.554 . . . . 63.43 114.485 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 67.64 118.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.676 1.59 . . . . 71.3 112.263 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.4 HD11 HD21 ' A' ' 14' ' ' LEU . 42.7 tp -81.44 140.49 34.61 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.671 0.789 . . . . 72.03 111.678 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 15' ' ' VAL . 45.2 tt0 -142.22 100.8 3.79 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.69 0.796 . . . . 72.2 110.273 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 12' ' ' LEU . 54.0 mt -89.86 103.63 16.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.641 0.776 . . . . 75.32 109.916 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 ' HG2' ' A' ' 13' ' ' GLU . 61.4 t -104.79 110.21 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.646 0.778 . . . . 75.44 109.339 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG21 ' SG ' ' A' ' 66' ' ' CYS . 11.6 m -99.17 146.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.626 0.726 . . . . 53.12 111.05 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -122.38 29.42 6.97 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.864 -1.062 . . . . 73.5 109.234 165.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.501 HD21 ' SG ' ' A' ' 66' ' ' CYS . 0.9 OUTLIER -41.75 139.25 1.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.052 1.13 . . . . 53.5 114.052 176.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -94.66 31.46 1.79 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.462 0.705 . . . . 63.41 111.285 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.99 -176.3 45.82 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-N 116.258 -0.428 . . . . 54.35 113.064 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 175.75 10.89 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 75.43 113.53 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.83 132.92 46.76 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.877 -0.601 . . . . 63.34 112.936 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.02 -131.78 0.96 Allowed Glycine 0 CA--C 1.548 2.134 0 CA-C-O 119.146 -0.808 . . . . 61.42 114.872 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.1 124.29 5.19 Favored 'Cis proline' 0 C--N 1.386 2.514 0 CA-C-N 120.695 2.247 . . . . 71.12 113.641 -0.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.413 HG11 ' SG ' ' A' ' 66' ' ' CYS . 98.6 t -73.7 142.84 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 C-N-CA 123.394 0.677 . . . . 70.33 110.855 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -96.54 169.89 9.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.26 1.024 . . . . 73.02 111.199 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.503 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 81.6 m95 -131.52 125.96 33.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.958 0.903 . . . . 72.3 110.467 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.3 m-85 -116.93 163.16 16.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.353 1.061 . . . . 73.53 109.973 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 64' ' ' TYR . 1.9 tmtp? -159.48 128.21 5.15 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.303 0.641 . . . . 70.2 110.547 176.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.52 23.29 13.59 Favored 'General case' 0 CA--C 1.566 1.585 0 C-N-CA 124.306 1.042 . . . . 75.54 111.631 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.6 -8.36 63.95 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 115.754 -0.657 . . . . 52.14 114.505 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -129.64 138.13 51.04 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.199 0.999 . . . . 73.43 111.46 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -58.35 146.61 33.97 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.754 0.822 . . . . 64.42 112.759 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.565 ' HB3' HG11 ' A' ' 40' ' ' VAL . 38.6 mt -87.2 134.8 33.49 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.309 -0.405 . . . . 44.05 110.066 171.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.14 160.46 15.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.552 0.741 . . . . 74.03 110.775 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 p -72.47 83.7 1.1 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.705 0.764 . . . . 65.11 110.687 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.71 165.08 11.57 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.987 0.915 . . . . 63.42 110.378 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.28 -44.66 93.31 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 114.088 0.395 . . . . 73.02 114.088 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HG3' HG23 ' A' ' 40' ' ' VAL . 15.5 ptm180 -77.95 -37.74 46.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.002 0.521 . . . . 74.4 111.075 174.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 39' ' ' ARG . 59.7 t -94.34 83.08 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.704 0.802 . . . . 63.11 110.387 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 34.0 mm-40 -81.46 106.09 13.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.608 0.763 . . . . 72.33 111.237 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.44 101.59 13.52 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.184 0.594 . . . . 72.5 110.86 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 32.0 tt0 -92.42 98.76 11.68 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.442 0.697 . . . . 73.15 109.842 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.27 102.06 14.13 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 74.13 108.215 173.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.07 -179.27 3.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.843 0.857 . . . . 74.41 110.922 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.26 89.31 0.07 OUTLIER Glycine 0 C--N 1.352 1.452 0 O-C-N 123.387 0.429 . . . . 74.31 112.819 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.39 -27.93 0.19 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 125.965 1.706 . . . . 73.41 113.36 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -85.3 104.54 15.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.441 0.696 . . . . 74.1 111.002 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.503 ' HB3' ' HE1' ' A' ' 27' ' ' TRP . 34.1 mm-40 -98.5 112.16 24.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.097 0.559 . . . . 73.32 109.549 173.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 61.6 t -109.5 108.98 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.054 0.454 . . . . 64.12 110.836 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.21 117.53 30.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.641 -0.874 . . . . 73.21 108.641 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.7 mtm-85 -113.04 117.33 31.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.525 0.73 . . . . 64.41 109.891 174.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.06 100.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.31 0.576 . . . . 75.43 109.681 171.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.46 139.75 42.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.727 -0.67 . . . . 71.21 109.666 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.86 24.79 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 112.311 -0.316 . . . . 75.1 112.311 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.3 87.19 2.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.143 0.577 . . . . 72.1 111.189 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' O ' HG11 ' A' ' 79' ' ' VAL . 78.7 ttt180 -127.51 -82.86 0.6 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.229 0.612 . . . . 64.34 111.592 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 m -93.09 -70.66 0.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.172 0.589 . . . . 74.31 111.539 -173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.93 28.33 4.11 Favored Glycine 0 CA--C 1.543 1.784 0 N-CA-C 114.754 0.662 . . . . 55.43 114.754 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -93.44 -31.86 14.44 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.398 0.679 . . . . 73.3 110.812 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.13 107.43 2.31 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.804 0.842 . . . . 64.13 111.285 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.25 178.02 43.21 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.183 -0.462 . . . . 74.35 114.14 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.03 108.8 17.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.08 0.552 . . . . 71.54 110.14 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.664 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 19.5 m-85 -93.95 155.52 17.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.495 0.718 . . . . 74.34 109.898 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.709 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 44.2 tp -144.1 102.87 3.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.031 0.382 . . . . 60.41 112.031 -173.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.501 ' SG ' HD21 ' A' ' 18' ' ' LEU . 34.3 t -79.57 88.85 5.09 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 109.147 -0.686 . . . . 73.05 109.147 170.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.56 102.12 14.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.288 1.035 . . . . 64.11 112.786 -167.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.14 162.99 59.75 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.397 0.679 . . . . 64.22 110.51 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.73 31.9 0.19 Allowed 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.067 2.511 . . . . 74.43 115.104 174.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -172.39 -62.96 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.544 1.138 . . . . 73.3 109.065 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.67 176.35 6.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.705 0.802 . . . . 64.14 111.019 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 65' ' ' LEU . 85.5 p -165.64 134.89 3.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.406 0.682 . . . . 71.32 110.322 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -106.78 124.4 49.56 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.38 0.672 . . . . 43.44 110.351 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.55 HG13 HD13 ' A' ' 65' ' ' LEU . 3.2 mp -102.32 124.49 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.238 0.615 . . . . 64.44 110.073 -175.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 64.1 m-85 -101.17 126.38 47.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.344 1.058 . . . . 71.3 111.207 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.52 93.36 8.05 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.747 -1.205 . . . . 74.35 107.747 161.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 63.2 t -85.34 106.32 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.273 -0.639 . . . . 63.34 109.273 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.1 p -103.51 117.25 34.0 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.801 . . . . 63.42 110.027 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 57' ' ' ARG . 63.3 t -84.17 106.64 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.022 -0.732 . . . . 63.52 109.022 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 11.3 pt-20 -150.39 -166.94 2.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.336 1.054 . . . . 74.34 110.216 -174.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 40.1 mt-10 57.88 54.37 6.29 Favored Pre-proline 0 CA--C 1.571 1.765 0 C-N-CA 124.209 1.004 . . . . 73.54 112.121 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.455 0 C-N-CA 123.11 2.54 . . . . 71.43 112.466 -174.633 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 tpp . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 109.616 -0.513 . . . . 61.52 109.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.4 p -62.94 108.01 1.11 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.359 0.664 . . . . 71.23 111.363 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.79 120.28 38.76 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.485 -0.931 . . . . 64.03 108.485 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.498 ' HB ' HG22 ' A' ' 77' ' ' VAL . 98.8 t -122.24 140.94 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.706 0.802 . . . . 73.23 109.948 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.87 127.93 44.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.058 0.543 . . . . 70.14 109.54 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -122.34 162.33 21.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.245 0.618 . . . . 60.55 111.179 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.75 140.5 26.42 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.35 0.66 . . . . 75.23 111.939 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.84 119.33 6.01 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.103 2.535 . . . . 61.44 112.97 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.56 30.79 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.073 -0.512 . . . . 32.12 113.078 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.93 -131.22 3.98 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 117.094 0.447 . . . . 74.43 112.957 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -146.97 150.05 34.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.472 0.709 . . . . 73.45 110.837 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD21 ' A' ' 14' ' ' LEU . 64.3 tp -97.61 143.62 28.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.017 0.927 . . . . 54.22 110.283 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.56 113.38 6.76 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.284 0.633 . . . . 62.43 109.771 171.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 12' ' ' LEU . 75.6 mt -107.21 103.18 12.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.988 0.915 . . . . 64.53 109.6 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 117.2 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 109.105 -0.702 . . . . 74.24 109.105 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.627 HG21 ' SG ' ' A' ' 66' ' ' CYS . 1.6 t -97.85 147.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.095 0.474 . . . . 74.11 110.493 -174.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.41 29.81 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.853 0.861 . . . . 71.44 110.09 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.453 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.1 pp -53.2 158.59 1.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.791 1.034 . . . . 71.23 113.791 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 m -95.05 23.53 5.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.414 -0.812 . . . . 71.33 111.214 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.73 119.14 8.83 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.14 -0.811 . . . . 51.4 112.79 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.93 104.99 0.89 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.29 2.66 . . . . 74.5 114.221 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.38 52.01 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.358 0.903 . . . . 70.53 115.358 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.14 176.29 18.39 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-O 119.318 -0.712 . . . . 34.2 112.99 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.36 119.97 5.52 Favored 'Cis proline' 0 C--N 1.377 2.038 0 CA-C-N 120.052 1.926 . . . . 64.11 113.962 1.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -82.54 115.72 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 109.088 -0.708 . . . . 53.32 109.088 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -98.33 137.09 37.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.646 0.778 . . . . 75.14 111.659 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -96.3 124.34 40.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.459 0.704 . . . . 74.35 110.629 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 86.9 m-85 -119.03 134.71 55.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.778 0.831 . . . . 74.14 110.486 176.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.4 tptp -119.46 128.12 53.7 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.053 0.541 . . . . 75.44 109.842 173.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 63.37 5.7 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.644 1.178 . . . . 53.24 113.858 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.97 -25.01 4.2 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.555 -0.58 . . . . 44.34 114.046 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -131.03 150.2 52.26 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.516 1.158 . . . . 41.35 112.33 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.554 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -67.41 154.86 40.37 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.743 1.386 . . . . 72.52 114.743 -169.092 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.568 ' HB3' HG11 ' A' ' 40' ' ' VAL . 26.6 mt -102.55 162.29 13.04 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.805 1.242 . . . . 74.53 110.446 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.77 153.2 46.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.725 0.81 . . . . 64.34 110.533 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -71.26 83.14 0.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.956 0.884 . . . . 54.54 110.955 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.36 -178.63 3.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.114 0.965 . . . . 75.34 110.765 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.61 97.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 114.089 0.395 . . . . 51.2 114.089 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -90.5 -14.87 31.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.44 0.696 . . . . 62.33 112.05 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 34' ' ' LEU . 54.3 t -124.74 81.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.42 0.688 . . . . 73.52 109.831 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.628 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.4 mt-30 -85.11 125.66 32.97 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.263 0.625 . . . . 75.4 111.062 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.457 HD21 HD23 ' A' ' 51' ' ' LEU . 89.8 mt -118.48 96.86 5.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.538 0.735 . . . . 73.11 112.185 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.53 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 1.7 mp0 -85.86 96.63 9.84 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.88 -0.785 . . . . 73.33 108.88 165.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -111.21 113.85 26.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.725 0.81 . . . . 73.33 111.227 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.19 -157.95 0.85 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.413 1.085 . . . . 74.24 111.083 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.29 111.47 3.31 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 119.385 -0.675 . . . . 70.14 111.997 172.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.39 -52.6 0.7 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 125.925 1.69 . . . . 65.14 112.716 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 30.0 ttt85 -66.75 101.21 0.78 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.708 0.803 . . . . 73.24 111.515 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' HG23 ' A' ' 16' ' ' VAL . 67.7 mm-40 -112.04 125.8 54.47 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 51.5 t -117.96 110.53 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 122.705 0.402 . . . . 73.04 110.904 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.457 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -102.56 121.2 41.9 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.736 0.814 . . . . 71.44 109.452 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 68.3 mtp180 -120.68 109.15 14.87 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.08 0.552 . . . . 74.1 111.153 -176.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 61.6 t -92.61 114.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.244 0.545 . . . . 52.53 110.678 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -79.1 123.24 27.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.501 1.121 . . . . 71.5 110.351 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 42.88 23.97 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.736 -0.211 . . . . 74.1 113.394 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.78 112.83 4.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.275 0.63 . . . . 44.03 111.409 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -68.25 0.2 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.012 0.525 . . . . 72.24 111.256 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -95.49 -87.19 0.29 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.935 0.717 . . . . 72.35 112.935 -167.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.83 6.1 63.29 Favored Glycine 0 C--N 1.36 1.907 0 O-C-N 122.109 -0.37 . . . . 23.03 113.785 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB3' HG11 ' A' ' 53' ' ' VAL . 5.9 m-20 -84.2 -5.01 59.19 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.544 1.138 . . . . 72.01 110.995 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.15 128.17 36.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.035 0.934 . . . . 73.52 109.487 171.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.6 -173.34 41.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.238 -0.437 . . . . 73.12 112.915 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.27 126.74 33.94 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.058 0.543 . . . . 73.21 110.508 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 76.5 m-85 -112.85 110.2 20.14 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.93 0.892 . . . . 64.23 110.096 175.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -91.97 102.26 14.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.221 0.608 . . . . 73.14 110.331 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.627 ' SG ' HG21 ' A' ' 16' ' ' VAL . 44.9 t -82.12 89.11 6.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.545 0.738 . . . . 73.2 109.378 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -96.39 94.12 7.24 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.019 1.328 . . . . 71.13 112.192 -168.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.64 158.66 82.82 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.437 1.095 . . . . 62.25 111.784 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -47.76 -32.77 17.6 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.873 3.048 . . . . 70.42 115.239 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.29 49.02 1.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.262 0.553 . . . . 63.13 109.638 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -178.61 162.63 1.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.056 1.342 . . . . 71.32 109.564 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.7 p -160.36 121.01 2.95 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.169 0.44 . . . . 73.54 110.772 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -106.43 127.94 53.67 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.518 0.727 . . . . 75.53 110.36 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.62 121.51 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.044 -0.725 . . . . 73.34 109.044 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 32.0 m-85 -98.21 100.73 12.05 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.1 -0.704 . . . . 73.45 109.1 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.7 91.78 4.08 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.176 -1.046 . . . . 54.35 108.176 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 4' ' ' VAL . 67.4 t -104.27 112.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 115.194 -0.912 . . . . 71.33 110.482 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 p -111.12 110.52 21.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.137 0.575 . . . . 63.15 109.455 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.42 104.05 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.907 -1.145 . . . . 72.21 107.907 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.97 179.12 9.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.716 0.807 . . . . 63.54 110.7 -170.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 61.71 90.63 0.09 OUTLIER Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.132 0.973 . . . . 74.12 110.974 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 C--N 1.383 2.343 0 C-N-CA 123.154 2.569 . . . . 75.32 113.891 -171.265 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 ttm . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.38 -0.23 . . . . 40.33 110.38 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 p -65.17 105.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.864 0.466 . . . . 71.2 111.26 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -107.58 109.74 21.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.366 1.067 . . . . 65.12 110.671 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 86.8 t -122.95 118.08 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.589 . . . . 61.43 110.863 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.5 134.86 33.91 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.856 -0.424 . . . . 73.41 109.856 173.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.802 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.7 t -112.23 157.11 21.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.928 0.491 . . . . 74.32 110.237 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -83.46 146.03 49.48 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.289 0.635 . . . . 74.11 111.559 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.02 105.86 0.72 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.145 2.563 . . . . 73.01 113.502 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.65 15.8 56.06 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 115.404 -0.816 . . . . 41.03 113.346 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.96 -167.75 30.59 Favored Glycine 0 N--CA 1.477 1.403 0 N-CA-C 112.558 -0.217 . . . . 64.12 112.558 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -107.01 119.75 40.22 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.099 -0.648 . . . . 63.2 111.198 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 6' ' ' SER . 58.9 tp -75.82 147.78 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.999 0.92 . . . . 72.31 110.453 174.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -145.0 116.42 8.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.027 0.531 . . . . 73.23 109.583 169.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 77.4 mt -102.08 101.23 11.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.354 0.662 . . . . 53.0 109.374 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.18 113.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.476 -0.935 . . . . 71.52 108.476 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 18' ' ' LEU . 3.5 t -108.34 137.71 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.906 0.882 . . . . 71.03 110.536 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -134.48 51.27 2.12 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.437 0.637 . . . . 74.24 109.35 169.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -54.57 159.88 1.98 Allowed 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.53 -0.759 . . . . 71.1 112.598 166.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.1 m -82.39 41.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.782 0.833 . . . . 34.44 111.496 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.17 85.72 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.528 -0.595 . . . . 72.12 112.564 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.38 151.59 26.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.8 2.334 . . . . 54.0 113.021 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -90.02 0.7 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 116.211 -0.45 . . . . 45.34 112.384 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.01 -114.36 4.01 Favored Glycine 0 CA--C 1.546 1.997 0 CA-C-O 118.729 -1.039 . . . . 74.23 113.792 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -72.57 158.03 97.87 Favored 'Cis proline' 0 C--N 1.383 2.386 0 CA-C-N 120.999 2.399 . . . . 72.42 113.532 -0.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.49 HG11 ' SG ' ' A' ' 66' ' ' CYS . 32.2 t -90.29 129.11 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.033 0.533 . . . . 71.2 110.7 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -98.12 132.2 43.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.583 0.753 . . . . 75.13 110.778 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.494 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 70.3 m95 -97.74 118.24 33.82 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.649 0.379 . . . . 74.32 111.869 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.8 m-85 -112.29 147.98 35.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.315 1.046 . . . . 65.12 109.468 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' NZ ' ' HA ' ' A' ' 60' ' ' ASP . 15.6 tptm -128.31 113.11 15.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.156 0.503 . . . . 65.53 110.288 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.07 13.26 2.81 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 125.912 1.685 . . . . 54.53 113.281 168.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.1 -39.34 0.67 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.499 -0.611 . . . . 71.21 113.234 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -154.07 156.5 37.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.071 0.936 . . . . 74.23 112.773 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -60.62 152.68 25.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.953 1.834 . . . . 74.34 115.953 -166.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.3 mt -95.56 161.59 13.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.307 -0.861 . . . . 64.32 111.197 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.86 134.59 49.41 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.942 0.897 . . . . 62.42 109.782 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.7 p -68.16 89.07 0.31 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.37 0.668 . . . . 72.22 111.72 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -134.84 98.55 4.06 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.835 0.854 . . . . 51.33 111.163 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 -89.31 0.07 OUTLIER Glycine 0 C--N 1.357 1.726 0 O-C-N 123.841 0.713 . . . . 73.52 114.517 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -70.04 -38.51 75.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.676 0.79 . . . . 75.45 111.299 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 59.7 t -89.65 121.88 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.663 . . . . 63.12 109.365 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -129.54 121.35 27.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.401 0.68 . . . . 73.43 110.51 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.44 100.07 8.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 64.13 111.092 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.0 tm-20 -93.36 125.83 38.17 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.218 -1.03 . . . . 62.43 108.218 168.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.35 103.15 7.49 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.414 0.626 . . . . 61.4 111.159 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -100.81 -2.32 32.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.224 1.01 . . . . 72.02 112.101 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.52 -99.24 0.98 Allowed Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.192 -0.763 . . . . 53.33 111.192 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.66 -33.02 73.28 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.935 0.494 . . . . 74.33 111.616 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 58.3 ttp180 -89.19 115.65 26.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.992 0.517 . . . . 53.42 110.091 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HB3' ' HE1' ' A' ' 27' ' ' TRP . 37.9 mm-40 -114.29 141.45 47.57 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.706 0.803 . . . . 75.44 109.532 171.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 94.2 t -131.38 110.94 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.129 0.571 . . . . 73.14 110.264 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.84 112.16 24.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.677 0.791 . . . . 75.51 109.464 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 42.3 mtt-85 -100.14 137.36 38.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.04 0.536 . . . . 61.21 111.218 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.98 100.01 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.552 0.741 . . . . 55.21 109.337 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -75.18 126.26 30.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.793 -0.447 . . . . 65.33 109.793 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.43 30.18 19.82 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.411 0.444 . . . . 34.12 113.062 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.6 101.36 0.24 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.784 0.834 . . . . 61.52 111.519 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.11 -62.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.921 0.889 . . . . 63.41 109.795 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 m -54.66 -55.29 31.25 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.324 1.05 . . . . 55.53 113.721 -168.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.45 17.52 4.48 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 122.597 0.141 . . . . 70.34 112.912 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 13.8 m-20 -126.02 90.97 3.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 61.23 110.947 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.61 65.09 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.476 1.11 . . . . 64.42 109.369 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.84 -153.5 6.43 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-N 115.535 -0.757 . . . . 72.33 113.29 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 128.31 34.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.92 0.488 . . . . 74.54 111.329 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 57.2 m-85 -115.27 107.66 15.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.073 0.949 . . . . 65.32 109.095 173.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.6 tp -92.0 100.15 12.85 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.364 0.602 . . . . 72.22 110.608 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.49 ' SG ' HG11 ' A' ' 25' ' ' VAL . 29.8 t -80.55 87.31 5.74 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.539 -0.911 . . . . 71.44 108.539 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.01 96.05 10.42 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.349 1.06 . . . . 74.31 112.527 -168.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' H ' ' HA ' ' A' ' 72' ' ' SER . . . -90.42 138.73 26.81 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 122.932 0.493 . . . . 53.31 111.408 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.84 -29.62 64.0 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 123.677 2.918 . . . . 71.4 113.943 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -75.35 -63.8 1.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.013 0.525 . . . . 74.15 110.003 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 24.8 t70 -153.71 127.67 8.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.748 0.419 . . . . 62.12 110.927 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.434 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 31.2 t -72.65 177.6 4.64 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.222 1.009 . . . . 72.43 112.392 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.613 ' HA ' ' HE ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -154.99 127.18 7.74 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.536 0.735 . . . . 62.35 111.172 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.99 123.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.043 0.537 . . . . 75.44 109.685 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 36.8 m-85 -102.12 104.96 15.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.343 0.657 . . . . 74.44 111.419 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.25 93.63 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.598 -0.889 . . . . 75.34 108.598 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.1 t -99.36 114.51 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.898 0.479 . . . . 71.45 110.545 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.1 p -112.46 108.76 18.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.214 0.606 . . . . 61.51 110.135 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.802 HG22 ' HB3' ' A' ' 6' ' ' SER . 47.2 t -91.16 106.01 17.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.657 -0.868 . . . . 75.13 108.657 175.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -178.56 -27.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.314 0.646 . . . . 72.44 111.454 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.5 101.64 0.29 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.714 0.805 . . . . 74.34 109.992 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 CA--C 1.567 2.152 0 C-N-CA 122.883 2.389 . . . . 74.34 114.072 -165.223 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.618 0.247 . . . . 75.33 110.571 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m -75.57 90.8 2.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.747 0.819 . . . . 75.53 111.465 -171.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.34 135.25 33.8 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.542 0.737 . . . . 71.34 111.97 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.81 124.12 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.492 0.717 . . . . 73.0 110.948 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -90.25 142.06 28.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.173 0.589 . . . . 75.24 109.556 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.503 ' HB3' HG22 ' A' ' 79' ' ' VAL . 46.7 t -145.91 148.63 33.02 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.429 0.633 . . . . 74.22 112.021 -173.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 p -82.15 147.54 57.63 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 74.32 112.314 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -84.04 147.51 11.77 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.37 2.713 . . . . 71.42 112.716 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.12 -22.28 23.58 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 113.988 0.355 . . . . 54.22 113.988 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.05 -151.29 23.86 Favored Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.956 0.378 . . . . 71.2 113.32 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -112.93 127.0 56.09 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.26 0.53 . . . . 74.52 110.657 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.1 tp -75.8 128.65 35.61 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 109.155 -0.683 . . . . 55.02 109.155 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -129.13 105.34 8.11 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.923 -0.399 . . . . 65.23 109.923 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 50.1 mt -91.68 101.78 14.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.185 -0.672 . . . . 71.21 109.185 175.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.9 t -99.51 109.98 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 107.924 -1.139 . . . . 73.33 107.924 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.451 HG22 ' HZ ' ' A' ' 75' ' ' PHE . 2.8 t -98.37 135.86 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.781 0.324 . . . . 72.11 110.755 -168.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -116.66 32.75 5.96 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.849 0.859 . . . . 74.13 109.83 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.89 156.1 9.54 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.878 1.066 . . . . 75.33 113.878 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -82.71 5.68 20.5 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.184 0.994 . . . . 73.31 112.327 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.71 -175.35 23.38 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 114.422 0.529 . . . . 33.34 114.422 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.621 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 41.1 Cg_endo -83.66 179.6 4.77 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.486 2.791 . . . . 74.31 114.019 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.518 ' HA2' ' HA3' ' A' ' 46' ' ' GLY . . . -83.13 61.31 4.79 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.61 -0.723 . . . . 75.34 113.299 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 81.03 174.72 49.21 Favored Glycine 0 CA--C 1.543 1.814 0 N-CA-C 115.228 0.851 . . . . 75.14 115.228 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.52 99.77 0.28 Allowed 'Cis proline' 0 C--N 1.38 2.197 0 CA-C-N 118.893 1.346 . . . . 74.25 112.066 -6.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 22.8 t -79.27 132.88 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.167 0.587 . . . . 62.33 110.819 -176.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -98.28 153.19 18.69 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.968 0.907 . . . . 74.42 111.608 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -109.88 134.03 52.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.637 0.775 . . . . 72.54 111.291 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.782 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 46.5 m-85 -128.12 161.31 29.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.167 0.987 . . . . 72.12 110.646 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -153.77 129.03 9.74 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.434 1.094 . . . . 71.13 109.604 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 63.81 22.95 13.25 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.945 0.898 . . . . 72.0 111.189 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.04 -4.62 81.49 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.395 -0.82 . . . . 63.42 114.342 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.1 128.8 49.82 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.983 0.913 . . . . 74.04 111.054 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.71 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.49 146.2 49.35 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.999 1.111 . . . . 73.41 113.999 -175.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.407 ' HB3' HG11 ' A' ' 40' ' ' VAL . 52.2 mt -91.98 154.74 18.6 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.97 -1.014 . . . . 61.23 110.817 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.0 159.2 26.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.209 1.003 . . . . 73.42 110.278 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.7 p -66.22 91.96 0.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.436 0.694 . . . . 72.31 110.789 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 36.4 tt0 -114.83 164.41 14.14 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.29 1.036 . . . . 51.5 110.204 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.8 -18.83 47.63 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.265 0.866 . . . . 43.14 115.265 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -121.6 4.81 10.09 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.404 0.602 . . . . 74.41 111.973 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 70.5 t -127.59 86.27 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.244 1.017 . . . . 72.44 109.121 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 82.4 mt-30 -87.97 108.26 19.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.843 0.857 . . . . 72.24 111.158 -174.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 mt -98.21 141.57 30.96 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.079 0.551 . . . . 71.23 112.323 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -123.27 138.5 54.61 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.037 0.935 . . . . 73.22 110.234 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -118.03 108.79 15.67 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.433 0.693 . . . . 63.22 110.809 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.72 -48.98 1.25 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.872 0.869 . . . . 73.1 109.577 168.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.518 ' HA3' ' HA2' ' A' ' 22' ' ' GLY . . . 129.42 -75.01 0.43 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.577 -0.738 . . . . 72.33 112.149 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.23 -36.53 84.44 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.632 . . . . 65.42 111.015 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -111.64 109.63 19.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.336 0.654 . . . . 53.22 110.361 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.521 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.8 mm100 -107.28 135.38 48.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.47 0.708 . . . . 72.45 109.489 169.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 60.1 t -129.94 114.13 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 121.074 0.464 . . . . 65.44 111.647 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 120.48 42.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.802 1.241 . . . . 74.15 108.519 170.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 43.7 mtp180 -118.11 106.37 12.8 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.667 0.387 . . . . 72.43 110.783 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 60' ' ' ASP . 70.7 t -84.59 95.52 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.848 0.459 . . . . 74.32 110.089 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -75.13 107.33 7.15 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.488 0.715 . . . . 42.21 110.402 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.38 36.8 3.98 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.4 -0.363 . . . . 73.33 112.526 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.82 112.01 8.47 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.039 0.936 . . . . 75.12 112.011 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -167.96 -56.0 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.593 0.757 . . . . 73.2 112.101 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 m -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.119 0.967 . . . . 62.3 113.16 -167.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.88 26.38 1.46 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.235 -0.746 . . . . 75.04 111.235 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.534 ' HB3' HG11 ' A' ' 53' ' ' VAL . 6.0 m-20 -87.03 3.91 44.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.761 1.224 . . . . 72.31 111.903 -172.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.481 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -87.41 161.14 18.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 124.061 0.944 . . . . 74.23 109.603 166.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.56 -160.92 23.26 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 114.083 0.393 . . . . 53.41 114.083 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.2 mt-10 -93.9 118.16 31.09 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.224 0.61 . . . . 73.12 111.977 -172.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.18 152.86 22.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.226 1.01 . . . . 72.15 110.215 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.782 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.5 tp -128.98 101.93 6.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.788 0.435 . . . . 75.21 110.233 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -81.94 87.03 6.43 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 108.545 -0.909 . . . . 52.44 108.545 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.2 t70 -95.45 104.31 16.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.467 1.107 . . . . 75.11 111.918 -169.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.85 152.83 37.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.815 0.846 . . . . 71.53 110.878 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.43 -36.49 58.81 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.197 2.598 . . . . 72.54 114.925 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.621 ' HB2' ' HD3' ' A' ' 21' ' ' PRO . 82.0 mm-40 -90.3 -28.89 18.47 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.898 0.703 . . . . 70.23 112.898 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -157.35 128.76 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 112.176 0.436 . . . . 73.24 112.176 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.549 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.6 p -97.6 139.75 33.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.689 0.796 . . . . 73.45 110.529 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -123.83 123.43 40.45 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.739 0.416 . . . . 62.4 110.839 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -97.04 144.14 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 122.882 0.473 . . . . 74.23 110.118 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' HZ ' HG22 ' A' ' 16' ' ' VAL . 5.8 m-85 -117.71 139.03 51.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.036 1.334 . . . . 74.25 110.155 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.7 94.89 5.26 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.381 -0.97 . . . . 73.42 108.381 164.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.07 139.04 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.181 0.592 . . . . 75.14 111.711 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.2 p -126.49 108.89 11.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.782 0.833 . . . . 64.31 110.468 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.6 t -109.04 104.11 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.187 -1.042 . . . . 74.41 108.187 172.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 8.5 pt-20 179.03 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.501 0.72 . . . . 63.21 111.246 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 37.7 mt-10 -75.17 106.37 2.78 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.943 0.897 . . . . 71.31 110.622 -174.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 6.1 Cg_exo . . . . . 0 CA--C 1.569 2.239 0 C-N-CA 123.242 2.628 . . . . 74.43 113.58 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.684 0.278 . . . . 74.44 110.818 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.23 84.62 1.88 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.406 1.082 . . . . 54.25 111.099 -172.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.66 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 64.8 mtt85 -76.37 141.14 41.59 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.545 0.738 . . . . 74.3 112.254 -174.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.416 HG21 HD22 ' A' ' 14' ' ' LEU . 78.9 t -130.03 131.24 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.647 0.779 . . . . 54.32 110.977 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -90.25 129.62 36.47 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.291 1.037 . . . . 71.43 109.855 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -139.16 158.88 43.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.818 0.847 . . . . 74.54 111.136 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -101.33 152.77 38.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 123.881 0.873 . . . . 73.21 111.63 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.2 Cg_endo -83.06 73.11 5.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.499 2.8 . . . . 55.03 113.622 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.99 60.23 0.01 OUTLIER Glycine 0 N--CA 1.474 1.169 0 CA-C-N 115.794 -0.639 . . . . 44.01 112.36 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.51 -176.26 39.81 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 122.853 -0.204 . . . . 60.32 113.428 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.05 119.66 31.95 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.337 0.589 . . . . 75.45 110.681 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 61.4 tp -74.8 136.58 41.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.745 0.818 . . . . 75.4 109.568 174.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -134.5 107.95 7.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.953 0.501 . . . . 74.01 110.053 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.416 HD22 HG21 ' A' ' 4' ' ' VAL . 44.4 mt -92.78 104.18 16.46 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.45 0.7 . . . . 74.25 109.524 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.09 112.08 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.974 -0.75 . . . . 71.23 108.974 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.469 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t -100.64 126.66 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.738 0.415 . . . . 62.21 110.131 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -99.17 21.37 11.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.298 0.639 . . . . 72.44 111.483 174.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.442 ' H ' HG12 ' A' ' 16' ' ' VAL . 12.7 mt -49.25 138.16 13.0 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.616 0.766 . . . . 52.24 111.792 163.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.8 t -79.17 76.89 5.69 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.498 0.666 . . . . 42.51 110.11 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.82 85.2 0.39 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.985 -0.846 . . . . 53.51 110.985 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.37 -51.39 5.38 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.097 2.531 . . . . 72.02 113.71 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.69 96.52 0.28 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.347 -0.701 . . . . 63.24 111.347 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.68 -110.45 3.5 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 118.96 -0.911 . . . . 44.32 113.525 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.31 179.47 28.01 Favored 'Cis proline' 0 C--N 1.38 2.187 0 CA-C-N 120.382 2.091 . . . . 44.13 113.971 2.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 68' ' ' ALA . 42.0 t -80.31 145.54 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.461 -0.79 . . . . 70.2 110.441 171.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.5 128.05 43.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 74.11 109.09 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.403 ' CH2' ' SG ' ' A' ' 66' ' ' CYS . 92.4 m95 -100.37 137.08 39.28 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.554 0.742 . . . . 74.14 111.41 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 90.8 m-85 -131.61 119.99 22.22 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.014 0.525 . . . . 74.34 110.91 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -107.52 124.82 50.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.413 0.685 . . . . 65.15 109.686 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t70 65.73 12.48 8.33 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 124.657 1.183 . . . . 73.14 110.896 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.09 -23.42 23.34 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 123.604 0.621 . . . . 73.03 113.673 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -101.46 141.89 33.65 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.897 0.849 . . . . 63.51 111.277 -173.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 152.83 14.89 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.895 0.878 . . . . 71.03 113.238 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -93.19 158.65 15.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.09 0.556 . . . . 73.32 110.326 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 128.96 43.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.663 0.785 . . . . 64.34 110.447 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.8 p -65.09 88.91 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.663 0.785 . . . . 74.44 111.283 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -126.25 -171.1 2.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.736 1.214 . . . . 70.2 110.503 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.4 -34.03 78.76 Favored Glycine 0 N--CA 1.48 1.627 0 O-C-N 123.017 0.198 . . . . 75.23 113.345 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -71.99 -60.89 2.0 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 75.23 110.507 173.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.8 t -101.46 92.07 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.983 0.913 . . . . 60.24 110.977 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -97.85 115.89 28.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.84 0.856 . . . . 53.22 111.402 -174.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.43 HD21 HD23 ' A' ' 51' ' ' LEU . 96.2 mt -94.64 133.61 38.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.173 0.589 . . . . 65.4 110.984 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -123.94 103.07 8.11 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.618 -0.882 . . . . 71.55 108.618 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -85.07 121.98 28.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.407 0.683 . . . . 74.32 111.637 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.73 169.02 16.24 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.587 0.755 . . . . 32.11 110.604 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.52 111.9 4.49 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.359 -0.689 . . . . 71.44 112.003 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.59 -54.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.503 1.521 . . . . 64.15 112.195 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.5 ttt-85 -67.94 112.57 5.03 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.673 0.789 . . . . 74.15 112.136 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -107.97 137.06 46.63 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.582 0.753 . . . . 73.33 109.068 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 73.0 t -125.8 124.18 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 122.09 -0.381 . . . . 71.4 111.81 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.43 HD23 HD21 ' A' ' 42' ' ' LEU . 2.3 tm? -113.25 115.43 28.18 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.729 1.212 . . . . 75.41 108.454 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 75.0 mtt180 -112.54 106.96 15.52 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 122.056 -0.402 . . . . 74.22 111.779 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.1 t -98.25 95.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 109.651 -0.499 . . . . 64.34 109.651 172.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -71.68 101.6 2.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.103 -0.702 . . . . 73.41 109.103 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.48 11.99 0.53 Allowed Glycine 0 N--CA 1.471 0.998 0 CA-C-O 119.258 -0.745 . . . . 63.45 113.1 -173.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . . . -62.02 100.27 0.16 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.738 0.815 . . . . 32.51 110.918 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.4 tmm_? -158.74 -48.31 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 O-C-N 123.382 0.426 . . . . 75.32 112.027 -170.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.3 m -113.16 -97.5 0.43 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 118.183 0.447 . . . . 71.14 111.894 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.95 21.9 13.9 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 117.917 0.326 . . . . 73.32 113.672 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.21 -14.7 55.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.373 1.069 . . . . 74.01 110.8 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.454 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -77.77 104.4 8.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.386 0.675 . . . . 61.03 109.502 170.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.67 -173.93 40.97 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.182 -0.463 . . . . 65.51 113.404 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -85.22 115.51 23.04 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.428 0.691 . . . . 63.11 111.082 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 45.4 m-85 -106.05 111.71 24.45 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.767 0.827 . . . . 63.22 109.706 172.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.5 tp -91.5 107.81 19.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.267 0.627 . . . . 75.31 110.371 -171.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.403 ' SG ' ' CH2' ' A' ' 27' ' ' TRP . 80.3 m -73.58 90.98 1.8 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.839 -0.801 . . . . 73.32 108.839 164.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -52.32 -47.06 66.2 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.354 1.062 . . . . 65.45 111.399 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.649 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . 67.37 132.8 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 114.602 1.334 . . . . 60.42 114.602 167.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -77.68 37.76 0.63 Allowed 'Trans proline' 0 CA--C 1.57 2.276 0 C-N-CA 123.277 2.652 . . . . 55.4 113.477 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -161.92 -60.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.548 0.739 . . . . 75.14 110.996 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.59 127.17 7.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.295 0.638 . . . . 75.22 110.547 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.3 p -73.94 138.09 44.02 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 113.551 0.945 . . . . 41.05 113.551 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -127.56 126.99 43.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.399 1.08 . . . . 71.54 111.005 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.27 142.01 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.755 0.422 . . . . 60.4 110.445 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 11.6 m-85 -101.74 109.76 21.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.204 1.002 . . . . 74.44 109.943 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.66 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 63.1 mt -86.19 91.7 8.53 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.648 -0.871 . . . . 62.54 108.648 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -89.5 124.03 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.66 -0.7 . . . . 72.45 110.658 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -108.37 107.07 17.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.834 0.853 . . . . 33.15 110.037 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.454 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 94.5 t -94.1 106.68 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 108.363 -0.977 . . . . 74.45 108.363 173.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -164.01 176.03 9.74 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.22 1.008 . . . . 65.32 110.658 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.6 84.72 0.2 Allowed Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.112 0.965 . . . . 74.15 111.514 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo . . . . . 0 CA--C 1.567 2.138 0 C-N-CA 123.222 2.614 . . . . 71.44 114.121 178.052 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 24.6 mmt . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.123 0.487 . . . . 64.22 111.069 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 p -92.9 140.96 28.95 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.392 1.077 . . . . 63.01 109.842 171.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -132.44 116.84 17.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.472 0.709 . . . . 74.32 110.342 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.2 t -129.98 147.49 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.765 0.826 . . . . 73.12 110.825 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -124.25 146.93 48.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.251 1.021 . . . . 74.24 112.226 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -141.09 163.54 32.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.314 1.046 . . . . 74.25 110.315 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 81' ' ' GLU . 1.1 p -93.66 145.39 29.83 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 123.31 0.644 . . . . 72.23 111.706 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 73.1 Cg_endo -68.11 130.88 22.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.269 2.646 . . . . 74.12 113.231 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.81 -18.41 34.53 Favored Glycine 0 N--CA 1.474 1.219 0 CA-C-N 116.156 -0.474 . . . . 61.14 113.557 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.2 -127.56 5.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 117.202 0.501 . . . . 44.15 112.289 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.34 155.45 46.79 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.417 0.627 . . . . 71.11 111.389 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.25 152.81 25.0 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.639 0.776 . . . . 71.3 109.86 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.23 108.09 4.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.975 0.51 . . . . 75.34 110.357 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 51' ' ' LEU . 65.3 mt -106.34 102.04 11.47 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.385 0.674 . . . . 64.45 110.054 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -96.53 125.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.044 -0.725 . . . . 72.55 109.044 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 2.8 t -112.75 142.66 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.48 0.712 . . . . 71.22 111.361 -170.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -138.1 45.63 2.1 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.092 0.957 . . . . 72.35 110.191 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.492 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -57.46 151.01 17.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.144 0.794 . . . . 51.34 113.144 170.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.6 m -91.68 3.62 54.65 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.694 0.798 . . . . 72.24 111.996 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.36 116.9 6.01 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 119.053 -0.86 . . . . 74.01 113.484 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.41 111.51 1.16 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.95 2.434 . . . . 71.32 112.363 173.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' A' ' 69' ' ' PRO . . . 177.25 138.26 2.93 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.304 -0.407 . . . . 24.54 112.691 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.78 112.61 0.55 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.956 -0.913 . . . . 54.24 112.057 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.67 162.07 79.17 Favored 'Cis proline' 0 C--N 1.375 1.944 0 CA-C-N 120.192 1.996 . . . . 73.32 113.612 -3.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.482 HG23 ' HA2' ' A' ' 46' ' ' GLY . 89.5 t -86.9 151.25 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-N 115.146 -0.934 . . . . 71.01 109.624 172.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -93.24 164.41 13.24 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.125 0.57 . . . . 74.25 110.56 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 78.9 m95 -133.03 127.88 35.06 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.85 0.86 . . . . 73.15 110.773 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 87.8 m-85 -131.28 126.15 34.65 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.222 1.009 . . . . 75.24 110.865 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB3' HD21 ' A' ' 34' ' ' LEU . 20.8 tptm -113.67 132.96 55.59 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.673 0.789 . . . . 73.22 108.994 169.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.24 22.27 13.26 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.294 1.045 . . . . 72.03 110.224 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.71 -6.16 71.19 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.543 -0.753 . . . . 63.42 114.108 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -107.26 136.45 47.07 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.988 0.894 . . . . 73.21 111.15 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -59.89 147.97 36.62 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.344 0.868 . . . . 71.43 113.344 -173.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.58 HD21 ' HB3' ' A' ' 29' ' ' LYS . 41.6 mt -100.45 125.53 46.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.301 0.641 . . . . 72.22 110.238 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.46 139.12 32.41 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.752 0.821 . . . . 73.43 109.932 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 p -64.04 92.95 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.515 0.674 . . . . 71.13 111.11 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -111.88 -171.27 1.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.936 0.894 . . . . 54.34 111.834 -175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.29 -44.73 95.07 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.285 -0.416 . . . . 71.0 112.764 174.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 84.3 mtt180 -73.61 -52.87 11.94 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.352 0.661 . . . . 61.52 111.133 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.571 HG11 ' HB3' ' A' ' 34' ' ' LEU . 67.5 t -79.48 95.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 123.322 0.649 . . . . 74.32 111.421 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.5 mt-30 -90.79 100.05 12.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.018 0.927 . . . . 75.23 109.996 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.63 133.05 41.62 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.139 0.575 . . . . 63.32 111.752 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 52.4 mm-40 -107.71 130.42 54.94 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.223 1.009 . . . . 72.54 110.301 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -103.02 141.77 35.25 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.933 0.493 . . . . 75.3 110.883 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.52 -49.05 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.84 1.256 . . . . 74.13 109.457 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 121.2 -72.17 0.37 Allowed Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.106 -0.952 . . . . 72.03 111.226 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -17.97 61.91 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.701 0.8 . . . . 70.14 112.19 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -135.06 107.96 7.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.532 0.733 . . . . 72.45 110.34 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 13.8 mm100 -115.12 143.03 45.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.319 0.648 . . . . 74.45 109.402 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 58.6 t -133.42 114.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 117.984 0.356 . . . . 71.13 110.417 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 14' ' ' LEU . 1.1 tm? -104.98 117.14 33.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.753 0.821 . . . . 73.21 108.889 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 81.5 mtp180 -115.69 112.95 22.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.92 -0.582 . . . . 74.51 110.568 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.16 102.24 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.719 -0.474 . . . . 75.25 109.719 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 39' ' ' ARG . 0.6 OUTLIER -66.87 116.59 7.91 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.168 -0.679 . . . . 65.13 109.168 174.241 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.14 43.9 2.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.203 -0.453 . . . . 65.14 112.511 -173.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . -74.92 118.2 17.62 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.877 0.471 . . . . 62.33 110.107 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -158.34 112.44 2.5 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.863 0.465 . . . . 74.44 111.579 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m 53.38 -78.87 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.323 1.449 . . . . 74.23 114.413 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -11.87 59.99 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 114.815 0.686 . . . . 74.4 114.815 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HB3' HG21 ' A' ' 79' ' ' VAL . 17.7 t70 -66.26 -25.87 67.09 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.507 0.723 . . . . 70.3 111.132 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.725 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -66.97 100.04 0.7 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.082 0.953 . . . . 64.55 110.689 176.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -164.23 -172.71 32.04 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.979 -0.555 . . . . 34.31 113.346 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -86.28 111.03 20.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.387 0.675 . . . . 65.34 110.824 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.783 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 44.1 m-85 -96.44 156.88 16.15 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.087 0.955 . . . . 45.2 109.442 169.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.7 tp -140.44 101.34 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.873 0.368 . . . . 70.21 110.824 -173.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.6 t -85.71 89.97 7.89 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.77 -0.826 . . . . 61.21 108.77 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -100.76 99.9 10.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.706 0.802 . . . . 74.15 112.664 -168.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.8 155.91 67.86 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.614 0.766 . . . . 73.54 110.068 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.522 ' HD2' ' HA3' ' A' ' 22' ' ' GLY . 50.3 Cg_exo -59.77 -2.43 1.56 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.273 2.649 . . . . 72.11 115.746 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -126.01 -43.63 1.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.696 0.798 . . . . 71.54 111.088 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.46 149.04 51.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.033 0.533 . . . . 74.54 111.246 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.476 ' HB2' HD11 ' A' ' 65' ' ' LEU . 79.7 p -129.92 133.18 46.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.637 0.775 . . . . 73.24 110.871 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -106.77 125.22 50.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.273 0.629 . . . . 63.14 110.035 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.451 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 2.2 mp -92.7 125.67 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.853 -0.795 . . . . 72.4 108.853 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.783 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 33.6 m-85 -98.15 101.95 13.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.437 0.695 . . . . 74.23 109.302 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.6 mt -77.55 92.94 4.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.03 -1.1 . . . . 60.03 108.03 172.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.8 t -94.03 139.17 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.153 -0.93 . . . . 63.43 110.718 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.9 p -131.2 107.4 8.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.86 -0.609 . . . . 72.11 109.763 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.725 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 57.4 t -90.11 107.34 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.594 -0.891 . . . . 74.44 108.594 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.79 179.71 7.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.995 0.918 . . . . 73.34 111.06 -167.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 7' ' ' THR . 12.5 tp10 64.21 87.97 0.12 Allowed Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 124.462 1.105 . . . . 73.41 110.584 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo . . . . . 0 C--N 1.383 2.344 0 C-N-CA 124.493 3.462 . . . . 52.03 115.742 -174.86 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.675 0.274 . . . . 74.02 110.795 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.8 m -73.41 95.16 2.17 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 124.297 1.039 . . . . 73.34 110.093 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -83.87 136.27 34.18 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.889 0.876 . . . . 60.14 111.668 -166.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.6 143.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.923 0.889 . . . . 54.32 110.344 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -121.71 138.54 54.31 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.298 1.039 . . . . 74.32 110.377 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t -137.34 178.08 7.37 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.464 0.706 . . . . 71.02 110.45 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 81' ' ' GLU . 4.2 p -124.99 147.71 57.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 124.016 0.926 . . . . 62.55 111.655 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -69.85 87.61 0.56 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.486 2.791 . . . . 74.04 113.402 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.22 -27.11 2.0 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.337 -0.847 . . . . 64.34 112.431 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.71 17.01 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.102 0.401 . . . . 43.3 114.102 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.47 158.25 16.35 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.382 0.673 . . . . 72.52 110.874 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 54.7 tp -119.24 108.25 14.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.337 0.655 . . . . 74.42 110.064 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.34 114.85 23.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.161 0.584 . . . . 72.43 110.242 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 15.2 mt -103.62 103.29 13.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.815 -0.809 . . . . 73.33 108.815 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.467 HG22 HG22 ' A' ' 50' ' ' VAL . 67.3 t -105.56 122.1 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.14 -0.689 . . . . 73.42 109.14 175.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.549 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -100.78 148.27 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.742 0.417 . . . . 42.31 110.717 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 67.4 m80 -128.25 51.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.187 0.994 . . . . 73.25 109.827 166.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.22 170.26 14.43 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.228 -1.351 . . . . 72.41 112.961 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.7 m -90.7 23.89 2.91 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.565 1.146 . . . . 72.51 112.705 -175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.82 157.28 18.08 Favored Glycine 0 CA--C 1.546 2.025 0 CA-C-O 119.959 -0.356 . . . . 64.14 113.933 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.23 -168.14 0.57 Allowed 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.615 2.876 . . . . 61.51 113.428 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.18 -51.24 55.44 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 123.264 0.459 . . . . 41.43 114.066 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.29 -97.2 1.22 Allowed Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.474 0.95 . . . . 73.51 115.474 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.85 126.44 9.63 Favored 'Cis proline' 0 C--N 1.383 2.353 0 CA-C-N 120.891 2.345 . . . . 60.11 114.384 5.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 89.7 t -66.58 131.62 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.439 0.696 . . . . 63.25 110.274 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.06 150.81 20.07 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.46 0.647 . . . . 72.22 110.637 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -110.34 125.24 52.97 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.893 0.877 . . . . 74.32 109.296 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.772 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 81.0 m-85 -111.71 161.7 16.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.149 0.58 . . . . 71.0 110.438 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HB3' HD21 ' A' ' 34' ' ' LEU . 27.2 tptp -146.68 122.9 10.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.741 0.816 . . . . 74.01 109.51 171.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 54.54 25.74 6.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.929 0.891 . . . . 72.13 113.068 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.76 -30.52 7.73 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-N 116.121 -0.491 . . . . 60.24 114.165 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.9 131.79 55.14 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.788 0.794 . . . . 75.33 111.379 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -62.18 151.89 34.7 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.107 0.963 . . . . 75.53 113.536 -177.195 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 29' ' ' LYS . 27.3 mt -100.99 142.32 32.64 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.165 0.986 . . . . 52.21 110.345 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.63 157.46 17.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.997 0.919 . . . . 72.1 109.996 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.9 p -61.62 97.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.841 0.829 . . . . 71.53 111.035 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.506 ' NE2' ' H ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -109.55 163.28 13.59 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.887 1.275 . . . . 73.44 108.135 -175.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' H ' ' NE2' ' A' ' 37' ' ' GLN . . . -53.92 -35.84 54.4 Favored Glycine 0 CA--C 1.543 1.798 0 N-CA-C 114.145 0.418 . . . . 74.4 114.145 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -89.5 -33.06 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.021 0.528 . . . . 74.53 110.821 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.04 86.01 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.93 0.892 . . . . 75.2 111.152 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 68.1 mt-30 -82.82 101.25 10.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.623 0.769 . . . . 75.43 110.751 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.441 HD21 HD23 ' A' ' 51' ' ' LEU . 61.2 mt -89.91 152.86 21.03 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.33 0.586 . . . . 72.41 112.201 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.5 tm-20 -146.48 131.83 18.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.743 -1.206 . . . . 74.32 107.743 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -124.8 103.14 7.92 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.012 0.525 . . . . 75.15 111.034 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.86 11.17 11.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.937 0.895 . . . . 74.23 111.969 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.67 -86.36 1.47 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.179 0.419 . . . . 61.41 113.408 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' HIS . . . -72.56 -5.39 36.79 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.347 0.659 . . . . 32.14 111.865 175.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 54.0 ttp180 -133.71 101.21 5.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.003 0.921 . . . . 60.32 109.745 172.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.0 mm100 -106.09 126.58 52.37 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 109.549 -0.537 . . . . 70.15 109.549 173.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 40.6 t -115.83 122.15 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-O 120.869 0.366 . . . . 62.41 111.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -111.34 114.47 27.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.334 1.054 . . . . 72.22 108.402 169.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.601 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 83.6 mtm180 -114.43 108.31 16.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.992 0.517 . . . . 62.15 111.202 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.7 t -96.55 120.89 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.634 -0.506 . . . . 63.31 109.634 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -79.2 116.08 19.25 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.257 0.623 . . . . 74.23 109.731 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.61 72.45 1.26 Allowed Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.336 -0.393 . . . . 72.52 113.429 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . . . -80.48 102.54 9.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.683 0.793 . . . . 51.23 111.447 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.34 -73.63 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.599 0.759 . . . . 74.5 111.614 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.8 m -127.71 -67.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.855 0.462 . . . . 75.51 111.867 -171.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.1 -12.53 60.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 113.974 0.349 . . . . 72.22 113.974 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.87 -17.48 43.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.292 1.037 . . . . 64.44 110.694 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.64 134.17 34.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.023 0.929 . . . . 55.35 109.554 172.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.04 -178.64 36.92 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.867 -0.606 . . . . 70.14 113.066 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.1 117.67 25.99 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.357 0.599 . . . . 75.34 110.467 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 38.4 m-85 -94.57 157.02 16.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.283 1.033 . . . . 75.34 109.934 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.4 tp -127.94 105.56 8.5 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.828 -0.545 . . . . 74.02 110.525 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' HG21 ' A' ' 16' ' ' VAL . 48.6 t -82.93 88.22 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.637 -0.875 . . . . 41.44 108.637 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -79.36 86.72 5.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.121 0.968 . . . . 63.31 111.684 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -81.01 140.57 49.96 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.816 -0.629 . . . . 74.32 110.054 171.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.32 -35.86 16.44 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 124.498 3.466 . . . . 71.22 115.896 -173.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -124.18 0.38 8.41 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.802 0.841 . . . . 71.24 112.406 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -156.49 49.45 0.48 Allowed 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.785 0.802 . . . . 73.1 111.046 -165.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -66.8 121.6 15.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.148 0.979 . . . . 35.32 112.025 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -127.47 142.66 51.34 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.933 0.716 . . . . 64.31 112.933 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mp -91.05 139.95 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.962 0.905 . . . . 74.32 109.947 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.586 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 9.3 m-85 -102.06 114.89 29.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.563 1.145 . . . . 73.52 111.121 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 93.9 mt -77.36 93.87 4.12 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.591 -0.892 . . . . 75.41 108.591 166.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.486 HG11 HD21 ' A' ' 12' ' ' LEU . 73.5 t -105.45 113.14 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.345 0.658 . . . . 63.01 110.691 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 t -118.1 117.65 29.76 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.564 -0.744 . . . . 64.44 110.747 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.3 t -84.82 106.26 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 107.947 -1.131 . . . . 72.02 107.947 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.41 -173.95 4.17 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.184 0.994 . . . . 74.24 109.922 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 7' ' ' THR . 44.6 tt0 59.78 81.15 0.25 Allowed Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.978 0.911 . . . . 74.14 110.763 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo . . . . . 0 CA--C 1.575 2.566 0 C-N-CA 124.278 3.318 . . . . 74.44 115.875 -177.112 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.579 0.228 . . . . 71.41 111.528 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -79.67 95.19 5.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.674 -0.861 . . . . 75.55 108.674 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.566 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 41.2 mtp180 -93.9 148.34 22.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.567 0.747 . . . . 74.41 112.824 -166.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 79.4 t -130.57 138.57 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.031 0.932 . . . . 64.44 109.473 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.17 119.13 32.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.023 0.929 . . . . 55.15 109.076 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.419 ' HB3' HG22 ' A' ' 79' ' ' VAL . 35.0 t -132.45 163.16 29.38 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.796 0.808 . . . . 53.13 112.568 -170.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.1 p -99.74 155.82 36.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.047 -0.978 . . . . 72.15 111.189 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -82.02 46.71 2.28 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.444 2.762 . . . . 70.3 113.292 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.1 45.67 0.56 Allowed Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.316 -0.402 . . . . 63.5 113.115 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.73 172.98 36.12 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-O 119.635 -0.536 . . . . 72.52 112.193 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.78 135.37 41.71 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.553 0.677 . . . . 73.53 111.131 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.489 HD21 HG11 ' A' ' 77' ' ' VAL . 49.5 tp -78.84 107.44 11.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.782 0.433 . . . . 44.33 110.883 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 36.2 tt0 -111.24 104.59 13.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.922 0.489 . . . . 74.41 110.171 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HG ' HD12 ' A' ' 51' ' ' LEU . 29.3 mt -94.45 106.12 18.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.96 0.904 . . . . 75.11 110.402 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -93.95 113.27 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.588 0.755 . . . . 64.42 110.003 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 18' ' ' LEU . 2.1 t -100.05 149.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.688 0.795 . . . . 71.21 110.631 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -112.02 15.15 20.77 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.308 0.643 . . . . 51.35 111.14 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.609 ' H ' HG12 ' A' ' 16' ' ' VAL . 14.4 mt -54.24 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.514 0.725 . . . . 72.11 112.003 174.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.8 t -68.24 81.36 0.24 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.637 0.775 . . . . 62.21 110.349 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.29 164.18 30.63 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.292 -0.867 . . . . 73.24 113.268 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.09 23.7 0.51 Allowed 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.231 2.621 . . . . 74.22 113.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.74 59.76 4.26 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 122.838 0.256 . . . . 25.15 112.501 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.31 -69.49 1.37 Allowed Glycine 0 CA--C 1.551 2.299 0 CA-C-O 119.616 -0.547 . . . . 73.1 114.44 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.7 -167.35 5.99 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 120.19 1.995 . . . . 65.42 113.534 0.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' HB ' ' HG3' ' A' ' 49' ' ' GLN . 92.6 t -87.77 146.11 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 123.705 0.802 . . . . 54.21 110.459 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.709 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 97.4 mtt180 -96.2 169.72 9.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 75.21 110.66 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 94.8 m95 -131.22 136.92 48.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.824 0.85 . . . . 74.14 110.168 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 59.9 m-85 -134.46 123.67 24.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 123.036 0.535 . . . . 74.34 110.569 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.1 tptp -117.93 133.74 55.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.002 -0.74 . . . . 73.13 109.002 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 61.29 22.31 12.69 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.808 0.843 . . . . 74.21 111.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.09 5.6 82.96 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 114.268 0.467 . . . . 53.24 114.268 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -130.66 133.95 46.54 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.901 0.851 . . . . 72.4 112.358 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.511 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -62.85 150.87 40.61 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.022 1.489 . . . . 75.42 115.022 -171.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.567 HD12 HG21 ' A' ' 40' ' ' VAL . 3.8 mm? -92.61 163.79 13.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.237 1.415 . . . . 72.25 111.024 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.65 140.04 42.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.555 0.742 . . . . 54.31 110.407 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.1 p -81.74 31.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.509 0.724 . . . . 54.12 112.813 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -121.87 124.97 45.36 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.03 0.932 . . . . 74.42 110.655 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.71 -100.03 0.46 Allowed Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.731 0.652 . . . . 71.14 114.731 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -52.37 -46.04 66.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 125.024 1.33 . . . . 74.52 113.03 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.567 HG21 HD12 ' A' ' 34' ' ' LEU . 98.9 t -116.96 143.12 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.366 -0.834 . . . . 72.42 110.616 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -126.0 131.02 52.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.349 1.06 . . . . 62.04 110.156 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 82.6 mt -119.66 145.15 46.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.887 0.475 . . . . 62.13 112.068 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.46 130.69 54.81 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.32 0.648 . . . . 74.43 109.329 166.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -106.32 103.71 13.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.826 0.851 . . . . 64.33 110.018 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.55 178.12 6.31 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.37 0.668 . . . . 74.35 111.316 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.92 -24.79 75.33 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.332 -0.395 . . . . 62.13 113.501 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.65 -55.14 0.73 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.179 0.592 . . . . 73.11 111.868 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 46.7 ttp180 -81.8 97.83 8.18 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.959 0.409 . . . . 64.04 112.053 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 39.6 mm-40 -91.65 133.72 35.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.57 -0.9 . . . . 70.25 108.57 173.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 87.8 t -121.44 115.68 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 122.014 -0.429 . . . . 65.52 110.894 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.6 tm? -95.51 129.61 42.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.153 0.981 . . . . 73.33 108.644 171.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 63.1 mtp180 -131.66 105.34 7.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.853 0.752 . . . . 73.32 111.334 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 51' ' ' LEU . 46.5 t -96.23 105.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.836 -0.801 . . . . 63.21 108.836 171.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -72.39 109.96 6.47 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.53 0.732 . . . . 63.12 112.612 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.01 48.8 1.42 Allowed Glycine 0 C--N 1.35 1.348 0 CA-C-N 116.253 -0.431 . . . . 43.22 113.472 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.11 115.13 12.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.466 0.706 . . . . 74.31 111.551 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -157.5 -65.48 0.09 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.586 0.754 . . . . 53.34 111.989 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.5 m -80.22 -70.48 0.52 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.2 0.815 . . . . 61.12 113.2 -163.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -116.31 30.14 6.65 Favored Glycine 0 N--CA 1.487 2.034 0 CA-C-O 121.075 0.264 . . . . 74.32 112.859 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.95 -6.14 43.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 52.44 112.314 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -83.63 129.09 34.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.366 -0.605 . . . . 75.54 109.366 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 163.39 -174.2 39.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.121 -0.561 . . . . 45.32 114.212 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -91.53 110.65 21.97 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.107 0.563 . . . . 75.22 110.395 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.8 m-85 -95.6 113.63 25.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.854 0.461 . . . . 73.22 110.031 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 54.2 tp -92.85 101.77 14.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.547 0.739 . . . . 74.13 110.277 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 26' ' ' ARG . 72.6 m -71.41 88.48 0.89 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.335 -0.848 . . . . 54.35 109.614 169.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.0 t70 -80.04 89.85 5.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.39 0.614 . . . . 72.43 110.599 -176.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.44 151.39 50.74 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.226 -0.897 . . . . 73.4 111.31 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.62 -21.86 73.05 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.409 2.073 . . . . 71.3 112.633 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.92 93.19 3.92 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.529 -0.915 . . . . 74.14 108.529 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.53 109.61 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 125.3 1.44 . . . . 72.52 113.216 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -75.93 134.34 40.26 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.873 0.869 . . . . 73.14 112.035 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -107.39 141.37 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.329 0.652 . . . . 74.43 110.962 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.5 mp -104.84 137.78 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.092 0.557 . . . . 72.14 110.289 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 7.0 m-85 -108.46 105.44 15.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.312 1.045 . . . . 73.21 110.861 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 95.6 mt -77.17 97.78 4.88 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.324 -0.621 . . . . 63.34 109.324 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG11 HD21 ' A' ' 12' ' ' LEU . 45.3 t -107.65 131.58 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.834 0.454 . . . . 72.24 111.171 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.6 m -119.6 111.62 18.3 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.116 0.567 . . . . 70.32 109.788 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.62 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 40.5 t -109.31 105.25 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.138 -1.06 . . . . 71.11 108.138 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.59 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.523 0.935 . . . . 65.13 113.523 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 51.3 mt-10 -68.57 108.31 2.78 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.132 0.573 . . . . 74.13 110.995 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 26.4 Cg_exo . . . . . 0 C--N 1.383 2.355 0 C-N-CA 123.243 2.628 . . . . 62.23 113.879 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.965 0.412 . . . . 75.01 111.414 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -76.48 156.03 33.34 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.932 0.893 . . . . 62.34 112.29 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -150.75 129.92 12.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.28 1.032 . . . . 72.0 109.587 172.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 99.0 t -129.67 134.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.724 0.81 . . . . 72.1 109.612 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.3 144.17 26.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.026 0.53 . . . . 74.54 110.865 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.483 ' HB2' HD13 ' A' ' 12' ' ' LEU . 40.4 t -125.66 153.7 43.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.021 0.928 . . . . 65.33 109.851 172.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -102.0 150.42 37.43 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.354 0.662 . . . . 73.04 111.024 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.35 96.48 0.19 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.284 2.656 . . . . 75.53 113.769 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.24 38.49 4.53 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.673 -0.694 . . . . 65.13 113.975 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.57 168.85 22.58 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-O 120.085 -0.286 . . . . 74.31 112.547 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 37.0 t70 -70.42 140.95 52.16 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.222 0.534 . . . . 71.12 111.34 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 6' ' ' SER . 64.3 tp -109.41 152.39 25.41 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.421 1.088 . . . . 52.03 109.538 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.73 130.66 19.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.393 0.677 . . . . 71.02 109.653 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.31 105.39 14.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.501 0.721 . . . . 50.42 109.214 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.35 120.72 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.477 0.711 . . . . 65.31 109.239 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.668 ' HB ' ' H ' ' A' ' 49' ' ' GLN . 94.5 t -107.64 131.3 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.893 0.877 . . . . 73.4 111.964 -172.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -143.28 31.33 1.37 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.222 1.009 . . . . 64.0 110.897 172.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -57.61 168.14 0.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.857 0.688 . . . . 72.12 112.857 169.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.3 t -89.58 31.97 0.9 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.074 0.55 . . . . 71.41 111.168 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.62 80.42 0.29 Allowed Glycine 0 CA--C 1.541 1.661 0 CA-C-O 119.367 -0.685 . . . . 75.25 112.683 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.18 175.28 11.02 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.296 2.664 . . . . 53.54 113.466 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.2 -84.78 0.6 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.156 -0.474 . . . . 72.5 113.028 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.28 -161.85 17.4 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.401 -0.666 . . . . 52.23 113.75 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.45 116.1 4.18 Favored 'Cis proline' 0 C--N 1.378 2.129 0 CA-C-N 119.844 1.822 . . . . 63.41 113.422 -1.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.34 123.33 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.787 -0.642 . . . . 71.25 109.636 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -103.85 159.77 15.36 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.276 0.63 . . . . 52.5 111.819 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.43 ' HB3' HD23 ' A' ' 34' ' ' LEU . 86.0 m95 -115.49 137.61 51.88 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.956 0.902 . . . . 72.15 110.249 173.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 98.2 m-85 -135.29 123.33 22.77 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.381 0.672 . . . . 64.02 110.823 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 24.9 tptp -103.53 112.74 25.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.158 0.583 . . . . 72.32 110.379 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 55.59 3.07 0.07 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 126.12 1.768 . . . . 74.03 115.38 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.3 -27.43 1.54 Allowed Glycine 0 N--CA 1.481 1.675 0 O-C-N 121.152 -0.967 . . . . 64.45 114.738 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -113.28 147.15 38.14 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.366 1.083 . . . . 65.12 111.549 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.577 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -69.18 153.08 44.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.741 0.645 . . . . 75.33 112.741 175.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 27' ' ' TRP . 3.2 mm? -90.37 154.74 19.45 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.408 -0.815 . . . . 43.23 109.888 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.6 125.62 12.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.211 1.004 . . . . 33.31 108.671 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 p -55.4 99.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.746 0.818 . . . . 73.23 112.592 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -159.7 116.28 2.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.474 0.71 . . . . 72.43 111.62 -171.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.42 -89.88 0.06 OUTLIER Glycine 0 C--N 1.353 1.522 0 O-C-N 123.547 0.53 . . . . 51.12 113.655 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -75.27 -42.76 54.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.832 0.853 . . . . 73.12 111.601 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.27 106.71 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 116.116 -0.493 . . . . 74.44 110.151 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.658 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.5 mm100 -110.09 104.6 13.49 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.109 0.564 . . . . 70.4 109.625 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD21 HD23 ' A' ' 51' ' ' LEU . 84.9 mt -98.59 143.85 28.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 74.33 112.098 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 40.1 tt0 -140.47 136.75 33.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.224 1.01 . . . . 74.32 109.01 173.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.02 106.56 9.16 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.873 0.844 . . . . 72.44 110.869 -176.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -111.76 21.5 15.98 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.428 1.091 . . . . 72.3 110.967 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.17 -87.09 0.95 Allowed Glycine 0 N--CA 1.477 1.393 0 CA-C-N 116.34 -0.391 . . . . 74.24 112.787 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.87 -40.75 18.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.306 0.642 . . . . 70.45 110.647 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 46.3 ttt180 -78.5 106.38 10.41 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.416 -0.811 . . . . 73.23 110.699 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.668 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 79.9 mm-40 -106.91 155.45 19.75 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.616 0.766 . . . . 72.42 109.587 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 65.1 t -135.76 117.39 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.867 0.467 . . . . 63.0 109.953 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.434 HD23 HD21 ' A' ' 42' ' ' LEU . 2.8 tm? -110.51 118.7 36.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.834 -0.802 . . . . 74.42 108.834 168.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 84.2 mtt180 -113.81 141.42 47.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.06 0.544 . . . . 75.21 110.854 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.7 t -128.83 101.73 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.742 0.817 . . . . 65.12 108.992 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -74.23 121.73 21.72 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.051 -0.351 . . . . 73.23 110.051 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.34 36.47 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.79 -0.186 . . . . 62.41 113.291 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 90.31 0.06 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.573 0.749 . . . . 71.32 111.362 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -88.35 -56.68 3.21 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.055 1.132 . . . . 74.11 114.055 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -161.67 -58.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.326 0.25 . . . . 73.23 111.563 -174.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -9.96 55.03 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.485 -0.325 . . . . 63.33 113.442 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.78 -3.42 44.32 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.687 1.195 . . . . 73.41 111.973 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.67 127.5 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.509 0.724 . . . . 31.32 109.955 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 164.59 -172.72 40.41 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 121.225 0.347 . . . . 75.3 113.695 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -87.26 111.85 21.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.676 0.79 . . . . 51.04 111.45 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -99.35 111.35 23.73 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.819 -0.808 . . . . 73.44 108.819 170.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 tp -94.09 106.63 18.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.249 1.02 . . . . 74.14 110.379 -171.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.433 ' SG ' HD21 ' A' ' 18' ' ' LEU . 42.2 t -79.89 88.06 5.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.629 0.728 . . . . 70.34 109.165 171.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -78.18 89.93 4.28 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.994 -1.003 . . . . 61.34 110.845 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -94.51 148.31 34.73 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.491 0.717 . . . . 64.14 111.264 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -55.04 -32.1 77.73 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 123.538 2.825 . . . . 55.11 114.774 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -86.81 -51.73 5.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.969 0.508 . . . . 44.32 111.592 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -149.39 126.02 11.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.287 0.635 . . . . 62.24 112.164 -175.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -87.08 118.93 26.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.83 0.852 . . . . 72.13 110.41 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.524 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -105.79 131.21 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.227 0.611 . . . . 74.14 111.325 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.5 mt -88.87 117.96 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.791 0.837 . . . . 60.24 109.939 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.487 ' CZ ' HG22 ' A' ' 16' ' ' VAL . 17.8 m-85 -98.58 103.63 15.6 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.831 -0.803 . . . . 65.35 108.831 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.18 93.56 3.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.178 -0.675 . . . . 71.12 109.178 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.1 t -85.2 99.95 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.734 0.778 . . . . 64.53 109.748 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.4 p -95.51 108.79 21.05 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.744 -1.116 . . . . 73.13 109.937 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 6' ' ' SER . 85.6 t -82.37 106.09 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 107.682 -1.229 . . . . 54.01 107.682 173.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -156.24 -178.11 7.08 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.513 1.125 . . . . 65.41 109.888 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 58.25 75.06 0.56 Allowed Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.591 0.757 . . . . 61.02 110.563 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 CA--C 1.572 2.383 0 C-N-CA 123.154 2.57 . . . . 72.23 113.459 -176.69 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.457 0.17 . . . . 75.54 111.311 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -62.06 133.67 55.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.374 0.67 . . . . 54.12 110.124 167.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -126.63 111.74 14.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.345 0.658 . . . . 73.42 109.818 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.2 t -115.16 139.39 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.31 0.644 . . . . 65.32 111.092 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -90.05 136.05 33.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.64 0.776 . . . . 70.2 110.209 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 t -125.37 152.03 45.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.677 0.791 . . . . 74.5 110.145 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 81' ' ' GLU . 1.6 p -104.67 152.28 39.43 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.564 0.745 . . . . 73.23 111.752 177.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 57.1 Cg_endo -80.54 42.71 1.38 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.368 2.712 . . . . 64.31 113.747 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.73 66.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.926 0 N-CA-C 112.293 -0.323 . . . . 35.25 112.293 -173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.32 -136.3 4.12 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-O 120.164 -0.242 . . . . 73.03 112.782 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.47 152.57 51.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.648 0.779 . . . . 50.01 110.761 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.2 tp -89.71 146.73 24.3 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.29 0.636 . . . . 73.44 109.903 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -145.57 114.06 6.73 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.913 -0.402 . . . . 74.14 109.913 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 63.4 mt -106.82 102.02 11.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.582 0.753 . . . . 73.42 110.061 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -94.52 113.19 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.283 -1.006 . . . . 75.33 108.283 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 18' ' ' LEU . 2.9 t -100.01 146.7 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.035 0.534 . . . . 63.11 111.429 -169.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -131.86 43.71 3.0 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.461 0.705 . . . . 75.04 110.426 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.527 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -59.19 164.59 3.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.018 0.747 . . . . 74.33 113.018 172.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.2 p -84.78 38.31 0.69 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.807 0.843 . . . . 53.15 112.319 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 70' ' ' GLN . . . -127.05 84.84 0.34 Allowed Glycine 0 N--CA 1.478 1.482 0 CA-C-O 119.537 -0.59 . . . . 43.32 112.502 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.41 156.77 60.95 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.079 2.519 . . . . 41.55 113.269 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.8 -119.85 11.65 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.908 -0.587 . . . . 65.43 113.473 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -173.74 -164.42 28.86 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-O 119.493 -0.615 . . . . 72.42 113.305 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.0 101.79 0.38 Allowed 'Cis proline' 0 CA--C 1.565 2.032 0 CA-C-N 120.096 1.948 . . . . 62.42 113.029 -3.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HA2' ' A' ' 23' ' ' GLY . 30.7 t -79.89 123.0 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 109.817 -0.438 . . . . 62.31 109.817 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -100.68 158.41 15.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.558 0.743 . . . . 74.22 111.449 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.474 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 62.8 m95 -114.33 142.37 46.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 73.44 111.157 175.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 54.6 m-85 -135.76 160.2 39.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.316 1.047 . . . . 73.51 110.597 177.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.6 tptp -140.75 130.71 24.58 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.54 109.591 165.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 57.68 27.71 14.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.268 1.027 . . . . 65.33 112.63 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 -1.13 76.17 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 115.829 -0.623 . . . . 70.2 114.507 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HG3' HH11 ' A' ' 33' ' ' ARG . 35.3 tt0 -124.78 131.04 53.49 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.325 1.063 . . . . 71.42 111.496 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.611 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.08 143.35 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.524 1.13 . . . . 74.13 113.94 -172.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.6 mt -95.62 147.54 23.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 72.22 111.011 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.49 150.52 23.3 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.936 0.894 . . . . 62.31 110.402 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.9 p -76.36 77.34 3.11 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.281 0.562 . . . . 75.34 110.177 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -76.09 -64.69 1.04 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.7 0.8 . . . . 64.44 112.488 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.36 -49.58 0.24 Allowed Glycine 0 N--CA 1.475 1.266 0 N-CA-C 112.257 -0.337 . . . . 65.11 112.257 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.07 -46.22 15.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.798 -0.816 . . . . 63.13 108.798 164.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.38 93.26 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 108.919 -0.771 . . . . 75.42 108.919 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.227 1.011 . . . . 73.32 110.788 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.22 137.95 51.7 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.084 0.554 . . . . 74.44 110.69 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -122.88 114.4 20.41 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.483 -0.932 . . . . 71.05 108.483 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -103.54 104.03 14.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.76 0.79 . . . . 72.24 110.519 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.13 178.28 6.12 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.499 1.12 . . . . 71.0 110.56 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 95.07 0.22 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.619 -0.545 . . . . 74.51 113.212 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.55 -34.6 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.573 1.549 . . . . 73.41 113.597 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 69.9 ttp85 -85.76 94.08 9.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.5 0.667 . . . . 74.41 110.893 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.506 ' HG3' ' SG ' ' A' ' 66' ' ' CYS . 15.7 mm100 -94.64 142.79 27.04 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.485 -0.78 . . . . 72.45 110.102 172.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 47.4 t -131.26 109.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.037 0.446 . . . . 64.13 111.069 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 HG23 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -96.7 130.9 43.84 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.381 -0.97 . . . . 74.5 108.381 169.027 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -128.57 108.67 10.71 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 61.44 109.339 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 HD11 ' A' ' 51' ' ' LEU . 89.4 t -98.2 96.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.625 0.648 . . . . 74.32 109.868 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.06 96.83 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.204 0.602 . . . . 62.0 110.314 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.38 46.47 0.2 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.839 -0.619 . . . . 74.23 112.019 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.4 113.86 17.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.755 0.822 . . . . 52.2 110.317 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 44.1 ttt85 -161.29 -41.77 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.168 0.803 . . . . 73.52 113.168 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.2 m -129.43 -77.55 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 122.75 0.42 . . . . 64.32 111.759 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.33 -3.37 70.42 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 114.479 0.552 . . . . 44.11 114.479 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -67.51 -26.28 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.15 0.98 . . . . 61.54 112.501 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.28 117.56 16.23 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.638 0.375 . . . . 63.33 110.083 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.31 -171.51 41.34 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 114.196 0.438 . . . . 44.3 114.196 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -87.45 117.17 26.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 74.13 111.277 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.572 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 77.7 m-85 -105.36 108.12 19.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.4 0.68 . . . . 71.41 110.096 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.1 tp -92.59 110.41 21.84 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.284 0.564 . . . . 74.02 109.924 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.506 ' SG ' ' HG3' ' A' ' 49' ' ' GLN . 37.9 t -89.1 88.06 7.42 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.846 0.858 . . . . 53.32 108.98 170.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.6 95.45 6.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.238 1.015 . . . . 62.41 112.473 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.41 137.46 30.69 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.884 0.473 . . . . 75.12 111.004 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.42 -23.51 47.48 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.319 2.679 . . . . 64.0 113.873 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.515 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 24.8 mp0 -85.58 -57.49 3.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.62 0.768 . . . . 62.13 111.096 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -157.0 117.11 3.51 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 112.135 0.42 . . . . 74.52 112.135 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 65' ' ' LEU . 10.5 m -76.06 140.26 41.81 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 64.53 112.204 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 126.86 54.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.672 0.789 . . . . 75.32 110.645 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.1 mp -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.417 -0.586 . . . . 55.2 109.417 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.572 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 37.8 m-85 -100.45 125.52 46.76 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.235 1.014 . . . . 74.2 110.386 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.2 mt -102.6 93.88 5.35 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.424 -0.954 . . . . 63.34 108.424 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.04 126.77 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.638 0.775 . . . . 64.44 110.469 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -119.0 117.52 29.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.689 0.796 . . . . 74.14 110.667 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.0 t -84.82 108.14 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.048 0.452 . . . . 60.03 109.894 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -164.61 -170.04 1.91 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.511 1.125 . . . . 73.2 109.617 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 7' ' ' THR . 32.3 tt0 59.84 72.81 0.72 Allowed Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.571 0.748 . . . . 72.45 110.322 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.571 2.329 0 C-N-CA 122.578 2.186 . . . . 74.24 113.357 -172.542 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.72 0.295 . . . . 71.23 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.8 m -83.59 88.71 7.03 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.806 0.842 . . . . 74.54 108.93 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -98.8 135.5 40.17 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.787 0.835 . . . . 72.45 112.14 -166.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.57 143.49 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.967 0.907 . . . . 71.33 110.233 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -92.21 145.23 24.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.727 0.411 . . . . 73.41 110.712 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.716 ' HB2' HD13 ' A' ' 12' ' ' LEU . 37.8 t -120.95 166.66 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.68 0.792 . . . . 61.31 110.081 166.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.07 138.57 21.78 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 123.069 0.548 . . . . 31.21 111.303 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 96.0 Cg_exo -47.32 117.11 2.09 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 124.13 3.22 . . . . 52.13 114.434 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.69 13.32 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 116.254 -0.43 . . . . 55.11 113.934 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.82 52.92 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 121.151 0.306 . . . . 74.55 113.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 5.5 p-10 -91.5 129.51 37.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.146 0.498 . . . . 73.42 111.463 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.716 HD13 ' HB2' ' A' ' 6' ' ' SER . 51.5 tp -74.65 150.15 39.7 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.706 0.802 . . . . 71.2 109.292 169.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.7 115.56 8.27 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.036 0.534 . . . . 65.21 109.943 170.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 76.2 mt -99.18 101.6 12.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.519 0.728 . . . . 71.14 109.729 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.3 t -90.36 113.02 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.386 -0.968 . . . . 64.51 108.386 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 47.4 t -96.72 122.11 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.242 0.544 . . . . 53.25 112.144 -165.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -120.0 70.53 0.87 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 122.06 0.933 . . . . 74.21 108.823 170.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HG ' ' CG1' ' A' ' 16' ' ' VAL . 19.7 mt -55.68 156.22 5.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.299 1.44 . . . . 73.12 113.278 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.8 m -77.72 -33.53 52.98 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.4 -0.818 . . . . 62.45 110.665 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.37 79.86 0.27 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-N 115.853 -0.612 . . . . 73.43 112.123 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.8 -167.93 0.54 Allowed 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 122.983 2.456 . . . . 44.24 114.007 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.97 -169.72 42.67 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.635 -0.711 . . . . 42.12 112.595 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.99 136.61 5.65 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.355 -0.692 . . . . 45.2 112.911 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.86 162.97 84.0 Favored 'Cis proline' 0 C--N 1.381 2.257 0 CA-C-N 120.032 1.916 . . . . 50.12 113.489 -6.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.566 HG11 ' SG ' ' A' ' 66' ' ' CYS . 53.9 t -115.09 134.57 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.926 0.89 . . . . 72.24 110.321 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -97.6 131.77 43.87 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.827 0.851 . . . . 72.2 110.643 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.2 137.29 41.55 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.796 0.839 . . . . 74.2 111.605 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.7 m-85 -130.51 124.04 31.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.695 0.798 . . . . 73.12 110.316 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB3' HD21 ' A' ' 34' ' ' LEU . 18.7 tptm -104.4 120.26 40.81 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 73.24 109.231 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.44 22.45 13.25 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.113 0.965 . . . . 75.12 111.216 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.17 -26.5 22.8 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.841 -0.618 . . . . 53.51 113.724 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.15 129.96 44.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.431 0.692 . . . . 63.32 110.805 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 152.55 16.14 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.888 0.875 . . . . 70.43 112.953 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 29' ' ' LYS . 28.6 mt -107.71 138.74 43.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.886 0.474 . . . . 72.31 111.293 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 144.8 29.07 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.773 0.829 . . . . 42.31 111.089 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -71.76 92.68 1.22 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.658 0.783 . . . . 51.42 111.678 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.455 0.702 . . . . 74.23 112.309 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.03 -57.21 21.06 Favored Glycine 0 C--N 1.36 1.87 0 N-CA-C 115.078 0.791 . . . . 71.24 115.078 -172.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -77.4 -40.71 42.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.812 0.445 . . . . 62.12 111.544 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 54.7 t -95.41 85.6 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.425 0.69 . . . . 70.34 110.541 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -92.79 125.11 37.24 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.995 0.518 . . . . 74.43 112.145 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.34 93.38 4.5 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.522 0.729 . . . . 63.04 111.049 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.756 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 37.0 tt0 -87.57 105.48 17.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.778 0.831 . . . . 70.4 110.566 173.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -94.22 110.04 21.8 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.226 0.61 . . . . 74.42 110.506 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.16 -45.65 5.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.428 0.691 . . . . 63.44 111.254 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.09 -91.1 0.12 Allowed Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.534 -0.626 . . . . 73.1 111.534 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -38.55 64.48 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.615 0.721 . . . . 70.51 109.913 169.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -81.19 125.89 30.83 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.417 -1.265 . . . . 74.14 110.431 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 83.4 mm-40 -117.49 152.42 35.09 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.898 -1.149 . . . . 54.44 107.898 164.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t -138.71 116.24 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.671 0.388 . . . . 72.44 110.617 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.47 128.48 54.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.554 0.742 . . . . 60.25 109.28 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 57.4 mtt180 -116.3 136.73 52.74 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.91 0.884 . . . . 72.41 110.393 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.26 97.57 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.298 0.639 . . . . 74.5 109.532 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -75.2 130.01 38.45 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.942 -0.392 . . . . 73.24 109.942 178.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.56 23.43 39.69 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.485 -0.325 . . . . 71.34 112.868 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.6 99.23 0.42 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.496 0.718 . . . . 74.15 110.221 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.632 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 63.9 mtp85 -104.9 -177.28 3.32 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.588 0.755 . . . . 73.31 112.113 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.0 m -62.57 108.68 1.19 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.299 0.64 . . . . 64.41 110.896 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.62 -15.36 8.02 Favored Glycine 0 N--CA 1.481 1.634 0 CA-C-N 116.233 -0.439 . . . . 53.33 112.88 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.43 -12.08 59.99 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.991 0.917 . . . . 73.21 111.809 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.621 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -63.61 92.36 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.557 1.143 . . . . 73.41 111.545 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.13 -179.93 20.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.488 -0.778 . . . . 60.11 113.511 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.33 124.89 31.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.109 0.564 . . . . 72.52 111.24 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 71.0 m-85 -112.9 108.65 17.68 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.177 0.991 . . . . 75.11 109.51 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 65.4 tp -91.14 103.41 16.1 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.952 -0.467 . . . . 72.41 110.364 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.566 ' SG ' HG11 ' A' ' 25' ' ' VAL . 40.5 t -77.67 86.91 3.96 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.682 0.753 . . . . 71.25 109.316 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.01 97.02 9.05 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.019 -0.991 . . . . 43.21 110.747 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.57 159.37 46.9 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 122.96 0.504 . . . . 70.4 111.039 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.94 36.21 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.635 2.223 . . . . 72.02 113.596 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -165.47 -54.33 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.14 0.576 . . . . 74.53 109.641 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -138.58 108.73 6.41 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.848 0.859 . . . . 64.52 110.862 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 p -93.38 124.05 37.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 70.03 110.985 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.83 139.22 48.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.794 0.437 . . . . 71.21 112.107 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.5 mt -89.04 130.82 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 109.478 -0.564 . . . . 62.11 109.478 170.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 3.0 m-85 -103.75 103.39 13.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.452 0.701 . . . . 74.42 109.333 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.42 93.05 5.93 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.725 -0.843 . . . . 75.21 108.725 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -91.13 127.86 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.084 0.554 . . . . 63.43 111.014 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.8 p -107.08 108.77 20.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.147 0.579 . . . . 70.04 109.918 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 6' ' ' SER . 22.2 t -98.45 106.36 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.073 -0.714 . . . . 72.13 109.073 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -168.56 172.89 7.8 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.692 0.397 . . . . 72.23 111.992 -171.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 58.56 86.85 0.15 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 124.577 1.151 . . . . 73.55 110.85 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.574 2.491 0 C-N-CA 122.817 2.345 . . . . 36.5 114.034 -173.206 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.603 -0.517 . . . . 54.44 109.603 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -62.37 127.24 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.22 0.608 . . . . 54.31 110.946 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -137.77 126.85 24.32 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.776 0.831 . . . . 74.05 109.982 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.1 131.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 121.423 0.63 . . . . 65.41 111.808 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.439 ' NH2' ' HB2' ' A' ' 81' ' ' GLU . 60.3 ttt85 -90.38 139.73 30.39 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.789 1.236 . . . . 74.52 110.054 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.549 ' HB3' HG22 ' A' ' 79' ' ' VAL . 34.1 t -137.69 172.0 13.6 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.121 0.568 . . . . 74.25 110.613 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 p -130.81 148.16 69.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.873 0.869 . . . . 74.13 111.214 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.33 145.88 39.18 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.637 2.225 . . . . 75.01 112.659 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.77 37.29 8.68 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 116.049 -0.523 . . . . 33.42 113.931 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.23 -134.67 1.7 Allowed Glycine 0 N--CA 1.475 1.275 0 CA-C-O 119.972 -0.349 . . . . 61.41 112.675 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.24 155.43 49.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 117.275 0.538 . . . . 72.4 111.18 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.11 143.18 32.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.505 1.122 . . . . 73.2 109.185 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.81 99.0 3.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.107 0.48 . . . . 64.4 111.267 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 51' ' ' LEU . 49.0 mt -92.23 105.53 17.72 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.106 0.962 . . . . 64.41 110.732 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.2 t -103.58 127.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.902 -0.407 . . . . 73.43 109.902 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 66' ' ' CYS . 3.4 m -108.3 149.93 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.412 0.685 . . . . 75.22 111.693 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -128.36 31.41 5.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.104 0.962 . . . . 75.11 109.444 163.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' HG ' ' HB ' ' A' ' 16' ' ' VAL . 1.2 pp -51.69 166.02 0.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.89 1.07 . . . . 42.03 113.89 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -86.64 32.86 0.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.338 0.655 . . . . 74.13 112.756 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.586 ' HA3' ' HB1' ' A' ' 68' ' ' ALA . . . -112.39 90.11 0.55 Allowed Glycine 0 CA--C 1.544 1.888 0 CA-C-O 119.506 -0.608 . . . . 64.11 112.654 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.19 165.4 23.73 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.116 2.544 . . . . 73.32 113.237 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.87 -86.23 0.17 Allowed Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.879 -0.601 . . . . 42.45 113.62 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.07 8.56 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-O 118.782 -1.01 . . . . 52.41 114.028 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.28 117.44 2.67 Favored 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.828 2.314 . . . . 71.13 113.635 1.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.501 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 91.3 t -65.24 124.05 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.706 -0.679 . . . . 72.41 110.084 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 89.0 mtm180 -94.89 164.43 12.92 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.511 0.725 . . . . 71.3 111.003 -171.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -120.81 134.96 55.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.96 0.904 . . . . 74.44 109.716 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.9 m-85 -122.1 162.53 21.08 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.244 1.018 . . . . 74.42 110.791 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.6 tptp -154.32 128.33 8.9 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.425 1.09 . . . . 72.41 108.929 169.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 64.72 17.3 10.88 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.011 0.924 . . . . 74.03 111.988 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.47 -7.14 81.9 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.534 -0.303 . . . . 71.42 113.726 -173.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -109.31 121.58 45.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.713 0.805 . . . . 70.41 110.444 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.7 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.9 143.58 57.34 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.732 0.642 . . . . 75.32 112.732 -175.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.2 mt -87.49 152.62 22.07 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.291 1.037 . . . . 74.45 110.988 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.42 158.85 20.12 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.835 0.854 . . . . 65.22 110.343 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -70.62 82.8 0.6 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.789 0.804 . . . . 62.05 110.954 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -96.78 170.47 9.16 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.104 1.362 . . . . 75.31 110.509 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.15 -43.25 93.47 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.544 0.116 . . . . 73.43 113.348 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.26 -53.6 13.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.935 0.494 . . . . 75.31 110.708 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 34' ' ' LEU . 59.7 t -88.17 90.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 124.138 0.975 . . . . 73.43 112.03 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.628 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.2 mt-30 -82.32 114.89 21.1 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.45 0.7 . . . . 71.24 110.379 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.411 ' HB3' HE22 ' A' ' 44' ' ' GLN . 29.1 mt -110.06 104.36 13.22 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.203 0.601 . . . . 53.53 111.76 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.81 98.55 11.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.925 0.89 . . . . 70.54 110.559 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.411 HE22 ' HB3' ' A' ' 42' ' ' LEU . 23.4 mp0 -99.92 132.02 45.53 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.364 0.666 . . . . 75.31 110.994 172.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.26 -49.0 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.97 0.908 . . . . 52.25 110.415 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.98 122.15 1.52 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-O 119.045 -0.864 . . . . 63.11 111.155 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 69.21 -65.58 0.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.944 1.297 . . . . 63.24 112.288 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 ttp180 -79.07 95.91 5.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.866 0.466 . . . . 72.43 110.806 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 8.6 mm100 -116.49 136.95 52.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.753 0.821 . . . . 75.53 109.458 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG12 ' HG3' ' A' ' 52' ' ' ARG . 36.0 t -121.52 124.24 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.152 0.501 . . . . 65.42 111.18 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.67 120.36 40.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 52.54 108.562 168.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 73.6 mtp180 -119.61 107.91 13.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.944 0.498 . . . . 72.24 110.094 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -96.42 100.96 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.943 0.497 . . . . 62.21 110.005 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -71.79 103.09 3.01 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.936 0.494 . . . . 73.22 109.975 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.39 42.51 0.25 Allowed Glycine 0 N--CA 1.474 1.198 0 CA-C-N 116.293 -0.412 . . . . 74.22 112.695 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.44 131.5 49.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.007 0.523 . . . . 71.41 110.642 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -163.56 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.232 0.827 . . . . 74.41 113.232 -167.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 m -159.07 -56.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 123.273 0.629 . . . . 33.14 111.305 -171.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -20.59 70.92 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.069 0.388 . . . . 61.13 114.069 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -81.46 -16.0 53.32 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.146 0.978 . . . . 62.45 111.193 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 79' ' ' VAL . . . -74.13 111.57 9.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.88 0.472 . . . . 72.13 109.737 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.2 -171.9 44.78 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 114.081 0.393 . . . . 72.54 114.081 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -81.25 113.46 19.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.391 0.676 . . . . 70.21 110.941 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 32.8 m-85 -95.36 155.95 16.53 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.994 0.918 . . . . 74.43 109.334 167.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.9 tp -133.57 104.89 6.58 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.135 -0.353 . . . . 72.2 110.075 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 16' ' ' VAL . 34.4 t -74.99 89.35 2.4 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.883 . . . . 74.25 108.617 169.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 22.5 t70 -74.86 92.09 2.5 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.659 1.184 . . . . 62.01 111.582 -173.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB1' ' HA3' ' A' ' 20' ' ' GLY . . . -96.05 148.4 34.46 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.256 0.623 . . . . 70.35 111.355 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.42 -21.75 66.2 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.985 2.457 . . . . 73.41 113.625 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.525 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 86.1 mm-40 -112.57 -51.44 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.25 0.62 . . . . 74.13 112.147 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.45 97.41 3.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.728 0.411 . . . . 74.02 111.467 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -85.09 141.9 29.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.298 0.639 . . . . 75.22 110.706 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -130.26 131.97 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.055 0.542 . . . . 71.21 112.191 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.73 131.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.506 1.122 . . . . 71.23 109.93 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 39.8 m-85 -100.79 111.26 23.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.388 0.675 . . . . 73.11 110.772 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.33 93.56 7.18 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.786 -1.19 . . . . 71.24 107.786 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.0 119.94 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.126 0.57 . . . . 72.44 110.684 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.1 p -118.4 112.22 19.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.526 0.731 . . . . 55.22 110.411 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 6' ' ' SER . 44.7 t -86.08 107.21 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 121.287 0.565 . . . . 72.4 109.492 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.4 -171.21 2.54 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.637 1.175 . . . . 64.13 110.103 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . 31.2 tt0 60.09 63.41 3.08 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 124.056 0.942 . . . . 65.24 111.944 166.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.574 2.519 0 C-N-CA 122.69 2.26 . . . . 71.4 114.491 -166.157 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.869 0.366 . . . . 71.32 111.206 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -83.72 85.89 7.22 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.935 0.894 . . . . 43.45 110.37 -170.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.587 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 40.6 mtm180 -84.53 144.74 28.48 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.772 0.829 . . . . 70.3 112.098 -170.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 74.9 t -139.58 133.83 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.175 0.99 . . . . 74.42 110.604 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -101.14 145.86 28.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.504 0.722 . . . . 70.21 110.85 171.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 163.25 32.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.064 0.546 . . . . 73.15 111.65 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 81' ' ' GLU . 23.7 p -98.24 146.04 30.86 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 123.676 0.79 . . . . 72.04 111.608 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.16 92.07 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.051 2.5 . . . . 62.14 112.022 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.16 -14.92 5.38 Favored Glycine 0 N--CA 1.477 1.399 0 CA-C-N 115.617 -0.719 . . . . 35.34 113.24 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.71 149.34 18.52 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-O 119.504 -0.609 . . . . 74.03 112.066 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.02 131.09 44.83 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.845 0.823 . . . . 75.42 111.74 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 77' ' ' VAL . 55.6 tp -78.83 98.28 6.27 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.778 -0.646 . . . . 61.53 109.747 172.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -101.51 109.67 21.53 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 110.077 -0.342 . . . . 74.15 110.077 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.0 103.5 15.8 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.311 -0.626 . . . . 63.25 109.311 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 t -92.43 101.45 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.769 -0.826 . . . . 73.32 108.769 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.54 HG12 ' HG ' ' A' ' 18' ' ' LEU . 12.1 t -101.63 130.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.166 0.586 . . . . 54.22 111.565 -168.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.0 45.58 1.77 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.752 0.821 . . . . 43.23 110.753 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.54 ' HG ' HG12 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.4 178.04 0.11 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 113.479 0.918 . . . . 52.41 113.479 169.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 m -87.41 24.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.615 0.766 . . . . 73.05 112.534 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.24 90.85 0.55 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 119.395 -0.669 . . . . 43.42 112.197 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.38 127.95 14.79 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.031 2.487 . . . . 73.21 113.547 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 -111.59 4.3 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.353 -0.385 . . . . 72.43 113.319 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 -82.99 0.31 Allowed Glycine 0 CA--C 1.547 2.061 0 CA-C-O 119.121 -0.822 . . . . 71.4 113.744 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HG2' HH22 ' A' ' 26' ' ' ARG . 90.7 Cg_endo -73.99 148.16 91.28 Favored 'Cis proline' 0 C--N 1.382 2.308 0 CA-C-N 120.778 2.289 . . . . 54.32 113.041 1.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.633 HG11 ' SG ' ' A' ' 66' ' ' CYS . 86.9 t -62.63 136.92 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.57 0.748 . . . . 73.42 111.681 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.536 HH22 ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -97.73 128.98 44.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.421 0.688 . . . . 74.1 109.762 -177.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -97.57 136.41 38.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.107 0.563 . . . . 65.41 111.102 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 88.0 m-85 -133.14 147.97 52.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.028 0.931 . . . . 74.2 110.516 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 28.3 tptp -136.36 133.38 36.74 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.422 1.089 . . . . 72.5 108.945 165.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.85 17.62 11.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.217 1.007 . . . . 63.33 112.259 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.01 86.69 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 113.753 0.261 . . . . 71.3 113.753 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -117.05 135.11 53.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.436 0.694 . . . . 71.41 109.777 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.85 151.86 17.11 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 113.257 0.836 . . . . 63.55 113.257 -176.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 29' ' ' LYS . 21.5 mt -98.18 163.59 12.67 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.347 0.594 . . . . 64.34 111.204 171.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.53 151.9 49.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.128 0.971 . . . . 64.32 109.729 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 77.6 p -79.29 98.39 6.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.843 0.457 . . . . 73.04 110.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -102.75 -78.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.95 -0.469 . . . . 54.12 110.925 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.42 -59.66 0.01 OUTLIER Glycine 0 N--CA 1.472 1.071 0 N-CA-C 111.563 -0.615 . . . . 72.4 111.563 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -70.04 -44.28 69.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.247 0.619 . . . . 71.54 110.412 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.7 t -82.53 99.03 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.237 0.615 . . . . 70.25 109.428 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.3 mt-30 -95.2 110.6 22.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.538 0.735 . . . . 74.31 110.148 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 54.9 mt -106.31 111.99 24.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.914 0.486 . . . . 63.23 111.206 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.4 tp10 -94.98 106.29 18.27 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.659 1.184 . . . . 64.34 110.098 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.35 103.76 16.37 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.939 0.496 . . . . 54.54 109.926 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 48' ' ' ARG . . . -125.02 -164.03 1.24 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.385 0.674 . . . . 73.51 110.595 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.67 -89.29 0.14 Allowed Glycine 0 C--N 1.353 1.503 0 N-CA-C 112.586 -0.206 . . . . 34.52 112.586 172.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.36 -27.35 24.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.367 0.667 . . . . 70.45 112.102 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 62.6 ttp180 -90.04 87.99 7.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.332 0.653 . . . . 60.41 111.669 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -91.75 129.2 37.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.462 -0.57 . . . . 74.51 109.462 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 33.5 t -130.31 110.92 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-O 120.811 0.339 . . . . 54.44 111.582 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -100.25 113.86 26.86 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.775 0.83 . . . . 71.44 108.807 168.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 72.5 mtp180 -111.34 107.77 17.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.029 0.532 . . . . 75.34 110.404 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 57.6 t -88.0 95.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.22 -0.659 . . . . 64.25 109.22 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.24 121.29 9.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.763 0.825 . . . . 60.12 112.241 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 60.35 8.14 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 123.205 0.316 . . . . 73.11 113.636 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.98 110.55 14.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.523 0.729 . . . . 74.21 112.623 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -171.75 3.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.368 0.667 . . . . 74.44 111.26 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m -61.66 -26.28 67.92 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.991 0.737 . . . . 62.1 112.991 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.92 73.28 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.565 -0.289 . . . . 54.12 113.761 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.15 0.1 57.34 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.038 0.935 . . . . 74.24 112.35 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -77.33 101.32 6.26 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.178 0.591 . . . . 52.22 109.912 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.43 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -167.62 -175.25 37.34 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 114.228 0.451 . . . . 60.44 114.228 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -89.21 108.86 19.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.122 0.569 . . . . 72.44 110.575 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -98.62 112.32 24.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.397 0.679 . . . . 73.13 109.758 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 38.1 tp -91.43 104.34 16.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.457 0.646 . . . . 63.31 110.336 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.633 ' SG ' HG11 ' A' ' 25' ' ' VAL . 51.3 t -85.7 86.33 7.37 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.738 -0.838 . . . . 54.05 108.738 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.09 105.88 13.54 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.299 -0.864 . . . . 55.23 110.204 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -113.9 160.33 32.58 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.285 0.634 . . . . 32.12 111.959 -174.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.78 120.45 8.36 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.587 2.192 . . . . 74.33 112.351 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 75.53 -60.92 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.526 1.53 . . . . 74.21 112.387 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 38.4 t70 -105.68 98.91 8.54 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.282 0.633 . . . . 73.43 111.872 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 t -95.01 129.52 42.05 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.921 0.889 . . . . 73.43 111.196 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -119.03 131.05 55.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.412 0.685 . . . . 50.33 112.344 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.46 135.55 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.857 -0.794 . . . . 61.35 108.857 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.414 ' CZ ' HG22 ' A' ' 16' ' ' VAL . 4.8 m-85 -106.2 103.39 12.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.512 0.725 . . . . 71.03 109.747 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.587 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 78.9 mt -78.08 92.87 4.42 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.944 -0.761 . . . . 62.31 108.944 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.507 HG21 HD21 ' A' ' 12' ' ' LEU . 55.6 t -87.77 132.88 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.554 -0.748 . . . . 71.35 110.774 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.0 m -134.56 109.23 8.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.618 -0.719 . . . . 75.23 110.798 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.409 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 76.6 t -89.08 106.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 107.985 -1.117 . . . . 64.35 107.985 173.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.57 12.06 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 113.565 0.95 . . . . 64.55 113.565 -167.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 7' ' ' THR . 34.7 tt0 -125.71 100.4 31.32 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.781 -0.628 . . . . 74.51 109.55 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 CA--C 1.568 2.18 0 C-N-CA 123.43 2.753 . . . . 71.31 114.255 -178.7 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.561 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 49.7 tpp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.135 -0.321 . . . . 42.43 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 p -65.22 93.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.37 0.668 . . . . 45.41 112.045 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -90.93 129.57 36.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 71.03 110.344 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 78.0 t -131.27 138.34 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 124.062 0.945 . . . . 63.32 110.007 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -106.45 130.28 54.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.206 0.602 . . . . 71.42 110.82 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.438 ' HB3' HG22 ' A' ' 79' ' ' VAL . 37.0 t -112.99 171.76 7.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.636 0.774 . . . . 51.33 111.626 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 81' ' ' GLU . 22.5 p -120.81 138.2 27.37 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 113.453 0.909 . . . . 62.13 113.453 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.8 Cg_endo -77.49 91.09 1.2 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.605 2.87 . . . . 74.51 112.734 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.74 -13.58 8.65 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.221 -0.9 . . . . 71.21 112.23 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.81 -137.39 8.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.495 -0.058 . . . . 63.12 113.015 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -149.88 150.71 32.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.243 0.617 . . . . 71.4 111.135 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.88 148.24 23.96 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.527 0.731 . . . . 74.34 110.795 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.01 109.73 5.01 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.453 0.701 . . . . 74.52 110.043 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 79.7 mt -106.48 101.58 11.03 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.384 -0.599 . . . . 73.24 109.384 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.6 114.81 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.724 -0.843 . . . . 70.31 108.724 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.48 HG12 ' HG ' ' A' ' 18' ' ' LEU . 6.9 t -103.24 138.97 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.364 0.666 . . . . 75.01 111.576 -166.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -132.23 30.07 4.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.549 0.74 . . . . 63.13 110.917 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.48 ' HG ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -54.77 158.89 2.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.193 0.812 . . . . 72.44 113.193 171.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -90.83 48.31 1.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.175 0.59 . . . . 73.24 111.093 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.91 128.25 8.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.983 -0.898 . . . . 73.03 112.69 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.34 89.92 0.26 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.991 2.461 . . . . 74.15 113.753 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.49 -84.15 0.1 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.905 -0.589 . . . . 75.51 114.346 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.41 -173.68 44.79 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.631 -0.538 . . . . 72.34 113.269 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.33 114.33 3.29 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 119.586 1.693 . . . . 65.42 112.814 -4.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.67 120.93 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 109.369 -0.604 . . . . 71.14 109.369 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 50.0 mtt180 -95.38 164.99 12.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.386 1.074 . . . . 73.32 110.904 -173.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -128.46 130.67 47.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.052 0.941 . . . . 72.4 109.985 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.784 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 97.9 m-85 -123.35 164.64 18.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.754 0.822 . . . . 75.4 110.81 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 19.3 tptm -154.3 125.64 7.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.566 0.746 . . . . 70.02 110.05 174.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.09 17.15 9.92 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.187 0.995 . . . . 71.2 111.333 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.06 -31.07 5.44 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.752 -0.471 . . . . 72.24 114.237 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.32 147.06 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.091 0.946 . . . . 74.21 112.614 -170.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.93 153.03 30.39 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 74.32 115.249 -167.013 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.5 154.94 18.13 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.753 0.821 . . . . 73.32 111.17 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.82 148.54 51.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.421 1.088 . . . . 64.35 109.021 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 t -58.78 97.48 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.383 0.673 . . . . 61.22 110.747 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -136.05 84.23 2.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.753 0.821 . . . . 63.21 110.732 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.77 -88.65 0.02 OUTLIER Glycine 0 N--CA 1.478 1.467 0 CA-C-N 115.336 -0.847 . . . . 61.12 114.424 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.253 1.021 . . . . 72.33 111.003 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.03 104.83 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.382 0.673 . . . . 64.32 109.672 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 74.1 mt-30 -109.86 119.3 38.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.13 0.972 . . . . 75.33 110.354 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.65 137.38 46.69 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.469 0.707 . . . . 63.32 112.013 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 15.2 tp10 -133.36 102.3 5.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.534 1.134 . . . . 74.2 109.369 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -101.9 104.05 14.75 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.421 0.629 . . . . 65.22 111.361 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.15 75.74 1.64 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.61 0.764 . . . . 75.24 110.331 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.58 -117.15 6.93 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 115.877 -0.601 . . . . 64.31 112.783 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.85 -21.99 27.78 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.45 0.7 . . . . 63.14 111.125 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.92 91.0 1.5 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.743 0.817 . . . . 73.51 110.155 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -102.93 139.14 38.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.616 0.767 . . . . 54.51 110.068 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 99.7 t -129.16 124.91 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.841 0.353 . . . . 54.35 110.664 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -117.09 122.91 45.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.09 0.956 . . . . 75.11 108.66 170.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.548 HH11 ' HB3' ' A' ' 52' ' ' ARG . 0.8 OUTLIER -119.57 134.84 55.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.493 0.717 . . . . 74.31 109.972 176.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.46 98.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.097 -0.705 . . . . 63.43 109.097 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.74 115.39 16.46 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.61 -0.723 . . . . 63.32 110.846 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.18 52.95 1.3 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-O 120.881 0.156 . . . . 75.21 113.089 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.32 160.89 30.47 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.666 0.786 . . . . 72.1 111.794 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 29.9 ttm180 -166.97 -55.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.991 0.516 . . . . 73.33 111.495 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -147.64 -47.43 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 122.855 0.462 . . . . 74.22 111.382 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.48 -17.13 59.43 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.778 0.671 . . . . 42.23 114.778 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.407 ' HB3' HG21 ' A' ' 79' ' ' VAL . 30.7 t70 -72.22 -27.48 62.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.024 0.93 . . . . 72.02 112.186 174.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -72.95 103.74 3.85 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 72.3 111.514 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . -177.0 -173.5 42.61 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.85 -0.614 . . . . 74.25 113.659 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -90.58 117.13 29.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.78 0.432 . . . . 72.21 110.039 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 66.8 m-85 -102.27 106.33 17.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.879 0.872 . . . . 73.32 110.55 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 63.4 tp -91.94 102.08 14.64 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.028 -0.42 . . . . 72.03 110.242 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -79.34 87.18 5.02 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.771 -0.826 . . . . 73.23 108.771 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 17.5 t70 -76.04 130.54 38.53 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.764 0.826 . . . . 65.53 111.275 -173.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.599 ' HB3' ' H ' ' A' ' 72' ' ' SER . . . -127.77 143.83 49.04 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 118.664 -0.684 . . . . 61.33 110.393 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.56 -29.49 7.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 124.248 3.299 . . . . 73.44 115.099 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -152.32 66.74 0.83 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.632 0.773 . . . . 74.11 109.494 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 28.9 t70 -172.42 -80.2 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 123.917 0.887 . . . . 71.13 110.709 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.599 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 40.0 m 65.46 106.24 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.052 1.341 . . . . 71.11 112.548 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.15 135.15 49.17 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.818 0.847 . . . . 72.41 110.938 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.561 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 64.6 mt -100.96 119.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.961 0.504 . . . . 71.2 110.804 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 2' ' ' THR . 29.3 m-85 -100.34 101.81 12.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.286 0.634 . . . . 72.34 110.631 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.0 mt -81.88 93.84 6.97 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.317 -0.623 . . . . 73.43 109.317 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 75.5 t -98.12 121.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.69 0.796 . . . . 50.33 111.269 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.2 p -121.46 116.64 25.1 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 73.41 111.371 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.9 t -83.81 110.6 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.316 -0.624 . . . . 73.4 109.316 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -151.57 -41.63 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.589 0.588 . . . . 65.01 112.589 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 7' ' ' THR . 10.8 tp10 -66.8 106.03 1.03 Allowed Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.93 0.892 . . . . 73.22 110.607 -175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo . . . . . 0 CA--C 1.57 2.295 0 C-N-CA 123.078 2.519 . . . . 74.41 113.747 -172.759 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 110.158 -0.312 . . . . 65.51 110.158 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.1 m -80.38 83.92 6.12 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.536 0.735 . . . . 75.4 110.061 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.594 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 55.4 mtm180 -83.67 140.41 32.17 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.548 0.739 . . . . 74.04 112.342 -172.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.01 144.0 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.06 0.944 . . . . 71.14 109.97 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.94 145.28 51.98 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.455 0.702 . . . . 65.22 110.848 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.7 t -146.85 171.66 14.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.907 0.883 . . . . 73.1 110.31 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -76.03 148.87 82.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 112.982 0.734 . . . . 71.42 112.982 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.16 110.87 3.19 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.391 2.727 . . . . 73.4 112.907 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.47 -7.73 43.29 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.318 -0.855 . . . . 73.14 112.981 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.67 -156.67 31.53 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 122.767 0.222 . . . . 64.2 113.174 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 164.41 23.48 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.874 0.47 . . . . 61.44 110.502 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.494 HD21 HG11 ' A' ' 77' ' ' VAL . 47.5 tp -135.58 110.95 9.07 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.623 -0.51 . . . . 62.23 109.623 167.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.11 110.75 15.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.068 -0.345 . . . . 71.1 110.068 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.7 mt -89.41 104.72 17.25 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.679 -0.86 . . . . 74.22 108.679 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.76 107.65 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.445 -0.946 . . . . 42.3 108.445 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.431 HG12 ' HG ' ' A' ' 18' ' ' LEU . 16.0 t -115.35 129.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.384 0.674 . . . . 41.44 111.116 -170.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -140.82 43.71 1.83 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.711 0.804 . . . . 71.21 110.489 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' HG ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -58.71 167.52 1.49 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.464 0.706 . . . . 73.43 112.55 170.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -59.77 -49.1 79.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.862 0.465 . . . . 75.45 111.145 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.0 66.0 1.82 Allowed Glycine 0 C--N 1.356 1.668 0 N-CA-C 115.544 0.978 . . . . 64.2 115.544 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.24 97.02 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.669 2.246 . . . . 74.33 112.682 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.0 -154.33 22.4 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.797 -0.638 . . . . 74.11 113.079 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.24 -179.82 41.42 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.584 -0.564 . . . . 62.23 113.039 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.9 156.72 97.63 Favored 'Cis proline' 0 C--N 1.376 1.99 0 CA-C-N 119.791 1.796 . . . . 74.21 113.99 -4.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.87 130.23 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 123.504 0.722 . . . . 73.34 109.534 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -104.31 147.39 27.56 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.073 0.949 . . . . 72.41 111.232 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -104.96 132.41 51.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.993 0.517 . . . . 74.15 111.106 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.5 m-85 -126.84 165.36 19.49 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.493 1.117 . . . . 72.14 110.387 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -152.35 114.83 4.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.805 0.842 . . . . 73.23 110.05 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 t70 72.64 -27.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.653 1.581 . . . . 52.0 113.965 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.03 -11.17 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.138 0.399 . . . . 71.4 112.784 -172.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -129.45 138.47 51.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.256 0.623 . . . . 75.23 110.739 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.747 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.67 150.95 26.12 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.938 0.895 . . . . 71.41 112.692 177.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.08 134.28 34.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.879 0.472 . . . . 75.23 110.563 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.07 163.32 12.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.817 0.847 . . . . 70.34 110.383 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 p -68.74 89.38 0.39 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.601 0.715 . . . . 71.2 110.854 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 46.9 tt0 -99.1 164.79 12.02 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.42 1.088 . . . . 72.35 109.935 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.12 -40.09 90.92 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 113.52 0.168 . . . . 74.44 113.52 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -77.98 -54.34 6.4 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.157 0.583 . . . . 73.11 110.485 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 66.9 t -82.46 86.77 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 124.086 0.954 . . . . 65.31 111.63 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 37.8 mt-30 -80.25 133.34 35.98 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.926 0.89 . . . . 74.32 110.822 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.7 mt -118.95 154.67 32.64 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.102 0.561 . . . . 70.54 112.131 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.624 ' HG3' HH12 ' A' ' 52' ' ' ARG . 39.8 mt-10 -126.46 113.83 17.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.235 1.014 . . . . 64.43 110.58 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -94.01 114.9 27.18 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.684 0.794 . . . . 65.34 110.691 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.88 -68.23 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.765 0.426 . . . . 71.31 111.596 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.59 139.08 6.02 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 119.19 -0.783 . . . . 44.13 111.38 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 64.15 -69.87 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.235 1.014 . . . . 55.03 110.488 -165.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -71.41 116.59 11.92 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.25 0.547 . . . . 64.43 110.286 166.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -134.13 133.79 41.47 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.075 1.35 . . . . 71.04 108.269 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -136.53 117.14 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 121.775 -0.578 . . . . 74.11 110.374 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -101.77 123.92 46.54 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.248 1.019 . . . . 73.22 109.136 172.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.624 HH12 ' HG3' ' A' ' 43' ' ' GLU . 1.5 mpp_? -116.19 108.02 15.61 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.184 0.594 . . . . 75.42 110.799 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.432 HG23 HD11 ' A' ' 51' ' ' LEU . 76.2 t -96.67 96.71 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.271 -0.64 . . . . 75.51 109.271 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.24 129.18 38.22 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.469 0.708 . . . . 71.31 110.987 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.47 40.34 33.09 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.151 0.306 . . . . 72.34 112.891 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 131.87 36.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.137 0.975 . . . . 42.45 112.265 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -156.75 -84.47 0.05 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.239 0.616 . . . . 73.24 110.768 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.1 t -92.45 121.9 34.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.623 0.769 . . . . 61.44 110.547 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.3 -31.7 5.3 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.531 -0.304 . . . . 62.14 112.732 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.2 -29.21 60.26 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.088 0.955 . . . . 74.2 111.435 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.15 113.67 10.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.23 -0.655 . . . . 62.34 109.23 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.12 -170.22 43.32 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 123.123 0.264 . . . . 73.42 113.242 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -89.16 114.26 25.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.0 0.52 . . . . 74.4 111.126 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 46.5 m-85 -96.77 154.34 17.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.742 0.817 . . . . 73.13 109.797 171.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.4 tp -132.88 105.13 6.94 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.687 0.395 . . . . 64.31 110.759 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.73 87.93 6.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.226 -1.027 . . . . 51.35 108.226 169.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.74 95.24 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.796 -1.093 . . . . 64.12 110.907 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -100.99 145.67 30.81 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.466 0.706 . . . . 54.42 110.644 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.206 2.604 . . . . 75.33 113.19 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 61.09 35.02 18.88 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.51 1.124 . . . . 52.14 112.335 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 12.6 t70 -140.79 -83.06 0.23 Allowed 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 123.628 0.771 . . . . 70.14 109.726 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.9 m 56.73 103.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.701 1.371 . . . . 74.43 114.701 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -107.1 135.54 48.47 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.201 0.6 . . . . 75.14 111.815 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.39 138.95 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.114 0.965 . . . . 54.21 109.225 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.8 m-85 -115.91 104.1 11.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.586 1.155 . . . . 74.35 109.546 -174.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.594 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 73.9 mt -78.35 91.28 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.944 -1.132 . . . . 72.3 107.944 171.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.494 HG11 HD21 ' A' ' 12' ' ' LEU . 82.0 t -99.16 119.64 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 115.344 -0.844 . . . . 72.3 110.884 -175.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.4 p -112.94 108.07 16.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.828 0.851 . . . . 74.01 110.037 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.0 t -95.56 104.28 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.309 -0.997 . . . . 54.23 108.309 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -173.82 -165.43 0.25 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.516 1.126 . . . . 73.24 108.893 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 64.55 82.34 0.21 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.674 0.79 . . . . 50.41 109.45 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 C--N 1.384 2.403 0 C-N-CA 123.359 2.706 . . . . 71.11 114.029 -171.965 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.645 -0.502 . . . . 55.04 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 33.3 m -83.23 106.86 15.35 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.911 0.484 . . . . 61.04 110.595 -172.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -112.44 145.24 40.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.781 0.832 . . . . 73.2 110.908 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.1 t -138.22 137.55 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 123.636 0.775 . . . . 72.24 110.68 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -113.55 138.84 49.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.387 0.675 . . . . 74.22 110.4 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.1 t -129.95 166.02 20.92 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.502 0.721 . . . . 73.12 110.575 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.2 p -83.28 148.83 56.92 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.237 0.615 . . . . 62.12 112.208 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -78.78 75.14 5.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.308 2.672 . . . . 73.42 113.206 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.77 -32.4 0.21 Allowed Glycine 0 C--N 1.342 0.861 0 CA-C-N 115.455 -0.793 . . . . 75.44 113.159 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.51 -138.1 3.9 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.885 0.314 . . . . 72.0 113.885 -174.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.51 140.08 49.48 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.028 0.531 . . . . 75.33 109.926 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 HG11 ' A' ' 77' ' ' VAL . 55.3 tp -85.74 99.87 11.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.201 0.6 . . . . 62.13 110.021 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.66 103.15 13.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.116 0.567 . . . . 71.43 110.279 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 51' ' ' LEU . 45.0 mt -96.1 102.72 14.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.303 0.641 . . . . 73.42 110.383 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.77 115.58 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.367 0.667 . . . . 71.14 109.711 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -99.35 138.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-O 121.022 0.439 . . . . 74.23 110.068 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -104.63 38.06 1.98 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.894 0.878 . . . . 74.5 109.973 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 73' ' ' ARG . 17.2 mt -53.73 -40.12 65.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.96 1.304 . . . . 60.24 112.334 173.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 t 62.75 19.99 11.8 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.358 1.063 . . . . 54.4 111.811 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.75 135.36 14.61 Favored Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.911 -0.939 . . . . 53.3 112.167 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.19 89.37 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.125 2.55 . . . . 72.15 114.017 -173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.9 -95.11 0.26 Allowed Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.639 -0.71 . . . . 50.23 113.853 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 69' ' ' PRO . . . 121.67 -89.48 0.43 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-O 119.155 -0.803 . . . . 74.05 113.082 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.66 145.13 82.23 Favored 'Cis proline' 0 C--N 1.379 2.183 0 CA-C-N 120.266 2.033 . . . . 73.12 113.859 4.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 68' ' ' ALA . 75.8 t -65.93 129.69 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.4 -0.818 . . . . 63.2 110.882 173.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.466 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 99.2 mtt180 -96.41 127.66 42.61 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.342 -0.614 . . . . 51.55 109.342 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -98.31 131.59 44.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.02 0.528 . . . . 72.44 110.014 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.722 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 84.2 m-85 -126.0 136.66 53.24 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.854 0.862 . . . . 65.41 109.809 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' A' ' 64' ' ' TYR . 17.3 tptm -104.81 116.86 32.73 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.821 0.848 . . . . 74.34 108.994 171.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.71 -59.51 0.53 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.773 1.629 . . . . 71.12 111.13 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 32' ' ' GLU . . . -164.79 -9.93 0.03 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 123.867 0.746 . . . . 61.22 112.355 172.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 31' ' ' GLY . 44.6 tt0 -106.2 135.26 47.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.716 0.807 . . . . 70.51 110.667 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.49 152.82 20.88 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.072 1.138 . . . . 75.21 114.072 -171.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -86.3 161.42 18.75 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.62 -0.718 . . . . 72.32 110.309 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.51 106.33 5.92 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.916 0.886 . . . . 54.42 109.637 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 p -63.91 99.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.655 0.782 . . . . 72.34 111.307 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -124.7 -65.04 1.06 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.468 0.707 . . . . 75.3 111.565 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.09 -64.9 0.01 OUTLIER Glycine 0 N--CA 1.478 1.438 0 N-CA-C 112.748 -0.141 . . . . 32.23 112.748 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -67.3 -58.97 3.83 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.979 -0.749 . . . . 72.22 108.979 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.9 t -72.91 124.04 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.713 -1.131 . . . . 74.33 110.47 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -135.34 113.83 11.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.223 1.009 . . . . 72.52 109.525 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -97.53 108.25 20.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.6 0.76 . . . . 72.13 110.52 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.7 tm-20 -98.33 108.29 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.59 1.156 . . . . 54.34 109.474 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -99.5 102.22 13.7 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.532 0.733 . . . . 65.11 109.354 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.78 -29.63 17.5 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.232 0.613 . . . . 71.05 112.207 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 -42.41 1.6 Allowed Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.789 0.233 . . . . 25.03 112.528 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.17 -28.26 7.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.756 0.822 . . . . 74.34 110.192 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -105.92 141.3 37.56 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.279 1.032 . . . . 71.24 111.166 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HG3' HG21 ' A' ' 25' ' ' VAL . 84.3 mm-40 -125.2 128.34 48.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.778 0.831 . . . . 63.45 109.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 39.3 t -129.58 110.59 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 112.252 0.464 . . . . 52.51 112.252 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -93.98 112.81 24.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.084 -0.71 . . . . 73.53 109.084 168.564 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 67.4 mtp180 -106.52 119.59 39.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.216 0.606 . . . . 71.24 110.223 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.25 102.24 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.274 0.629 . . . . 72.45 109.492 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -74.9 131.93 41.08 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.231 0.613 . . . . 73.22 111.27 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.5 5.35 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 116.015 -0.538 . . . . 70.04 112.29 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.38 114.81 25.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.992 0.917 . . . . 65.01 112.242 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.23 -80.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.13 0.972 . . . . 73.31 112.262 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.2 p -101.22 -76.65 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.415 0.686 . . . . 53.2 112.439 -163.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 -6.29 58.29 Favored Glycine 0 C--N 1.356 1.689 0 N-CA-C 114.142 0.417 . . . . 64.14 114.142 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.38 -24.05 63.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.295 1.038 . . . . 73.34 111.322 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.617 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -73.49 128.4 35.39 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.667 0.787 . . . . 74.43 109.608 172.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.0 178.78 39.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.67 -0.3 . . . . 65.41 113.344 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -84.73 115.88 22.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.599 0.36 . . . . 61.23 110.478 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' CZ ' ' HD3' ' A' ' 29' ' ' LYS . 50.1 m-85 -102.08 123.19 45.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.132 0.492 . . . . 65.15 110.966 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 58.8 tp -94.12 100.71 12.76 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.748 0.819 . . . . 60.12 109.471 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 16' ' ' VAL . 46.2 t -90.34 88.08 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.622 0.725 . . . . 52.24 109.658 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.4 t70 -72.09 94.87 1.56 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.48 1.112 . . . . 75.45 111.485 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -76.46 163.11 68.13 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.543 1.137 . . . . 63.31 113.058 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.528 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 77.7 Cg_endo -75.22 -4.22 15.03 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.569 2.18 . . . . 74.14 113.892 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -117.63 -56.17 2.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.457 0.703 . . . . 74.05 110.972 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.21 119.56 5.53 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.346 0.659 . . . . 71.31 110.011 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.407 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 35.7 t -62.35 128.08 34.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.551 0.741 . . . . 74.21 111.924 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -107.37 147.15 30.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.48 0.712 . . . . 75.41 111.136 -177.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.82 146.96 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.225 0.61 . . . . 74.3 110.337 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.622 ' HB3' HG23 ' A' ' 77' ' ' VAL . 10.7 m-85 -107.47 139.03 42.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.841 1.256 . . . . 74.23 110.893 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.11 93.77 4.87 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.599 -1.259 . . . . 61.23 107.599 162.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 75' ' ' PHE . 78.8 t -101.02 132.2 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.688 -0.687 . . . . 54.24 111.356 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 76.7 p -127.17 124.54 39.27 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.154 0.982 . . . . 71.34 108.987 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.617 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 39.5 t -104.43 105.2 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.012 -1.107 . . . . 62.1 108.012 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.93 -168.39 0.66 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.923 1.289 . . . . 72.12 109.618 -170.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 62.53 85.8 0.16 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 123.849 0.86 . . . . 54.11 109.786 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.572 2.422 0 C-N-CA 123.131 2.554 . . . . 73.43 113.235 -174.769 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.463 ' SD ' HD11 ' A' ' 76' ' ' LEU . 62.9 mtt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.517 0.199 . . . . 75.24 110.591 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 m -102.58 88.46 3.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.908 0.883 . . . . 35.12 110.097 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.604 ' HG3' ' HB2' ' A' ' 76' ' ' LEU . 3.8 mpt_? -78.35 138.58 38.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.503 0.721 . . . . 54.33 111.966 -172.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 91.6 t -140.91 134.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.161 0.984 . . . . 64.24 109.663 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -90.68 145.28 24.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.098 0.559 . . . . 65.52 110.401 176.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB2' HD13 ' A' ' 12' ' ' LEU . 41.0 t -127.91 159.73 34.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.212 0.605 . . . . 74.44 111.848 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 81' ' ' GLU . 18.2 p -112.95 150.67 43.22 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 124.603 1.161 . . . . 54.53 111.529 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.43 98.49 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.272 2.648 . . . . 72.14 113.682 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.81 -14.33 22.02 Favored Glycine 0 N--CA 1.479 1.514 0 CA-C-N 116.006 -0.543 . . . . 42.01 114.245 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.53 -143.17 3.89 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 117.54 0.67 . . . . 74.12 113.764 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.08 127.0 37.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.153 0.581 . . . . 64.13 111.024 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.9 tp -77.64 123.6 26.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.45 0.7 . . . . 54.51 110.022 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -115.87 112.65 22.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.199 0.454 . . . . 73.0 109.891 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 51' ' ' LEU . 79.0 mt -91.75 101.64 14.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.409 -0.589 . . . . 65.12 109.409 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.59 108.03 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 108.842 -0.799 . . . . 74.14 108.842 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 18' ' ' LEU . 6.1 t -98.63 113.53 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.572 0.349 . . . . 61.41 110.863 -169.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -90.2 33.85 0.88 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 122.944 0.498 . . . . 71.11 111.672 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' H ' HG12 ' A' ' 16' ' ' VAL . 9.9 mt -51.07 155.93 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.327 1.051 . . . . 74.43 111.866 164.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 t -75.28 74.14 2.39 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.691 -0.855 . . . . 72.42 108.691 167.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.52 119.48 16.52 Favored Glycine 0 CA--C 1.541 1.696 0 CA-C-N 115.48 -0.782 . . . . 72.03 114.415 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.6 29.97 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.818 2.346 . . . . 73.34 112.895 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -59.42 4.9 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.876 0.274 . . . . 64.52 112.441 -174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.01 174.69 24.44 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.759 -0.467 . . . . 55.42 112.719 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.27 148.04 28.46 Favored 'Cis proline' 0 CA--C 1.559 1.736 0 CA-C-N 119.147 1.474 . . . . 72.35 113.571 -4.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' SG ' ' A' ' 66' ' ' CYS . 85.4 t -114.57 136.42 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.223 0.609 . . . . 62.3 109.695 174.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -98.25 128.17 44.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 74.22 110.586 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.414 ' HB3' HD23 ' A' ' 34' ' ' LEU . 77.4 m95 -99.39 143.3 29.8 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.399 0.68 . . . . 74.23 110.76 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 93.3 m-85 -135.45 124.25 23.95 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.426 0.691 . . . . 72.02 110.725 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.9 tptp -118.51 132.45 56.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.281 0.632 . . . . 73.2 109.431 172.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.3 26.09 15.97 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.816 0.846 . . . . 71.51 111.51 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -2.06 86.36 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 114.941 0.737 . . . . 72.51 114.941 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -125.01 144.29 50.47 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.531 1.166 . . . . 72.4 111.367 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.68 152.66 43.7 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.053 1.131 . . . . 73.41 114.053 -172.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.444 ' HB3' HG11 ' A' ' 40' ' ' VAL . 3.9 mm? -88.85 162.02 16.39 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.837 0.855 . . . . 55.3 111.397 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.16 107.5 4.38 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.05 0.94 . . . . 13.34 110.164 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 p -66.42 91.94 0.19 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.692 0.797 . . . . 75.11 112.251 -176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -139.94 -73.3 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.267 0.627 . . . . 73.51 111.131 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -94.4 1.75 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 122.684 0.183 . . . . 41.52 113.141 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -70.18 -32.36 70.25 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.474 0.31 . . . . 63.34 111.495 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 34' ' ' LEU . 87.2 t -81.86 120.27 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.44 0.696 . . . . 65.42 110.493 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 72.6 mt-30 -126.16 97.1 4.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.044 0.938 . . . . 74.25 109.392 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.1 152.38 23.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.28 0.562 . . . . 55.04 112.024 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.77 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.0 tm-20 -138.54 106.45 5.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 107.774 -1.195 . . . . 71.14 107.774 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -100.34 102.75 14.07 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.533 0.333 . . . . 72.2 110.152 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.37 3.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.791 0.836 . . . . 72.14 111.115 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.61 -72.82 0.65 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 116.356 -0.384 . . . . 33.2 113.318 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.6 19.97 12.62 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.728 0.811 . . . . 74.4 112.23 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -148.23 151.41 35.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.259 0.552 . . . . 73.04 112.182 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.1 155.45 38.36 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.143 0.977 . . . . 63.04 108.61 164.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 84.7 t -141.91 136.62 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.175 0.512 . . . . 73.51 110.432 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 14' ' ' LEU . 1.7 tm? -120.5 116.14 24.82 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.445 -0.946 . . . . 64.42 108.445 171.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 99.6 mtt180 -108.14 109.43 20.84 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.328 0.651 . . . . 62.24 111.349 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.3 t -88.42 98.08 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.985 0.514 . . . . 73.41 110.264 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.95 127.35 32.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.943 0.497 . . . . 62.34 109.974 168.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.77 33.69 15.21 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 112.675 -0.17 . . . . 23.53 112.675 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.71 110.87 2.95 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.763 0.825 . . . . 64.2 111.288 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -163.28 124.49 2.4 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.132 0.573 . . . . 65.15 109.95 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.539 ' H ' HG11 ' A' ' 79' ' ' VAL . 50.2 m 55.93 -82.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.305 1.442 . . . . 54.24 113.851 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.9 -7.24 55.41 Favored Glycine 0 C--N 1.363 2.043 0 N-CA-C 114.702 0.641 . . . . 74.02 114.702 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.69 -32.81 74.41 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.767 0.827 . . . . 71.43 111.618 170.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.679 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -67.82 100.68 0.96 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 72.03 111.286 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -166.65 -174.07 35.59 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.679 -0.691 . . . . 62.11 113.059 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -93.49 113.02 25.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.506 0.722 . . . . 64.31 110.536 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.684 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 49.2 m-85 -101.17 111.89 24.22 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.393 0.677 . . . . 70.34 109.947 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 72' ' ' SER . 61.0 tp -92.1 100.6 13.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 122.869 0.468 . . . . 75.13 110.122 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.418 ' SG ' HG11 ' A' ' 25' ' ' VAL . 37.8 t -79.0 86.09 4.89 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.926 0.87 . . . . 73.41 108.74 170.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -94.13 115.69 28.01 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.423 -1.262 . . . . 73.54 112.229 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.04 154.48 55.66 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.776 0.83 . . . . 61.42 109.36 171.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.48 -19.32 17.31 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.616 2.211 . . . . 71.41 113.003 171.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -76.35 -72.83 0.31 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.879 0.872 . . . . 64.53 110.92 170.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -139.25 144.12 38.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.834 0.854 . . . . 63.34 111.4 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 65' ' ' LEU . 51.5 p -112.4 109.32 18.86 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.916 0.886 . . . . 44.4 110.382 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.98 127.77 53.37 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.07 0.948 . . . . 74.41 110.987 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.32 128.43 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.574 0.75 . . . . 55.41 110.179 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 4.1 m-85 -102.2 111.18 23.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 61.44 110.15 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.604 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 78.9 mt -85.02 94.12 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 75.52 109.734 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.6 t -94.71 137.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.711 0.804 . . . . 74.02 110.639 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -137.17 111.26 8.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.141 0.576 . . . . 74.0 110.865 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.679 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 46.4 t -83.94 103.43 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.089 -1.078 . . . . 65.15 108.089 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.94 33.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.848 0.832 . . . . 70.22 110.978 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' O ' HG22 ' A' ' 7' ' ' THR . 10.1 tp10 -130.91 92.87 32.66 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 115.17 -0.923 . . . . 52.45 109.131 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo . . . . . 0 CA--C 1.571 2.342 0 C-N-CA 122.526 2.151 . . . . 53.12 113.197 -179.472 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.631 0.253 . . . . 73.44 111.004 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m -75.44 79.17 2.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.31 1.052 . . . . 61.24 109.746 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -92.55 131.63 37.51 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.512 -1.222 . . . . 73.33 111.971 -163.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.0 t -121.78 127.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.837 0.855 . . . . 72.42 110.694 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -93.2 142.89 26.8 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.729 0.812 . . . . 74.42 109.918 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -137.25 160.23 39.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.647 0.779 . . . . 60.31 110.968 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -96.16 148.46 34.55 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 123.686 0.795 . . . . 74.15 111.135 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 95.4 Cg_endo -72.9 128.36 13.14 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.131 2.554 . . . . 65.34 112.938 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.81 66.12 1.23 Allowed Glycine 0 C--N 1.357 1.748 0 CA-C-N 116.656 -0.247 . . . . 63.14 113.162 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.74 -115.73 0.38 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 113.439 0.136 . . . . 55.44 113.439 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -144.67 131.47 20.17 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.054 0.941 . . . . 73.34 109.731 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 65.3 tp -96.65 101.63 13.27 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.031 0.532 . . . . 74.43 110.092 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.18 112.08 24.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.905 0.482 . . . . 74.25 110.302 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.42 HD12 HD12 ' A' ' 51' ' ' LEU . 41.6 mt -108.17 103.93 13.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.887 0.875 . . . . 64.12 109.584 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' A' ' 48' ' ' ARG . 74.4 t -91.31 134.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.5 0.72 . . . . 63.12 109.34 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 49' ' ' GLN . 39.6 t -99.09 141.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 121.292 0.568 . . . . 72.2 111.678 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.57 -34.85 5.71 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.851 0.86 . . . . 75.34 110.876 166.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 73' ' ' ARG . 6.8 mt 63.52 178.07 0.16 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 123.857 0.863 . . . . 61.15 113.117 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 t -102.77 -24.72 13.7 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.992 -0.549 . . . . 74.44 110.144 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.54 103.38 0.83 Allowed Glycine 0 CA--C 1.543 1.819 0 CA-C-O 119.635 -0.536 . . . . 75.15 112.985 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.51 102.3 1.54 Allowed 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 122.798 2.332 . . . . 61.33 113.379 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.5 131.57 1.58 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 121.455 -0.402 . . . . 62.03 113.891 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.94 169.94 49.06 Favored Glycine 0 CA--C 1.547 2.087 0 CA-C-O 119.477 -0.624 . . . . 53.03 113.587 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.26 115.49 3.92 Favored 'Cis proline' 0 C--N 1.379 2.163 0 CA-C-N 120.079 1.939 . . . . 63.2 112.962 1.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.87 118.9 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 122.986 0.514 . . . . 74.24 109.967 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -99.96 146.54 26.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.522 0.729 . . . . 64.23 111.783 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.415 ' CD1' HD22 ' A' ' 42' ' ' LEU . 79.6 m95 -100.17 134.18 43.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.164 0.986 . . . . 74.01 110.844 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.593 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 41.6 m-85 -130.03 139.28 51.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.323 1.049 . . . . 74.43 109.007 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.1 tptp -116.55 127.05 54.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.566 0.621 . . . . 73.33 110.098 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 56.39 20.49 4.75 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.088 1.355 . . . . 70.24 113.57 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.53 4.42 32.4 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.095 0.798 . . . . 74.21 115.095 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -141.3 141.11 33.93 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 1.168 . . . . 74.35 111.594 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.71 151.77 16.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.456 1.28 . . . . 61.53 114.456 -171.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 29' ' ' LYS . 19.5 mt -103.34 157.33 17.1 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.753 0.821 . . . . 51.24 111.002 172.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.86 143.68 44.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.161 0.985 . . . . 72.42 110.197 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.8 p -80.09 73.21 6.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.178 0.591 . . . . 61.42 110.511 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -134.68 -92.65 0.31 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.759 0.652 . . . . 75.31 112.759 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.81 87.28 1.51 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-O 120.012 -0.326 . . . . 42.14 113.29 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 69.88 -11.52 0.54 Allowed 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.947 1.299 . . . . 71.43 113.269 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.16 114.17 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.518 1.127 . . . . 64.05 108.933 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 45.6 mt-30 -113.18 132.25 55.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.476 1.11 . . . . 72.41 110.145 -173.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 27' ' ' TRP . 79.6 mt -119.03 92.14 3.73 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.721 0.408 . . . . 74.14 110.651 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 2.6 mp0 -82.06 98.7 8.77 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.434 0.694 . . . . 71.53 110.369 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.28 126.88 34.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.178 0.514 . . . . 72.22 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.81 13.34 2.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.559 0.744 . . . . 63.45 112.095 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.15 -77.68 0.87 Allowed Glycine 0 C--N 1.35 1.349 0 N-CA-C 112.49 -0.244 . . . . 73.42 112.49 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.07 -54.02 5.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.035 0.534 . . . . 70.5 110.145 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.589 ' HG3' HG13 ' A' ' 15' ' ' VAL . 48.3 ttp180 -82.84 90.45 6.93 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.603 0.716 . . . . 72.51 111.675 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 16' ' ' VAL . 9.8 mm100 -95.97 126.67 41.37 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.447 -0.946 . . . . 71.23 108.447 170.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 46.6 t -114.9 108.94 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 O-C-N 121.911 -0.493 . . . . 34.21 110.836 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.42 HD12 HD12 ' A' ' 14' ' ' LEU . 1.5 tm? -91.23 112.51 24.45 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.668 -0.864 . . . . 72.14 108.668 170.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 74.2 mtp180 -113.49 104.73 12.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.809 0.444 . . . . 74.42 110.988 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 51' ' ' LEU . 61.2 t -93.33 97.01 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.185 -1.043 . . . . 64.33 108.185 168.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.05 96.09 0.42 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.469 -0.787 . . . . 73.24 110.705 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.36 -60.1 0.19 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.833 -1.076 . . . . 64.54 110.886 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . 45.5 69.69 0.43 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.404 1.481 . . . . 73.55 112.734 174.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.68 -56.24 0.08 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.158 0.429 . . . . 65.31 112.158 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -141.86 117.81 10.56 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.137 0.575 . . . . 74.34 110.986 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.25 80.7 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.484 -0.326 . . . . 74.42 113.462 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.05 -31.87 39.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.341 1.056 . . . . 74.12 111.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.02 120.19 21.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.583 0.753 . . . . 53.33 109.784 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.08 -175.58 45.97 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.657 -0.306 . . . . 50.42 113.706 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.79 112.45 24.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.836 0.454 . . . . 63.5 110.159 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 59.4 m-85 -98.84 124.1 43.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.294 0.637 . . . . 75.12 111.717 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 46.5 tp -94.75 118.32 31.55 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.969 0.508 . . . . 65.5 110.683 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.3 t -92.63 88.95 6.49 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.157 0.983 . . . . 71.04 109.93 170.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.593 ' HB3' ' HE1' ' A' ' 28' ' ' TYR . 14.0 t70 -91.11 107.23 19.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.787 0.835 . . . . 63.43 111.44 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.66 157.86 43.34 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.762 0.825 . . . . 42.31 111.038 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.02 -32.06 96.84 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.334 2.023 . . . . 75.34 111.979 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.0 101.85 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.259 1.024 . . . . 74.1 109.138 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 71.42 143.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.709 1.203 . . . . 55.35 113.811 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.3 p -118.58 120.58 37.91 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.951 0.9 . . . . 72.25 108.97 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -109.62 149.32 29.86 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.183 0.593 . . . . 63.1 111.313 -174.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.05 134.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.183 0.593 . . . . 74.13 110.581 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 6.5 m-85 -114.7 104.05 11.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.707 1.203 . . . . 61.21 109.903 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.09 112.39 20.18 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.799 -0.445 . . . . 74.23 109.799 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.5 t -106.65 131.09 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.059 0.543 . . . . 73.35 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -126.76 108.8 11.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.527 0.731 . . . . 73.44 110.322 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.16 107.4 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.336 0.655 . . . . 62.02 109.328 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.34 178.45 8.67 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.542 0.737 . . . . 55.13 111.479 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 61.39 79.78 0.27 Allowed Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 124.696 1.198 . . . . 75.12 111.213 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.573 2.452 0 C-N-CA 123.393 2.729 . . . . 74.1 114.291 -176.568 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.87 0.366 . . . . 65.23 111.44 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.0 m -75.55 86.41 2.64 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.333 1.053 . . . . 72.31 110.562 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 44.7 mtm180 -89.08 152.1 21.85 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.778 0.659 . . . . 74.0 112.778 -172.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.7 t -139.64 135.5 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 124.328 1.051 . . . . 72.44 110.34 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -94.36 145.95 24.4 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 122.992 0.517 . . . . 71.52 110.927 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.2 t -134.29 156.52 48.3 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.601 0.76 . . . . 72.22 110.762 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -84.62 147.01 48.09 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 123.144 0.577 . . . . 70.5 111.419 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.9 82.12 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.29 2.66 . . . . 72.24 113.298 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.3 7.38 4.45 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 114.521 -1.218 . . . . 63.24 112.543 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.94 26.38 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 114.724 0.649 . . . . 72.32 114.724 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.71 110.53 21.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.865 0.866 . . . . 74.21 110.456 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.9 tp -74.09 138.92 44.26 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.433 -0.58 . . . . 74.15 109.433 169.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -145.02 111.39 5.65 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.27 0.628 . . . . 74.53 109.957 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 46.0 mt -98.99 101.65 13.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.098 -0.705 . . . . 73.33 109.098 175.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -97.4 106.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 108.46 -0.941 . . . . 61.14 108.46 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 18.2 t -98.93 141.37 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.974 0.91 . . . . 64.32 111.324 -166.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -137.75 48.86 1.99 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.371 0.668 . . . . 73.3 109.89 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -57.04 174.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.075 1.139 . . . . 74.51 114.075 172.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -91.49 20.52 5.27 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.556 0.742 . . . . 64.11 112.408 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 121.36 19.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.905 -0.941 . . . . 72.03 112.888 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.89 21.99 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.472 2.781 . . . . 73.35 115.006 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.51 -105.27 0.22 Allowed Glycine 0 C--N 1.35 1.353 0 O-C-N 122.416 -0.177 . . . . 44.04 113.157 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.96 -176.91 40.65 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.421 -0.655 . . . . 63.44 113.103 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.18 161.76 84.53 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 119.783 1.791 . . . . 62.35 112.771 -4.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.446 HG11 ' SG ' ' A' ' 66' ' ' CYS . 62.4 t -107.23 147.35 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.93 0.892 . . . . 73.43 110.293 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 94.6 mtt180 -97.83 164.79 12.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.726 0.81 . . . . 73.21 111.105 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -133.14 122.98 24.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.755 0.822 . . . . 75.35 111.101 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.2 m-85 -120.2 163.97 16.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.868 0.867 . . . . 74.52 110.908 175.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -152.3 119.98 6.09 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.953 0.901 . . . . 55.14 109.898 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 62.65 21.07 12.48 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 124.557 1.143 . . . . 72.45 111.965 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.54 55.64 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 114.696 0.638 . . . . 75.33 114.696 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -128.78 128.79 44.67 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.865 0.832 . . . . 75.34 110.988 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.47 151.04 25.03 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.037 0.754 . . . . 74.33 113.037 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.3 mt -95.24 154.46 17.18 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.278 0.631 . . . . 55.24 110.536 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.04 146.82 28.56 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.491 0.716 . . . . 62.4 110.43 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 45.3 p -74.46 85.03 2.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.252 0.621 . . . . 75.15 110.899 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -121.35 -175.94 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.968 0.907 . . . . 71.13 112.073 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.76 147.38 43.31 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 110.905 -0.878 . . . . 34.44 110.905 164.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 74.7 -55.22 0.66 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.232 1.413 . . . . 74.04 111.843 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.06 89.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.141 0.976 . . . . 51.23 110.117 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -91.86 134.36 34.83 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.028 0.931 . . . . 62.45 111.657 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 51' ' ' LEU . 66.8 mt -114.25 130.98 56.65 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.936 0.494 . . . . 54.33 110.374 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.19 121.58 39.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.573 0.749 . . . . 72.02 110.146 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -108.06 102.05 11.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.532 0.682 . . . . 70.15 110.095 171.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.98 -56.09 2.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.226 0.61 . . . . 72.21 109.612 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.3 -90.47 0.1 Allowed Glycine 0 N--CA 1.475 1.242 0 N-CA-C 111.192 -0.763 . . . . 54.34 111.192 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.64 -42.0 82.97 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.37 0.668 . . . . 45.32 110.367 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.6 ttp180 -91.99 118.34 30.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.332 -0.849 . . . . 70.11 110.968 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -116.42 135.22 54.03 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.569 -0.9 . . . . 73.14 108.569 169.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 61.6 t -125.78 109.74 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.246 0.546 . . . . 63.3 111.932 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -101.11 121.96 42.74 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.246 1.018 . . . . 73.3 108.725 169.172 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -120.08 107.51 13.14 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.717 -0.475 . . . . 72.31 109.717 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -104.1 109.33 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 118.576 0.625 . . . . 54.3 110.017 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -83.62 145.78 28.64 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.526 0.73 . . . . 72.24 110.799 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.6 54.26 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 112.325 -0.31 . . . . 71.41 112.325 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 112.1 7.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.616 1.166 . . . . 35.24 111.763 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.26 -95.39 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 118.46 0.573 . . . . 64.44 112.534 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -83.43 -61.81 1.75 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.749 -0.595 . . . . 45.32 111.631 -168.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.68 -5.27 73.4 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 116.217 -0.447 . . . . 64.01 114.184 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.01 -35.26 43.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.387 0.675 . . . . 74.02 111.673 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 106.56 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.035 0.534 . . . . 62.31 111.149 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.71 -169.81 40.88 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.854 -0.612 . . . . 65.14 114.369 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.6 121.67 27.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.924 0.89 . . . . 75.15 111.062 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.2 m-85 -111.7 112.61 24.42 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.94 0.896 . . . . 71.43 110.174 173.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -93.21 101.25 13.52 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.752 -0.592 . . . . 73.4 111.027 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.446 ' SG ' HG11 ' A' ' 25' ' ' VAL . 37.8 t -82.2 89.82 6.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.908 0.883 . . . . 50.13 109.028 171.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 31.3 t70 -89.0 92.59 9.29 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.627 0.771 . . . . 61.41 112.261 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -85.64 159.29 55.64 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 122.957 0.503 . . . . 53.32 111.752 177.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -45.61 101.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 123.615 2.877 . . . . 54.24 114.159 171.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 63.68 13.98 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.2 1.4 . . . . 65.21 114.025 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 24.3 t70 -147.19 81.1 1.53 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.48 0.657 . . . . 71.13 111.045 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.538 ' HB2' HD11 ' A' ' 65' ' ' LEU . 88.1 p -78.99 148.52 32.53 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.331 -0.395 . . . . 72.01 110.803 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 126.83 29.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.948 0.499 . . . . 73.24 110.303 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.0 130.16 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.852 -0.425 . . . . 71.41 109.852 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 14.0 m-85 -109.26 102.94 11.83 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.336 1.054 . . . . 73.14 109.611 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 71.0 mt -81.48 92.15 6.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.212 -1.033 . . . . 60.22 108.212 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.8 t -83.12 114.98 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.767 -0.651 . . . . 63.12 110.012 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -103.07 107.58 18.43 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.227 -0.657 . . . . 72.25 109.227 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 6' ' ' SER . 20.6 t -94.17 107.98 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 109.765 -0.457 . . . . 54.13 109.765 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.64 -172.2 3.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.107 0.963 . . . . 73.43 109.828 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 63.86 84.27 0.19 Allowed Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 123.965 0.906 . . . . 72.24 110.677 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--N 1.384 2.43 0 C-N-CA 123.247 2.631 . . . . 71.34 114.089 -175.033 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.528 ' SD ' HD11 ' A' ' 76' ' ' LEU . 65.7 mtt . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.545 0.212 . . . . 73.11 110.62 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 m -80.6 91.35 5.81 Favored 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 124.875 1.27 . . . . 74.21 110.933 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 32.6 mtt180 -82.05 139.43 34.47 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.37 1.248 . . . . 71.15 114.37 -170.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 76.9 t -141.8 135.83 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 124.926 1.29 . . . . 63.32 109.956 172.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -106.48 144.43 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.175 0.59 . . . . 73.22 110.36 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 79' ' ' VAL . 37.3 t -135.14 161.92 33.97 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.419 0.688 . . . . 74.13 110.718 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -102.96 147.16 33.69 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 123.555 0.742 . . . . 72.52 111.696 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.44 107.95 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.584 2.856 . . . . 72.33 114.086 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.89 47.23 1.28 Allowed Glycine 0 C--N 1.355 1.622 0 C-N-CA 123.001 0.334 . . . . 73.01 113.593 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.45 -114.17 0.93 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 112.167 -0.373 . . . . 63.21 112.167 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.1 164.14 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.48 0.712 . . . . 63.41 110.478 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 62.4 tp -128.98 102.49 6.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.441 0.697 . . . . 65.22 109.613 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -110.11 104.63 13.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.101 0.56 . . . . 72.53 109.794 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.492 HD12 HD12 ' A' ' 51' ' ' LEU . 65.7 mt -90.43 101.94 14.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.529 -0.545 . . . . 74.54 109.529 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.73 119.7 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.129 -1.063 . . . . 72.04 108.129 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 18' ' ' LEU . 20.1 t -113.36 133.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.621 0.768 . . . . 65.43 111.075 -168.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -134.58 54.72 1.93 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.839 0.856 . . . . 75.03 109.351 166.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -59.07 160.71 5.83 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.071 0.767 . . . . 71.11 113.071 170.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -77.87 -1.59 32.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.773 0.829 . . . . 54.21 112.281 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.92 -178.41 41.27 Favored Glycine 0 CA--C 1.545 1.942 0 CA-C-O 119.918 -0.379 . . . . 71.03 113.543 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 -37.98 3.68 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.842 2.361 . . . . 71.21 113.54 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.89 -130.19 8.15 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.75 -0.54 . . . . 42.11 111.75 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' ' N ' ' A' ' 25' ' ' VAL . . . -91.23 156.93 24.55 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.445 -0.642 . . . . 51.2 114.297 -174.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.76 106.2 0.82 Allowed 'Cis proline' 0 C--N 1.383 2.388 0 CA-C-N 119.548 1.674 . . . . 72.33 112.552 1.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' N ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -86.1 162.16 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 C-N-CA 123.029 0.532 . . . . 75.53 110.991 -174.407 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 36.6 mmt180 -98.87 150.63 21.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.041 0.936 . . . . 74.25 110.105 171.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.39 145.33 51.14 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.376 1.07 . . . . 73.33 109.066 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.682 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.5 m-85 -135.72 124.3 23.64 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.098 0.559 . . . . 61.13 110.668 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 21.1 tptm -122.19 131.79 54.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.313 0.645 . . . . 71.35 109.951 172.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 68.15 16.25 9.41 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.624 1.169 . . . . 75.25 111.627 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.95 61.23 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.247 -0.433 . . . . 74.12 113.609 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.31 135.93 39.33 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.569 0.747 . . . . 61.13 110.584 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 145.29 40.92 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.861 0.864 . . . . 54.42 113.111 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB3' HG11 ' A' ' 40' ' ' VAL . 53.6 mt -89.31 135.4 33.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.484 0.714 . . . . 73.22 110.428 174.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.44 158.97 15.98 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.783 0.833 . . . . 74.25 110.256 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 p -69.85 89.98 0.59 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.723 0.773 . . . . 63.02 110.212 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -112.76 166.02 11.76 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.424 1.09 . . . . 73.45 111.088 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.18 97.01 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 113.791 0.276 . . . . 72.42 113.791 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 54' ' ' GLN . 5.0 mpt_? -77.29 -37.73 52.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.675 0.39 . . . . 75.41 111.422 172.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 34' ' ' LEU . 53.9 t -102.69 82.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.637 0.732 . . . . 44.13 110.712 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 73.5 mt-30 -82.23 104.59 12.65 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.547 0.739 . . . . 64.22 111.378 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -98.65 113.52 25.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.566 0.747 . . . . 65.11 112.4 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -91.81 132.46 36.41 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.567 0.747 . . . . 74.45 109.861 170.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.718 ' HA ' HE22 ' A' ' 49' ' ' GLN . 9.8 pt20 -125.28 109.35 12.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.764 0.826 . . . . 75.44 110.315 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.69 177.4 9.54 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.552 0.741 . . . . 73.24 111.925 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.02 113.25 5.08 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.416 -0.658 . . . . 71.55 112.769 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.26 -56.83 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 125.657 1.583 . . . . 63.52 113.593 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 44.7 ttp180 -83.18 111.92 19.37 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.182 0.438 . . . . 71.1 112.182 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.718 HE22 ' HA ' ' A' ' 44' ' ' GLN . 11.2 mm100 -101.97 147.21 26.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.674 0.79 . . . . 43.22 109.111 166.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.94 110.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.782 -0.573 . . . . 73.24 111.001 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 HD12 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -95.7 123.59 39.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.663 -0.866 . . . . 74.24 108.663 169.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.0 mtm180 -121.68 108.52 13.64 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.889 0.476 . . . . 75.4 111.403 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -91.47 120.87 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.328 0.651 . . . . 74.25 110.242 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.45 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . 33.4 tt0 -75.35 122.58 23.97 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.46 0.704 . . . . 45.02 109.853 173.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.28 -78.5 0.38 Allowed Glycine 0 C--N 1.346 1.138 0 N-CA-C 112.357 -0.297 . . . . 43.42 112.357 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 56.13 80.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.521 1.129 . . . . 72.12 112.178 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -159.96 -68.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.9 0.48 . . . . 74.02 111.62 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.5 m -137.51 119.19 15.03 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.384 0.673 . . . . 73.55 110.227 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.79 -15.77 53.64 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 116.433 -0.349 . . . . 74.44 112.931 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.14 -20.6 51.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.525 1.13 . . . . 75.43 111.845 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.59 122.1 27.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.449 0.7 . . . . 60.23 109.948 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . 168.45 -170.5 42.21 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.319 -0.4 . . . . 73.43 113.352 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -89.63 119.15 29.8 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.845 0.858 . . . . 75.22 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 62.0 m-85 -104.96 106.07 16.39 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.797 0.839 . . . . 63.21 109.667 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.1 tp -94.71 99.69 11.75 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.425 0.69 . . . . 62.1 110.489 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.1 t -81.77 93.19 6.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.335 0.654 . . . . 72.53 110.167 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 28.2 t70 -97.04 132.54 42.75 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.592 0.757 . . . . 74.4 112.238 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.22 152.98 80.49 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.835 0.854 . . . . 71.25 109.317 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.99 -21.2 33.04 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.286 2.657 . . . . 64.02 113.883 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -59.36 2.22 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.6 0.76 . . . . 65.12 110.132 174.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.72 149.94 37.9 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.05 0.54 . . . . 54.24 111.784 -171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -131.45 135.2 46.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.769 0.828 . . . . 74.12 111.041 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -113.5 134.75 54.5 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.88 . . . . 73.41 111.267 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.45 HG12 HD13 ' A' ' 65' ' ' LEU . 57.5 mt -89.17 123.11 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.1 -0.704 . . . . 70.12 109.1 170.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.0 m-85 -100.11 103.84 15.36 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.933 -0.395 . . . . 73.32 109.933 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.651 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 82.1 mt -78.1 92.53 4.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.949 -0.76 . . . . 73.25 108.949 175.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.5 t -101.49 113.11 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.112 -0.949 . . . . 71.43 110.1 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -110.4 107.78 17.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.25 0.547 . . . . 75.14 109.588 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 6' ' ' SER . 61.5 t -84.74 120.56 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.405 -0.961 . . . . 64.42 108.405 171.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.4 -177.71 4.16 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.63 0.772 . . . . 53.51 110.459 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 60.77 81.77 0.24 Allowed Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.937 0.895 . . . . 65.43 111.431 166.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo . . . . . 0 C--N 1.382 2.313 0 C-N-CA 123.133 2.555 . . . . 44.44 113.429 -177.189 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.886 -0.413 . . . . 72.3 109.886 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 m -94.12 95.88 9.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.75 -0.833 . . . . 54.34 108.75 -174.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -122.79 148.97 44.75 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.51 0.724 . . . . 72.41 112.42 -169.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.9 t -138.93 138.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.874 0.87 . . . . 71.54 110.427 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.94 117.95 35.33 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.357 0.663 . . . . 73.55 110.029 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t -94.49 161.6 14.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.634 0.774 . . . . 73.1 110.546 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.2 153.7 37.88 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 123.283 0.633 . . . . 73.45 111.387 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -56.24 99.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.533 2.822 . . . . 64.13 112.95 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.34 18.62 68.51 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 116.118 -0.492 . . . . 43.13 113.733 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.81 -10.45 69.67 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 114.485 0.554 . . . . 63.43 114.485 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 67.64 118.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.676 1.59 . . . . 71.3 112.263 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD11 HD21 ' A' ' 14' ' ' LEU . 42.7 tp -81.44 140.49 34.61 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.671 0.789 . . . . 72.03 111.678 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 15' ' ' VAL . 45.2 tt0 -142.22 100.8 3.79 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.69 0.796 . . . . 72.2 110.273 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 12' ' ' LEU . 54.0 mt -89.86 103.63 16.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.641 0.776 . . . . 75.32 109.916 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 ' HG2' ' A' ' 13' ' ' GLU . 61.4 t -104.79 110.21 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.646 0.778 . . . . 75.44 109.339 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG21 ' SG ' ' A' ' 66' ' ' CYS . 11.6 m -99.17 146.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.626 0.726 . . . . 53.12 111.05 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -122.38 29.42 6.97 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.864 -1.062 . . . . 73.5 109.234 165.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.501 HD21 ' SG ' ' A' ' 66' ' ' CYS . 0.9 OUTLIER -41.75 139.25 1.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.052 1.13 . . . . 53.5 114.052 176.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -94.66 31.46 1.79 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.462 0.705 . . . . 63.41 111.285 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.99 -176.3 45.82 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-N 116.258 -0.428 . . . . 54.35 113.064 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 175.75 10.89 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 75.43 113.53 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.83 132.92 46.76 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.877 -0.601 . . . . 63.34 112.936 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.02 -131.78 0.96 Allowed Glycine 0 CA--C 1.548 2.134 0 CA-C-O 119.146 -0.808 . . . . 61.42 114.872 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.1 124.29 5.19 Favored 'Cis proline' 0 C--N 1.386 2.514 0 CA-C-N 120.695 2.247 . . . . 71.12 113.641 -0.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.413 HG11 ' SG ' ' A' ' 66' ' ' CYS . 98.6 t -73.7 142.84 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 C-N-CA 123.394 0.677 . . . . 70.33 110.855 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -96.54 169.89 9.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.26 1.024 . . . . 73.02 111.199 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.503 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 81.6 m95 -131.52 125.96 33.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.958 0.903 . . . . 72.3 110.467 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.3 m-85 -116.93 163.16 16.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.353 1.061 . . . . 73.53 109.973 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 64' ' ' TYR . 1.9 tmtp? -159.48 128.21 5.15 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.303 0.641 . . . . 70.2 110.547 176.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.52 23.29 13.59 Favored 'General case' 0 CA--C 1.566 1.585 0 C-N-CA 124.306 1.042 . . . . 75.54 111.631 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.6 -8.36 63.95 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 115.754 -0.657 . . . . 52.14 114.505 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -129.64 138.13 51.04 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.199 0.999 . . . . 73.43 111.46 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -58.35 146.61 33.97 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.754 0.822 . . . . 64.42 112.759 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.565 ' HB3' HG11 ' A' ' 40' ' ' VAL . 38.6 mt -87.2 134.8 33.49 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.309 -0.405 . . . . 44.05 110.066 171.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.14 160.46 15.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.552 0.741 . . . . 74.03 110.775 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 p -72.47 83.7 1.1 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.705 0.764 . . . . 65.11 110.687 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.71 165.08 11.57 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.987 0.915 . . . . 63.42 110.378 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.28 -44.66 93.31 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 114.088 0.395 . . . . 73.02 114.088 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HG3' HG23 ' A' ' 40' ' ' VAL . 15.5 ptm180 -77.95 -37.74 46.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.002 0.521 . . . . 74.4 111.075 174.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 39' ' ' ARG . 59.7 t -94.34 83.08 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.704 0.802 . . . . 63.11 110.387 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 34.0 mm-40 -81.46 106.09 13.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.608 0.763 . . . . 72.33 111.237 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.44 101.59 13.52 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.184 0.594 . . . . 72.5 110.86 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 32.0 tt0 -92.42 98.76 11.68 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.442 0.697 . . . . 73.15 109.842 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.27 102.06 14.13 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 74.13 108.215 173.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.07 -179.27 3.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.843 0.857 . . . . 74.41 110.922 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.26 89.31 0.07 OUTLIER Glycine 0 C--N 1.352 1.452 0 O-C-N 123.387 0.429 . . . . 74.31 112.819 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.39 -27.93 0.19 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 125.965 1.706 . . . . 73.41 113.36 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -85.3 104.54 15.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.441 0.696 . . . . 74.1 111.002 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.503 ' HB3' ' HE1' ' A' ' 27' ' ' TRP . 34.1 mm-40 -98.5 112.16 24.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.097 0.559 . . . . 73.32 109.549 173.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 61.6 t -109.5 108.98 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.054 0.454 . . . . 64.12 110.836 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.21 117.53 30.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.641 -0.874 . . . . 73.21 108.641 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.7 mtm-85 -113.04 117.33 31.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.525 0.73 . . . . 64.41 109.891 174.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.06 100.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.31 0.576 . . . . 75.43 109.681 171.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.46 139.75 42.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.727 -0.67 . . . . 71.21 109.666 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.86 24.79 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 112.311 -0.316 . . . . 75.1 112.311 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.3 87.19 2.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.143 0.577 . . . . 72.1 111.189 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' O ' HG11 ' A' ' 79' ' ' VAL . 78.7 ttt180 -127.51 -82.86 0.6 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.229 0.612 . . . . 64.34 111.592 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 m -93.09 -70.66 0.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.172 0.589 . . . . 74.31 111.539 -173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.93 28.33 4.11 Favored Glycine 0 CA--C 1.543 1.784 0 N-CA-C 114.754 0.662 . . . . 55.43 114.754 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -93.44 -31.86 14.44 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.398 0.679 . . . . 73.3 110.812 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.13 107.43 2.31 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.804 0.842 . . . . 64.13 111.285 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.25 178.02 43.21 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.183 -0.462 . . . . 74.35 114.14 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.03 108.8 17.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.08 0.552 . . . . 71.54 110.14 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.664 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 19.5 m-85 -93.95 155.52 17.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.495 0.718 . . . . 74.34 109.898 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.709 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 44.2 tp -144.1 102.87 3.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.031 0.382 . . . . 60.41 112.031 -173.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.501 ' SG ' HD21 ' A' ' 18' ' ' LEU . 34.3 t -79.57 88.85 5.09 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 109.147 -0.686 . . . . 73.05 109.147 170.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.56 102.12 14.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.288 1.035 . . . . 64.11 112.786 -167.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.14 162.99 59.75 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.397 0.679 . . . . 64.22 110.51 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.73 31.9 0.19 Allowed 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.067 2.511 . . . . 74.43 115.104 174.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -172.39 -62.96 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.544 1.138 . . . . 73.3 109.065 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.67 176.35 6.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.705 0.802 . . . . 64.14 111.019 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 65' ' ' LEU . 85.5 p -165.64 134.89 3.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.406 0.682 . . . . 71.32 110.322 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -106.78 124.4 49.56 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.38 0.672 . . . . 43.44 110.351 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.55 HG13 HD13 ' A' ' 65' ' ' LEU . 3.2 mp -102.32 124.49 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.238 0.615 . . . . 64.44 110.073 -175.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 64.1 m-85 -101.17 126.38 47.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.344 1.058 . . . . 71.3 111.207 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.52 93.36 8.05 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.747 -1.205 . . . . 74.35 107.747 161.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 63.2 t -85.34 106.32 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.273 -0.639 . . . . 63.34 109.273 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.1 p -103.51 117.25 34.0 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.801 . . . . 63.42 110.027 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 57' ' ' ARG . 63.3 t -84.17 106.64 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.022 -0.732 . . . . 63.52 109.022 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 11.3 pt-20 -150.39 -166.94 2.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.336 1.054 . . . . 74.34 110.216 -174.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 40.1 mt-10 57.88 54.37 6.29 Favored Pre-proline 0 CA--C 1.571 1.765 0 C-N-CA 124.209 1.004 . . . . 73.54 112.121 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.455 0 C-N-CA 123.11 2.54 . . . . 71.43 112.466 -174.633 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 tpp . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 109.616 -0.513 . . . . 61.52 109.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.4 p -62.94 108.01 1.11 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.359 0.664 . . . . 71.23 111.363 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.79 120.28 38.76 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.485 -0.931 . . . . 64.03 108.485 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.498 ' HB ' HG22 ' A' ' 77' ' ' VAL . 98.8 t -122.24 140.94 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.706 0.802 . . . . 73.23 109.948 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.87 127.93 44.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.058 0.543 . . . . 70.14 109.54 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -122.34 162.33 21.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.245 0.618 . . . . 60.55 111.179 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.75 140.5 26.42 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.35 0.66 . . . . 75.23 111.939 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.84 119.33 6.01 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.103 2.535 . . . . 61.44 112.97 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.56 30.79 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.073 -0.512 . . . . 32.12 113.078 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.93 -131.22 3.98 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 117.094 0.447 . . . . 74.43 112.957 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -146.97 150.05 34.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.472 0.709 . . . . 73.45 110.837 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD21 ' A' ' 14' ' ' LEU . 64.3 tp -97.61 143.62 28.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.017 0.927 . . . . 54.22 110.283 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.56 113.38 6.76 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.284 0.633 . . . . 62.43 109.771 171.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 12' ' ' LEU . 75.6 mt -107.21 103.18 12.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.988 0.915 . . . . 64.53 109.6 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 117.2 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 109.105 -0.702 . . . . 74.24 109.105 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.627 HG21 ' SG ' ' A' ' 66' ' ' CYS . 1.6 t -97.85 147.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.095 0.474 . . . . 74.11 110.493 -174.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.41 29.81 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.853 0.861 . . . . 71.44 110.09 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.453 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.1 pp -53.2 158.59 1.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.791 1.034 . . . . 71.23 113.791 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 m -95.05 23.53 5.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.414 -0.812 . . . . 71.33 111.214 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.73 119.14 8.83 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.14 -0.811 . . . . 51.4 112.79 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.93 104.99 0.89 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.29 2.66 . . . . 74.5 114.221 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.38 52.01 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.358 0.903 . . . . 70.53 115.358 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.14 176.29 18.39 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-O 119.318 -0.712 . . . . 34.2 112.99 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.36 119.97 5.52 Favored 'Cis proline' 0 C--N 1.377 2.038 0 CA-C-N 120.052 1.926 . . . . 64.11 113.962 1.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -82.54 115.72 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 109.088 -0.708 . . . . 53.32 109.088 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -98.33 137.09 37.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.646 0.778 . . . . 75.14 111.659 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -96.3 124.34 40.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.459 0.704 . . . . 74.35 110.629 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 86.9 m-85 -119.03 134.71 55.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.778 0.831 . . . . 74.14 110.486 176.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.4 tptp -119.46 128.12 53.7 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.053 0.541 . . . . 75.44 109.842 173.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 63.37 5.7 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.644 1.178 . . . . 53.24 113.858 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.97 -25.01 4.2 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.555 -0.58 . . . . 44.34 114.046 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -131.03 150.2 52.26 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.516 1.158 . . . . 41.35 112.33 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.554 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -67.41 154.86 40.37 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.743 1.386 . . . . 72.52 114.743 -169.092 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' HB3' HG11 ' A' ' 40' ' ' VAL . 26.6 mt -102.55 162.29 13.04 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.805 1.242 . . . . 74.53 110.446 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.77 153.2 46.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.725 0.81 . . . . 64.34 110.533 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -71.26 83.14 0.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.956 0.884 . . . . 54.54 110.955 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.36 -178.63 3.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.114 0.965 . . . . 75.34 110.765 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.61 97.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 114.089 0.395 . . . . 51.2 114.089 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -90.5 -14.87 31.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.44 0.696 . . . . 62.33 112.05 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 34' ' ' LEU . 54.3 t -124.74 81.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.42 0.688 . . . . 73.52 109.831 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.628 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.4 mt-30 -85.11 125.66 32.97 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.263 0.625 . . . . 75.4 111.062 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD21 HD23 ' A' ' 51' ' ' LEU . 89.8 mt -118.48 96.86 5.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.538 0.735 . . . . 73.11 112.185 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.53 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 1.7 mp0 -85.86 96.63 9.84 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.88 -0.785 . . . . 73.33 108.88 165.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -111.21 113.85 26.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.725 0.81 . . . . 73.33 111.227 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.19 -157.95 0.85 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.413 1.085 . . . . 74.24 111.083 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.29 111.47 3.31 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 119.385 -0.675 . . . . 70.14 111.997 172.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.39 -52.6 0.7 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 125.925 1.69 . . . . 65.14 112.716 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 30.0 ttt85 -66.75 101.21 0.78 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.708 0.803 . . . . 73.24 111.515 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' HG23 ' A' ' 16' ' ' VAL . 67.7 mm-40 -112.04 125.8 54.47 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 51.5 t -117.96 110.53 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 122.705 0.402 . . . . 73.04 110.904 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.457 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -102.56 121.2 41.9 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.736 0.814 . . . . 71.44 109.452 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 68.3 mtp180 -120.68 109.15 14.87 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.08 0.552 . . . . 74.1 111.153 -176.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 61.6 t -92.61 114.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.244 0.545 . . . . 52.53 110.678 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -79.1 123.24 27.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.501 1.121 . . . . 71.5 110.351 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 42.88 23.97 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.736 -0.211 . . . . 74.1 113.394 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.78 112.83 4.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.275 0.63 . . . . 44.03 111.409 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -68.25 0.2 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.012 0.525 . . . . 72.24 111.256 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -95.49 -87.19 0.29 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.935 0.717 . . . . 72.35 112.935 -167.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.83 6.1 63.29 Favored Glycine 0 C--N 1.36 1.907 0 O-C-N 122.109 -0.37 . . . . 23.03 113.785 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB3' HG11 ' A' ' 53' ' ' VAL . 5.9 m-20 -84.2 -5.01 59.19 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.544 1.138 . . . . 72.01 110.995 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.15 128.17 36.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.035 0.934 . . . . 73.52 109.487 171.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.6 -173.34 41.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.238 -0.437 . . . . 73.12 112.915 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.27 126.74 33.94 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.058 0.543 . . . . 73.21 110.508 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 76.5 m-85 -112.85 110.2 20.14 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.93 0.892 . . . . 64.23 110.096 175.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -91.97 102.26 14.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.221 0.608 . . . . 73.14 110.331 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.627 ' SG ' HG21 ' A' ' 16' ' ' VAL . 44.9 t -82.12 89.11 6.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.545 0.738 . . . . 73.2 109.378 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -96.39 94.12 7.24 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.019 1.328 . . . . 71.13 112.192 -168.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.64 158.66 82.82 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.437 1.095 . . . . 62.25 111.784 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -47.76 -32.77 17.6 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.873 3.048 . . . . 70.42 115.239 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.29 49.02 1.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.262 0.553 . . . . 63.13 109.638 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -178.61 162.63 1.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.056 1.342 . . . . 71.32 109.564 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.7 p -160.36 121.01 2.95 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.169 0.44 . . . . 73.54 110.772 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -106.43 127.94 53.67 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.518 0.727 . . . . 75.53 110.36 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.62 121.51 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.044 -0.725 . . . . 73.34 109.044 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 32.0 m-85 -98.21 100.73 12.05 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.1 -0.704 . . . . 73.45 109.1 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.7 91.78 4.08 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.176 -1.046 . . . . 54.35 108.176 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 4' ' ' VAL . 67.4 t -104.27 112.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 115.194 -0.912 . . . . 71.33 110.482 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 p -111.12 110.52 21.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.137 0.575 . . . . 63.15 109.455 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.42 104.05 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.907 -1.145 . . . . 72.21 107.907 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.97 179.12 9.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.716 0.807 . . . . 63.54 110.7 -170.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 61.71 90.63 0.09 OUTLIER Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.132 0.973 . . . . 74.12 110.974 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 C--N 1.383 2.343 0 C-N-CA 123.154 2.569 . . . . 75.32 113.891 -171.265 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 ttm . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.38 -0.23 . . . . 40.33 110.38 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 p -65.17 105.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.864 0.466 . . . . 71.2 111.26 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -107.58 109.74 21.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.366 1.067 . . . . 65.12 110.671 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 86.8 t -122.95 118.08 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.589 . . . . 61.43 110.863 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.5 134.86 33.91 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.856 -0.424 . . . . 73.41 109.856 173.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.802 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.7 t -112.23 157.11 21.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.928 0.491 . . . . 74.32 110.237 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -83.46 146.03 49.48 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.289 0.635 . . . . 74.11 111.559 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.02 105.86 0.72 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.145 2.563 . . . . 73.01 113.502 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.65 15.8 56.06 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 115.404 -0.816 . . . . 41.03 113.346 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.96 -167.75 30.59 Favored Glycine 0 N--CA 1.477 1.403 0 N-CA-C 112.558 -0.217 . . . . 64.12 112.558 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -107.01 119.75 40.22 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.099 -0.648 . . . . 63.2 111.198 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 6' ' ' SER . 58.9 tp -75.82 147.78 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.999 0.92 . . . . 72.31 110.453 174.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -145.0 116.42 8.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.027 0.531 . . . . 73.23 109.583 169.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 77.4 mt -102.08 101.23 11.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.354 0.662 . . . . 53.0 109.374 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.18 113.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.476 -0.935 . . . . 71.52 108.476 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 18' ' ' LEU . 3.5 t -108.34 137.71 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.906 0.882 . . . . 71.03 110.536 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -134.48 51.27 2.12 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.437 0.637 . . . . 74.24 109.35 169.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -54.57 159.88 1.98 Allowed 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.53 -0.759 . . . . 71.1 112.598 166.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.1 m -82.39 41.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.782 0.833 . . . . 34.44 111.496 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.17 85.72 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.528 -0.595 . . . . 72.12 112.564 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.38 151.59 26.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.8 2.334 . . . . 54.0 113.021 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -90.02 0.7 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 116.211 -0.45 . . . . 45.34 112.384 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.01 -114.36 4.01 Favored Glycine 0 CA--C 1.546 1.997 0 CA-C-O 118.729 -1.039 . . . . 74.23 113.792 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -72.57 158.03 97.87 Favored 'Cis proline' 0 C--N 1.383 2.386 0 CA-C-N 120.999 2.399 . . . . 72.42 113.532 -0.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.49 HG11 ' SG ' ' A' ' 66' ' ' CYS . 32.2 t -90.29 129.11 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.033 0.533 . . . . 71.2 110.7 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -98.12 132.2 43.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.583 0.753 . . . . 75.13 110.778 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.494 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 70.3 m95 -97.74 118.24 33.82 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.649 0.379 . . . . 74.32 111.869 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.8 m-85 -112.29 147.98 35.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.315 1.046 . . . . 65.12 109.468 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' NZ ' ' HA ' ' A' ' 60' ' ' ASP . 15.6 tptm -128.31 113.11 15.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.156 0.503 . . . . 65.53 110.288 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.07 13.26 2.81 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 125.912 1.685 . . . . 54.53 113.281 168.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.1 -39.34 0.67 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.499 -0.611 . . . . 71.21 113.234 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -154.07 156.5 37.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.071 0.936 . . . . 74.23 112.773 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -60.62 152.68 25.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.953 1.834 . . . . 74.34 115.953 -166.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.3 mt -95.56 161.59 13.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.307 -0.861 . . . . 64.32 111.197 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.86 134.59 49.41 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.942 0.897 . . . . 62.42 109.782 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.7 p -68.16 89.07 0.31 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.37 0.668 . . . . 72.22 111.72 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -134.84 98.55 4.06 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.835 0.854 . . . . 51.33 111.163 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 -89.31 0.07 OUTLIER Glycine 0 C--N 1.357 1.726 0 O-C-N 123.841 0.713 . . . . 73.52 114.517 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -70.04 -38.51 75.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.676 0.79 . . . . 75.45 111.299 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 59.7 t -89.65 121.88 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.663 . . . . 63.12 109.365 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -129.54 121.35 27.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.401 0.68 . . . . 73.43 110.51 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.44 100.07 8.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 64.13 111.092 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.0 tm-20 -93.36 125.83 38.17 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.218 -1.03 . . . . 62.43 108.218 168.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.35 103.15 7.49 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.414 0.626 . . . . 61.4 111.159 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -100.81 -2.32 32.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.224 1.01 . . . . 72.02 112.101 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.52 -99.24 0.98 Allowed Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.192 -0.763 . . . . 53.33 111.192 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.66 -33.02 73.28 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.935 0.494 . . . . 74.33 111.616 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 58.3 ttp180 -89.19 115.65 26.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.992 0.517 . . . . 53.42 110.091 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HB3' ' HE1' ' A' ' 27' ' ' TRP . 37.9 mm-40 -114.29 141.45 47.57 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.706 0.803 . . . . 75.44 109.532 171.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 94.2 t -131.38 110.94 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.129 0.571 . . . . 73.14 110.264 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.84 112.16 24.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.677 0.791 . . . . 75.51 109.464 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 42.3 mtt-85 -100.14 137.36 38.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.04 0.536 . . . . 61.21 111.218 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.98 100.01 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.552 0.741 . . . . 55.21 109.337 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -75.18 126.26 30.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.793 -0.447 . . . . 65.33 109.793 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.43 30.18 19.82 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.411 0.444 . . . . 34.12 113.062 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.6 101.36 0.24 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.784 0.834 . . . . 61.52 111.519 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.11 -62.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.921 0.889 . . . . 63.41 109.795 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 m -54.66 -55.29 31.25 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.324 1.05 . . . . 55.53 113.721 -168.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.45 17.52 4.48 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 122.597 0.141 . . . . 70.34 112.912 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 13.8 m-20 -126.02 90.97 3.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 61.23 110.947 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.61 65.09 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.476 1.11 . . . . 64.42 109.369 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.84 -153.5 6.43 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-N 115.535 -0.757 . . . . 72.33 113.29 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 128.31 34.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.92 0.488 . . . . 74.54 111.329 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 57.2 m-85 -115.27 107.66 15.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.073 0.949 . . . . 65.32 109.095 173.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.6 tp -92.0 100.15 12.85 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.364 0.602 . . . . 72.22 110.608 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.49 ' SG ' HG11 ' A' ' 25' ' ' VAL . 29.8 t -80.55 87.31 5.74 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.539 -0.911 . . . . 71.44 108.539 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.01 96.05 10.42 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.349 1.06 . . . . 74.31 112.527 -168.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' H ' ' HA ' ' A' ' 72' ' ' SER . . . -90.42 138.73 26.81 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 122.932 0.493 . . . . 53.31 111.408 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.84 -29.62 64.0 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 123.677 2.918 . . . . 71.4 113.943 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -75.35 -63.8 1.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.013 0.525 . . . . 74.15 110.003 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 24.8 t70 -153.71 127.67 8.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.748 0.419 . . . . 62.12 110.927 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.434 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 31.2 t -72.65 177.6 4.64 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.222 1.009 . . . . 72.43 112.392 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.613 ' HA ' ' HE ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -154.99 127.18 7.74 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.536 0.735 . . . . 62.35 111.172 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.99 123.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.043 0.537 . . . . 75.44 109.685 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 36.8 m-85 -102.12 104.96 15.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.343 0.657 . . . . 74.44 111.419 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.25 93.63 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.598 -0.889 . . . . 75.34 108.598 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.1 t -99.36 114.51 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.898 0.479 . . . . 71.45 110.545 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.1 p -112.46 108.76 18.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.214 0.606 . . . . 61.51 110.135 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.802 HG22 ' HB3' ' A' ' 6' ' ' SER . 47.2 t -91.16 106.01 17.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.657 -0.868 . . . . 75.13 108.657 175.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -178.56 -27.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.314 0.646 . . . . 72.44 111.454 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.5 101.64 0.29 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.714 0.805 . . . . 74.34 109.992 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 CA--C 1.567 2.152 0 C-N-CA 122.883 2.389 . . . . 74.34 114.072 -165.223 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.618 0.247 . . . . 75.33 110.571 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m -75.57 90.8 2.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.747 0.819 . . . . 75.53 111.465 -171.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.34 135.25 33.8 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.542 0.737 . . . . 71.34 111.97 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.81 124.12 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.492 0.717 . . . . 73.0 110.948 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -90.25 142.06 28.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.173 0.589 . . . . 75.24 109.556 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.503 ' HB3' HG22 ' A' ' 79' ' ' VAL . 46.7 t -145.91 148.63 33.02 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.429 0.633 . . . . 74.22 112.021 -173.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 p -82.15 147.54 57.63 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 74.32 112.314 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -84.04 147.51 11.77 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.37 2.713 . . . . 71.42 112.716 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.12 -22.28 23.58 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 113.988 0.355 . . . . 54.22 113.988 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.05 -151.29 23.86 Favored Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.956 0.378 . . . . 71.2 113.32 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -112.93 127.0 56.09 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.26 0.53 . . . . 74.52 110.657 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.1 tp -75.8 128.65 35.61 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 109.155 -0.683 . . . . 55.02 109.155 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -129.13 105.34 8.11 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.923 -0.399 . . . . 65.23 109.923 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 50.1 mt -91.68 101.78 14.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.185 -0.672 . . . . 71.21 109.185 175.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.9 t -99.51 109.98 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 107.924 -1.139 . . . . 73.33 107.924 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.451 HG22 ' HZ ' ' A' ' 75' ' ' PHE . 2.8 t -98.37 135.86 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.781 0.324 . . . . 72.11 110.755 -168.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -116.66 32.75 5.96 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.849 0.859 . . . . 74.13 109.83 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.89 156.1 9.54 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.878 1.066 . . . . 75.33 113.878 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -82.71 5.68 20.5 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.184 0.994 . . . . 73.31 112.327 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.71 -175.35 23.38 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 114.422 0.529 . . . . 33.34 114.422 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.621 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 41.1 Cg_endo -83.66 179.6 4.77 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.486 2.791 . . . . 74.31 114.019 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.518 ' HA2' ' HA3' ' A' ' 46' ' ' GLY . . . -83.13 61.31 4.79 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.61 -0.723 . . . . 75.34 113.299 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 81.03 174.72 49.21 Favored Glycine 0 CA--C 1.543 1.814 0 N-CA-C 115.228 0.851 . . . . 75.14 115.228 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.52 99.77 0.28 Allowed 'Cis proline' 0 C--N 1.38 2.197 0 CA-C-N 118.893 1.346 . . . . 74.25 112.066 -6.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 22.8 t -79.27 132.88 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.167 0.587 . . . . 62.33 110.819 -176.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -98.28 153.19 18.69 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.968 0.907 . . . . 74.42 111.608 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -109.88 134.03 52.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.637 0.775 . . . . 72.54 111.291 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.782 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 46.5 m-85 -128.12 161.31 29.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.167 0.987 . . . . 72.12 110.646 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -153.77 129.03 9.74 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.434 1.094 . . . . 71.13 109.604 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 63.81 22.95 13.25 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.945 0.898 . . . . 72.0 111.189 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.04 -4.62 81.49 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.395 -0.82 . . . . 63.42 114.342 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.1 128.8 49.82 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.983 0.913 . . . . 74.04 111.054 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.71 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.49 146.2 49.35 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.999 1.111 . . . . 73.41 113.999 -175.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.407 ' HB3' HG11 ' A' ' 40' ' ' VAL . 52.2 mt -91.98 154.74 18.6 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.97 -1.014 . . . . 61.23 110.817 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.0 159.2 26.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.209 1.003 . . . . 73.42 110.278 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.7 p -66.22 91.96 0.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.436 0.694 . . . . 72.31 110.789 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 36.4 tt0 -114.83 164.41 14.14 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.29 1.036 . . . . 51.5 110.204 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.8 -18.83 47.63 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.265 0.866 . . . . 43.14 115.265 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -121.6 4.81 10.09 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.404 0.602 . . . . 74.41 111.973 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 70.5 t -127.59 86.27 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.244 1.017 . . . . 72.44 109.121 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 82.4 mt-30 -87.97 108.26 19.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.843 0.857 . . . . 72.24 111.158 -174.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 mt -98.21 141.57 30.96 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.079 0.551 . . . . 71.23 112.323 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -123.27 138.5 54.61 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.037 0.935 . . . . 73.22 110.234 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -118.03 108.79 15.67 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.433 0.693 . . . . 63.22 110.809 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.72 -48.98 1.25 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.872 0.869 . . . . 73.1 109.577 168.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.518 ' HA3' ' HA2' ' A' ' 22' ' ' GLY . . . 129.42 -75.01 0.43 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.577 -0.738 . . . . 72.33 112.149 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.23 -36.53 84.44 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.632 . . . . 65.42 111.015 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -111.64 109.63 19.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.336 0.654 . . . . 53.22 110.361 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.521 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.8 mm100 -107.28 135.38 48.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.47 0.708 . . . . 72.45 109.489 169.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 60.1 t -129.94 114.13 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 121.074 0.464 . . . . 65.44 111.647 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 120.48 42.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.802 1.241 . . . . 74.15 108.519 170.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 43.7 mtp180 -118.11 106.37 12.8 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.667 0.387 . . . . 72.43 110.783 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 60' ' ' ASP . 70.7 t -84.59 95.52 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.848 0.459 . . . . 74.32 110.089 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -75.13 107.33 7.15 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.488 0.715 . . . . 42.21 110.402 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.38 36.8 3.98 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.4 -0.363 . . . . 73.33 112.526 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.82 112.01 8.47 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.039 0.936 . . . . 75.12 112.011 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -167.96 -56.0 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.593 0.757 . . . . 73.2 112.101 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 m -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.119 0.967 . . . . 62.3 113.16 -167.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.88 26.38 1.46 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.235 -0.746 . . . . 75.04 111.235 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.534 ' HB3' HG11 ' A' ' 53' ' ' VAL . 6.0 m-20 -87.03 3.91 44.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.761 1.224 . . . . 72.31 111.903 -172.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.481 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -87.41 161.14 18.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 124.061 0.944 . . . . 74.23 109.603 166.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.56 -160.92 23.26 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 114.083 0.393 . . . . 53.41 114.083 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.2 mt-10 -93.9 118.16 31.09 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.224 0.61 . . . . 73.12 111.977 -172.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.18 152.86 22.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.226 1.01 . . . . 72.15 110.215 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.782 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.5 tp -128.98 101.93 6.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.788 0.435 . . . . 75.21 110.233 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -81.94 87.03 6.43 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 108.545 -0.909 . . . . 52.44 108.545 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.2 t70 -95.45 104.31 16.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.467 1.107 . . . . 75.11 111.918 -169.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.85 152.83 37.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.815 0.846 . . . . 71.53 110.878 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.43 -36.49 58.81 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.197 2.598 . . . . 72.54 114.925 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.621 ' HB2' ' HD3' ' A' ' 21' ' ' PRO . 82.0 mm-40 -90.3 -28.89 18.47 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.898 0.703 . . . . 70.23 112.898 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -157.35 128.76 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 112.176 0.436 . . . . 73.24 112.176 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.549 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.6 p -97.6 139.75 33.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.689 0.796 . . . . 73.45 110.529 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -123.83 123.43 40.45 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.739 0.416 . . . . 62.4 110.839 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -97.04 144.14 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 122.882 0.473 . . . . 74.23 110.118 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' HZ ' HG22 ' A' ' 16' ' ' VAL . 5.8 m-85 -117.71 139.03 51.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.036 1.334 . . . . 74.25 110.155 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.7 94.89 5.26 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.381 -0.97 . . . . 73.42 108.381 164.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.07 139.04 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.181 0.592 . . . . 75.14 111.711 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.2 p -126.49 108.89 11.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.782 0.833 . . . . 64.31 110.468 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.6 t -109.04 104.11 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.187 -1.042 . . . . 74.41 108.187 172.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 8.5 pt-20 179.03 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.501 0.72 . . . . 63.21 111.246 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 37.7 mt-10 -75.17 106.37 2.78 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.943 0.897 . . . . 71.31 110.622 -174.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 6.1 Cg_exo . . . . . 0 CA--C 1.569 2.239 0 C-N-CA 123.242 2.628 . . . . 74.43 113.58 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.684 0.278 . . . . 74.44 110.818 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.23 84.62 1.88 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.406 1.082 . . . . 54.25 111.099 -172.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.66 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 64.8 mtt85 -76.37 141.14 41.59 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.545 0.738 . . . . 74.3 112.254 -174.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.416 HG21 HD22 ' A' ' 14' ' ' LEU . 78.9 t -130.03 131.24 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.647 0.779 . . . . 54.32 110.977 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -90.25 129.62 36.47 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.291 1.037 . . . . 71.43 109.855 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -139.16 158.88 43.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.818 0.847 . . . . 74.54 111.136 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -101.33 152.77 38.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 123.881 0.873 . . . . 73.21 111.63 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.2 Cg_endo -83.06 73.11 5.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.499 2.8 . . . . 55.03 113.622 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.99 60.23 0.01 OUTLIER Glycine 0 N--CA 1.474 1.169 0 CA-C-N 115.794 -0.639 . . . . 44.01 112.36 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.51 -176.26 39.81 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 122.853 -0.204 . . . . 60.32 113.428 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.05 119.66 31.95 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.337 0.589 . . . . 75.45 110.681 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 61.4 tp -74.8 136.58 41.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.745 0.818 . . . . 75.4 109.568 174.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -134.5 107.95 7.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.953 0.501 . . . . 74.01 110.053 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.416 HD22 HG21 ' A' ' 4' ' ' VAL . 44.4 mt -92.78 104.18 16.46 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.45 0.7 . . . . 74.25 109.524 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.09 112.08 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.974 -0.75 . . . . 71.23 108.974 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.469 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t -100.64 126.66 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.738 0.415 . . . . 62.21 110.131 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -99.17 21.37 11.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.298 0.639 . . . . 72.44 111.483 174.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.442 ' H ' HG12 ' A' ' 16' ' ' VAL . 12.7 mt -49.25 138.16 13.0 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.616 0.766 . . . . 52.24 111.792 163.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.8 t -79.17 76.89 5.69 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.498 0.666 . . . . 42.51 110.11 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.82 85.2 0.39 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.985 -0.846 . . . . 53.51 110.985 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.37 -51.39 5.38 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.097 2.531 . . . . 72.02 113.71 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.69 96.52 0.28 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.347 -0.701 . . . . 63.24 111.347 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.68 -110.45 3.5 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 118.96 -0.911 . . . . 44.32 113.525 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.31 179.47 28.01 Favored 'Cis proline' 0 C--N 1.38 2.187 0 CA-C-N 120.382 2.091 . . . . 44.13 113.971 2.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 68' ' ' ALA . 42.0 t -80.31 145.54 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.461 -0.79 . . . . 70.2 110.441 171.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.5 128.05 43.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 74.11 109.09 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.403 ' CH2' ' SG ' ' A' ' 66' ' ' CYS . 92.4 m95 -100.37 137.08 39.28 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.554 0.742 . . . . 74.14 111.41 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 90.8 m-85 -131.61 119.99 22.22 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.014 0.525 . . . . 74.34 110.91 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -107.52 124.82 50.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.413 0.685 . . . . 65.15 109.686 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t70 65.73 12.48 8.33 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 124.657 1.183 . . . . 73.14 110.896 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.09 -23.42 23.34 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 123.604 0.621 . . . . 73.03 113.673 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -101.46 141.89 33.65 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.897 0.849 . . . . 63.51 111.277 -173.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 152.83 14.89 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.895 0.878 . . . . 71.03 113.238 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -93.19 158.65 15.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.09 0.556 . . . . 73.32 110.326 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 128.96 43.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.663 0.785 . . . . 64.34 110.447 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.8 p -65.09 88.91 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.663 0.785 . . . . 74.44 111.283 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -126.25 -171.1 2.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.736 1.214 . . . . 70.2 110.503 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.4 -34.03 78.76 Favored Glycine 0 N--CA 1.48 1.627 0 O-C-N 123.017 0.198 . . . . 75.23 113.345 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -71.99 -60.89 2.0 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 75.23 110.507 173.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.8 t -101.46 92.07 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.983 0.913 . . . . 60.24 110.977 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -97.85 115.89 28.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.84 0.856 . . . . 53.22 111.402 -174.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.43 HD21 HD23 ' A' ' 51' ' ' LEU . 96.2 mt -94.64 133.61 38.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.173 0.589 . . . . 65.4 110.984 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -123.94 103.07 8.11 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.618 -0.882 . . . . 71.55 108.618 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -85.07 121.98 28.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.407 0.683 . . . . 74.32 111.637 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.73 169.02 16.24 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.587 0.755 . . . . 32.11 110.604 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.52 111.9 4.49 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.359 -0.689 . . . . 71.44 112.003 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.59 -54.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.503 1.521 . . . . 64.15 112.195 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.5 ttt-85 -67.94 112.57 5.03 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.673 0.789 . . . . 74.15 112.136 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -107.97 137.06 46.63 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.582 0.753 . . . . 73.33 109.068 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 73.0 t -125.8 124.18 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 122.09 -0.381 . . . . 71.4 111.81 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.43 HD23 HD21 ' A' ' 42' ' ' LEU . 2.3 tm? -113.25 115.43 28.18 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.729 1.212 . . . . 75.41 108.454 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 75.0 mtt180 -112.54 106.96 15.52 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 122.056 -0.402 . . . . 74.22 111.779 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.1 t -98.25 95.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 109.651 -0.499 . . . . 64.34 109.651 172.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -71.68 101.6 2.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.103 -0.702 . . . . 73.41 109.103 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.48 11.99 0.53 Allowed Glycine 0 N--CA 1.471 0.998 0 CA-C-O 119.258 -0.745 . . . . 63.45 113.1 -173.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . . . -62.02 100.27 0.16 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.738 0.815 . . . . 32.51 110.918 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.4 tmm_? -158.74 -48.31 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 O-C-N 123.382 0.426 . . . . 75.32 112.027 -170.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.3 m -113.16 -97.5 0.43 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 118.183 0.447 . . . . 71.14 111.894 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.95 21.9 13.9 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 117.917 0.326 . . . . 73.32 113.672 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.21 -14.7 55.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.373 1.069 . . . . 74.01 110.8 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.454 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -77.77 104.4 8.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.386 0.675 . . . . 61.03 109.502 170.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.67 -173.93 40.97 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.182 -0.463 . . . . 65.51 113.404 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -85.22 115.51 23.04 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.428 0.691 . . . . 63.11 111.082 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 45.4 m-85 -106.05 111.71 24.45 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.767 0.827 . . . . 63.22 109.706 172.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.5 tp -91.5 107.81 19.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.267 0.627 . . . . 75.31 110.371 -171.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.403 ' SG ' ' CH2' ' A' ' 27' ' ' TRP . 80.3 m -73.58 90.98 1.8 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.839 -0.801 . . . . 73.32 108.839 164.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -52.32 -47.06 66.2 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.354 1.062 . . . . 65.45 111.399 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.649 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . 67.37 132.8 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 114.602 1.334 . . . . 60.42 114.602 167.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -77.68 37.76 0.63 Allowed 'Trans proline' 0 CA--C 1.57 2.276 0 C-N-CA 123.277 2.652 . . . . 55.4 113.477 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -161.92 -60.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.548 0.739 . . . . 75.14 110.996 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.59 127.17 7.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.295 0.638 . . . . 75.22 110.547 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.3 p -73.94 138.09 44.02 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 113.551 0.945 . . . . 41.05 113.551 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -127.56 126.99 43.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.399 1.08 . . . . 71.54 111.005 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.27 142.01 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.755 0.422 . . . . 60.4 110.445 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 11.6 m-85 -101.74 109.76 21.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.204 1.002 . . . . 74.44 109.943 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.66 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 63.1 mt -86.19 91.7 8.53 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.648 -0.871 . . . . 62.54 108.648 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -89.5 124.03 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.66 -0.7 . . . . 72.45 110.658 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -108.37 107.07 17.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.834 0.853 . . . . 33.15 110.037 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.454 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 94.5 t -94.1 106.68 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 108.363 -0.977 . . . . 74.45 108.363 173.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -164.01 176.03 9.74 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.22 1.008 . . . . 65.32 110.658 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.6 84.72 0.2 Allowed Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.112 0.965 . . . . 74.15 111.514 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo . . . . . 0 CA--C 1.567 2.138 0 C-N-CA 123.222 2.614 . . . . 71.44 114.121 178.052 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 24.6 mmt . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.123 0.487 . . . . 64.22 111.069 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 p -92.9 140.96 28.95 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.392 1.077 . . . . 63.01 109.842 171.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -132.44 116.84 17.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.472 0.709 . . . . 74.32 110.342 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.2 t -129.98 147.49 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.765 0.826 . . . . 73.12 110.825 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -124.25 146.93 48.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.251 1.021 . . . . 74.24 112.226 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -141.09 163.54 32.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.314 1.046 . . . . 74.25 110.315 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 81' ' ' GLU . 1.1 p -93.66 145.39 29.83 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 123.31 0.644 . . . . 72.23 111.706 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 73.1 Cg_endo -68.11 130.88 22.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.269 2.646 . . . . 74.12 113.231 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.81 -18.41 34.53 Favored Glycine 0 N--CA 1.474 1.219 0 CA-C-N 116.156 -0.474 . . . . 61.14 113.557 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.2 -127.56 5.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 117.202 0.501 . . . . 44.15 112.289 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.34 155.45 46.79 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.417 0.627 . . . . 71.11 111.389 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.25 152.81 25.0 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.639 0.776 . . . . 71.3 109.86 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.23 108.09 4.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.975 0.51 . . . . 75.34 110.357 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 51' ' ' LEU . 65.3 mt -106.34 102.04 11.47 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.385 0.674 . . . . 64.45 110.054 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -96.53 125.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.044 -0.725 . . . . 72.55 109.044 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 2.8 t -112.75 142.66 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.48 0.712 . . . . 71.22 111.361 -170.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -138.1 45.63 2.1 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.092 0.957 . . . . 72.35 110.191 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.492 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -57.46 151.01 17.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.144 0.794 . . . . 51.34 113.144 170.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.6 m -91.68 3.62 54.65 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.694 0.798 . . . . 72.24 111.996 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.36 116.9 6.01 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 119.053 -0.86 . . . . 74.01 113.484 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.41 111.51 1.16 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.95 2.434 . . . . 71.32 112.363 173.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' A' ' 69' ' ' PRO . . . 177.25 138.26 2.93 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.304 -0.407 . . . . 24.54 112.691 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.78 112.61 0.55 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.956 -0.913 . . . . 54.24 112.057 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.67 162.07 79.17 Favored 'Cis proline' 0 C--N 1.375 1.944 0 CA-C-N 120.192 1.996 . . . . 73.32 113.612 -3.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.482 HG23 ' HA2' ' A' ' 46' ' ' GLY . 89.5 t -86.9 151.25 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-N 115.146 -0.934 . . . . 71.01 109.624 172.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -93.24 164.41 13.24 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.125 0.57 . . . . 74.25 110.56 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 78.9 m95 -133.03 127.88 35.06 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.85 0.86 . . . . 73.15 110.773 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 87.8 m-85 -131.28 126.15 34.65 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.222 1.009 . . . . 75.24 110.865 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB3' HD21 ' A' ' 34' ' ' LEU . 20.8 tptm -113.67 132.96 55.59 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.673 0.789 . . . . 73.22 108.994 169.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.24 22.27 13.26 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.294 1.045 . . . . 72.03 110.224 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.71 -6.16 71.19 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.543 -0.753 . . . . 63.42 114.108 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -107.26 136.45 47.07 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.988 0.894 . . . . 73.21 111.15 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -59.89 147.97 36.62 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.344 0.868 . . . . 71.43 113.344 -173.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.58 HD21 ' HB3' ' A' ' 29' ' ' LYS . 41.6 mt -100.45 125.53 46.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.301 0.641 . . . . 72.22 110.238 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.46 139.12 32.41 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.752 0.821 . . . . 73.43 109.932 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 p -64.04 92.95 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.515 0.674 . . . . 71.13 111.11 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -111.88 -171.27 1.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.936 0.894 . . . . 54.34 111.834 -175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.29 -44.73 95.07 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.285 -0.416 . . . . 71.0 112.764 174.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 84.3 mtt180 -73.61 -52.87 11.94 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.352 0.661 . . . . 61.52 111.133 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.571 HG11 ' HB3' ' A' ' 34' ' ' LEU . 67.5 t -79.48 95.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 123.322 0.649 . . . . 74.32 111.421 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.5 mt-30 -90.79 100.05 12.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.018 0.927 . . . . 75.23 109.996 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.63 133.05 41.62 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.139 0.575 . . . . 63.32 111.752 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 52.4 mm-40 -107.71 130.42 54.94 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.223 1.009 . . . . 72.54 110.301 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -103.02 141.77 35.25 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.933 0.493 . . . . 75.3 110.883 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.52 -49.05 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.84 1.256 . . . . 74.13 109.457 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 121.2 -72.17 0.37 Allowed Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.106 -0.952 . . . . 72.03 111.226 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -17.97 61.91 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.701 0.8 . . . . 70.14 112.19 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -135.06 107.96 7.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.532 0.733 . . . . 72.45 110.34 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 13.8 mm100 -115.12 143.03 45.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.319 0.648 . . . . 74.45 109.402 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 58.6 t -133.42 114.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 117.984 0.356 . . . . 71.13 110.417 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 14' ' ' LEU . 1.1 tm? -104.98 117.14 33.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.753 0.821 . . . . 73.21 108.889 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 81.5 mtp180 -115.69 112.95 22.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.92 -0.582 . . . . 74.51 110.568 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.16 102.24 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.719 -0.474 . . . . 75.25 109.719 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 39' ' ' ARG . 0.6 OUTLIER -66.87 116.59 7.91 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.168 -0.679 . . . . 65.13 109.168 174.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.14 43.9 2.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.203 -0.453 . . . . 65.14 112.511 -173.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . -74.92 118.2 17.62 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.877 0.471 . . . . 62.33 110.107 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -158.34 112.44 2.5 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.863 0.465 . . . . 74.44 111.579 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m 53.38 -78.87 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.323 1.449 . . . . 74.23 114.413 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -11.87 59.99 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 114.815 0.686 . . . . 74.4 114.815 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HB3' HG21 ' A' ' 79' ' ' VAL . 17.7 t70 -66.26 -25.87 67.09 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.507 0.723 . . . . 70.3 111.132 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.725 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -66.97 100.04 0.7 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.082 0.953 . . . . 64.55 110.689 176.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -164.23 -172.71 32.04 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.979 -0.555 . . . . 34.31 113.346 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -86.28 111.03 20.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.387 0.675 . . . . 65.34 110.824 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.783 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 44.1 m-85 -96.44 156.88 16.15 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.087 0.955 . . . . 45.2 109.442 169.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.7 tp -140.44 101.34 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.873 0.368 . . . . 70.21 110.824 -173.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.6 t -85.71 89.97 7.89 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.77 -0.826 . . . . 61.21 108.77 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -100.76 99.9 10.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.706 0.802 . . . . 74.15 112.664 -168.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.8 155.91 67.86 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.614 0.766 . . . . 73.54 110.068 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.522 ' HD2' ' HA3' ' A' ' 22' ' ' GLY . 50.3 Cg_exo -59.77 -2.43 1.56 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.273 2.649 . . . . 72.11 115.746 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -126.01 -43.63 1.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.696 0.798 . . . . 71.54 111.088 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.46 149.04 51.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.033 0.533 . . . . 74.54 111.246 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.476 ' HB2' HD11 ' A' ' 65' ' ' LEU . 79.7 p -129.92 133.18 46.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.637 0.775 . . . . 73.24 110.871 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -106.77 125.22 50.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.273 0.629 . . . . 63.14 110.035 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.451 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 2.2 mp -92.7 125.67 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.853 -0.795 . . . . 72.4 108.853 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.783 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 33.6 m-85 -98.15 101.95 13.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.437 0.695 . . . . 74.23 109.302 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.6 mt -77.55 92.94 4.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.03 -1.1 . . . . 60.03 108.03 172.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.8 t -94.03 139.17 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.153 -0.93 . . . . 63.43 110.718 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.9 p -131.2 107.4 8.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.86 -0.609 . . . . 72.11 109.763 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.725 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 57.4 t -90.11 107.34 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.594 -0.891 . . . . 74.44 108.594 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.79 179.71 7.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.995 0.918 . . . . 73.34 111.06 -167.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 7' ' ' THR . 12.5 tp10 64.21 87.97 0.12 Allowed Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 124.462 1.105 . . . . 73.41 110.584 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo . . . . . 0 C--N 1.383 2.344 0 C-N-CA 124.493 3.462 . . . . 52.03 115.742 -174.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.564 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.675 0.274 . . . . 74.019999999999996 110.795 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.8 m -73.41 95.16 2.17 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 124.297 1.039 . . . . 73.340000000000003 110.093 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -83.87 136.27 34.18 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.889 0.876 . . . . 60.140000000000001 111.668 -166.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.6 143.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.923 0.889 . . . . 54.32 110.344 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -121.71 138.54 54.31 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.298 1.039 . . . . 74.319999999999993 110.377 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t -137.34 178.08 7.37 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.464 0.706 . . . . 71.019999999999996 110.45 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 81' ' ' GLU . 4.2 p -124.99 147.71 57.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 124.016 0.926 . . . . 62.549999999999997 111.655 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -69.85 87.61 0.56 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.486 2.791 . . . . 74.040000000000006 113.402 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.22 -27.11 2.0 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.337 -0.847 . . . . 64.340000000000003 112.431 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.71 17.01 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.102 0.401 . . . . 43.299999999999997 114.102 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.47 158.25 16.35 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.382 0.673 . . . . 72.519999999999996 110.874 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 54.7 tp -119.24 108.25 14.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.337 0.655 . . . . 74.420000000000002 110.064 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.34 114.85 23.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.161 0.584 . . . . 72.430000000000007 110.242 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 15.2 mt -103.62 103.29 13.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.815 -0.809 . . . . 73.329999999999998 108.815 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.467 HG22 HG22 ' A' ' 50' ' ' VAL . 67.3 t -105.56 122.1 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.14 -0.689 . . . . 73.420000000000002 109.14 175.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.549 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -100.78 148.27 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.742 0.417 . . . . 42.310000000000002 110.717 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 67.4 m80 -128.25 51.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.187 0.994 . . . . 73.25 109.827 166.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.22 170.26 14.43 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.228 -1.351 . . . . 72.409999999999997 112.961 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.7 m -90.7 23.89 2.91 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.565 1.146 . . . . 72.510000000000005 112.705 -175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.82 157.28 18.08 Favored Glycine 0 CA--C 1.546 2.025 0 CA-C-O 119.959 -0.356 . . . . 64.140000000000001 113.933 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.23 -168.14 0.57 Allowed 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.615 2.876 . . . . 61.509999999999998 113.428 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.18 -51.24 55.44 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 123.264 0.459 . . . . 41.43 114.066 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.29 -97.2 1.22 Allowed Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.474 0.95 . . . . 73.510000000000005 115.474 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.85 126.44 9.63 Favored 'Cis proline' 0 C--N 1.383 2.353 0 CA-C-N 120.891 2.345 . . . . 60.109999999999999 114.384 5.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 89.7 t -66.58 131.62 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.439 0.696 . . . . 63.25 110.274 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.06 150.81 20.07 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.46 0.647 . . . . 72.219999999999999 110.637 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -110.34 125.24 52.97 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.893 0.877 . . . . 74.319999999999993 109.296 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.772 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 81.0 m-85 -111.71 161.7 16.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.149 0.58 . . . . 71.0 110.438 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HB3' HD21 ' A' ' 34' ' ' LEU . 27.2 tptp -146.68 122.9 10.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.741 0.816 . . . . 74.010000000000005 109.51 171.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 54.54 25.74 6.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.929 0.891 . . . . 72.129999999999995 113.068 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.76 -30.52 7.73 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-N 116.121 -0.491 . . . . 60.240000000000002 114.165 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.9 131.79 55.14 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.788 0.794 . . . . 75.329999999999998 111.379 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -62.18 151.89 34.7 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.107 0.963 . . . . 75.530000000000001 113.536 -177.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 29' ' ' LYS . 27.3 mt -100.99 142.32 32.64 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.165 0.986 . . . . 52.210000000000001 110.345 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.63 157.46 17.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.997 0.919 . . . . 72.099999999999994 109.996 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.9 p -61.62 97.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.841 0.829 . . . . 71.530000000000001 111.035 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.506 ' NE2' ' H ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -109.55 163.28 13.59 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.887 1.275 . . . . 73.439999999999998 108.135 -175.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' H ' ' NE2' ' A' ' 37' ' ' GLN . . . -53.92 -35.84 54.4 Favored Glycine 0 CA--C 1.543 1.798 0 N-CA-C 114.145 0.418 . . . . 74.400000000000006 114.145 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -89.5 -33.06 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.021 0.528 . . . . 74.530000000000001 110.821 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.04 86.01 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.93 0.892 . . . . 75.200000000000003 111.152 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 68.1 mt-30 -82.82 101.25 10.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.623 0.769 . . . . 75.430000000000007 110.751 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.441 HD21 HD23 ' A' ' 51' ' ' LEU . 61.2 mt -89.91 152.86 21.03 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.33 0.586 . . . . 72.409999999999997 112.201 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.5 tm-20 -146.48 131.83 18.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.743 -1.206 . . . . 74.319999999999993 107.743 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -124.8 103.14 7.92 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.012 0.525 . . . . 75.150000000000006 111.034 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.86 11.17 11.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.937 0.895 . . . . 74.230000000000004 111.969 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.67 -86.36 1.47 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.179 0.419 . . . . 61.409999999999997 113.408 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' HIS . . . -72.56 -5.39 36.79 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.347 0.659 . . . . 32.140000000000001 111.865 175.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 54.0 ttp180 -133.71 101.21 5.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.003 0.921 . . . . 60.32 109.745 172.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.0 mm100 -106.09 126.58 52.37 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 109.549 -0.537 . . . . 70.150000000000006 109.549 173.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 40.6 t -115.83 122.15 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-O 120.869 0.366 . . . . 62.409999999999997 111.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -111.34 114.47 27.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.334 1.054 . . . . 72.219999999999999 108.402 169.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.601 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 83.6 mtm180 -114.43 108.31 16.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.992 0.517 . . . . 62.149999999999999 111.202 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.7 t -96.55 120.89 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.634 -0.506 . . . . 63.310000000000002 109.634 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -79.2 116.08 19.25 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.257 0.623 . . . . 74.230000000000004 109.731 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.61 72.45 1.26 Allowed Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.336 -0.393 . . . . 72.519999999999996 113.429 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . . . -80.48 102.54 9.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.683 0.793 . . . . 51.229999999999997 111.447 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.34 -73.63 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.599 0.759 . . . . 74.5 111.614 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.8 m -127.71 -67.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.855 0.462 . . . . 75.510000000000005 111.867 -171.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.1 -12.53 60.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 113.974 0.349 . . . . 72.219999999999999 113.974 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.87 -17.48 43.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.292 1.037 . . . . 64.439999999999998 110.694 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.64 134.17 34.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.023 0.929 . . . . 55.350000000000001 109.554 172.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.04 -178.64 36.92 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.867 -0.606 . . . . 70.140000000000001 113.066 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.1 117.67 25.99 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.357 0.599 . . . . 75.340000000000003 110.467 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 38.4 m-85 -94.57 157.02 16.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.283 1.033 . . . . 75.340000000000003 109.934 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.4 tp -127.94 105.56 8.5 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.828 -0.545 . . . . 74.019999999999996 110.525 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' HG21 ' A' ' 16' ' ' VAL . 48.6 t -82.93 88.22 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.637 -0.875 . . . . 41.439999999999998 108.637 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -79.36 86.72 5.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.121 0.968 . . . . 63.310000000000002 111.684 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -81.01 140.57 49.96 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.816 -0.629 . . . . 74.319999999999993 110.054 171.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.32 -35.86 16.44 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 124.498 3.466 . . . . 71.219999999999999 115.896 -173.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -124.18 0.38 8.41 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.802 0.841 . . . . 71.239999999999995 112.406 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -156.49 49.45 0.48 Allowed 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.785 0.802 . . . . 73.099999999999994 111.046 -165.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -66.8 121.6 15.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.148 0.979 . . . . 35.32 112.025 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -127.47 142.66 51.34 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.933 0.716 . . . . 64.310000000000002 112.933 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mp -91.05 139.95 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.962 0.905 . . . . 74.319999999999993 109.947 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.586 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 9.3 m-85 -102.06 114.89 29.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.563 1.145 . . . . 73.519999999999996 111.121 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 93.9 mt -77.36 93.87 4.12 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.591 -0.892 . . . . 75.409999999999997 108.591 166.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.486 HG11 HD21 ' A' ' 12' ' ' LEU . 73.5 t -105.45 113.14 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.345 0.658 . . . . 63.009999999999998 110.691 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 t -118.1 117.65 29.76 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.564 -0.744 . . . . 64.439999999999998 110.747 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.3 t -84.82 106.26 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 107.947 -1.131 . . . . 72.019999999999996 107.947 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.41 -173.95 4.17 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.184 0.994 . . . . 74.239999999999995 109.922 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 7' ' ' THR . 44.6 tt0 59.78 81.15 0.25 Allowed Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.763 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo . . . . . 0 CA--C 1.575 2.566 0 C-N-CA 124.278 3.318 . . . . 74.439999999999998 115.875 -177.112 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.579 0.228 . . . . 71.409999999999997 111.528 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -79.67 95.19 5.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.674 -0.861 . . . . 75.549999999999997 108.674 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.566 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 41.2 mtp180 -93.9 148.34 22.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.567 0.747 . . . . 74.409999999999997 112.824 -166.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 79.4 t -130.57 138.57 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.031 0.932 . . . . 64.439999999999998 109.473 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.17 119.13 32.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.023 0.929 . . . . 55.149999999999999 109.076 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.419 ' HB3' HG22 ' A' ' 79' ' ' VAL . 35.0 t -132.45 163.16 29.38 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.796 0.808 . . . . 53.130000000000003 112.568 -170.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.1 p -99.74 155.82 36.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.047 -0.978 . . . . 72.150000000000006 111.189 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -82.02 46.71 2.28 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.444 2.762 . . . . 70.299999999999997 113.292 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.1 45.67 0.56 Allowed Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.316 -0.402 . . . . 63.5 113.115 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.73 172.98 36.12 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-O 119.635 -0.536 . . . . 72.519999999999996 112.193 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.78 135.37 41.71 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.553 0.677 . . . . 73.530000000000001 111.131 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.489 HD21 HG11 ' A' ' 77' ' ' VAL . 49.5 tp -78.84 107.44 11.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.782 0.433 . . . . 44.329999999999998 110.883 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 36.2 tt0 -111.24 104.59 13.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.922 0.489 . . . . 74.409999999999997 110.171 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HG ' HD12 ' A' ' 51' ' ' LEU . 29.3 mt -94.45 106.12 18.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.96 0.904 . . . . 75.109999999999999 110.402 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -93.95 113.27 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.588 0.755 . . . . 64.420000000000002 110.003 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 18' ' ' LEU . 2.1 t -100.05 149.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.688 0.795 . . . . 71.209999999999994 110.631 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -112.02 15.15 20.77 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.308 0.643 . . . . 51.350000000000001 111.14 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.609 ' H ' HG12 ' A' ' 16' ' ' VAL . 14.4 mt -54.24 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.514 0.725 . . . . 72.109999999999999 112.003 174.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.8 t -68.24 81.36 0.24 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.637 0.775 . . . . 62.210000000000001 110.349 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.29 164.18 30.63 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.292 -0.867 . . . . 73.239999999999995 113.268 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.09 23.7 0.51 Allowed 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.231 2.621 . . . . 74.219999999999999 113.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.74 59.76 4.26 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 122.838 0.256 . . . . 25.149999999999999 112.501 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.31 -69.49 1.37 Allowed Glycine 0 CA--C 1.551 2.299 0 CA-C-O 119.616 -0.547 . . . . 73.099999999999994 114.44 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.7 -167.35 5.99 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 120.19 1.995 . . . . 65.420000000000002 113.534 0.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' HB ' ' HG3' ' A' ' 49' ' ' GLN . 92.6 t -87.77 146.11 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 123.705 0.802 . . . . 54.210000000000001 110.459 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.709 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 97.4 mtt180 -96.2 169.72 9.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 75.209999999999994 110.66 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 94.8 m95 -131.22 136.92 48.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.824 0.85 . . . . 74.140000000000001 110.168 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 59.9 m-85 -134.46 123.67 24.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 123.036 0.535 . . . . 74.340000000000003 110.569 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.1 tptp -117.93 133.74 55.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.002 -0.74 . . . . 73.129999999999995 109.002 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 61.29 22.31 12.69 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.808 0.843 . . . . 74.209999999999994 111.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.09 5.6 82.96 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 114.268 0.467 . . . . 53.240000000000002 114.268 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -130.66 133.95 46.54 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.901 0.851 . . . . 72.400000000000006 112.358 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.511 ' HD3' ' H ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -62.85 150.87 40.61 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.022 1.489 . . . . 75.420000000000002 115.022 -171.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.567 HD12 HG21 ' A' ' 40' ' ' VAL . 3.8 mm? -92.61 163.79 13.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.237 1.415 . . . . 72.25 111.024 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.65 140.04 42.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.555 0.742 . . . . 54.310000000000002 110.407 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.1 p -81.74 31.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.509 0.724 . . . . 54.119999999999997 112.813 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -121.87 124.97 45.36 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.03 0.932 . . . . 74.420000000000002 110.655 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.71 -100.03 0.46 Allowed Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.731 0.652 . . . . 71.140000000000001 114.731 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -52.37 -46.04 66.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 125.024 1.33 . . . . 74.519999999999996 113.03 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.567 HG21 HD12 ' A' ' 34' ' ' LEU . 98.9 t -116.96 143.12 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.366 -0.834 . . . . 72.420000000000002 110.616 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -126.0 131.02 52.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.349 1.06 . . . . 62.039999999999999 110.156 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 82.6 mt -119.66 145.15 46.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.887 0.475 . . . . 62.130000000000003 112.068 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.46 130.69 54.81 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.32 0.648 . . . . 74.430000000000007 109.329 166.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -106.32 103.71 13.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.826 0.851 . . . . 64.329999999999998 110.018 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.55 178.12 6.31 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.37 0.668 . . . . 74.349999999999994 111.316 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.92 -24.79 75.33 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.332 -0.395 . . . . 62.130000000000003 113.501 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.65 -55.14 0.73 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.179 0.592 . . . . 73.109999999999999 111.868 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 46.7 ttp180 -81.8 97.83 8.18 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.959 0.409 . . . . 64.040000000000006 112.053 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.439 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 39.6 mm-40 -91.65 133.72 35.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.57 -0.9 . . . . 70.25 108.57 173.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 87.8 t -121.44 115.68 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 122.014 -0.429 . . . . 65.519999999999996 110.894 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.6 tm? -95.51 129.61 42.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.153 0.981 . . . . 73.329999999999998 108.644 171.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 63.1 mtp180 -131.66 105.34 7.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.853 0.752 . . . . 73.319999999999993 111.334 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 51' ' ' LEU . 46.5 t -96.23 105.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.836 -0.801 . . . . 63.210000000000001 108.836 171.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -72.39 109.96 6.47 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.53 0.732 . . . . 63.119999999999997 112.612 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.01 48.8 1.42 Allowed Glycine 0 C--N 1.35 1.348 0 CA-C-N 116.253 -0.431 . . . . 43.219999999999999 113.472 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.11 115.13 12.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.466 0.706 . . . . 74.310000000000002 111.551 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -157.5 -65.48 0.09 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.586 0.754 . . . . 53.340000000000003 111.989 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.5 m -80.22 -70.48 0.52 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.2 0.815 . . . . 61.119999999999997 113.2 -163.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -116.31 30.14 6.65 Favored Glycine 0 N--CA 1.487 2.034 0 CA-C-O 121.075 0.264 . . . . 74.319999999999993 112.859 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.95 -6.14 43.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 52.439999999999998 112.314 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -83.63 129.09 34.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.366 -0.605 . . . . 75.540000000000006 109.366 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 163.39 -174.2 39.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.121 -0.561 . . . . 45.32 114.212 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -91.53 110.65 21.97 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.107 0.563 . . . . 75.219999999999999 110.395 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.8 m-85 -95.6 113.63 25.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.854 0.461 . . . . 73.219999999999999 110.031 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 54.2 tp -92.85 101.77 14.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.547 0.739 . . . . 74.129999999999995 110.277 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 26' ' ' ARG . 72.6 m -71.41 88.48 0.89 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.335 -0.848 . . . . 54.350000000000001 109.614 169.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.0 t70 -80.04 89.85 5.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.39 0.614 . . . . 72.430000000000007 110.599 -176.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.44 151.39 50.74 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.226 -0.897 . . . . 73.400000000000006 111.31 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.62 -21.86 73.05 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.409 2.073 . . . . 71.299999999999997 112.633 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.92 93.19 3.92 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.529 -0.915 . . . . 74.140000000000001 108.529 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.53 109.61 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 125.3 1.44 . . . . 72.519999999999996 113.216 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -75.93 134.34 40.26 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.873 0.869 . . . . 73.140000000000001 112.035 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -107.39 141.37 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.329 0.652 . . . . 74.430000000000007 110.962 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.5 mp -104.84 137.78 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.092 0.557 . . . . 72.140000000000001 110.289 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 7.0 m-85 -108.46 105.44 15.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.312 1.045 . . . . 73.209999999999994 110.861 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 95.6 mt -77.17 97.78 4.88 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.324 -0.621 . . . . 63.340000000000003 109.324 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG11 HD21 ' A' ' 12' ' ' LEU . 45.3 t -107.65 131.58 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.834 0.454 . . . . 72.239999999999995 111.171 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.6 m -119.6 111.62 18.3 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.116 0.567 . . . . 70.319999999999993 109.788 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.62 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 40.5 t -109.31 105.25 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.138 -1.06 . . . . 71.109999999999999 108.138 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.59 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.523 0.935 . . . . 65.129999999999995 113.523 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 51.3 mt-10 -68.57 108.31 2.78 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.132 0.573 . . . . 74.129999999999995 110.995 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 26.4 Cg_exo . . . . . 0 C--N 1.383 2.355 0 C-N-CA 123.243 2.628 . . . . 62.229999999999997 113.879 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.965 0.412 . . . . 75.010000000000005 111.414 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -76.48 156.03 33.34 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.932 0.893 . . . . 62.340000000000003 112.29 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -150.75 129.92 12.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.28 1.032 . . . . 72.0 109.587 172.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 99.0 t -129.67 134.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.724 0.81 . . . . 72.099999999999994 109.612 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.3 144.17 26.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.026 0.53 . . . . 74.540000000000006 110.865 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.483 ' HB2' HD13 ' A' ' 12' ' ' LEU . 40.4 t -125.66 153.7 43.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.021 0.928 . . . . 65.329999999999998 109.851 172.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -102.0 150.42 37.43 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.354 0.662 . . . . 73.040000000000006 111.024 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.35 96.48 0.19 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.284 2.656 . . . . 75.530000000000001 113.769 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.24 38.49 4.53 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.673 -0.694 . . . . 65.129999999999995 113.975 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.57 168.85 22.58 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-O 120.085 -0.286 . . . . 74.310000000000002 112.547 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 37.0 t70 -70.42 140.95 52.16 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.222 0.534 . . . . 71.120000000000005 111.34 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 6' ' ' SER . 64.3 tp -109.41 152.39 25.41 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.421 1.088 . . . . 52.030000000000001 109.538 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.73 130.66 19.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.393 0.677 . . . . 71.019999999999996 109.653 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.31 105.39 14.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.501 0.721 . . . . 50.420000000000002 109.214 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.35 120.72 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.477 0.711 . . . . 65.310000000000002 109.239 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.668 ' HB ' ' H ' ' A' ' 49' ' ' GLN . 94.5 t -107.64 131.3 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.893 0.877 . . . . 73.400000000000006 111.964 -172.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -143.28 31.33 1.37 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.222 1.009 . . . . 64.0 110.897 172.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -57.61 168.14 0.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.857 0.688 . . . . 72.120000000000005 112.857 169.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.3 t -89.58 31.97 0.9 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.074 0.55 . . . . 71.409999999999997 111.168 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.62 80.42 0.29 Allowed Glycine 0 CA--C 1.541 1.661 0 CA-C-O 119.367 -0.685 . . . . 75.25 112.683 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.18 175.28 11.02 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.296 2.664 . . . . 53.539999999999999 113.466 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.2 -84.78 0.6 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.156 -0.474 . . . . 72.5 113.028 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.28 -161.85 17.4 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.401 -0.666 . . . . 52.229999999999997 113.75 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.45 116.1 4.18 Favored 'Cis proline' 0 C--N 1.378 2.129 0 CA-C-N 119.844 1.822 . . . . 63.409999999999997 113.422 -1.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.34 123.33 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.787 -0.642 . . . . 71.25 109.636 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -103.85 159.77 15.36 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.276 0.63 . . . . 52.5 111.819 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.43 ' HB3' HD23 ' A' ' 34' ' ' LEU . 86.0 m95 -115.49 137.61 51.88 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.956 0.902 . . . . 72.150000000000006 110.249 173.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 98.2 m-85 -135.29 123.33 22.77 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.381 0.672 . . . . 64.019999999999996 110.823 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 24.9 tptp -103.53 112.74 25.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.158 0.583 . . . . 72.319999999999993 110.379 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 55.59 3.07 0.07 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 126.12 1.768 . . . . 74.030000000000001 115.38 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.3 -27.43 1.54 Allowed Glycine 0 N--CA 1.481 1.675 0 O-C-N 121.152 -0.967 . . . . 64.450000000000003 114.738 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -113.28 147.15 38.14 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.366 1.083 . . . . 65.120000000000005 111.549 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.577 ' HD3' ' H ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -69.18 153.08 44.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.741 0.645 . . . . 75.329999999999998 112.741 175.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 27' ' ' TRP . 3.2 mm? -90.37 154.74 19.45 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.408 -0.815 . . . . 43.229999999999997 109.888 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.6 125.62 12.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.211 1.004 . . . . 33.310000000000002 108.671 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 p -55.4 99.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.746 0.818 . . . . 73.230000000000004 112.592 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -159.7 116.28 2.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.474 0.71 . . . . 72.430000000000007 111.62 -171.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.42 -89.88 0.06 OUTLIER Glycine 0 C--N 1.353 1.522 0 O-C-N 123.547 0.53 . . . . 51.119999999999997 113.655 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -75.27 -42.76 54.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.832 0.853 . . . . 73.120000000000005 111.601 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.27 106.71 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 116.116 -0.493 . . . . 74.439999999999998 110.151 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.658 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.5 mm100 -110.09 104.6 13.49 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.109 0.564 . . . . 70.400000000000006 109.625 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD21 HD23 ' A' ' 51' ' ' LEU . 84.9 mt -98.59 143.85 28.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 74.329999999999998 112.098 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 40.1 tt0 -140.47 136.75 33.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.224 1.01 . . . . 74.319999999999993 109.01 173.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.02 106.56 9.16 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.873 0.844 . . . . 72.439999999999998 110.869 -176.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -111.76 21.5 15.98 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.428 1.091 . . . . 72.299999999999997 110.967 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.17 -87.09 0.95 Allowed Glycine 0 N--CA 1.477 1.393 0 CA-C-N 116.34 -0.391 . . . . 74.239999999999995 112.787 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.87 -40.75 18.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.306 0.642 . . . . 70.450000000000003 110.647 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 46.3 ttt180 -78.5 106.38 10.41 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.416 -0.811 . . . . 73.230000000000004 110.699 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.668 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 79.9 mm-40 -106.91 155.45 19.75 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.616 0.766 . . . . 72.420000000000002 109.587 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 65.1 t -135.76 117.39 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.867 0.467 . . . . 63.0 109.953 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.434 HD23 HD21 ' A' ' 42' ' ' LEU . 2.8 tm? -110.51 118.7 36.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.834 -0.802 . . . . 74.420000000000002 108.834 168.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 84.2 mtt180 -113.81 141.42 47.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.06 0.544 . . . . 75.209999999999994 110.854 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.7 t -128.83 101.73 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.742 0.817 . . . . 65.120000000000005 108.992 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -74.23 121.73 21.72 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.051 -0.351 . . . . 73.230000000000004 110.051 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.34 36.47 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.79 -0.186 . . . . 62.409999999999997 113.291 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 90.31 0.06 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.573 0.749 . . . . 71.319999999999993 111.362 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -88.35 -56.68 3.21 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.055 1.132 . . . . 74.109999999999999 114.055 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -161.67 -58.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.326 0.25 . . . . 73.230000000000004 111.563 -174.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -9.96 55.03 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.485 -0.325 . . . . 63.329999999999998 113.442 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.78 -3.42 44.32 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.687 1.195 . . . . 73.409999999999997 111.973 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.67 127.5 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.509 0.724 . . . . 31.32 109.955 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 164.59 -172.72 40.41 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 121.225 0.347 . . . . 75.299999999999997 113.695 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -87.26 111.85 21.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.676 0.79 . . . . 51.039999999999999 111.45 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -99.35 111.35 23.73 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.819 -0.808 . . . . 73.439999999999998 108.819 170.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 tp -94.09 106.63 18.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.249 1.02 . . . . 74.140000000000001 110.379 -171.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.433 ' SG ' HD21 ' A' ' 18' ' ' LEU . 42.2 t -79.89 88.06 5.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.629 0.728 . . . . 70.340000000000003 109.165 171.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -78.18 89.93 4.28 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.994 -1.003 . . . . 61.340000000000003 110.845 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -94.51 148.31 34.73 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.491 0.717 . . . . 64.140000000000001 111.264 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -55.04 -32.1 77.73 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 123.538 2.825 . . . . 55.109999999999999 114.774 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -86.81 -51.73 5.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.969 0.508 . . . . 44.32 111.592 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -149.39 126.02 11.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.287 0.635 . . . . 62.240000000000002 112.164 -175.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -87.08 118.93 26.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.83 0.852 . . . . 72.129999999999995 110.41 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.524 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -105.79 131.21 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.227 0.611 . . . . 74.140000000000001 111.325 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.5 mt -88.87 117.96 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.791 0.837 . . . . 60.240000000000002 109.939 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.487 ' CZ ' HG22 ' A' ' 16' ' ' VAL . 17.8 m-85 -98.58 103.63 15.6 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.831 -0.803 . . . . 65.349999999999994 108.831 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.18 93.56 3.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.178 -0.675 . . . . 71.120000000000005 109.178 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.1 t -85.2 99.95 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.734 0.778 . . . . 64.530000000000001 109.748 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.4 p -95.51 108.79 21.05 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.744 -1.116 . . . . 73.129999999999995 109.937 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 6' ' ' SER . 85.6 t -82.37 106.09 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 107.682 -1.229 . . . . 54.009999999999998 107.682 173.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -156.24 -178.11 7.08 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.513 1.125 . . . . 65.409999999999997 109.888 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 58.25 75.06 0.56 Allowed Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.591 0.757 . . . . 61.020000000000003 110.563 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 CA--C 1.572 2.383 0 C-N-CA 123.154 2.57 . . . . 72.230000000000004 113.459 -176.69 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.457 0.17 . . . . 75.540000000000006 111.311 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -62.06 133.67 55.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.374 0.67 . . . . 54.119999999999997 110.124 167.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -126.63 111.74 14.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.345 0.658 . . . . 73.420000000000002 109.818 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.2 t -115.16 139.39 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.31 0.644 . . . . 65.319999999999993 111.092 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -90.05 136.05 33.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.64 0.776 . . . . 70.200000000000003 110.209 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 t -125.37 152.03 45.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.677 0.791 . . . . 74.5 110.145 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 81' ' ' GLU . 1.6 p -104.67 152.28 39.43 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.564 0.745 . . . . 73.230000000000004 111.752 177.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 57.1 Cg_endo -80.54 42.71 1.38 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.368 2.712 . . . . 64.310000000000002 113.747 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.73 66.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.926 0 N-CA-C 112.293 -0.323 . . . . 35.25 112.293 -173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.32 -136.3 4.12 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-O 120.164 -0.242 . . . . 73.030000000000001 112.782 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.47 152.57 51.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.648 0.779 . . . . 50.009999999999998 110.761 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.2 tp -89.71 146.73 24.3 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.29 0.636 . . . . 73.439999999999998 109.903 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -145.57 114.06 6.73 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.913 -0.402 . . . . 74.140000000000001 109.913 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 63.4 mt -106.82 102.02 11.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.582 0.753 . . . . 73.420000000000002 110.061 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -94.52 113.19 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.283 -1.006 . . . . 75.329999999999998 108.283 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 18' ' ' LEU . 2.9 t -100.01 146.7 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.035 0.534 . . . . 63.109999999999999 111.429 -169.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -131.86 43.71 3.0 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.461 0.705 . . . . 75.040000000000006 110.426 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.527 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -59.19 164.59 3.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.018 0.747 . . . . 74.329999999999998 113.018 172.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.2 p -84.78 38.31 0.69 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.807 0.843 . . . . 53.149999999999999 112.319 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 70' ' ' GLN . . . -127.05 84.84 0.34 Allowed Glycine 0 N--CA 1.478 1.482 0 CA-C-O 119.537 -0.59 . . . . 43.32 112.502 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.41 156.77 60.95 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.079 2.519 . . . . 41.549999999999997 113.269 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.8 -119.85 11.65 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.908 -0.587 . . . . 65.430000000000007 113.473 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -173.74 -164.42 28.86 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-O 119.493 -0.615 . . . . 72.420000000000002 113.305 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.0 101.79 0.38 Allowed 'Cis proline' 0 CA--C 1.565 2.032 0 CA-C-N 120.096 1.948 . . . . 62.420000000000002 113.029 -3.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HA2' ' A' ' 23' ' ' GLY . 30.7 t -79.89 123.0 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 109.817 -0.438 . . . . 62.310000000000002 109.817 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -100.68 158.41 15.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.558 0.743 . . . . 74.219999999999999 111.449 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.474 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 62.8 m95 -114.33 142.37 46.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 73.439999999999998 111.157 175.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 54.6 m-85 -135.76 160.2 39.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.316 1.047 . . . . 73.510000000000005 110.597 177.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.6 tptp -140.75 130.71 24.58 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.540000000000006 109.591 165.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 57.68 27.71 14.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.268 1.027 . . . . 65.329999999999998 112.63 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 -1.13 76.17 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 115.829 -0.623 . . . . 70.200000000000003 114.507 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HG3' HH11 ' A' ' 33' ' ' ARG . 35.3 tt0 -124.78 131.04 53.49 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.325 1.063 . . . . 71.420000000000002 111.496 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.611 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.08 143.35 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.524 1.13 . . . . 74.129999999999995 113.94 -172.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.6 mt -95.62 147.54 23.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 72.219999999999999 111.011 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.49 150.52 23.3 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.936 0.894 . . . . 62.310000000000002 110.402 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.9 p -76.36 77.34 3.11 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.281 0.562 . . . . 75.340000000000003 110.177 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -76.09 -64.69 1.04 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.7 0.8 . . . . 64.439999999999998 112.488 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.36 -49.58 0.24 Allowed Glycine 0 N--CA 1.475 1.266 0 N-CA-C 112.257 -0.337 . . . . 65.109999999999999 112.257 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.07 -46.22 15.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.798 -0.816 . . . . 63.130000000000003 108.798 164.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.38 93.26 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 108.919 -0.771 . . . . 75.420000000000002 108.919 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.227 1.011 . . . . 73.319999999999993 110.788 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.22 137.95 51.7 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.084 0.554 . . . . 74.439999999999998 110.69 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -122.88 114.4 20.41 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.483 -0.932 . . . . 71.049999999999997 108.483 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -103.54 104.03 14.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.76 0.79 . . . . 72.239999999999995 110.519 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.13 178.28 6.12 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.499 1.12 . . . . 71.0 110.56 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 95.07 0.22 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.619 -0.545 . . . . 74.510000000000005 113.212 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.55 -34.6 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.573 1.549 . . . . 73.409999999999997 113.597 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 69.9 ttp85 -85.76 94.08 9.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.5 0.667 . . . . 74.409999999999997 110.893 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.506 ' HG3' ' SG ' ' A' ' 66' ' ' CYS . 15.7 mm100 -94.64 142.79 27.04 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.485 -0.78 . . . . 72.450000000000003 110.102 172.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 47.4 t -131.26 109.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.037 0.446 . . . . 64.129999999999995 111.069 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 HG23 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -96.7 130.9 43.84 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.381 -0.97 . . . . 74.5 108.381 169.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -128.57 108.67 10.71 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 61.439999999999998 109.339 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 HD11 ' A' ' 51' ' ' LEU . 89.4 t -98.2 96.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.625 0.648 . . . . 74.319999999999993 109.868 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.06 96.83 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.204 0.602 . . . . 62.0 110.314 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.38 46.47 0.2 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.839 -0.619 . . . . 74.230000000000004 112.019 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.4 113.86 17.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.755 0.822 . . . . 52.200000000000003 110.317 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 44.1 ttt85 -161.29 -41.77 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.168 0.803 . . . . 73.519999999999996 113.168 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.2 m -129.43 -77.55 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 122.75 0.42 . . . . 64.319999999999993 111.759 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.33 -3.37 70.42 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 114.479 0.552 . . . . 44.109999999999999 114.479 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -67.51 -26.28 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.15 0.98 . . . . 61.539999999999999 112.501 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.28 117.56 16.23 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.638 0.375 . . . . 63.329999999999998 110.083 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.31 -171.51 41.34 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 114.196 0.438 . . . . 44.299999999999997 114.196 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -87.45 117.17 26.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 74.129999999999995 111.277 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.572 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 77.7 m-85 -105.36 108.12 19.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.4 0.68 . . . . 71.409999999999997 110.096 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.1 tp -92.59 110.41 21.84 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.284 0.564 . . . . 74.019999999999996 109.924 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.506 ' SG ' ' HG3' ' A' ' 49' ' ' GLN . 37.9 t -89.1 88.06 7.42 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.846 0.858 . . . . 53.32 108.98 170.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.6 95.45 6.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.238 1.015 . . . . 62.409999999999997 112.473 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.41 137.46 30.69 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.884 0.473 . . . . 75.120000000000005 111.004 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.42 -23.51 47.48 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.319 2.679 . . . . 64.0 113.873 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.515 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 24.8 mp0 -85.58 -57.49 3.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.62 0.768 . . . . 62.130000000000003 111.096 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -157.0 117.11 3.51 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 112.135 0.42 . . . . 74.519999999999996 112.135 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 65' ' ' LEU . 10.5 m -76.06 140.26 41.81 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 64.530000000000001 112.204 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 126.86 54.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.672 0.789 . . . . 75.319999999999993 110.645 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.1 mp -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.417 -0.586 . . . . 55.200000000000003 109.417 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.572 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 37.8 m-85 -100.45 125.52 46.76 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.235 1.014 . . . . 74.200000000000003 110.386 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.2 mt -102.6 93.88 5.35 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.424 -0.954 . . . . 63.340000000000003 108.424 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.04 126.77 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.638 0.775 . . . . 64.439999999999998 110.469 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -119.0 117.52 29.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.689 0.796 . . . . 74.140000000000001 110.667 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.0 t -84.82 108.14 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.048 0.452 . . . . 60.030000000000001 109.894 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -164.61 -170.04 1.91 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.511 1.125 . . . . 73.200000000000003 109.617 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 7' ' ' THR . 32.3 tt0 59.84 72.81 0.72 Allowed Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.571 0.748 . . . . 72.450000000000003 110.322 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.571 2.329 0 C-N-CA 122.578 2.186 . . . . 74.239999999999995 113.357 -172.542 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.72 0.295 . . . . 71.230000000000004 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.8 m -83.59 88.71 7.03 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.806 0.842 . . . . 74.540000000000006 108.93 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -98.8 135.5 40.17 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.787 0.835 . . . . 72.450000000000003 112.14 -166.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.57 143.49 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.967 0.907 . . . . 71.329999999999998 110.233 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -92.21 145.23 24.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.727 0.411 . . . . 73.409999999999997 110.712 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.716 ' HB2' HD13 ' A' ' 12' ' ' LEU . 37.8 t -120.95 166.66 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.68 0.792 . . . . 61.310000000000002 110.081 166.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.07 138.57 21.78 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 123.069 0.548 . . . . 31.210000000000001 111.303 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 96.0 Cg_exo -47.32 117.11 2.09 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 124.13 3.22 . . . . 52.130000000000003 114.434 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.69 13.32 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 116.254 -0.43 . . . . 55.109999999999999 113.934 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.82 52.92 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 121.151 0.306 . . . . 74.549999999999997 113.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 5.5 p-10 -91.5 129.51 37.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.146 0.498 . . . . 73.420000000000002 111.463 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.716 HD13 ' HB2' ' A' ' 6' ' ' SER . 51.5 tp -74.65 150.15 39.7 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.706 0.802 . . . . 71.200000000000003 109.292 169.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.7 115.56 8.27 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.036 0.534 . . . . 65.209999999999994 109.943 170.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 76.2 mt -99.18 101.6 12.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.519 0.728 . . . . 71.140000000000001 109.729 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.3 t -90.36 113.02 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.386 -0.968 . . . . 64.510000000000005 108.386 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 47.4 t -96.72 122.11 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.242 0.544 . . . . 53.25 112.144 -165.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -120.0 70.53 0.87 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 122.06 0.933 . . . . 74.209999999999994 108.823 170.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HG ' ' CG1' ' A' ' 16' ' ' VAL . 19.7 mt -55.68 156.22 5.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.299 1.44 . . . . 73.120000000000005 113.278 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.8 m -77.72 -33.53 52.98 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.4 -0.818 . . . . 62.450000000000003 110.665 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.486 ' HA3' ' NE2' ' A' ' 70' ' ' GLN . . . -141.37 79.86 0.27 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-N 115.853 -0.612 . . . . 73.430000000000007 112.123 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.8 -167.93 0.54 Allowed 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 122.983 2.456 . . . . 44.240000000000002 114.007 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.97 -169.72 42.67 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.635 -0.711 . . . . 42.119999999999997 112.595 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.99 136.61 5.65 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.355 -0.692 . . . . 45.200000000000003 112.911 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.86 162.97 84.0 Favored 'Cis proline' 0 C--N 1.381 2.257 0 CA-C-N 120.032 1.916 . . . . 50.119999999999997 113.489 -6.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.566 HG11 ' SG ' ' A' ' 66' ' ' CYS . 53.9 t -115.09 134.57 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.926 0.89 . . . . 72.239999999999995 110.321 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -97.6 131.77 43.87 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.827 0.851 . . . . 72.200000000000003 110.643 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.2 137.29 41.55 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.796 0.839 . . . . 74.200000000000003 111.605 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.7 m-85 -130.51 124.04 31.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.695 0.798 . . . . 73.120000000000005 110.316 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB3' HD21 ' A' ' 34' ' ' LEU . 18.7 tptm -104.4 120.26 40.81 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 73.239999999999995 109.231 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.44 22.45 13.25 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.113 0.965 . . . . 75.120000000000005 111.216 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.17 -26.5 22.8 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.841 -0.618 . . . . 53.509999999999998 113.724 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.15 129.96 44.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.431 0.692 . . . . 63.32 110.805 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 152.55 16.14 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.888 0.875 . . . . 70.430000000000007 112.953 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 29' ' ' LYS . 28.6 mt -107.71 138.74 43.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.886 0.474 . . . . 72.310000000000002 111.293 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 144.8 29.07 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.773 0.829 . . . . 42.310000000000002 111.089 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -71.76 92.68 1.22 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.658 0.783 . . . . 51.420000000000002 111.678 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.455 0.702 . . . . 74.230000000000004 112.309 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.03 -57.21 21.06 Favored Glycine 0 C--N 1.36 1.87 0 N-CA-C 115.078 0.791 . . . . 71.239999999999995 115.078 -172.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -77.4 -40.71 42.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.812 0.445 . . . . 62.119999999999997 111.544 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 54.7 t -95.41 85.6 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.425 0.69 . . . . 70.340000000000003 110.541 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -92.79 125.11 37.24 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.995 0.518 . . . . 74.430000000000007 112.145 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.34 93.38 4.5 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.522 0.729 . . . . 63.039999999999999 111.049 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.756 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 37.0 tt0 -87.57 105.48 17.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.778 0.831 . . . . 70.400000000000006 110.566 173.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.22 110.04 21.8 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.226 0.61 . . . . 74.420000000000002 110.506 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.16 -45.65 5.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.428 0.691 . . . . 63.439999999999998 111.254 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.09 -91.1 0.12 Allowed Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.534 -0.626 . . . . 73.099999999999994 111.534 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -38.55 64.48 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.615 0.721 . . . . 70.510000000000005 109.913 169.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -81.19 125.89 30.83 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.417 -1.265 . . . . 74.140000000000001 110.431 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 83.4 mm-40 -117.49 152.42 35.09 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.898 -1.149 . . . . 54.439999999999998 107.898 164.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t -138.71 116.24 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.671 0.388 . . . . 72.439999999999998 110.617 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.47 128.48 54.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.554 0.742 . . . . 60.25 109.28 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 57.4 mtt180 -116.3 136.73 52.74 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.91 0.884 . . . . 72.409999999999997 110.393 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.26 97.57 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.298 0.639 . . . . 74.5 109.532 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -75.2 130.01 38.45 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.942 -0.392 . . . . 73.239999999999995 109.942 178.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.56 23.43 39.69 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.485 -0.325 . . . . 71.340000000000003 112.868 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.6 99.23 0.42 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.496 0.718 . . . . 74.150000000000006 110.221 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.632 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 63.9 mtp85 -104.9 -177.28 3.32 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.588 0.755 . . . . 73.310000000000002 112.113 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.0 m -62.57 108.68 1.19 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.299 0.64 . . . . 64.409999999999997 110.896 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.62 -15.36 8.02 Favored Glycine 0 N--CA 1.481 1.634 0 CA-C-N 116.233 -0.439 . . . . 53.329999999999998 112.88 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.43 -12.08 59.99 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.991 0.917 . . . . 73.209999999999994 111.809 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.621 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -63.61 92.36 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.557 1.143 . . . . 73.409999999999997 111.545 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.13 -179.93 20.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.488 -0.778 . . . . 60.109999999999999 113.511 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.33 124.89 31.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.109 0.564 . . . . 72.519999999999996 111.24 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 71.0 m-85 -112.9 108.65 17.68 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.177 0.991 . . . . 75.109999999999999 109.51 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 65.4 tp -91.14 103.41 16.1 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.952 -0.467 . . . . 72.409999999999997 110.364 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.566 ' SG ' HG11 ' A' ' 25' ' ' VAL . 40.5 t -77.67 86.91 3.96 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.682 0.753 . . . . 71.25 109.316 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.01 97.02 9.05 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.019 -0.991 . . . . 43.210000000000001 110.747 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.57 159.37 46.9 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 122.96 0.504 . . . . 70.400000000000006 111.039 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.94 36.21 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.635 2.223 . . . . 72.019999999999996 113.596 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.486 ' NE2' ' HA3' ' A' ' 20' ' ' GLY . 0.4 OUTLIER -165.47 -54.33 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.14 0.576 . . . . 74.530000000000001 109.641 -176.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -138.58 108.73 6.41 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.848 0.859 . . . . 64.519999999999996 110.862 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 p -93.38 124.05 37.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 70.030000000000001 110.985 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.83 139.22 48.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.794 0.437 . . . . 71.209999999999994 112.107 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.5 mt -89.04 130.82 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 109.478 -0.564 . . . . 62.109999999999999 109.478 170.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 3.0 m-85 -103.75 103.39 13.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.452 0.701 . . . . 74.420000000000002 109.333 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.42 93.05 5.93 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.725 -0.843 . . . . 75.209999999999994 108.725 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -91.13 127.86 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.084 0.554 . . . . 63.43 111.014 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.8 p -107.08 108.77 20.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.147 0.579 . . . . 70.040000000000006 109.918 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 6' ' ' SER . 22.2 t -98.45 106.36 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.073 -0.714 . . . . 72.129999999999995 109.073 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -168.56 172.89 7.8 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.692 0.397 . . . . 72.230000000000004 111.992 -171.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 58.56 86.85 0.15 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 124.577 1.151 . . . . 73.549999999999997 110.85 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.574 2.491 0 C-N-CA 122.817 2.345 . . . . 36.5 114.034 -173.206 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.603 -0.517 . . . . 54.439999999999998 109.603 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -62.37 127.24 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.22 0.608 . . . . 54.310000000000002 110.946 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -137.77 126.85 24.32 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.776 0.831 . . . . 74.049999999999997 109.982 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.1 131.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 121.423 0.63 . . . . 65.409999999999997 111.808 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.439 ' NH2' ' HB2' ' A' ' 81' ' ' GLU . 60.3 ttt85 -90.38 139.73 30.39 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.789 1.236 . . . . 74.519999999999996 110.054 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.549 ' HB3' HG22 ' A' ' 79' ' ' VAL . 34.1 t -137.69 172.0 13.6 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.121 0.568 . . . . 74.25 110.613 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 p -130.81 148.16 69.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.873 0.869 . . . . 74.129999999999995 111.214 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.33 145.88 39.18 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.637 2.225 . . . . 75.010000000000005 112.659 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.77 37.29 8.68 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 116.049 -0.523 . . . . 33.420000000000002 113.931 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.23 -134.67 1.7 Allowed Glycine 0 N--CA 1.475 1.275 0 CA-C-O 119.972 -0.349 . . . . 61.409999999999997 112.675 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.24 155.43 49.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 117.275 0.538 . . . . 72.400000000000006 111.18 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.11 143.18 32.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.505 1.122 . . . . 73.200000000000003 109.185 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.81 99.0 3.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.107 0.48 . . . . 64.400000000000006 111.267 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 51' ' ' LEU . 49.0 mt -92.23 105.53 17.72 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.106 0.962 . . . . 64.409999999999997 110.732 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.2 t -103.58 127.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.902 -0.407 . . . . 73.430000000000007 109.902 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 66' ' ' CYS . 3.4 m -108.3 149.93 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.412 0.685 . . . . 75.219999999999999 111.693 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -128.36 31.41 5.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.104 0.962 . . . . 75.109999999999999 109.444 163.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' HG ' ' HB ' ' A' ' 16' ' ' VAL . 1.2 pp -51.69 166.02 0.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.89 1.07 . . . . 42.030000000000001 113.89 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -86.64 32.86 0.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.338 0.655 . . . . 74.129999999999995 112.756 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.586 ' HA3' ' HB1' ' A' ' 68' ' ' ALA . . . -112.39 90.11 0.55 Allowed Glycine 0 CA--C 1.544 1.888 0 CA-C-O 119.506 -0.608 . . . . 64.109999999999999 112.654 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.19 165.4 23.73 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.116 2.544 . . . . 73.319999999999993 113.237 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.87 -86.23 0.17 Allowed Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.879 -0.601 . . . . 42.450000000000003 113.62 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.07 8.56 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-O 118.782 -1.01 . . . . 52.409999999999997 114.028 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.28 117.44 2.67 Favored 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.828 2.314 . . . . 71.129999999999995 113.635 1.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.501 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 91.3 t -65.24 124.05 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.706 -0.679 . . . . 72.409999999999997 110.084 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 89.0 mtm180 -94.89 164.43 12.92 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.511 0.725 . . . . 71.299999999999997 111.003 -171.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -120.81 134.96 55.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.96 0.904 . . . . 74.439999999999998 109.716 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.9 m-85 -122.1 162.53 21.08 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.244 1.018 . . . . 74.420000000000002 110.791 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.6 tptp -154.32 128.33 8.9 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.425 1.09 . . . . 72.409999999999997 108.929 169.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 64.72 17.3 10.88 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.011 0.924 . . . . 74.030000000000001 111.988 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.47 -7.14 81.9 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.534 -0.303 . . . . 71.420000000000002 113.726 -173.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -109.31 121.58 45.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.713 0.805 . . . . 70.409999999999997 110.444 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.7 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.9 143.58 57.34 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.732 0.642 . . . . 75.319999999999993 112.732 -175.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.2 mt -87.49 152.62 22.07 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.291 1.037 . . . . 74.450000000000003 110.988 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.42 158.85 20.12 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.835 0.854 . . . . 65.219999999999999 110.343 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -70.62 82.8 0.6 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.789 0.804 . . . . 62.049999999999997 110.954 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -96.78 170.47 9.16 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.104 1.362 . . . . 75.310000000000002 110.509 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.15 -43.25 93.47 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.544 0.116 . . . . 73.430000000000007 113.348 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.26 -53.6 13.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.935 0.494 . . . . 75.310000000000002 110.708 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 34' ' ' LEU . 59.7 t -88.17 90.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 124.138 0.975 . . . . 73.430000000000007 112.03 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.628 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.2 mt-30 -82.32 114.89 21.1 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.45 0.7 . . . . 71.239999999999995 110.379 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.411 ' HB3' HE22 ' A' ' 44' ' ' GLN . 29.1 mt -110.06 104.36 13.22 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.203 0.601 . . . . 53.530000000000001 111.76 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.81 98.55 11.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.925 0.89 . . . . 70.540000000000006 110.559 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.411 HE22 ' HB3' ' A' ' 42' ' ' LEU . 23.4 mp0 -99.92 132.02 45.53 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.364 0.666 . . . . 75.310000000000002 110.994 172.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.26 -49.0 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.97 0.908 . . . . 52.25 110.415 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.98 122.15 1.52 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-O 119.045 -0.864 . . . . 63.109999999999999 111.155 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 69.21 -65.58 0.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.944 1.297 . . . . 63.240000000000002 112.288 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 ttp180 -79.07 95.91 5.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.866 0.466 . . . . 72.430000000000007 110.806 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.501 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 8.6 mm100 -116.49 136.95 52.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.753 0.821 . . . . 75.530000000000001 109.458 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG12 ' HG3' ' A' ' 52' ' ' ARG . 36.0 t -121.52 124.24 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.152 0.501 . . . . 65.420000000000002 111.18 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.67 120.36 40.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 52.539999999999999 108.562 168.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 73.6 mtp180 -119.61 107.91 13.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.944 0.498 . . . . 72.239999999999995 110.094 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -96.42 100.96 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.943 0.497 . . . . 62.210000000000001 110.005 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -71.79 103.09 3.01 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.936 0.494 . . . . 73.219999999999999 109.975 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.39 42.51 0.25 Allowed Glycine 0 N--CA 1.474 1.198 0 CA-C-N 116.293 -0.412 . . . . 74.219999999999999 112.695 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.44 131.5 49.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.007 0.523 . . . . 71.409999999999997 110.642 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -163.56 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.232 0.827 . . . . 74.409999999999997 113.232 -167.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 m -159.07 -56.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 123.273 0.629 . . . . 33.140000000000001 111.305 -171.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -20.59 70.92 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.069 0.388 . . . . 61.130000000000003 114.069 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -81.46 -16.0 53.32 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.146 0.978 . . . . 62.450000000000003 111.193 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 79' ' ' VAL . . . -74.13 111.57 9.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.88 0.472 . . . . 72.129999999999995 109.737 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.2 -171.9 44.78 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 114.081 0.393 . . . . 72.540000000000006 114.081 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -81.25 113.46 19.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.391 0.676 . . . . 70.209999999999994 110.941 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 32.8 m-85 -95.36 155.95 16.53 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.994 0.918 . . . . 74.430000000000007 109.334 167.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.9 tp -133.57 104.89 6.58 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.135 -0.353 . . . . 72.200000000000003 110.075 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 16' ' ' VAL . 34.4 t -74.99 89.35 2.4 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.883 . . . . 74.25 108.617 169.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 22.5 t70 -74.86 92.09 2.5 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.659 1.184 . . . . 62.009999999999998 111.582 -173.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB1' ' HA3' ' A' ' 20' ' ' GLY . . . -96.05 148.4 34.46 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.256 0.623 . . . . 70.349999999999994 111.355 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.42 -21.75 66.2 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.985 2.457 . . . . 73.409999999999997 113.625 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.525 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 86.1 mm-40 -112.57 -51.44 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.25 0.62 . . . . 74.129999999999995 112.147 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.45 97.41 3.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.728 0.411 . . . . 74.019999999999996 111.467 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -85.09 141.9 29.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.298 0.639 . . . . 75.219999999999999 110.706 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -130.26 131.97 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.055 0.542 . . . . 71.209999999999994 112.191 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.73 131.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.506 1.122 . . . . 71.230000000000004 109.93 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 39.8 m-85 -100.79 111.26 23.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.388 0.675 . . . . 73.109999999999999 110.772 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.33 93.56 7.18 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.786 -1.19 . . . . 71.239999999999995 107.786 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.0 119.94 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.126 0.57 . . . . 72.439999999999998 110.684 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.1 p -118.4 112.22 19.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.526 0.731 . . . . 55.219999999999999 110.411 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 6' ' ' SER . 44.7 t -86.08 107.21 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 121.287 0.565 . . . . 72.400000000000006 109.492 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.4 -171.21 2.54 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.637 1.175 . . . . 64.129999999999995 110.103 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . 31.2 tt0 60.09 63.41 3.08 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 124.056 0.942 . . . . 65.239999999999995 111.944 166.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.574 2.519 0 C-N-CA 122.69 2.26 . . . . 71.400000000000006 114.491 -166.157 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.869 0.366 . . . . 71.319999999999993 111.206 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -83.72 85.89 7.22 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.935 0.894 . . . . 43.450000000000003 110.37 -170.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.587 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 40.6 mtm180 -84.53 144.74 28.48 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.772 0.829 . . . . 70.299999999999997 112.098 -170.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 74.9 t -139.58 133.83 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.175 0.99 . . . . 74.420000000000002 110.604 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -101.14 145.86 28.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.504 0.722 . . . . 70.209999999999994 110.85 171.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 163.25 32.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.064 0.546 . . . . 73.150000000000006 111.65 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 81' ' ' GLU . 23.7 p -98.24 146.04 30.86 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 123.676 0.79 . . . . 72.040000000000006 111.608 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.16 92.07 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.051 2.5 . . . . 62.140000000000001 112.022 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.16 -14.92 5.38 Favored Glycine 0 N--CA 1.477 1.399 0 CA-C-N 115.617 -0.719 . . . . 35.340000000000003 113.24 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.71 149.34 18.52 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-O 119.504 -0.609 . . . . 74.030000000000001 112.066 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.02 131.09 44.83 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.845 0.823 . . . . 75.420000000000002 111.74 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 77' ' ' VAL . 55.6 tp -78.83 98.28 6.27 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.778 -0.646 . . . . 61.530000000000001 109.747 172.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -101.51 109.67 21.53 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 110.077 -0.342 . . . . 74.150000000000006 110.077 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.0 103.5 15.8 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.311 -0.626 . . . . 63.25 109.311 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 t -92.43 101.45 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.769 -0.826 . . . . 73.319999999999993 108.769 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.54 HG12 ' HG ' ' A' ' 18' ' ' LEU . 12.1 t -101.63 130.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.166 0.586 . . . . 54.219999999999999 111.565 -168.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.0 45.58 1.77 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.752 0.821 . . . . 43.229999999999997 110.753 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.54 ' HG ' HG12 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.4 178.04 0.11 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 113.479 0.918 . . . . 52.409999999999997 113.479 169.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 m -87.41 24.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.615 0.766 . . . . 73.049999999999997 112.534 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.24 90.85 0.55 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 119.395 -0.669 . . . . 43.420000000000002 112.197 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.38 127.95 14.79 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.031 2.487 . . . . 73.209999999999994 113.547 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 -111.59 4.3 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.353 -0.385 . . . . 72.430000000000007 113.319 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 -82.99 0.31 Allowed Glycine 0 CA--C 1.547 2.061 0 CA-C-O 119.121 -0.822 . . . . 71.400000000000006 113.744 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HG2' HH22 ' A' ' 26' ' ' ARG . 90.7 Cg_endo -73.99 148.16 91.28 Favored 'Cis proline' 0 C--N 1.382 2.308 0 CA-C-N 120.778 2.289 . . . . 54.32 113.041 1.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.633 HG11 ' SG ' ' A' ' 66' ' ' CYS . 86.9 t -62.63 136.92 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.57 0.748 . . . . 73.420000000000002 111.681 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.536 HH22 ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -97.73 128.98 44.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.421 0.688 . . . . 74.099999999999994 109.762 -177.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -97.57 136.41 38.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.107 0.563 . . . . 65.409999999999997 111.102 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 88.0 m-85 -133.14 147.97 52.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.028 0.931 . . . . 74.200000000000003 110.516 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 28.3 tptp -136.36 133.38 36.74 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.422 1.089 . . . . 72.5 108.945 165.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.85 17.62 11.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.217 1.007 . . . . 63.329999999999998 112.259 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.01 86.69 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 113.753 0.261 . . . . 71.299999999999997 113.753 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -117.05 135.11 53.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.436 0.694 . . . . 71.409999999999997 109.777 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.85 151.86 17.11 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 113.257 0.836 . . . . 63.549999999999997 113.257 -176.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 29' ' ' LYS . 21.5 mt -98.18 163.59 12.67 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.347 0.594 . . . . 64.340000000000003 111.204 171.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.53 151.9 49.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.128 0.971 . . . . 64.319999999999993 109.729 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 77.6 p -79.29 98.39 6.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.843 0.457 . . . . 73.040000000000006 110.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -102.75 -78.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.95 -0.469 . . . . 54.119999999999997 110.925 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.42 -59.66 0.01 OUTLIER Glycine 0 N--CA 1.472 1.071 0 N-CA-C 111.563 -0.615 . . . . 72.400000000000006 111.563 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -70.04 -44.28 69.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.247 0.619 . . . . 71.540000000000006 110.412 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.7 t -82.53 99.03 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.237 0.615 . . . . 70.25 109.428 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.3 mt-30 -95.2 110.6 22.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.538 0.735 . . . . 74.310000000000002 110.148 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 54.9 mt -106.31 111.99 24.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.914 0.486 . . . . 63.229999999999997 111.206 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.4 tp10 -94.98 106.29 18.27 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.659 1.184 . . . . 64.340000000000003 110.098 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.35 103.76 16.37 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.939 0.496 . . . . 54.539999999999999 109.926 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 48' ' ' ARG . . . -125.02 -164.03 1.24 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.385 0.674 . . . . 73.510000000000005 110.595 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.67 -89.29 0.14 Allowed Glycine 0 C--N 1.353 1.503 0 N-CA-C 112.586 -0.206 . . . . 34.520000000000003 112.586 172.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.36 -27.35 24.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.367 0.667 . . . . 70.450000000000003 112.102 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 62.6 ttp180 -90.04 87.99 7.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.332 0.653 . . . . 60.409999999999997 111.669 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -91.75 129.2 37.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.462 -0.57 . . . . 74.510000000000005 109.462 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 33.5 t -130.31 110.92 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-O 120.811 0.339 . . . . 54.439999999999998 111.582 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -100.25 113.86 26.86 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.775 0.83 . . . . 71.439999999999998 108.807 168.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 72.5 mtp180 -111.34 107.77 17.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.029 0.532 . . . . 75.340000000000003 110.404 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 57.6 t -88.0 95.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.22 -0.659 . . . . 64.25 109.22 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.24 121.29 9.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.763 0.825 . . . . 60.119999999999997 112.241 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 60.35 8.14 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 123.205 0.316 . . . . 73.109999999999999 113.636 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.98 110.55 14.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.523 0.729 . . . . 74.209999999999994 112.623 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -171.75 3.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.368 0.667 . . . . 74.439999999999998 111.26 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m -61.66 -26.28 67.92 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.991 0.737 . . . . 62.100000000000001 112.991 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.92 73.28 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.565 -0.289 . . . . 54.119999999999997 113.761 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.15 0.1 57.34 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.038 0.935 . . . . 74.239999999999995 112.35 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -77.33 101.32 6.26 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.178 0.591 . . . . 52.219999999999999 109.912 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.43 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -167.62 -175.25 37.34 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 114.228 0.451 . . . . 60.439999999999998 114.228 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -89.21 108.86 19.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.122 0.569 . . . . 72.439999999999998 110.575 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -98.62 112.32 24.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.397 0.679 . . . . 73.129999999999995 109.758 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 38.1 tp -91.43 104.34 16.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.457 0.646 . . . . 63.310000000000002 110.336 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.633 ' SG ' HG11 ' A' ' 25' ' ' VAL . 51.3 t -85.7 86.33 7.37 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.738 -0.838 . . . . 54.049999999999997 108.738 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.09 105.88 13.54 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.299 -0.864 . . . . 55.229999999999997 110.204 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -113.9 160.33 32.58 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.285 0.634 . . . . 32.119999999999997 111.959 -174.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.78 120.45 8.36 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.587 2.192 . . . . 74.329999999999998 112.351 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 75.53 -60.92 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.526 1.53 . . . . 74.209999999999994 112.387 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 38.4 t70 -105.68 98.91 8.54 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.282 0.633 . . . . 73.430000000000007 111.872 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 t -95.01 129.52 42.05 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.921 0.889 . . . . 73.430000000000007 111.196 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -119.03 131.05 55.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.412 0.685 . . . . 50.329999999999998 112.344 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.46 135.55 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.857 -0.794 . . . . 61.350000000000001 108.857 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.414 ' CZ ' HG22 ' A' ' 16' ' ' VAL . 4.8 m-85 -106.2 103.39 12.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.512 0.725 . . . . 71.030000000000001 109.747 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.587 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 78.9 mt -78.08 92.87 4.42 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.944 -0.761 . . . . 62.310000000000002 108.944 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.507 HG21 HD21 ' A' ' 12' ' ' LEU . 55.6 t -87.77 132.88 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.554 -0.748 . . . . 71.349999999999994 110.774 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.0 m -134.56 109.23 8.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.618 -0.719 . . . . 75.230000000000004 110.798 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.409 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 76.6 t -89.08 106.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 107.985 -1.117 . . . . 64.349999999999994 107.985 173.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.57 12.06 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 113.565 0.95 . . . . 64.549999999999997 113.565 -167.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 7' ' ' THR . 34.7 tt0 -125.71 100.4 31.32 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.781 -0.628 . . . . 74.510000000000005 109.55 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 CA--C 1.568 2.18 0 C-N-CA 123.43 2.753 . . . . 71.310000000000002 114.255 -178.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.561 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 49.7 tpp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.135 -0.321 . . . . 42.43 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 p -65.22 93.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.37 0.668 . . . . 45.409999999999997 112.045 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -90.93 129.57 36.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 71.030000000000001 110.344 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 78.0 t -131.27 138.34 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 124.062 0.945 . . . . 63.32 110.007 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -106.45 130.28 54.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.206 0.602 . . . . 71.420000000000002 110.82 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.438 ' HB3' HG22 ' A' ' 79' ' ' VAL . 37.0 t -112.99 171.76 7.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.636 0.774 . . . . 51.329999999999998 111.626 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 81' ' ' GLU . 22.5 p -120.81 138.2 27.37 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 113.453 0.909 . . . . 62.130000000000003 113.453 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.8 Cg_endo -77.49 91.09 1.2 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.605 2.87 . . . . 74.510000000000005 112.734 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.74 -13.58 8.65 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.221 -0.9 . . . . 71.209999999999994 112.23 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.81 -137.39 8.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.495 -0.058 . . . . 63.119999999999997 113.015 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -149.88 150.71 32.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.243 0.617 . . . . 71.400000000000006 111.135 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.88 148.24 23.96 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.527 0.731 . . . . 74.340000000000003 110.795 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.01 109.73 5.01 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.453 0.701 . . . . 74.519999999999996 110.043 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 79.7 mt -106.48 101.58 11.03 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.384 -0.599 . . . . 73.239999999999995 109.384 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.6 114.81 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.724 -0.843 . . . . 70.310000000000002 108.724 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.48 HG12 ' HG ' ' A' ' 18' ' ' LEU . 6.9 t -103.24 138.97 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 111.576 -166.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -132.23 30.07 4.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.549 0.74 . . . . 63.130000000000003 110.917 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.48 ' HG ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -54.77 158.89 2.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.193 0.812 . . . . 72.439999999999998 113.193 171.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -90.83 48.31 1.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.175 0.59 . . . . 73.239999999999995 111.093 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.91 128.25 8.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.983 -0.898 . . . . 73.030000000000001 112.69 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.34 89.92 0.26 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.991 2.461 . . . . 74.150000000000006 113.753 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.49 -84.15 0.1 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.905 -0.589 . . . . 75.510000000000005 114.346 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.41 -173.68 44.79 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.631 -0.538 . . . . 72.340000000000003 113.269 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.33 114.33 3.29 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 119.586 1.693 . . . . 65.420000000000002 112.814 -4.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.67 120.93 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 109.369 -0.604 . . . . 71.140000000000001 109.369 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 50.0 mtt180 -95.38 164.99 12.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.386 1.074 . . . . 73.319999999999993 110.904 -173.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -128.46 130.67 47.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.052 0.941 . . . . 72.400000000000006 109.985 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.784 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 97.9 m-85 -123.35 164.64 18.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.754 0.822 . . . . 75.400000000000006 110.81 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 19.3 tptm -154.3 125.64 7.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.566 0.746 . . . . 70.019999999999996 110.05 174.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.09 17.15 9.92 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.187 0.995 . . . . 71.200000000000003 111.333 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.06 -31.07 5.44 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.752 -0.471 . . . . 72.239999999999995 114.237 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.32 147.06 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.091 0.946 . . . . 74.209999999999994 112.614 -170.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.93 153.03 30.39 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 74.319999999999993 115.249 -167.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.5 154.94 18.13 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.753 0.821 . . . . 73.319999999999993 111.17 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.82 148.54 51.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.421 1.088 . . . . 64.349999999999994 109.021 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 t -58.78 97.48 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.383 0.673 . . . . 61.219999999999999 110.747 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -136.05 84.23 2.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.753 0.821 . . . . 63.210000000000001 110.732 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.77 -88.65 0.02 OUTLIER Glycine 0 N--CA 1.478 1.467 0 CA-C-N 115.336 -0.847 . . . . 61.119999999999997 114.424 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.253 1.021 . . . . 72.329999999999998 111.003 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.03 104.83 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.382 0.673 . . . . 64.319999999999993 109.672 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 74.1 mt-30 -109.86 119.3 38.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.13 0.972 . . . . 75.329999999999998 110.354 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.65 137.38 46.69 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.469 0.707 . . . . 63.32 112.013 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 15.2 tp10 -133.36 102.3 5.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.534 1.134 . . . . 74.200000000000003 109.369 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -101.9 104.05 14.75 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.421 0.629 . . . . 65.219999999999999 111.361 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.15 75.74 1.64 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.61 0.764 . . . . 75.239999999999995 110.331 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.58 -117.15 6.93 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 115.877 -0.601 . . . . 64.310000000000002 112.783 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.85 -21.99 27.78 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.45 0.7 . . . . 63.140000000000001 111.125 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.92 91.0 1.5 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.743 0.817 . . . . 73.510000000000005 110.155 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -102.93 139.14 38.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.616 0.767 . . . . 54.509999999999998 110.068 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 99.7 t -129.16 124.91 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.841 0.353 . . . . 54.350000000000001 110.664 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -117.09 122.91 45.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.09 0.956 . . . . 75.109999999999999 108.66 170.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB3' HH11 ' A' ' 52' ' ' ARG . 0.8 OUTLIER -119.57 134.84 55.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.493 0.717 . . . . 74.310000000000002 109.972 176.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.46 98.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.097 -0.705 . . . . 63.43 109.097 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.74 115.39 16.46 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.61 -0.723 . . . . 63.32 110.846 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.18 52.95 1.3 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-O 120.881 0.156 . . . . 75.209999999999994 113.089 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.32 160.89 30.47 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.666 0.786 . . . . 72.099999999999994 111.794 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 29.9 ttm180 -166.97 -55.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.991 0.516 . . . . 73.329999999999998 111.495 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -147.64 -47.43 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 122.855 0.462 . . . . 74.219999999999999 111.382 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.48 -17.13 59.43 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.778 0.671 . . . . 42.229999999999997 114.778 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.407 ' HB3' HG21 ' A' ' 79' ' ' VAL . 30.7 t70 -72.22 -27.48 62.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.024 0.93 . . . . 72.019999999999996 112.186 174.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -72.95 103.74 3.85 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 72.299999999999997 111.514 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . -177.0 -173.5 42.61 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.85 -0.614 . . . . 74.25 113.659 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -90.58 117.13 29.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.78 0.432 . . . . 72.209999999999994 110.039 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 66.8 m-85 -102.27 106.33 17.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.879 0.872 . . . . 73.319999999999993 110.55 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 63.4 tp -91.94 102.08 14.64 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.028 -0.42 . . . . 72.030000000000001 110.242 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -79.34 87.18 5.02 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.771 -0.826 . . . . 73.230000000000004 108.771 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 17.5 t70 -76.04 130.54 38.53 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.764 0.826 . . . . 65.530000000000001 111.275 -173.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.599 ' HB3' ' H ' ' A' ' 72' ' ' SER . . . -127.77 143.83 49.04 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 118.664 -0.684 . . . . 61.329999999999998 110.393 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.56 -29.49 7.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 124.248 3.299 . . . . 73.439999999999998 115.099 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -152.32 66.74 0.83 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.632 0.773 . . . . 74.109999999999999 109.494 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 28.9 t70 -172.42 -80.2 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 123.917 0.887 . . . . 71.129999999999995 110.709 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.599 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 40.0 m 65.46 106.24 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.052 1.341 . . . . 71.109999999999999 112.548 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.15 135.15 49.17 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.818 0.847 . . . . 72.409999999999997 110.938 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.561 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 64.6 mt -100.96 119.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.961 0.504 . . . . 71.200000000000003 110.804 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 2' ' ' THR . 29.3 m-85 -100.34 101.81 12.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.286 0.634 . . . . 72.340000000000003 110.631 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.0 mt -81.88 93.84 6.97 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.317 -0.623 . . . . 73.430000000000007 109.317 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 75.5 t -98.12 121.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.69 0.796 . . . . 50.329999999999998 111.269 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.2 p -121.46 116.64 25.1 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 73.409999999999997 111.371 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.9 t -83.81 110.6 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.316 -0.624 . . . . 73.400000000000006 109.316 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -151.57 -41.63 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.589 0.588 . . . . 65.010000000000005 112.589 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 7' ' ' THR . 10.8 tp10 -66.8 106.03 1.03 Allowed Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.93 0.892 . . . . 73.219999999999999 110.607 -175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo . . . . . 0 CA--C 1.57 2.295 0 C-N-CA 123.078 2.519 . . . . 74.409999999999997 113.747 -172.759 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 110.158 -0.312 . . . . 65.510000000000005 110.158 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.1 m -80.38 83.92 6.12 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.536 0.735 . . . . 75.400000000000006 110.061 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.594 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 55.4 mtm180 -83.67 140.41 32.17 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.548 0.739 . . . . 74.040000000000006 112.342 -172.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.01 144.0 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.06 0.944 . . . . 71.140000000000001 109.97 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.94 145.28 51.98 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.455 0.702 . . . . 65.219999999999999 110.848 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.7 t -146.85 171.66 14.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.907 0.883 . . . . 73.099999999999994 110.31 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -76.03 148.87 82.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 112.982 0.734 . . . . 71.420000000000002 112.982 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.16 110.87 3.19 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.391 2.727 . . . . 73.400000000000006 112.907 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.47 -7.73 43.29 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.318 -0.855 . . . . 73.140000000000001 112.981 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.67 -156.67 31.53 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 122.767 0.222 . . . . 64.200000000000003 113.174 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 164.41 23.48 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.874 0.47 . . . . 61.439999999999998 110.502 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.494 HD21 HG11 ' A' ' 77' ' ' VAL . 47.5 tp -135.58 110.95 9.07 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.623 -0.51 . . . . 62.229999999999997 109.623 167.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.11 110.75 15.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.068 -0.345 . . . . 71.099999999999994 110.068 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.7 mt -89.41 104.72 17.25 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.679 -0.86 . . . . 74.219999999999999 108.679 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.76 107.65 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.445 -0.946 . . . . 42.299999999999997 108.445 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.431 HG12 ' HG ' ' A' ' 18' ' ' LEU . 16.0 t -115.35 129.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.384 0.674 . . . . 41.439999999999998 111.116 -170.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -140.82 43.71 1.83 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.711 0.804 . . . . 71.209999999999994 110.489 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.431 ' HG ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -58.71 167.52 1.49 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.464 0.706 . . . . 73.430000000000007 112.55 170.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -59.77 -49.1 79.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.862 0.465 . . . . 75.450000000000003 111.145 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.0 66.0 1.82 Allowed Glycine 0 C--N 1.356 1.668 0 N-CA-C 115.544 0.978 . . . . 64.200000000000003 115.544 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.24 97.02 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.669 2.246 . . . . 74.329999999999998 112.682 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.0 -154.33 22.4 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.797 -0.638 . . . . 74.109999999999999 113.079 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.24 -179.82 41.42 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.584 -0.564 . . . . 62.229999999999997 113.039 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.9 156.72 97.63 Favored 'Cis proline' 0 C--N 1.376 1.99 0 CA-C-N 119.791 1.796 . . . . 74.209999999999994 113.99 -4.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.87 130.23 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 123.504 0.722 . . . . 73.340000000000003 109.534 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -104.31 147.39 27.56 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.073 0.949 . . . . 72.409999999999997 111.232 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -104.96 132.41 51.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.993 0.517 . . . . 74.150000000000006 111.106 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.5 m-85 -126.84 165.36 19.49 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.493 1.117 . . . . 72.140000000000001 110.387 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -152.35 114.83 4.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.805 0.842 . . . . 73.230000000000004 110.05 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 t70 72.64 -27.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.653 1.581 . . . . 52.0 113.965 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.03 -11.17 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.138 0.399 . . . . 71.400000000000006 112.784 -172.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -129.45 138.47 51.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.256 0.623 . . . . 75.230000000000004 110.739 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.747 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.67 150.95 26.12 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.938 0.895 . . . . 71.409999999999997 112.692 177.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.08 134.28 34.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.879 0.472 . . . . 75.230000000000004 110.563 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.07 163.32 12.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.817 0.847 . . . . 70.340000000000003 110.383 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 p -68.74 89.38 0.39 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.601 0.715 . . . . 71.200000000000003 110.854 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 46.9 tt0 -99.1 164.79 12.02 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.42 1.088 . . . . 72.349999999999994 109.935 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.12 -40.09 90.92 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 113.52 0.168 . . . . 74.439999999999998 113.52 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -77.98 -54.34 6.4 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.157 0.583 . . . . 73.109999999999999 110.485 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 66.9 t -82.46 86.77 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 124.086 0.954 . . . . 65.310000000000002 111.63 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 37.8 mt-30 -80.25 133.34 35.98 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.926 0.89 . . . . 74.319999999999993 110.822 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.7 mt -118.95 154.67 32.64 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.102 0.561 . . . . 70.540000000000006 112.131 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.624 ' HG3' HH12 ' A' ' 52' ' ' ARG . 39.8 mt-10 -126.46 113.83 17.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.235 1.014 . . . . 64.430000000000007 110.58 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -94.01 114.9 27.18 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.684 0.794 . . . . 65.340000000000003 110.691 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.88 -68.23 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.765 0.426 . . . . 71.310000000000002 111.596 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.59 139.08 6.02 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 119.19 -0.783 . . . . 44.130000000000003 111.38 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 64.15 -69.87 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.235 1.014 . . . . 55.030000000000001 110.488 -165.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -71.41 116.59 11.92 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.25 0.547 . . . . 64.430000000000007 110.286 166.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -134.13 133.79 41.47 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.075 1.35 . . . . 71.040000000000006 108.269 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -136.53 117.14 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 121.775 -0.578 . . . . 74.109999999999999 110.374 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -101.77 123.92 46.54 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.248 1.019 . . . . 73.219999999999999 109.136 172.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.624 HH12 ' HG3' ' A' ' 43' ' ' GLU . 1.5 mpp_? -116.19 108.02 15.61 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.184 0.594 . . . . 75.420000000000002 110.799 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.432 HG23 HD11 ' A' ' 51' ' ' LEU . 76.2 t -96.67 96.71 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.271 -0.64 . . . . 75.510000000000005 109.271 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.24 129.18 38.22 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.469 0.708 . . . . 71.310000000000002 110.987 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.47 40.34 33.09 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.151 0.306 . . . . 72.340000000000003 112.891 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 131.87 36.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.137 0.975 . . . . 42.450000000000003 112.265 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -156.75 -84.47 0.05 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.239 0.616 . . . . 73.239999999999995 110.768 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.1 t -92.45 121.9 34.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.623 0.769 . . . . 61.439999999999998 110.547 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.3 -31.7 5.3 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.531 -0.304 . . . . 62.140000000000001 112.732 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.2 -29.21 60.26 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.088 0.955 . . . . 74.200000000000003 111.435 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.15 113.67 10.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.23 -0.655 . . . . 62.340000000000003 109.23 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.12 -170.22 43.32 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 123.123 0.264 . . . . 73.420000000000002 113.242 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -89.16 114.26 25.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.0 0.52 . . . . 74.400000000000006 111.126 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 46.5 m-85 -96.77 154.34 17.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.742 0.817 . . . . 73.129999999999995 109.797 171.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.4 tp -132.88 105.13 6.94 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.687 0.395 . . . . 64.310000000000002 110.759 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.73 87.93 6.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.226 -1.027 . . . . 51.350000000000001 108.226 169.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.74 95.24 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.796 -1.093 . . . . 64.120000000000005 110.907 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -100.99 145.67 30.81 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.466 0.706 . . . . 54.420000000000002 110.644 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.206 2.604 . . . . 75.329999999999998 113.19 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 61.09 35.02 18.88 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.51 1.124 . . . . 52.140000000000001 112.335 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 12.6 t70 -140.79 -83.06 0.23 Allowed 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 123.628 0.771 . . . . 70.140000000000001 109.726 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.9 m 56.73 103.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.701 1.371 . . . . 74.430000000000007 114.701 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -107.1 135.54 48.47 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.201 0.6 . . . . 75.140000000000001 111.815 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.39 138.95 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.114 0.965 . . . . 54.210000000000001 109.225 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.8 m-85 -115.91 104.1 11.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.586 1.155 . . . . 74.349999999999994 109.546 -174.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.594 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 73.9 mt -78.35 91.28 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.944 -1.132 . . . . 72.299999999999997 107.944 171.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.494 HG11 HD21 ' A' ' 12' ' ' LEU . 82.0 t -99.16 119.64 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 115.344 -0.844 . . . . 72.299999999999997 110.884 -175.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.4 p -112.94 108.07 16.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.828 0.851 . . . . 74.010000000000005 110.037 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.0 t -95.56 104.28 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.309 -0.997 . . . . 54.229999999999997 108.309 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -173.82 -165.43 0.25 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.516 1.126 . . . . 73.239999999999995 108.893 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 64.55 82.34 0.21 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.674 0.79 . . . . 50.409999999999997 109.45 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 C--N 1.384 2.403 0 C-N-CA 123.359 2.706 . . . . 71.109999999999999 114.029 -171.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.645 -0.502 . . . . 55.039999999999999 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 33.3 m -83.23 106.86 15.35 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.911 0.484 . . . . 61.039999999999999 110.595 -172.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -112.44 145.24 40.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.781 0.832 . . . . 73.200000000000003 110.908 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.1 t -138.22 137.55 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 123.636 0.775 . . . . 72.239999999999995 110.68 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -113.55 138.84 49.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.387 0.675 . . . . 74.219999999999999 110.4 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.1 t -129.95 166.02 20.92 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.502 0.721 . . . . 73.120000000000005 110.575 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.2 p -83.28 148.83 56.92 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.237 0.615 . . . . 62.119999999999997 112.208 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -78.78 75.14 5.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.308 2.672 . . . . 73.420000000000002 113.206 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.77 -32.4 0.21 Allowed Glycine 0 C--N 1.342 0.861 0 CA-C-N 115.455 -0.793 . . . . 75.439999999999998 113.159 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.51 -138.1 3.9 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.885 0.314 . . . . 72.0 113.885 -174.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.51 140.08 49.48 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.028 0.531 . . . . 75.329999999999998 109.926 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 HG11 ' A' ' 77' ' ' VAL . 55.3 tp -85.74 99.87 11.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.201 0.6 . . . . 62.130000000000003 110.021 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.66 103.15 13.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.116 0.567 . . . . 71.430000000000007 110.279 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 51' ' ' LEU . 45.0 mt -96.1 102.72 14.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.303 0.641 . . . . 73.420000000000002 110.383 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.77 115.58 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.367 0.667 . . . . 71.140000000000001 109.711 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -99.35 138.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-O 121.022 0.439 . . . . 74.230000000000004 110.068 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -104.63 38.06 1.98 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.894 0.878 . . . . 74.5 109.973 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 73' ' ' ARG . 17.2 mt -53.73 -40.12 65.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.96 1.304 . . . . 60.240000000000002 112.334 173.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 t 62.75 19.99 11.8 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.358 1.063 . . . . 54.399999999999999 111.811 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.75 135.36 14.61 Favored Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.911 -0.939 . . . . 53.299999999999997 112.167 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.19 89.37 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.125 2.55 . . . . 72.150000000000006 114.017 -173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.9 -95.11 0.26 Allowed Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.639 -0.71 . . . . 50.229999999999997 113.853 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 69' ' ' PRO . . . 121.67 -89.48 0.43 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-O 119.155 -0.803 . . . . 74.049999999999997 113.082 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.66 145.13 82.23 Favored 'Cis proline' 0 C--N 1.379 2.183 0 CA-C-N 120.266 2.033 . . . . 73.120000000000005 113.859 4.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 68' ' ' ALA . 75.8 t -65.93 129.69 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.4 -0.818 . . . . 63.200000000000003 110.882 173.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.466 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 99.2 mtt180 -96.41 127.66 42.61 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.342 -0.614 . . . . 51.549999999999997 109.342 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -98.31 131.59 44.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.02 0.528 . . . . 72.439999999999998 110.014 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.722 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 84.2 m-85 -126.0 136.66 53.24 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.854 0.862 . . . . 65.409999999999997 109.809 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' A' ' 64' ' ' TYR . 17.3 tptm -104.81 116.86 32.73 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.821 0.848 . . . . 74.340000000000003 108.994 171.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.71 -59.51 0.53 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.773 1.629 . . . . 71.120000000000005 111.13 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 32' ' ' GLU . . . -164.79 -9.93 0.03 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 123.867 0.746 . . . . 61.219999999999999 112.355 172.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 31' ' ' GLY . 44.6 tt0 -106.2 135.26 47.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.716 0.807 . . . . 70.510000000000005 110.667 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.49 152.82 20.88 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.072 1.138 . . . . 75.209999999999994 114.072 -171.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -86.3 161.42 18.75 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.62 -0.718 . . . . 72.319999999999993 110.309 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.51 106.33 5.92 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.916 0.886 . . . . 54.420000000000002 109.637 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 p -63.91 99.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.655 0.782 . . . . 72.340000000000003 111.307 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -124.7 -65.04 1.06 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.468 0.707 . . . . 75.299999999999997 111.565 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.09 -64.9 0.01 OUTLIER Glycine 0 N--CA 1.478 1.438 0 N-CA-C 112.748 -0.141 . . . . 32.229999999999997 112.748 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -67.3 -58.97 3.83 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.979 -0.749 . . . . 72.219999999999999 108.979 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.9 t -72.91 124.04 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.713 -1.131 . . . . 74.329999999999998 110.47 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.34 113.83 11.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.223 1.009 . . . . 72.519999999999996 109.525 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -97.53 108.25 20.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.6 0.76 . . . . 72.129999999999995 110.52 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.7 tm-20 -98.33 108.29 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.59 1.156 . . . . 54.340000000000003 109.474 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HG3' HE22 ' A' ' 49' ' ' GLN . 2.7 mp0 -99.5 102.22 13.7 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.532 0.733 . . . . 65.109999999999999 109.354 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.78 -29.63 17.5 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.232 0.613 . . . . 71.049999999999997 112.207 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 -42.41 1.6 Allowed Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.789 0.233 . . . . 25.030000000000001 112.528 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.17 -28.26 7.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.756 0.822 . . . . 74.340000000000003 110.192 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -105.92 141.3 37.56 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.279 1.032 . . . . 71.239999999999995 111.166 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.592 HE22 ' HG3' ' A' ' 44' ' ' GLN . 16.7 mm100 -125.2 128.34 48.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.778 0.831 . . . . 63.450000000000003 109.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 39.3 t -129.58 110.59 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 112.252 0.464 . . . . 52.509999999999998 112.252 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -93.98 112.81 24.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.084 -0.71 . . . . 73.530000000000001 109.084 168.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 67.4 mtp180 -106.52 119.59 39.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.216 0.606 . . . . 71.239999999999995 110.223 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.25 102.24 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.274 0.629 . . . . 72.450000000000003 109.492 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -74.9 131.93 41.08 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.231 0.613 . . . . 73.219999999999999 111.27 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.5 5.35 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 116.015 -0.538 . . . . 70.040000000000006 112.29 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.38 114.81 25.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.992 0.917 . . . . 65.010000000000005 112.242 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.23 -80.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.13 0.972 . . . . 73.310000000000002 112.262 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.2 p -101.22 -76.65 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.415 0.686 . . . . 53.200000000000003 112.439 -163.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 -6.29 58.29 Favored Glycine 0 C--N 1.356 1.689 0 N-CA-C 114.142 0.417 . . . . 64.140000000000001 114.142 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.38 -24.05 63.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.295 1.038 . . . . 73.340000000000003 111.322 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.617 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -73.49 128.4 35.39 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.667 0.787 . . . . 74.430000000000007 109.608 172.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.0 178.78 39.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.67 -0.3 . . . . 65.409999999999997 113.344 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -84.73 115.88 22.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.599 0.36 . . . . 61.229999999999997 110.478 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' CZ ' ' HD3' ' A' ' 29' ' ' LYS . 50.1 m-85 -102.08 123.19 45.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.132 0.492 . . . . 65.150000000000006 110.966 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 58.8 tp -94.12 100.71 12.76 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.748 0.819 . . . . 60.119999999999997 109.471 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 16' ' ' VAL . 46.2 t -90.34 88.08 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.622 0.725 . . . . 52.240000000000002 109.658 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.4 t70 -72.09 94.87 1.56 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.48 1.112 . . . . 75.450000000000003 111.485 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -76.46 163.11 68.13 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.543 1.137 . . . . 63.310000000000002 113.058 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.528 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 77.7 Cg_endo -75.22 -4.22 15.03 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.569 2.18 . . . . 74.140000000000001 113.892 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -117.63 -56.17 2.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.457 0.703 . . . . 74.049999999999997 110.972 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.21 119.56 5.53 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.346 0.659 . . . . 71.310000000000002 110.011 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.407 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 35.7 t -62.35 128.08 34.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.551 0.741 . . . . 74.209999999999994 111.924 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -107.37 147.15 30.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.48 0.712 . . . . 75.409999999999997 111.136 -177.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.82 146.96 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.225 0.61 . . . . 74.299999999999997 110.337 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.622 ' HB3' HG23 ' A' ' 77' ' ' VAL . 10.7 m-85 -107.47 139.03 42.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.841 1.256 . . . . 74.230000000000004 110.893 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.11 93.77 4.87 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.599 -1.259 . . . . 61.229999999999997 107.599 162.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 75' ' ' PHE . 78.8 t -101.02 132.2 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.688 -0.687 . . . . 54.240000000000002 111.356 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 76.7 p -127.17 124.54 39.27 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.154 0.982 . . . . 71.340000000000003 108.987 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.617 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 39.5 t -104.43 105.2 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.012 -1.107 . . . . 62.100000000000001 108.012 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.93 -168.39 0.66 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.923 1.289 . . . . 72.120000000000005 109.618 -170.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 62.53 85.8 0.16 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 123.849 0.86 . . . . 54.109999999999999 109.786 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.572 2.422 0 C-N-CA 123.131 2.554 . . . . 73.430000000000007 113.235 -174.769 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.463 ' SD ' HD11 ' A' ' 76' ' ' LEU . 62.9 mtt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.517 0.199 . . . . 75.239999999999995 110.591 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 m -102.58 88.46 3.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.908 0.883 . . . . 35.119999999999997 110.097 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.604 ' HG3' ' HB2' ' A' ' 76' ' ' LEU . 3.8 mpt_? -78.35 138.58 38.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.503 0.721 . . . . 54.329999999999998 111.966 -172.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 91.6 t -140.91 134.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.161 0.984 . . . . 64.239999999999995 109.663 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -90.68 145.28 24.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.098 0.559 . . . . 65.519999999999996 110.401 176.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB2' HD13 ' A' ' 12' ' ' LEU . 41.0 t -127.91 159.73 34.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.212 0.605 . . . . 74.439999999999998 111.848 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 81' ' ' GLU . 18.2 p -112.95 150.67 43.22 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 124.603 1.161 . . . . 54.530000000000001 111.529 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.43 98.49 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.272 2.648 . . . . 72.140000000000001 113.682 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.81 -14.33 22.02 Favored Glycine 0 N--CA 1.479 1.514 0 CA-C-N 116.006 -0.543 . . . . 42.009999999999998 114.245 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.53 -143.17 3.89 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 117.54 0.67 . . . . 74.120000000000005 113.764 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.08 127.0 37.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.153 0.581 . . . . 64.129999999999995 111.024 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.9 tp -77.64 123.6 26.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.45 0.7 . . . . 54.509999999999998 110.022 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -115.87 112.65 22.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.199 0.454 . . . . 73.0 109.891 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 51' ' ' LEU . 79.0 mt -91.75 101.64 14.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.409 -0.589 . . . . 65.120000000000005 109.409 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.59 108.03 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 108.842 -0.799 . . . . 74.140000000000001 108.842 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 18' ' ' LEU . 6.1 t -98.63 113.53 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.572 0.349 . . . . 61.409999999999997 110.863 -169.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -90.2 33.85 0.88 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 122.944 0.498 . . . . 71.109999999999999 111.672 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' H ' HG12 ' A' ' 16' ' ' VAL . 9.9 mt -51.07 155.93 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.327 1.051 . . . . 74.430000000000007 111.866 164.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 t -75.28 74.14 2.39 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 167.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.52 119.48 16.52 Favored Glycine 0 CA--C 1.541 1.696 0 CA-C-N 115.48 -0.782 . . . . 72.030000000000001 114.415 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.6 29.97 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.818 2.346 . . . . 73.340000000000003 112.895 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -59.42 4.9 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.876 0.274 . . . . 64.519999999999996 112.441 -174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.01 174.69 24.44 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.759 -0.467 . . . . 55.420000000000002 112.719 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.27 148.04 28.46 Favored 'Cis proline' 0 CA--C 1.559 1.736 0 CA-C-N 119.147 1.474 . . . . 72.349999999999994 113.571 -4.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' SG ' ' A' ' 66' ' ' CYS . 85.4 t -114.57 136.42 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.223 0.609 . . . . 62.299999999999997 109.695 174.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -98.25 128.17 44.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 74.219999999999999 110.586 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.414 ' HB3' HD23 ' A' ' 34' ' ' LEU . 77.4 m95 -99.39 143.3 29.8 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.399 0.68 . . . . 74.230000000000004 110.76 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 93.3 m-85 -135.45 124.25 23.95 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.426 0.691 . . . . 72.019999999999996 110.725 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.9 tptp -118.51 132.45 56.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.281 0.632 . . . . 73.200000000000003 109.431 172.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.3 26.09 15.97 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.816 0.846 . . . . 71.510000000000005 111.51 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -2.06 86.36 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 114.941 0.737 . . . . 72.510000000000005 114.941 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -125.01 144.29 50.47 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.531 1.166 . . . . 72.400000000000006 111.367 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.68 152.66 43.7 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.053 1.131 . . . . 73.409999999999997 114.053 -172.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.444 ' HB3' HG11 ' A' ' 40' ' ' VAL . 3.9 mm? -88.85 162.02 16.39 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.837 0.855 . . . . 55.299999999999997 111.397 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.16 107.5 4.38 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.05 0.94 . . . . 13.34 110.164 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 p -66.42 91.94 0.19 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.692 0.797 . . . . 75.109999999999999 112.251 -176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -139.94 -73.3 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.267 0.627 . . . . 73.510000000000005 111.131 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -94.4 1.75 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 122.684 0.183 . . . . 41.520000000000003 113.141 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -70.18 -32.36 70.25 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.474 0.31 . . . . 63.340000000000003 111.495 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 34' ' ' LEU . 87.2 t -81.86 120.27 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.44 0.696 . . . . 65.420000000000002 110.493 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 72.6 mt-30 -126.16 97.1 4.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.044 0.938 . . . . 74.25 109.392 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.1 152.38 23.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.28 0.562 . . . . 55.039999999999999 112.024 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.77 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.0 tm-20 -138.54 106.45 5.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 107.774 -1.195 . . . . 71.140000000000001 107.774 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -100.34 102.75 14.07 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.533 0.333 . . . . 72.200000000000003 110.152 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.37 3.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.791 0.836 . . . . 72.140000000000001 111.115 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.61 -72.82 0.65 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 116.356 -0.384 . . . . 33.200000000000003 113.318 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.6 19.97 12.62 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.728 0.811 . . . . 74.400000000000006 112.23 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -148.23 151.41 35.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.259 0.552 . . . . 73.040000000000006 112.182 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.1 155.45 38.36 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.143 0.977 . . . . 63.039999999999999 108.61 164.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 84.7 t -141.91 136.62 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.175 0.512 . . . . 73.510000000000005 110.432 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 14' ' ' LEU . 1.7 tm? -120.5 116.14 24.82 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.445 -0.946 . . . . 64.420000000000002 108.445 171.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 99.6 mtt180 -108.14 109.43 20.84 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.328 0.651 . . . . 62.240000000000002 111.349 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.3 t -88.42 98.08 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.985 0.514 . . . . 73.409999999999997 110.264 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.95 127.35 32.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.943 0.497 . . . . 62.340000000000003 109.974 168.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.77 33.69 15.21 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 112.675 -0.17 . . . . 23.530000000000001 112.675 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.71 110.87 2.95 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.763 0.825 . . . . 64.200000000000003 111.288 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -163.28 124.49 2.4 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.132 0.573 . . . . 65.150000000000006 109.95 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.539 ' H ' HG11 ' A' ' 79' ' ' VAL . 50.2 m 55.93 -82.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.305 1.442 . . . . 54.240000000000002 113.851 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.9 -7.24 55.41 Favored Glycine 0 C--N 1.363 2.043 0 N-CA-C 114.702 0.641 . . . . 74.019999999999996 114.702 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.69 -32.81 74.41 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.767 0.827 . . . . 71.430000000000007 111.618 170.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.679 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -67.82 100.68 0.96 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 72.030000000000001 111.286 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -166.65 -174.07 35.59 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.679 -0.691 . . . . 62.109999999999999 113.059 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -93.49 113.02 25.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.506 0.722 . . . . 64.310000000000002 110.536 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.684 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 49.2 m-85 -101.17 111.89 24.22 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.393 0.677 . . . . 70.340000000000003 109.947 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 72' ' ' SER . 61.0 tp -92.1 100.6 13.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 122.869 0.468 . . . . 75.129999999999995 110.122 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.418 ' SG ' HG11 ' A' ' 25' ' ' VAL . 37.8 t -79.0 86.09 4.89 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.926 0.87 . . . . 73.409999999999997 108.74 170.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -94.13 115.69 28.01 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.423 -1.262 . . . . 73.540000000000006 112.229 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.04 154.48 55.66 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.776 0.83 . . . . 61.420000000000002 109.36 171.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.48 -19.32 17.31 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.616 2.211 . . . . 71.409999999999997 113.003 171.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -76.35 -72.83 0.31 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.879 0.872 . . . . 64.530000000000001 110.92 170.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -139.25 144.12 38.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.834 0.854 . . . . 63.340000000000003 111.4 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 65' ' ' LEU . 51.5 p -112.4 109.32 18.86 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.916 0.886 . . . . 44.399999999999999 110.382 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.98 127.77 53.37 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.07 0.948 . . . . 74.409999999999997 110.987 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.32 128.43 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.574 0.75 . . . . 55.409999999999997 110.179 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 4.1 m-85 -102.2 111.18 23.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 61.439999999999998 110.15 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.604 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 78.9 mt -85.02 94.12 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 75.519999999999996 109.734 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.6 t -94.71 137.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.711 0.804 . . . . 74.019999999999996 110.639 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -137.17 111.26 8.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.141 0.576 . . . . 74.0 110.865 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.679 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 46.4 t -83.94 103.43 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.089 -1.078 . . . . 65.150000000000006 108.089 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.94 33.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.848 0.832 . . . . 70.219999999999999 110.978 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' O ' HG22 ' A' ' 7' ' ' THR . 10.1 tp10 -130.91 92.87 32.66 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 115.17 -0.923 . . . . 52.450000000000003 109.131 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo . . . . . 0 CA--C 1.571 2.342 0 C-N-CA 122.526 2.151 . . . . 53.119999999999997 113.197 -179.472 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.631 0.253 . . . . 73.439999999999998 111.004 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m -75.44 79.17 2.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.31 1.052 . . . . 61.240000000000002 109.746 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -92.55 131.63 37.51 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.512 -1.222 . . . . 73.329999999999998 111.971 -163.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.0 t -121.78 127.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.837 0.855 . . . . 72.420000000000002 110.694 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -93.2 142.89 26.8 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.729 0.812 . . . . 74.420000000000002 109.918 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -137.25 160.23 39.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.647 0.779 . . . . 60.310000000000002 110.968 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -96.16 148.46 34.55 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 123.686 0.795 . . . . 74.150000000000006 111.135 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 95.4 Cg_endo -72.9 128.36 13.14 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.131 2.554 . . . . 65.340000000000003 112.938 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.81 66.12 1.23 Allowed Glycine 0 C--N 1.357 1.748 0 CA-C-N 116.656 -0.247 . . . . 63.140000000000001 113.162 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.74 -115.73 0.38 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 113.439 0.136 . . . . 55.439999999999998 113.439 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -144.67 131.47 20.17 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.054 0.941 . . . . 73.340000000000003 109.731 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 65.3 tp -96.65 101.63 13.27 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.031 0.532 . . . . 74.430000000000007 110.092 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.18 112.08 24.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.905 0.482 . . . . 74.25 110.302 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.42 HD12 HD12 ' A' ' 51' ' ' LEU . 41.6 mt -108.17 103.93 13.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.887 0.875 . . . . 64.120000000000005 109.584 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' A' ' 48' ' ' ARG . 74.4 t -91.31 134.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.5 0.72 . . . . 63.119999999999997 109.34 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 49' ' ' GLN . 39.6 t -99.09 141.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 121.292 0.568 . . . . 72.200000000000003 111.678 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.57 -34.85 5.71 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.851 0.86 . . . . 75.340000000000003 110.876 166.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 73' ' ' ARG . 6.8 mt 63.52 178.07 0.16 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 123.857 0.863 . . . . 61.149999999999999 113.117 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 t -102.77 -24.72 13.7 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.992 -0.549 . . . . 74.439999999999998 110.144 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.54 103.38 0.83 Allowed Glycine 0 CA--C 1.543 1.819 0 CA-C-O 119.635 -0.536 . . . . 75.150000000000006 112.985 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.51 102.3 1.54 Allowed 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 122.798 2.332 . . . . 61.329999999999998 113.379 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.5 131.57 1.58 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 121.455 -0.402 . . . . 62.030000000000001 113.891 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.94 169.94 49.06 Favored Glycine 0 CA--C 1.547 2.087 0 CA-C-O 119.477 -0.624 . . . . 53.030000000000001 113.587 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.26 115.49 3.92 Favored 'Cis proline' 0 C--N 1.379 2.163 0 CA-C-N 120.079 1.939 . . . . 63.200000000000003 112.962 1.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.87 118.9 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 122.986 0.514 . . . . 74.239999999999995 109.967 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -99.96 146.54 26.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.522 0.729 . . . . 64.230000000000004 111.783 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.415 ' CD1' HD22 ' A' ' 42' ' ' LEU . 79.6 m95 -100.17 134.18 43.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.164 0.986 . . . . 74.010000000000005 110.844 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.593 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 41.6 m-85 -130.03 139.28 51.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.323 1.049 . . . . 74.430000000000007 109.007 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.1 tptp -116.55 127.05 54.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.566 0.621 . . . . 73.329999999999998 110.098 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 56.39 20.49 4.75 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.088 1.355 . . . . 70.239999999999995 113.57 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.53 4.42 32.4 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.095 0.798 . . . . 74.209999999999994 115.095 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -141.3 141.11 33.93 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 1.168 . . . . 74.349999999999994 111.594 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.71 151.77 16.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.456 1.28 . . . . 61.530000000000001 114.456 -171.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 29' ' ' LYS . 19.5 mt -103.34 157.33 17.1 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.753 0.821 . . . . 51.240000000000002 111.002 172.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.86 143.68 44.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.161 0.985 . . . . 72.420000000000002 110.197 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.8 p -80.09 73.21 6.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.178 0.591 . . . . 61.420000000000002 110.511 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -134.68 -92.65 0.31 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.759 0.652 . . . . 75.310000000000002 112.759 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.81 87.28 1.51 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-O 120.012 -0.326 . . . . 42.140000000000001 113.29 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 69.88 -11.52 0.54 Allowed 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.947 1.299 . . . . 71.430000000000007 113.269 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.16 114.17 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.518 1.127 . . . . 64.049999999999997 108.933 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 45.6 mt-30 -113.18 132.25 55.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.476 1.11 . . . . 72.409999999999997 110.145 -173.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 27' ' ' TRP . 79.6 mt -119.03 92.14 3.73 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.721 0.408 . . . . 74.140000000000001 110.651 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 2.6 mp0 -82.06 98.7 8.77 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.434 0.694 . . . . 71.530000000000001 110.369 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.28 126.88 34.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.178 0.514 . . . . 72.219999999999999 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.81 13.34 2.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.559 0.744 . . . . 63.450000000000003 112.095 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.15 -77.68 0.87 Allowed Glycine 0 C--N 1.35 1.349 0 N-CA-C 112.49 -0.244 . . . . 73.420000000000002 112.49 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.07 -54.02 5.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.035 0.534 . . . . 70.5 110.145 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.589 ' HG3' HG13 ' A' ' 15' ' ' VAL . 48.3 ttp180 -82.84 90.45 6.93 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.603 0.716 . . . . 72.510000000000005 111.675 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 16' ' ' VAL . 9.8 mm100 -95.97 126.67 41.37 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.447 -0.946 . . . . 71.230000000000004 108.447 170.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 46.6 t -114.9 108.94 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 O-C-N 121.911 -0.493 . . . . 34.210000000000001 110.836 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.42 HD12 HD12 ' A' ' 14' ' ' LEU . 1.5 tm? -91.23 112.51 24.45 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.668 -0.864 . . . . 72.140000000000001 108.668 170.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 74.2 mtp180 -113.49 104.73 12.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.809 0.444 . . . . 74.420000000000002 110.988 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 51' ' ' LEU . 61.2 t -93.33 97.01 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.185 -1.043 . . . . 64.329999999999998 108.185 168.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.05 96.09 0.42 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.469 -0.787 . . . . 73.239999999999995 110.705 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.36 -60.1 0.19 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.833 -1.076 . . . . 64.540000000000006 110.886 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . 45.5 69.69 0.43 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.404 1.481 . . . . 73.549999999999997 112.734 174.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.68 -56.24 0.08 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.158 0.429 . . . . 65.310000000000002 112.158 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -141.86 117.81 10.56 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.137 0.575 . . . . 74.340000000000003 110.986 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.25 80.7 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.484 -0.326 . . . . 74.420000000000002 113.462 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.05 -31.87 39.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.341 1.056 . . . . 74.120000000000005 111.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.02 120.19 21.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.583 0.753 . . . . 53.329999999999998 109.784 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.08 -175.58 45.97 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.657 -0.306 . . . . 50.420000000000002 113.706 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.79 112.45 24.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.836 0.454 . . . . 63.5 110.159 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 59.4 m-85 -98.84 124.1 43.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.294 0.637 . . . . 75.120000000000005 111.717 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 46.5 tp -94.75 118.32 31.55 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.969 0.508 . . . . 65.5 110.683 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.3 t -92.63 88.95 6.49 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.157 0.983 . . . . 71.040000000000006 109.93 170.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.593 ' HB3' ' HE1' ' A' ' 28' ' ' TYR . 14.0 t70 -91.11 107.23 19.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.787 0.835 . . . . 63.43 111.44 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.66 157.86 43.34 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.762 0.825 . . . . 42.310000000000002 111.038 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.02 -32.06 96.84 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.334 2.023 . . . . 75.340000000000003 111.979 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.0 101.85 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.259 1.024 . . . . 74.099999999999994 109.138 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 71.42 143.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.709 1.203 . . . . 55.350000000000001 113.811 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.3 p -118.58 120.58 37.91 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.951 0.9 . . . . 72.25 108.97 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -109.62 149.32 29.86 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.183 0.593 . . . . 63.100000000000001 111.313 -174.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.05 134.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.183 0.593 . . . . 74.129999999999995 110.581 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 6.5 m-85 -114.7 104.05 11.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.707 1.203 . . . . 61.210000000000001 109.903 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.09 112.39 20.18 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.799 -0.445 . . . . 74.230000000000004 109.799 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.5 t -106.65 131.09 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.059 0.543 . . . . 73.349999999999994 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -126.76 108.8 11.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.527 0.731 . . . . 73.439999999999998 110.322 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.16 107.4 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.336 0.655 . . . . 62.020000000000003 109.328 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.34 178.45 8.67 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.542 0.737 . . . . 55.130000000000003 111.479 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 61.39 79.78 0.27 Allowed Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 124.696 1.198 . . . . 75.120000000000005 111.213 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.573 2.452 0 C-N-CA 123.393 2.729 . . . . 74.099999999999994 114.291 -176.568 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.87 0.366 . . . . 65.230000000000004 111.44 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.0 m -75.55 86.41 2.64 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.333 1.053 . . . . 72.310000000000002 110.562 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 44.7 mtm180 -89.08 152.1 21.85 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.778 0.659 . . . . 74.0 112.778 -172.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.7 t -139.64 135.5 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 124.328 1.051 . . . . 72.439999999999998 110.34 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -94.36 145.95 24.4 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 122.992 0.517 . . . . 71.519999999999996 110.927 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.2 t -134.29 156.52 48.3 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.601 0.76 . . . . 72.219999999999999 110.762 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -84.62 147.01 48.09 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 123.144 0.577 . . . . 70.5 111.419 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.9 82.12 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.29 2.66 . . . . 72.239999999999995 113.298 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.3 7.38 4.45 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 114.521 -1.218 . . . . 63.240000000000002 112.543 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.94 26.38 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 114.724 0.649 . . . . 72.319999999999993 114.724 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.71 110.53 21.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.865 0.866 . . . . 74.209999999999994 110.456 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.9 tp -74.09 138.92 44.26 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.433 -0.58 . . . . 74.150000000000006 109.433 169.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -145.02 111.39 5.65 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.27 0.628 . . . . 74.530000000000001 109.957 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 46.0 mt -98.99 101.65 13.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.098 -0.705 . . . . 73.329999999999998 109.098 175.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -97.4 106.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 108.46 -0.941 . . . . 61.140000000000001 108.46 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 18.2 t -98.93 141.37 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.974 0.91 . . . . 64.319999999999993 111.324 -166.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -137.75 48.86 1.99 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.371 0.668 . . . . 73.299999999999997 109.89 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -57.04 174.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.075 1.139 . . . . 74.510000000000005 114.075 172.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -91.49 20.52 5.27 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.556 0.742 . . . . 64.109999999999999 112.408 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 121.36 19.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.905 -0.941 . . . . 72.030000000000001 112.888 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.89 21.99 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.472 2.781 . . . . 73.349999999999994 115.006 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.51 -105.27 0.22 Allowed Glycine 0 C--N 1.35 1.353 0 O-C-N 122.416 -0.177 . . . . 44.039999999999999 113.157 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.96 -176.91 40.65 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.421 -0.655 . . . . 63.439999999999998 113.103 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.18 161.76 84.53 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 119.783 1.791 . . . . 62.350000000000001 112.771 -4.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.446 HG11 ' SG ' ' A' ' 66' ' ' CYS . 62.4 t -107.23 147.35 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.93 0.892 . . . . 73.430000000000007 110.293 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 94.6 mtt180 -97.83 164.79 12.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.726 0.81 . . . . 73.209999999999994 111.105 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -133.14 122.98 24.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.755 0.822 . . . . 75.349999999999994 111.101 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.2 m-85 -120.2 163.97 16.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.868 0.867 . . . . 74.519999999999996 110.908 175.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -152.3 119.98 6.09 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.953 0.901 . . . . 55.140000000000001 109.898 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 62.65 21.07 12.48 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 124.557 1.143 . . . . 72.450000000000003 111.965 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.54 55.64 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 114.696 0.638 . . . . 75.329999999999998 114.696 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -128.78 128.79 44.67 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.865 0.832 . . . . 75.340000000000003 110.988 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.47 151.04 25.03 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.037 0.754 . . . . 74.329999999999998 113.037 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.3 mt -95.24 154.46 17.18 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.278 0.631 . . . . 55.240000000000002 110.536 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.04 146.82 28.56 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.491 0.716 . . . . 62.399999999999999 110.43 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 45.3 p -74.46 85.03 2.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.252 0.621 . . . . 75.150000000000006 110.899 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -121.35 -175.94 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.968 0.907 . . . . 71.129999999999995 112.073 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.76 147.38 43.31 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 110.905 -0.878 . . . . 34.439999999999998 110.905 164.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 74.7 -55.22 0.66 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.232 1.413 . . . . 74.040000000000006 111.843 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.06 89.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.141 0.976 . . . . 51.229999999999997 110.117 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -91.86 134.36 34.83 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.028 0.931 . . . . 62.450000000000003 111.657 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 51' ' ' LEU . 66.8 mt -114.25 130.98 56.65 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.936 0.494 . . . . 54.329999999999998 110.374 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.19 121.58 39.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.573 0.749 . . . . 72.019999999999996 110.146 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -108.06 102.05 11.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.532 0.682 . . . . 70.150000000000006 110.095 171.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.98 -56.09 2.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.226 0.61 . . . . 72.209999999999994 109.612 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.3 -90.47 0.1 Allowed Glycine 0 N--CA 1.475 1.242 0 N-CA-C 111.192 -0.763 . . . . 54.340000000000003 111.192 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.64 -42.0 82.97 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.37 0.668 . . . . 45.32 110.367 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.6 ttp180 -91.99 118.34 30.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.332 -0.849 . . . . 70.109999999999999 110.968 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -116.42 135.22 54.03 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.569 -0.9 . . . . 73.140000000000001 108.569 169.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 61.6 t -125.78 109.74 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.246 0.546 . . . . 63.299999999999997 111.932 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -101.11 121.96 42.74 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.246 1.018 . . . . 73.299999999999997 108.725 169.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -120.08 107.51 13.14 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.717 -0.475 . . . . 72.310000000000002 109.717 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -104.1 109.33 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 118.576 0.625 . . . . 54.299999999999997 110.017 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -83.62 145.78 28.64 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.526 0.73 . . . . 72.239999999999995 110.799 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.6 54.26 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 112.325 -0.31 . . . . 71.409999999999997 112.325 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 112.1 7.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.616 1.166 . . . . 35.240000000000002 111.763 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.26 -95.39 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 118.46 0.573 . . . . 64.439999999999998 112.534 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -83.43 -61.81 1.75 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.749 -0.595 . . . . 45.32 111.631 -168.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.68 -5.27 73.4 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 116.217 -0.447 . . . . 64.010000000000005 114.184 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.01 -35.26 43.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.387 0.675 . . . . 74.019999999999996 111.673 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 106.56 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.035 0.534 . . . . 62.310000000000002 111.149 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.71 -169.81 40.88 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.854 -0.612 . . . . 65.140000000000001 114.369 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.6 121.67 27.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.924 0.89 . . . . 75.150000000000006 111.062 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.2 m-85 -111.7 112.61 24.42 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.94 0.896 . . . . 71.430000000000007 110.174 173.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -93.21 101.25 13.52 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.752 -0.592 . . . . 73.400000000000006 111.027 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.446 ' SG ' HG11 ' A' ' 25' ' ' VAL . 37.8 t -82.2 89.82 6.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.908 0.883 . . . . 50.130000000000003 109.028 171.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 31.3 t70 -89.0 92.59 9.29 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.627 0.771 . . . . 61.409999999999997 112.261 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -85.64 159.29 55.64 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 122.957 0.503 . . . . 53.32 111.752 177.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -45.61 101.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 123.615 2.877 . . . . 54.240000000000002 114.159 171.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 63.68 13.98 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.2 1.4 . . . . 65.209999999999994 114.025 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 24.3 t70 -147.19 81.1 1.53 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.48 0.657 . . . . 71.129999999999995 111.045 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.538 ' HB2' HD11 ' A' ' 65' ' ' LEU . 88.1 p -78.99 148.52 32.53 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.331 -0.395 . . . . 72.010000000000005 110.803 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 126.83 29.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.948 0.499 . . . . 73.239999999999995 110.303 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.0 130.16 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.852 -0.425 . . . . 71.409999999999997 109.852 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 14.0 m-85 -109.26 102.94 11.83 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.336 1.054 . . . . 73.140000000000001 109.611 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 71.0 mt -81.48 92.15 6.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.212 -1.033 . . . . 60.219999999999999 108.212 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.8 t -83.12 114.98 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.767 -0.651 . . . . 63.119999999999997 110.012 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -103.07 107.58 18.43 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.227 -0.657 . . . . 72.25 109.227 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 6' ' ' SER . 20.6 t -94.17 107.98 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 109.765 -0.457 . . . . 54.130000000000003 109.765 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.64 -172.2 3.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.107 0.963 . . . . 73.430000000000007 109.828 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 63.86 84.27 0.19 Allowed Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 123.965 0.906 . . . . 72.239999999999995 110.677 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--N 1.384 2.43 0 C-N-CA 123.247 2.631 . . . . 71.340000000000003 114.089 -175.033 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.528 ' SD ' HD11 ' A' ' 76' ' ' LEU . 65.7 mtt . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.545 0.212 . . . . 73.109999999999999 110.62 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 m -80.6 91.35 5.81 Favored 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 124.875 1.27 . . . . 74.209999999999994 110.933 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 32.6 mtt180 -82.05 139.43 34.47 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.37 1.248 . . . . 71.150000000000006 114.37 -170.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 76.9 t -141.8 135.83 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 124.926 1.29 . . . . 63.32 109.956 172.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -106.48 144.43 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.175 0.59 . . . . 73.219999999999999 110.36 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 79' ' ' VAL . 37.3 t -135.14 161.92 33.97 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.419 0.688 . . . . 74.129999999999995 110.718 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -102.96 147.16 33.69 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 123.555 0.742 . . . . 72.519999999999996 111.696 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.44 107.95 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.584 2.856 . . . . 72.329999999999998 114.086 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.89 47.23 1.28 Allowed Glycine 0 C--N 1.355 1.622 0 C-N-CA 123.001 0.334 . . . . 73.010000000000005 113.593 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.45 -114.17 0.93 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 112.167 -0.373 . . . . 63.210000000000001 112.167 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.1 164.14 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.48 0.712 . . . . 63.409999999999997 110.478 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 62.4 tp -128.98 102.49 6.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.441 0.697 . . . . 65.219999999999999 109.613 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -110.11 104.63 13.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.101 0.56 . . . . 72.530000000000001 109.794 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.492 HD12 HD12 ' A' ' 51' ' ' LEU . 65.7 mt -90.43 101.94 14.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.529 -0.545 . . . . 74.540000000000006 109.529 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.73 119.7 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.129 -1.063 . . . . 72.040000000000006 108.129 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 18' ' ' LEU . 20.1 t -113.36 133.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.621 0.768 . . . . 65.430000000000007 111.075 -168.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -134.58 54.72 1.93 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.839 0.856 . . . . 75.030000000000001 109.351 166.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.463 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -59.07 160.71 5.83 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.071 0.767 . . . . 71.109999999999999 113.071 170.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -77.87 -1.59 32.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.773 0.829 . . . . 54.210000000000001 112.281 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.92 -178.41 41.27 Favored Glycine 0 CA--C 1.545 1.942 0 CA-C-O 119.918 -0.379 . . . . 71.030000000000001 113.543 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 -37.98 3.68 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.842 2.361 . . . . 71.209999999999994 113.54 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.89 -130.19 8.15 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.75 -0.54 . . . . 42.109999999999999 111.75 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' ' N ' ' A' ' 25' ' ' VAL . . . -91.23 156.93 24.55 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.445 -0.642 . . . . 51.200000000000003 114.297 -174.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.76 106.2 0.82 Allowed 'Cis proline' 0 C--N 1.383 2.388 0 CA-C-N 119.548 1.674 . . . . 72.329999999999998 112.552 1.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' N ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -86.1 162.16 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 C-N-CA 123.029 0.532 . . . . 75.530000000000001 110.991 -174.407 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 36.6 mmt180 -98.87 150.63 21.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.041 0.936 . . . . 74.25 110.105 171.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.39 145.33 51.14 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.376 1.07 . . . . 73.329999999999998 109.066 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.682 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.5 m-85 -135.72 124.3 23.64 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.098 0.559 . . . . 61.130000000000003 110.668 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 21.1 tptm -122.19 131.79 54.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.313 0.645 . . . . 71.349999999999994 109.951 172.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 68.15 16.25 9.41 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.624 1.169 . . . . 75.25 111.627 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.95 61.23 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 113.609 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.31 135.93 39.33 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.569 0.747 . . . . 61.130000000000003 110.584 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 145.29 40.92 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.861 0.864 . . . . 54.420000000000002 113.111 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB3' HG11 ' A' ' 40' ' ' VAL . 53.6 mt -89.31 135.4 33.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.484 0.714 . . . . 73.219999999999999 110.428 174.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.44 158.97 15.98 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.783 0.833 . . . . 74.25 110.256 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 p -69.85 89.98 0.59 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.723 0.773 . . . . 63.020000000000003 110.212 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -112.76 166.02 11.76 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.424 1.09 . . . . 73.450000000000003 111.088 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.18 97.01 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 113.791 0.276 . . . . 72.420000000000002 113.791 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 54' ' ' GLN . 5.0 mpt_? -77.29 -37.73 52.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.675 0.39 . . . . 75.409999999999997 111.422 172.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 34' ' ' LEU . 53.9 t -102.69 82.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.637 0.732 . . . . 44.130000000000003 110.712 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 73.5 mt-30 -82.23 104.59 12.65 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.547 0.739 . . . . 64.219999999999999 111.378 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -98.65 113.52 25.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.566 0.747 . . . . 65.109999999999999 112.4 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -91.81 132.46 36.41 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.567 0.747 . . . . 74.450000000000003 109.861 170.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.718 ' HA ' HE22 ' A' ' 49' ' ' GLN . 9.8 pt20 -125.28 109.35 12.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.764 0.826 . . . . 75.439999999999998 110.315 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.69 177.4 9.54 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.552 0.741 . . . . 73.239999999999995 111.925 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.02 113.25 5.08 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.416 -0.658 . . . . 71.549999999999997 112.769 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.26 -56.83 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 125.657 1.583 . . . . 63.520000000000003 113.593 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 44.7 ttp180 -83.18 111.92 19.37 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.182 0.438 . . . . 71.099999999999994 112.182 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.718 HE22 ' HA ' ' A' ' 44' ' ' GLN . 11.2 mm100 -101.97 147.21 26.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.674 0.79 . . . . 43.219999999999999 109.111 166.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.94 110.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.782 -0.573 . . . . 73.239999999999995 111.001 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 HD12 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -95.7 123.59 39.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.663 -0.866 . . . . 74.239999999999995 108.663 169.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.0 mtm180 -121.68 108.52 13.64 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.889 0.476 . . . . 75.400000000000006 111.403 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -91.47 120.87 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.328 0.651 . . . . 74.25 110.242 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.45 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . 33.4 tt0 -75.35 122.58 23.97 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.46 0.704 . . . . 45.020000000000003 109.853 173.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.28 -78.5 0.38 Allowed Glycine 0 C--N 1.346 1.138 0 N-CA-C 112.357 -0.297 . . . . 43.420000000000002 112.357 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 56.13 80.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.521 1.129 . . . . 72.120000000000005 112.178 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -159.96 -68.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.9 0.48 . . . . 74.019999999999996 111.62 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.5 m -137.51 119.19 15.03 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.384 0.673 . . . . 73.549999999999997 110.227 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.79 -15.77 53.64 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 116.433 -0.349 . . . . 74.439999999999998 112.931 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.14 -20.6 51.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.525 1.13 . . . . 75.430000000000007 111.845 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.59 122.1 27.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.449 0.7 . . . . 60.229999999999997 109.948 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . 168.45 -170.5 42.21 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.319 -0.4 . . . . 73.430000000000007 113.352 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -89.63 119.15 29.8 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.845 0.858 . . . . 75.219999999999999 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 62.0 m-85 -104.96 106.07 16.39 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.797 0.839 . . . . 63.210000000000001 109.667 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.1 tp -94.71 99.69 11.75 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.425 0.69 . . . . 62.100000000000001 110.489 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.1 t -81.77 93.19 6.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.335 0.654 . . . . 72.530000000000001 110.167 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 28.2 t70 -97.04 132.54 42.75 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.592 0.757 . . . . 74.400000000000006 112.238 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.22 152.98 80.49 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.835 0.854 . . . . 71.25 109.317 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.99 -21.2 33.04 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.286 2.657 . . . . 64.019999999999996 113.883 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -59.36 2.22 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.6 0.76 . . . . 65.120000000000005 110.132 174.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.72 149.94 37.9 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.05 0.54 . . . . 54.240000000000002 111.784 -171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -131.45 135.2 46.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.769 0.828 . . . . 74.120000000000005 111.041 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -113.5 134.75 54.5 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.88 . . . . 73.409999999999997 111.267 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.45 HG12 HD13 ' A' ' 65' ' ' LEU . 57.5 mt -89.17 123.11 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.1 -0.704 . . . . 70.120000000000005 109.1 170.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.0 m-85 -100.11 103.84 15.36 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.933 -0.395 . . . . 73.319999999999993 109.933 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.651 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 82.1 mt -78.1 92.53 4.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.949 -0.76 . . . . 73.25 108.949 175.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.5 t -101.49 113.11 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.112 -0.949 . . . . 71.430000000000007 110.1 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -110.4 107.78 17.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.25 0.547 . . . . 75.140000000000001 109.588 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 6' ' ' SER . 61.5 t -84.74 120.56 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.405 -0.961 . . . . 64.420000000000002 108.405 171.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.4 -177.71 4.16 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.63 0.772 . . . . 53.509999999999998 110.459 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 60.77 81.77 0.24 Allowed Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.937 0.895 . . . . 65.430000000000007 111.431 166.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo . . . . . 0 C--N 1.382 2.313 0 C-N-CA 123.133 2.555 . . . . 44.439999999999998 113.429 -177.189 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.886 -0.413 . . . . 72.299999999999997 109.886 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 m -94.12 95.88 9.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.75 -0.833 . . . . 54.340000000000003 108.75 -174.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -122.79 148.97 44.75 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.51 0.724 . . . . 72.409999999999997 112.42 -169.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.9 t -138.93 138.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.874 0.87 . . . . 71.540000000000006 110.427 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.94 117.95 35.33 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.357 0.663 . . . . 73.549999999999997 110.029 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t -94.49 161.6 14.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.634 0.774 . . . . 73.099999999999994 110.546 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.2 153.7 37.88 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 123.283 0.633 . . . . 73.450000000000003 111.387 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -56.24 99.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.533 2.822 . . . . 64.129999999999995 112.95 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.34 18.62 68.51 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 116.118 -0.492 . . . . 43.130000000000003 113.733 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.81 -10.45 69.67 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 114.485 0.554 . . . . 63.43 114.485 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 67.64 118.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.676 1.59 . . . . 71.299999999999997 112.263 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.4 HD11 HD21 ' A' ' 14' ' ' LEU . 42.7 tp -81.44 140.49 34.61 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.671 0.789 . . . . 72.030000000000001 111.678 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 15' ' ' VAL . 45.2 tt0 -142.22 100.8 3.79 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.69 0.796 . . . . 72.200000000000003 110.273 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 12' ' ' LEU . 54.0 mt -89.86 103.63 16.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.641 0.776 . . . . 75.319999999999993 109.916 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 ' HG2' ' A' ' 13' ' ' GLU . 61.4 t -104.79 110.21 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.646 0.778 . . . . 75.439999999999998 109.339 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG21 ' SG ' ' A' ' 66' ' ' CYS . 11.6 m -99.17 146.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.626 0.726 . . . . 53.119999999999997 111.05 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -122.38 29.42 6.97 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.864 -1.062 . . . . 73.5 109.234 165.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.501 HD21 ' SG ' ' A' ' 66' ' ' CYS . 0.9 OUTLIER -41.75 139.25 1.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.052 1.13 . . . . 53.5 114.052 176.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -94.66 31.46 1.79 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.462 0.705 . . . . 63.409999999999997 111.285 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.99 -176.3 45.82 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-N 116.258 -0.428 . . . . 54.350000000000001 113.064 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 175.75 10.89 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 75.430000000000007 113.53 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.83 132.92 46.76 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.877 -0.601 . . . . 63.340000000000003 112.936 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.02 -131.78 0.96 Allowed Glycine 0 CA--C 1.548 2.134 0 CA-C-O 119.146 -0.808 . . . . 61.420000000000002 114.872 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.1 124.29 5.19 Favored 'Cis proline' 0 C--N 1.386 2.514 0 CA-C-N 120.695 2.247 . . . . 71.120000000000005 113.641 -0.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.413 HG11 ' SG ' ' A' ' 66' ' ' CYS . 98.6 t -73.7 142.84 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 C-N-CA 123.394 0.677 . . . . 70.329999999999998 110.855 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -96.54 169.89 9.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.26 1.024 . . . . 73.019999999999996 111.199 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.503 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 81.6 m95 -131.52 125.96 33.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.958 0.903 . . . . 72.299999999999997 110.467 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.3 m-85 -116.93 163.16 16.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.353 1.061 . . . . 73.530000000000001 109.973 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 64' ' ' TYR . 1.9 tmtp? -159.48 128.21 5.15 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.303 0.641 . . . . 70.200000000000003 110.547 176.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.52 23.29 13.59 Favored 'General case' 0 CA--C 1.566 1.585 0 C-N-CA 124.306 1.042 . . . . 75.540000000000006 111.631 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.6 -8.36 63.95 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 115.754 -0.657 . . . . 52.140000000000001 114.505 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -129.64 138.13 51.04 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.199 0.999 . . . . 73.430000000000007 111.46 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -58.35 146.61 33.97 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.754 0.822 . . . . 64.420000000000002 112.759 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.565 ' HB3' HG11 ' A' ' 40' ' ' VAL . 38.6 mt -87.2 134.8 33.49 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.309 -0.405 . . . . 44.049999999999997 110.066 171.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.14 160.46 15.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.552 0.741 . . . . 74.030000000000001 110.775 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 p -72.47 83.7 1.1 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.705 0.764 . . . . 65.109999999999999 110.687 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.71 165.08 11.57 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.987 0.915 . . . . 63.420000000000002 110.378 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.28 -44.66 93.31 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 114.088 0.395 . . . . 73.019999999999996 114.088 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HG3' HG23 ' A' ' 40' ' ' VAL . 15.5 ptm180 -77.95 -37.74 46.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.002 0.521 . . . . 74.400000000000006 111.075 174.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 39' ' ' ARG . 59.7 t -94.34 83.08 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.704 0.802 . . . . 63.109999999999999 110.387 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 34.0 mm-40 -81.46 106.09 13.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.608 0.763 . . . . 72.329999999999998 111.237 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.44 101.59 13.52 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.184 0.594 . . . . 72.5 110.86 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 32.0 tt0 -92.42 98.76 11.68 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.442 0.697 . . . . 73.150000000000006 109.842 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.648 ' HG2' HE22 ' A' ' 49' ' ' GLN . 0.2 OUTLIER -87.27 102.06 14.13 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 74.129999999999995 108.215 173.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.07 -179.27 3.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.843 0.857 . . . . 74.409999999999997 110.922 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.26 89.31 0.07 OUTLIER Glycine 0 C--N 1.352 1.452 0 O-C-N 123.387 0.429 . . . . 74.310000000000002 112.819 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.39 -27.93 0.19 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 125.965 1.706 . . . . 73.409999999999997 113.36 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -85.3 104.54 15.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.441 0.696 . . . . 74.099999999999994 111.002 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.648 HE22 ' HG2' ' A' ' 44' ' ' GLN . 14.2 mm100 -98.5 112.16 24.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.097 0.559 . . . . 73.319999999999993 109.549 173.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 61.6 t -109.5 108.98 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.054 0.454 . . . . 64.120000000000005 110.836 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.21 117.53 30.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.641 -0.874 . . . . 73.209999999999994 108.641 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.7 mtm-85 -113.04 117.33 31.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.525 0.73 . . . . 64.409999999999997 109.891 174.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.06 100.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.31 0.576 . . . . 75.430000000000007 109.681 171.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.46 139.75 42.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.727 -0.67 . . . . 71.209999999999994 109.666 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.86 24.79 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 112.311 -0.316 . . . . 75.099999999999994 112.311 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.3 87.19 2.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.143 0.577 . . . . 72.099999999999994 111.189 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' O ' HG11 ' A' ' 79' ' ' VAL . 78.7 ttt180 -127.51 -82.86 0.6 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.229 0.612 . . . . 64.340000000000003 111.592 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 m -93.09 -70.66 0.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.172 0.589 . . . . 74.310000000000002 111.539 -173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.93 28.33 4.11 Favored Glycine 0 CA--C 1.543 1.784 0 N-CA-C 114.754 0.662 . . . . 55.43 114.754 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -93.44 -31.86 14.44 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.398 0.679 . . . . 73.299999999999997 110.812 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.13 107.43 2.31 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.804 0.842 . . . . 64.129999999999995 111.285 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.25 178.02 43.21 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 114.14 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.03 108.8 17.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.08 0.552 . . . . 71.540000000000006 110.14 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.664 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 19.5 m-85 -93.95 155.52 17.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.495 0.718 . . . . 74.340000000000003 109.898 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.709 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 44.2 tp -144.1 102.87 3.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.031 0.382 . . . . 60.409999999999997 112.031 -173.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.501 ' SG ' HD21 ' A' ' 18' ' ' LEU . 34.3 t -79.57 88.85 5.09 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 109.147 -0.686 . . . . 73.049999999999997 109.147 170.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.56 102.12 14.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.288 1.035 . . . . 64.109999999999999 112.786 -167.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.14 162.99 59.75 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.397 0.679 . . . . 64.219999999999999 110.51 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.73 31.9 0.19 Allowed 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.067 2.511 . . . . 74.430000000000007 115.104 174.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -172.39 -62.96 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.544 1.138 . . . . 73.299999999999997 109.065 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.67 176.35 6.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.705 0.802 . . . . 64.140000000000001 111.019 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 65' ' ' LEU . 85.5 p -165.64 134.89 3.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.406 0.682 . . . . 71.319999999999993 110.322 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -106.78 124.4 49.56 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.38 0.672 . . . . 43.439999999999998 110.351 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.55 HG13 HD13 ' A' ' 65' ' ' LEU . 3.2 mp -102.32 124.49 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.238 0.615 . . . . 64.439999999999998 110.073 -175.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 64.1 m-85 -101.17 126.38 47.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.344 1.058 . . . . 71.299999999999997 111.207 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.52 93.36 8.05 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.747 -1.205 . . . . 74.349999999999994 107.747 161.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 63.2 t -85.34 106.32 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.273 -0.639 . . . . 63.340000000000003 109.273 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.1 p -103.51 117.25 34.0 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.801 . . . . 63.420000000000002 110.027 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 57' ' ' ARG . 63.3 t -84.17 106.64 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.022 -0.732 . . . . 63.520000000000003 109.022 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 11.3 pt-20 -150.39 -166.94 2.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.336 1.054 . . . . 74.340000000000003 110.216 -174.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 40.1 mt-10 57.88 54.37 6.29 Favored Pre-proline 0 CA--C 1.571 1.765 0 C-N-CA 124.209 1.004 . . . . 73.540000000000006 112.121 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.455 0 C-N-CA 123.11 2.54 . . . . 71.430000000000007 112.466 -174.633 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 tpp . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 109.616 -0.513 . . . . 61.520000000000003 109.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.4 p -62.94 108.01 1.11 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.359 0.664 . . . . 71.230000000000004 111.363 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.79 120.28 38.76 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.485 -0.931 . . . . 64.030000000000001 108.485 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.498 ' HB ' HG22 ' A' ' 77' ' ' VAL . 98.8 t -122.24 140.94 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.706 0.802 . . . . 73.230000000000004 109.948 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.87 127.93 44.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.058 0.543 . . . . 70.140000000000001 109.54 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -122.34 162.33 21.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.245 0.618 . . . . 60.549999999999997 111.179 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.75 140.5 26.42 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.35 0.66 . . . . 75.230000000000004 111.939 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.84 119.33 6.01 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.103 2.535 . . . . 61.439999999999998 112.97 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.56 30.79 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.073 -0.512 . . . . 32.119999999999997 113.078 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.93 -131.22 3.98 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 117.094 0.447 . . . . 74.430000000000007 112.957 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -146.97 150.05 34.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.472 0.709 . . . . 73.450000000000003 110.837 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD21 ' A' ' 14' ' ' LEU . 64.3 tp -97.61 143.62 28.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.017 0.927 . . . . 54.219999999999999 110.283 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.56 113.38 6.76 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.284 0.633 . . . . 62.43 109.771 171.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 12' ' ' LEU . 75.6 mt -107.21 103.18 12.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.988 0.915 . . . . 64.530000000000001 109.6 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 117.2 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 109.105 -0.702 . . . . 74.239999999999995 109.105 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.627 HG21 ' SG ' ' A' ' 66' ' ' CYS . 1.6 t -97.85 147.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.095 0.474 . . . . 74.109999999999999 110.493 -174.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.41 29.81 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.853 0.861 . . . . 71.439999999999998 110.09 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.453 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.1 pp -53.2 158.59 1.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.791 1.034 . . . . 71.230000000000004 113.791 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 m -95.05 23.53 5.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.414 -0.812 . . . . 71.329999999999998 111.214 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.73 119.14 8.83 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.14 -0.811 . . . . 51.399999999999999 112.79 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.93 104.99 0.89 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.29 2.66 . . . . 74.5 114.221 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.38 52.01 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.358 0.903 . . . . 70.530000000000001 115.358 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.14 176.29 18.39 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-O 119.318 -0.712 . . . . 34.200000000000003 112.99 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.36 119.97 5.52 Favored 'Cis proline' 0 C--N 1.377 2.038 0 CA-C-N 120.052 1.926 . . . . 64.109999999999999 113.962 1.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -82.54 115.72 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 109.088 -0.708 . . . . 53.32 109.088 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -98.33 137.09 37.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.646 0.778 . . . . 75.140000000000001 111.659 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -96.3 124.34 40.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.459 0.704 . . . . 74.349999999999994 110.629 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 86.9 m-85 -119.03 134.71 55.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.778 0.831 . . . . 74.140000000000001 110.486 176.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.4 tptp -119.46 128.12 53.7 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.053 0.541 . . . . 75.439999999999998 109.842 173.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 63.37 5.7 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.644 1.178 . . . . 53.240000000000002 113.858 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.97 -25.01 4.2 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.555 -0.58 . . . . 44.340000000000003 114.046 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -131.03 150.2 52.26 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.516 1.158 . . . . 41.350000000000001 112.33 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -67.41 154.86 40.37 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.743 1.386 . . . . 72.519999999999996 114.743 -169.092 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.568 ' HB3' HG11 ' A' ' 40' ' ' VAL . 26.6 mt -102.55 162.29 13.04 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.805 1.242 . . . . 74.530000000000001 110.446 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.77 153.2 46.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.725 0.81 . . . . 64.340000000000003 110.533 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -71.26 83.14 0.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.956 0.884 . . . . 54.539999999999999 110.955 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.36 -178.63 3.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.114 0.965 . . . . 75.340000000000003 110.765 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.61 97.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 114.089 0.395 . . . . 51.200000000000003 114.089 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -90.5 -14.87 31.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.44 0.696 . . . . 62.329999999999998 112.05 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 34' ' ' LEU . 54.3 t -124.74 81.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.42 0.688 . . . . 73.519999999999996 109.831 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.628 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.4 mt-30 -85.11 125.66 32.97 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.263 0.625 . . . . 75.400000000000006 111.062 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.457 HD21 HD23 ' A' ' 51' ' ' LEU . 89.8 mt -118.48 96.86 5.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.538 0.735 . . . . 73.109999999999999 112.185 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.53 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 1.7 mp0 -85.86 96.63 9.84 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.88 -0.785 . . . . 73.329999999999998 108.88 165.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -111.21 113.85 26.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.725 0.81 . . . . 73.329999999999998 111.227 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.19 -157.95 0.85 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.413 1.085 . . . . 74.239999999999995 111.083 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.29 111.47 3.31 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 119.385 -0.675 . . . . 70.140000000000001 111.997 172.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.39 -52.6 0.7 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 125.925 1.69 . . . . 65.140000000000001 112.716 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 30.0 ttt85 -66.75 101.21 0.78 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.708 0.803 . . . . 73.239999999999995 111.515 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' HG23 ' A' ' 16' ' ' VAL . 67.7 mm-40 -112.04 125.8 54.47 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.749 -0.834 . . . . 74.439999999999998 108.749 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 51.5 t -117.96 110.53 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 122.705 0.402 . . . . 73.040000000000006 110.904 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.457 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -102.56 121.2 41.9 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.736 0.814 . . . . 71.439999999999998 109.452 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 68.3 mtp180 -120.68 109.15 14.87 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.08 0.552 . . . . 74.099999999999994 111.153 -176.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 61.6 t -92.61 114.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.244 0.545 . . . . 52.530000000000001 110.678 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -79.1 123.24 27.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.501 1.121 . . . . 71.5 110.351 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 42.88 23.97 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.736 -0.211 . . . . 74.099999999999994 113.394 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.78 112.83 4.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.275 0.63 . . . . 44.030000000000001 111.409 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -68.25 0.2 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.012 0.525 . . . . 72.239999999999995 111.256 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -95.49 -87.19 0.29 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.935 0.717 . . . . 72.349999999999994 112.935 -167.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.83 6.1 63.29 Favored Glycine 0 C--N 1.36 1.907 0 O-C-N 122.109 -0.37 . . . . 23.030000000000001 113.785 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB3' HG11 ' A' ' 53' ' ' VAL . 5.9 m-20 -84.2 -5.01 59.19 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.544 1.138 . . . . 72.010000000000005 110.995 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.15 128.17 36.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.035 0.934 . . . . 73.519999999999996 109.487 171.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.6 -173.34 41.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.238 -0.437 . . . . 73.120000000000005 112.915 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.27 126.74 33.94 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.058 0.543 . . . . 73.209999999999994 110.508 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 76.5 m-85 -112.85 110.2 20.14 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.93 0.892 . . . . 64.230000000000004 110.096 175.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -91.97 102.26 14.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.221 0.608 . . . . 73.140000000000001 110.331 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.627 ' SG ' HG21 ' A' ' 16' ' ' VAL . 44.9 t -82.12 89.11 6.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.545 0.738 . . . . 73.200000000000003 109.378 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -96.39 94.12 7.24 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.019 1.328 . . . . 71.129999999999995 112.192 -168.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.64 158.66 82.82 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.437 1.095 . . . . 62.25 111.784 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -47.76 -32.77 17.6 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.873 3.048 . . . . 70.420000000000002 115.239 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.29 49.02 1.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.262 0.553 . . . . 63.130000000000003 109.638 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -178.61 162.63 1.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.056 1.342 . . . . 71.319999999999993 109.564 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.7 p -160.36 121.01 2.95 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.169 0.44 . . . . 73.540000000000006 110.772 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -106.43 127.94 53.67 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.518 0.727 . . . . 75.530000000000001 110.36 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.62 121.51 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.044 -0.725 . . . . 73.340000000000003 109.044 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 32.0 m-85 -98.21 100.73 12.05 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.1 -0.704 . . . . 73.450000000000003 109.1 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.7 91.78 4.08 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.176 -1.046 . . . . 54.350000000000001 108.176 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 4' ' ' VAL . 67.4 t -104.27 112.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 115.194 -0.912 . . . . 71.329999999999998 110.482 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 p -111.12 110.52 21.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.137 0.575 . . . . 63.149999999999999 109.455 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.42 104.05 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.907 -1.145 . . . . 72.209999999999994 107.907 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.97 179.12 9.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.716 0.807 . . . . 63.539999999999999 110.7 -170.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 61.71 90.63 0.09 OUTLIER Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.132 0.973 . . . . 74.120000000000005 110.974 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 C--N 1.383 2.343 0 C-N-CA 123.154 2.569 . . . . 75.319999999999993 113.891 -171.265 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 ttm . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.38 -0.23 . . . . 40.329999999999998 110.38 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 p -65.17 105.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.864 0.466 . . . . 71.200000000000003 111.26 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -107.58 109.74 21.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.366 1.067 . . . . 65.120000000000005 110.671 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 86.8 t -122.95 118.08 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.589 . . . . 61.43 110.863 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.5 134.86 33.91 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.856 -0.424 . . . . 73.409999999999997 109.856 173.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.802 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.7 t -112.23 157.11 21.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.928 0.491 . . . . 74.319999999999993 110.237 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -83.46 146.03 49.48 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.289 0.635 . . . . 74.109999999999999 111.559 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.02 105.86 0.72 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.145 2.563 . . . . 73.010000000000005 113.502 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.65 15.8 56.06 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 115.404 -0.816 . . . . 41.030000000000001 113.346 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.96 -167.75 30.59 Favored Glycine 0 N--CA 1.477 1.403 0 N-CA-C 112.558 -0.217 . . . . 64.120000000000005 112.558 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -107.01 119.75 40.22 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.099 -0.648 . . . . 63.200000000000003 111.198 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 6' ' ' SER . 58.9 tp -75.82 147.78 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.999 0.92 . . . . 72.310000000000002 110.453 174.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -145.0 116.42 8.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.027 0.531 . . . . 73.230000000000004 109.583 169.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 77.4 mt -102.08 101.23 11.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.354 0.662 . . . . 53.0 109.374 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.18 113.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.476 -0.935 . . . . 71.519999999999996 108.476 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 18' ' ' LEU . 3.5 t -108.34 137.71 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.906 0.882 . . . . 71.030000000000001 110.536 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -134.48 51.27 2.12 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.437 0.637 . . . . 74.239999999999995 109.35 169.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -54.57 159.88 1.98 Allowed 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.53 -0.759 . . . . 71.099999999999994 112.598 166.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.1 m -82.39 41.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.782 0.833 . . . . 34.439999999999998 111.496 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.17 85.72 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.528 -0.595 . . . . 72.120000000000005 112.564 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.38 151.59 26.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.8 2.334 . . . . 54.0 113.021 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -90.02 0.7 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 116.211 -0.45 . . . . 45.340000000000003 112.384 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.01 -114.36 4.01 Favored Glycine 0 CA--C 1.546 1.997 0 CA-C-O 118.729 -1.039 . . . . 74.230000000000004 113.792 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -72.57 158.03 97.87 Favored 'Cis proline' 0 C--N 1.383 2.386 0 CA-C-N 120.999 2.399 . . . . 72.420000000000002 113.532 -0.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.49 HG11 ' SG ' ' A' ' 66' ' ' CYS . 32.2 t -90.29 129.11 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.033 0.533 . . . . 71.200000000000003 110.7 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -98.12 132.2 43.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.583 0.753 . . . . 75.129999999999995 110.778 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.494 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 70.3 m95 -97.74 118.24 33.82 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.649 0.379 . . . . 74.319999999999993 111.869 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.8 m-85 -112.29 147.98 35.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.315 1.046 . . . . 65.120000000000005 109.468 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' NZ ' ' HA ' ' A' ' 60' ' ' ASP . 15.6 tptm -128.31 113.11 15.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.156 0.503 . . . . 65.530000000000001 110.288 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.07 13.26 2.81 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 125.912 1.685 . . . . 54.530000000000001 113.281 168.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.1 -39.34 0.67 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.499 -0.611 . . . . 71.209999999999994 113.234 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -154.07 156.5 37.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.071 0.936 . . . . 74.230000000000004 112.773 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -60.62 152.68 25.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.953 1.834 . . . . 74.340000000000003 115.953 -166.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.3 mt -95.56 161.59 13.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.307 -0.861 . . . . 64.319999999999993 111.197 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.86 134.59 49.41 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.942 0.897 . . . . 62.420000000000002 109.782 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.7 p -68.16 89.07 0.31 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.37 0.668 . . . . 72.219999999999999 111.72 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -134.84 98.55 4.06 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.835 0.854 . . . . 51.329999999999998 111.163 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 -89.31 0.07 OUTLIER Glycine 0 C--N 1.357 1.726 0 O-C-N 123.841 0.713 . . . . 73.519999999999996 114.517 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -70.04 -38.51 75.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.676 0.79 . . . . 75.450000000000003 111.299 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 59.7 t -89.65 121.88 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.663 . . . . 63.119999999999997 109.365 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -129.54 121.35 27.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.401 0.68 . . . . 73.430000000000007 110.51 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.44 100.07 8.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 64.129999999999995 111.092 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.0 tm-20 -93.36 125.83 38.17 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.218 -1.03 . . . . 62.43 108.218 168.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.35 103.15 7.49 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.414 0.626 . . . . 61.399999999999999 111.159 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -100.81 -2.32 32.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.224 1.01 . . . . 72.019999999999996 112.101 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.52 -99.24 0.98 Allowed Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.192 -0.763 . . . . 53.329999999999998 111.192 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.66 -33.02 73.28 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.935 0.494 . . . . 74.329999999999998 111.616 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 58.3 ttp180 -89.19 115.65 26.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.992 0.517 . . . . 53.420000000000002 110.091 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HB3' ' HE1' ' A' ' 27' ' ' TRP . 37.9 mm-40 -114.29 141.45 47.57 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.706 0.803 . . . . 75.439999999999998 109.532 171.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 94.2 t -131.38 110.94 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.129 0.571 . . . . 73.140000000000001 110.264 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.84 112.16 24.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.677 0.791 . . . . 75.510000000000005 109.464 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 42.3 mtt-85 -100.14 137.36 38.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.04 0.536 . . . . 61.210000000000001 111.218 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.98 100.01 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.552 0.741 . . . . 55.210000000000001 109.337 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -75.18 126.26 30.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.793 -0.447 . . . . 65.329999999999998 109.793 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.43 30.18 19.82 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.411 0.444 . . . . 34.119999999999997 113.062 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.6 101.36 0.24 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.784 0.834 . . . . 61.520000000000003 111.519 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.11 -62.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.921 0.889 . . . . 63.409999999999997 109.795 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 m -54.66 -55.29 31.25 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.324 1.05 . . . . 55.530000000000001 113.721 -168.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.45 17.52 4.48 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 122.597 0.141 . . . . 70.340000000000003 112.912 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 13.8 m-20 -126.02 90.97 3.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 61.229999999999997 110.947 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.61 65.09 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.476 1.11 . . . . 64.420000000000002 109.369 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.84 -153.5 6.43 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-N 115.535 -0.757 . . . . 72.329999999999998 113.29 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 128.31 34.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.92 0.488 . . . . 74.540000000000006 111.329 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 57.2 m-85 -115.27 107.66 15.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.073 0.949 . . . . 65.319999999999993 109.095 173.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.6 tp -92.0 100.15 12.85 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.364 0.602 . . . . 72.219999999999999 110.608 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.49 ' SG ' HG11 ' A' ' 25' ' ' VAL . 29.8 t -80.55 87.31 5.74 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.539 -0.911 . . . . 71.439999999999998 108.539 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.01 96.05 10.42 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.349 1.06 . . . . 74.310000000000002 112.527 -168.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' H ' ' HA ' ' A' ' 72' ' ' SER . . . -90.42 138.73 26.81 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 122.932 0.493 . . . . 53.310000000000002 111.408 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.84 -29.62 64.0 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 123.677 2.918 . . . . 71.400000000000006 113.943 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -75.35 -63.8 1.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.013 0.525 . . . . 74.150000000000006 110.003 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 24.8 t70 -153.71 127.67 8.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.748 0.419 . . . . 62.119999999999997 110.927 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.434 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 31.2 t -72.65 177.6 4.64 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.222 1.009 . . . . 72.430000000000007 112.392 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.613 ' HE ' ' HA ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -154.99 127.18 7.74 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.536 0.735 . . . . 62.350000000000001 111.172 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.99 123.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.043 0.537 . . . . 75.439999999999998 109.685 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 36.8 m-85 -102.12 104.96 15.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.343 0.657 . . . . 74.439999999999998 111.419 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.25 93.63 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.598 -0.889 . . . . 75.340000000000003 108.598 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.1 t -99.36 114.51 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.898 0.479 . . . . 71.450000000000003 110.545 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.1 p -112.46 108.76 18.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.214 0.606 . . . . 61.509999999999998 110.135 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.802 HG22 ' HB3' ' A' ' 6' ' ' SER . 47.2 t -91.16 106.01 17.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.657 -0.868 . . . . 75.129999999999995 108.657 175.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -178.56 -27.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.314 0.646 . . . . 72.439999999999998 111.454 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.5 101.64 0.29 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.714 0.805 . . . . 74.340000000000003 109.992 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 CA--C 1.567 2.152 0 C-N-CA 122.883 2.389 . . . . 74.340000000000003 114.072 -165.223 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.618 0.247 . . . . 75.329999999999998 110.571 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m -75.57 90.8 2.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.747 0.819 . . . . 75.530000000000001 111.465 -171.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.34 135.25 33.8 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.542 0.737 . . . . 71.340000000000003 111.97 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.81 124.12 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.492 0.717 . . . . 73.0 110.948 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -90.25 142.06 28.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.173 0.589 . . . . 75.239999999999995 109.556 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.503 ' HB3' HG22 ' A' ' 79' ' ' VAL . 46.7 t -145.91 148.63 33.02 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.429 0.633 . . . . 74.219999999999999 112.021 -173.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 p -82.15 147.54 57.63 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 74.319999999999993 112.314 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -84.04 147.51 11.77 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.37 2.713 . . . . 71.420000000000002 112.716 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.12 -22.28 23.58 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 113.988 0.355 . . . . 54.219999999999999 113.988 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.05 -151.29 23.86 Favored Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.956 0.378 . . . . 71.200000000000003 113.32 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -112.93 127.0 56.09 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.26 0.53 . . . . 74.519999999999996 110.657 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.1 tp -75.8 128.65 35.61 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 109.155 -0.683 . . . . 55.020000000000003 109.155 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -129.13 105.34 8.11 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.923 -0.399 . . . . 65.230000000000004 109.923 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 50.1 mt -91.68 101.78 14.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.185 -0.672 . . . . 71.209999999999994 109.185 175.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.9 t -99.51 109.98 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 107.924 -1.139 . . . . 73.329999999999998 107.924 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.451 HG22 ' HZ ' ' A' ' 75' ' ' PHE . 2.8 t -98.37 135.86 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.781 0.324 . . . . 72.109999999999999 110.755 -168.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -116.66 32.75 5.96 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.849 0.859 . . . . 74.129999999999995 109.83 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.89 156.1 9.54 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.878 1.066 . . . . 75.329999999999998 113.878 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -82.71 5.68 20.5 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.184 0.994 . . . . 73.310000000000002 112.327 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.71 -175.35 23.38 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 114.422 0.529 . . . . 33.340000000000003 114.422 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.621 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 41.1 Cg_endo -83.66 179.6 4.77 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.486 2.791 . . . . 74.310000000000002 114.019 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.518 ' HA2' ' HA3' ' A' ' 46' ' ' GLY . . . -83.13 61.31 4.79 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.61 -0.723 . . . . 75.340000000000003 113.299 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 81.03 174.72 49.21 Favored Glycine 0 CA--C 1.543 1.814 0 N-CA-C 115.228 0.851 . . . . 75.140000000000001 115.228 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.52 99.77 0.28 Allowed 'Cis proline' 0 C--N 1.38 2.197 0 CA-C-N 118.893 1.346 . . . . 74.25 112.066 -6.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 22.8 t -79.27 132.88 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.167 0.587 . . . . 62.329999999999998 110.819 -176.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -98.28 153.19 18.69 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.968 0.907 . . . . 74.420000000000002 111.608 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -109.88 134.03 52.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.637 0.775 . . . . 72.540000000000006 111.291 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.782 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 46.5 m-85 -128.12 161.31 29.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.167 0.987 . . . . 72.120000000000005 110.646 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -153.77 129.03 9.74 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.434 1.094 . . . . 71.129999999999995 109.604 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 63.81 22.95 13.25 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.945 0.898 . . . . 72.0 111.189 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.04 -4.62 81.49 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.395 -0.82 . . . . 63.420000000000002 114.342 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.1 128.8 49.82 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.983 0.913 . . . . 74.040000000000006 111.054 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.71 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.49 146.2 49.35 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.999 1.111 . . . . 73.409999999999997 113.999 -175.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.407 ' HB3' HG11 ' A' ' 40' ' ' VAL . 52.2 mt -91.98 154.74 18.6 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.97 -1.014 . . . . 61.229999999999997 110.817 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.0 159.2 26.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.209 1.003 . . . . 73.420000000000002 110.278 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.7 p -66.22 91.96 0.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.436 0.694 . . . . 72.310000000000002 110.789 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 36.4 tt0 -114.83 164.41 14.14 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.29 1.036 . . . . 51.5 110.204 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.8 -18.83 47.63 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.265 0.866 . . . . 43.140000000000001 115.265 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -121.6 4.81 10.09 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.404 0.602 . . . . 74.409999999999997 111.973 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 70.5 t -127.59 86.27 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.244 1.017 . . . . 72.439999999999998 109.121 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 82.4 mt-30 -87.97 108.26 19.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.843 0.857 . . . . 72.239999999999995 111.158 -174.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 mt -98.21 141.57 30.96 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.079 0.551 . . . . 71.230000000000004 112.323 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -123.27 138.5 54.61 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.037 0.935 . . . . 73.219999999999999 110.234 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -118.03 108.79 15.67 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.433 0.693 . . . . 63.219999999999999 110.809 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.72 -48.98 1.25 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.872 0.869 . . . . 73.099999999999994 109.577 168.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.518 ' HA3' ' HA2' ' A' ' 22' ' ' GLY . . . 129.42 -75.01 0.43 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.577 -0.738 . . . . 72.329999999999998 112.149 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.23 -36.53 84.44 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.632 . . . . 65.420000000000002 111.015 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -111.64 109.63 19.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.336 0.654 . . . . 53.219999999999999 110.361 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.521 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.8 mm100 -107.28 135.38 48.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.47 0.708 . . . . 72.450000000000003 109.489 169.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 60.1 t -129.94 114.13 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 121.074 0.464 . . . . 65.439999999999998 111.647 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 120.48 42.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.802 1.241 . . . . 74.150000000000006 108.519 170.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 43.7 mtp180 -118.11 106.37 12.8 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.667 0.387 . . . . 72.430000000000007 110.783 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 60' ' ' ASP . 70.7 t -84.59 95.52 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.848 0.459 . . . . 74.319999999999993 110.089 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -75.13 107.33 7.15 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.488 0.715 . . . . 42.210000000000001 110.402 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.38 36.8 3.98 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.4 -0.363 . . . . 73.329999999999998 112.526 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.82 112.01 8.47 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.039 0.936 . . . . 75.120000000000005 112.011 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -167.96 -56.0 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.593 0.757 . . . . 73.200000000000003 112.101 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 m -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.119 0.967 . . . . 62.299999999999997 113.16 -167.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.88 26.38 1.46 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.235 -0.746 . . . . 75.040000000000006 111.235 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.534 ' HB3' HG11 ' A' ' 53' ' ' VAL . 6.0 m-20 -87.03 3.91 44.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.761 1.224 . . . . 72.310000000000002 111.903 -172.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.481 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -87.41 161.14 18.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 124.061 0.944 . . . . 74.230000000000004 109.603 166.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.56 -160.92 23.26 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 114.083 0.393 . . . . 53.409999999999997 114.083 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.2 mt-10 -93.9 118.16 31.09 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.224 0.61 . . . . 73.120000000000005 111.977 -172.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.18 152.86 22.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.226 1.01 . . . . 72.150000000000006 110.215 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.782 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.5 tp -128.98 101.93 6.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.788 0.435 . . . . 75.209999999999994 110.233 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -81.94 87.03 6.43 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 108.545 -0.909 . . . . 52.439999999999998 108.545 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.2 t70 -95.45 104.31 16.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.467 1.107 . . . . 75.109999999999999 111.918 -169.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.85 152.83 37.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.815 0.846 . . . . 71.530000000000001 110.878 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.43 -36.49 58.81 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.197 2.598 . . . . 72.540000000000006 114.925 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.621 ' HB2' ' HD3' ' A' ' 21' ' ' PRO . 82.0 mm-40 -90.3 -28.89 18.47 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.898 0.703 . . . . 70.230000000000004 112.898 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -157.35 128.76 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 112.176 0.436 . . . . 73.239999999999995 112.176 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.549 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.6 p -97.6 139.75 33.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.689 0.796 . . . . 73.450000000000003 110.529 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -123.83 123.43 40.45 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.739 0.416 . . . . 62.399999999999999 110.839 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -97.04 144.14 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 122.882 0.473 . . . . 74.230000000000004 110.118 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' HZ ' HG22 ' A' ' 16' ' ' VAL . 5.8 m-85 -117.71 139.03 51.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.036 1.334 . . . . 74.25 110.155 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.7 94.89 5.26 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.381 -0.97 . . . . 73.420000000000002 108.381 164.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.07 139.04 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.181 0.592 . . . . 75.140000000000001 111.711 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.2 p -126.49 108.89 11.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.782 0.833 . . . . 64.310000000000002 110.468 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.6 t -109.04 104.11 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.187 -1.042 . . . . 74.409999999999997 108.187 172.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 8.5 pt-20 179.03 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.501 0.72 . . . . 63.210000000000001 111.246 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 37.7 mt-10 -75.17 106.37 2.78 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.943 0.897 . . . . 71.310000000000002 110.622 -174.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 6.1 Cg_exo . . . . . 0 CA--C 1.569 2.239 0 C-N-CA 123.242 2.628 . . . . 74.430000000000007 113.58 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.684 0.278 . . . . 74.439999999999998 110.818 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.23 84.62 1.88 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.406 1.082 . . . . 54.25 111.099 -172.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.66 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 64.8 mtt85 -76.37 141.14 41.59 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.545 0.738 . . . . 74.299999999999997 112.254 -174.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.416 HG21 HD22 ' A' ' 14' ' ' LEU . 78.9 t -130.03 131.24 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.647 0.779 . . . . 54.32 110.977 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -90.25 129.62 36.47 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.291 1.037 . . . . 71.430000000000007 109.855 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -139.16 158.88 43.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.818 0.847 . . . . 74.540000000000006 111.136 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -101.33 152.77 38.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 123.881 0.873 . . . . 73.209999999999994 111.63 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.2 Cg_endo -83.06 73.11 5.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.499 2.8 . . . . 55.030000000000001 113.622 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.99 60.23 0.01 OUTLIER Glycine 0 N--CA 1.474 1.169 0 CA-C-N 115.794 -0.639 . . . . 44.009999999999998 112.36 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.51 -176.26 39.81 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 122.853 -0.204 . . . . 60.32 113.428 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.05 119.66 31.95 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.337 0.589 . . . . 75.450000000000003 110.681 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 61.4 tp -74.8 136.58 41.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.745 0.818 . . . . 75.400000000000006 109.568 174.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -134.5 107.95 7.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.953 0.501 . . . . 74.010000000000005 110.053 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.416 HD22 HG21 ' A' ' 4' ' ' VAL . 44.4 mt -92.78 104.18 16.46 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.45 0.7 . . . . 74.25 109.524 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.09 112.08 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.974 -0.75 . . . . 71.230000000000004 108.974 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.469 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t -100.64 126.66 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.738 0.415 . . . . 62.210000000000001 110.131 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -99.17 21.37 11.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.298 0.639 . . . . 72.439999999999998 111.483 174.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.442 ' H ' HG12 ' A' ' 16' ' ' VAL . 12.7 mt -49.25 138.16 13.0 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.616 0.766 . . . . 52.240000000000002 111.792 163.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.8 t -79.17 76.89 5.69 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.498 0.666 . . . . 42.509999999999998 110.11 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.82 85.2 0.39 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.985 -0.846 . . . . 53.509999999999998 110.985 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.37 -51.39 5.38 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.097 2.531 . . . . 72.019999999999996 113.71 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.69 96.52 0.28 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.347 -0.701 . . . . 63.240000000000002 111.347 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.68 -110.45 3.5 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 118.96 -0.911 . . . . 44.32 113.525 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.31 179.47 28.01 Favored 'Cis proline' 0 C--N 1.38 2.187 0 CA-C-N 120.382 2.091 . . . . 44.130000000000003 113.971 2.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 68' ' ' ALA . 42.0 t -80.31 145.54 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.461 -0.79 . . . . 70.200000000000003 110.441 171.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.5 128.05 43.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 74.109999999999999 109.09 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.403 ' CH2' ' SG ' ' A' ' 66' ' ' CYS . 92.4 m95 -100.37 137.08 39.28 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.554 0.742 . . . . 74.140000000000001 111.41 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 90.8 m-85 -131.61 119.99 22.22 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.014 0.525 . . . . 74.340000000000003 110.91 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -107.52 124.82 50.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.413 0.685 . . . . 65.150000000000006 109.686 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t70 65.73 12.48 8.33 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 124.657 1.183 . . . . 73.140000000000001 110.896 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.09 -23.42 23.34 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 123.604 0.621 . . . . 73.030000000000001 113.673 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -101.46 141.89 33.65 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.897 0.849 . . . . 63.509999999999998 111.277 -173.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 152.83 14.89 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.895 0.878 . . . . 71.030000000000001 113.238 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -93.19 158.65 15.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.09 0.556 . . . . 73.319999999999993 110.326 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 128.96 43.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.663 0.785 . . . . 64.340000000000003 110.447 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.8 p -65.09 88.91 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.663 0.785 . . . . 74.439999999999998 111.283 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -126.25 -171.1 2.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.736 1.214 . . . . 70.200000000000003 110.503 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.4 -34.03 78.76 Favored Glycine 0 N--CA 1.48 1.627 0 O-C-N 123.017 0.198 . . . . 75.230000000000004 113.345 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -71.99 -60.89 2.0 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 75.230000000000004 110.507 173.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.8 t -101.46 92.07 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.983 0.913 . . . . 60.240000000000002 110.977 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -97.85 115.89 28.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.84 0.856 . . . . 53.219999999999999 111.402 -174.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.43 HD21 HD23 ' A' ' 51' ' ' LEU . 96.2 mt -94.64 133.61 38.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.173 0.589 . . . . 65.400000000000006 110.984 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -123.94 103.07 8.11 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.618 -0.882 . . . . 71.549999999999997 108.618 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -85.07 121.98 28.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.407 0.683 . . . . 74.319999999999993 111.637 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.73 169.02 16.24 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.587 0.755 . . . . 32.109999999999999 110.604 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.52 111.9 4.49 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.359 -0.689 . . . . 71.439999999999998 112.003 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.59 -54.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.503 1.521 . . . . 64.150000000000006 112.195 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.5 ttt-85 -67.94 112.57 5.03 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.673 0.789 . . . . 74.150000000000006 112.136 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -107.97 137.06 46.63 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.582 0.753 . . . . 73.329999999999998 109.068 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 73.0 t -125.8 124.18 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 122.09 -0.381 . . . . 71.400000000000006 111.81 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.43 HD23 HD21 ' A' ' 42' ' ' LEU . 2.3 tm? -113.25 115.43 28.18 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.729 1.212 . . . . 75.409999999999997 108.454 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 75.0 mtt180 -112.54 106.96 15.52 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 122.056 -0.402 . . . . 74.219999999999999 111.779 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.1 t -98.25 95.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 109.651 -0.499 . . . . 64.340000000000003 109.651 172.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -71.68 101.6 2.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.103 -0.702 . . . . 73.409999999999997 109.103 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.48 11.99 0.53 Allowed Glycine 0 N--CA 1.471 0.998 0 CA-C-O 119.258 -0.745 . . . . 63.450000000000003 113.1 -173.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . . . -62.02 100.27 0.16 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.738 0.815 . . . . 32.509999999999998 110.918 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.4 tmm_? -158.74 -48.31 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 O-C-N 123.382 0.426 . . . . 75.319999999999993 112.027 -170.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.3 m -113.16 -97.5 0.43 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 118.183 0.447 . . . . 71.140000000000001 111.894 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.95 21.9 13.9 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 117.917 0.326 . . . . 73.319999999999993 113.672 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.21 -14.7 55.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.373 1.069 . . . . 74.010000000000005 110.8 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.454 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -77.77 104.4 8.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.386 0.675 . . . . 61.030000000000001 109.502 170.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.67 -173.93 40.97 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.182 -0.463 . . . . 65.510000000000005 113.404 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -85.22 115.51 23.04 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.428 0.691 . . . . 63.109999999999999 111.082 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 45.4 m-85 -106.05 111.71 24.45 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.767 0.827 . . . . 63.219999999999999 109.706 172.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.5 tp -91.5 107.81 19.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.267 0.627 . . . . 75.310000000000002 110.371 -171.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.403 ' SG ' ' CH2' ' A' ' 27' ' ' TRP . 80.3 m -73.58 90.98 1.8 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.839 -0.801 . . . . 73.319999999999993 108.839 164.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -52.32 -47.06 66.2 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.354 1.062 . . . . 65.450000000000003 111.399 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.649 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . 67.37 132.8 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 114.602 1.334 . . . . 60.420000000000002 114.602 167.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -77.68 37.76 0.63 Allowed 'Trans proline' 0 CA--C 1.57 2.276 0 C-N-CA 123.277 2.652 . . . . 55.399999999999999 113.477 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -161.92 -60.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.548 0.739 . . . . 75.140000000000001 110.996 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.59 127.17 7.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.295 0.638 . . . . 75.219999999999999 110.547 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.3 p -73.94 138.09 44.02 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 113.551 0.945 . . . . 41.049999999999997 113.551 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -127.56 126.99 43.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.399 1.08 . . . . 71.540000000000006 111.005 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.27 142.01 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.755 0.422 . . . . 60.399999999999999 110.445 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 11.6 m-85 -101.74 109.76 21.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.204 1.002 . . . . 74.439999999999998 109.943 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.66 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 63.1 mt -86.19 91.7 8.53 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.648 -0.871 . . . . 62.539999999999999 108.648 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -89.5 124.03 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.66 -0.7 . . . . 72.450000000000003 110.658 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -108.37 107.07 17.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.834 0.853 . . . . 33.149999999999999 110.037 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.454 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 94.5 t -94.1 106.68 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 108.363 -0.977 . . . . 74.450000000000003 108.363 173.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -164.01 176.03 9.74 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.22 1.008 . . . . 65.319999999999993 110.658 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.6 84.72 0.2 Allowed Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.112 0.965 . . . . 74.150000000000006 111.514 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo . . . . . 0 CA--C 1.567 2.138 0 C-N-CA 123.222 2.614 . . . . 71.439999999999998 114.121 178.052 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 24.6 mmt . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.123 0.487 . . . . 64.219999999999999 111.069 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 p -92.9 140.96 28.95 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.392 1.077 . . . . 63.009999999999998 109.842 171.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -132.44 116.84 17.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.472 0.709 . . . . 74.319999999999993 110.342 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.2 t -129.98 147.49 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.765 0.826 . . . . 73.120000000000005 110.825 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -124.25 146.93 48.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.251 1.021 . . . . 74.239999999999995 112.226 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -141.09 163.54 32.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.314 1.046 . . . . 74.25 110.315 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 81' ' ' GLU . 1.1 p -93.66 145.39 29.83 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 123.31 0.644 . . . . 72.230000000000004 111.706 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 73.1 Cg_endo -68.11 130.88 22.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.269 2.646 . . . . 74.120000000000005 113.231 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.81 -18.41 34.53 Favored Glycine 0 N--CA 1.474 1.219 0 CA-C-N 116.156 -0.474 . . . . 61.140000000000001 113.557 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.2 -127.56 5.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 117.202 0.501 . . . . 44.149999999999999 112.289 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.34 155.45 46.79 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.417 0.627 . . . . 71.109999999999999 111.389 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.25 152.81 25.0 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.639 0.776 . . . . 71.299999999999997 109.86 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.23 108.09 4.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.975 0.51 . . . . 75.340000000000003 110.357 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 51' ' ' LEU . 65.3 mt -106.34 102.04 11.47 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.385 0.674 . . . . 64.450000000000003 110.054 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -96.53 125.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.044 -0.725 . . . . 72.549999999999997 109.044 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 2.8 t -112.75 142.66 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.48 0.712 . . . . 71.219999999999999 111.361 -170.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -138.1 45.63 2.1 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.092 0.957 . . . . 72.349999999999994 110.191 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.492 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -57.46 151.01 17.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.144 0.794 . . . . 51.340000000000003 113.144 170.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.6 m -91.68 3.62 54.65 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.694 0.798 . . . . 72.239999999999995 111.996 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.36 116.9 6.01 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 119.053 -0.86 . . . . 74.010000000000005 113.484 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.41 111.51 1.16 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.95 2.434 . . . . 71.319999999999993 112.363 173.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' A' ' 69' ' ' PRO . . . 177.25 138.26 2.93 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.304 -0.407 . . . . 24.539999999999999 112.691 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.78 112.61 0.55 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.956 -0.913 . . . . 54.240000000000002 112.057 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.67 162.07 79.17 Favored 'Cis proline' 0 C--N 1.375 1.944 0 CA-C-N 120.192 1.996 . . . . 73.319999999999993 113.612 -3.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.482 HG23 ' HA2' ' A' ' 46' ' ' GLY . 89.5 t -86.9 151.25 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-N 115.146 -0.934 . . . . 71.010000000000005 109.624 172.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -93.24 164.41 13.24 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.125 0.57 . . . . 74.25 110.56 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 78.9 m95 -133.03 127.88 35.06 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.85 0.86 . . . . 73.150000000000006 110.773 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 87.8 m-85 -131.28 126.15 34.65 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.222 1.009 . . . . 75.239999999999995 110.865 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB3' HD21 ' A' ' 34' ' ' LEU . 20.8 tptm -113.67 132.96 55.59 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.673 0.789 . . . . 73.219999999999999 108.994 169.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.24 22.27 13.26 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.294 1.045 . . . . 72.030000000000001 110.224 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.71 -6.16 71.19 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.543 -0.753 . . . . 63.420000000000002 114.108 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -107.26 136.45 47.07 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.988 0.894 . . . . 73.209999999999994 111.15 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -59.89 147.97 36.62 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.344 0.868 . . . . 71.430000000000007 113.344 -173.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.58 HD21 ' HB3' ' A' ' 29' ' ' LYS . 41.6 mt -100.45 125.53 46.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.301 0.641 . . . . 72.219999999999999 110.238 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.46 139.12 32.41 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.752 0.821 . . . . 73.430000000000007 109.932 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 p -64.04 92.95 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.515 0.674 . . . . 71.129999999999995 111.11 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -111.88 -171.27 1.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.936 0.894 . . . . 54.340000000000003 111.834 -175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.29 -44.73 95.07 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.285 -0.416 . . . . 71.0 112.764 174.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 84.3 mtt180 -73.61 -52.87 11.94 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.352 0.661 . . . . 61.520000000000003 111.133 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.571 HG11 ' HB3' ' A' ' 34' ' ' LEU . 67.5 t -79.48 95.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 123.322 0.649 . . . . 74.319999999999993 111.421 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.5 mt-30 -90.79 100.05 12.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.018 0.927 . . . . 75.230000000000004 109.996 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.63 133.05 41.62 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.139 0.575 . . . . 63.32 111.752 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 52.4 mm-40 -107.71 130.42 54.94 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.223 1.009 . . . . 72.540000000000006 110.301 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -103.02 141.77 35.25 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.933 0.493 . . . . 75.299999999999997 110.883 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.52 -49.05 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.84 1.256 . . . . 74.129999999999995 109.457 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 121.2 -72.17 0.37 Allowed Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.106 -0.952 . . . . 72.030000000000001 111.226 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -17.97 61.91 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.701 0.8 . . . . 70.140000000000001 112.19 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -135.06 107.96 7.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 110.34 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 13.8 mm100 -115.12 143.03 45.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.319 0.648 . . . . 74.450000000000003 109.402 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 58.6 t -133.42 114.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 117.984 0.356 . . . . 71.129999999999995 110.417 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 14' ' ' LEU . 1.1 tm? -104.98 117.14 33.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.753 0.821 . . . . 73.209999999999994 108.889 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 81.5 mtp180 -115.69 112.95 22.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.92 -0.582 . . . . 74.510000000000005 110.568 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.16 102.24 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.719 -0.474 . . . . 75.25 109.719 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 39' ' ' ARG . 0.6 OUTLIER -66.87 116.59 7.91 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.168 -0.679 . . . . 65.129999999999995 109.168 174.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.14 43.9 2.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.203 -0.453 . . . . 65.140000000000001 112.511 -173.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . -74.92 118.2 17.62 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.877 0.471 . . . . 62.329999999999998 110.107 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -158.34 112.44 2.5 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.863 0.465 . . . . 74.439999999999998 111.579 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m 53.38 -78.87 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.323 1.449 . . . . 74.230000000000004 114.413 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -11.87 59.99 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 114.815 0.686 . . . . 74.400000000000006 114.815 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HB3' HG21 ' A' ' 79' ' ' VAL . 17.7 t70 -66.26 -25.87 67.09 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.507 0.723 . . . . 70.299999999999997 111.132 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.725 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -66.97 100.04 0.7 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.082 0.953 . . . . 64.549999999999997 110.689 176.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -164.23 -172.71 32.04 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.979 -0.555 . . . . 34.310000000000002 113.346 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -86.28 111.03 20.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.387 0.675 . . . . 65.340000000000003 110.824 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.783 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 44.1 m-85 -96.44 156.88 16.15 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.087 0.955 . . . . 45.200000000000003 109.442 169.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.7 tp -140.44 101.34 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.873 0.368 . . . . 70.209999999999994 110.824 -173.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.6 t -85.71 89.97 7.89 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.77 -0.826 . . . . 61.210000000000001 108.77 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -100.76 99.9 10.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.706 0.802 . . . . 74.150000000000006 112.664 -168.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.8 155.91 67.86 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.614 0.766 . . . . 73.540000000000006 110.068 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.522 ' HD2' ' HA3' ' A' ' 22' ' ' GLY . 50.3 Cg_exo -59.77 -2.43 1.56 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.273 2.649 . . . . 72.109999999999999 115.746 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -126.01 -43.63 1.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.696 0.798 . . . . 71.540000000000006 111.088 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.46 149.04 51.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.033 0.533 . . . . 74.540000000000006 111.246 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.476 ' HB2' HD11 ' A' ' 65' ' ' LEU . 79.7 p -129.92 133.18 46.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.637 0.775 . . . . 73.239999999999995 110.871 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -106.77 125.22 50.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.273 0.629 . . . . 63.140000000000001 110.035 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.451 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 2.2 mp -92.7 125.67 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.853 -0.795 . . . . 72.400000000000006 108.853 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.783 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 33.6 m-85 -98.15 101.95 13.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.437 0.695 . . . . 74.230000000000004 109.302 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.6 mt -77.55 92.94 4.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.03 -1.1 . . . . 60.030000000000001 108.03 172.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.8 t -94.03 139.17 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.153 -0.93 . . . . 63.43 110.718 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.9 p -131.2 107.4 8.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.86 -0.609 . . . . 72.109999999999999 109.763 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.725 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 57.4 t -90.11 107.34 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.594 -0.891 . . . . 74.439999999999998 108.594 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.79 179.71 7.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.995 0.918 . . . . 73.340000000000003 111.06 -167.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 7' ' ' THR . 12.5 tp10 64.21 87.97 0.12 Allowed Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 124.462 1.105 . . . . 73.409999999999997 110.584 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo . . . . . 0 C--N 1.383 2.344 0 C-N-CA 124.493 3.462 . . . . 52.030000000000001 115.742 -174.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.675 0.274 . . . . 74.019999999999996 110.795 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.8 m -73.41 95.16 2.17 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 124.297 1.039 . . . . 73.340000000000003 110.093 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -83.87 136.27 34.18 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.889 0.876 . . . . 60.140000000000001 111.668 -166.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.6 143.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 123.923 0.889 . . . . 54.32 110.344 171.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -121.71 138.54 54.31 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.298 1.039 . . . . 74.319999999999993 110.377 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 t -137.34 178.08 7.37 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.464 0.706 . . . . 71.019999999999996 110.45 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 81' ' ' GLU . 4.2 p -124.99 147.71 57.66 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 124.016 0.926 . . . . 62.549999999999997 111.655 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -69.85 87.61 0.56 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.486 2.791 . . . . 74.040000000000006 113.402 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.22 -27.11 2.0 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.337 -0.847 . . . . 64.340000000000003 112.431 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.32 -159.71 17.01 Favored Glycine 0 C--N 1.348 1.203 0 N-CA-C 114.102 0.401 . . . . 43.299999999999997 114.102 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -102.47 158.25 16.35 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.382 0.673 . . . . 72.519999999999996 110.874 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 54.7 tp -119.24 108.25 14.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.337 0.655 . . . . 74.420000000000002 110.064 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -118.34 114.85 23.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.161 0.584 . . . . 72.430000000000007 110.242 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 15.2 mt -103.62 103.29 13.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.815 -0.809 . . . . 73.329999999999998 108.815 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.467 HG22 HG22 ' A' ' 50' ' ' VAL . 67.3 t -105.56 122.1 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.14 -0.689 . . . . 73.420000000000002 109.14 175.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.549 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -100.78 148.27 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.742 0.417 . . . . 42.310000000000002 110.717 -178.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 67.4 m80 -128.25 51.34 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.187 0.994 . . . . 73.25 109.827 166.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -72.22 170.26 14.43 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 114.228 -1.351 . . . . 72.409999999999997 112.961 173.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.7 m -90.7 23.89 2.91 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.565 1.146 . . . . 72.510000000000005 112.705 -175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.82 157.28 18.08 Favored Glycine 0 CA--C 1.546 2.025 0 CA-C-O 119.959 -0.356 . . . . 64.140000000000001 113.933 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.23 -168.14 0.57 Allowed 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.615 2.876 . . . . 61.509999999999998 113.428 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.18 -51.24 55.44 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 123.264 0.459 . . . . 41.43 114.066 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.29 -97.2 1.22 Allowed Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.474 0.95 . . . . 73.510000000000005 115.474 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.85 126.44 9.63 Favored 'Cis proline' 0 C--N 1.383 2.353 0 CA-C-N 120.891 2.345 . . . . 60.109999999999999 114.384 5.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 89.7 t -66.58 131.62 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.439 0.696 . . . . 63.25 110.274 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.06 150.81 20.07 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.46 0.647 . . . . 72.219999999999999 110.637 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -110.34 125.24 52.97 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.893 0.877 . . . . 74.319999999999993 109.296 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.772 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 81.0 m-85 -111.71 161.7 16.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.149 0.58 . . . . 71.0 110.438 173.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HB3' HD21 ' A' ' 34' ' ' LEU . 27.2 tptp -146.68 122.9 10.88 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.741 0.816 . . . . 74.010000000000005 109.51 171.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 54.54 25.74 6.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.929 0.891 . . . . 72.129999999999995 113.068 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.76 -30.52 7.73 Favored Glycine 0 C--N 1.353 1.514 0 CA-C-N 116.121 -0.491 . . . . 60.240000000000002 114.165 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -111.9 131.79 55.14 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.788 0.794 . . . . 75.329999999999998 111.379 -173.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.772 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -62.18 151.89 34.7 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.107 0.963 . . . . 75.530000000000001 113.536 -177.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 29' ' ' LYS . 27.3 mt -100.99 142.32 32.64 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.165 0.986 . . . . 52.210000000000001 110.345 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.63 157.46 17.39 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.997 0.919 . . . . 72.099999999999994 109.996 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.9 p -61.62 97.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.841 0.829 . . . . 71.530000000000001 111.035 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.506 ' NE2' ' H ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -109.55 163.28 13.59 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.887 1.275 . . . . 73.439999999999998 108.135 -175.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' H ' ' NE2' ' A' ' 37' ' ' GLN . . . -53.92 -35.84 54.4 Favored Glycine 0 CA--C 1.543 1.798 0 N-CA-C 114.145 0.418 . . . . 74.400000000000006 114.145 174.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -89.5 -33.06 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.021 0.528 . . . . 74.530000000000001 110.821 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.04 86.01 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.93 0.892 . . . . 75.200000000000003 111.152 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 68.1 mt-30 -82.82 101.25 10.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.623 0.769 . . . . 75.430000000000007 110.751 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.441 HD21 HD23 ' A' ' 51' ' ' LEU . 61.2 mt -89.91 152.86 21.03 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.33 0.586 . . . . 72.409999999999997 112.201 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.5 tm-20 -146.48 131.83 18.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 107.743 -1.206 . . . . 74.319999999999993 107.743 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -124.8 103.14 7.92 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.012 0.525 . . . . 75.150000000000006 111.034 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.86 11.17 11.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.937 0.895 . . . . 74.230000000000004 111.969 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.67 -86.36 1.47 Allowed Glycine 0 C--N 1.346 1.119 0 C-N-CA 123.179 0.419 . . . . 61.409999999999997 113.408 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' HIS . . . -72.56 -5.39 36.79 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.347 0.659 . . . . 32.140000000000001 111.865 175.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 54.0 ttp180 -133.71 101.21 5.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.003 0.921 . . . . 60.32 109.745 172.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.506 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.0 mm100 -106.09 126.58 52.37 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 109.549 -0.537 . . . . 70.150000000000006 109.549 173.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 40.6 t -115.83 122.15 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-O 120.869 0.366 . . . . 62.409999999999997 111.344 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -111.34 114.47 27.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.334 1.054 . . . . 72.219999999999999 108.402 169.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.601 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 83.6 mtm180 -114.43 108.31 16.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.992 0.517 . . . . 62.149999999999999 111.202 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.7 t -96.55 120.89 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.634 -0.506 . . . . 63.310000000000002 109.634 171.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -79.2 116.08 19.25 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.257 0.623 . . . . 74.230000000000004 109.731 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.61 72.45 1.26 Allowed Glycine 0 CA--C 1.534 1.252 0 CA-C-N 116.336 -0.393 . . . . 72.519999999999996 113.429 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . . . -80.48 102.54 9.76 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.683 0.793 . . . . 51.229999999999997 111.447 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.34 -73.63 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.599 0.759 . . . . 74.5 111.614 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.8 m -127.71 -67.15 0.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.855 0.462 . . . . 75.510000000000005 111.867 -171.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.1 -12.53 60.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 113.974 0.349 . . . . 72.219999999999999 113.974 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -82.87 -17.48 43.68 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.292 1.037 . . . . 64.439999999999998 110.694 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.64 134.17 34.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.023 0.929 . . . . 55.350000000000001 109.554 172.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.04 -178.64 36.92 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.867 -0.606 . . . . 70.140000000000001 113.066 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.1 117.67 25.99 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.357 0.599 . . . . 75.340000000000003 110.467 175.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 38.4 m-85 -94.57 157.02 16.17 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.283 1.033 . . . . 75.340000000000003 109.934 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.4 tp -127.94 105.56 8.5 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.828 -0.545 . . . . 74.019999999999996 110.525 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.549 ' SG ' HG21 ' A' ' 16' ' ' VAL . 48.6 t -82.93 88.22 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.637 -0.875 . . . . 41.439999999999998 108.637 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -79.36 86.72 5.06 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.121 0.968 . . . . 63.310000000000002 111.684 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -81.01 140.57 49.96 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-N 115.816 -0.629 . . . . 74.319999999999993 110.054 171.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -46.32 -35.86 16.44 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 124.498 3.466 . . . . 71.219999999999999 115.896 -173.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -124.18 0.38 8.41 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.802 0.841 . . . . 71.239999999999995 112.406 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -156.49 49.45 0.48 Allowed 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.785 0.802 . . . . 73.099999999999994 111.046 -165.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 t -66.8 121.6 15.82 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.148 0.979 . . . . 35.32 112.025 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -127.47 142.66 51.34 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.933 0.716 . . . . 64.310000000000002 112.933 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.564 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mp -91.05 139.95 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 123.962 0.905 . . . . 74.319999999999993 109.947 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.586 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 9.3 m-85 -102.06 114.89 29.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.563 1.145 . . . . 73.519999999999996 111.121 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 93.9 mt -77.36 93.87 4.12 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.591 -0.892 . . . . 75.409999999999997 108.591 166.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.486 HG11 HD21 ' A' ' 12' ' ' LEU . 73.5 t -105.45 113.14 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.345 0.658 . . . . 63.009999999999998 110.691 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 t -118.1 117.65 29.76 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.564 -0.744 . . . . 64.439999999999998 110.747 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.3 t -84.82 106.26 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 107.947 -1.131 . . . . 72.019999999999996 107.947 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.41 -173.95 4.17 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.184 0.994 . . . . 74.239999999999995 109.922 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 7' ' ' THR . 44.6 tt0 59.78 81.15 0.25 Allowed Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 123.978 0.911 . . . . 74.140000000000001 110.763 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo . . . . . 0 CA--C 1.575 2.566 0 C-N-CA 124.278 3.318 . . . . 74.439999999999998 115.875 -177.112 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.579 0.228 . . . . 71.409999999999997 111.528 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -79.67 95.19 5.86 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.674 -0.861 . . . . 75.549999999999997 108.674 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.566 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 41.2 mtp180 -93.9 148.34 22.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.567 0.747 . . . . 74.409999999999997 112.824 -166.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 79.4 t -130.57 138.57 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.031 0.932 . . . . 64.439999999999998 109.473 171.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.17 119.13 32.37 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.023 0.929 . . . . 55.149999999999999 109.076 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.419 ' HB3' HG22 ' A' ' 79' ' ' VAL . 35.0 t -132.45 163.16 29.38 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.796 0.808 . . . . 53.130000000000003 112.568 -170.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.1 p -99.74 155.82 36.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 115.047 -0.978 . . . . 72.150000000000006 111.189 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -82.02 46.71 2.28 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.444 2.762 . . . . 70.299999999999997 113.292 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.1 45.67 0.56 Allowed Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.316 -0.402 . . . . 63.5 113.115 -172.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.73 172.98 36.12 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-O 119.635 -0.536 . . . . 72.519999999999996 112.193 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.78 135.37 41.71 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.553 0.677 . . . . 73.530000000000001 111.131 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.489 HD21 HG11 ' A' ' 77' ' ' VAL . 49.5 tp -78.84 107.44 11.56 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.782 0.433 . . . . 44.329999999999998 110.883 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 36.2 tt0 -111.24 104.59 13.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.922 0.489 . . . . 74.409999999999997 110.171 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HG ' HD12 ' A' ' 51' ' ' LEU . 29.3 mt -94.45 106.12 18.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.96 0.904 . . . . 75.109999999999999 110.402 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -93.95 113.27 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.588 0.755 . . . . 64.420000000000002 110.003 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 18' ' ' LEU . 2.1 t -100.05 149.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.688 0.795 . . . . 71.209999999999994 110.631 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -112.02 15.15 20.77 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.308 0.643 . . . . 51.350000000000001 111.14 174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.609 ' H ' HG12 ' A' ' 16' ' ' VAL . 14.4 mt -54.24 95.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.514 0.725 . . . . 72.109999999999999 112.003 174.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.8 t -68.24 81.36 0.24 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.637 0.775 . . . . 62.210000000000001 110.349 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.29 164.18 30.63 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.292 -0.867 . . . . 73.239999999999995 113.268 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.09 23.7 0.51 Allowed 'Trans proline' 0 CA--C 1.568 2.185 0 C-N-CA 123.231 2.621 . . . . 74.219999999999999 113.98 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.74 59.76 4.26 Favored Glycine 0 C--N 1.353 1.49 0 C-N-CA 122.838 0.256 . . . . 25.149999999999999 112.501 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.31 -69.49 1.37 Allowed Glycine 0 CA--C 1.551 2.299 0 CA-C-O 119.616 -0.547 . . . . 73.099999999999994 114.44 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.7 -167.35 5.99 Favored 'Cis proline' 0 C--N 1.38 2.19 0 CA-C-N 120.19 1.995 . . . . 65.420000000000002 113.534 0.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' HB ' ' HG3' ' A' ' 49' ' ' GLN . 92.6 t -87.77 146.11 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 123.705 0.802 . . . . 54.210000000000001 110.459 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.709 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 97.4 mtt180 -96.2 169.72 9.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 75.209999999999994 110.66 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.45 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 94.8 m95 -131.22 136.92 48.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.824 0.85 . . . . 74.140000000000001 110.168 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 59.9 m-85 -134.46 123.67 24.37 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 123.036 0.535 . . . . 74.340000000000003 110.569 174.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.1 tptp -117.93 133.74 55.63 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.002 -0.74 . . . . 73.129999999999995 109.002 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 61.29 22.31 12.69 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.808 0.843 . . . . 74.209999999999994 111.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.09 5.6 82.96 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 114.268 0.467 . . . . 53.240000000000002 114.268 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -130.66 133.95 46.54 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.901 0.851 . . . . 72.400000000000006 112.358 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.511 ' HD3' ' H ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -62.85 150.87 40.61 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 115.022 1.489 . . . . 75.420000000000002 115.022 -171.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.567 HD12 HG21 ' A' ' 40' ' ' VAL . 3.8 mm? -92.61 163.79 13.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.237 1.415 . . . . 72.25 111.024 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.65 140.04 42.46 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.555 0.742 . . . . 54.310000000000002 110.407 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.1 p -81.74 31.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.509 0.724 . . . . 54.119999999999997 112.813 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -121.87 124.97 45.36 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.03 0.932 . . . . 74.420000000000002 110.655 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.71 -100.03 0.46 Allowed Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.731 0.652 . . . . 71.140000000000001 114.731 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -52.37 -46.04 66.01 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 125.024 1.33 . . . . 74.519999999999996 113.03 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.567 HG21 HD12 ' A' ' 34' ' ' LEU . 98.9 t -116.96 143.12 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.366 -0.834 . . . . 72.420000000000002 110.616 -175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -126.0 131.02 52.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.349 1.06 . . . . 62.039999999999999 110.156 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 82.6 mt -119.66 145.15 46.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.887 0.475 . . . . 62.130000000000003 112.068 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -107.46 130.69 54.81 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.32 0.648 . . . . 74.430000000000007 109.329 166.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -106.32 103.71 13.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.826 0.851 . . . . 64.329999999999998 110.018 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.55 178.12 6.31 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.37 0.668 . . . . 74.349999999999994 111.316 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.92 -24.79 75.33 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.332 -0.395 . . . . 62.130000000000003 113.501 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.65 -55.14 0.73 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.179 0.592 . . . . 73.109999999999999 111.868 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 46.7 ttp180 -81.8 97.83 8.18 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.959 0.409 . . . . 64.040000000000006 112.053 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 39.6 mm-40 -91.65 133.72 35.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.57 -0.9 . . . . 70.25 108.57 173.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 87.8 t -121.44 115.68 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 O-C-N 122.014 -0.429 . . . . 65.519999999999996 110.894 -177.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' GLU . 2.6 tm? -95.51 129.61 42.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.153 0.981 . . . . 73.329999999999998 108.644 171.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 63.1 mtp180 -131.66 105.34 7.46 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.853 0.752 . . . . 73.319999999999993 111.334 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 51' ' ' LEU . 46.5 t -96.23 105.62 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.836 -0.801 . . . . 63.210000000000001 108.836 171.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -72.39 109.96 6.47 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.53 0.732 . . . . 63.119999999999997 112.612 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.01 48.8 1.42 Allowed Glycine 0 C--N 1.35 1.348 0 CA-C-N 116.253 -0.431 . . . . 43.219999999999999 113.472 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.11 115.13 12.07 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.466 0.706 . . . . 74.310000000000002 111.551 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -157.5 -65.48 0.09 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.586 0.754 . . . . 53.340000000000003 111.989 -176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.5 m -80.22 -70.48 0.52 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.2 0.815 . . . . 61.119999999999997 113.2 -163.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -116.31 30.14 6.65 Favored Glycine 0 N--CA 1.487 2.034 0 CA-C-O 121.075 0.264 . . . . 74.319999999999993 112.859 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.95 -6.14 43.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 52.439999999999998 112.314 -173.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.62 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -83.63 129.09 34.95 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.366 -0.605 . . . . 75.540000000000006 109.366 172.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 163.39 -174.2 39.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.121 -0.561 . . . . 45.32 114.212 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -91.53 110.65 21.97 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.107 0.563 . . . . 75.219999999999999 110.395 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.8 m-85 -95.6 113.63 25.3 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.854 0.461 . . . . 73.219999999999999 110.031 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 54.2 tp -92.85 101.77 14.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.547 0.739 . . . . 74.129999999999995 110.277 -174.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 26' ' ' ARG . 72.6 m -71.41 88.48 0.89 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.335 -0.848 . . . . 54.350000000000001 109.614 169.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.0 t70 -80.04 89.85 5.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.39 0.614 . . . . 72.430000000000007 110.599 -176.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.44 151.39 50.74 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.226 -0.897 . . . . 73.400000000000006 111.31 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.62 -21.86 73.05 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.409 2.073 . . . . 71.299999999999997 112.633 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.92 93.19 3.92 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.529 -0.915 . . . . 74.140000000000001 108.529 172.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.53 109.61 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 125.3 1.44 . . . . 72.519999999999996 113.216 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -75.93 134.34 40.26 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.873 0.869 . . . . 73.140000000000001 112.035 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -107.39 141.37 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.329 0.652 . . . . 74.430000000000007 110.962 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.5 mp -104.84 137.78 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.092 0.557 . . . . 72.140000000000001 110.289 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 7.0 m-85 -108.46 105.44 15.1 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.312 1.045 . . . . 73.209999999999994 110.861 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 95.6 mt -77.17 97.78 4.88 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.324 -0.621 . . . . 63.340000000000003 109.324 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG11 HD21 ' A' ' 12' ' ' LEU . 45.3 t -107.65 131.58 57.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.834 0.454 . . . . 72.239999999999995 111.171 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.6 m -119.6 111.62 18.3 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.116 0.567 . . . . 70.319999999999993 109.788 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.62 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 40.5 t -109.31 105.25 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.138 -1.06 . . . . 71.109999999999999 108.138 174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.59 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.523 0.935 . . . . 65.129999999999995 113.523 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 51.3 mt-10 -68.57 108.31 2.78 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.132 0.573 . . . . 74.129999999999995 110.995 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 26.4 Cg_exo . . . . . 0 C--N 1.383 2.355 0 C-N-CA 123.243 2.628 . . . . 62.229999999999997 113.879 -166.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.965 0.412 . . . . 75.010000000000005 111.414 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -76.48 156.03 33.34 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.932 0.893 . . . . 62.340000000000003 112.29 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -150.75 129.92 12.72 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.28 1.032 . . . . 72.0 109.587 172.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 99.0 t -129.67 134.75 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.724 0.81 . . . . 72.099999999999994 109.612 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.3 144.17 26.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.026 0.53 . . . . 74.540000000000006 110.865 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.483 ' HB2' HD13 ' A' ' 12' ' ' LEU . 40.4 t -125.66 153.7 43.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.021 0.928 . . . . 65.329999999999998 109.851 172.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 p -102.0 150.42 37.43 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 123.354 0.662 . . . . 73.040000000000006 111.024 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.35 96.48 0.19 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.284 2.656 . . . . 75.530000000000001 113.769 -175.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.24 38.49 4.53 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 115.673 -0.694 . . . . 65.129999999999995 113.975 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.57 168.85 22.58 Favored Glycine 0 N--CA 1.474 1.171 0 CA-C-O 120.085 -0.286 . . . . 74.310000000000002 112.547 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 54' ' ' GLN . 37.0 t70 -70.42 140.95 52.16 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.222 0.534 . . . . 71.120000000000005 111.34 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 6' ' ' SER . 64.3 tp -109.41 152.39 25.41 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.421 1.088 . . . . 52.030000000000001 109.538 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.73 130.66 19.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.393 0.677 . . . . 71.019999999999996 109.653 168.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.31 105.39 14.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.501 0.721 . . . . 50.420000000000002 109.214 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.35 120.72 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.477 0.711 . . . . 65.310000000000002 109.239 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.668 ' HB ' ' H ' ' A' ' 49' ' ' GLN . 94.5 t -107.64 131.3 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.893 0.877 . . . . 73.400000000000006 111.964 -172.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -143.28 31.33 1.37 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.222 1.009 . . . . 64.0 110.897 172.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -57.61 168.14 0.92 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.857 0.688 . . . . 72.120000000000005 112.857 169.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.3 t -89.58 31.97 0.9 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.074 0.55 . . . . 71.409999999999997 111.168 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.62 80.42 0.29 Allowed Glycine 0 CA--C 1.541 1.661 0 CA-C-O 119.367 -0.685 . . . . 75.25 112.683 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.18 175.28 11.02 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.296 2.664 . . . . 53.539999999999999 113.466 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.2 -84.78 0.6 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 116.156 -0.474 . . . . 72.5 113.028 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.28 -161.85 17.4 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.401 -0.666 . . . . 52.229999999999997 113.75 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.45 116.1 4.18 Favored 'Cis proline' 0 C--N 1.378 2.129 0 CA-C-N 119.844 1.822 . . . . 63.409999999999997 113.422 -1.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -82.34 123.33 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.787 -0.642 . . . . 71.25 109.636 177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -103.85 159.77 15.36 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.276 0.63 . . . . 52.5 111.819 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.43 ' HB3' HD23 ' A' ' 34' ' ' LEU . 86.0 m95 -115.49 137.61 51.88 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.956 0.902 . . . . 72.150000000000006 110.249 173.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 98.2 m-85 -135.29 123.33 22.77 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.381 0.672 . . . . 64.019999999999996 110.823 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 24.9 tptp -103.53 112.74 25.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.158 0.583 . . . . 72.319999999999993 110.379 176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 55.59 3.07 0.07 Allowed 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 126.12 1.768 . . . . 74.030000000000001 115.38 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.3 -27.43 1.54 Allowed Glycine 0 N--CA 1.481 1.675 0 O-C-N 121.152 -0.967 . . . . 64.450000000000003 114.738 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -113.28 147.15 38.14 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.366 1.083 . . . . 65.120000000000005 111.549 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.577 ' HD3' ' H ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -69.18 153.08 44.28 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.741 0.645 . . . . 75.329999999999998 112.741 175.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 27' ' ' TRP . 3.2 mm? -90.37 154.74 19.45 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.408 -0.815 . . . . 43.229999999999997 109.888 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.6 125.62 12.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.211 1.004 . . . . 33.310000000000002 108.671 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 p -55.4 99.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.746 0.818 . . . . 73.230000000000004 112.592 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -159.7 116.28 2.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.474 0.71 . . . . 72.430000000000007 111.62 -171.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.42 -89.88 0.06 OUTLIER Glycine 0 C--N 1.353 1.522 0 O-C-N 123.547 0.53 . . . . 51.119999999999997 113.655 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -75.27 -42.76 54.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.832 0.853 . . . . 73.120000000000005 111.601 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -76.27 106.71 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 116.116 -0.493 . . . . 74.439999999999998 110.151 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.658 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.5 mm100 -110.09 104.6 13.49 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.109 0.564 . . . . 70.400000000000006 109.625 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD21 HD23 ' A' ' 51' ' ' LEU . 84.9 mt -98.59 143.85 28.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.498 0.719 . . . . 74.329999999999998 112.098 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 40.1 tt0 -140.47 136.75 33.29 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.224 1.01 . . . . 74.319999999999993 109.01 173.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.02 106.56 9.16 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.873 0.844 . . . . 72.439999999999998 110.869 -176.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -111.76 21.5 15.98 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.428 1.091 . . . . 72.299999999999997 110.967 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.17 -87.09 0.95 Allowed Glycine 0 N--CA 1.477 1.393 0 CA-C-N 116.34 -0.391 . . . . 74.239999999999995 112.787 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.87 -40.75 18.24 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.306 0.642 . . . . 70.450000000000003 110.647 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 46.3 ttt180 -78.5 106.38 10.41 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.416 -0.811 . . . . 73.230000000000004 110.699 176.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.668 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 79.9 mm-40 -106.91 155.45 19.75 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.616 0.766 . . . . 72.420000000000002 109.587 171.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 65.1 t -135.76 117.39 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.867 0.467 . . . . 63.0 109.953 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.434 HD23 HD21 ' A' ' 42' ' ' LEU . 2.8 tm? -110.51 118.7 36.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.834 -0.802 . . . . 74.420000000000002 108.834 168.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 84.2 mtt180 -113.81 141.42 47.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.06 0.544 . . . . 75.209999999999994 110.854 175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.7 t -128.83 101.73 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.742 0.817 . . . . 65.120000000000005 108.992 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -74.23 121.73 21.72 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.051 -0.351 . . . . 73.230000000000004 110.051 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.34 36.47 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.79 -0.186 . . . . 62.409999999999997 113.291 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 90.31 0.06 Allowed 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.573 0.749 . . . . 71.319999999999993 111.362 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -88.35 -56.68 3.21 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.055 1.132 . . . . 74.109999999999999 114.055 -165.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.5 t -161.67 -58.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 122.326 0.25 . . . . 73.230000000000004 111.563 -174.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -9.96 55.03 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.485 -0.325 . . . . 63.329999999999998 113.442 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.78 -3.42 44.32 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.687 1.195 . . . . 73.409999999999997 111.973 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.67 127.5 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.509 0.724 . . . . 31.32 109.955 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.459 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . 164.59 -172.72 40.41 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 121.225 0.347 . . . . 75.299999999999997 113.695 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -87.26 111.85 21.45 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.676 0.79 . . . . 51.039999999999999 111.45 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -99.35 111.35 23.73 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.819 -0.808 . . . . 73.439999999999998 108.819 170.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.4 tp -94.09 106.63 18.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.249 1.02 . . . . 74.140000000000001 110.379 -171.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.433 ' SG ' HD21 ' A' ' 18' ' ' LEU . 42.2 t -79.89 88.06 5.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.629 0.728 . . . . 70.340000000000003 109.165 171.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -78.18 89.93 4.28 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.994 -1.003 . . . . 61.340000000000003 110.845 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -94.51 148.31 34.73 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.491 0.717 . . . . 64.140000000000001 111.264 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -55.04 -32.1 77.73 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 123.538 2.825 . . . . 55.109999999999999 114.774 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -86.81 -51.73 5.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.969 0.508 . . . . 44.32 111.592 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -149.39 126.02 11.02 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.287 0.635 . . . . 62.240000000000002 112.164 -175.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -87.08 118.93 26.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.83 0.852 . . . . 72.129999999999995 110.41 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.524 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -105.79 131.21 53.41 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.227 0.611 . . . . 74.140000000000001 111.325 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.5 mt -88.87 117.96 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.791 0.837 . . . . 60.240000000000002 109.939 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.487 ' CZ ' HG22 ' A' ' 16' ' ' VAL . 17.8 m-85 -98.58 103.63 15.6 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.831 -0.803 . . . . 65.349999999999994 108.831 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.8 mt -76.18 93.56 3.39 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.178 -0.675 . . . . 71.120000000000005 109.178 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 74.1 t -85.2 99.95 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.734 0.778 . . . . 64.530000000000001 109.748 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.4 p -95.51 108.79 21.05 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.744 -1.116 . . . . 73.129999999999995 109.937 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 6' ' ' SER . 85.6 t -82.37 106.09 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 107.682 -1.229 . . . . 54.009999999999998 107.682 173.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -156.24 -178.11 7.08 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.513 1.125 . . . . 65.409999999999997 109.888 -173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 58.25 75.06 0.56 Allowed Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.591 0.757 . . . . 61.020000000000003 110.563 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 CA--C 1.572 2.383 0 C-N-CA 123.154 2.57 . . . . 72.230000000000004 113.459 -176.69 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.457 0.17 . . . . 75.540000000000006 111.311 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 p -62.06 133.67 55.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.374 0.67 . . . . 54.119999999999997 110.124 167.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -126.63 111.74 14.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.345 0.658 . . . . 73.420000000000002 109.818 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.2 t -115.16 139.39 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.31 0.644 . . . . 65.319999999999993 111.092 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -90.05 136.05 33.28 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.64 0.776 . . . . 70.200000000000003 110.209 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 t -125.37 152.03 45.32 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.677 0.791 . . . . 74.5 110.145 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 81' ' ' GLU . 1.6 p -104.67 152.28 39.43 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 123.564 0.745 . . . . 73.230000000000004 111.752 177.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 57.1 Cg_endo -80.54 42.71 1.38 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.368 2.712 . . . . 64.310000000000002 113.747 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.73 66.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.926 0 N-CA-C 112.293 -0.323 . . . . 35.25 112.293 -173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.32 -136.3 4.12 Favored Glycine 0 N--CA 1.472 1.052 0 CA-C-O 120.164 -0.242 . . . . 73.030000000000001 112.782 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -135.47 152.57 51.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.648 0.779 . . . . 50.009999999999998 110.761 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.2 tp -89.71 146.73 24.3 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.29 0.636 . . . . 73.439999999999998 109.903 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -145.57 114.06 6.73 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.913 -0.402 . . . . 74.140000000000001 109.913 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 63.4 mt -106.82 102.02 11.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.582 0.753 . . . . 73.420000000000002 110.061 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.4 t -94.52 113.19 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.283 -1.006 . . . . 75.329999999999998 108.283 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 18' ' ' LEU . 2.9 t -100.01 146.7 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.035 0.534 . . . . 63.109999999999999 111.429 -169.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -131.86 43.71 3.0 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.461 0.705 . . . . 75.040000000000006 110.426 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.527 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.8 OUTLIER -59.19 164.59 3.04 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.018 0.747 . . . . 74.329999999999998 113.018 172.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.2 p -84.78 38.31 0.69 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.807 0.843 . . . . 53.149999999999999 112.319 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 70' ' ' GLN . . . -127.05 84.84 0.34 Allowed Glycine 0 N--CA 1.478 1.482 0 CA-C-O 119.537 -0.59 . . . . 43.32 112.502 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.41 156.77 60.95 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.079 2.519 . . . . 41.549999999999997 113.269 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.8 -119.85 11.65 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 115.908 -0.587 . . . . 65.430000000000007 113.473 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -173.74 -164.42 28.86 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-O 119.493 -0.615 . . . . 72.420000000000002 113.305 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.0 101.79 0.38 Allowed 'Cis proline' 0 CA--C 1.565 2.032 0 CA-C-N 120.096 1.948 . . . . 62.420000000000002 113.029 -3.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG23 ' HA2' ' A' ' 23' ' ' GLY . 30.7 t -79.89 123.0 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 109.817 -0.438 . . . . 62.310000000000002 109.817 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -100.68 158.41 15.97 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.558 0.743 . . . . 74.219999999999999 111.449 -171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.474 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 62.8 m95 -114.33 142.37 46.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 73.439999999999998 111.157 175.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 54.6 m-85 -135.76 160.2 39.3 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.316 1.047 . . . . 73.510000000000005 110.597 177.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.6 tptp -140.75 130.71 24.58 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.269 1.028 . . . . 71.540000000000006 109.591 165.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 57.68 27.71 14.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.268 1.027 . . . . 65.329999999999998 112.63 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 -1.13 76.17 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 115.829 -0.623 . . . . 70.200000000000003 114.507 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HG3' HH11 ' A' ' 33' ' ' ARG . 35.3 tt0 -124.78 131.04 53.49 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.325 1.063 . . . . 71.420000000000002 111.496 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.611 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.08 143.35 38.88 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.524 1.13 . . . . 74.129999999999995 113.94 -172.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.6 mt -95.62 147.54 23.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.944 0.498 . . . . 72.219999999999999 111.011 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.49 150.52 23.3 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.936 0.894 . . . . 62.310000000000002 110.402 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.9 p -76.36 77.34 3.11 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.281 0.562 . . . . 75.340000000000003 110.177 175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -76.09 -64.69 1.04 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.7 0.8 . . . . 64.439999999999998 112.488 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.36 -49.58 0.24 Allowed Glycine 0 N--CA 1.475 1.266 0 N-CA-C 112.257 -0.337 . . . . 65.109999999999999 112.257 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -81.07 -46.22 15.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.798 -0.816 . . . . 63.130000000000003 108.798 164.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -82.38 93.26 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 108.919 -0.771 . . . . 75.420000000000002 108.919 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.227 1.011 . . . . 73.319999999999993 110.788 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.9 mt -116.22 137.95 51.7 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.084 0.554 . . . . 74.439999999999998 110.69 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -122.88 114.4 20.41 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.483 -0.932 . . . . 71.049999999999997 108.483 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -103.54 104.03 14.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-O 121.76 0.79 . . . . 72.239999999999995 110.519 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.13 178.28 6.12 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.499 1.12 . . . . 71.0 110.56 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.89 95.07 0.22 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.619 -0.545 . . . . 74.510000000000005 113.212 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.55 -34.6 0.25 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.573 1.549 . . . . 73.409999999999997 113.597 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 69.9 ttp85 -85.76 94.08 9.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.5 0.667 . . . . 74.409999999999997 110.893 177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.506 ' HG3' ' SG ' ' A' ' 66' ' ' CYS . 15.7 mm100 -94.64 142.79 27.04 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.485 -0.78 . . . . 72.450000000000003 110.102 172.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 47.4 t -131.26 109.07 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.037 0.446 . . . . 64.129999999999995 111.069 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.449 HD11 HG23 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -96.7 130.9 43.84 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.381 -0.97 . . . . 74.5 108.381 169.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -128.57 108.67 10.71 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.268 0.627 . . . . 61.439999999999998 109.339 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 HD11 ' A' ' 51' ' ' LEU . 89.4 t -98.2 96.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.625 0.648 . . . . 74.319999999999993 109.868 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.06 96.83 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.204 0.602 . . . . 62.0 110.314 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.38 46.47 0.2 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.839 -0.619 . . . . 74.230000000000004 112.019 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.4 113.86 17.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.755 0.822 . . . . 52.200000000000003 110.317 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 44.1 ttt85 -161.29 -41.77 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.168 0.803 . . . . 73.519999999999996 113.168 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.2 m -129.43 -77.55 0.55 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 122.75 0.42 . . . . 64.319999999999993 111.759 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.33 -3.37 70.42 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 114.479 0.552 . . . . 44.109999999999999 114.479 -174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -67.51 -26.28 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.15 0.98 . . . . 61.539999999999999 112.501 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.28 117.56 16.23 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.638 0.375 . . . . 63.329999999999998 110.083 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.31 -171.51 41.34 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 114.196 0.438 . . . . 44.299999999999997 114.196 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -87.45 117.17 26.06 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.398 0.679 . . . . 74.129999999999995 111.277 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.572 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 77.7 m-85 -105.36 108.12 19.47 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.4 0.68 . . . . 71.409999999999997 110.096 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.1 tp -92.59 110.41 21.84 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.284 0.564 . . . . 74.019999999999996 109.924 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.506 ' SG ' ' HG3' ' A' ' 49' ' ' GLN . 37.9 t -89.1 88.06 7.42 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.846 0.858 . . . . 53.32 108.98 170.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.6 95.45 6.54 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.238 1.015 . . . . 62.409999999999997 112.473 -173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.41 137.46 30.69 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.884 0.473 . . . . 75.120000000000005 111.004 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.42 -23.51 47.48 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.319 2.679 . . . . 64.0 113.873 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.515 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 24.8 mp0 -85.58 -57.49 3.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.62 0.768 . . . . 62.130000000000003 111.096 173.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -157.0 117.11 3.51 Favored 'General case' 0 CA--C 1.563 1.445 0 N-CA-C 112.135 0.42 . . . . 74.519999999999996 112.135 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 65' ' ' LEU . 10.5 m -76.06 140.26 41.81 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.192 0.997 . . . . 64.530000000000001 112.204 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 126.86 54.63 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.672 0.789 . . . . 75.319999999999993 110.645 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 3.1 mp -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 109.417 -0.586 . . . . 55.200000000000003 109.417 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.572 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 37.8 m-85 -100.45 125.52 46.76 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.235 1.014 . . . . 74.200000000000003 110.386 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.2 mt -102.6 93.88 5.35 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.424 -0.954 . . . . 63.340000000000003 108.424 174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.04 126.77 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.638 0.775 . . . . 64.439999999999998 110.469 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.4 p -119.0 117.52 29.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.689 0.796 . . . . 74.140000000000001 110.667 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.0 t -84.82 108.14 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.048 0.452 . . . . 60.030000000000001 109.894 175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -164.61 -170.04 1.91 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.511 1.125 . . . . 73.200000000000003 109.617 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.408 ' O ' HG22 ' A' ' 7' ' ' THR . 32.3 tt0 59.84 72.81 0.72 Allowed Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.571 0.748 . . . . 72.450000000000003 110.322 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.571 2.329 0 C-N-CA 122.578 2.186 . . . . 74.239999999999995 113.357 -172.542 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.72 0.295 . . . . 71.230000000000004 111.139 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.8 m -83.59 88.71 7.03 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.806 0.842 . . . . 74.540000000000006 108.93 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -98.8 135.5 40.17 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.787 0.835 . . . . 72.450000000000003 112.14 -166.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.57 143.49 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.967 0.907 . . . . 71.329999999999998 110.233 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 ttm180 -92.21 145.23 24.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.727 0.411 . . . . 73.409999999999997 110.712 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.716 ' HB2' HD13 ' A' ' 12' ' ' LEU . 37.8 t -120.95 166.66 13.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.68 0.792 . . . . 61.310000000000002 110.081 166.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.07 138.57 21.78 Favored Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 123.069 0.548 . . . . 31.210000000000001 111.303 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 96.0 Cg_exo -47.32 117.11 2.09 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 124.13 3.22 . . . . 52.130000000000003 114.434 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.69 13.32 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 116.254 -0.43 . . . . 55.109999999999999 113.934 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.82 52.92 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 121.151 0.306 . . . . 74.549999999999997 113.456 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 5.5 p-10 -91.5 129.51 37.47 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.146 0.498 . . . . 73.420000000000002 111.463 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.716 HD13 ' HB2' ' A' ' 6' ' ' SER . 51.5 tp -74.65 150.15 39.7 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.706 0.802 . . . . 71.200000000000003 109.292 169.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.7 115.56 8.27 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.036 0.534 . . . . 65.209999999999994 109.943 170.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 76.2 mt -99.18 101.6 12.98 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.519 0.728 . . . . 71.140000000000001 109.729 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.3 t -90.36 113.02 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 108.386 -0.968 . . . . 64.510000000000005 108.386 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 47.4 t -96.72 122.11 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.242 0.544 . . . . 53.25 112.144 -165.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -120.0 70.53 0.87 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 122.06 0.933 . . . . 74.209999999999994 108.823 170.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HG ' ' CG1' ' A' ' 16' ' ' VAL . 19.7 mt -55.68 156.22 5.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.299 1.44 . . . . 73.120000000000005 113.278 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.8 m -77.72 -33.53 52.98 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.4 -0.818 . . . . 62.450000000000003 110.665 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.486 ' HA3' ' NE2' ' A' ' 70' ' ' GLN . . . -141.37 79.86 0.27 Allowed Glycine 0 CA--C 1.541 1.67 0 CA-C-N 115.853 -0.612 . . . . 73.430000000000007 112.123 175.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.8 -167.93 0.54 Allowed 'Trans proline' 0 CA--C 1.555 1.564 0 C-N-CA 122.983 2.456 . . . . 44.240000000000002 114.007 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.97 -169.72 42.67 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.635 -0.711 . . . . 42.119999999999997 112.595 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.99 136.61 5.65 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.355 -0.692 . . . . 45.200000000000003 112.911 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.86 162.97 84.0 Favored 'Cis proline' 0 C--N 1.381 2.257 0 CA-C-N 120.032 1.916 . . . . 50.119999999999997 113.489 -6.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.566 HG11 ' SG ' ' A' ' 66' ' ' CYS . 53.9 t -115.09 134.57 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.926 0.89 . . . . 72.239999999999995 110.321 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -97.6 131.77 43.87 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.827 0.851 . . . . 72.200000000000003 110.643 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -103.2 137.29 41.55 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.796 0.839 . . . . 74.200000000000003 111.605 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.7 m-85 -130.51 124.04 31.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.695 0.798 . . . . 73.120000000000005 110.316 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB3' HD21 ' A' ' 34' ' ' LEU . 18.7 tptm -104.4 120.26 40.81 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 73.239999999999995 109.231 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.44 22.45 13.25 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.113 0.965 . . . . 75.120000000000005 111.216 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.17 -26.5 22.8 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.841 -0.618 . . . . 53.509999999999998 113.724 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.15 129.96 44.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.431 0.692 . . . . 63.32 110.805 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 152.55 16.14 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.888 0.875 . . . . 70.430000000000007 112.953 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 29' ' ' LYS . 28.6 mt -107.71 138.74 43.4 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.886 0.474 . . . . 72.310000000000002 111.293 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 144.8 29.07 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.773 0.829 . . . . 42.310000000000002 111.089 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -71.76 92.68 1.22 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.658 0.783 . . . . 51.420000000000002 111.678 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -131.02 -167.62 1.87 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.455 0.702 . . . . 74.230000000000004 112.309 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.03 -57.21 21.06 Favored Glycine 0 C--N 1.36 1.87 0 N-CA-C 115.078 0.791 . . . . 71.239999999999995 115.078 -172.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -77.4 -40.71 42.65 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.812 0.445 . . . . 62.119999999999997 111.544 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 54.7 t -95.41 85.6 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 123.425 0.69 . . . . 70.340000000000003 110.541 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -92.79 125.11 37.24 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 122.995 0.518 . . . . 74.430000000000007 112.145 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.34 93.38 4.5 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.522 0.729 . . . . 63.039999999999999 111.049 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.756 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 37.0 tt0 -87.57 105.48 17.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.778 0.831 . . . . 70.400000000000006 110.566 173.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.22 110.04 21.8 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.226 0.61 . . . . 74.420000000000002 110.506 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.16 -45.65 5.08 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.428 0.691 . . . . 63.439999999999998 111.254 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.09 -91.1 0.12 Allowed Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.534 -0.626 . . . . 73.099999999999994 111.534 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.84 -38.55 64.48 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.615 0.721 . . . . 70.510000000000005 109.913 169.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -81.19 125.89 30.83 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.417 -1.265 . . . . 74.140000000000001 110.431 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' H ' ' HB ' ' A' ' 16' ' ' VAL . 83.4 mm-40 -117.49 152.42 35.09 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.898 -1.149 . . . . 54.439999999999998 107.898 164.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t -138.71 116.24 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 122.671 0.388 . . . . 72.439999999999998 110.617 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -107.47 128.48 54.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.554 0.742 . . . . 60.25 109.28 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 57.4 mtt180 -116.3 136.73 52.74 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.91 0.884 . . . . 72.409999999999997 110.393 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.26 97.57 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.298 0.639 . . . . 74.5 109.532 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -75.2 130.01 38.45 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 109.942 -0.392 . . . . 73.239999999999995 109.942 178.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.56 23.43 39.69 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.485 -0.325 . . . . 71.340000000000003 112.868 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.6 99.23 0.42 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.496 0.718 . . . . 74.150000000000006 110.221 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.632 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 63.9 mtp85 -104.9 -177.28 3.32 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.588 0.755 . . . . 73.310000000000002 112.113 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.0 m -62.57 108.68 1.19 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.299 0.64 . . . . 64.409999999999997 110.896 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.62 -15.36 8.02 Favored Glycine 0 N--CA 1.481 1.634 0 CA-C-N 116.233 -0.439 . . . . 53.329999999999998 112.88 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.43 -12.08 59.99 Favored 'General case' 0 CA--C 1.561 1.404 0 C-N-CA 123.991 0.917 . . . . 73.209999999999994 111.809 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.621 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -63.61 92.36 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.557 1.143 . . . . 73.409999999999997 111.545 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.13 -179.93 20.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.488 -0.778 . . . . 60.109999999999999 113.511 -173.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.33 124.89 31.06 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.109 0.564 . . . . 72.519999999999996 111.24 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 71.0 m-85 -112.9 108.65 17.68 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.177 0.991 . . . . 75.109999999999999 109.51 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 65.4 tp -91.14 103.41 16.1 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.952 -0.467 . . . . 72.409999999999997 110.364 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.566 ' SG ' HG11 ' A' ' 25' ' ' VAL . 40.5 t -77.67 86.91 3.96 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.682 0.753 . . . . 71.25 109.316 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.01 97.02 9.05 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.019 -0.991 . . . . 43.210000000000001 110.747 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.57 159.37 46.9 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 122.96 0.504 . . . . 70.400000000000006 111.039 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.94 36.21 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.635 2.223 . . . . 72.019999999999996 113.596 173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.486 ' NE2' ' HA3' ' A' ' 20' ' ' GLY . 0.4 OUTLIER -165.47 -54.33 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.14 0.576 . . . . 74.530000000000001 109.641 -176.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -138.58 108.73 6.41 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.848 0.859 . . . . 64.519999999999996 110.862 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 p -93.38 124.05 37.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.88 0.872 . . . . 70.030000000000001 110.985 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.83 139.22 48.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.794 0.437 . . . . 71.209999999999994 112.107 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.5 mt -89.04 130.82 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 109.478 -0.564 . . . . 62.109999999999999 109.478 170.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 3.0 m-85 -103.75 103.39 13.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.452 0.701 . . . . 74.420000000000002 109.333 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.7 mt -80.42 93.05 5.93 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.725 -0.843 . . . . 75.209999999999994 108.725 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -91.13 127.86 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.084 0.554 . . . . 63.43 111.014 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.8 p -107.08 108.77 20.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.147 0.579 . . . . 70.040000000000006 109.918 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 6' ' ' SER . 22.2 t -98.45 106.36 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.073 -0.714 . . . . 72.129999999999995 109.073 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -168.56 172.89 7.8 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.692 0.397 . . . . 72.230000000000004 111.992 -171.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 58.56 86.85 0.15 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 124.577 1.151 . . . . 73.549999999999997 110.85 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.574 2.491 0 C-N-CA 122.817 2.345 . . . . 36.5 114.034 -173.206 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 tpp . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.603 -0.517 . . . . 54.439999999999998 109.603 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -62.37 127.24 30.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.22 0.608 . . . . 54.310000000000002 110.946 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -137.77 126.85 24.32 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.776 0.831 . . . . 74.049999999999997 109.982 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.1 131.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 121.423 0.63 . . . . 65.409999999999997 111.808 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.439 ' NH2' ' HB2' ' A' ' 81' ' ' GLU . 60.3 ttt85 -90.38 139.73 30.39 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.789 1.236 . . . . 74.519999999999996 110.054 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.549 ' HB3' HG22 ' A' ' 79' ' ' VAL . 34.1 t -137.69 172.0 13.6 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.121 0.568 . . . . 74.25 110.613 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 p -130.81 148.16 69.06 Favored Pre-proline 0 N--CA 1.486 1.358 0 C-N-CA 123.873 0.869 . . . . 74.129999999999995 111.214 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.33 145.88 39.18 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.637 2.225 . . . . 75.010000000000005 112.659 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.77 37.29 8.68 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 116.049 -0.523 . . . . 33.420000000000002 113.931 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.23 -134.67 1.7 Allowed Glycine 0 N--CA 1.475 1.275 0 CA-C-O 119.972 -0.349 . . . . 61.409999999999997 112.675 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -137.24 155.43 49.5 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 117.275 0.538 . . . . 72.400000000000006 111.18 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.11 143.18 32.25 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.505 1.122 . . . . 73.200000000000003 109.185 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.81 99.0 3.51 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.107 0.48 . . . . 64.400000000000006 111.267 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 51' ' ' LEU . 49.0 mt -92.23 105.53 17.72 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.106 0.962 . . . . 64.409999999999997 110.732 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 36.2 t -103.58 127.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 109.902 -0.407 . . . . 73.430000000000007 109.902 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 66' ' ' CYS . 3.4 m -108.3 149.93 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.412 0.685 . . . . 75.219999999999999 111.693 175.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -128.36 31.41 5.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.104 0.962 . . . . 75.109999999999999 109.444 163.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' HG ' ' HB ' ' A' ' 16' ' ' VAL . 1.2 pp -51.69 166.02 0.15 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 113.89 1.07 . . . . 42.030000000000001 113.89 173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -86.64 32.86 0.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.338 0.655 . . . . 74.129999999999995 112.756 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.586 ' HA3' ' HB1' ' A' ' 68' ' ' ALA . . . -112.39 90.11 0.55 Allowed Glycine 0 CA--C 1.544 1.888 0 CA-C-O 119.506 -0.608 . . . . 64.109999999999999 112.654 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.19 165.4 23.73 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.116 2.544 . . . . 73.319999999999993 113.237 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.87 -86.23 0.17 Allowed Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.879 -0.601 . . . . 42.450000000000003 113.62 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 -127.07 8.56 Favored Glycine 0 CA--C 1.546 1.982 0 CA-C-O 118.782 -1.01 . . . . 52.409999999999997 114.028 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.28 117.44 2.67 Favored 'Cis proline' 0 C--N 1.386 2.505 0 CA-C-N 120.828 2.314 . . . . 71.129999999999995 113.635 1.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.501 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 91.3 t -65.24 124.05 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.706 -0.679 . . . . 72.409999999999997 110.084 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 89.0 mtm180 -94.89 164.43 12.92 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.511 0.725 . . . . 71.299999999999997 111.003 -171.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -120.81 134.96 55.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.96 0.904 . . . . 74.439999999999998 109.716 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.9 m-85 -122.1 162.53 21.08 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.244 1.018 . . . . 74.420000000000002 110.791 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.6 tptp -154.32 128.33 8.9 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.425 1.09 . . . . 72.409999999999997 108.929 169.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 64.72 17.3 10.88 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.011 0.924 . . . . 74.030000000000001 111.988 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.47 -7.14 81.9 Favored Glycine 0 CA--C 1.541 1.69 0 CA-C-N 116.534 -0.303 . . . . 71.420000000000002 113.726 -173.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -109.31 121.58 45.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.713 0.805 . . . . 70.409999999999997 110.444 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.7 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -65.9 143.58 57.34 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.732 0.642 . . . . 75.319999999999993 112.732 -175.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.572 HD21 ' HB3' ' A' ' 29' ' ' LYS . 29.2 mt -87.49 152.62 22.07 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.291 1.037 . . . . 74.450000000000003 110.988 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.42 158.85 20.12 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.835 0.854 . . . . 65.219999999999999 110.343 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -70.62 82.8 0.6 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.789 0.804 . . . . 62.049999999999997 110.954 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -96.78 170.47 9.16 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.104 1.362 . . . . 75.310000000000002 110.509 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.15 -43.25 93.47 Favored Glycine 0 C--N 1.354 1.581 0 C-N-CA 122.544 0.116 . . . . 73.430000000000007 113.348 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.26 -53.6 13.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.935 0.494 . . . . 75.310000000000002 110.708 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 34' ' ' LEU . 59.7 t -88.17 90.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 124.138 0.975 . . . . 73.430000000000007 112.03 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.628 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.2 mt-30 -82.32 114.89 21.1 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.45 0.7 . . . . 71.239999999999995 110.379 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.411 ' HB3' HE22 ' A' ' 44' ' ' GLN . 29.1 mt -110.06 104.36 13.22 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.203 0.601 . . . . 53.530000000000001 111.76 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.81 98.55 11.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.925 0.89 . . . . 70.540000000000006 110.559 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.411 HE22 ' HB3' ' A' ' 42' ' ' LEU . 23.4 mp0 -99.92 132.02 45.53 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.364 0.666 . . . . 75.310000000000002 110.994 172.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.26 -49.0 0.11 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.97 0.908 . . . . 52.25 110.415 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.98 122.15 1.52 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-O 119.045 -0.864 . . . . 63.109999999999999 111.155 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 69.21 -65.58 0.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.944 1.297 . . . . 63.240000000000002 112.288 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 ttp180 -79.07 95.91 5.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.866 0.466 . . . . 72.430000000000007 110.806 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 8.6 mm100 -116.49 136.95 52.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.753 0.821 . . . . 75.530000000000001 109.458 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG12 ' HG3' ' A' ' 52' ' ' ARG . 36.0 t -121.52 124.24 71.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.152 0.501 . . . . 65.420000000000002 111.18 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.67 120.36 40.76 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 52.539999999999999 108.562 168.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 73.6 mtp180 -119.61 107.91 13.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.944 0.498 . . . . 72.239999999999995 110.094 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -96.42 100.96 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 122.943 0.497 . . . . 62.210000000000001 110.005 174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -71.79 103.09 3.01 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.936 0.494 . . . . 73.219999999999999 109.975 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.39 42.51 0.25 Allowed Glycine 0 N--CA 1.474 1.198 0 CA-C-N 116.293 -0.412 . . . . 74.219999999999999 112.695 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.44 131.5 49.4 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.007 0.523 . . . . 71.409999999999997 110.642 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttm-85 -163.56 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.232 0.827 . . . . 74.409999999999997 113.232 -167.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 m -159.07 -56.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 123.273 0.629 . . . . 33.140000000000001 111.305 -171.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.0 -20.59 70.92 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 114.069 0.388 . . . . 61.130000000000003 114.069 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -81.46 -16.0 53.32 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.146 0.978 . . . . 62.450000000000003 111.193 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 79' ' ' VAL . . . -74.13 111.57 9.42 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.88 0.472 . . . . 72.129999999999995 109.737 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.2 -171.9 44.78 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 114.081 0.393 . . . . 72.540000000000006 114.081 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -81.25 113.46 19.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.391 0.676 . . . . 70.209999999999994 110.941 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 32.8 m-85 -95.36 155.95 16.53 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.994 0.918 . . . . 74.430000000000007 109.334 167.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 53.9 tp -133.57 104.89 6.58 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.135 -0.353 . . . . 72.200000000000003 110.075 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 16' ' ' VAL . 34.4 t -74.99 89.35 2.4 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.883 . . . . 74.25 108.617 169.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 22.5 t70 -74.86 92.09 2.5 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.659 1.184 . . . . 62.009999999999998 111.582 -173.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB1' ' HA3' ' A' ' 20' ' ' GLY . . . -96.05 148.4 34.46 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.256 0.623 . . . . 70.349999999999994 111.355 177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -64.42 -21.75 66.2 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.985 2.457 . . . . 73.409999999999997 113.625 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.525 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 86.1 mm-40 -112.57 -51.44 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.25 0.62 . . . . 74.129999999999995 112.147 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.45 97.41 3.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.728 0.411 . . . . 74.019999999999996 111.467 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.4 p -85.09 141.9 29.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.298 0.639 . . . . 75.219999999999999 110.706 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -130.26 131.97 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.055 0.542 . . . . 71.209999999999994 112.191 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.73 131.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.506 1.122 . . . . 71.230000000000004 109.93 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 39.8 m-85 -100.79 111.26 23.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.388 0.675 . . . . 73.109999999999999 110.772 174.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.33 93.56 7.18 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 107.786 -1.19 . . . . 71.239999999999995 107.786 167.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.0 119.94 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.126 0.57 . . . . 72.439999999999998 110.684 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.1 p -118.4 112.22 19.71 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.526 0.731 . . . . 55.219999999999999 110.411 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 6' ' ' SER . 44.7 t -86.08 107.21 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-O 121.287 0.565 . . . . 72.400000000000006 109.492 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.4 -171.21 2.54 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.637 1.175 . . . . 64.129999999999995 110.103 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HB2' ' NH2' ' A' ' 5' ' ' ARG . 31.2 tt0 60.09 63.41 3.08 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 124.056 0.942 . . . . 65.239999999999995 111.944 166.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.574 2.519 0 C-N-CA 122.69 2.26 . . . . 71.400000000000006 114.491 -166.157 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.869 0.366 . . . . 71.319999999999993 111.206 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -83.72 85.89 7.22 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.935 0.894 . . . . 43.450000000000003 110.37 -170.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.587 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 40.6 mtm180 -84.53 144.74 28.48 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.772 0.829 . . . . 70.299999999999997 112.098 -170.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 74.9 t -139.58 133.83 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.175 0.99 . . . . 74.420000000000002 110.604 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -101.14 145.86 28.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.504 0.722 . . . . 70.209999999999994 110.85 171.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.2 t -138.86 163.25 32.76 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.064 0.546 . . . . 73.150000000000006 111.65 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 81' ' ' GLU . 23.7 p -98.24 146.04 30.86 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 123.676 0.79 . . . . 72.040000000000006 111.608 174.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.16 92.07 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.051 2.5 . . . . 62.140000000000001 112.022 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.16 -14.92 5.38 Favored Glycine 0 N--CA 1.477 1.399 0 CA-C-N 115.617 -0.719 . . . . 35.340000000000003 113.24 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.71 149.34 18.52 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-O 119.504 -0.609 . . . . 74.030000000000001 112.066 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -68.02 131.09 44.83 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.845 0.823 . . . . 75.420000000000002 111.74 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 77' ' ' VAL . 55.6 tp -78.83 98.28 6.27 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.778 -0.646 . . . . 61.530000000000001 109.747 172.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -101.51 109.67 21.53 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 110.077 -0.342 . . . . 74.150000000000006 110.077 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.1 mt -93.0 103.5 15.8 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.311 -0.626 . . . . 63.25 109.311 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.1 t -92.43 101.45 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 108.769 -0.826 . . . . 73.319999999999993 108.769 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.54 HG12 ' HG ' ' A' ' 18' ' ' LEU . 12.1 t -101.63 130.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.166 0.586 . . . . 54.219999999999999 111.565 -168.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -141.0 45.58 1.77 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.752 0.821 . . . . 43.229999999999997 110.753 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.54 ' HG ' HG12 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.4 178.04 0.11 Allowed 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 113.479 0.918 . . . . 52.409999999999997 113.479 169.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 m -87.41 24.5 1.62 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 123.615 0.766 . . . . 73.049999999999997 112.534 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.24 90.85 0.55 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 119.395 -0.669 . . . . 43.420000000000002 112.197 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.38 127.95 14.79 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.031 2.487 . . . . 73.209999999999994 113.547 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 -111.59 4.3 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.353 -0.385 . . . . 72.430000000000007 113.319 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.69 -82.99 0.31 Allowed Glycine 0 CA--C 1.547 2.061 0 CA-C-O 119.121 -0.822 . . . . 71.400000000000006 113.744 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HG2' HH22 ' A' ' 26' ' ' ARG . 90.7 Cg_endo -73.99 148.16 91.28 Favored 'Cis proline' 0 C--N 1.382 2.308 0 CA-C-N 120.778 2.289 . . . . 54.32 113.041 1.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.633 HG11 ' SG ' ' A' ' 66' ' ' CYS . 86.9 t -62.63 136.92 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.57 0.748 . . . . 73.420000000000002 111.681 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.536 HH22 ' HG2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -97.73 128.98 44.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.421 0.688 . . . . 74.099999999999994 109.762 -177.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -97.57 136.41 38.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.107 0.563 . . . . 65.409999999999997 111.102 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.678 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 88.0 m-85 -133.14 147.97 52.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.028 0.931 . . . . 74.200000000000003 110.516 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 28.3 tptp -136.36 133.38 36.74 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.422 1.089 . . . . 72.5 108.945 165.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 64.85 17.62 11.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.217 1.007 . . . . 63.329999999999998 112.259 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.86 2.01 86.69 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 113.753 0.261 . . . . 71.299999999999997 113.753 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -117.05 135.11 53.97 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.436 0.694 . . . . 71.409999999999997 109.777 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.85 151.86 17.11 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 113.257 0.836 . . . . 63.549999999999997 113.257 -176.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 29' ' ' LYS . 21.5 mt -98.18 163.59 12.67 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.347 0.594 . . . . 64.340000000000003 111.204 171.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.53 151.9 49.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.128 0.971 . . . . 64.319999999999993 109.729 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 77.6 p -79.29 98.39 6.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.843 0.457 . . . . 73.040000000000006 110.687 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -102.75 -78.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.95 -0.469 . . . . 54.119999999999997 110.925 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.42 -59.66 0.01 OUTLIER Glycine 0 N--CA 1.472 1.071 0 N-CA-C 111.563 -0.615 . . . . 72.400000000000006 111.563 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -70.04 -44.28 69.54 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.247 0.619 . . . . 71.540000000000006 110.412 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.7 t -82.53 99.03 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.237 0.615 . . . . 70.25 109.428 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.3 mt-30 -95.2 110.6 22.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.538 0.735 . . . . 74.310000000000002 110.148 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 36' ' ' SER . 54.9 mt -106.31 111.99 24.82 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.914 0.486 . . . . 63.229999999999997 111.206 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.4 tp10 -94.98 106.29 18.27 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.659 1.184 . . . . 64.340000000000003 110.098 175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -91.35 103.76 16.37 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.939 0.496 . . . . 54.539999999999999 109.926 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 48' ' ' ARG . . . -125.02 -164.03 1.24 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.385 0.674 . . . . 73.510000000000005 110.595 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.67 -89.29 0.14 Allowed Glycine 0 C--N 1.353 1.503 0 N-CA-C 112.586 -0.206 . . . . 34.520000000000003 112.586 172.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.36 -27.35 24.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.367 0.667 . . . . 70.450000000000003 112.102 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 62.6 ttp180 -90.04 87.99 7.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.332 0.653 . . . . 60.409999999999997 111.669 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -91.75 129.2 37.76 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.462 -0.57 . . . . 74.510000000000005 109.462 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 33.5 t -130.31 110.92 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-O 120.811 0.339 . . . . 54.439999999999998 111.582 -177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -100.25 113.86 26.86 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.775 0.83 . . . . 71.439999999999998 108.807 168.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 72.5 mtp180 -111.34 107.77 17.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.029 0.532 . . . . 75.340000000000003 110.404 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 57.6 t -88.0 95.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.22 -0.659 . . . . 64.25 109.22 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.24 121.29 9.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.763 0.825 . . . . 60.119999999999997 112.241 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.05 60.35 8.14 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 123.205 0.316 . . . . 73.109999999999999 113.636 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.98 110.55 14.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.523 0.729 . . . . 74.209999999999994 112.623 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.49 -171.75 3.7 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.368 0.667 . . . . 74.439999999999998 111.26 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m -61.66 -26.28 67.92 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.991 0.737 . . . . 62.100000000000001 112.991 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.92 73.28 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.565 -0.289 . . . . 54.119999999999997 113.761 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -90.15 0.1 57.34 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.038 0.935 . . . . 74.239999999999995 112.35 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -77.33 101.32 6.26 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.178 0.591 . . . . 52.219999999999999 109.912 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.43 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -167.62 -175.25 37.34 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 114.228 0.451 . . . . 60.439999999999998 114.228 -173.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -89.21 108.86 19.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.122 0.569 . . . . 72.439999999999998 110.575 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -98.62 112.32 24.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.397 0.679 . . . . 73.129999999999995 109.758 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 38.1 tp -91.43 104.34 16.86 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.457 0.646 . . . . 63.310000000000002 110.336 -174.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.633 ' SG ' HG11 ' A' ' 25' ' ' VAL . 51.3 t -85.7 86.33 7.37 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.738 -0.838 . . . . 54.049999999999997 108.738 170.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.09 105.88 13.54 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.299 -0.864 . . . . 55.229999999999997 110.204 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -113.9 160.33 32.58 Favored Pre-proline 0 N--CA 1.483 1.211 0 C-N-CA 123.285 0.634 . . . . 32.119999999999997 111.959 -174.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.78 120.45 8.36 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.587 2.192 . . . . 74.329999999999998 112.351 175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 75.53 -60.92 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.526 1.53 . . . . 74.209999999999994 112.387 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 38.4 t70 -105.68 98.91 8.54 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.282 0.633 . . . . 73.430000000000007 111.872 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.7 t -95.01 129.52 42.05 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.921 0.889 . . . . 73.430000000000007 111.196 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -119.03 131.05 55.95 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.412 0.685 . . . . 50.329999999999998 112.344 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.46 135.55 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.857 -0.794 . . . . 61.350000000000001 108.857 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.414 ' CZ ' HG22 ' A' ' 16' ' ' VAL . 4.8 m-85 -106.2 103.39 12.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.512 0.725 . . . . 71.030000000000001 109.747 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.587 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 78.9 mt -78.08 92.87 4.42 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.944 -0.761 . . . . 62.310000000000002 108.944 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.507 HG21 HD21 ' A' ' 12' ' ' LEU . 55.6 t -87.77 132.88 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.554 -0.748 . . . . 71.349999999999994 110.774 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.0 m -134.56 109.23 8.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.618 -0.719 . . . . 75.230000000000004 110.798 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.409 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 76.6 t -89.08 106.75 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 107.985 -1.117 . . . . 64.349999999999994 107.985 173.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.57 12.06 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 113.565 0.95 . . . . 64.549999999999997 113.565 -167.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' HG22 ' A' ' 7' ' ' THR . 34.7 tt0 -125.71 100.4 31.32 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.781 -0.628 . . . . 74.510000000000005 109.55 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 CA--C 1.568 2.18 0 C-N-CA 123.43 2.753 . . . . 71.310000000000002 114.255 -178.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.561 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 49.7 tpp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.135 -0.321 . . . . 42.43 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 p -65.22 93.09 0.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.37 0.668 . . . . 45.409999999999997 112.045 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -90.93 129.57 36.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.249 0.62 . . . . 71.030000000000001 110.344 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 78.0 t -131.27 138.34 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 124.062 0.945 . . . . 63.32 110.007 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -106.45 130.28 54.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.206 0.602 . . . . 71.420000000000002 110.82 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.438 ' HB3' HG22 ' A' ' 79' ' ' VAL . 37.0 t -112.99 171.76 7.34 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.636 0.774 . . . . 51.329999999999998 111.626 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 81' ' ' GLU . 22.5 p -120.81 138.2 27.37 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 113.453 0.909 . . . . 62.130000000000003 113.453 -171.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.8 Cg_endo -77.49 91.09 1.2 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.605 2.87 . . . . 74.510000000000005 112.734 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.74 -13.58 8.65 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.221 -0.9 . . . . 71.209999999999994 112.23 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.81 -137.39 8.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-O 120.495 -0.058 . . . . 63.119999999999997 113.015 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -149.88 150.71 32.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.243 0.617 . . . . 71.400000000000006 111.135 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.88 148.24 23.96 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.527 0.731 . . . . 74.340000000000003 110.795 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.01 109.73 5.01 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.453 0.701 . . . . 74.519999999999996 110.043 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 79.7 mt -106.48 101.58 11.03 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.384 -0.599 . . . . 73.239999999999995 109.384 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.6 114.81 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.724 -0.843 . . . . 70.310000000000002 108.724 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.48 HG12 ' HG ' ' A' ' 18' ' ' LEU . 6.9 t -103.24 138.97 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 111.576 -166.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -132.23 30.07 4.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.549 0.74 . . . . 63.130000000000003 110.917 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.48 ' HG ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -54.77 158.89 2.45 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.193 0.812 . . . . 72.439999999999998 113.193 171.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -90.83 48.31 1.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.175 0.59 . . . . 73.239999999999995 111.093 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.91 128.25 8.37 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 118.983 -0.898 . . . . 73.030000000000001 112.69 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.34 89.92 0.26 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.991 2.461 . . . . 74.150000000000006 113.753 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.49 -84.15 0.1 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 115.905 -0.589 . . . . 75.510000000000005 114.346 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.41 -173.68 44.79 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.631 -0.538 . . . . 72.340000000000003 113.269 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.33 114.33 3.29 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 119.586 1.693 . . . . 65.420000000000002 112.814 -4.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.67 120.93 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 109.369 -0.604 . . . . 71.140000000000001 109.369 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 50.0 mtt180 -95.38 164.99 12.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.386 1.074 . . . . 73.319999999999993 110.904 -173.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -128.46 130.67 47.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.052 0.941 . . . . 72.400000000000006 109.985 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.784 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 97.9 m-85 -123.35 164.64 18.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.754 0.822 . . . . 75.400000000000006 110.81 176.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 19.3 tptm -154.3 125.64 7.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.566 0.746 . . . . 70.019999999999996 110.05 174.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.9 t70 63.09 17.15 9.92 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 124.187 0.995 . . . . 71.200000000000003 111.333 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.06 -31.07 5.44 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.752 -0.471 . . . . 72.239999999999995 114.237 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -130.32 147.06 51.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 118.091 0.946 . . . . 74.209999999999994 112.614 -170.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.784 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.93 153.03 30.39 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.249 1.574 . . . . 74.319999999999993 115.249 -167.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.5 154.94 18.13 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.753 0.821 . . . . 73.319999999999993 111.17 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.82 148.54 51.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.421 1.088 . . . . 64.349999999999994 109.021 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.0 t -58.78 97.48 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.383 0.673 . . . . 61.219999999999999 110.747 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -136.05 84.23 2.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.753 0.821 . . . . 63.210000000000001 110.732 -172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.77 -88.65 0.02 OUTLIER Glycine 0 N--CA 1.478 1.467 0 CA-C-N 115.336 -0.847 . . . . 61.119999999999997 114.424 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.3 mtm-85 -61.03 -43.63 98.6 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.253 1.021 . . . . 72.329999999999998 111.003 174.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.03 104.83 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.382 0.673 . . . . 64.319999999999993 109.672 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 74.1 mt-30 -109.86 119.3 38.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.13 0.972 . . . . 75.329999999999998 110.354 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.65 137.38 46.69 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.469 0.707 . . . . 63.32 112.013 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.661 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 15.2 tp10 -133.36 102.3 5.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.534 1.134 . . . . 74.200000000000003 109.369 175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -101.9 104.05 14.75 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.421 0.629 . . . . 65.219999999999999 111.361 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.15 75.74 1.64 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.61 0.764 . . . . 75.239999999999995 110.331 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.58 -117.15 6.93 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 115.877 -0.601 . . . . 64.310000000000002 112.783 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.85 -21.99 27.78 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.45 0.7 . . . . 63.140000000000001 111.125 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.92 91.0 1.5 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.743 0.817 . . . . 73.510000000000005 110.155 174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -102.93 139.14 38.88 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.616 0.767 . . . . 54.509999999999998 110.068 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 99.7 t -129.16 124.91 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-O 120.841 0.353 . . . . 54.350000000000001 110.664 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -117.09 122.91 45.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.09 0.956 . . . . 75.109999999999999 108.66 170.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB3' HH11 ' A' ' 52' ' ' ARG . 0.8 OUTLIER -119.57 134.84 55.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.493 0.717 . . . . 74.310000000000002 109.972 176.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.46 98.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 109.097 -0.705 . . . . 63.43 109.097 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.74 115.39 16.46 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.61 -0.723 . . . . 63.32 110.846 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.18 52.95 1.3 Allowed Glycine 0 CA--C 1.533 1.189 0 CA-C-O 120.881 0.156 . . . . 75.209999999999994 113.089 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.32 160.89 30.47 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.666 0.786 . . . . 72.099999999999994 111.794 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 29.9 ttm180 -166.97 -55.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.991 0.516 . . . . 73.329999999999998 111.495 174.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -147.64 -47.43 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 122.855 0.462 . . . . 74.219999999999999 111.382 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.48 -17.13 59.43 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 114.778 0.671 . . . . 42.229999999999997 114.778 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.407 ' HB3' HG21 ' A' ' 79' ' ' VAL . 30.7 t70 -72.22 -27.48 62.56 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.024 0.93 . . . . 72.019999999999996 112.186 174.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -72.95 103.74 3.85 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 72.299999999999997 111.514 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . -177.0 -173.5 42.61 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.85 -0.614 . . . . 74.25 113.659 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -90.58 117.13 29.01 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.78 0.432 . . . . 72.209999999999994 110.039 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 66.8 m-85 -102.27 106.33 17.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.879 0.872 . . . . 73.319999999999993 110.55 175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 63.4 tp -91.94 102.08 14.64 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.028 -0.42 . . . . 72.030000000000001 110.242 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 37.2 t -79.34 87.18 5.02 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.771 -0.826 . . . . 73.230000000000004 108.771 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 17.5 t70 -76.04 130.54 38.53 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.764 0.826 . . . . 65.530000000000001 111.275 -173.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.599 ' HB3' ' H ' ' A' ' 72' ' ' SER . . . -127.77 143.83 49.04 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 118.664 -0.684 . . . . 61.329999999999998 110.393 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.56 -29.49 7.51 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 124.248 3.299 . . . . 73.439999999999998 115.099 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -152.32 66.74 0.83 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.632 0.773 . . . . 74.109999999999999 109.494 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 28.9 t70 -172.42 -80.2 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 123.917 0.887 . . . . 71.129999999999995 110.709 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.599 ' H ' ' HB3' ' A' ' 68' ' ' ALA . 40.0 m 65.46 106.24 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.052 1.341 . . . . 71.109999999999999 112.548 -174.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.15 135.15 49.17 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.818 0.847 . . . . 72.409999999999997 110.938 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.561 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 64.6 mt -100.96 119.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.961 0.504 . . . . 71.200000000000003 110.804 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 2' ' ' THR . 29.3 m-85 -100.34 101.81 12.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.286 0.634 . . . . 72.340000000000003 110.631 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.0 mt -81.88 93.84 6.97 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.317 -0.623 . . . . 73.430000000000007 109.317 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 75.5 t -98.12 121.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.69 0.796 . . . . 50.329999999999998 111.269 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.2 p -121.46 116.64 25.1 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.449 0.7 . . . . 73.409999999999997 111.371 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.9 t -83.81 110.6 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 109.316 -0.624 . . . . 73.400000000000006 109.316 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -151.57 -41.63 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.589 0.588 . . . . 65.010000000000005 112.589 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.505 ' O ' HG22 ' A' ' 7' ' ' THR . 10.8 tp10 -66.8 106.03 1.03 Allowed Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.93 0.892 . . . . 73.219999999999999 110.607 -175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo . . . . . 0 CA--C 1.57 2.295 0 C-N-CA 123.078 2.519 . . . . 74.409999999999997 113.747 -172.759 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 110.158 -0.312 . . . . 65.510000000000005 110.158 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.1 m -80.38 83.92 6.12 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.536 0.735 . . . . 75.400000000000006 110.061 -177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.594 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 55.4 mtm180 -83.67 140.41 32.17 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.548 0.739 . . . . 74.040000000000006 112.342 -172.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.01 144.0 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.06 0.944 . . . . 71.140000000000001 109.97 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.94 145.28 51.98 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.455 0.702 . . . . 65.219999999999999 110.848 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.7 t -146.85 171.66 14.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.907 0.883 . . . . 73.099999999999994 110.31 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -76.03 148.87 82.02 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 112.982 0.734 . . . . 71.420000000000002 112.982 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.16 110.87 3.19 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.391 2.727 . . . . 73.400000000000006 112.907 -174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.47 -7.73 43.29 Favored Glycine 0 N--CA 1.473 1.135 0 CA-C-N 115.318 -0.855 . . . . 73.140000000000001 112.981 -176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.67 -156.67 31.53 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 122.767 0.222 . . . . 64.200000000000003 113.174 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.99 164.41 23.48 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.874 0.47 . . . . 61.439999999999998 110.502 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.494 HD21 HG11 ' A' ' 77' ' ' VAL . 47.5 tp -135.58 110.95 9.07 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.623 -0.51 . . . . 62.229999999999997 109.623 167.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.11 110.75 15.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.068 -0.345 . . . . 71.099999999999994 110.068 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 15.7 mt -89.41 104.72 17.25 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.679 -0.86 . . . . 74.219999999999999 108.679 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.6 t -88.76 107.65 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.445 -0.946 . . . . 42.299999999999997 108.445 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.431 HG12 ' HG ' ' A' ' 18' ' ' LEU . 16.0 t -115.35 129.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.384 0.674 . . . . 41.439999999999998 111.116 -170.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -140.82 43.71 1.83 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.711 0.804 . . . . 71.209999999999994 110.489 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' HG ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -58.71 167.52 1.49 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.464 0.706 . . . . 73.430000000000007 112.55 170.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -59.77 -49.1 79.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.862 0.465 . . . . 75.450000000000003 111.145 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 46.0 66.0 1.82 Allowed Glycine 0 C--N 1.356 1.668 0 N-CA-C 115.544 0.978 . . . . 64.200000000000003 115.544 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.24 97.02 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.669 2.246 . . . . 74.329999999999998 112.682 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.0 -154.33 22.4 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 115.797 -0.638 . . . . 74.109999999999999 113.079 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.24 -179.82 41.42 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.584 -0.564 . . . . 62.229999999999997 113.039 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.9 156.72 97.63 Favored 'Cis proline' 0 C--N 1.376 1.99 0 CA-C-N 119.791 1.796 . . . . 74.209999999999994 113.99 -4.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t -96.87 130.23 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 C-N-CA 123.504 0.722 . . . . 73.340000000000003 109.534 173.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -104.31 147.39 27.56 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.073 0.949 . . . . 72.409999999999997 111.232 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -104.96 132.41 51.24 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.993 0.517 . . . . 74.150000000000006 111.106 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.5 m-85 -126.84 165.36 19.49 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.493 1.117 . . . . 72.140000000000001 110.387 176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -152.35 114.83 4.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.805 0.842 . . . . 73.230000000000004 110.05 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.0 t70 72.64 -27.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.653 1.581 . . . . 52.0 113.965 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 159.03 -11.17 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.138 0.399 . . . . 71.400000000000006 112.784 -172.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -129.45 138.47 51.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.256 0.623 . . . . 75.230000000000004 110.739 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.747 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.67 150.95 26.12 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.938 0.895 . . . . 71.409999999999997 112.692 177.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.08 134.28 34.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.879 0.472 . . . . 75.230000000000004 110.563 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.07 163.32 12.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.817 0.847 . . . . 70.340000000000003 110.383 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.5 p -68.74 89.38 0.39 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.601 0.715 . . . . 71.200000000000003 110.854 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 46.9 tt0 -99.1 164.79 12.02 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.42 1.088 . . . . 72.349999999999994 109.935 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.12 -40.09 90.92 Favored Glycine 0 CA--C 1.538 1.52 0 N-CA-C 113.52 0.168 . . . . 74.439999999999998 113.52 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -77.98 -54.34 6.4 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.157 0.583 . . . . 73.109999999999999 110.485 170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 66.9 t -82.46 86.77 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 124.086 0.954 . . . . 65.310000000000002 111.63 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 37.8 mt-30 -80.25 133.34 35.98 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.926 0.89 . . . . 74.319999999999993 110.822 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.7 mt -118.95 154.67 32.64 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.102 0.561 . . . . 70.540000000000006 112.131 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.624 ' HG3' HH12 ' A' ' 52' ' ' ARG . 39.8 mt-10 -126.46 113.83 17.36 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.235 1.014 . . . . 64.430000000000007 110.58 172.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -94.01 114.9 27.18 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.684 0.794 . . . . 65.340000000000003 110.691 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.88 -68.23 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.765 0.426 . . . . 71.310000000000002 111.596 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.59 139.08 6.02 Favored Glycine 0 N--CA 1.482 1.756 0 CA-C-O 119.19 -0.783 . . . . 44.130000000000003 111.38 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 64.15 -69.87 0.08 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.235 1.014 . . . . 55.030000000000001 110.488 -165.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -71.41 116.59 11.92 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.25 0.547 . . . . 64.430000000000007 110.286 166.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -134.13 133.79 41.47 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.075 1.35 . . . . 71.040000000000006 108.269 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.2 t -136.53 117.14 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 O-C-N 121.775 -0.578 . . . . 74.109999999999999 110.374 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -101.77 123.92 46.54 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.248 1.019 . . . . 73.219999999999999 109.136 172.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.624 HH12 ' HG3' ' A' ' 43' ' ' GLU . 1.5 mpp_? -116.19 108.02 15.61 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.184 0.594 . . . . 75.420000000000002 110.799 176.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.432 HG23 HD11 ' A' ' 51' ' ' LEU . 76.2 t -96.67 96.71 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 109.271 -0.64 . . . . 75.510000000000005 109.271 169.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.24 129.18 38.22 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.469 0.708 . . . . 71.310000000000002 110.987 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.47 40.34 33.09 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 121.151 0.306 . . . . 72.340000000000003 112.891 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 131.87 36.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.137 0.975 . . . . 42.450000000000003 112.265 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -156.75 -84.47 0.05 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.239 0.616 . . . . 73.239999999999995 110.768 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.1 t -92.45 121.9 34.37 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.623 0.769 . . . . 61.439999999999998 110.547 -173.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.3 -31.7 5.3 Favored Glycine 0 N--CA 1.476 1.351 0 CA-C-N 116.531 -0.304 . . . . 62.140000000000001 112.732 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.2 -29.21 60.26 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.088 0.955 . . . . 74.200000000000003 111.435 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.15 113.67 10.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.23 -0.655 . . . . 62.340000000000003 109.23 171.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.12 -170.22 43.32 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 123.123 0.264 . . . . 73.420000000000002 113.242 -175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -89.16 114.26 25.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.0 0.52 . . . . 74.400000000000006 111.126 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 46.5 m-85 -96.77 154.34 17.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.742 0.817 . . . . 73.129999999999995 109.797 171.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.4 tp -132.88 105.13 6.94 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.687 0.395 . . . . 64.310000000000002 110.759 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.73 87.93 6.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.226 -1.027 . . . . 51.350000000000001 108.226 169.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.74 95.24 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.796 -1.093 . . . . 64.120000000000005 110.907 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -100.99 145.67 30.81 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.466 0.706 . . . . 54.420000000000002 110.644 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.206 2.604 . . . . 75.329999999999998 113.19 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 61.09 35.02 18.88 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.51 1.124 . . . . 52.140000000000001 112.335 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 12.6 t70 -140.79 -83.06 0.23 Allowed 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 123.628 0.771 . . . . 70.140000000000001 109.726 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.9 m 56.73 103.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.701 1.371 . . . . 74.430000000000007 114.701 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -107.1 135.54 48.47 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.201 0.6 . . . . 75.140000000000001 111.815 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.39 138.95 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.114 0.965 . . . . 54.210000000000001 109.225 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.8 m-85 -115.91 104.1 11.27 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.586 1.155 . . . . 74.349999999999994 109.546 -174.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.594 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 73.9 mt -78.35 91.28 4.43 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.944 -1.132 . . . . 72.299999999999997 107.944 171.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.494 HG11 HD21 ' A' ' 12' ' ' LEU . 82.0 t -99.16 119.64 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 115.344 -0.844 . . . . 72.299999999999997 110.884 -175.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.4 p -112.94 108.07 16.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.828 0.851 . . . . 74.010000000000005 110.037 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.0 t -95.56 104.28 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.309 -0.997 . . . . 54.229999999999997 108.309 171.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -173.82 -165.43 0.25 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.516 1.126 . . . . 73.239999999999995 108.893 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 64.55 82.34 0.21 Allowed Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.674 0.79 . . . . 50.409999999999997 109.45 -177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 C--N 1.384 2.403 0 C-N-CA 123.359 2.706 . . . . 71.109999999999999 114.029 -171.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.645 -0.502 . . . . 55.039999999999999 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 33.3 m -83.23 106.86 15.35 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.911 0.484 . . . . 61.039999999999999 110.595 -172.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -112.44 145.24 40.52 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.781 0.832 . . . . 73.200000000000003 110.908 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.1 t -138.22 137.55 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 123.636 0.775 . . . . 72.239999999999995 110.68 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -113.55 138.84 49.57 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.387 0.675 . . . . 74.219999999999999 110.4 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.1 t -129.95 166.02 20.92 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.502 0.721 . . . . 73.120000000000005 110.575 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.2 p -83.28 148.83 56.92 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 123.237 0.615 . . . . 62.119999999999997 112.208 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -78.78 75.14 5.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.308 2.672 . . . . 73.420000000000002 113.206 -173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.77 -32.4 0.21 Allowed Glycine 0 C--N 1.342 0.861 0 CA-C-N 115.455 -0.793 . . . . 75.439999999999998 113.159 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.51 -138.1 3.9 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 113.885 0.314 . . . . 72.0 113.885 -174.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -115.51 140.08 49.48 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.028 0.531 . . . . 75.329999999999998 109.926 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD21 HG11 ' A' ' 77' ' ' VAL . 55.3 tp -85.74 99.87 11.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.201 0.6 . . . . 62.130000000000003 110.021 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -101.66 103.15 13.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.116 0.567 . . . . 71.430000000000007 110.279 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 51' ' ' LEU . 45.0 mt -96.1 102.72 14.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.303 0.641 . . . . 73.420000000000002 110.383 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.7 t -103.77 115.58 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.367 0.667 . . . . 71.140000000000001 109.711 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -99.35 138.05 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-O 121.022 0.439 . . . . 74.230000000000004 110.068 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -104.63 38.06 1.98 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.894 0.878 . . . . 74.5 109.973 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 73' ' ' ARG . 17.2 mt -53.73 -40.12 65.84 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.96 1.304 . . . . 60.240000000000002 112.334 173.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 t 62.75 19.99 11.8 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.358 1.063 . . . . 54.399999999999999 111.811 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.75 135.36 14.61 Favored Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.911 -0.939 . . . . 53.299999999999997 112.167 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.19 89.37 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.125 2.55 . . . . 72.150000000000006 114.017 -173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.9 -95.11 0.26 Allowed Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.639 -0.71 . . . . 50.229999999999997 113.853 173.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 69' ' ' PRO . . . 121.67 -89.48 0.43 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-O 119.155 -0.803 . . . . 74.049999999999997 113.082 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.66 145.13 82.23 Favored 'Cis proline' 0 C--N 1.379 2.183 0 CA-C-N 120.266 2.033 . . . . 73.120000000000005 113.859 4.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 68' ' ' ALA . 75.8 t -65.93 129.69 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.4 -0.818 . . . . 63.200000000000003 110.882 173.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.466 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 99.2 mtt180 -96.41 127.66 42.61 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.342 -0.614 . . . . 51.549999999999997 109.342 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -98.31 131.59 44.5 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.02 0.528 . . . . 72.439999999999998 110.014 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.722 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 84.2 m-85 -126.0 136.66 53.24 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.854 0.862 . . . . 65.409999999999997 109.809 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD3' ' CZ ' ' A' ' 64' ' ' TYR . 17.3 tptm -104.81 116.86 32.73 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.821 0.848 . . . . 74.340000000000003 108.994 171.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.5 t70 70.71 -59.51 0.53 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.773 1.629 . . . . 71.120000000000005 111.13 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 32' ' ' GLU . . . -164.79 -9.93 0.03 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 123.867 0.746 . . . . 61.219999999999999 112.355 172.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 31' ' ' GLY . 44.6 tt0 -106.2 135.26 47.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.716 0.807 . . . . 70.510000000000005 110.667 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.49 152.82 20.88 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.072 1.138 . . . . 75.209999999999994 114.072 -171.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -86.3 161.42 18.75 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.62 -0.718 . . . . 72.319999999999993 110.309 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.51 106.33 5.92 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.916 0.886 . . . . 54.420000000000002 109.637 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 p -63.91 99.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.655 0.782 . . . . 72.340000000000003 111.307 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -124.7 -65.04 1.06 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.468 0.707 . . . . 75.299999999999997 111.565 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.09 -64.9 0.01 OUTLIER Glycine 0 N--CA 1.478 1.438 0 N-CA-C 112.748 -0.141 . . . . 32.229999999999997 112.748 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -67.3 -58.97 3.83 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.979 -0.749 . . . . 72.219999999999999 108.979 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.9 t -72.91 124.04 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.713 -1.131 . . . . 74.329999999999998 110.47 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -135.34 113.83 11.62 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.223 1.009 . . . . 72.519999999999996 109.525 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.5 mt -97.53 108.25 20.93 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.6 0.76 . . . . 72.129999999999995 110.52 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 3.7 tm-20 -98.33 108.29 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.59 1.156 . . . . 54.340000000000003 109.474 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HG3' HE22 ' A' ' 49' ' ' GLN . 2.7 mp0 -99.5 102.22 13.7 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.532 0.733 . . . . 65.109999999999999 109.354 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.78 -29.63 17.5 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.232 0.613 . . . . 71.049999999999997 112.207 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 -42.41 1.6 Allowed Glycine 0 N--CA 1.482 1.708 0 C-N-CA 122.789 0.233 . . . . 25.030000000000001 112.528 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.17 -28.26 7.01 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.756 0.822 . . . . 74.340000000000003 110.192 170.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -105.92 141.3 37.56 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.279 1.032 . . . . 71.239999999999995 111.166 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.592 HE22 ' HG3' ' A' ' 44' ' ' GLN . 16.7 mm100 -125.2 128.34 48.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.778 0.831 . . . . 63.450000000000003 109.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 39.3 t -129.58 110.59 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 112.252 0.464 . . . . 52.509999999999998 112.252 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -93.98 112.81 24.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.084 -0.71 . . . . 73.530000000000001 109.084 168.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 67.4 mtp180 -106.52 119.59 39.68 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.216 0.606 . . . . 71.239999999999995 110.223 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 92.6 t -108.25 102.24 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.274 0.629 . . . . 72.450000000000003 109.492 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -74.9 131.93 41.08 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.231 0.613 . . . . 73.219999999999999 111.27 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.5 5.35 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 116.015 -0.538 . . . . 70.040000000000006 112.29 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.38 114.81 25.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.992 0.917 . . . . 65.010000000000005 112.242 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.23 -80.87 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.13 0.972 . . . . 73.310000000000002 112.262 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.2 p -101.22 -76.65 0.56 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.415 0.686 . . . . 53.200000000000003 112.439 -163.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 -6.29 58.29 Favored Glycine 0 C--N 1.356 1.689 0 N-CA-C 114.142 0.417 . . . . 64.140000000000001 114.142 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.38 -24.05 63.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.295 1.038 . . . . 73.340000000000003 111.322 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.617 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -73.49 128.4 35.39 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.667 0.787 . . . . 74.430000000000007 109.608 172.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.0 178.78 39.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.67 -0.3 . . . . 65.409999999999997 113.344 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -84.73 115.88 22.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.599 0.36 . . . . 61.229999999999997 110.478 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' CZ ' ' HD3' ' A' ' 29' ' ' LYS . 50.1 m-85 -102.08 123.19 45.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.132 0.492 . . . . 65.150000000000006 110.966 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 58.8 tp -94.12 100.71 12.76 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.748 0.819 . . . . 60.119999999999997 109.471 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 16' ' ' VAL . 46.2 t -90.34 88.08 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.622 0.725 . . . . 52.240000000000002 109.658 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 33.4 t70 -72.09 94.87 1.56 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.48 1.112 . . . . 75.450000000000003 111.485 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -76.46 163.11 68.13 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.543 1.137 . . . . 63.310000000000002 113.058 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.528 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 77.7 Cg_endo -75.22 -4.22 15.03 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.569 2.18 . . . . 74.140000000000001 113.892 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -117.63 -56.17 2.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.457 0.703 . . . . 74.049999999999997 110.972 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.21 119.56 5.53 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.346 0.659 . . . . 71.310000000000002 110.011 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.407 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 35.7 t -62.35 128.08 34.38 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.551 0.741 . . . . 74.209999999999994 111.924 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -107.37 147.15 30.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.48 0.712 . . . . 75.409999999999997 111.136 -177.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.82 146.96 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.225 0.61 . . . . 74.299999999999997 110.337 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.622 ' HB3' HG23 ' A' ' 77' ' ' VAL . 10.7 m-85 -107.47 139.03 42.61 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.841 1.256 . . . . 74.230000000000004 110.893 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.11 93.77 4.87 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.599 -1.259 . . . . 61.229999999999997 107.599 162.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 75' ' ' PHE . 78.8 t -101.02 132.2 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.688 -0.687 . . . . 54.240000000000002 111.356 -174.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 76.7 p -127.17 124.54 39.27 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.154 0.982 . . . . 71.340000000000003 108.987 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.617 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 39.5 t -104.43 105.2 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.012 -1.107 . . . . 62.100000000000001 108.012 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.93 -168.39 0.66 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.923 1.289 . . . . 72.120000000000005 109.618 -170.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 62.53 85.8 0.16 Allowed Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 123.849 0.86 . . . . 54.109999999999999 109.786 -174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.572 2.422 0 C-N-CA 123.131 2.554 . . . . 73.430000000000007 113.235 -174.769 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.463 ' SD ' HD11 ' A' ' 76' ' ' LEU . 62.9 mtt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.517 0.199 . . . . 75.239999999999995 110.591 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 m -102.58 88.46 3.25 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.908 0.883 . . . . 35.119999999999997 110.097 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.604 ' HG3' ' HB2' ' A' ' 76' ' ' LEU . 3.8 mpt_? -78.35 138.58 38.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 123.503 0.721 . . . . 54.329999999999998 111.966 -172.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 91.6 t -140.91 134.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 124.161 0.984 . . . . 64.239999999999995 109.663 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -90.68 145.28 24.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.098 0.559 . . . . 65.519999999999996 110.401 176.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB2' HD13 ' A' ' 12' ' ' LEU . 41.0 t -127.91 159.73 34.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.212 0.605 . . . . 74.439999999999998 111.848 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 81' ' ' GLU . 18.2 p -112.95 150.67 43.22 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 124.603 1.161 . . . . 54.530000000000001 111.529 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.43 98.49 1.16 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.272 2.648 . . . . 72.140000000000001 113.682 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.81 -14.33 22.02 Favored Glycine 0 N--CA 1.479 1.514 0 CA-C-N 116.006 -0.543 . . . . 42.009999999999998 114.245 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.53 -143.17 3.89 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 117.54 0.67 . . . . 74.120000000000005 113.764 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.08 127.0 37.29 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.153 0.581 . . . . 64.129999999999995 111.024 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.9 tp -77.64 123.6 26.86 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.45 0.7 . . . . 54.509999999999998 110.022 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -115.87 112.65 22.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.199 0.454 . . . . 73.0 109.891 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 51' ' ' LEU . 79.0 mt -91.75 101.64 14.24 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.409 -0.589 . . . . 65.120000000000005 109.409 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -91.59 108.03 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 108.842 -0.799 . . . . 74.140000000000001 108.842 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 18' ' ' LEU . 6.1 t -98.63 113.53 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.572 0.349 . . . . 61.409999999999997 110.863 -169.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -90.2 33.85 0.88 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 122.944 0.498 . . . . 71.109999999999999 111.672 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' H ' HG12 ' A' ' 16' ' ' VAL . 9.9 mt -51.07 155.93 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.327 1.051 . . . . 74.430000000000007 111.866 164.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 t -75.28 74.14 2.39 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.691 -0.855 . . . . 72.420000000000002 108.691 167.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.52 119.48 16.52 Favored Glycine 0 CA--C 1.541 1.696 0 CA-C-N 115.48 -0.782 . . . . 72.030000000000001 114.415 -171.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.6 29.97 0.51 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.818 2.346 . . . . 73.340000000000003 112.895 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.23 -59.42 4.9 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 122.876 0.274 . . . . 64.519999999999996 112.441 -174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.01 174.69 24.44 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.759 -0.467 . . . . 55.420000000000002 112.719 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.27 148.04 28.46 Favored 'Cis proline' 0 CA--C 1.559 1.736 0 CA-C-N 119.147 1.474 . . . . 72.349999999999994 113.571 -4.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' SG ' ' A' ' 66' ' ' CYS . 85.4 t -114.57 136.42 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.223 0.609 . . . . 62.299999999999997 109.695 174.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -98.25 128.17 44.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.75 0.82 . . . . 74.219999999999999 110.586 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.414 ' HB3' HD23 ' A' ' 34' ' ' LEU . 77.4 m95 -99.39 143.3 29.8 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.399 0.68 . . . . 74.230000000000004 110.76 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 93.3 m-85 -135.45 124.25 23.95 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.426 0.691 . . . . 72.019999999999996 110.725 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HE2' ' HA3' ' A' ' 62' ' ' GLY . 27.9 tptp -118.51 132.45 56.22 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.281 0.632 . . . . 73.200000000000003 109.431 172.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.3 26.09 15.97 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.816 0.846 . . . . 71.510000000000005 111.51 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.36 -2.06 86.36 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 114.941 0.737 . . . . 72.510000000000005 114.941 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -125.01 144.29 50.47 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.531 1.166 . . . . 72.400000000000006 111.367 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.68 152.66 43.7 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.053 1.131 . . . . 73.409999999999997 114.053 -172.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.444 ' HB3' HG11 ' A' ' 40' ' ' VAL . 3.9 mm? -88.85 162.02 16.39 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.837 0.855 . . . . 55.299999999999997 111.397 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.16 107.5 4.38 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.05 0.94 . . . . 13.34 110.164 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.7 p -66.42 91.94 0.19 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.692 0.797 . . . . 75.109999999999999 112.251 -176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -139.94 -73.3 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.267 0.627 . . . . 73.510000000000005 111.131 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -94.4 1.75 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 122.684 0.183 . . . . 41.520000000000003 113.141 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -70.18 -32.36 70.25 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.474 0.31 . . . . 63.340000000000003 111.495 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 34' ' ' LEU . 87.2 t -81.86 120.27 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.44 0.696 . . . . 65.420000000000002 110.493 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 72.6 mt-30 -126.16 97.1 4.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.044 0.938 . . . . 74.25 109.392 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.1 152.38 23.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.28 0.562 . . . . 55.039999999999999 112.024 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.77 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 2.0 tm-20 -138.54 106.45 5.68 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 107.774 -1.195 . . . . 71.140000000000001 107.774 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -100.34 102.75 14.07 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.533 0.333 . . . . 72.200000000000003 110.152 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.14 -179.37 3.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.791 0.836 . . . . 72.140000000000001 111.115 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.61 -72.82 0.65 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 116.356 -0.384 . . . . 33.200000000000003 113.318 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.6 19.97 12.62 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.728 0.811 . . . . 74.400000000000006 112.23 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -148.23 151.41 35.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.259 0.552 . . . . 73.040000000000006 112.182 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -124.1 155.45 38.36 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.143 0.977 . . . . 63.039999999999999 108.61 164.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.77 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 84.7 t -141.91 136.62 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.175 0.512 . . . . 73.510000000000005 110.432 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HD12 ' A' ' 14' ' ' LEU . 1.7 tm? -120.5 116.14 24.82 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.445 -0.946 . . . . 64.420000000000002 108.445 171.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 99.6 mtt180 -108.14 109.43 20.84 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.328 0.651 . . . . 62.240000000000002 111.349 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.3 t -88.42 98.08 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.985 0.514 . . . . 73.409999999999997 110.264 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.95 127.35 32.22 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.943 0.497 . . . . 62.340000000000003 109.974 168.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.77 33.69 15.21 Favored Glycine 0 N--CA 1.473 1.146 0 N-CA-C 112.675 -0.17 . . . . 23.530000000000001 112.675 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.71 110.87 2.95 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.763 0.825 . . . . 64.200000000000003 111.288 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -163.28 124.49 2.4 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.132 0.573 . . . . 65.150000000000006 109.95 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.539 ' H ' HG11 ' A' ' 79' ' ' VAL . 50.2 m 55.93 -82.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.305 1.442 . . . . 54.240000000000002 113.851 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.9 -7.24 55.41 Favored Glycine 0 C--N 1.363 2.043 0 N-CA-C 114.702 0.641 . . . . 74.019999999999996 114.702 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.69 -32.81 74.41 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.767 0.827 . . . . 71.430000000000007 111.618 170.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.679 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -67.82 100.68 0.96 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.213 0.605 . . . . 72.030000000000001 111.286 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA3' ' HE2' ' A' ' 29' ' ' LYS . . . -166.65 -174.07 35.59 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.679 -0.691 . . . . 62.109999999999999 113.059 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -93.49 113.02 25.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.506 0.722 . . . . 64.310000000000002 110.536 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.684 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 49.2 m-85 -101.17 111.89 24.22 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.393 0.677 . . . . 70.340000000000003 109.947 175.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 72' ' ' SER . 61.0 tp -92.1 100.6 13.2 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 122.869 0.468 . . . . 75.129999999999995 110.122 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.418 ' SG ' HG11 ' A' ' 25' ' ' VAL . 37.8 t -79.0 86.09 4.89 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.926 0.87 . . . . 73.409999999999997 108.74 170.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -94.13 115.69 28.01 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.423 -1.262 . . . . 73.540000000000006 112.229 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.04 154.48 55.66 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.776 0.83 . . . . 61.420000000000002 109.36 171.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.48 -19.32 17.31 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.616 2.211 . . . . 71.409999999999997 113.003 171.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -76.35 -72.83 0.31 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.879 0.872 . . . . 64.530000000000001 110.92 170.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -139.25 144.12 38.28 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.834 0.854 . . . . 63.340000000000003 111.4 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 65' ' ' LEU . 51.5 p -112.4 109.32 18.86 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.916 0.886 . . . . 44.399999999999999 110.382 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -105.98 127.77 53.37 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.07 0.948 . . . . 74.409999999999997 110.987 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.32 128.43 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.574 0.75 . . . . 55.409999999999997 110.179 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 4.1 m-85 -102.2 111.18 23.36 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.305 0.642 . . . . 61.439999999999998 110.15 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.604 ' HB2' ' HG3' ' A' ' 3' ' ' ARG . 78.9 mt -85.02 94.12 8.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 75.519999999999996 109.734 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.6 t -94.71 137.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.711 0.804 . . . . 74.019999999999996 110.639 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -137.17 111.26 8.35 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.141 0.576 . . . . 74.0 110.865 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.679 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 46.4 t -83.94 103.43 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 108.089 -1.078 . . . . 65.150000000000006 108.089 175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -167.94 33.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.848 0.832 . . . . 70.219999999999999 110.978 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' O ' HG22 ' A' ' 7' ' ' THR . 10.1 tp10 -130.91 92.87 32.66 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 115.17 -0.923 . . . . 52.450000000000003 109.131 178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo . . . . . 0 CA--C 1.571 2.342 0 C-N-CA 122.526 2.151 . . . . 53.119999999999997 113.197 -179.472 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.631 0.253 . . . . 73.439999999999998 111.004 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m -75.44 79.17 2.48 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.31 1.052 . . . . 61.240000000000002 109.746 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -92.55 131.63 37.51 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.512 -1.222 . . . . 73.329999999999998 111.971 -163.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.0 t -121.78 127.2 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.837 0.855 . . . . 72.420000000000002 110.694 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -93.2 142.89 26.8 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.729 0.812 . . . . 74.420000000000002 109.918 170.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.6 t -137.25 160.23 39.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.647 0.779 . . . . 60.310000000000002 110.968 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -96.16 148.46 34.55 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 123.686 0.795 . . . . 74.150000000000006 111.135 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 95.4 Cg_endo -72.9 128.36 13.14 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.131 2.554 . . . . 65.340000000000003 112.938 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.81 66.12 1.23 Allowed Glycine 0 C--N 1.357 1.748 0 CA-C-N 116.656 -0.247 . . . . 63.140000000000001 113.162 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.74 -115.73 0.38 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 113.439 0.136 . . . . 55.439999999999998 113.439 178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -144.67 131.47 20.17 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.054 0.941 . . . . 73.340000000000003 109.731 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 65.3 tp -96.65 101.63 13.27 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.031 0.532 . . . . 74.430000000000007 110.092 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -106.18 112.08 24.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.905 0.482 . . . . 74.25 110.302 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.42 HD12 HD12 ' A' ' 51' ' ' LEU . 41.6 mt -108.17 103.93 13.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.887 0.875 . . . . 64.120000000000005 109.584 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.589 HG13 ' HG3' ' A' ' 48' ' ' ARG . 74.4 t -91.31 134.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.5 0.72 . . . . 63.119999999999997 109.34 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 49' ' ' GLN . 39.6 t -99.09 141.01 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 121.292 0.568 . . . . 72.200000000000003 111.678 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.57 -34.85 5.71 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.851 0.86 . . . . 75.340000000000003 110.876 166.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 73' ' ' ARG . 6.8 mt 63.52 178.07 0.16 Allowed 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 123.857 0.863 . . . . 61.149999999999999 113.117 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.8 t -102.77 -24.72 13.7 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.992 -0.549 . . . . 74.439999999999998 110.144 164.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.54 103.38 0.83 Allowed Glycine 0 CA--C 1.543 1.819 0 CA-C-O 119.635 -0.536 . . . . 75.150000000000006 112.985 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.51 102.3 1.54 Allowed 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 122.798 2.332 . . . . 61.329999999999998 113.379 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.5 131.57 1.58 Allowed Glycine 0 C--N 1.351 1.405 0 C-N-CA 121.455 -0.402 . . . . 62.030000000000001 113.891 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.94 169.94 49.06 Favored Glycine 0 CA--C 1.547 2.087 0 CA-C-O 119.477 -0.624 . . . . 53.030000000000001 113.587 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.26 115.49 3.92 Favored 'Cis proline' 0 C--N 1.379 2.163 0 CA-C-N 120.079 1.939 . . . . 63.200000000000003 112.962 1.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.87 118.9 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 122.986 0.514 . . . . 74.239999999999995 109.967 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -99.96 146.54 26.57 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.522 0.729 . . . . 64.230000000000004 111.783 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.415 ' CD1' HD22 ' A' ' 42' ' ' LEU . 79.6 m95 -100.17 134.18 43.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.164 0.986 . . . . 74.010000000000005 110.844 175.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.593 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 41.6 m-85 -130.03 139.28 51.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.323 1.049 . . . . 74.430000000000007 109.007 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB3' HD21 ' A' ' 34' ' ' LEU . 25.1 tptp -116.55 127.05 54.17 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.566 0.621 . . . . 73.329999999999998 110.098 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 56.39 20.49 4.75 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.088 1.355 . . . . 70.239999999999995 113.57 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.53 4.42 32.4 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 115.095 0.798 . . . . 74.209999999999994 115.095 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -141.3 141.11 33.93 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 1.168 . . . . 74.349999999999994 111.594 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -57.71 151.77 16.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.456 1.28 . . . . 61.530000000000001 114.456 -171.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 29' ' ' LYS . 19.5 mt -103.34 157.33 17.1 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.753 0.821 . . . . 51.240000000000002 111.002 172.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.86 143.68 44.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.161 0.985 . . . . 72.420000000000002 110.197 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.8 p -80.09 73.21 6.91 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.178 0.591 . . . . 61.420000000000002 110.511 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -134.68 -92.65 0.31 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.759 0.652 . . . . 75.310000000000002 112.759 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.81 87.28 1.51 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-O 120.012 -0.326 . . . . 42.140000000000001 113.29 -169.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 69.88 -11.52 0.54 Allowed 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 124.947 1.299 . . . . 71.430000000000007 113.269 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.16 114.17 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.518 1.127 . . . . 64.049999999999997 108.933 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 45.6 mt-30 -113.18 132.25 55.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.476 1.11 . . . . 72.409999999999997 110.145 -173.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 27' ' ' TRP . 79.6 mt -119.03 92.14 3.73 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.721 0.408 . . . . 74.140000000000001 110.651 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 2.6 mp0 -82.06 98.7 8.77 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.434 0.694 . . . . 71.530000000000001 110.369 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.28 126.88 34.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.178 0.514 . . . . 72.219999999999999 111.777 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.81 13.34 2.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.559 0.744 . . . . 63.450000000000003 112.095 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.15 -77.68 0.87 Allowed Glycine 0 C--N 1.35 1.349 0 N-CA-C 112.49 -0.244 . . . . 73.420000000000002 112.49 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.07 -54.02 5.36 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.035 0.534 . . . . 70.5 110.145 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.589 ' HG3' HG13 ' A' ' 15' ' ' VAL . 48.3 ttp180 -82.84 90.45 6.93 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.603 0.716 . . . . 72.510000000000005 111.675 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 16' ' ' VAL . 9.8 mm100 -95.97 126.67 41.37 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.447 -0.946 . . . . 71.230000000000004 108.447 170.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 46.6 t -114.9 108.94 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 O-C-N 121.911 -0.493 . . . . 34.210000000000001 110.836 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.42 HD12 HD12 ' A' ' 14' ' ' LEU . 1.5 tm? -91.23 112.51 24.45 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.668 -0.864 . . . . 72.140000000000001 108.668 170.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 74.2 mtp180 -113.49 104.73 12.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 122.809 0.444 . . . . 74.420000000000002 110.988 173.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 51' ' ' LEU . 61.2 t -93.33 97.01 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 108.185 -1.043 . . . . 64.329999999999998 108.185 168.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.05 96.09 0.42 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.469 -0.787 . . . . 73.239999999999995 110.705 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.36 -60.1 0.19 Allowed Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.833 -1.076 . . . . 64.540000000000006 110.886 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . 45.5 69.69 0.43 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.404 1.481 . . . . 73.549999999999997 112.734 174.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.68 -56.24 0.08 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.158 0.429 . . . . 65.310000000000002 112.158 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -141.86 117.81 10.56 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.137 0.575 . . . . 74.340000000000003 110.986 -174.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.25 80.7 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 116.484 -0.326 . . . . 74.420000000000002 113.462 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.05 -31.87 39.42 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.341 1.056 . . . . 74.120000000000005 111.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.02 120.19 21.78 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.583 0.753 . . . . 53.329999999999998 109.784 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.08 -175.58 45.97 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.657 -0.306 . . . . 50.420000000000002 113.706 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.79 112.45 24.38 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.836 0.454 . . . . 63.5 110.159 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 59.4 m-85 -98.84 124.1 43.53 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.294 0.637 . . . . 75.120000000000005 111.717 174.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 46.5 tp -94.75 118.32 31.55 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.969 0.508 . . . . 65.5 110.683 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 38.3 t -92.63 88.95 6.49 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.157 0.983 . . . . 71.040000000000006 109.93 170.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.593 ' HB3' ' HE1' ' A' ' 28' ' ' TYR . 14.0 t70 -91.11 107.23 19.06 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.787 0.835 . . . . 63.43 111.44 -176.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.66 157.86 43.34 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.762 0.825 . . . . 42.310000000000002 111.038 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.02 -32.06 96.84 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 122.334 2.023 . . . . 75.340000000000003 111.979 170.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -106.0 101.85 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.259 1.024 . . . . 74.099999999999994 109.138 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.7 t70 71.42 143.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.709 1.203 . . . . 55.350000000000001 113.811 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 79.3 p -118.58 120.58 37.91 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.951 0.9 . . . . 72.25 108.97 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -109.62 149.32 29.86 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.183 0.593 . . . . 63.100000000000001 111.313 -174.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.5 mm -107.05 134.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 123.183 0.593 . . . . 74.129999999999995 110.581 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 6.5 m-85 -114.7 104.05 11.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.707 1.203 . . . . 61.210000000000001 109.903 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.09 112.39 20.18 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.799 -0.445 . . . . 74.230000000000004 109.799 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.5 t -106.65 131.09 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.059 0.543 . . . . 73.349999999999994 111.363 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.8 m -126.76 108.8 11.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.527 0.731 . . . . 73.439999999999998 110.322 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.16 107.4 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.336 0.655 . . . . 62.020000000000003 109.328 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.34 178.45 8.67 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.542 0.737 . . . . 55.130000000000003 111.479 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 61.39 79.78 0.27 Allowed Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 124.696 1.198 . . . . 75.120000000000005 111.213 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.573 2.452 0 C-N-CA 123.393 2.729 . . . . 74.099999999999994 114.291 -176.568 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.87 0.366 . . . . 65.230000000000004 111.44 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.0 m -75.55 86.41 2.64 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.333 1.053 . . . . 72.310000000000002 110.562 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 44.7 mtm180 -89.08 152.1 21.85 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.778 0.659 . . . . 74.0 112.778 -172.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.7 t -139.64 135.5 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 124.328 1.051 . . . . 72.439999999999998 110.34 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -94.36 145.95 24.4 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 122.992 0.517 . . . . 71.519999999999996 110.927 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.2 t -134.29 156.52 48.3 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.601 0.76 . . . . 72.219999999999999 110.762 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 p -84.62 147.01 48.09 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 123.144 0.577 . . . . 70.5 111.419 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.9 82.12 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.29 2.66 . . . . 72.239999999999995 113.298 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.3 7.38 4.45 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 114.521 -1.218 . . . . 63.240000000000002 112.543 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.94 26.38 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 114.724 0.649 . . . . 72.319999999999993 114.724 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.71 110.53 21.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.865 0.866 . . . . 74.209999999999994 110.456 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.9 tp -74.09 138.92 44.26 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.433 -0.58 . . . . 74.150000000000006 109.433 169.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -145.02 111.39 5.65 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.27 0.628 . . . . 74.530000000000001 109.957 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 46.0 mt -98.99 101.65 13.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.098 -0.705 . . . . 73.329999999999998 109.098 175.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.6 t -97.4 106.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 108.46 -0.941 . . . . 61.140000000000001 108.46 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 18.2 t -98.93 141.37 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.974 0.91 . . . . 64.319999999999993 111.324 -166.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -137.75 48.86 1.99 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.371 0.668 . . . . 73.299999999999997 109.89 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.491 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -57.04 174.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.075 1.139 . . . . 74.510000000000005 114.075 172.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -91.49 20.52 5.27 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.556 0.742 . . . . 64.109999999999999 112.408 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 121.36 19.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.905 -0.941 . . . . 72.030000000000001 112.888 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.89 21.99 0.63 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.472 2.781 . . . . 73.349999999999994 115.006 -170.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.51 -105.27 0.22 Allowed Glycine 0 C--N 1.35 1.353 0 O-C-N 122.416 -0.177 . . . . 44.039999999999999 113.157 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.96 -176.91 40.65 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.421 -0.655 . . . . 63.439999999999998 113.103 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.18 161.76 84.53 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 119.783 1.791 . . . . 62.350000000000001 112.771 -4.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.446 HG11 ' SG ' ' A' ' 66' ' ' CYS . 62.4 t -107.23 147.35 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.93 0.892 . . . . 73.430000000000007 110.293 -177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 94.6 mtt180 -97.83 164.79 12.24 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.726 0.81 . . . . 73.209999999999994 111.105 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -133.14 122.98 24.84 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.755 0.822 . . . . 75.349999999999994 111.101 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 95.2 m-85 -120.2 163.97 16.94 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.868 0.867 . . . . 74.519999999999996 110.908 175.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -152.3 119.98 6.09 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.953 0.901 . . . . 55.140000000000001 109.898 173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 62.65 21.07 12.48 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 124.557 1.143 . . . . 72.450000000000003 111.965 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.54 55.64 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 114.696 0.638 . . . . 75.329999999999998 114.696 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -128.78 128.79 44.67 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 117.865 0.832 . . . . 75.340000000000003 110.988 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -59.47 151.04 25.03 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.037 0.754 . . . . 74.329999999999998 113.037 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 57.3 mt -95.24 154.46 17.18 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.278 0.631 . . . . 55.240000000000002 110.536 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.04 146.82 28.56 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.491 0.716 . . . . 62.399999999999999 110.43 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 42' ' ' LEU . 45.3 p -74.46 85.03 2.0 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.252 0.621 . . . . 75.150000000000006 110.899 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -121.35 -175.94 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.968 0.907 . . . . 71.129999999999995 112.073 -177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.76 147.38 43.31 Favored Glycine 0 C--N 1.35 1.321 0 N-CA-C 110.905 -0.878 . . . . 34.439999999999998 110.905 164.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 74.7 -55.22 0.66 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.232 1.413 . . . . 74.040000000000006 111.843 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.06 89.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.141 0.976 . . . . 51.229999999999997 110.117 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -91.86 134.36 34.83 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.028 0.931 . . . . 62.450000000000003 111.657 -175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 51' ' ' LEU . 66.8 mt -114.25 130.98 56.65 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.936 0.494 . . . . 54.329999999999998 110.374 171.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -120.19 121.58 39.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.573 0.749 . . . . 72.019999999999996 110.146 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -108.06 102.05 11.25 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.532 0.682 . . . . 70.150000000000006 110.095 171.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.98 -56.09 2.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.226 0.61 . . . . 72.209999999999994 109.612 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.3 -90.47 0.1 Allowed Glycine 0 N--CA 1.475 1.242 0 N-CA-C 111.192 -0.763 . . . . 54.340000000000003 111.192 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.64 -42.0 82.97 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.37 0.668 . . . . 45.32 110.367 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.6 ttp180 -91.99 118.34 30.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.332 -0.849 . . . . 70.109999999999999 110.968 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -116.42 135.22 54.03 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.569 -0.9 . . . . 73.140000000000001 108.569 169.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 61.6 t -125.78 109.74 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-O 121.246 0.546 . . . . 63.299999999999997 111.932 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 HD23 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -101.11 121.96 42.74 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.246 1.018 . . . . 73.299999999999997 108.725 169.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -120.08 107.51 13.14 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.717 -0.475 . . . . 72.310000000000002 109.717 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.6 t -104.1 109.33 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 118.576 0.625 . . . . 54.299999999999997 110.017 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -83.62 145.78 28.64 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.526 0.73 . . . . 72.239999999999995 110.799 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.32 31.6 54.26 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 112.325 -0.31 . . . . 71.409999999999997 112.325 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.18 112.1 7.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.616 1.166 . . . . 35.240000000000002 111.763 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.26 -95.39 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 118.46 0.573 . . . . 64.439999999999998 112.534 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -83.43 -61.81 1.75 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 121.749 -0.595 . . . . 45.32 111.631 -168.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.68 -5.27 73.4 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 116.217 -0.447 . . . . 64.010000000000005 114.184 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.01 -35.26 43.05 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.387 0.675 . . . . 74.019999999999996 111.673 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.2 106.56 2.05 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.035 0.534 . . . . 62.310000000000002 111.149 -176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.71 -169.81 40.88 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.854 -0.612 . . . . 65.140000000000001 114.369 -175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.6 121.67 27.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.924 0.89 . . . . 75.150000000000006 111.062 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 48.2 m-85 -111.7 112.61 24.42 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.94 0.896 . . . . 71.430000000000007 110.174 173.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -93.21 101.25 13.52 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.752 -0.592 . . . . 73.400000000000006 111.027 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.446 ' SG ' HG11 ' A' ' 25' ' ' VAL . 37.8 t -82.2 89.82 6.54 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.908 0.883 . . . . 50.130000000000003 109.028 171.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 31.3 t70 -89.0 92.59 9.29 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.627 0.771 . . . . 61.409999999999997 112.261 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' ASP . . . -85.64 159.29 55.64 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 122.957 0.503 . . . . 53.32 111.752 177.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -45.61 101.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 123.615 2.877 . . . . 54.240000000000002 114.159 171.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 63.68 13.98 7.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.2 1.4 . . . . 65.209999999999994 114.025 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 24.3 t70 -147.19 81.1 1.53 Allowed 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.48 0.657 . . . . 71.129999999999995 111.045 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.538 ' HB2' HD11 ' A' ' 65' ' ' LEU . 88.1 p -78.99 148.52 32.53 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 116.331 -0.395 . . . . 72.010000000000005 110.803 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 126.83 29.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.948 0.499 . . . . 73.239999999999995 110.303 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.0 130.16 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.852 -0.425 . . . . 71.409999999999997 109.852 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.545 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 14.0 m-85 -109.26 102.94 11.83 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.336 1.054 . . . . 73.140000000000001 109.611 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 71.0 mt -81.48 92.15 6.43 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.212 -1.033 . . . . 60.219999999999999 108.212 174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.8 t -83.12 114.98 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.767 -0.651 . . . . 63.119999999999997 110.012 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -103.07 107.58 18.43 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.227 -0.657 . . . . 72.25 109.227 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 6' ' ' SER . 20.6 t -94.17 107.98 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 109.765 -0.457 . . . . 54.130000000000003 109.765 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.64 -172.2 3.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.107 0.963 . . . . 73.430000000000007 109.828 -174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 63.86 84.27 0.19 Allowed Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 123.965 0.906 . . . . 72.239999999999995 110.677 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--N 1.384 2.43 0 C-N-CA 123.247 2.631 . . . . 71.340000000000003 114.089 -175.033 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.528 ' SD ' HD11 ' A' ' 76' ' ' LEU . 65.7 mtt . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.545 0.212 . . . . 73.109999999999999 110.62 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 m -80.6 91.35 5.81 Favored 'General case' 0 CA--C 1.57 1.733 0 C-N-CA 124.875 1.27 . . . . 74.209999999999994 110.933 -171.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.651 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 32.6 mtt180 -82.05 139.43 34.47 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.37 1.248 . . . . 71.150000000000006 114.37 -170.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 76.9 t -141.8 135.83 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 124.926 1.29 . . . . 63.32 109.956 172.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -106.48 144.43 33.17 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.175 0.59 . . . . 73.219999999999999 110.36 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.464 ' HB3' HG22 ' A' ' 79' ' ' VAL . 37.3 t -135.14 161.92 33.97 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.419 0.688 . . . . 74.129999999999995 110.718 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -102.96 147.16 33.69 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 123.555 0.742 . . . . 72.519999999999996 111.696 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.44 107.95 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.584 2.856 . . . . 72.329999999999998 114.086 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.89 47.23 1.28 Allowed Glycine 0 C--N 1.355 1.622 0 C-N-CA 123.001 0.334 . . . . 73.010000000000005 113.593 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.45 -114.17 0.93 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 112.167 -0.373 . . . . 63.210000000000001 112.167 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.1 164.14 33.1 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.48 0.712 . . . . 63.409999999999997 110.478 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 62.4 tp -128.98 102.49 6.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.441 0.697 . . . . 65.219999999999999 109.613 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -110.11 104.63 13.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.101 0.56 . . . . 72.530000000000001 109.794 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.492 HD12 HD12 ' A' ' 51' ' ' LEU . 65.7 mt -90.43 101.94 14.67 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.529 -0.545 . . . . 74.540000000000006 109.529 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.73 119.7 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.129 -1.063 . . . . 72.040000000000006 108.129 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 18' ' ' LEU . 20.1 t -113.36 133.8 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.621 0.768 . . . . 65.430000000000007 111.075 -168.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -134.58 54.72 1.93 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.839 0.856 . . . . 75.030000000000001 109.351 166.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.9 OUTLIER -59.07 160.71 5.83 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.071 0.767 . . . . 71.109999999999999 113.071 170.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -77.87 -1.59 32.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.773 0.829 . . . . 54.210000000000001 112.281 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.92 -178.41 41.27 Favored Glycine 0 CA--C 1.545 1.942 0 CA-C-O 119.918 -0.379 . . . . 71.030000000000001 113.543 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.58 -37.98 3.68 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.842 2.361 . . . . 71.209999999999994 113.54 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.89 -130.19 8.15 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.75 -0.54 . . . . 42.109999999999999 111.75 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' ' N ' ' A' ' 25' ' ' VAL . . . -91.23 156.93 24.55 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.445 -0.642 . . . . 51.200000000000003 114.297 -174.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.76 106.2 0.82 Allowed 'Cis proline' 0 C--N 1.383 2.388 0 CA-C-N 119.548 1.674 . . . . 72.329999999999998 112.552 1.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' N ' ' HA2' ' A' ' 23' ' ' GLY . 0.3 OUTLIER -86.1 162.16 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 C-N-CA 123.029 0.532 . . . . 75.530000000000001 110.991 -174.407 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 67' ' ' ASP . 36.6 mmt180 -98.87 150.63 21.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.041 0.936 . . . . 74.25 110.105 171.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.39 145.33 51.14 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.376 1.07 . . . . 73.329999999999998 109.066 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.682 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 95.5 m-85 -135.72 124.3 23.64 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.098 0.559 . . . . 61.130000000000003 110.668 178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE3' ' HA3' ' A' ' 62' ' ' GLY . 21.1 tptm -122.19 131.79 54.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.313 0.645 . . . . 71.349999999999994 109.951 172.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 68.15 16.25 9.41 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.624 1.169 . . . . 75.25 111.627 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.43 15.95 61.23 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 113.609 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -136.31 135.93 39.33 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.569 0.747 . . . . 61.130000000000003 110.584 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.75 145.29 40.92 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.861 0.864 . . . . 54.420000000000002 113.111 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB3' HG11 ' A' ' 40' ' ' VAL . 53.6 mt -89.31 135.4 33.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.484 0.714 . . . . 73.219999999999999 110.428 174.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.44 158.97 15.98 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.783 0.833 . . . . 74.25 110.256 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 p -69.85 89.98 0.59 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.723 0.773 . . . . 63.020000000000003 110.212 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -112.76 166.02 11.76 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.424 1.09 . . . . 73.450000000000003 111.088 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.18 97.01 Favored Glycine 0 CA--C 1.541 1.659 0 N-CA-C 113.791 0.276 . . . . 72.420000000000002 113.791 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 54' ' ' GLN . 5.0 mpt_? -77.29 -37.73 52.17 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.675 0.39 . . . . 75.409999999999997 111.422 172.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 34' ' ' LEU . 53.9 t -102.69 82.39 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-O 121.637 0.732 . . . . 44.130000000000003 110.712 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 73.5 mt-30 -82.23 104.59 12.65 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.547 0.739 . . . . 64.219999999999999 111.378 -176.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -98.65 113.52 25.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.566 0.747 . . . . 65.109999999999999 112.4 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -91.81 132.46 36.41 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.567 0.747 . . . . 74.450000000000003 109.861 170.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.718 ' HA ' HE22 ' A' ' 49' ' ' GLN . 9.8 pt20 -125.28 109.35 12.71 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.764 0.826 . . . . 75.439999999999998 110.315 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.69 177.4 9.54 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.552 0.741 . . . . 73.239999999999995 111.925 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.02 113.25 5.08 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 119.416 -0.658 . . . . 71.549999999999997 112.769 175.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.26 -56.83 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 125.657 1.583 . . . . 63.520000000000003 113.593 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 44.7 ttp180 -83.18 111.92 19.37 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.182 0.438 . . . . 71.099999999999994 112.182 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.718 HE22 ' HA ' ' A' ' 44' ' ' GLN . 11.2 mm100 -101.97 147.21 26.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.674 0.79 . . . . 43.219999999999999 109.111 166.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -137.94 110.48 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.782 -0.573 . . . . 73.239999999999995 111.001 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 HD12 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -95.7 123.59 39.33 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.663 -0.866 . . . . 74.239999999999995 108.663 169.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.0 mtm180 -121.68 108.52 13.64 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.889 0.476 . . . . 75.400000000000006 111.403 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -91.47 120.87 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.328 0.651 . . . . 74.25 110.242 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.45 ' HB3' ' HG3' ' A' ' 39' ' ' ARG . 33.4 tt0 -75.35 122.58 23.97 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.46 0.704 . . . . 45.020000000000003 109.853 173.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.28 -78.5 0.38 Allowed Glycine 0 C--N 1.346 1.138 0 N-CA-C 112.357 -0.297 . . . . 43.420000000000002 112.357 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 56.13 80.31 0.15 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.521 1.129 . . . . 72.120000000000005 112.178 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -159.96 -68.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.9 0.48 . . . . 74.019999999999996 111.62 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.5 m -137.51 119.19 15.03 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.384 0.673 . . . . 73.549999999999997 110.227 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.79 -15.77 53.64 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 116.433 -0.349 . . . . 74.439999999999998 112.931 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.14 -20.6 51.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.525 1.13 . . . . 75.430000000000007 111.845 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.59 122.1 27.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.449 0.7 . . . . 60.229999999999997 109.948 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' HA3' ' HE3' ' A' ' 29' ' ' LYS . . . 168.45 -170.5 42.21 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 116.319 -0.4 . . . . 73.430000000000007 113.352 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -89.63 119.15 29.8 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.845 0.858 . . . . 75.219999999999999 110.266 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 62.0 m-85 -104.96 106.07 16.39 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.797 0.839 . . . . 63.210000000000001 109.667 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.1 tp -94.71 99.69 11.75 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.425 0.69 . . . . 62.100000000000001 110.489 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 49.1 t -81.77 93.19 6.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.335 0.654 . . . . 72.530000000000001 110.167 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 26' ' ' ARG . 28.2 t70 -97.04 132.54 42.75 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.592 0.757 . . . . 74.400000000000006 112.238 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.22 152.98 80.49 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.835 0.854 . . . . 71.25 109.317 173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.99 -21.2 33.04 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.286 2.657 . . . . 64.019999999999996 113.883 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -59.36 2.22 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.6 0.76 . . . . 65.120000000000005 110.132 174.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -143.72 149.94 37.9 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.05 0.54 . . . . 54.240000000000002 111.784 -171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.3 t -131.45 135.2 46.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.769 0.828 . . . . 74.120000000000005 111.041 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -113.5 134.75 54.5 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.899 0.88 . . . . 73.409999999999997 111.267 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.45 HG12 HD13 ' A' ' 65' ' ' LEU . 57.5 mt -89.17 123.11 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.1 -0.704 . . . . 70.120000000000005 109.1 170.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.516 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 5.0 m-85 -100.11 103.84 15.36 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.933 -0.395 . . . . 73.319999999999993 109.933 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.651 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 82.1 mt -78.1 92.53 4.41 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.949 -0.76 . . . . 73.25 108.949 175.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 87.5 t -101.49 113.11 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.112 -0.949 . . . . 71.430000000000007 110.1 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -110.4 107.78 17.6 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.25 0.547 . . . . 75.140000000000001 109.588 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 6' ' ' SER . 61.5 t -84.74 120.56 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.405 -0.961 . . . . 64.420000000000002 108.405 171.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -166.4 -177.71 4.16 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.63 0.772 . . . . 53.509999999999998 110.459 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 60.77 81.77 0.24 Allowed Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.937 0.895 . . . . 65.430000000000007 111.431 166.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo . . . . . 0 C--N 1.382 2.313 0 C-N-CA 123.133 2.555 . . . . 44.439999999999998 113.429 -177.189 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ttt . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.886 -0.413 . . . . 72.299999999999997 109.886 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.3 m -94.12 95.88 9.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.75 -0.833 . . . . 54.340000000000003 108.75 -174.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -122.79 148.97 44.75 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.51 0.724 . . . . 72.409999999999997 112.42 -169.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 88.9 t -138.93 138.72 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.874 0.87 . . . . 71.540000000000006 110.427 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -99.94 117.95 35.33 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.357 0.663 . . . . 73.549999999999997 110.029 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 t -94.49 161.6 14.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.634 0.774 . . . . 73.099999999999994 110.546 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.2 153.7 37.88 Favored Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 123.283 0.633 . . . . 73.450000000000003 111.387 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -56.24 99.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.533 2.822 . . . . 64.129999999999995 112.95 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.34 18.62 68.51 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-N 116.118 -0.492 . . . . 43.130000000000003 113.733 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.81 -10.45 69.67 Favored Glycine 0 N--CA 1.477 1.428 0 N-CA-C 114.485 0.554 . . . . 63.43 114.485 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 67.64 118.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.676 1.59 . . . . 71.299999999999997 112.263 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD11 HD21 ' A' ' 14' ' ' LEU . 42.7 tp -81.44 140.49 34.61 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.671 0.789 . . . . 72.030000000000001 111.678 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 15' ' ' VAL . 45.2 tt0 -142.22 100.8 3.79 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.69 0.796 . . . . 72.200000000000003 110.273 170.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 12' ' ' LEU . 54.0 mt -89.86 103.63 16.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.641 0.776 . . . . 75.319999999999993 109.916 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 ' HG2' ' A' ' 13' ' ' GLU . 61.4 t -104.79 110.21 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.646 0.778 . . . . 75.439999999999998 109.339 176.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG21 ' SG ' ' A' ' 66' ' ' CYS . 11.6 m -99.17 146.09 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.626 0.726 . . . . 53.119999999999997 111.05 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -122.38 29.42 6.97 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.864 -1.062 . . . . 73.5 109.234 165.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.501 HD21 ' SG ' ' A' ' 66' ' ' CYS . 0.9 OUTLIER -41.75 139.25 1.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.052 1.13 . . . . 53.5 114.052 176.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -94.66 31.46 1.79 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.462 0.705 . . . . 63.409999999999997 111.285 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.99 -176.3 45.82 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-N 116.258 -0.428 . . . . 54.350000000000001 113.064 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 175.75 10.89 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 75.430000000000007 113.53 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.83 132.92 46.76 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.877 -0.601 . . . . 63.340000000000003 112.936 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.02 -131.78 0.96 Allowed Glycine 0 CA--C 1.548 2.134 0 CA-C-O 119.146 -0.808 . . . . 61.420000000000002 114.872 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.1 124.29 5.19 Favored 'Cis proline' 0 C--N 1.386 2.514 0 CA-C-N 120.695 2.247 . . . . 71.120000000000005 113.641 -0.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.413 HG11 ' SG ' ' A' ' 66' ' ' CYS . 98.6 t -73.7 142.84 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 C-N-CA 123.394 0.677 . . . . 70.329999999999998 110.855 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -96.54 169.89 9.59 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.26 1.024 . . . . 73.019999999999996 111.199 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.503 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 81.6 m95 -131.52 125.96 33.7 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.958 0.903 . . . . 72.299999999999997 110.467 172.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.3 m-85 -116.93 163.16 16.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.353 1.061 . . . . 73.530000000000001 109.973 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 64' ' ' TYR . 1.9 tmtp? -159.48 128.21 5.15 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.303 0.641 . . . . 70.200000000000003 110.547 176.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.7 t70 61.52 23.29 13.59 Favored 'General case' 0 CA--C 1.566 1.585 0 C-N-CA 124.306 1.042 . . . . 75.540000000000006 111.631 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.6 -8.36 63.95 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 115.754 -0.657 . . . . 52.140000000000001 114.505 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -129.64 138.13 51.04 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.199 0.999 . . . . 73.430000000000007 111.46 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -58.35 146.61 33.97 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.754 0.822 . . . . 64.420000000000002 112.759 -177.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.565 ' HB3' HG11 ' A' ' 40' ' ' VAL . 38.6 mt -87.2 134.8 33.49 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 116.309 -0.405 . . . . 44.049999999999997 110.066 171.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.14 160.46 15.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.552 0.741 . . . . 74.030000000000001 110.775 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.2 p -72.47 83.7 1.1 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.705 0.764 . . . . 65.109999999999999 110.687 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.71 165.08 11.57 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.987 0.915 . . . . 63.420000000000002 110.378 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.28 -44.66 93.31 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 114.088 0.395 . . . . 73.019999999999996 114.088 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HG3' HG23 ' A' ' 40' ' ' VAL . 15.5 ptm180 -77.95 -37.74 46.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.002 0.521 . . . . 74.400000000000006 111.075 174.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 39' ' ' ARG . 59.7 t -94.34 83.08 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 C-N-CA 123.704 0.802 . . . . 63.109999999999999 110.387 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 34.0 mm-40 -81.46 106.09 13.14 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.608 0.763 . . . . 72.329999999999998 111.237 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.44 101.59 13.52 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.184 0.594 . . . . 72.5 110.86 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 32.0 tt0 -92.42 98.76 11.68 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.442 0.697 . . . . 73.150000000000006 109.842 175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.648 ' HG2' HE22 ' A' ' 49' ' ' GLN . 0.2 OUTLIER -87.27 102.06 14.13 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.215 -1.031 . . . . 74.129999999999995 108.215 173.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.07 -179.27 3.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.843 0.857 . . . . 74.409999999999997 110.922 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.26 89.31 0.07 OUTLIER Glycine 0 C--N 1.352 1.452 0 O-C-N 123.387 0.429 . . . . 74.310000000000002 112.819 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.39 -27.93 0.19 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 125.965 1.706 . . . . 73.409999999999997 113.36 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -85.3 104.54 15.23 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.441 0.696 . . . . 74.099999999999994 111.002 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.648 HE22 ' HG2' ' A' ' 44' ' ' GLN . 14.2 mm100 -98.5 112.16 24.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.097 0.559 . . . . 73.319999999999993 109.549 173.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 61.6 t -109.5 108.98 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.054 0.454 . . . . 64.120000000000005 110.836 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.21 117.53 30.24 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.641 -0.874 . . . . 73.209999999999994 108.641 170.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.545 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 44.7 mtm-85 -113.04 117.33 31.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.525 0.73 . . . . 64.409999999999997 109.891 174.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.06 100.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.31 0.576 . . . . 75.430000000000007 109.681 171.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -75.46 139.75 42.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.727 -0.67 . . . . 71.209999999999994 109.666 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.86 24.79 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 112.311 -0.316 . . . . 75.099999999999994 112.311 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.3 87.19 2.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.143 0.577 . . . . 72.099999999999994 111.189 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' O ' HG11 ' A' ' 79' ' ' VAL . 78.7 ttt180 -127.51 -82.86 0.6 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.229 0.612 . . . . 64.340000000000003 111.592 -174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 m -93.09 -70.66 0.69 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.172 0.589 . . . . 74.310000000000002 111.539 -173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.93 28.33 4.11 Favored Glycine 0 CA--C 1.543 1.784 0 N-CA-C 114.754 0.662 . . . . 55.43 114.754 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -93.44 -31.86 14.44 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.398 0.679 . . . . 73.299999999999997 110.812 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.13 107.43 2.31 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.804 0.842 . . . . 64.129999999999995 111.285 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.25 178.02 43.21 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 114.14 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.03 108.8 17.8 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.08 0.552 . . . . 71.540000000000006 110.14 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.664 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 19.5 m-85 -93.95 155.52 17.1 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.495 0.718 . . . . 74.340000000000003 109.898 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.709 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 44.2 tp -144.1 102.87 3.94 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.031 0.382 . . . . 60.409999999999997 112.031 -173.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.501 ' SG ' HD21 ' A' ' 18' ' ' LEU . 34.3 t -79.57 88.85 5.09 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 109.147 -0.686 . . . . 73.049999999999997 109.147 170.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -92.56 102.12 14.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.288 1.035 . . . . 64.109999999999999 112.786 -167.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.14 162.99 59.75 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.397 0.679 . . . . 64.219999999999999 110.51 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -69.73 31.9 0.19 Allowed 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.067 2.511 . . . . 74.430000000000007 115.104 174.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -172.39 -62.96 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.544 1.138 . . . . 73.299999999999997 109.065 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.67 176.35 6.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.705 0.802 . . . . 64.140000000000001 111.019 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 65' ' ' LEU . 85.5 p -165.64 134.89 3.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.406 0.682 . . . . 71.319999999999993 110.322 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -106.78 124.4 49.56 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.38 0.672 . . . . 43.439999999999998 110.351 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.55 HG13 HD13 ' A' ' 65' ' ' LEU . 3.2 mp -102.32 124.49 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.238 0.615 . . . . 64.439999999999998 110.073 -175.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 64.1 m-85 -101.17 126.38 47.87 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.344 1.058 . . . . 71.299999999999997 111.207 176.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.0 mt -93.52 93.36 8.05 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.747 -1.205 . . . . 74.349999999999994 107.747 161.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 63.2 t -85.34 106.32 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.273 -0.639 . . . . 63.340000000000003 109.273 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 82.1 p -103.51 117.25 34.0 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.439 -0.801 . . . . 63.420000000000002 110.027 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 57' ' ' ARG . 63.3 t -84.17 106.64 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.022 -0.732 . . . . 63.520000000000003 109.022 176.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 11.3 pt-20 -150.39 -166.94 2.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.336 1.054 . . . . 74.340000000000003 110.216 -174.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 40.1 mt-10 57.88 54.37 6.29 Favored Pre-proline 0 CA--C 1.571 1.765 0 C-N-CA 124.209 1.004 . . . . 73.540000000000006 112.121 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.385 2.455 0 C-N-CA 123.11 2.54 . . . . 71.430000000000007 112.466 -174.633 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 tpp . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 109.616 -0.513 . . . . 61.520000000000003 109.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 7.4 p -62.94 108.01 1.11 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.359 0.664 . . . . 71.230000000000004 111.363 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.79 120.28 38.76 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.485 -0.931 . . . . 64.030000000000001 108.485 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.498 ' HB ' HG22 ' A' ' 77' ' ' VAL . 98.8 t -122.24 140.94 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.706 0.802 . . . . 73.230000000000004 109.948 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.87 127.93 44.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.058 0.543 . . . . 70.140000000000001 109.54 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.5 m -122.34 162.33 21.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.245 0.618 . . . . 60.549999999999997 111.179 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.75 140.5 26.42 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.35 0.66 . . . . 75.230000000000004 111.939 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.84 119.33 6.01 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.103 2.535 . . . . 61.439999999999998 112.97 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.56 30.79 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 116.073 -0.512 . . . . 32.119999999999997 113.078 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.93 -131.22 3.98 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 117.094 0.447 . . . . 74.430000000000007 112.957 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -146.97 150.05 34.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.472 0.709 . . . . 73.450000000000003 110.837 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.454 HD11 HD21 ' A' ' 14' ' ' LEU . 64.3 tp -97.61 143.62 28.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.017 0.927 . . . . 54.219999999999999 110.283 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.56 113.38 6.76 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.284 0.633 . . . . 62.43 109.771 171.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.454 HD21 HD11 ' A' ' 12' ' ' LEU . 75.6 mt -107.21 103.18 12.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.988 0.915 . . . . 64.530000000000001 109.6 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.09 117.2 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 109.105 -0.702 . . . . 74.239999999999995 109.105 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.627 HG21 ' SG ' ' A' ' 66' ' ' CYS . 1.6 t -97.85 147.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.095 0.474 . . . . 74.109999999999999 110.493 -174.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -130.41 29.81 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.853 0.861 . . . . 71.439999999999998 110.09 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.453 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.1 pp -53.2 158.59 1.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.791 1.034 . . . . 71.230000000000004 113.791 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.4 m -95.05 23.53 5.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.414 -0.812 . . . . 71.329999999999998 111.214 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.73 119.14 8.83 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.14 -0.811 . . . . 51.399999999999999 112.79 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.93 104.99 0.89 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 123.29 2.66 . . . . 74.5 114.221 -176.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 -172.38 52.01 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 115.358 0.903 . . . . 70.530000000000001 115.358 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.14 176.29 18.39 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-O 119.318 -0.712 . . . . 34.200000000000003 112.99 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.36 119.97 5.52 Favored 'Cis proline' 0 C--N 1.377 2.038 0 CA-C-N 120.052 1.926 . . . . 64.109999999999999 113.962 1.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -82.54 115.72 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 109.088 -0.708 . . . . 53.32 109.088 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -98.33 137.09 37.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.646 0.778 . . . . 75.140000000000001 111.659 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -96.3 124.34 40.26 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.459 0.704 . . . . 74.349999999999994 110.629 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 86.9 m-85 -119.03 134.71 55.03 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.778 0.831 . . . . 74.140000000000001 110.486 176.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB3' HD21 ' A' ' 34' ' ' LEU . 26.4 tptp -119.46 128.12 53.7 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.053 0.541 . . . . 75.439999999999998 109.842 173.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 63.37 5.7 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.644 1.178 . . . . 53.240000000000002 113.858 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.97 -25.01 4.2 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.555 -0.58 . . . . 44.340000000000003 114.046 -177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -131.03 150.2 52.26 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.516 1.158 . . . . 41.350000000000001 112.33 -172.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -67.41 154.86 40.37 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.743 1.386 . . . . 72.519999999999996 114.743 -169.092 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' HB3' HG11 ' A' ' 40' ' ' VAL . 26.6 mt -102.55 162.29 13.04 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.805 1.242 . . . . 74.530000000000001 110.446 175.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.77 153.2 46.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.725 0.81 . . . . 64.340000000000003 110.533 178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -71.26 83.14 0.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.956 0.884 . . . . 54.539999999999999 110.955 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -111.36 -178.63 3.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.114 0.965 . . . . 75.340000000000003 110.765 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.61 97.59 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 114.089 0.395 . . . . 51.200000000000003 114.089 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -90.5 -14.87 31.84 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.44 0.696 . . . . 62.329999999999998 112.05 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 34' ' ' LEU . 54.3 t -124.74 81.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.42 0.688 . . . . 73.519999999999996 109.831 -177.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.628 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 41.4 mt-30 -85.11 125.66 32.97 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.263 0.625 . . . . 75.400000000000006 111.062 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD21 HD23 ' A' ' 51' ' ' LEU . 89.8 mt -118.48 96.86 5.47 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.538 0.735 . . . . 73.109999999999999 112.185 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.53 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 1.7 mp0 -85.86 96.63 9.84 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.88 -0.785 . . . . 73.329999999999998 108.88 165.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -111.21 113.85 26.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.725 0.81 . . . . 73.329999999999998 111.227 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.19 -157.95 0.85 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.413 1.085 . . . . 74.239999999999995 111.083 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.29 111.47 3.31 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 119.385 -0.675 . . . . 70.140000000000001 111.997 172.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 73.39 -52.6 0.7 Allowed 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 125.925 1.69 . . . . 65.140000000000001 112.716 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 30.0 ttt85 -66.75 101.21 0.78 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.708 0.803 . . . . 73.239999999999995 111.515 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' HG23 ' A' ' 16' ' ' VAL . 67.7 mm-40 -112.04 125.8 54.47 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.749 -0.834 . . . . 74.439999999999998 108.749 172.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 43' ' ' GLU . 51.5 t -117.96 110.53 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 122.705 0.402 . . . . 73.040000000000006 110.904 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.457 HD23 HD21 ' A' ' 42' ' ' LEU . 1.9 tm? -102.56 121.2 41.9 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.736 0.814 . . . . 71.439999999999998 109.452 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 68.3 mtp180 -120.68 109.15 14.87 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.08 0.552 . . . . 74.099999999999994 111.153 -176.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 61.6 t -92.61 114.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.244 0.545 . . . . 52.530000000000001 110.678 174.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -79.1 123.24 27.16 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.501 1.121 . . . . 71.5 110.351 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.92 42.88 23.97 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.736 -0.211 . . . . 74.099999999999994 113.394 -177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.78 112.83 4.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.275 0.63 . . . . 44.030000000000001 111.409 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -68.25 0.2 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.012 0.525 . . . . 72.239999999999995 111.256 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.4 t -95.49 -87.19 0.29 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.935 0.717 . . . . 72.349999999999994 112.935 -167.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.83 6.1 63.29 Favored Glycine 0 C--N 1.36 1.907 0 O-C-N 122.109 -0.37 . . . . 23.030000000000001 113.785 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB3' HG11 ' A' ' 53' ' ' VAL . 5.9 m-20 -84.2 -5.01 59.19 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.544 1.138 . . . . 72.010000000000005 110.995 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.15 128.17 36.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.035 0.934 . . . . 73.519999999999996 109.487 171.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.6 -173.34 41.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.238 -0.437 . . . . 73.120000000000005 112.915 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -85.27 126.74 33.94 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.058 0.543 . . . . 73.209999999999994 110.508 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 76.5 m-85 -112.85 110.2 20.14 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.93 0.892 . . . . 64.230000000000004 110.096 175.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.4 tp -91.97 102.26 14.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.221 0.608 . . . . 73.140000000000001 110.331 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.627 ' SG ' HG21 ' A' ' 16' ' ' VAL . 44.9 t -82.12 89.11 6.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.545 0.738 . . . . 73.200000000000003 109.378 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -96.39 94.12 7.24 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.019 1.328 . . . . 71.129999999999995 112.192 -168.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.64 158.66 82.82 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.437 1.095 . . . . 62.25 111.784 176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -47.76 -32.77 17.6 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.873 3.048 . . . . 70.420000000000002 115.239 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.29 49.02 1.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.262 0.553 . . . . 63.130000000000003 109.638 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -178.61 162.63 1.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.056 1.342 . . . . 71.319999999999993 109.564 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.7 p -160.36 121.01 2.95 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.169 0.44 . . . . 73.540000000000006 110.772 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -106.43 127.94 53.67 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.518 0.727 . . . . 75.530000000000001 110.36 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.62 121.51 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.044 -0.725 . . . . 73.340000000000003 109.044 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 32.0 m-85 -98.21 100.73 12.05 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.1 -0.704 . . . . 73.450000000000003 109.1 177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -77.7 91.78 4.08 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.176 -1.046 . . . . 54.350000000000001 108.176 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 4' ' ' VAL . 67.4 t -104.27 112.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 115.194 -0.912 . . . . 71.329999999999998 110.482 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 p -111.12 110.52 21.08 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.137 0.575 . . . . 63.149999999999999 109.455 172.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.42 104.05 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.907 -1.145 . . . . 72.209999999999994 107.907 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -154.97 179.12 9.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.716 0.807 . . . . 63.539999999999999 110.7 -170.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 61.71 90.63 0.09 OUTLIER Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 124.132 0.973 . . . . 74.120000000000005 110.974 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 C--N 1.383 2.343 0 C-N-CA 123.154 2.569 . . . . 75.319999999999993 113.891 -171.265 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 ttm . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 110.38 -0.23 . . . . 40.329999999999998 110.38 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 p -65.17 105.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.864 0.466 . . . . 71.200000000000003 111.26 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -107.58 109.74 21.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.366 1.067 . . . . 65.120000000000005 110.671 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 86.8 t -122.95 118.08 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.589 . . . . 61.43 110.863 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.5 134.86 33.91 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.856 -0.424 . . . . 73.409999999999997 109.856 173.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.802 ' HB3' HG22 ' A' ' 79' ' ' VAL . 47.7 t -112.23 157.11 21.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.928 0.491 . . . . 74.319999999999993 110.237 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 p -83.46 146.03 49.48 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.289 0.635 . . . . 74.109999999999999 111.559 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.02 105.86 0.72 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.145 2.563 . . . . 73.010000000000005 113.502 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.65 15.8 56.06 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 115.404 -0.816 . . . . 41.030000000000001 113.346 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.96 -167.75 30.59 Favored Glycine 0 N--CA 1.477 1.403 0 N-CA-C 112.558 -0.217 . . . . 64.120000000000005 112.558 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -107.01 119.75 40.22 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 122.099 -0.648 . . . . 63.200000000000003 111.198 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 6' ' ' SER . 58.9 tp -75.82 147.78 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.999 0.92 . . . . 72.310000000000002 110.453 174.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -145.0 116.42 8.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.027 0.531 . . . . 73.230000000000004 109.583 169.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 77.4 mt -102.08 101.23 11.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.354 0.662 . . . . 53.0 109.374 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.18 113.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.476 -0.935 . . . . 71.519999999999996 108.476 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 18' ' ' LEU . 3.5 t -108.34 137.71 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.906 0.882 . . . . 71.030000000000001 110.536 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -134.48 51.27 2.12 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.437 0.637 . . . . 74.239999999999995 109.35 169.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -54.57 159.88 1.98 Allowed 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.53 -0.759 . . . . 71.099999999999994 112.598 166.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.1 m -82.39 41.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.782 0.833 . . . . 34.439999999999998 111.496 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.17 85.72 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.528 -0.595 . . . . 72.120000000000005 112.564 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.38 151.59 26.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.8 2.334 . . . . 54.0 113.021 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.22 -90.02 0.7 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 116.211 -0.45 . . . . 45.340000000000003 112.384 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.01 -114.36 4.01 Favored Glycine 0 CA--C 1.546 1.997 0 CA-C-O 118.729 -1.039 . . . . 74.230000000000004 113.792 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -72.57 158.03 97.87 Favored 'Cis proline' 0 C--N 1.383 2.386 0 CA-C-N 120.999 2.399 . . . . 72.420000000000002 113.532 -0.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.49 HG11 ' SG ' ' A' ' 66' ' ' CYS . 32.2 t -90.29 129.11 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.033 0.533 . . . . 71.200000000000003 110.7 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -98.12 132.2 43.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.583 0.753 . . . . 75.129999999999995 110.778 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.494 ' HE1' ' HB3' ' A' ' 49' ' ' GLN . 70.3 m95 -97.74 118.24 33.82 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.649 0.379 . . . . 74.319999999999993 111.869 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.711 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 90.8 m-85 -112.29 147.98 35.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.315 1.046 . . . . 65.120000000000005 109.468 172.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' NZ ' ' HA ' ' A' ' 60' ' ' ASP . 15.6 tptm -128.31 113.11 15.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.156 0.503 . . . . 65.530000000000001 110.288 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.07 13.26 2.81 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 125.912 1.685 . . . . 54.530000000000001 113.281 168.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.1 -39.34 0.67 Allowed Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.499 -0.611 . . . . 71.209999999999994 113.234 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -154.07 156.5 37.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.071 0.936 . . . . 74.230000000000004 112.773 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.711 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.2 OUTLIER -60.62 152.68 25.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.953 1.834 . . . . 74.340000000000003 115.953 -166.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.3 mt -95.56 161.59 13.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.307 -0.861 . . . . 64.319999999999993 111.197 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.86 134.59 49.41 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.942 0.897 . . . . 62.420000000000002 109.782 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.7 p -68.16 89.07 0.31 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.37 0.668 . . . . 72.219999999999999 111.72 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -134.84 98.55 4.06 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.835 0.854 . . . . 51.329999999999998 111.163 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 -89.31 0.07 OUTLIER Glycine 0 C--N 1.357 1.726 0 O-C-N 123.841 0.713 . . . . 73.519999999999996 114.517 172.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -70.04 -38.51 75.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.676 0.79 . . . . 75.450000000000003 111.299 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ARG . 59.7 t -89.65 121.88 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.356 0.663 . . . . 63.119999999999997 109.365 174.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.0 mt-30 -129.54 121.35 27.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.401 0.68 . . . . 73.430000000000007 110.51 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.44 100.07 8.48 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.495 0.718 . . . . 64.129999999999995 111.092 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 6.0 tm-20 -93.36 125.83 38.17 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.218 -1.03 . . . . 62.43 108.218 168.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.35 103.15 7.49 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 121.414 0.626 . . . . 61.399999999999999 111.159 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 48' ' ' ARG . . . -100.81 -2.32 32.55 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.224 1.01 . . . . 72.019999999999996 112.101 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.52 -99.24 0.98 Allowed Glycine 0 C--N 1.35 1.311 0 N-CA-C 111.192 -0.763 . . . . 53.329999999999998 111.192 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.66 -33.02 73.28 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.935 0.494 . . . . 74.329999999999998 111.616 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 58.3 ttp180 -89.19 115.65 26.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.992 0.517 . . . . 53.420000000000002 110.091 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HB3' ' HE1' ' A' ' 27' ' ' TRP . 37.9 mm-40 -114.29 141.45 47.57 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.706 0.803 . . . . 75.439999999999998 109.532 171.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 94.2 t -131.38 110.94 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.129 0.571 . . . . 73.140000000000001 110.264 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -108.84 112.16 24.27 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.677 0.791 . . . . 75.510000000000005 109.464 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 42.3 mtt-85 -100.14 137.36 38.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.04 0.536 . . . . 61.210000000000001 111.218 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.4 t -126.98 100.01 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.552 0.741 . . . . 55.210000000000001 109.337 168.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -75.18 126.26 30.65 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.793 -0.447 . . . . 65.329999999999998 109.793 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.43 30.18 19.82 Favored Glycine 0 C--N 1.346 1.118 0 O-C-N 123.411 0.444 . . . . 34.119999999999997 113.062 -172.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.6 101.36 0.24 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.784 0.834 . . . . 61.520000000000003 111.519 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.11 -62.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.921 0.889 . . . . 63.409999999999997 109.795 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 m -54.66 -55.29 31.25 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.324 1.05 . . . . 55.530000000000001 113.721 -168.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -133.45 17.52 4.48 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 122.597 0.141 . . . . 70.340000000000003 112.912 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 13.8 m-20 -126.02 90.97 3.29 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.457 0.703 . . . . 61.229999999999997 110.947 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -165.61 65.09 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.476 1.11 . . . . 64.420000000000002 109.369 173.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.84 -153.5 6.43 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-N 115.535 -0.757 . . . . 72.329999999999998 113.29 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 128.31 34.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.92 0.488 . . . . 74.540000000000006 111.329 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 57.2 m-85 -115.27 107.66 15.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.073 0.949 . . . . 65.319999999999993 109.095 173.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.6 tp -92.0 100.15 12.85 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.364 0.602 . . . . 72.219999999999999 110.608 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.49 ' SG ' HG11 ' A' ' 25' ' ' VAL . 29.8 t -80.55 87.31 5.74 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.539 -0.911 . . . . 71.439999999999998 108.539 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.01 96.05 10.42 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.349 1.06 . . . . 74.310000000000002 112.527 -168.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' H ' ' HA ' ' A' ' 72' ' ' SER . . . -90.42 138.73 26.81 Favored Pre-proline 0 N--CA 1.483 1.177 0 C-N-CA 122.932 0.493 . . . . 53.310000000000002 111.408 176.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.84 -29.62 64.0 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 123.677 2.918 . . . . 71.400000000000006 113.943 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -75.35 -63.8 1.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.013 0.525 . . . . 74.150000000000006 110.003 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 24.8 t70 -153.71 127.67 8.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.748 0.419 . . . . 62.119999999999997 110.927 175.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.434 ' HA ' ' H ' ' A' ' 68' ' ' ALA . 31.2 t -72.65 177.6 4.64 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.222 1.009 . . . . 72.430000000000007 112.392 -178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.613 ' HE ' ' HA ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -154.99 127.18 7.74 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.536 0.735 . . . . 62.350000000000001 111.172 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.99 123.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.043 0.537 . . . . 75.439999999999998 109.685 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 36.8 m-85 -102.12 104.96 15.61 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.343 0.657 . . . . 74.439999999999998 111.419 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.3 mt -76.25 93.63 3.43 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.598 -0.889 . . . . 75.340000000000003 108.598 169.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' VAL . 84.1 t -99.36 114.51 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 122.898 0.479 . . . . 71.450000000000003 110.545 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.1 p -112.46 108.76 18.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.214 0.606 . . . . 61.509999999999998 110.135 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.802 HG22 ' HB3' ' A' ' 6' ' ' SER . 47.2 t -91.16 106.01 17.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.657 -0.868 . . . . 75.129999999999995 108.657 175.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -178.56 -27.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.314 0.646 . . . . 72.439999999999998 111.454 -171.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.5 101.64 0.29 Allowed Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.714 0.805 . . . . 74.340000000000003 109.992 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 CA--C 1.567 2.152 0 C-N-CA 122.883 2.389 . . . . 74.340000000000003 114.072 -165.223 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.618 0.247 . . . . 75.329999999999998 110.571 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m -75.57 90.8 2.78 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.747 0.819 . . . . 75.530000000000001 111.465 -171.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.34 135.25 33.8 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.542 0.737 . . . . 71.340000000000003 111.97 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.4 t -125.81 124.12 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.492 0.717 . . . . 73.0 110.948 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -90.25 142.06 28.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.173 0.589 . . . . 75.239999999999995 109.556 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.503 ' HB3' HG22 ' A' ' 79' ' ' VAL . 46.7 t -145.91 148.63 33.02 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.429 0.633 . . . . 74.219999999999999 112.021 -173.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 p -82.15 147.54 57.63 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 74.319999999999993 112.314 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -84.04 147.51 11.77 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.37 2.713 . . . . 71.420000000000002 112.716 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.12 -22.28 23.58 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 113.988 0.355 . . . . 54.219999999999999 113.988 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.05 -151.29 23.86 Favored Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.956 0.378 . . . . 71.200000000000003 113.32 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -112.93 127.0 56.09 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 117.26 0.53 . . . . 74.519999999999996 110.657 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 49.1 tp -75.8 128.65 35.61 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 109.155 -0.683 . . . . 55.020000000000003 109.155 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -129.13 105.34 8.11 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.923 -0.399 . . . . 65.230000000000004 109.923 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 50.1 mt -91.68 101.78 14.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.185 -0.672 . . . . 71.209999999999994 109.185 175.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.9 t -99.51 109.98 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 107.924 -1.139 . . . . 73.329999999999998 107.924 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.451 HG22 ' HZ ' ' A' ' 75' ' ' PHE . 2.8 t -98.37 135.86 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.781 0.324 . . . . 72.109999999999999 110.755 -168.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -116.66 32.75 5.96 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.849 0.859 . . . . 74.129999999999995 109.83 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.89 156.1 9.54 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 113.878 1.066 . . . . 75.329999999999998 113.878 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -82.71 5.68 20.5 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.184 0.994 . . . . 73.310000000000002 112.327 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.71 -175.35 23.38 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 114.422 0.529 . . . . 33.340000000000003 114.422 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.621 ' HD3' ' HB2' ' A' ' 70' ' ' GLN . 41.1 Cg_endo -83.66 179.6 4.77 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.486 2.791 . . . . 74.310000000000002 114.019 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.518 ' HA2' ' HA3' ' A' ' 46' ' ' GLY . . . -83.13 61.31 4.79 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-N 115.61 -0.723 . . . . 75.340000000000003 113.299 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 81.03 174.72 49.21 Favored Glycine 0 CA--C 1.543 1.814 0 N-CA-C 115.228 0.851 . . . . 75.140000000000001 115.228 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.52 99.77 0.28 Allowed 'Cis proline' 0 C--N 1.38 2.197 0 CA-C-N 118.893 1.346 . . . . 74.25 112.066 -6.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 49' ' ' GLN . 22.8 t -79.27 132.88 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.167 0.587 . . . . 62.329999999999998 110.819 -176.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -98.28 153.19 18.69 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.968 0.907 . . . . 74.420000000000002 111.608 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -109.88 134.03 52.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.637 0.775 . . . . 72.540000000000006 111.291 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.782 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 46.5 m-85 -128.12 161.31 29.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.167 0.987 . . . . 72.120000000000005 110.646 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -153.77 129.03 9.74 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.434 1.094 . . . . 71.129999999999995 109.604 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 63.81 22.95 13.25 Favored 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 123.945 0.898 . . . . 72.0 111.189 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.04 -4.62 81.49 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 115.395 -0.82 . . . . 63.420000000000002 114.342 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.1 128.8 49.82 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.983 0.913 . . . . 74.040000000000006 111.054 -176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.71 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -61.49 146.2 49.35 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.999 1.111 . . . . 73.409999999999997 113.999 -175.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.407 ' HB3' HG11 ' A' ' 40' ' ' VAL . 52.2 mt -91.98 154.74 18.6 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.97 -1.014 . . . . 61.229999999999997 110.817 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -121.0 159.2 26.12 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.209 1.003 . . . . 73.420000000000002 110.278 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.7 p -66.22 91.96 0.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.436 0.694 . . . . 72.310000000000002 110.789 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 36.4 tt0 -114.83 164.41 14.14 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 124.29 1.036 . . . . 51.5 110.204 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.8 -18.83 47.63 Favored Glycine 0 CA--C 1.544 1.897 0 N-CA-C 115.265 0.866 . . . . 43.140000000000001 115.265 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -121.6 4.81 10.09 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.404 0.602 . . . . 74.409999999999997 111.973 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 37' ' ' GLN . 70.5 t -127.59 86.27 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.244 1.017 . . . . 72.439999999999998 109.121 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 82.4 mt-30 -87.97 108.26 19.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.843 0.857 . . . . 72.239999999999995 111.158 -174.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 mt -98.21 141.57 30.96 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.079 0.551 . . . . 71.230000000000004 112.323 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -123.27 138.5 54.61 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.037 0.935 . . . . 73.219999999999999 110.234 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -118.03 108.79 15.67 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.433 0.693 . . . . 63.219999999999999 110.809 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.72 -48.98 1.25 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.872 0.869 . . . . 73.099999999999994 109.577 168.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.518 ' HA3' ' HA2' ' A' ' 22' ' ' GLY . . . 129.42 -75.01 0.43 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.577 -0.738 . . . . 72.329999999999998 112.149 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.23 -36.53 84.44 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.279 0.632 . . . . 65.420000000000002 111.015 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -111.64 109.63 19.62 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.336 0.654 . . . . 53.219999999999999 110.361 170.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.521 ' NE2' ' HB ' ' A' ' 25' ' ' VAL . 16.8 mm100 -107.28 135.38 48.88 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.47 0.708 . . . . 72.450000000000003 109.489 169.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 60.1 t -129.94 114.13 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 121.074 0.464 . . . . 65.439999999999998 111.647 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.08 120.48 42.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.802 1.241 . . . . 74.150000000000006 108.519 170.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 43.7 mtp180 -118.11 106.37 12.8 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.667 0.387 . . . . 72.430000000000007 110.783 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 60' ' ' ASP . 70.7 t -84.59 95.52 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 122.848 0.459 . . . . 74.319999999999993 110.089 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -75.13 107.33 7.15 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.488 0.715 . . . . 42.210000000000001 110.402 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.38 36.8 3.98 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 116.4 -0.363 . . . . 73.329999999999998 112.526 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.82 112.01 8.47 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.039 0.936 . . . . 75.120000000000005 112.011 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -167.96 -56.0 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.593 0.757 . . . . 73.200000000000003 112.101 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 m -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.119 0.967 . . . . 62.299999999999997 113.16 -167.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.88 26.38 1.46 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 111.235 -0.746 . . . . 75.040000000000006 111.235 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.534 ' HB3' HG11 ' A' ' 53' ' ' VAL . 6.0 m-20 -87.03 3.91 44.07 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.761 1.224 . . . . 72.310000000000002 111.903 -172.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.481 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -87.41 161.14 18.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 124.061 0.944 . . . . 74.230000000000004 109.603 166.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.56 -160.92 23.26 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 114.083 0.393 . . . . 53.409999999999997 114.083 174.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 37.2 mt-10 -93.9 118.16 31.09 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.224 0.61 . . . . 73.120000000000005 111.977 -172.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -105.18 152.86 22.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.226 1.01 . . . . 72.150000000000006 110.215 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.782 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 61.5 tp -128.98 101.93 6.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.788 0.435 . . . . 75.209999999999994 110.233 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.8 t -81.94 87.03 6.43 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 108.545 -0.909 . . . . 52.439999999999998 108.545 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.2 t70 -95.45 104.31 16.2 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.467 1.107 . . . . 75.109999999999999 111.918 -169.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.85 152.83 37.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.815 0.846 . . . . 71.530000000000001 110.878 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.43 -36.49 58.81 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.197 2.598 . . . . 72.540000000000006 114.925 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.621 ' HB2' ' HD3' ' A' ' 21' ' ' PRO . 82.0 mm-40 -90.3 -28.89 18.47 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.898 0.703 . . . . 70.230000000000004 112.898 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -157.35 128.76 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 112.176 0.436 . . . . 73.239999999999995 112.176 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.549 ' HB2' HD11 ' A' ' 65' ' ' LEU . 77.6 p -97.6 139.75 33.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.689 0.796 . . . . 73.450000000000003 110.529 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -123.83 123.43 40.45 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.739 0.416 . . . . 62.399999999999999 110.839 -174.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -97.04 144.14 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 122.882 0.473 . . . . 74.230000000000004 110.118 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' HZ ' HG22 ' A' ' 16' ' ' VAL . 5.8 m-85 -117.71 139.03 51.59 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.036 1.334 . . . . 74.25 110.155 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.7 94.89 5.26 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.381 -0.97 . . . . 73.420000000000002 108.381 164.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.07 139.04 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.181 0.592 . . . . 75.140000000000001 111.711 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.2 p -126.49 108.89 11.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.782 0.833 . . . . 64.310000000000002 110.468 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 6' ' ' SER . 21.6 t -109.04 104.11 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.187 -1.042 . . . . 74.409999999999997 108.187 172.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 81' ' ' GLU . 8.5 pt-20 179.03 -34.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.501 0.72 . . . . 63.210000000000001 111.246 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 37.7 mt-10 -75.17 106.37 2.78 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.943 0.897 . . . . 71.310000000000002 110.622 -174.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 81' ' ' GLU . 6.1 Cg_exo . . . . . 0 CA--C 1.569 2.239 0 C-N-CA 123.242 2.628 . . . . 74.430000000000007 113.58 -168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.684 0.278 . . . . 74.439999999999998 110.818 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.23 84.62 1.88 Allowed 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 124.406 1.082 . . . . 54.25 111.099 -172.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.66 ' HG2' ' HB2' ' A' ' 76' ' ' LEU . 64.8 mtt85 -76.37 141.14 41.59 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.545 0.738 . . . . 74.299999999999997 112.254 -174.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.416 HG21 HD22 ' A' ' 14' ' ' LEU . 78.9 t -130.03 131.24 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.647 0.779 . . . . 54.32 110.977 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -90.25 129.62 36.47 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.291 1.037 . . . . 71.430000000000007 109.855 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -139.16 158.88 43.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.818 0.847 . . . . 74.540000000000006 111.136 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 p -101.33 152.77 38.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 123.881 0.873 . . . . 73.209999999999994 111.63 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.2 Cg_endo -83.06 73.11 5.54 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.499 2.8 . . . . 55.030000000000001 113.622 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.99 60.23 0.01 OUTLIER Glycine 0 N--CA 1.474 1.169 0 CA-C-N 115.794 -0.639 . . . . 44.009999999999998 112.36 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.51 -176.26 39.81 Favored Glycine 0 N--CA 1.475 1.266 0 O-C-N 122.853 -0.204 . . . . 60.32 113.428 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.05 119.66 31.95 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 121.337 0.589 . . . . 75.450000000000003 110.681 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 61.4 tp -74.8 136.58 41.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.745 0.818 . . . . 75.400000000000006 109.568 174.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -134.5 107.95 7.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.953 0.501 . . . . 74.010000000000005 110.053 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.416 HD22 HG21 ' A' ' 4' ' ' VAL . 44.4 mt -92.78 104.18 16.46 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.45 0.7 . . . . 74.25 109.524 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -98.09 112.08 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.974 -0.75 . . . . 71.230000000000004 108.974 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.469 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t -100.64 126.66 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.738 0.415 . . . . 62.210000000000001 110.131 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -99.17 21.37 11.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.298 0.639 . . . . 72.439999999999998 111.483 174.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.442 ' H ' HG12 ' A' ' 16' ' ' VAL . 12.7 mt -49.25 138.16 13.0 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.616 0.766 . . . . 52.240000000000002 111.792 163.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.8 t -79.17 76.89 5.69 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.498 0.666 . . . . 42.509999999999998 110.11 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.82 85.2 0.39 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.985 -0.846 . . . . 53.509999999999998 110.985 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.37 -51.39 5.38 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 123.097 2.531 . . . . 72.019999999999996 113.71 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.69 96.52 0.28 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.347 -0.701 . . . . 63.240000000000002 111.347 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.68 -110.45 3.5 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 118.96 -0.911 . . . . 44.32 113.525 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.31 179.47 28.01 Favored 'Cis proline' 0 C--N 1.38 2.187 0 CA-C-N 120.382 2.091 . . . . 44.130000000000003 113.971 2.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG22 ' HA ' ' A' ' 68' ' ' ALA . 42.0 t -80.31 145.54 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 CA-C-N 115.461 -0.79 . . . . 70.200000000000003 110.441 171.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.5 128.05 43.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 74.109999999999999 109.09 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.403 ' CH2' ' SG ' ' A' ' 66' ' ' CYS . 92.4 m95 -100.37 137.08 39.28 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.554 0.742 . . . . 74.140000000000001 111.41 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 90.8 m-85 -131.61 119.99 22.22 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.014 0.525 . . . . 74.340000000000003 110.91 174.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -107.52 124.82 50.47 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.413 0.685 . . . . 65.150000000000006 109.686 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t70 65.73 12.48 8.33 Favored 'General case' 0 CA--C 1.568 1.65 0 C-N-CA 124.657 1.183 . . . . 73.140000000000001 110.896 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.09 -23.42 23.34 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 123.604 0.621 . . . . 73.030000000000001 113.673 -175.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -101.46 141.89 33.65 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.897 0.849 . . . . 63.509999999999998 111.277 -173.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.78 152.83 14.89 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.895 0.878 . . . . 71.030000000000001 113.238 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 40' ' ' VAL . 4.0 mm? -93.19 158.65 15.65 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.09 0.556 . . . . 73.319999999999993 110.326 171.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 128.96 43.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.663 0.785 . . . . 64.340000000000003 110.447 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.8 p -65.09 88.91 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.663 0.785 . . . . 74.439999999999998 111.283 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -126.25 -171.1 2.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.736 1.214 . . . . 70.200000000000003 110.503 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.4 -34.03 78.76 Favored Glycine 0 N--CA 1.48 1.627 0 O-C-N 123.017 0.198 . . . . 75.230000000000004 113.345 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -71.99 -60.89 2.0 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 75.230000000000004 110.507 173.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 34' ' ' LEU . 86.8 t -101.46 92.07 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.983 0.913 . . . . 60.240000000000002 110.977 -174.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -97.85 115.89 28.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.84 0.856 . . . . 53.219999999999999 111.402 -174.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.43 HD21 HD23 ' A' ' 51' ' ' LEU . 96.2 mt -94.64 133.61 38.11 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.173 0.589 . . . . 65.400000000000006 110.984 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -123.94 103.07 8.11 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.618 -0.882 . . . . 71.549999999999997 108.618 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -85.07 121.98 28.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.407 0.683 . . . . 74.319999999999993 111.637 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.73 169.02 16.24 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.587 0.755 . . . . 32.109999999999999 110.604 170.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.52 111.9 4.49 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.359 -0.689 . . . . 71.439999999999998 112.003 174.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 75.59 -54.29 0.63 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.503 1.521 . . . . 64.150000000000006 112.195 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.5 ttt-85 -67.94 112.57 5.03 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.673 0.789 . . . . 74.150000000000006 112.136 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -107.97 137.06 46.63 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.582 0.753 . . . . 73.329999999999998 109.068 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' GLU . 73.0 t -125.8 124.18 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 122.09 -0.381 . . . . 71.400000000000006 111.81 -177.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.43 HD23 HD21 ' A' ' 42' ' ' LEU . 2.3 tm? -113.25 115.43 28.18 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.729 1.212 . . . . 75.409999999999997 108.454 171.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 75.0 mtt180 -112.54 106.96 15.52 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 122.056 -0.402 . . . . 74.219999999999999 111.779 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.1 t -98.25 95.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 109.651 -0.499 . . . . 64.340000000000003 109.651 172.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -71.68 101.6 2.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.103 -0.702 . . . . 73.409999999999997 109.103 171.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.48 11.99 0.53 Allowed Glycine 0 N--CA 1.471 0.998 0 CA-C-O 119.258 -0.745 . . . . 63.450000000000003 113.1 -173.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . . . -62.02 100.27 0.16 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.738 0.815 . . . . 32.509999999999998 110.918 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 2.4 tmm_? -158.74 -48.31 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 O-C-N 123.382 0.426 . . . . 75.319999999999993 112.027 -170.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.3 m -113.16 -97.5 0.43 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 118.183 0.447 . . . . 71.140000000000001 111.894 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.95 21.9 13.9 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 117.917 0.326 . . . . 73.319999999999993 113.672 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.21 -14.7 55.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.373 1.069 . . . . 74.010000000000005 110.8 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.454 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -77.77 104.4 8.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.386 0.675 . . . . 61.030000000000001 109.502 170.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.67 -173.93 40.97 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.182 -0.463 . . . . 65.510000000000005 113.404 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -85.22 115.51 23.04 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.428 0.691 . . . . 63.109999999999999 111.082 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 45.4 m-85 -106.05 111.71 24.45 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.767 0.827 . . . . 63.219999999999999 109.706 172.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 57.5 tp -91.5 107.81 19.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.267 0.627 . . . . 75.310000000000002 110.371 -171.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.403 ' SG ' ' CH2' ' A' ' 27' ' ' TRP . 80.3 m -73.58 90.98 1.8 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.839 -0.801 . . . . 73.319999999999993 108.839 164.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -52.32 -47.06 66.2 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.354 1.062 . . . . 65.450000000000003 111.399 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.649 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . 67.37 132.8 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 114.602 1.334 . . . . 60.420000000000002 114.602 167.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -77.68 37.76 0.63 Allowed 'Trans proline' 0 CA--C 1.57 2.276 0 C-N-CA 123.277 2.652 . . . . 55.399999999999999 113.477 176.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -161.92 -60.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.548 0.739 . . . . 75.140000000000001 110.996 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.59 127.17 7.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.295 0.638 . . . . 75.219999999999999 110.547 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.3 p -73.94 138.09 44.02 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 113.551 0.945 . . . . 41.049999999999997 113.551 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -127.56 126.99 43.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.399 1.08 . . . . 71.540000000000006 111.005 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.27 142.01 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.755 0.422 . . . . 60.399999999999999 110.445 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 11.6 m-85 -101.74 109.76 21.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.204 1.002 . . . . 74.439999999999998 109.943 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.66 ' HB2' ' HG2' ' A' ' 3' ' ' ARG . 63.1 mt -86.19 91.7 8.53 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.648 -0.871 . . . . 62.539999999999999 108.648 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -89.5 124.03 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.66 -0.7 . . . . 72.450000000000003 110.658 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.3 m -108.37 107.07 17.49 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.834 0.853 . . . . 33.149999999999999 110.037 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.454 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 94.5 t -94.1 106.68 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 108.363 -0.977 . . . . 74.450000000000003 108.363 173.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -164.01 176.03 9.74 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.22 1.008 . . . . 65.319999999999993 110.658 -168.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.6 84.72 0.2 Allowed Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.112 0.965 . . . . 74.150000000000006 111.514 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo . . . . . 0 CA--C 1.567 2.138 0 C-N-CA 123.222 2.614 . . . . 71.439999999999998 114.121 178.052 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HB ' ' A' ' 74' ' ' ILE . 24.6 mmt . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.123 0.487 . . . . 64.219999999999999 111.069 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 p -92.9 140.96 28.95 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.392 1.077 . . . . 63.009999999999998 109.842 171.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -132.44 116.84 17.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.472 0.709 . . . . 74.319999999999993 110.342 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 97.2 t -129.98 147.49 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.765 0.826 . . . . 73.120000000000005 110.825 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -124.25 146.93 48.44 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.251 1.021 . . . . 74.239999999999995 112.226 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -141.09 163.54 32.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.314 1.046 . . . . 74.25 110.315 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 81' ' ' GLU . 1.1 p -93.66 145.39 29.83 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 123.31 0.644 . . . . 72.230000000000004 111.706 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 56' ' ' ALA . 73.1 Cg_endo -68.11 130.88 22.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.269 2.646 . . . . 74.120000000000005 113.231 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.81 -18.41 34.53 Favored Glycine 0 N--CA 1.474 1.219 0 CA-C-N 116.156 -0.474 . . . . 61.140000000000001 113.557 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.2 -127.56 5.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 117.202 0.501 . . . . 44.149999999999999 112.289 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.34 155.45 46.79 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.417 0.627 . . . . 71.109999999999999 111.389 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp -83.25 152.81 25.0 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.639 0.776 . . . . 71.299999999999997 109.86 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -144.23 108.09 4.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.975 0.51 . . . . 75.340000000000003 110.357 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 51' ' ' LEU . 65.3 mt -106.34 102.04 11.47 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.385 0.674 . . . . 64.450000000000003 110.054 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.4 t -96.53 125.52 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.044 -0.725 . . . . 72.549999999999997 109.044 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 2.8 t -112.75 142.66 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.48 0.712 . . . . 71.219999999999999 111.361 -170.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -138.1 45.63 2.1 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.092 0.957 . . . . 72.349999999999994 110.191 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.492 ' H ' HG12 ' A' ' 16' ' ' VAL . 1.7 pp -57.46 151.01 17.38 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.144 0.794 . . . . 51.340000000000003 113.144 170.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.6 m -91.68 3.62 54.65 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.694 0.798 . . . . 72.239999999999995 111.996 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.36 116.9 6.01 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 119.053 -0.86 . . . . 74.010000000000005 113.484 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.41 111.51 1.16 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.95 2.434 . . . . 71.319999999999993 112.363 173.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' A' ' 69' ' ' PRO . . . 177.25 138.26 2.93 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.304 -0.407 . . . . 24.539999999999999 112.691 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.78 112.61 0.55 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.956 -0.913 . . . . 54.240000000000002 112.057 -176.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.67 162.07 79.17 Favored 'Cis proline' 0 C--N 1.375 1.944 0 CA-C-N 120.192 1.996 . . . . 73.319999999999993 113.612 -3.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.482 HG23 ' HA2' ' A' ' 46' ' ' GLY . 89.5 t -86.9 151.25 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 CA-C-N 115.146 -0.934 . . . . 71.010000000000005 109.624 172.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -93.24 164.41 13.24 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.125 0.57 . . . . 74.25 110.56 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 78.9 m95 -133.03 127.88 35.06 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.85 0.86 . . . . 73.150000000000006 110.773 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 87.8 m-85 -131.28 126.15 34.65 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.222 1.009 . . . . 75.239999999999995 110.865 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB3' HD21 ' A' ' 34' ' ' LEU . 20.8 tptm -113.67 132.96 55.59 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.673 0.789 . . . . 73.219999999999999 108.994 169.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.24 22.27 13.26 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-O 122.294 1.045 . . . . 72.030000000000001 110.224 -171.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.71 -6.16 71.19 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.543 -0.753 . . . . 63.420000000000002 114.108 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -107.26 136.45 47.07 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.988 0.894 . . . . 73.209999999999994 111.15 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -59.89 147.97 36.62 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.344 0.868 . . . . 71.430000000000007 113.344 -173.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.58 HD21 ' HB3' ' A' ' 29' ' ' LYS . 41.6 mt -100.45 125.53 46.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.301 0.641 . . . . 72.219999999999999 110.238 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.46 139.12 32.41 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.752 0.821 . . . . 73.430000000000007 109.932 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 p -64.04 92.95 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.515 0.674 . . . . 71.129999999999995 111.11 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -111.88 -171.27 1.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.936 0.894 . . . . 54.340000000000003 111.834 -175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.29 -44.73 95.07 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.285 -0.416 . . . . 71.0 112.764 174.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 54' ' ' GLN . 84.3 mtt180 -73.61 -52.87 11.94 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.352 0.661 . . . . 61.520000000000003 111.133 172.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.571 HG11 ' HB3' ' A' ' 34' ' ' LEU . 67.5 t -79.48 95.19 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 123.322 0.649 . . . . 74.319999999999993 111.421 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 43.5 mt-30 -90.79 100.05 12.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.018 0.927 . . . . 75.230000000000004 109.996 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.63 133.05 41.62 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.139 0.575 . . . . 63.32 111.752 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' H ' ' A' ' 50' ' ' VAL . 52.4 mm-40 -107.71 130.42 54.94 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.223 1.009 . . . . 72.540000000000006 110.301 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -103.02 141.77 35.25 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.933 0.493 . . . . 75.299999999999997 110.883 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.52 -49.05 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.84 1.256 . . . . 74.129999999999995 109.457 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . 121.2 -72.17 0.37 Allowed Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.106 -0.952 . . . . 72.030000000000001 111.226 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -17.97 61.91 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.701 0.8 . . . . 70.140000000000001 112.19 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -135.06 107.96 7.56 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 110.34 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' HG3' ' HB ' ' A' ' 25' ' ' VAL . 13.8 mm100 -115.12 143.03 45.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.319 0.648 . . . . 74.450000000000003 109.402 174.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 58.6 t -133.42 114.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 117.984 0.356 . . . . 71.129999999999995 110.417 174.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 14' ' ' LEU . 1.1 tm? -104.98 117.14 33.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.753 0.821 . . . . 73.209999999999994 108.889 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 81.5 mtp180 -115.69 112.95 22.84 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.92 -0.582 . . . . 74.510000000000005 110.568 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.16 102.24 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 109.719 -0.474 . . . . 75.25 109.719 175.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 39' ' ' ARG . 0.6 OUTLIER -66.87 116.59 7.91 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.168 -0.679 . . . . 65.129999999999995 109.168 174.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.14 43.9 2.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.203 -0.453 . . . . 65.140000000000001 112.511 -173.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 8' ' ' PRO . . . -74.92 118.2 17.62 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.877 0.471 . . . . 62.329999999999998 110.107 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -158.34 112.44 2.5 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.863 0.465 . . . . 74.439999999999998 111.579 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m 53.38 -78.87 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.323 1.449 . . . . 74.230000000000004 114.413 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.33 -11.87 59.99 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 114.815 0.686 . . . . 74.400000000000006 114.815 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' HB3' HG21 ' A' ' 79' ' ' VAL . 17.7 t70 -66.26 -25.87 67.09 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.507 0.723 . . . . 70.299999999999997 111.132 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.725 ' HB2' ' H ' ' A' ' 79' ' ' VAL . . . -66.97 100.04 0.7 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.082 0.953 . . . . 64.549999999999997 110.689 176.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -164.23 -172.71 32.04 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.979 -0.555 . . . . 34.310000000000002 113.346 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -86.28 111.03 20.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.387 0.675 . . . . 65.340000000000003 110.824 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.783 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 44.1 m-85 -96.44 156.88 16.15 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.087 0.955 . . . . 45.200000000000003 109.442 169.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 52.7 tp -140.44 101.34 4.09 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.873 0.368 . . . . 70.209999999999994 110.824 -173.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 16.6 t -85.71 89.97 7.89 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.77 -0.826 . . . . 61.210000000000001 108.77 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -100.76 99.9 10.5 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.706 0.802 . . . . 74.150000000000006 112.664 -168.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.8 155.91 67.86 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.614 0.766 . . . . 73.540000000000006 110.068 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.522 ' HD2' ' HA3' ' A' ' 22' ' ' GLY . 50.3 Cg_exo -59.77 -2.43 1.56 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.273 2.649 . . . . 72.109999999999999 115.746 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -126.01 -43.63 1.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.696 0.798 . . . . 71.540000000000006 111.088 179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -133.46 149.04 51.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.033 0.533 . . . . 74.540000000000006 111.246 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.476 ' HB2' HD11 ' A' ' 65' ' ' LEU . 79.7 p -129.92 133.18 46.68 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.637 0.775 . . . . 73.239999999999995 110.871 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -106.77 125.22 50.72 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.273 0.629 . . . . 63.140000000000001 110.035 175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.451 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 2.2 mp -92.7 125.67 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.853 -0.795 . . . . 72.400000000000006 108.853 174.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.783 ' HB2' ' HB2' ' A' ' 64' ' ' TYR . 33.6 m-85 -98.15 101.95 13.56 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.437 0.695 . . . . 74.230000000000004 109.302 178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.6 mt -77.55 92.94 4.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.03 -1.1 . . . . 60.030000000000001 108.03 172.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.8 t -94.03 139.17 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.153 -0.93 . . . . 63.43 110.718 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.9 p -131.2 107.4 8.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.86 -0.609 . . . . 72.109999999999999 109.763 172.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.725 ' H ' ' HB2' ' A' ' 61' ' ' ALA . 57.4 t -90.11 107.34 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.594 -0.891 . . . . 74.439999999999998 108.594 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.79 179.71 7.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.995 0.918 . . . . 73.340000000000003 111.06 -167.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 7' ' ' THR . 12.5 tp10 64.21 87.97 0.12 Allowed Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 124.462 1.105 . . . . 73.409999999999997 110.584 -173.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo . . . . . 0 C--N 1.383 2.344 0 C-N-CA 124.493 3.462 . . . . 52.030000000000001 115.742 -174.86 . . . . . . . . 0 0 . 1 stop_ save_